No. Protein EnsemblID Cancer Name Design Control Cancer tissue/cell line Up/Down Ratio Pubmed 1 LASP1_HUMAN ENSP00000325240 Non-small cell lung carcinoma Metastasis non-metastatic CL1-0 lung cancer cell highly metastatic CL1-5 lung cancer cell cell line Down 17537172 2 PRDX1_HUMAN ENSP00000262746 Non-small cell lung carcinoma Metastasis non-metastatic CL1-0 lung cancer cell highly metastatic CL1-5 lung cancer cell cell line Down 17537172 3 PIR_HUMAN ENSP00000369786 Non-small cell lung carcinoma Metastasis non-metastatic CL1-0 lung cancer cell highly metastatic CL1-5 lung cancer cell cell line Down 17537172 4 PFD5_HUMAN ENSP00000334188 Non-small cell lung carcinoma Metastasis non-metastatic CL1-0 lung cancer cell highly metastatic CL1-5 lung cancer cell cell line Down 17537172 5 GRB2_HUMAN ENSP00000376347 Non-small cell lung carcinoma Metastasis non-metastatic CL1-0 lung cancer cell highly metastatic CL1-5 lung cancer cell cell line Down 17537172 6 HSPB1_HUMAN ENSP00000248553 Non-small cell lung carcinoma Metastasis non-metastatic CL1-0 lung cancer cell highly metastatic CL1-5 lung cancer cell cell line Down 17537172 7 ANXA1_HUMAN ENSP00000366109 Non-small cell lung carcinoma Metastasis non-metastatic CL1-0 lung cancer cell highly metastatic CL1-5 lung cancer cell cell line Down 17537172 8 PEBP1_HUMAN ENSP00000261313 Non-small cell lung carcinoma Metastasis non-metastatic CL1-0 lung cancer cell highly metastatic CL1-5 lung cancer cell cell line Down 17537172 9 GDIR1_HUMAN ENSP00000269321 Non-small cell lung carcinoma Metastasis non-metastatic CL1-0 lung cancer cell highly metastatic CL1-5 lung cancer cell cell line Up 17537172 10 HSP7C_HUMAN ENSP00000227378 Non-small cell lung carcinoma Metastasis non-metastatic CL1-0 lung cancer cell highly metastatic CL1-5 lung cancer cell cell line Up 17537172 11 S10AB_HUMAN ENSP00000271638 Non-small cell lung carcinoma Metastasis non-metastatic CL1-0 lung cancer cell highly metastatic CL1-5 lung cancer cell cell line Up 17537172 12 PDCD5_HUMAN ENSP00000221784 Non-small cell lung carcinoma Metastasis non-metastatic CL1-0 lung cancer cell highly metastatic CL1-5 lung cancer cell cell line Up 17537172 13 VIME_HUMAN ENSP00000224237 Non-small cell lung carcinoma Metastasis non-metastatic CL1-0 lung cancer cell highly metastatic CL1-5 lung cancer cell cell line Up 17537172 14 HMGB1_HUMAN ENSP00000382417 Non-small cell lung carcinoma Metastasis non-metastatic CL1-0 lung cancer cell highly metastatic CL1-5 lung cancer cell cell line Up 17537172 15 TPIS_HUMAN ENSP00000379933 Non-small cell lung carcinoma Metastasis non-metastatic CL1-0 lung cancer cell highly metastatic CL1-5 lung cancer cell cell line Up 17537172 16 ENOA_HUMAN ENSP00000234590 Non-small cell lung carcinoma Metastasis non-metastatic CL1-0 lung cancer cell highly metastatic CL1-5 lung cancer cell cell line Up 17537172 17 STMN1_HUMAN ENSP00000382633 Non-small cell lung carcinoma Metastasis non-metastatic CL1-0 lung cancer cell highly metastatic CL1-5 lung cancer cell cell line Up 17537172 18 K2C8_HUMAN ENSP00000293308 Non-small cell lung carcinoma Metastasis non-metastatic CL1-0 lung cancer cell highly metastatic CL1-5 lung cancer cell cell line Up 17537172 19 K1C18_HUMAN ENSP00000373489 Non-small cell lung carcinoma Metastasis non-metastatic CL1-0 lung cancer cell highly metastatic CL1-5 lung cancer cell cell line Up 17537172 20 ASSY_HUMAN ENSP00000361470 hepatitis C virus Normal vs. Cancer adjacent non-neoplastic liver tissues liver tumor tissue tissue Down 0.2 18715028 21 K1C18_HUMAN ENSP00000373489 hepatitis C virus Normal vs. Cancer adjacent non-neoplastic liver tissues liver tumor tissue tissue Down 0.2 18715028 22 K2C8_HUMAN ENSP00000293308 hepatitis C virus Normal vs. Cancer adjacent non-neoplastic liver tissues liver tumor tissue tissue Down 0.2 18715028 23 CATD_HUMAN ENSP00000236671 hepatitis C virus Normal vs. Cancer adjacent non-neoplastic liver tissues liver tumor tissue tissue Down 0.2 18715028 24 CP3A4_HUMAN ENSP00000337915 hepatitis C virus Normal vs. Cancer adjacent non-neoplastic liver tissues liver tumor tissue tissue Down 0.2 18715028 25 PEBP1_HUMAN ENSP00000261313 hepatitis C virus Normal vs. Cancer adjacent non-neoplastic liver tissues liver tumor tissue tissue Down 0.2 18715028 26 ACSL1_HUMAN ENSP00000281455 hepatitis C virus Normal vs. Cancer adjacent non-neoplastic liver tissues liver tumor tissue tissue Down 0.2 18715028 27 TAGL2_HUMAN ENSP00000357075 hepatitis C virus Normal vs. Cancer adjacent non-neoplastic liver tissues liver tumor tissue tissue Down 0.2 18715028 28 GNMT_HUMAN ENSP00000361894 hepatitis C virus Normal vs. Cancer adjacent non-neoplastic liver tissues liver tumor tissue tissue Down 0.2 18715028 29 G6PI_HUMAN ENSP00000348877 hepatitis C virus Normal vs. Cancer adjacent non-neoplastic liver tissues liver tumor tissue tissue Down 0.3 18715028 30 F16P1_HUMAN ENSP00000408025 hepatitis C virus Normal vs. Cancer adjacent non-neoplastic liver tissues liver tumor tissue tissue Down 0.3 18715028 31 ACOC_HUMAN ENSP00000369255 hepatitis C virus Normal vs. Cancer adjacent non-neoplastic liver tissues liver tumor tissue tissue Down 0.3 18715028 32 AMRP_HUMAN ENSP00000421922 hepatitis C virus Normal vs. Cancer adjacent non-neoplastic liver tissues liver tumor tissue tissue Down 0.3 18715028 33 TPIS_HUMAN ENSP00000379933 hepatitis C virus Normal vs. Cancer adjacent non-neoplastic liver tissues liver tumor tissue tissue Down 0.3 18715028 34 PARK7_HUMAN ENSP00000366708 hepatitis C virus Normal vs. Cancer adjacent non-neoplastic liver tissues liver tumor tissue tissue Down 0.3 18715028 35 CO1A1_HUMAN ENSP00000225964 hepatitis C virus Normal vs. Cancer adjacent non-neoplastic liver tissues liver tumor tissue tissue Down 0.4 18715028 36 APOB_HUMAN ENSP00000233242 hepatitis C virus Normal vs. Cancer adjacent non-neoplastic liver tissues liver tumor tissue tissue Down 0.4 18715028 37 PGM1_HUMAN ENSP00000360125 hepatitis C virus Normal vs. Cancer adjacent non-neoplastic liver tissues liver tumor tissue tissue Down 0.4 18715028 38 FAS_HUMAN ENSP00000304592 hepatitis C virus Normal vs. Cancer adjacent non-neoplastic liver tissues liver tumor tissue tissue Down 0.4 18715028 39 SPTB2_HUMAN ENSP00000349259 hepatitis C virus Normal vs. Cancer adjacent non-neoplastic liver tissues liver tumor tissue tissue Down 0.4 18715028 40 IPYR_HUMAN ENSP00000362329 hepatitis C virus Normal vs. Cancer adjacent non-neoplastic liver tissues liver tumor tissue tissue Down 0.4 18715028 41 CO3_HUMAN ENSP00000245907 hepatitis C virus Normal vs. Cancer adjacent non-neoplastic liver tissues liver tumor tissue tissue Up 3 18715028 42 MYLK_HUMAN ENSP00000353452 hepatitis C virus Normal vs. Cancer adjacent non-neoplastic liver tissues liver tumor tissue tissue Up 3.1 18715028 43 GNAI2_HUMAN ENSP00000312999 hepatitis C virus Normal vs. Cancer adjacent non-neoplastic liver tissues liver tumor tissue tissue Up 3.3 18715028 44 PGBM_HUMAN ENSP00000363827 hepatitis C virus Normal vs. Cancer adjacent non-neoplastic liver tissues liver tumor tissue tissue Up 3.3 18715028 45 FIBA_HUMAN ENSP00000306361 hepatitis C virus Normal vs. Cancer adjacent non-neoplastic liver tissues liver tumor tissue tissue Up 3.4 18715028 46 FINC_HUMAN ENSP00000352696 hepatitis C virus Normal vs. Cancer adjacent non-neoplastic liver tissues liver tumor tissue tissue Up 3.4 18715028 47 KAP0_HUMAN ENSP00000376474 hepatitis C virus Normal vs. Cancer adjacent non-neoplastic liver tissues liver tumor tissue tissue Up 3.4 18715028 48 NID1_HUMAN ENSP00000264187 hepatitis C virus Normal vs. Cancer adjacent non-neoplastic liver tissues liver tumor tissue tissue Up 3.7 18715028 49 PLMN_HUMAN ENSP00000308938 hepatitis C virus Normal vs. Cancer adjacent non-neoplastic liver tissues liver tumor tissue tissue Up 3.8 18715028 50 GBB2_HUMAN ENSP00000377501 hepatitis C virus Normal vs. Cancer adjacent non-neoplastic liver tissues liver tumor tissue tissue Up 3.8 18715028 51 DESM_HUMAN ENSP00000363071 hepatitis C virus Normal vs. Cancer adjacent non-neoplastic liver tissues liver tumor tissue tissue Up 3.9 18715028 52 APOA1_HUMAN ENSP00000236850 hepatitis C virus Normal vs. Cancer adjacent non-neoplastic liver tissues liver tumor tissue tissue Up 4 18715028 53 CAV1_HUMAN ENSP00000339191 hepatitis C virus Normal vs. Cancer adjacent non-neoplastic liver tissues liver tumor tissue tissue Up 4.2 18715028 54 APOA2_HUMAN ENSP00000356969 hepatitis C virus Normal vs. Cancer adjacent non-neoplastic liver tissues liver tumor tissue tissue Up 4.4 18715028 55 ALBU_HUMAN ENSP00000295897 hepatitis C virus Normal vs. Cancer adjacent non-neoplastic liver tissues liver tumor tissue tissue Up 4.5 18715028 56 VTNC_HUMAN ENSP00000226218 hepatitis C virus Normal vs. Cancer adjacent non-neoplastic liver tissues liver tumor tissue tissue Up 4.5 18715028 57 FINC_HUMAN ENSP00000352696 hepatitis C virus Normal vs. Cancer adjacent non-neoplastic liver tissues liver tumor tissue tissue Up 4.9 18715028 58 FHL1_HUMAN ENSP00000377710 hepatitis C virus Normal vs. Cancer adjacent non-neoplastic liver tissues liver tumor tissue tissue Up 9.6 18715028 59 S10A4_HUMAN ENSP00000357703 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-producing HepG2 liver cancer cells cell line Down 0.019 18646787 60 MOES_HUMAN ENSP00000353408 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-producing HepG2 liver cancer cells cell line Down 0.036 18646787 61 IF2A_HUMAN ENSP00000256383 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-producing HepG2 liver cancer cells cell line Down 0.063 18646787 62 VIME_HUMAN ENSP00000224237 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-producing HepG2 liver cancer cells cell line Down 0.077 18646787 63 TAGL2_HUMAN ENSP00000357075 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-producing HepG2 liver cancer cells cell line Down 0.083 18646787 64 CAN2_HUMAN ENSP00000295006 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-producing HepG2 liver cancer cells cell line Down 0.14 18646787 65 1433S_HUMAN ENSP00000340989 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-producing HepG2 liver cancer cells cell line Down 0.15 18646787 66 4F2_HUMAN ENSP00000367124 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-producing HepG2 liver cancer cells cell line Down 0.17 18646787 67 LEG3_HUMAN ENSP00000254301 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-producing HepG2 liver cancer cells cell line Down 0.17 18646787 68 SCAM3_HUMAN ENSP00000307275 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-producing HepG2 liver cancer cells cell line Down 0.24 18646787 69 VINC_HUMAN ENSP00000211998 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-producing HepG2 liver cancer cells cell line Down 0.29 18646787 70 TFR1_HUMAN ENSP00000376197 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-producing HepG2 liver cancer cells cell line Down 0.31 18646787 71 LMNA_HUMAN ENSP00000357283 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-producing HepG2 liver cancer cells cell line Down 0.32 18646787 72 PRDX5_HUMAN ENSP00000265462 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-producing HepG2 liver cancer cells cell line Down 0.35 18646787 73 ISG15_HUMAN ENSP00000368699 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-producing HepG2 liver cancer cells cell line Down 0.35 18646787 74 NSUN2_HUMAN ENSP00000264670 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-producing HepG2 liver cancer cells cell line Down 0.35 18646787 75 CDK3_HUMAN ENSP00000400088 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-producing HepG2 liver cancer cells cell line Down 0.36 18646787 76 SSRP1_HUMAN ENSP00000278412 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-producing HepG2 liver cancer cells cell line Down 0.36 18646787 77 PGM1_HUMAN ENSP00000360125 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-producing HepG2 liver cancer cells cell line Down 0.4 18646787 78 MCM7_HUMAN ENSP00000307288 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-producing HepG2 liver cancer cells cell line Down 0.41 18646787 79 CND1_HUMAN ENSP00000325017 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-producing HepG2 liver cancer cells cell line Down 0.42 18646787 80 HCD2_HUMAN ENSP00000168216 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-producing HepG2 liver cancer cells cell line Down 0.42 18646787 81 ACLY_HUMAN ENSP00000253792 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-producing HepG2 liver cancer cells cell line Down 0.43 18646787 82 HSPB1_HUMAN ENSP00000248553 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-producing HepG2 liver cancer cells cell line Down 0.45 18646787 83 IQGA1_HUMAN ENSP00000268182 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-producing HepG2 liver cancer cells cell line Down 0.47 18646787 84 RRAS_HUMAN ENSP00000246792 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-producing HepG2 liver cancer cells cell line Down 0.49 18646787 85 PYR1_HUMAN ENSP00000264705 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-producing HepG2 liver cancer cells cell line Down 0.5 18646787 86 HNRH3_HUMAN ENSP00000265866 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-producing HepG2 liver cancer cells cell line Up 2 18646787 87 VIGLN_HUMAN ENSP00000312042 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-producing HepG2 liver cancer cells cell line Up 2 18646787 88 PEBP1_HUMAN ENSP00000261313 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-producing HepG2 liver cancer cells cell line Up 2.1 18646787 89 TERA_HUMAN ENSP00000351777 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-producing HepG2 liver cancer cells cell line Up 2.1 18646787 90 LASP1_HUMAN ENSP00000325240 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-producing HepG2 liver cancer cells cell line Up 2.2 18646787 91 CLIC1_HUMAN ENSP00000379229 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-producing HepG2 liver cancer cells cell line Up 2.3 18646787 92 TGM2_HUMAN ENSP00000355330 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-producing HepG2 liver cancer cells cell line Up 2.3 18646787 93 DDX18_HUMAN ENSP00000263239 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-producing HepG2 liver cancer cells cell line Up 2.3 18646787 94 BAX_HUMAN ENSP00000263262 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-producing HepG2 liver cancer cells cell line Up 2.3 18646787 95 MATR3_HUMAN ENSP00000354346 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-producing HepG2 liver cancer cells cell line Up 2.4 18646787 96 ECHB_HUMAN ENSP00000325136 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-producing HepG2 liver cancer cells cell line Up 2.4 18646787 97 TBA1A_HUMAN ENSP00000301071 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-producing HepG2 liver cancer cells cell line Up 2.4 18646787 98 MPRI_HUMAN ENSP00000349437 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-producing HepG2 liver cancer cells cell line Up 2.8 18646787 99 IF6_HUMAN ENSP00000363574 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-producing HepG2 liver cancer cells cell line Up 3 18646787 100 ENPL_HUMAN ENSP00000299767 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-producing HepG2 liver cancer cells cell line Up 3.3 18646787 101 SODM_HUMAN ENSP00000337127 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-producing HepG2 liver cancer cells cell line Up 3.4 18646787 102 PHS_HUMAN ENSP00000299299 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-producing HepG2 liver cancer cells cell line Up 3.4 18646787 103 H2B1L_HUMAN ENSP00000366618 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-producing HepG2 liver cancer cells cell line Up 4.6 18646787 104 1433F_HUMAN ENSP00000248975 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-producing HepG2 liver cancer cells cell line Up 4.9 18646787 105 PRS7_HUMAN ENSP00000292644 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-producing HepG2 liver cancer cells cell line Up 5 18646787 106 H4_HUMAN ENSP00000376663 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-producing HepG2 liver cancer cells cell line Up 5.3 18646787 107 PYGB_HUMAN ENSP00000216962 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-producing HepG2 liver cancer cells cell line Up 5.4 18646787 108 HNRPC_HUMAN ENSP00000319690 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-producing HepG2 liver cancer cells cell line Up 5.5 18646787 109 DHPR_HUMAN ENSP00000281243 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-producing HepG2 liver cancer cells cell line Up 5.5 18646787 110 NOLC1_HUMAN ENSP00000359024 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-producing HepG2 liver cancer cells cell line Up 5.6 18646787 111 NHRF1_HUMAN ENSP00000262613 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-producing HepG2 liver cancer cells cell line Up 6.3 18646787 112 GTR1_HUMAN ENSP00000416293 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-producing HepG2 liver cancer cells cell line Up 7.5 18646787 113 ICAM1_HUMAN ENSP00000264832 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-producing HepG2 liver cancer cells cell line Up 7.7 18646787 114 CATD_HUMAN ENSP00000236671 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-producing HepG2 liver cancer cells cell line Up 7.9 18646787 115 ARI3A_HUMAN ENSP00000263620 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-producing HepG2 liver cancer cells cell line Up 9.8 18646787 116 COMT_HUMAN ENSP00000385150 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-producing HepG2 liver cancer cells cell line Up 11 18646787 117 CNN3_HUMAN ENSP00000359225 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-producing HepG2 liver cancer cells cell line Up 11 18646787 118 S10A4_HUMAN ENSP00000357703 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-deficient SK-HEP-1 liver cancer cells cell line Down 0.037 18646787 119 ISG15_HUMAN ENSP00000368699 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-deficient SK-HEP-1 liver cancer cells cell line Down 0.045 18646787 120 IF2A_HUMAN ENSP00000256383 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-deficient SK-HEP-1 liver cancer cells cell line Down 0.098 18646787 121 DESP_HUMAN ENSP00000369129 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-deficient SK-HEP-1 liver cancer cells cell line Down 0.1 18646787 122 LEG3_HUMAN ENSP00000254301 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-deficient SK-HEP-1 liver cancer cells cell line Down 0.11 18646787 123 PGM1_HUMAN ENSP00000360125 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-deficient SK-HEP-1 liver cancer cells cell line Down 0.15 18646787 124 K2C8_HUMAN ENSP00000293308 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-deficient SK-HEP-1 liver cancer cells cell line Down 0.16 18646787 125 BAG2_HUMAN ENSP00000359727 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-deficient SK-HEP-1 liver cancer cells cell line Down 0.19 18646787 126 1433S_HUMAN ENSP00000340989 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-deficient SK-HEP-1 liver cancer cells cell line Down 0.2 18646787 127 TFR1_HUMAN ENSP00000376197 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-deficient SK-HEP-1 liver cancer cells cell line Down 0.24 18646787 128 NSUN2_HUMAN ENSP00000264670 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-deficient SK-HEP-1 liver cancer cells cell line Down 0.25 18646787 129 PRDX1_HUMAN ENSP00000262746 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-deficient SK-HEP-1 liver cancer cells cell line Down 0.26 18646787 130 HSP71_HUMAN ENSP00000364801 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-deficient SK-HEP-1 liver cancer cells cell line Down 0.26 18646787 131 PPAC_HUMAN ENSP00000272065 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-deficient SK-HEP-1 liver cancer cells cell line Down 0.28 18646787 132 SCAM3_HUMAN ENSP00000307275 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-deficient SK-HEP-1 liver cancer cells cell line Down 0.29 18646787 133 ICAM1_HUMAN ENSP00000264832 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-deficient SK-HEP-1 liver cancer cells cell line Down 0.3 18646787 134 NUP53_HUMAN ENSP00000295119 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-deficient SK-HEP-1 liver cancer cells cell line Down 0.3 18646787 135 TCP4_HUMAN ENSP00000265073 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-deficient SK-HEP-1 liver cancer cells cell line Down 0.31 18646787 136 4F2_HUMAN ENSP00000367124 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-deficient SK-HEP-1 liver cancer cells cell line Down 0.31 18646787 137 CALD1_HUMAN ENSP00000354826 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-deficient SK-HEP-1 liver cancer cells cell line Down 0.32 18646787 138 HNRPQ_HUMAN ENSP00000358635 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-deficient SK-HEP-1 liver cancer cells cell line Down 0.33 18646787 139 PSPC1_HUMAN ENSP00000343966 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-deficient SK-HEP-1 liver cancer cells cell line Down 0.33 18646787 140 CDK3_HUMAN ENSP00000400088 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-deficient SK-HEP-1 liver cancer cells cell line Down 0.34 18646787 141 GTR1_HUMAN ENSP00000416293 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-deficient SK-HEP-1 liver cancer cells cell line Down 0.34 18646787 142 PRDX5_HUMAN ENSP00000265462 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-deficient SK-HEP-1 liver cancer cells cell line Down 0.34 18646787 143 SRC8_HUMAN ENSP00000301843 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-deficient SK-HEP-1 liver cancer cells cell line Down 0.35 18646787 144 CTND1_HUMAN ENSP00000382004 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-deficient SK-HEP-1 liver cancer cells cell line Down 0.37 18646787 145 MPRI_HUMAN ENSP00000349437 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-deficient SK-HEP-1 liver cancer cells cell line Down 0.38 18646787 146 BPNT1_HUMAN ENSP00000318852 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-deficient SK-HEP-1 liver cancer cells cell line Down 0.41 18646787 147 K1C18_HUMAN ENSP00000373489 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-deficient SK-HEP-1 liver cancer cells cell line Down 0.42 18646787 148 SSRP1_HUMAN ENSP00000278412 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-deficient SK-HEP-1 liver cancer cells cell line Down 0.44 18646787 149 MAP4_HUMAN ENSP00000353375 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-deficient SK-HEP-1 liver cancer cells cell line Down 0.44 18646787 150 HCD2_HUMAN ENSP00000168216 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-deficient SK-HEP-1 liver cancer cells cell line Down 0.45 18646787 151 DDX3X_HUMAN ENSP00000382840 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-deficient SK-HEP-1 liver cancer cells cell line Down 0.45 18646787 152 DDX5_HUMAN ENSP00000225792 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-deficient SK-HEP-1 liver cancer cells cell line Down 0.46 18646787 153 ACLY_HUMAN ENSP00000253792 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-deficient SK-HEP-1 liver cancer cells cell line Down 0.48 18646787 154 TAGL2_HUMAN ENSP00000357075 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-deficient SK-HEP-1 liver cancer cells cell line Down 0.48 18646787 155 2A5D_HUMAN ENSP00000377669 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-deficient SK-HEP-1 liver cancer cells cell line Down 0.49 18646787 156 CAN2_HUMAN ENSP00000295006 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-deficient SK-HEP-1 liver cancer cells cell line Up 2.1 18646787 157 MARCS_HUMAN ENSP00000357624 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-deficient SK-HEP-1 liver cancer cells cell line Up 2.3 18646787 158 ARI3A_HUMAN ENSP00000263620 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-deficient SK-HEP-1 liver cancer cells cell line Up 2.3 18646787 159 ERF1_HUMAN ENSP00000353741 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-deficient SK-HEP-1 liver cancer cells cell line Up 2.3 18646787 160 1433F_HUMAN ENSP00000248975 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-deficient SK-HEP-1 liver cancer cells cell line Up 2.4 18646787 161 CLIC1_HUMAN ENSP00000379229 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-deficient SK-HEP-1 liver cancer cells cell line Up 2.4 18646787 162 BAX_HUMAN ENSP00000263262 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-deficient SK-HEP-1 liver cancer cells cell line Up 2.4 18646787 163 MOES_HUMAN ENSP00000353408 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-deficient SK-HEP-1 liver cancer cells cell line Up 2.5 18646787 164 RS10_HUMAN ENSP00000347271 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-deficient SK-HEP-1 liver cancer cells cell line Up 2.5 18646787 165 TLN1_HUMAN ENSP00000316029 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-deficient SK-HEP-1 liver cancer cells cell line Up 2.6 18646787 166 HSPB1_HUMAN ENSP00000248553 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-deficient SK-HEP-1 liver cancer cells cell line Up 2.6 18646787 167 TBA4A_HUMAN ENSP00000248437 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-deficient SK-HEP-1 liver cancer cells cell line Up 2.7 18646787 168 IF6_HUMAN ENSP00000363574 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-deficient SK-HEP-1 liver cancer cells cell line Up 2.8 18646787 169 ACTN1_HUMAN ENSP00000193403 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-deficient SK-HEP-1 liver cancer cells cell line Up 2.8 18646787 170 PYGB_HUMAN ENSP00000216962 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-deficient SK-HEP-1 liver cancer cells cell line Up 2.9 18646787 171 COMT_HUMAN ENSP00000385150 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-deficient SK-HEP-1 liver cancer cells cell line Up 3 18646787 172 ML12B_HUMAN ENSP00000383037 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-deficient SK-HEP-1 liver cancer cells cell line Up 3.1 18646787 173 TBA1A_HUMAN ENSP00000301071 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-deficient SK-HEP-1 liver cancer cells cell line Up 3.5 18646787 174 FLNA_HUMAN ENSP00000358866 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-deficient SK-HEP-1 liver cancer cells cell line Up 4.1 18646787 175 RRAS_HUMAN ENSP00000246792 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-deficient SK-HEP-1 liver cancer cells cell line Up 5.5 18646787 176 MYH9_HUMAN ENSP00000216181 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-deficient SK-HEP-1 liver cancer cells cell line Up 7.4 18646787 177 VIME_HUMAN ENSP00000224237 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-deficient SK-HEP-1 liver cancer cells cell line Up 11 18646787 178 CNN3_HUMAN ENSP00000359225 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-deficient SK-HEP-1 liver cancer cells cell line Up 14 18646787 179 TGM2_HUMAN ENSP00000355330 Hepatocellular Carcinoma Normal vs. Cancer HL-7702 normal cells AFP-deficient SK-HEP-1 liver cancer cells cell line Up 35 18646787 180 ACSL1_HUMAN ENSP00000281455 hepatitis B virus Normal vs. Cancer adjacent paired non-HCC tissues hepatocellular carcinoma tissues tissue Down 0.05 14726492 181 FIBA_HUMAN ENSP00000306361 hepatitis B virus Normal vs. Cancer adjacent paired non-HCC tissues hepatocellular carcinoma tissues tissue Down 0.07 14726492 182 FINC_HUMAN ENSP00000352696 hepatitis B virus Normal vs. Cancer adjacent paired non-HCC tissues hepatocellular carcinoma tissues tissue Down 0.16 14726492 183 ASSY_HUMAN ENSP00000361470 hepatitis B virus Normal vs. Cancer adjacent paired non-HCC tissues hepatocellular carcinoma tissues tissue Down 0.27 14726492 184 HNRPQ_HUMAN ENSP00000358635 hepatitis B virus Normal vs. Cancer adjacent paired non-HCC tissues hepatocellular carcinoma tissues tissue Down 0.3 14726492 185 FINC_HUMAN ENSP00000352696 hepatitis B virus Normal vs. Cancer adjacent paired non-HCC tissues hepatocellular carcinoma tissues tissue Down 0.32 14726492 186 ALBU_HUMAN ENSP00000295897 hepatitis B virus Normal vs. Cancer adjacent paired non-HCC tissues hepatocellular carcinoma tissues tissue Down 0.34 14726492 187 PRDX1_HUMAN ENSP00000262746 hepatitis B virus Normal vs. Cancer adjacent paired non-HCC tissues hepatocellular carcinoma tissues tissue Down 0.35 14726492 188 HCD2_HUMAN ENSP00000168216 hepatitis B virus Normal vs. Cancer adjacent paired non-HCC tissues hepatocellular carcinoma tissues tissue Down 0.35 14726492 189 TIA1_HUMAN ENSP00000401371 hepatitis B virus Normal vs. Cancer adjacent paired non-HCC tissues hepatocellular carcinoma tissues tissue Down 0.36 14726492 190 CNBP_HUMAN ENSP00000410619 hepatitis B virus Normal vs. Cancer adjacent paired non-HCC tissues hepatocellular carcinoma tissues tissue Down 0.36 14726492 191 ARHG7_HUMAN ENSP00000364893 hepatitis B virus Normal vs. Cancer adjacent paired non-HCC tissues hepatocellular carcinoma tissues tissue Down 0.39 14726492 192 CP2C9_HUMAN ENSP00000260682 hepatitis B virus Normal vs. Cancer adjacent paired non-HCC tissues hepatocellular carcinoma tissues tissue Down 0.45 14726492 193 ACTB_HUMAN ENSP00000349960 hepatitis B virus Normal vs. Cancer adjacent paired non-HCC tissues hepatocellular carcinoma tissues tissue Down 0.47 14726492 194 LAMC1_HUMAN ENSP00000258341 hepatitis B virus Normal vs. Cancer adjacent paired non-HCC tissues hepatocellular carcinoma tissues tissue Up 2.8 14726492 195 HBA_HUMAN ENSP00000322421 hepatitis B virus Normal vs. Cancer adjacent paired non-HCC tissues hepatocellular carcinoma tissues tissue Up 3.4 14726492 196 HBB_HUMAN ENSP00000333994 hepatitis B virus Normal vs. Cancer adjacent paired non-HCC tissues hepatocellular carcinoma tissues tissue Up 4.3 14726492 197 NOCT_HUMAN ENSP00000280614 hepatitis B virus Normal vs. Cancer adjacent paired non-HCC tissues hepatocellular carcinoma tissues tissue Up 4.6 14726492 198 UBIP1_HUMAN ENSP00000283628 hepatitis B virus Normal vs. Cancer adjacent paired non-HCC tissues hepatocellular carcinoma tissues tissue Up 6.3 14726492 199 CAN1_HUMAN ENSP00000279247 hepatitis B virus Normal vs. Cancer adjacent paired non-HCC tissues hepatocellular carcinoma tissues tissue Up 18 14726492 200 RUXE_HUMAN ENSP00000400591 hepatitis B virus Normal vs. Cancer adjacent paired non-HCC tissues hepatocellular carcinoma tissues tissue Up 100 14726492 201 ANGT_HUMAN ENSP00000355627 Non-small cell lung carcinoma Normal vs. Cancer normal controls non-small-cell lung cancer (NSCLC) serum samples tissue Up 18465169 202 FIBA_HUMAN ENSP00000306361 Non-small cell lung carcinoma Normal vs. Cancer normal controls non-small-cell lung cancer (NSCLC) serum samples tissue Up 18465169 203 TSP1_HUMAN ENSP00000260356 Non-small cell lung carcinoma Normal vs. Cancer normal controls non-small-cell lung cancer (NSCLC) serum samples tissue Up 18465169 204 RL3R2_HUMAN ENSP00000357301 Lung Cancer Normal vs. Cancer serum samples control serum samples from patients with advanced lung adenocarcinoma (stage IV) tissue Down 0.29 17705522 205 APOB_HUMAN ENSP00000233242 Lung Cancer Normal vs. Cancer serum samples control serum samples from patients with advanced lung adenocarcinoma (stage IV) tissue Down 0.3 17705522 206 APOA1_HUMAN ENSP00000236850 Lung Cancer Normal vs. Cancer serum samples control serum samples from patients with advanced lung adenocarcinoma (stage IV) tissue Down 0.34 17705522 207 TSP2_HUMAN ENSP00000355751 Lung Cancer Normal vs. Cancer serum samples control serum samples from patients with advanced lung adenocarcinoma (stage IV) tissue Down 0.47 17705522 208 TSP1_HUMAN ENSP00000260356 Lung Cancer Normal vs. Cancer serum samples control serum samples from patients with advanced lung adenocarcinoma (stage IV) tissue Down 0.48 17705522 209 FINC_HUMAN ENSP00000352696 Lung Cancer Normal vs. Cancer serum samples control serum samples from patients with advanced lung adenocarcinoma (stage IV) tissue Up 2 17705522 210 ROR2_HUMAN ENSP00000364860 Lung Cancer Normal vs. Cancer serum samples control serum samples from patients with advanced lung adenocarcinoma (stage IV) tissue Up 2.2 17705522 211 FCG3A_HUMAN ENSP00000416607 Lung Cancer Normal vs. Cancer serum samples control serum samples from patients with advanced lung adenocarcinoma (stage IV) tissue Up 2.4 17705522 212 C4BPA_HUMAN ENSP00000356037 Lung Cancer Normal vs. Cancer serum samples control serum samples from patients with advanced lung adenocarcinoma (stage IV) tissue Up 2.5 17705522 213 APOB_HUMAN ENSP00000233242 Lung Cancer Normal vs. Cancer serum samples control serum samples from patients with advanced lung adenocarcinoma (stage IV) tissue Up 2.9 17705522 214 TRFL_HUMAN ENSP00000231751 Lung Cancer Normal vs. Cancer serum samples control serum samples from patients with advanced lung adenocarcinoma (stage IV) tissue Up 3.2 17705522 215 HSPB1_HUMAN ENSP00000248553 Breast Cancer Metastasis human MDA-MB-435 breast cancer cell line highly metastatic variant of human MDA-MB-435 breast cancer cell line cell line Up 16637015 216 CATD_HUMAN ENSP00000236671 Breast Cancer Metastasis human MDA-MB-435 breast cancer cell line highly metastatic variant of human MDA-MB-435 breast cancer cell line cell line Up 16637015 217 TPM2_HUMAN ENSP00000354219 Breast Cancer Metastasis human MDA-MB-435 breast cancer cell line highly metastatic variant of human MDA-MB-435 breast cancer cell line cell line Up 16637015 218 INS_HUMAN ENSP00000370731 Pancreatic Cancer Normal vs. Cancer non-neoplastic pancreatic ductal cells pancreatic cancer-derived cells tissue Down 0.05 16215274 219 K1C14_HUMAN ENSP00000167586 Pancreatic Cancer Normal vs. Cancer non-neoplastic pancreatic ductal cells pancreatic cancer-derived cells tissue Down 0.05 16215274 220 FINC_HUMAN ENSP00000352696 Pancreatic Cancer Normal vs. Cancer non-neoplastic pancreatic ductal cells pancreatic cancer-derived cells tissue Down 0.05 16215274 221 SLPI_HUMAN ENSP00000342082 Pancreatic Cancer Normal vs. Cancer non-neoplastic pancreatic ductal cells pancreatic cancer-derived cells tissue Down 0.05 16215274 222 PAI2_HUMAN ENSP00000401645 Pancreatic Cancer Normal vs. Cancer non-neoplastic pancreatic ductal cells pancreatic cancer-derived cells tissue Down 0.05 16215274 223 VIME_HUMAN ENSP00000224237 Pancreatic Cancer Normal vs. Cancer non-neoplastic pancreatic ductal cells pancreatic cancer-derived cells tissue Down 0.05 16215274 224 MMP9_HUMAN ENSP00000361405 Pancreatic Cancer Normal vs. Cancer non-neoplastic pancreatic ductal cells pancreatic cancer-derived cells tissue Down 0.05 16215274 225 S10A2_HUMAN ENSP00000357698 Pancreatic Cancer Normal vs. Cancer non-neoplastic pancreatic ductal cells pancreatic cancer-derived cells tissue Down 0.05 16215274 226 CTGF_HUMAN ENSP00000356954 Pancreatic Cancer Normal vs. Cancer non-neoplastic pancreatic ductal cells pancreatic cancer-derived cells tissue Down 0.05 16215274 227 TSP1_HUMAN ENSP00000260356 Pancreatic Cancer Normal vs. Cancer non-neoplastic pancreatic ductal cells pancreatic cancer-derived cells tissue Down 0.06 16215274 228 ENOA_HUMAN ENSP00000234590 Pancreatic Cancer Normal vs. Cancer non-neoplastic pancreatic ductal cells pancreatic cancer-derived cells tissue Down 0.2 16215274 229 G3P_HUMAN ENSP00000380068 Pancreatic Cancer Normal vs. Cancer non-neoplastic pancreatic ductal cells pancreatic cancer-derived cells tissue Down 0.24 16215274 230 SDC1_HUMAN ENSP00000370542 Pancreatic Cancer Normal vs. Cancer non-neoplastic pancreatic ductal cells pancreatic cancer-derived cells tissue Down 0.43 16215274 231 A4_HUMAN ENSP00000284981 Pancreatic Cancer Normal vs. Cancer non-neoplastic pancreatic ductal cells pancreatic cancer-derived cells tissue Up 3 16215274 232 ITB1_HUMAN ENSP00000379350 Pancreatic Cancer Normal vs. Cancer non-neoplastic pancreatic ductal cells pancreatic cancer-derived cells tissue Up 3.4 16215274 233 RAC2_HUMAN ENSP00000249071 Pancreatic Cancer Normal vs. Cancer non-neoplastic pancreatic ductal cells pancreatic cancer-derived cells tissue Up 3.5 16215274 234 VINC_HUMAN ENSP00000211998 Pancreatic Cancer Normal vs. Cancer non-neoplastic pancreatic ductal cells pancreatic cancer-derived cells tissue Up 4.3 16215274 235 ACTN4_HUMAN ENSP00000252699 Pancreatic Cancer Normal vs. Cancer non-neoplastic pancreatic ductal cells pancreatic cancer-derived cells tissue Up 5.2 16215274 236 GNAI2_HUMAN ENSP00000312999 Pancreatic Cancer Normal vs. Cancer non-neoplastic pancreatic ductal cells pancreatic cancer-derived cells tissue Up 5.4 16215274 237 CLIC1_HUMAN ENSP00000379229 Pancreatic Cancer Normal vs. Cancer non-neoplastic pancreatic ductal cells pancreatic cancer-derived cells tissue Up 5.6 16215274 238 1433T_HUMAN ENSP00000371267 Pancreatic Cancer Normal vs. Cancer non-neoplastic pancreatic ductal cells pancreatic cancer-derived cells tissue Up 6.2 16215274 239 CATD_HUMAN ENSP00000236671 Pancreatic Cancer Normal vs. Cancer non-neoplastic pancreatic ductal cells pancreatic cancer-derived cells tissue Up 6.7 16215274 240 APOE_HUMAN ENSP00000252486 Pancreatic Cancer Normal vs. Cancer non-neoplastic pancreatic ductal cells pancreatic cancer-derived cells tissue Up 20 16215274 241 K2C8_HUMAN ENSP00000293308 Pancreatic Cancer Normal vs. Cancer non-neoplastic pancreatic ductal cells pancreatic cancer-derived cells tissue Up 20 16215274 242 CCL2_HUMAN ENSP00000225831 Pancreatic Cancer Normal vs. Cancer non-neoplastic pancreatic ductal cells pancreatic cancer-derived cells tissue Up 20 16215274 243 K1C18_HUMAN ENSP00000373489 Breast Cancer Treatment (none vs. SEL1L treatment) Human breast adenocarcinoma MCF-7 cells MCF7-SEL1L EXPressing cells cell line Down 0.09 15880780 244 TPIS_HUMAN ENSP00000379933 Breast Cancer Treatment (none vs. SEL1L treatment) Human breast adenocarcinoma MCF-7 cells MCF7-SEL1L EXPressing cells cell line Down 0.11 15880780 245 PCBP2_HUMAN ENSP00000408949 Breast Cancer Treatment (none vs. SEL1L treatment) Human breast adenocarcinoma MCF-7 cells MCF7-SEL1L EXPressing cells cell line Down 0.2 15880780 246 COF1_HUMAN ENSP00000309629 Breast Cancer Treatment (none vs. SEL1L treatment) Human breast adenocarcinoma MCF-7 cells MCF7-SEL1L EXPressing cells cell line Down 0.28 15880780 247 ODPA_HUMAN ENSP00000440761 Breast Cancer Treatment (none vs. SEL1L treatment) Human breast adenocarcinoma MCF-7 cells MCF7-SEL1L EXPressing cells cell line Down 0.32 15880780 248 TBA1C_HUMAN ENSP00000301072 Breast Cancer Treatment (none vs. SEL1L treatment) Human breast adenocarcinoma MCF-7 cells MCF7-SEL1L EXPressing cells cell line Down 0.33 15880780 249 LMNA_HUMAN ENSP00000357283 Breast Cancer Treatment (none vs. SEL1L treatment) Human breast adenocarcinoma MCF-7 cells MCF7-SEL1L EXPressing cells cell line Up 3.2 15880780 250 G3P_HUMAN ENSP00000380068 Breast Cancer Treatment (none vs. SEL1L treatment) Human breast adenocarcinoma MCF-7 cells MCF7-SEL1L EXPressing cells cell line Up 3.4 15880780 251 COF1_HUMAN ENSP00000309629 Breast Cancer Treatment (none vs. SEL1L treatment) Human breast adenocarcinoma MCF-7 cells MCF7-SEL1L EXPressing cells cell line Up 4.3 15880780 252 XRCC5_HUMAN ENSP00000375977 Breast Cancer Normal vs. Cancer normal human breast luminal epithelial cells breast cancer cell system of ErbB-2 overEXPression tissue Down 0.59 12096126 253 XRCC5_HUMAN ENSP00000375977 Breast Cancer Normal vs. Cancer normal human breast luminal epithelial cells breast cancer cell system of ErbB-2 overEXPression tissue Down 0.62 12096126 254 LMNB1_HUMAN ENSP00000261366 Breast Cancer Normal vs. Cancer normal human breast luminal epithelial cells breast cancer cell system of ErbB-2 overEXPression tissue Down 0.67 12096126 255 RUVB1_HUMAN ENSP00000318297 Breast Cancer Normal vs. Cancer normal human breast luminal epithelial cells breast cancer cell system of ErbB-2 overEXPression tissue Down 0.71 12096126 256 1433B_HUMAN ENSP00000361930 Breast Cancer Normal vs. Cancer normal human breast luminal epithelial cells breast cancer cell system of ErbB-2 overEXPression tissue Up 1.2 12096126 257 GELS_HUMAN ENSP00000362924 breast ductal carcinoma Normal vs. Cancer normal breast tissue human breast infiltrating ductal carcinoma (IDCA) tissue Down 0.21 14625848 258 KPYM_HUMAN ENSP00000334983 breast ductal carcinoma Normal vs. Cancer normal breast tissue human breast infiltrating ductal carcinoma (IDCA) tissue Up 3.7 14625848 259 TITIN_HUMAN ENSP00000354117 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell the metastatic gastric cancer TMC-1 cells cell line Down 0.16 17022644 260 GBG12_HUMAN ENSP00000360021 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell the metastatic gastric cancer TMC-1 cells cell line Down 0.2 17022644 261 CSRP1_HUMAN ENSP00000345079 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell the metastatic gastric cancer TMC-1 cells cell line Down 0.3 17022644 262 DAPK3_HUMAN ENSP00000301264 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell the metastatic gastric cancer TMC-1 cells cell line Down 0.31 17022644 263 PEBB_HUMAN ENSP00000290858 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell the metastatic gastric cancer TMC-1 cells cell line Down 0.31 17022644 264 PGM1_HUMAN ENSP00000360125 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell the metastatic gastric cancer TMC-1 cells cell line Down 0.37 17022644 265 ICAM1_HUMAN ENSP00000264832 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell the metastatic gastric cancer TMC-1 cells cell line Down 0.38 17022644 266 KS6A1_HUMAN ENSP00000431651 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell the metastatic gastric cancer TMC-1 cells cell line Down 0.39 17022644 267 SHIP2_HUMAN ENSP00000298229 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell the metastatic gastric cancer TMC-1 cells cell line Down 0.41 17022644 268 UPAR_HUMAN ENSP00000339328 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell the metastatic gastric cancer TMC-1 cells cell line Down 0.42 17022644 269 PGAM1_HUMAN ENSP00000359991 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell the metastatic gastric cancer TMC-1 cells cell line Down 0.44 17022644 270 MYH9_HUMAN ENSP00000216181 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell the metastatic gastric cancer TMC-1 cells cell line Down 0.47 17022644 271 PEBP1_HUMAN ENSP00000261313 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell the metastatic gastric cancer TMC-1 cells cell line Down 0.48 17022644 272 DEST_HUMAN ENSP00000246069 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell the metastatic gastric cancer TMC-1 cells cell line Down 0.5 17022644 273 KPYM_HUMAN ENSP00000334983 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell the metastatic gastric cancer TMC-1 cells cell line Down 0.51 17022644 274 FHL2_HUMAN ENSP00000350846 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell the metastatic gastric cancer TMC-1 cells cell line Down 0.54 17022644 275 RHOC_HUMAN ENSP00000358647 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell the metastatic gastric cancer TMC-1 cells cell line Down 0.54 17022644 276 VINC_HUMAN ENSP00000211998 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell the metastatic gastric cancer TMC-1 cells cell line Down 0.54 17022644 277 PRKDC_HUMAN ENSP00000313420 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell the metastatic gastric cancer TMC-1 cells cell line Down 0.55 17022644 278 TAGL2_HUMAN ENSP00000357075 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell the metastatic gastric cancer TMC-1 cells cell line Down 0.56 17022644 279 CSDE1_HUMAN ENSP00000351329 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell the metastatic gastric cancer TMC-1 cells cell line Down 0.56 17022644 280 RIPK3_HUMAN ENSP00000216274 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell the metastatic gastric cancer TMC-1 cells cell line Down 0.58 17022644 281 RAD50_HUMAN ENSP00000265335 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell the metastatic gastric cancer TMC-1 cells cell line Down 0.58 17022644 282 MCM5_HUMAN ENSP00000216122 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell the metastatic gastric cancer TMC-1 cells cell line Down 0.58 17022644 283 LRRF1_HUMAN ENSP00000375857 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell the metastatic gastric cancer TMC-1 cells cell line Down 0.59 17022644 284 AT2A2_HUMAN ENSP00000378872 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell the metastatic gastric cancer TMC-1 cells cell line Down 0.64 17022644 285 NAMPT_HUMAN ENSP00000222553 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell the metastatic gastric cancer TMC-1 cells cell line Down 0.65 17022644 286 FAS_HUMAN ENSP00000304592 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell the metastatic gastric cancer TMC-1 cells cell line Down 0.65 17022644 287 CDC42_HUMAN ENSP00000314458 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell the metastatic gastric cancer TMC-1 cells cell line Down 0.67 17022644 288 CY1_HUMAN ENSP00000317159 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell the metastatic gastric cancer TMC-1 cells cell line Down 0.68 17022644 289 ANXA1_HUMAN ENSP00000366109 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell the metastatic gastric cancer TMC-1 cells cell line Down 0.68 17022644 290 SSRP1_HUMAN ENSP00000278412 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell the metastatic gastric cancer TMC-1 cells cell line Down 0.68 17022644 291 HS90B_HUMAN ENSP00000360609 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell the metastatic gastric cancer TMC-1 cells cell line Down 0.68 17022644 292 NSUN2_HUMAN ENSP00000264670 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell the metastatic gastric cancer TMC-1 cells cell line Down 0.68 17022644 293 SMC1A_HUMAN ENSP00000323421 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell the metastatic gastric cancer TMC-1 cells cell line Down 0.68 17022644 294 ACLY_HUMAN ENSP00000253792 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell the metastatic gastric cancer TMC-1 cells cell line Down 0.69 17022644 295 FUBP1_HUMAN ENSP00000359804 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell the metastatic gastric cancer TMC-1 cells cell line Down 0.69 17022644 296 PRP4_HUMAN ENSP00000363313 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell the metastatic gastric cancer TMC-1 cells cell line Down 0.69 17022644 297 CLIC1_HUMAN ENSP00000379229 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell the metastatic gastric cancer TMC-1 cells cell line Down 2.4 17022644 298 TGM2_HUMAN ENSP00000355330 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell the metastatic gastric cancer TMC-1 cells cell line Down 17022644 299 AT2B4_HUMAN ENSP00000356187 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell the metastatic gastric cancer TMC-1 cells cell line Down 17022644 300 GNAI2_HUMAN ENSP00000312999 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell the metastatic gastric cancer TMC-1 cells cell line Up 1.3 17022644 301 TERA_HUMAN ENSP00000351777 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell the metastatic gastric cancer TMC-1 cells cell line Up 1.4 17022644 302 COMT_HUMAN ENSP00000385150 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell the metastatic gastric cancer TMC-1 cells cell line Up 1.4 17022644 303 EXOS5_HUMAN ENSP00000221233 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell the metastatic gastric cancer TMC-1 cells cell line Up 1.4 17022644 304 ACTN4_HUMAN ENSP00000252699 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell the metastatic gastric cancer TMC-1 cells cell line Up 1.4 17022644 305 FLNA_HUMAN ENSP00000358866 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell the metastatic gastric cancer TMC-1 cells cell line Up 1.4 17022644 306 S10AB_HUMAN ENSP00000271638 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell the metastatic gastric cancer TMC-1 cells cell line Up 1.4 17022644 307 FKBP4_HUMAN ENSP00000001008 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell the metastatic gastric cancer TMC-1 cells cell line Up 1.5 17022644 308 SYSC_HUMAN ENSP00000234677 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell the metastatic gastric cancer TMC-1 cells cell line Up 1.5 17022644 309 NASP_HUMAN ENSP00000255120 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell the metastatic gastric cancer TMC-1 cells cell line Up 1.5 17022644 310 DESP_HUMAN ENSP00000369129 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell the metastatic gastric cancer TMC-1 cells cell line Up 1.6 17022644 311 HS105_HUMAN ENSP00000318687 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell the metastatic gastric cancer TMC-1 cells cell line Up 1.6 17022644 312 XRCC6_HUMAN ENSP00000384257 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell the metastatic gastric cancer TMC-1 cells cell line Up 1.6 17022644 313 THIO_HUMAN ENSP00000363641 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell the metastatic gastric cancer TMC-1 cells cell line Up 1.6 17022644 314 U2AF1_HUMAN ENSP00000291552 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell the metastatic gastric cancer TMC-1 cells cell line Up 1.6 17022644 315 PRS7_HUMAN ENSP00000292644 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell the metastatic gastric cancer TMC-1 cells cell line Up 1.7 17022644 316 UB2V1_HUMAN ENSP00000395264 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell the metastatic gastric cancer TMC-1 cells cell line Up 1.7 17022644 317 TBB3_HUMAN ENSP00000320295 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell the metastatic gastric cancer TMC-1 cells cell line Up 1.8 17022644 318 CTND1_HUMAN ENSP00000382004 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell the metastatic gastric cancer TMC-1 cells cell line Up 1.8 17022644 319 LA_HUMAN ENSP00000386636 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell the metastatic gastric cancer TMC-1 cells cell line Up 1.8 17022644 320 PRDX5_HUMAN ENSP00000265462 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell the metastatic gastric cancer TMC-1 cells cell line Up 1.8 17022644 321 HMGB1_HUMAN ENSP00000382417 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell the metastatic gastric cancer TMC-1 cells cell line Up 1.9 17022644 322 RCC1_HUMAN ENSP00000381931 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell the metastatic gastric cancer TMC-1 cells cell line Up 1.9 17022644 323 ITB4_HUMAN ENSP00000200181 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell the metastatic gastric cancer TMC-1 cells cell line Up 2 17022644 324 RUVB1_HUMAN ENSP00000318297 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell the metastatic gastric cancer TMC-1 cells cell line Up 2 17022644 325 RASK_HUMAN ENSP00000256078 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell the metastatic gastric cancer TMC-1 cells cell line Up 2.1 17022644 326 LMNA_HUMAN ENSP00000357283 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell the metastatic gastric cancer TMC-1 cells cell line Up 2.1 17022644 327 C163A_HUMAN ENSP00000352071 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell the metastatic gastric cancer TMC-1 cells cell line Up 2.2 17022644 328 PYR1_HUMAN ENSP00000264705 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell the metastatic gastric cancer TMC-1 cells cell line Up 2.2 17022644 329 DDB1_HUMAN ENSP00000301764 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell the metastatic gastric cancer TMC-1 cells cell line Up 2.3 17022644 330 MAP4_HUMAN ENSP00000353375 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell the metastatic gastric cancer TMC-1 cells cell line Up 2.3 17022644 331 1433S_HUMAN ENSP00000340989 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell the metastatic gastric cancer TMC-1 cells cell line Up 2.4 17022644 332 1433T_HUMAN ENSP00000371267 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell the metastatic gastric cancer TMC-1 cells cell line Up 2.5 17022644 333 HCD2_HUMAN ENSP00000168216 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell the metastatic gastric cancer TMC-1 cells cell line Up 2.5 17022644 334 ITA6_HUMAN ENSP00000341078 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell the metastatic gastric cancer TMC-1 cells cell line Up 3.3 17022644 335 CTNB1_HUMAN ENSP00000379488 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell the metastatic gastric cancer TMC-1 cells cell line Up 5.9 17022644 336 VIME_HUMAN ENSP00000224237 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell the metastatic gastric cancer TMC-1 cells cell line Up 26 17022644 337 VTNC_HUMAN ENSP00000226218 colorectal cancer Normal vs. Cancer Serum samples from normal Serum samples from Diffuse FAP (Familial adenomatous polyposis) tissue Up 1.4 18667268 338 PGM1_HUMAN ENSP00000360125 colorectal cancer Normal vs. Cancer control in colonic tissue late stage human colorectal cancer (CRC) tissue Down 0.46 19098285 339 A1AT_HUMAN ENSP00000348068 colorectal cancer Normal vs. Cancer control in colonic tissue late stage human colorectal cancer (CRC) tissue Down 0.6 19098285 340 PIPNA_HUMAN ENSP00000316809 colorectal cancer Normal vs. Cancer control in colonic tissue late stage human colorectal cancer (CRC) tissue Down 0.74 19098285 341 COMT_HUMAN ENSP00000385150 colorectal cancer Normal vs. Cancer control in colonic tissue late stage human colorectal cancer (CRC) tissue Up 1.5 19098285 342 DPYL2_HUMAN ENSP00000309539 colorectal cancer Normal vs. Cancer control in colonic tissue late stage human colorectal cancer (CRC) tissue Up 1.6 19098285 343 RUVB2_HUMAN ENSP00000221413 colorectal cancer Normal vs. Cancer control in colonic tissue late stage human colorectal cancer (CRC) tissue Up 1.6 19098285 344 FKBP4_HUMAN ENSP00000001008 colorectal cancer Normal vs. Cancer control in colonic tissue late stage human colorectal cancer (CRC) tissue Up 1.6 19098285 345 ML12B_HUMAN ENSP00000383037 colorectal cancer Normal vs. Cancer control in colonic tissue late stage human colorectal cancer (CRC) tissue Up 1.7 19098285 346 PGAM1_HUMAN ENSP00000359991 colorectal cancer Normal vs. Cancer control in colonic tissue late stage human colorectal cancer (CRC) tissue Up 2.6 19098285 347 ACTB_HUMAN ENSP00000349960 colorectal cancer Normal vs. Cancer control in colonic tissue late stage human colorectal cancer (CRC) tissue Up 3.5 19098285 348 TAGL_HUMAN ENSP00000278968 colorectal cancer Normal vs. Cancer control in colonic tissue late stage human colorectal cancer (CRC) tissue Up 4.1 19098285 349 K2C8_HUMAN ENSP00000293308 colorectal cancer Normal vs. Cancer control in colonic tissue late stage human colorectal cancer (CRC) tissue Up 6.1 19098285 350 LMNA_HUMAN ENSP00000357283 colorectal cancer Normal vs. Cancer control in colonic tissue late stage human colorectal cancer (CRC) tissue Up 1.6 19098285 351 HNRH3_HUMAN ENSP00000265866 Prostate Cancer Treatment (none vs. bicalutamide treatment) androgen (R1881) on the androgen-responsive prostate cancer LNCaP cell line anti-androgen (bicalutamide) on the androgen-responsive prostate cancer LNCaP cell line cell line Down 0.79 17152098 352 LMNA_HUMAN ENSP00000357283 Prostate Cancer Treatment (none vs. bicalutamide treatment) androgen (R1881) on the androgen-responsive prostate cancer LNCaP cell line anti-androgen (bicalutamide) on the androgen-responsive prostate cancer LNCaP cell line cell line Down 0.81 17152098 353 XRCC5_HUMAN ENSP00000375977 Prostate Cancer Treatment (none vs. bicalutamide treatment) androgen (R1881) on the androgen-responsive prostate cancer LNCaP cell line anti-androgen (bicalutamide) on the androgen-responsive prostate cancer LNCaP cell line cell line Down 0.82 17152098 354 PARK7_HUMAN ENSP00000366708 Prostate Cancer Treatment (none vs. bicalutamide treatment) androgen (R1881) on the androgen-responsive prostate cancer LNCaP cell line anti-androgen (bicalutamide) on the androgen-responsive prostate cancer LNCaP cell line cell line Up 1.3 17152098 355 VINC_HUMAN ENSP00000211998 Prostate Cancer Treatment (none vs. bicalutamide treatment) androgen (R1881) on the androgen-responsive prostate cancer LNCaP cell line anti-androgen (bicalutamide) on the androgen-responsive prostate cancer LNCaP cell line cell line Up 1.4 17152098 356 TERA_HUMAN ENSP00000351777 Prostate Cancer Treatment (none vs. bicalutamide treatment) androgen (R1881) on the androgen-responsive prostate cancer LNCaP cell line anti-androgen (bicalutamide) on the androgen-responsive prostate cancer LNCaP cell line cell line Up 1.4 17152098 357 EF2_HUMAN ENSP00000307940 Prostate Cancer Treatment (none vs. bicalutamide treatment) androgen (R1881) on the androgen-responsive prostate cancer LNCaP cell line anti-androgen (bicalutamide) on the androgen-responsive prostate cancer LNCaP cell line cell line Up 1.5 17152098 358 SYWC_HUMAN ENSP00000347495 Prostate Cancer Treatment (none vs. bicalutamide treatment) androgen (R1881) on the androgen-responsive prostate cancer LNCaP cell line anti-androgen (bicalutamide) on the androgen-responsive prostate cancer LNCaP cell line cell line Up 1.5 17152098 359 ACTG_HUMAN ENSP00000331514 Prostate Cancer Treatment (none vs. bicalutamide treatment) androgen (R1881) on the androgen-responsive prostate cancer LNCaP cell line anti-androgen (bicalutamide) on the androgen-responsive prostate cancer LNCaP cell line cell line Up 1.7 17152098 360 FAS_HUMAN ENSP00000304592 Prostate Cancer Treatment (none vs. bicalutamide treatment) androgen (R1881) on the androgen-responsive prostate cancer LNCaP cell line anti-androgen (bicalutamide) on the androgen-responsive prostate cancer LNCaP cell line cell line Up 1.9 17152098 361 EF2_HUMAN ENSP00000307940 Prostate Cancer Treatment (none vs. bicalutamide treatment) androgen (R1881) on the androgen-responsive prostate cancer LNCaP cell line anti-androgen (bicalutamide) on the androgen-responsive prostate cancer LNCaP cell line cell line Up 1.9 17152098 362 VINC_HUMAN ENSP00000211998 Prostate Cancer Treatment (none vs. bicalutamide treatment) androgen (R1881) on the androgen-responsive prostate cancer LNCaP cell line anti-androgen (bicalutamide) on the androgen-responsive prostate cancer LNCaP cell line cell line Up 2.2 17152098 363 EF2_HUMAN ENSP00000307940 Prostate Cancer Treatment (none vs. bicalutamide treatment) androgen (R1881) on the androgen-responsive prostate cancer LNCaP cell line anti-androgen (bicalutamide) on the androgen-responsive prostate cancer LNCaP cell line cell line Up 2.4 17152098 364 EF2_HUMAN ENSP00000307940 Prostate Cancer Treatment (none vs. bicalutamide treatment) androgen (R1881) on the androgen-responsive prostate cancer LNCaP cell line anti-androgen (bicalutamide) on the androgen-responsive prostate cancer LNCaP cell line cell line Up 2.7 17152098 365 TEBP_HUMAN ENSP00000262033 Prostate Cancer Metastasis low metastatic prostate cancer PC3M cell line high metastatic prostate cancer PC3M-LN4 cell line cell line Down 0.14 15102926 366 KAP0_HUMAN ENSP00000376474 Prostate Cancer Metastasis low metastatic prostate cancer PC3M cell line high metastatic prostate cancer PC3M-LN4 cell line cell line Down 0.21 15102926 367 DDX3X_HUMAN ENSP00000382840 Prostate Cancer Metastasis low metastatic prostate cancer PC3M cell line high metastatic prostate cancer PC3M-LN4 cell line cell line Down 0.29 15102926 368 HSPB1_HUMAN ENSP00000248553 Prostate Cancer Metastasis low metastatic prostate cancer PC3M cell line high metastatic prostate cancer PC3M-LN4 cell line cell line Down 0.33 15102926 369 G6PI_HUMAN ENSP00000348877 Prostate Cancer Metastasis low metastatic prostate cancer PC3M cell line high metastatic prostate cancer PC3M-LN4 cell line cell line Down 0.34 15102926 370 ANX11_HUMAN ENSP00000265447 Prostate Cancer Metastasis low metastatic prostate cancer PC3M cell line high metastatic prostate cancer PC3M-LN4 cell line cell line Up 6.6 15102926 371 ANXA1_HUMAN ENSP00000366109 Prostate Cancer Metastasis low metastatic prostate cancer PC3M cell line high metastatic prostate cancer PC3M-LN4 cell line cell line Up 8.3 15102926 372 C1R_HUMAN ENSP00000290575 Prostate Cancer Treatment (androgen-starved vs. androgen-stimulated) prostate tumor-derived LNCaP cell line grown in a low protein-defined media under androgen-starved (A-) prostate tumor-derived LNCaP cell line grown in a low protein-defined media under androgen-stimulated (A+) cell line Down 0.48 14729644 373 PTPRS_HUMAN ENSP00000349932 Prostate Cancer Treatment (androgen-starved vs. androgen-stimulated) prostate tumor-derived LNCaP cell line grown in a low protein-defined media under androgen-starved (A-) prostate tumor-derived LNCaP cell line grown in a low protein-defined media under androgen-stimulated (A+) cell line Up 2 14729644 374 EFNA5_HUMAN ENSP00000328777 Prostate Cancer Treatment (androgen-starved vs. androgen-stimulated) prostate tumor-derived LNCaP cell line grown in a low protein-defined media under androgen-starved (A-) prostate tumor-derived LNCaP cell line grown in a low protein-defined media under androgen-stimulated (A+) cell line Up 2 14729644 375 VLDLR_HUMAN ENSP00000371532 Prostate Cancer Treatment (androgen-starved vs. androgen-stimulated) prostate tumor-derived LNCaP cell line grown in a low protein-defined media under androgen-starved (A-) prostate tumor-derived LNCaP cell line grown in a low protein-defined media under androgen-stimulated (A+) cell line Up 2.1 14729644 376 NEO1_HUMAN ENSP00000261908 Prostate Cancer Treatment (androgen-starved vs. androgen-stimulated) prostate tumor-derived LNCaP cell line grown in a low protein-defined media under androgen-starved (A-) prostate tumor-derived LNCaP cell line grown in a low protein-defined media under androgen-stimulated (A+) cell line Up 2.3 14729644 377 NRP1_HUMAN ENSP00000364001 Prostate Cancer Treatment (androgen-starved vs. androgen-stimulated) prostate tumor-derived LNCaP cell line grown in a low protein-defined media under androgen-starved (A-) prostate tumor-derived LNCaP cell line grown in a low protein-defined media under androgen-stimulated (A+) cell line Up 2.3 14729644 378 KLK3_HUMAN ENSP00000314151 Prostate Cancer Treatment (androgen-starved vs. androgen-stimulated) prostate tumor-derived LNCaP cell line grown in a low protein-defined media under androgen-starved (A-) prostate tumor-derived LNCaP cell line grown in a low protein-defined media under androgen-stimulated (A+) cell line Up 3.5 14729644 379 LRIG1_HUMAN ENSP00000273261 Prostate Cancer Treatment (androgen-starved vs. androgen-stimulated) prostate tumor-derived LNCaP cell line grown in a low protein-defined media under androgen-starved (A-) prostate tumor-derived LNCaP cell line grown in a low protein-defined media under androgen-stimulated (A+) cell line Up 3.6 14729644 380 APLP2_HUMAN ENSP00000263574 Prostate Cancer Treatment (androgen-starved vs. androgen-stimulated) prostate tumor-derived LNCaP cell line grown in a low protein-defined media under androgen-starved (A-) prostate tumor-derived LNCaP cell line grown in a low protein-defined media under androgen-stimulated (A+) cell line Up 4.2 14729644 381 PIGR_HUMAN ENSP00000348888 Uterine Cancer Normal vs. Cancer Negative for Intraepithelial Lesions or Malignancy (NILM) High-Grade Squamous Intraepithelial Lesion(HSIL) tissue Down 17902640 382 SLPI_HUMAN ENSP00000342082 Uterine Cancer Normal vs. Cancer Negative for Intraepithelial Lesions or Malignancy (NILM) High-Grade Squamous Intraepithelial Lesion(HSIL) tissue Down 17902640 383 ANXA1_HUMAN ENSP00000366109 Uterine Cancer Normal vs. Cancer Negative for Intraepithelial Lesions or Malignancy (NILM) High-Grade Squamous Intraepithelial Lesion(HSIL) tissue Down 17902640 384 GELS_HUMAN ENSP00000362924 Uterine Cancer Normal vs. Cancer Negative for Intraepithelial Lesions or Malignancy (NILM) High-Grade Squamous Intraepithelial Lesion(HSIL) tissue Down 17902640 385 PLAK_HUMAN ENSP00000377508 Uterine Cancer Normal vs. Cancer Negative for Intraepithelial Lesions or Malignancy (NILM) High-Grade Squamous Intraepithelial Lesion(HSIL) tissue Down 17902640 386 EZRI_HUMAN ENSP00000356042 Uterine Cancer Normal vs. Cancer Negative for Intraepithelial Lesions or Malignancy (NILM) High-Grade Squamous Intraepithelial Lesion(HSIL) tissue Down 17902640 387 DESP_HUMAN ENSP00000369129 Uterine Cancer Normal vs. Cancer Negative for Intraepithelial Lesions or Malignancy (NILM) High-Grade Squamous Intraepithelial Lesion(HSIL) tissue Down 17902640 388 PGAM1_HUMAN ENSP00000359991 Uterine Cancer Normal vs. Cancer Negative for Intraepithelial Lesions or Malignancy (NILM) High-Grade Squamous Intraepithelial Lesion(HSIL) tissue Down 17902640 389 CALL3_HUMAN ENSP00000315299 Uterine Cancer Normal vs. Cancer Negative for Intraepithelial Lesions or Malignancy (NILM) High-Grade Squamous Intraepithelial Lesion(HSIL) tissue Down 17902640 390 SPB5_HUMAN ENSP00000372221 Uterine Cancer Normal vs. Cancer Negative for Intraepithelial Lesions or Malignancy (NILM) High-Grade Squamous Intraepithelial Lesion(HSIL) tissue Down 17902640 391 BRCA2_HUMAN ENSP00000369497 Uterine Cancer Normal vs. Cancer Negative for Intraepithelial Lesions or Malignancy (NILM) High-Grade Squamous Intraepithelial Lesion(HSIL) tissue Down 17902640 392 LRP1_HUMAN ENSP00000243077 Uterine Cancer Normal vs. Cancer Negative for Intraepithelial Lesions or Malignancy (NILM) High-Grade Squamous Intraepithelial Lesion(HSIL) tissue Down 17902640 393 CLIC1_HUMAN ENSP00000379229 Uterine Cancer Normal vs. Cancer Negative for Intraepithelial Lesions or Malignancy (NILM) High-Grade Squamous Intraepithelial Lesion(HSIL) tissue Up 17902640 394 A1AT_HUMAN ENSP00000348068 Uterine Cancer Normal vs. Cancer Negative for Intraepithelial Lesions or Malignancy (NILM) High-Grade Squamous Intraepithelial Lesion(HSIL) tissue Up 17902640 395 A2MG_HUMAN ENSP00000323929 Uterine Cancer Normal vs. Cancer Negative for Intraepithelial Lesions or Malignancy (NILM) High-Grade Squamous Intraepithelial Lesion(HSIL) tissue Up 17902640 396 CO3_HUMAN ENSP00000245907 Uterine Cancer Normal vs. Cancer Negative for Intraepithelial Lesions or Malignancy (NILM) High-Grade Squamous Intraepithelial Lesion(HSIL) tissue Up 17902640 397 LMNA_HUMAN ENSP00000357283 Uterine Cancer Normal vs. Cancer Negative for Intraepithelial Lesions or Malignancy (NILM) High-Grade Squamous Intraepithelial Lesion(HSIL) tissue Up 17902640 398 APOA1_HUMAN ENSP00000236850 Uterine Cancer Normal vs. Cancer Negative for Intraepithelial Lesions or Malignancy (NILM) High-Grade Squamous Intraepithelial Lesion(HSIL) tissue Up 17902640 399 FIBA_HUMAN ENSP00000306361 Uterine Cancer Normal vs. Cancer Negative for Intraepithelial Lesions or Malignancy (NILM) High-Grade Squamous Intraepithelial Lesion(HSIL) tissue Up 17902640 400 FINC_HUMAN ENSP00000352696 Uterine Cancer Normal vs. Cancer Negative for Intraepithelial Lesions or Malignancy (NILM) High-Grade Squamous Intraepithelial Lesion(HSIL) tissue Up 17902640 401 VTNC_HUMAN ENSP00000226218 Uterine Cancer Normal vs. Cancer Negative for Intraepithelial Lesions or Malignancy (NILM) High-Grade Squamous Intraepithelial Lesion(HSIL) tissue Up 17902640 402 SODM_HUMAN ENSP00000337127 Uterine Cancer Normal vs. Cancer Negative for Intraepithelial Lesions or Malignancy (NILM) High-Grade Squamous Intraepithelial Lesion(HSIL) tissue Up 17902640 403 K1C18_HUMAN ENSP00000373489 Uterine Cancer Normal vs. Cancer Negative for Intraepithelial Lesions or Malignancy (NILM) High-Grade Squamous Intraepithelial Lesion(HSIL) tissue Up 17902640 404 K2C8_HUMAN ENSP00000293308 Uterine Cancer Normal vs. Cancer Negative for Intraepithelial Lesions or Malignancy (NILM) High-Grade Squamous Intraepithelial Lesion(HSIL) tissue Up 17902640 405 NPM_HUMAN ENSP00000296930 Uterine Cancer Normal vs. Cancer Negative for Intraepithelial Lesions or Malignancy (NILM) High-Grade Squamous Intraepithelial Lesion(HSIL) tissue Up 17902640 406 HS90A_HUMAN ENSP00000335153 Uterine Cancer Normal vs. Cancer Negative for Intraepithelial Lesions or Malignancy (NILM) High-Grade Squamous Intraepithelial Lesion(HSIL) tissue Up 17902640 407 HNRPC_HUMAN ENSP00000319690 Uterine Cancer Normal vs. Cancer Negative for Intraepithelial Lesions or Malignancy (NILM) High-Grade Squamous Intraepithelial Lesion(HSIL) tissue Up 17902640 408 HSP71_HUMAN ENSP00000364801 Uterine Cancer Normal vs. Cancer Negative for Intraepithelial Lesions or Malignancy (NILM) High-Grade Squamous Intraepithelial Lesion(HSIL) tissue Up 17902640 409 HS90B_HUMAN ENSP00000360609 Uterine Cancer Normal vs. Cancer Negative for Intraepithelial Lesions or Malignancy (NILM) High-Grade Squamous Intraepithelial Lesion(HSIL) tissue Up 17902640 410 CATG_HUMAN ENSP00000216336 Uterine Cancer Normal vs. Cancer Negative for Intraepithelial Lesions or Malignancy (NILM) High-Grade Squamous Intraepithelial Lesion(HSIL) tissue Up 17902640 411 VIME_HUMAN ENSP00000224237 Uterine Cancer Normal vs. Cancer Negative for Intraepithelial Lesions or Malignancy (NILM) High-Grade Squamous Intraepithelial Lesion(HSIL) tissue Up 17902640 412 RSSA_HUMAN ENSP00000346067 Uterine Cancer Normal vs. Cancer Negative for Intraepithelial Lesions or Malignancy (NILM) High-Grade Squamous Intraepithelial Lesion(HSIL) tissue Up 17902640 413 F16P1_HUMAN ENSP00000408025 Uterine Cancer Normal vs. Cancer Negative for Intraepithelial Lesions or Malignancy (NILM) High-Grade Squamous Intraepithelial Lesion(HSIL) tissue Up 17902640 414 ACTN1_HUMAN ENSP00000193403 Uterine Cancer Normal vs. Cancer Negative for Intraepithelial Lesions or Malignancy (NILM) High-Grade Squamous Intraepithelial Lesion(HSIL) tissue Up 17902640 415 XRCC6_HUMAN ENSP00000384257 Uterine Cancer Normal vs. Cancer Negative for Intraepithelial Lesions or Malignancy (NILM) High-Grade Squamous Intraepithelial Lesion(HSIL) tissue Up 17902640 416 EF2_HUMAN ENSP00000307940 Uterine Cancer Normal vs. Cancer Negative for Intraepithelial Lesions or Malignancy (NILM) High-Grade Squamous Intraepithelial Lesion(HSIL) tissue Up 17902640 417 PLSL_HUMAN ENSP00000315757 Uterine Cancer Normal vs. Cancer Negative for Intraepithelial Lesions or Malignancy (NILM) High-Grade Squamous Intraepithelial Lesion(HSIL) tissue Up 17902640 418 KPYM_HUMAN ENSP00000334983 Uterine Cancer Normal vs. Cancer Negative for Intraepithelial Lesions or Malignancy (NILM) High-Grade Squamous Intraepithelial Lesion(HSIL) tissue Up 17902640 419 ENPL_HUMAN ENSP00000299767 Uterine Cancer Normal vs. Cancer Negative for Intraepithelial Lesions or Malignancy (NILM) High-Grade Squamous Intraepithelial Lesion(HSIL) tissue Up 17902640 420 VINC_HUMAN ENSP00000211998 Uterine Cancer Normal vs. Cancer Negative for Intraepithelial Lesions or Malignancy (NILM) High-Grade Squamous Intraepithelial Lesion(HSIL) tissue Up 17902640 421 NUCL_HUMAN ENSP00000318195 Uterine Cancer Normal vs. Cancer Negative for Intraepithelial Lesions or Malignancy (NILM) High-Grade Squamous Intraepithelial Lesion(HSIL) tissue Up 17902640 422 LMNB1_HUMAN ENSP00000261366 Uterine Cancer Normal vs. Cancer Negative for Intraepithelial Lesions or Malignancy (NILM) High-Grade Squamous Intraepithelial Lesion(HSIL) tissue Up 17902640 423 FLNA_HUMAN ENSP00000358866 Uterine Cancer Normal vs. Cancer Negative for Intraepithelial Lesions or Malignancy (NILM) High-Grade Squamous Intraepithelial Lesion(HSIL) tissue Up 17902640 424 UBA1_HUMAN ENSP00000338413 Uterine Cancer Normal vs. Cancer Negative for Intraepithelial Lesions or Malignancy (NILM) High-Grade Squamous Intraepithelial Lesion(HSIL) tissue Up 17902640 425 MOES_HUMAN ENSP00000353408 Uterine Cancer Normal vs. Cancer Negative for Intraepithelial Lesions or Malignancy (NILM) High-Grade Squamous Intraepithelial Lesion(HSIL) tissue Up 17902640 426 PTBP1_HUMAN ENSP00000014112 Uterine Cancer Normal vs. Cancer Negative for Intraepithelial Lesions or Malignancy (NILM) High-Grade Squamous Intraepithelial Lesion(HSIL) tissue Up 17902640 427 1433T_HUMAN ENSP00000371267 Uterine Cancer Normal vs. Cancer Negative for Intraepithelial Lesions or Malignancy (NILM) High-Grade Squamous Intraepithelial Lesion(HSIL) tissue Up 17902640 428 CALR_HUMAN ENSP00000320866 Uterine Cancer Normal vs. Cancer Negative for Intraepithelial Lesions or Malignancy (NILM) High-Grade Squamous Intraepithelial Lesion(HSIL) tissue Up 17902640 429 S10AB_HUMAN ENSP00000271638 Uterine Cancer Normal vs. Cancer Negative for Intraepithelial Lesions or Malignancy (NILM) High-Grade Squamous Intraepithelial Lesion(HSIL) tissue Up 17902640 430 MYH9_HUMAN ENSP00000216181 Uterine Cancer Normal vs. Cancer Negative for Intraepithelial Lesions or Malignancy (NILM) High-Grade Squamous Intraepithelial Lesion(HSIL) tissue Up 17902640 431 TAGL2_HUMAN ENSP00000357075 Uterine Cancer Normal vs. Cancer Negative for Intraepithelial Lesions or Malignancy (NILM) High-Grade Squamous Intraepithelial Lesion(HSIL) tissue Up 17902640 432 IF4A3_HUMAN ENSP00000269349 Uterine Cancer Normal vs. Cancer Negative for Intraepithelial Lesions or Malignancy (NILM) High-Grade Squamous Intraepithelial Lesion(HSIL) tissue Up 17902640 433 NAMPT_HUMAN ENSP00000222553 Uterine Cancer Normal vs. Cancer Negative for Intraepithelial Lesions or Malignancy (NILM) High-Grade Squamous Intraepithelial Lesion(HSIL) tissue Up 17902640 434 IQGA1_HUMAN ENSP00000268182 Uterine Cancer Normal vs. Cancer Negative for Intraepithelial Lesions or Malignancy (NILM) High-Grade Squamous Intraepithelial Lesion(HSIL) tissue Up 17902640 435 ANX11_HUMAN ENSP00000265447 Uterine Cancer Normal vs. Cancer Negative for Intraepithelial Lesions or Malignancy (NILM) High-Grade Squamous Intraepithelial Lesion(HSIL) tissue Up 17902640 436 HNRPK_HUMAN ENSP00000365440 Uterine Cancer Normal vs. Cancer Negative for Intraepithelial Lesions or Malignancy (NILM) High-Grade Squamous Intraepithelial Lesion(HSIL) tissue Up 17902640 437 RAN_HUMAN ENSP00000376176 Uterine Cancer Normal vs. Cancer Negative for Intraepithelial Lesions or Malignancy (NILM) High-Grade Squamous Intraepithelial Lesion(HSIL) tissue Up 17902640 438 HBB_HUMAN ENSP00000333994 Uterine Cancer Normal vs. Cancer Negative for Intraepithelial Lesions or Malignancy (NILM) High-Grade Squamous Intraepithelial Lesion(HSIL) tissue Up 17902640 439 HBA_HUMAN ENSP00000322421 Uterine Cancer Normal vs. Cancer Negative for Intraepithelial Lesions or Malignancy (NILM) High-Grade Squamous Intraepithelial Lesion(HSIL) tissue Up 17902640 440 PRKDC_HUMAN ENSP00000313420 Uterine Cancer Normal vs. Cancer Negative for Intraepithelial Lesions or Malignancy (NILM) High-Grade Squamous Intraepithelial Lesion(HSIL) tissue Up 17902640 441 H33_HUMAN ENSP00000254810 Uterine Cancer Normal vs. Cancer Negative for Intraepithelial Lesions or Malignancy (NILM) High-Grade Squamous Intraepithelial Lesion(HSIL) tissue Up 17902640 442 CLH1_HUMAN ENSP00000269122 Uterine Cancer Normal vs. Cancer Negative for Intraepithelial Lesions or Malignancy (NILM) High-Grade Squamous Intraepithelial Lesion(HSIL) tissue Up 17902640 443 SET_HUMAN ENSP00000361777 Uterine Cancer Normal vs. Cancer Negative for Intraepithelial Lesions or Malignancy (NILM) High-Grade Squamous Intraepithelial Lesion(HSIL) tissue Up 17902640 444 PRDX1_HUMAN ENSP00000262746 Uterine Cancer Normal vs. Cancer Negative for Intraepithelial Lesions or Malignancy (NILM) High-Grade Squamous Intraepithelial Lesion(HSIL) tissue Up 17902640 445 HNRPD_HUMAN ENSP00000313199 Uterine Cancer Normal vs. Cancer Negative for Intraepithelial Lesions or Malignancy (NILM) High-Grade Squamous Intraepithelial Lesion(HSIL) tissue Up 17902640 446 H2B1M_HUMAN ENSP00000352442 Uterine Cancer Normal vs. Cancer Negative for Intraepithelial Lesions or Malignancy (NILM) High-Grade Squamous Intraepithelial Lesion(HSIL) tissue Up 17902640 447 COF1_HUMAN ENSP00000309629 Ovarian Cancer Treatment (platinum-sensitive vs. platinum-resistant) platinum-sensitive ovarian cancer cell line (SKOV3) platinum-resistant ovarian cancer cell line (SKOV3/CDDP) cell line Down 0.46 17269733 448 DEST_HUMAN ENSP00000246069 Ovarian Cancer Treatment (platinum-sensitive vs. platinum-resistant) platinum-sensitive ovarian cancer cell line (SKOV3) platinum-resistant ovarian cancer cell line (SKOV3/CDDP) cell line Up 2 17269733 449 COF1_HUMAN ENSP00000309629 Ovarian Cancer Treatment (platinum-sensitive vs. platinum-resistant) platinum-sensitive ovarian cancer cell line (SKOV3) platinum-resistant ovarian cancer cell line (SKOV3/CBP) cell line Down 0.28 17269733 450 DEST_HUMAN ENSP00000246069 Ovarian Cancer Treatment (platinum-sensitive vs. platinum-resistant) platinum-sensitive ovarian cancer cell line (SKOV3) platinum-resistant ovarian cancer cell line (SKOV3/CBP) cell line Up 2.6 17269733 451 DEST_HUMAN ENSP00000246069 Ovarian Cancer Treatment (platinum-sensitive vs. platinum-resistant) platinum-sensitive ovarian cancer cell line (A2780) platinum-resistant ovarian cancer cell line (A2780/CDDP) cell line Up 2.1 17269733 452 COF1_HUMAN ENSP00000309629 Ovarian Cancer Treatment (platinum-sensitive vs. platinum-resistant) platinum-sensitive ovarian cancer cell line (A2780) platinum-resistant ovarian cancer cell line (A2780/CDDP) cell line Up 3.4 17269733 453 DEST_HUMAN ENSP00000246069 Ovarian Cancer Treatment (platinum-sensitive vs. platinum-resistant) platinum-sensitive ovarian cancer cell line (A2780) platinum-resistant ovarian cancer cell line (A2780/CBP) cell line Up 2.1 17269733 454 COF1_HUMAN ENSP00000309629 Ovarian Cancer Treatment (platinum-sensitive vs. platinum-resistant) platinum-sensitive ovarian cancer cell line (A2780) platinum-resistant ovarian cancer cell line (A2780/CBP) cell line Up 9.9 17269733 455 NELFB_HUMAN ENSP00000339495 Ovarian Cancer Treatment (cisplatin-sensitive vs. cisplatin-resistant) cisplatin-sensitive ovarian cancer cell line (IGROV-1 [corrected]) cisplatin-resistant ovarian cancer cell line (IGROV-1/CP [corrected]) cell line Down 0.21 16319398 456 PRDX5_HUMAN ENSP00000265462 Ovarian Cancer Treatment (cisplatin-sensitive vs. cisplatin-resistant) cisplatin-sensitive ovarian cancer cell line (IGROV-1 [corrected]) cisplatin-resistant ovarian cancer cell line (IGROV-1/CP [corrected]) cell line Down 0.3 16319398 457 DPYL2_HUMAN ENSP00000309539 Ovarian Cancer Treatment (cisplatin-sensitive vs. cisplatin-resistant) cisplatin-sensitive ovarian cancer cell line (IGROV-1 [corrected]) cisplatin-resistant ovarian cancer cell line (IGROV-1/CP [corrected]) cell line Down 0.31 16319398 458 SPTB2_HUMAN ENSP00000349259 Ovarian Cancer Treatment (cisplatin-sensitive vs. cisplatin-resistant) cisplatin-sensitive ovarian cancer cell line (IGROV-1 [corrected]) cisplatin-resistant ovarian cancer cell line (IGROV-1/CP [corrected]) cell line Down 0.42 16319398 459 PO210_HUMAN ENSP00000254508 Ovarian Cancer Treatment (cisplatin-sensitive vs. cisplatin-resistant) cisplatin-sensitive ovarian cancer cell line (IGROV-1 [corrected]) cisplatin-resistant ovarian cancer cell line (IGROV-1/CP [corrected]) cell line Down 0.48 16319398 460 PRC1_HUMAN ENSP00000377793 Ovarian Cancer Treatment (cisplatin-sensitive vs. cisplatin-resistant) cisplatin-sensitive ovarian cancer cell line (IGROV-1 [corrected]) cisplatin-resistant ovarian cancer cell line (IGROV-1/CP [corrected]) cell line Down 0.51 16319398 461 VIGLN_HUMAN ENSP00000312042 Ovarian Cancer Treatment (cisplatin-sensitive vs. cisplatin-resistant) cisplatin-sensitive ovarian cancer cell line (IGROV-1 [corrected]) cisplatin-resistant ovarian cancer cell line (IGROV-1/CP [corrected]) cell line Down 0.53 16319398 462 CDC42_HUMAN ENSP00000314458 Ovarian Cancer Treatment (cisplatin-sensitive vs. cisplatin-resistant) cisplatin-sensitive ovarian cancer cell line (IGROV-1 [corrected]) cisplatin-resistant ovarian cancer cell line (IGROV-1/CP [corrected]) cell line Down 0.56 16319398 463 HNRL1_HUMAN ENSP00000375863 Ovarian Cancer Treatment (cisplatin-sensitive vs. cisplatin-resistant) cisplatin-sensitive ovarian cancer cell line (IGROV-1 [corrected]) cisplatin-resistant ovarian cancer cell line (IGROV-1/CP [corrected]) cell line Down 0.56 16319398 464 EFTU_HUMAN ENSP00000322439 Ovarian Cancer Treatment (cisplatin-sensitive vs. cisplatin-resistant) cisplatin-sensitive ovarian cancer cell line (IGROV-1 [corrected]) cisplatin-resistant ovarian cancer cell line (IGROV-1/CP [corrected]) cell line Down 0.57 16319398 465 KPYM_HUMAN ENSP00000334983 Ovarian Cancer Treatment (cisplatin-sensitive vs. cisplatin-resistant) cisplatin-sensitive ovarian cancer cell line (IGROV-1 [corrected]) cisplatin-resistant ovarian cancer cell line (IGROV-1/CP [corrected]) cell line Up 1.9 16319398 466 APC7_HUMAN ENSP00000394394 Ovarian Cancer Treatment (cisplatin-sensitive vs. cisplatin-resistant) cisplatin-sensitive ovarian cancer cell line (IGROV-1 [corrected]) cisplatin-resistant ovarian cancer cell line (IGROV-1/CP [corrected]) cell line Up 2.1 16319398 467 EIF2A_HUMAN ENSP00000417229 Ovarian Cancer Treatment (cisplatin-sensitive vs. cisplatin-resistant) cisplatin-sensitive ovarian cancer cell line (IGROV-1 [corrected]) cisplatin-resistant ovarian cancer cell line (IGROV-1/CP [corrected]) cell line Up 2.2 16319398 468 GSTP1_HUMAN ENSP00000381607 Ovarian Cancer Treatment (cisplatin-sensitive vs. cisplatin-resistant) cisplatin-sensitive ovarian cancer cell line (IGROV-1 [corrected]) cisplatin-resistant ovarian cancer cell line (IGROV-1/CP [corrected]) cell line Up 3.2 16319398 469 PSA6_HUMAN ENSP00000261479 Ovarian Cancer Treatment (cisplatin-sensitive vs. cisplatin-resistant) cisplatin-sensitive ovarian cancer cell line (IGROV-1 [corrected]) cisplatin-resistant ovarian cancer cell line (IGROV-1/CP [corrected]) cell line Up 3.3 16319398 470 JAK3_HUMAN ENSP00000391676 Ovarian Cancer Treatment (cisplatin-sensitive vs. cisplatin-resistant) cisplatin-sensitive ovarian cancer cell line (IGROV-1 [corrected]) cisplatin-resistant ovarian cancer cell line (IGROV-1/CP [corrected]) cell line Up 4 16319398 471 TNR3_HUMAN ENSP00000228918 Ovarian Cancer Treatment (cisplatin-sensitive vs. cisplatin-resistant) cisplatin-sensitive ovarian cancer cell line (IGROV-1 [corrected]) cisplatin-resistant ovarian cancer cell line (IGROV-1/CP [corrected]) cell line Up 4.4 16319398 472 PDC6I_HUMAN ENSP00000307387 Ovarian Cancer Treatment (cisplatin-sensitive vs. cisplatin-resistant) cisplatin-sensitive ovarian cancer cell line (IGROV-1 [corrected]) cisplatin-resistant ovarian cancer cell line (IGROV-1/CP [corrected]) cell line Up 13 16319398 473 GBB2_HUMAN ENSP00000377501 Ovarian Cancer Treatment (cisplatin-sensitive vs. cisplatin-resistant) cisplatin-sensitive ovarian cancer cell line (IGROV-1 [corrected]) cisplatin-resistant ovarian cancer cell line (IGROV-1/CP [corrected]) cell line Up 39 16319398 474 DESM_HUMAN ENSP00000363071 colorectal cancer Normal vs. Cancer adjacent normal mucosa colorectal cancer tissues tissue Down 0.23 14997500 475 DESM_HUMAN ENSP00000363071 colorectal cancer Normal vs. Cancer adjacent normal mucosa colorectal cancer tissues tissue Down 0.3 14997500 476 VIME_HUMAN ENSP00000224237 colorectal cancer Normal vs. Cancer adjacent normal mucosa colorectal cancer tissues tissue Down 0.51 14997500 477 VINC_HUMAN ENSP00000211998 colorectal cancer Normal vs. Cancer adjacent normal mucosa colorectal cancer tissues tissue Down 0.66 14997500 478 TAGL_HUMAN ENSP00000278968 colorectal cancer Normal vs. Cancer adjacent normal mucosa colorectal cancer tissues tissue Down 0.69 14997500 479 TAGL_HUMAN ENSP00000278968 colorectal cancer Normal vs. Cancer adjacent normal mucosa colorectal cancer tissues tissue Down 0.89 14997500 480 TAGL_HUMAN ENSP00000278968 colorectal cancer Normal vs. Cancer adjacent normal mucosa colorectal cancer tissues tissue Up 1.1 14997500 481 TERA_HUMAN ENSP00000351777 colorectal cancer Normal vs. Cancer adjacent normal mucosa colorectal cancer tissues tissue Up 1.3 14997500 482 PSA6_HUMAN ENSP00000261479 colorectal cancer Normal vs. Cancer adjacent normal mucosa colorectal cancer tissues tissue Up 1.3 14997500 483 GDIR1_HUMAN ENSP00000269321 colorectal cancer Normal vs. Cancer adjacent normal mucosa colorectal cancer tissues tissue Up 1.4 14997500 484 CATD_HUMAN ENSP00000236671 colorectal cancer Normal vs. Cancer adjacent normal mucosa colorectal cancer tissues tissue Up 1.7 14997500 485 BIEA_HUMAN ENSP00000385757 colorectal cancer Normal vs. Cancer adjacent normal mucosa colorectal cancer tissues tissue Up 1.9 14997500 486 NDKA_HUMAN ENSP00000013034 colorectal cancer Normal vs. Cancer adjacent normal mucosa colorectal cancer tissues tissue Up 1.9 14997500 487 IPYR_HUMAN ENSP00000362329 colorectal cancer Normal vs. Cancer adjacent normal mucosa colorectal cancer tissues tissue Up 2 14997500 488 ENOA_HUMAN ENSP00000234590 colorectal cancer Normal vs. Cancer adjacent normal mucosa colorectal cancer tissues tissue Up 2.4 16554294 489 APOA1_HUMAN ENSP00000236850 colorectal cancer Normal vs. Cancer adjacent normal mucosa colorectal cancer tissues tissue Down 0.39 15924290 490 ALBU_HUMAN ENSP00000295897 colorectal cancer Normal vs. Cancer adjacent normal mucosa colorectal cancer tissues tissue Down 0.44 15924290 491 RSSA_HUMAN ENSP00000346067 colorectal cancer Normal vs. Cancer adjacent normal mucosa colorectal cancer tissues tissue Down 0.47 15924290 492 APC_HUMAN ENSP00000413133 colorectal cancer Normal vs. Cancer adjacent normal mucosa colorectal cancer tissues tissue Down 0.65 15924290 493 CATD_HUMAN ENSP00000236671 colorectal cancer Normal vs. Cancer adjacent normal mucosa colorectal cancer tissues tissue Down 0.71 15924290 494 CALR_HUMAN ENSP00000320866 colorectal cancer Normal vs. Cancer adjacent normal mucosa colorectal cancer tissues tissue Down 0.75 15924290 495 ACTB_HUMAN ENSP00000349960 colorectal cancer Normal vs. Cancer adjacent normal mucosa colorectal cancer tissues tissue Up 1.4 15924290 496 REL1_HUMAN ENSP00000223862 colorectal cancer Normal vs. Cancer adjacent normal mucosa colorectal cancer tissues tissue Up 1.6 15924290 497 MTA1_HUMAN ENSP00000333633 colorectal cancer Normal vs. Cancer adjacent normal mucosa colorectal cancer tissues tissue Up 1.9 15924290 498 CP21A_HUMAN ENSP00000398594 colorectal cancer Normal vs. Cancer adjacent normal mucosa colorectal cancer tissues tissue Up 3 15924290 499 VIME_HUMAN ENSP00000224237 colorectal cancer Normal vs. Cancer adjacent normal mucosa colorectal cancer tissues tissue Up 4.8 15924290 500 K2C8_HUMAN ENSP00000293308 colorectal cancer Normal vs. Cancer adjacent normal mucosa colorectal cancer tissues tissue Up 5.1 15924290 501 ANXA1_HUMAN ENSP00000366109 colorectal cancer Metastasis human colorectal carcinoma cell line (SW480) human colorectal carcinoma cell line (SW620 ) cell line Down 17503081 502 COF1_HUMAN ENSP00000309629 colorectal cancer Metastasis human colorectal carcinoma cell line (SW480) human colorectal carcinoma cell line (SW620 ) cell line Down 17503081 503 PGAM1_HUMAN ENSP00000359991 colorectal cancer Metastasis human colorectal carcinoma cell line (SW480) human colorectal carcinoma cell line (SW620 ) cell line Up 17503081 504 ACTB_HUMAN ENSP00000349960 Hepatocellular Carcinoma Normal vs. Cancer adjacent paired nontumorous tissues clinical hepatitis B virus associated HCC tissue samples tissue Down 0.05 15759316 505 FIBA_HUMAN ENSP00000306361 Hepatocellular Carcinoma Normal vs. Cancer adjacent paired nontumorous tissues clinical hepatitis B virus associated HCC tissue samples tissue Down 0.06 15759316 506 TPIS_HUMAN ENSP00000379933 Hepatocellular Carcinoma Normal vs. Cancer adjacent paired nontumorous tissues clinical hepatitis B virus associated HCC tissue samples tissue Down 0.06 15759316 507 GPX1_HUMAN ENSP00000407375 Hepatocellular Carcinoma Normal vs. Cancer adjacent paired nontumorous tissues clinical hepatitis B virus associated HCC tissue samples tissue Down 0.11 15759316 508 SODM_HUMAN ENSP00000337127 Hepatocellular Carcinoma Normal vs. Cancer adjacent paired nontumorous tissues clinical hepatitis B virus associated HCC tissue samples tissue Down 0.2 15759316 509 COMT_HUMAN ENSP00000385150 Hepatocellular Carcinoma Normal vs. Cancer adjacent paired nontumorous tissues clinical hepatitis B virus associated HCC tissue samples tissue Down 0.26 15759316 510 SODC_HUMAN ENSP00000270142 Hepatocellular Carcinoma Normal vs. Cancer adjacent paired nontumorous tissues clinical hepatitis B virus associated HCC tissue samples tissue Down 0.29 15759316 511 GDIR2_HUMAN ENSP00000228945 Hepatocellular Carcinoma Normal vs. Cancer adjacent paired nontumorous tissues clinical hepatitis B virus associated HCC tissue samples tissue Down 0.34 15759316 512 ENOA_HUMAN ENSP00000234590 Hepatocellular Carcinoma Normal vs. Cancer adjacent paired nontumorous tissues clinical hepatitis B virus associated HCC tissue samples tissue Up 2.8 15759316 513 FUBP1_HUMAN ENSP00000359804 Hepatocellular Carcinoma Normal vs. Cancer adjacent paired nontumorous tissues clinical hepatitis B virus associated HCC tissue samples tissue Up 2.9 15759316 514 NSF1C_HUMAN ENSP00000371074 Hepatocellular Carcinoma Normal vs. Cancer adjacent paired nontumorous tissues clinical hepatitis B virus associated HCC tissue samples tissue Up 2.9 15759316 515 STIP1_HUMAN ENSP00000305958 Hepatocellular Carcinoma Normal vs. Cancer adjacent paired nontumorous tissues clinical hepatitis B virus associated HCC tissue samples tissue Up 3 15759316 516 FKBP4_HUMAN ENSP00000001008 Hepatocellular Carcinoma Normal vs. Cancer adjacent paired nontumorous tissues clinical hepatitis B virus associated HCC tissue samples tissue Up 3 15759316 517 COF2_HUMAN ENSP00000298159 Hepatocellular Carcinoma Normal vs. Cancer adjacent paired nontumorous tissues clinical hepatitis B virus associated HCC tissue samples tissue Up 3.1 15759316 518 RUVB1_HUMAN ENSP00000318297 Hepatocellular Carcinoma Normal vs. Cancer adjacent paired nontumorous tissues clinical hepatitis B virus associated HCC tissue samples tissue Up 3.3 15759316 519 SRSF1_HUMAN ENSP00000258962 Hepatocellular Carcinoma Normal vs. Cancer adjacent paired nontumorous tissues clinical hepatitis B virus associated HCC tissue samples tissue Up 3.4 15759316 520 NDKA_HUMAN ENSP00000013034 Hepatocellular Carcinoma Normal vs. Cancer adjacent paired nontumorous tissues clinical hepatitis B virus associated HCC tissue samples tissue Up 3.5 15759316 521 HSPB1_HUMAN ENSP00000248553 Hepatocellular Carcinoma Normal vs. Cancer adjacent paired nontumorous tissues clinical hepatitis B virus associated HCC tissue samples tissue Up 3.8 15759316 522 RSSA_HUMAN ENSP00000346067 Hepatocellular Carcinoma Normal vs. Cancer adjacent paired nontumorous tissues clinical hepatitis B virus associated HCC tissue samples tissue Up 4.1 15759316 523 UBE2N_HUMAN ENSP00000316176 Hepatocellular Carcinoma Normal vs. Cancer adjacent paired nontumorous tissues clinical hepatitis B virus associated HCC tissue samples tissue Up 4.3 15759316 524 PCNA_HUMAN ENSP00000368458 Hepatocellular Carcinoma Normal vs. Cancer adjacent paired nontumorous tissues clinical hepatitis B virus associated HCC tissue samples tissue Up 9.1 15759316 525 STMN1_HUMAN ENSP00000382633 Hepatocellular Carcinoma Normal vs. Cancer adjacent paired nontumorous tissues clinical hepatitis B virus associated HCC tissue samples tissue Up 11 15759316 526 HSPB1_HUMAN ENSP00000248553 Breast Cancer Metastasis HER-2/neu-negative breast cancer (MDA-MB-231 and MCF-10A cell line) HER-2/neu-positive breast cancer (BT474 and SKBr3 cell line) cell line Up 5.5 16048908 527 ENOA_HUMAN ENSP00000234590 Breast Cancer Metastasis HER-2/neu-negative breast cancer (MDA-MB-231 and MCF-10A cell line) HER-2/neu-positive breast cancer (BT474 and SKBr3 cell line) cell line Up 7 16048908 528 FAS_HUMAN ENSP00000304592 Breast Cancer Metastasis HER-2/neu-negative breast cancer (MDA-MB-231 and MCF-10A cell line) HER-2/neu-positive breast cancer (BT474 and SKBr3 cell line) cell line Up 11 16048908 529 FA10_HUMAN ENSP00000364709 Pancreatic Cancer Normal vs. Cancer serum samples from individuals without cancer serum samples from individuals with pancreatic cancer tissue Down 2.8 16212428 530 AMBP_HUMAN ENSP00000265132 Pancreatic Cancer Normal vs. Cancer serum samples from individuals without cancer serum samples from individuals with pancreatic cancer tissue Down 3 16212428 531 ANT3_HUMAN ENSP00000356671 Pancreatic Cancer Normal vs. Cancer serum samples from individuals without cancer serum samples from individuals with pancreatic cancer tissue Down 3.1 16212428 532 TTHY_HUMAN ENSP00000237014 Pancreatic Cancer Normal vs. Cancer serum samples from individuals without cancer serum samples from individuals with pancreatic cancer tissue Down 7.9 16212428 533 SMC1A_HUMAN ENSP00000323421 Pancreatic Cancer Normal vs. Cancer serum samples from individuals without cancer serum samples from individuals with pancreatic cancer tissue Up 1.4 16212428 534 PRVA_HUMAN ENSP00000216200 Pancreatic Cancer Normal vs. Cancer serum samples from individuals without cancer serum samples from individuals with pancreatic cancer tissue Up 1.7 16212428 535 PLMN_HUMAN ENSP00000308938 Pancreatic Cancer Normal vs. Cancer serum samples from individuals without cancer serum samples from individuals with pancreatic cancer tissue Up 1.9 16212428 536 KNG1_HUMAN ENSP00000265023 Pancreatic Cancer Normal vs. Cancer serum samples from individuals without cancer serum samples from individuals with pancreatic cancer tissue Up 1.9 16212428 537 APOE_HUMAN ENSP00000252486 Pancreatic Cancer Normal vs. Cancer serum samples from individuals without cancer serum samples from individuals with pancreatic cancer tissue Up 7.7 16212428 538 ACTB_HUMAN ENSP00000349960 papillary thyroid carcinoma Normal vs. Cancer normal thyroid tissue Papillary thyroid carcinoma tissue Down 0.23 16788983 539 CO1A1_HUMAN ENSP00000225964 papillary thyroid carcinoma Normal vs. Cancer normal thyroid tissue Papillary thyroid carcinoma tissue Down 0.26 16788983 540 CO1A1_HUMAN ENSP00000225964 papillary thyroid carcinoma Normal vs. Cancer normal thyroid tissue Papillary thyroid carcinoma tissue Down 0.27 16788983 541 PP2AB_HUMAN ENSP00000384493 papillary thyroid carcinoma Normal vs. Cancer normal thyroid tissue Papillary thyroid carcinoma tissue Down 0.28 16788983 542 CALR_HUMAN ENSP00000320866 papillary thyroid carcinoma Normal vs. Cancer normal thyroid tissue Papillary thyroid carcinoma tissue Down 0.33 16788983 543 MOES_HUMAN ENSP00000353408 papillary thyroid carcinoma Normal vs. Cancer normal thyroid tissue Papillary thyroid carcinoma tissue Up 2 16788983 544 A1AT_HUMAN ENSP00000348068 papillary thyroid carcinoma Normal vs. Cancer normal thyroid tissue Papillary thyroid carcinoma tissue Up 2.1 16788983 545 LEG3_HUMAN ENSP00000254301 papillary thyroid carcinoma Normal vs. Cancer normal thyroid tissue Papillary thyroid carcinoma tissue Up 2.3 16788983 546 VDAC1_HUMAN ENSP00000378487 papillary thyroid carcinoma Normal vs. Cancer normal thyroid tissue Papillary thyroid carcinoma tissue Up 3.8 16788983 547 ANXA1_HUMAN ENSP00000366109 papillary thyroid carcinoma Normal vs. Cancer normal thyroid tissue Papillary thyroid carcinoma tissue Up 3.9 16788983 548 ANXA1_HUMAN ENSP00000366109 papillary thyroid carcinoma Normal vs. Cancer normal thyroid tissue Papillary thyroid carcinoma tissue Up 5 16788983 549 STMN1_HUMAN ENSP00000382633 Leukemia Normal vs. Cancer control (CD34+ selected bone marrow cells) Mixed lineage leukemia (MV4-11 cell line) cell line Down 0.22 17022645 550 EF1B_HUMAN ENSP00000376055 Leukemia Normal vs. Cancer control (CD34+ selected bone marrow cells) Mixed lineage leukemia (MV4-11 cell line) cell line Down 0.23 17022645 551 GSTP1_HUMAN ENSP00000381607 Leukemia Normal vs. Cancer control (CD34+ selected bone marrow cells) Mixed lineage leukemia (MV4-11 cell line) cell line Down 0.28 17022645 552 ENOA_HUMAN ENSP00000234590 Leukemia Normal vs. Cancer control (CD34+ selected bone marrow cells) Mixed lineage leukemia (MV4-11 cell line) cell line Down 0.29 17022645 553 NDKA_HUMAN ENSP00000013034 Leukemia Normal vs. Cancer control (CD34+ selected bone marrow cells) Mixed lineage leukemia (MV4-11 cell line) cell line Down 0.29 17022645 554 GRB2_HUMAN ENSP00000376347 Leukemia Normal vs. Cancer control (CD34+ selected bone marrow cells) Mixed lineage leukemia (MV4-11 cell line) cell line Down 0.33 17022645 555 EF2_HUMAN ENSP00000307940 Leukemia Normal vs. Cancer control (CD34+ selected bone marrow cells) Mixed lineage leukemia (MV4-11 cell line) cell line Down 0.34 17022645 556 DDX5_HUMAN ENSP00000225792 Leukemia Normal vs. Cancer control (CD34+ selected bone marrow cells) Mixed lineage leukemia (MV4-11 cell line) cell line Down 0.38 17022645 557 TBB5_HUMAN ENSP00000406811 Leukemia Normal vs. Cancer control (CD34+ selected bone marrow cells) Mixed lineage leukemia (MV4-11 cell line) cell line Down 0.39 17022645 558 KPYM_HUMAN ENSP00000334983 Leukemia Normal vs. Cancer control (CD34+ selected bone marrow cells) Mixed lineage leukemia (MV4-11 cell line) cell line Down 0.43 17022645 559 EGFR_HUMAN ENSP00000275493 Leukemia Normal vs. Cancer control (CD34+ selected bone marrow cells) Mixed lineage leukemia (MV4-11 cell line) cell line Down 0.45 17022645 560 HNRPK_HUMAN ENSP00000365440 Leukemia Normal vs. Cancer control (CD34+ selected bone marrow cells) Mixed lineage leukemia (MV4-11 cell line) cell line Down 0.45 17022645 561 FUBP1_HUMAN ENSP00000359804 Leukemia Normal vs. Cancer control (CD34+ selected bone marrow cells) Mixed lineage leukemia (MV4-11 cell line) cell line Down 0.47 17022645 562 PGAM1_HUMAN ENSP00000359991 Leukemia Normal vs. Cancer control (CD34+ selected bone marrow cells) Mixed lineage leukemia (MV4-11 cell line) cell line Up 2 17022645 563 ANXA2_HUMAN ENSP00000411352 Leukemia Normal vs. Cancer control (CD34+ selected bone marrow cells) Mixed lineage leukemia (MV4-11 cell line) cell line Up 2.4 17022645 564 ACTG_HUMAN ENSP00000331514 Leukemia Normal vs. Cancer control (CD34+ selected bone marrow cells) Mixed lineage leukemia (MV4-11 cell line) cell line Up 2.8 17022645 565 STIP1_HUMAN ENSP00000305958 Leukemia Normal vs. Cancer control (CD34+ selected bone marrow cells) Mixed lineage leukemia (MV4-11 cell line) cell line Up 3.5 17022645 566 MK01_HUMAN ENSP00000381803 Leukemia Normal vs. Cancer control (CD34+ selected bone marrow cells) Mixed lineage leukemia (MV4-11 cell line) cell line Up 5.7 17022645 567 IF4E_HUMAN ENSP00000389624 Leukemia Normal vs. Cancer control (CD34+ selected bone marrow cells) Mixed lineage leukemia (MV4-11 cell line) cell line Up 6.4 17022645 568 HSP7C_HUMAN ENSP00000227378 Leukemia Normal vs. Cancer control (CD34+ selected bone marrow cells) Mixed lineage leukemia (MV4-11 cell line) cell line Up 9.5 17022645 569 EF2_HUMAN ENSP00000307940 Leukemia Normal vs. Cancer control (CD34+ selected bone marrow cells) Mixed lineage leukemia (RS4:11 cell line) cell line Down 0.34 17022645 570 TBB5_HUMAN ENSP00000406811 Leukemia Normal vs. Cancer control (CD34+ selected bone marrow cells) Mixed lineage leukemia (RS4:11 cell line) cell line Down 0.35 17022645 571 EF1B_HUMAN ENSP00000376055 Leukemia Normal vs. Cancer control (CD34+ selected bone marrow cells) Mixed lineage leukemia (RS4:11 cell line) cell line Down 0.36 17022645 572 STIP1_HUMAN ENSP00000305958 Leukemia Normal vs. Cancer control (CD34+ selected bone marrow cells) Mixed lineage leukemia (RS4:11 cell line) cell line Down 0.36 17022645 573 KPYM_HUMAN ENSP00000334983 Leukemia Normal vs. Cancer control (CD34+ selected bone marrow cells) Mixed lineage leukemia (RS4:11 cell line) cell line Down 0.38 17022645 574 STMN1_HUMAN ENSP00000382633 Leukemia Normal vs. Cancer control (CD34+ selected bone marrow cells) Mixed lineage leukemia (RS4:11 cell line) cell line Down 0.38 17022645 575 DDX5_HUMAN ENSP00000225792 Leukemia Normal vs. Cancer control (CD34+ selected bone marrow cells) Mixed lineage leukemia (RS4:11 cell line) cell line Down 0.39 17022645 576 ENOA_HUMAN ENSP00000234590 Leukemia Normal vs. Cancer control (CD34+ selected bone marrow cells) Mixed lineage leukemia (RS4:11 cell line) cell line Down 0.43 17022645 577 HNRPK_HUMAN ENSP00000365440 Leukemia Normal vs. Cancer control (CD34+ selected bone marrow cells) Mixed lineage leukemia (RS4:11 cell line) cell line Down 0.45 17022645 578 FUBP1_HUMAN ENSP00000359804 Leukemia Normal vs. Cancer control (CD34+ selected bone marrow cells) Mixed lineage leukemia (RS4:11 cell line) cell line Down 0.47 17022645 579 ANXA2_HUMAN ENSP00000411352 Leukemia Normal vs. Cancer control (CD34+ selected bone marrow cells) Mixed lineage leukemia (RS4:11 cell line) cell line Up 2.2 17022645 580 NDKA_HUMAN ENSP00000013034 Leukemia Normal vs. Cancer control (CD34+ selected bone marrow cells) Mixed lineage leukemia (RS4:11 cell line) cell line Up 2.4 17022645 581 MK01_HUMAN ENSP00000381803 Leukemia Normal vs. Cancer control (CD34+ selected bone marrow cells) Mixed lineage leukemia (RS4:11 cell line) cell line Up 2.5 17022645 582 IF4E_HUMAN ENSP00000389624 Leukemia Normal vs. Cancer control (CD34+ selected bone marrow cells) Mixed lineage leukemia (RS4:11 cell line) cell line Up 3.3 17022645 583 GRB2_HUMAN ENSP00000376347 Leukemia Normal vs. Cancer control (CD34+ selected bone marrow cells) Mixed lineage leukemia (RS4:11 cell line) cell line Up 4.4 17022645 584 ACTG_HUMAN ENSP00000331514 Leukemia Normal vs. Cancer control (CD34+ selected bone marrow cells) Mixed lineage leukemia (RS4:11 cell line) cell line Up 5.2 17022645 585 EGFR_HUMAN ENSP00000275493 Leukemia Normal vs. Cancer control (CD34+ selected bone marrow cells) Mixed lineage leukemia (RS4:11 cell line) cell line Up 5.7 17022645 586 HSP7C_HUMAN ENSP00000227378 Leukemia Normal vs. Cancer control (CD34+ selected bone marrow cells) Mixed lineage leukemia (RS4:11 cell line) cell line Up 7.2 17022645 587 PGAM1_HUMAN ENSP00000359991 Leukemia Normal vs. Cancer control (CD34+ selected bone marrow cells) Mixed lineage leukemia (RS4:11 cell line) cell line Up 12 17022645 588 GSTP1_HUMAN ENSP00000381607 Leukemia Normal vs. Cancer control (CD34+ selected bone marrow cells) Mixed lineage leukemia (RS4:11 cell line) cell line Up 24 17022645 589 EF1B_HUMAN ENSP00000376055 Breast Cancer Normal vs. Cancer adjacent normal breast tissues breast cancer tissues tissue Up 17127214 590 TAGL2_HUMAN ENSP00000357075 Breast Cancer Normal vs. Cancer adjacent normal breast tissues breast cancer tissues tissue Up 17127214 591 SUMO3_HUMAN ENSP00000330343 Breast Cancer Normal vs. Cancer adjacent normal breast tissues breast cancer tissues tissue Up 17127214 592 VTNC_HUMAN ENSP00000226218 Hepatocellular Carcinoma Normal vs. Cancer adjacent nontumorous liver tissue Hepatocellular carcinoma (HCC) tissue Down 0.11 17627933 593 K2C8_HUMAN ENSP00000293308 Hepatocellular Carcinoma Normal vs. Cancer adjacent nontumorous liver tissue Hepatocellular carcinoma (HCC) tissue Down 0.16 17627933 594 HBA_HUMAN ENSP00000322421 Hepatocellular Carcinoma Normal vs. Cancer adjacent nontumorous liver tissue Hepatocellular carcinoma (HCC) tissue Down 0.27 17627933 595 HBB_HUMAN ENSP00000333994 Hepatocellular Carcinoma Normal vs. Cancer adjacent nontumorous liver tissue Hepatocellular carcinoma (HCC) tissue Down 0.29 17627933 596 COMT_HUMAN ENSP00000385150 Hepatocellular Carcinoma Normal vs. Cancer adjacent nontumorous liver tissue Hepatocellular carcinoma (HCC) tissue Down 0.34 17627933 597 GNMT_HUMAN ENSP00000361894 Hepatocellular Carcinoma Normal vs. Cancer adjacent nontumorous liver tissue Hepatocellular carcinoma (HCC) tissue Down 0.48 17627933 598 G3P_HUMAN ENSP00000380068 Hepatocellular Carcinoma Normal vs. Cancer adjacent nontumorous liver tissue Hepatocellular carcinoma (HCC) tissue Down 0.49 17627933 599 ENPL_HUMAN ENSP00000299767 Hepatocellular Carcinoma Normal vs. Cancer adjacent nontumorous liver tissue Hepatocellular carcinoma (HCC) tissue Up 2.1 17627933 600 HS90B_HUMAN ENSP00000360609 Hepatocellular Carcinoma Normal vs. Cancer adjacent nontumorous liver tissue Hepatocellular carcinoma (HCC) tissue Up 2.2 17627933 601 HNRPC_HUMAN ENSP00000319690 Hepatocellular Carcinoma Normal vs. Cancer adjacent nontumorous liver tissue Hepatocellular carcinoma (HCC) tissue Up 2.3 17627933 602 GELS_HUMAN ENSP00000362924 Hepatocellular Carcinoma Normal vs. Cancer adjacent nontumorous liver tissue Hepatocellular carcinoma (HCC) tissue Up 2.3 17627933 603 G3P_HUMAN ENSP00000380068 Hepatocellular Carcinoma Normal vs. Cancer adjacent nontumorous liver tissue Hepatocellular carcinoma (HCC) tissue Up 2.4 17627933 604 ALBU_HUMAN ENSP00000295897 Hepatocellular Carcinoma Normal vs. Cancer adjacent nontumorous liver tissue Hepatocellular carcinoma (HCC) tissue Up 2.4 17627933 605 HSP71_HUMAN ENSP00000364801 Hepatocellular Carcinoma Normal vs. Cancer adjacent nontumorous liver tissue Hepatocellular carcinoma (HCC) tissue Up 2.4 17627933 606 STIP1_HUMAN ENSP00000305958 Hepatocellular Carcinoma Normal vs. Cancer adjacent nontumorous liver tissue Hepatocellular carcinoma (HCC) tissue Up 2.4 17627933 607 LMNA_HUMAN ENSP00000357283 Hepatocellular Carcinoma Normal vs. Cancer adjacent nontumorous liver tissue Hepatocellular carcinoma (HCC) tissue Up 2.8 17627933 608 NPM_HUMAN ENSP00000296930 Hepatocellular Carcinoma Normal vs. Cancer adjacent nontumorous liver tissue Hepatocellular carcinoma (HCC) tissue Up 3 17627933 609 PCNA_HUMAN ENSP00000368458 Hepatocellular Carcinoma Normal vs. Cancer adjacent nontumorous liver tissue Hepatocellular carcinoma (HCC) tissue Up 3 17627933 610 EF1A1_HUMAN ENSP00000330054 Hepatocellular Carcinoma Normal vs. Cancer adjacent nontumorous liver tissue Hepatocellular carcinoma (HCC) tissue Up 3.4 17627933 611 CAN2_HUMAN ENSP00000295006 Thyroid Carcinoma Normal vs. Cancer normal thyroid tissue (ST) 27 solitary cold thyroid nodules (10 follicular adenoma and 20 adenomatous nodules) tissue Up 2.5 17194741 612 HSPB1_HUMAN ENSP00000248553 Thyroid Carcinoma Normal vs. Cancer normal thyroid tissue (ST) 27 solitary cold thyroid nodules (10 follicular adenoma and 20 adenomatous nodules) tissue Up 2.6 17194741 613 PSA3_HUMAN ENSP00000216455 Thyroid Carcinoma Normal vs. Cancer normal thyroid tissue (ST) 27 solitary cold thyroid nodules (10 follicular adenoma and 20 adenomatous nodules) tissue Up 2.6 17194741 614 CASP1_HUMAN ENSP00000410076 Thyroid Carcinoma Normal vs. Cancer normal thyroid tissue (ST) 27 solitary cold thyroid nodules (10 follicular adenoma and 20 adenomatous nodules) tissue Up 2.7 17194741 615 APOA1_HUMAN ENSP00000236850 Thyroid Carcinoma Normal vs. Cancer normal thyroid tissue (ST) 27 solitary cold thyroid nodules (10 follicular adenoma and 20 adenomatous nodules) tissue Up 3.2 17194741 616 TTHY_HUMAN ENSP00000237014 Thyroid Carcinoma Normal vs. Cancer normal thyroid tissue (ST) 27 solitary cold thyroid nodules (10 follicular adenoma and 20 adenomatous nodules) tissue Up 3.2 17194741 617 CALR_HUMAN ENSP00000320866 Thyroid Carcinoma Normal vs. Cancer normal thyroid tissue (ST) 27 solitary cold thyroid nodules (10 follicular adenoma and 20 adenomatous nodules) tissue Up 3.2 17194741 618 PARK7_HUMAN ENSP00000366708 Thyroid Carcinoma Normal vs. Cancer normal thyroid tissue (ST) 27 solitary cold thyroid nodules (10 follicular adenoma and 20 adenomatous nodules) tissue Up 3.2 17194741 619 GDIR1_HUMAN ENSP00000269321 Thyroid Carcinoma Normal vs. Cancer normal thyroid tissue (ST) 27 solitary cold thyroid nodules (10 follicular adenoma and 20 adenomatous nodules) tissue Up 3.3 17194741 620 HS90B_HUMAN ENSP00000360609 Thyroid Carcinoma Normal vs. Cancer normal thyroid tissue (ST) 27 solitary cold thyroid nodules (10 follicular adenoma and 20 adenomatous nodules) tissue Up 4.2 17194741 621 APOA1_HUMAN ENSP00000236850 Thyroid Carcinoma Normal vs. Cancer normal thyroid tissue (ST) 27 solitary cold thyroid nodules (10 follicular adenoma and 20 adenomatous nodules) tissue Up 5.2 17194741 622 GSTP1_HUMAN ENSP00000381607 Thyroid Carcinoma Normal vs. Cancer normal thyroid tissue (ST) 27 solitary cold thyroid nodules (10 follicular adenoma and 20 adenomatous nodules) tissue Up 5.2 17194741 623 ENPL_HUMAN ENSP00000299767 Prostate Cancer Metastasis poorly metastatic LNCaP cell line highly metastatic variant LNCaP-LN3 cell line cell line Up 1.6 18232632 624 NPM_HUMAN ENSP00000296930 Prostate Cancer Metastasis poorly metastatic LNCaP cell line highly metastatic variant LNCaP-LN3 cell line cell line Up 1.7 18232632 625 CALR_HUMAN ENSP00000320866 Prostate Cancer Metastasis poorly metastatic LNCaP cell line highly metastatic variant LNCaP-LN3 cell line cell line Up 1.9 18232632 626 K2C8_HUMAN ENSP00000293308 follicular thyroid carcinoma Normal vs. Cancer benign follicular thyroid adenoma (FTA) malignant follicular thyroid carcinoma (FTC) tissue Down 0.22 18316623 627 ENPL_HUMAN ENSP00000299767 follicular thyroid carcinoma Normal vs. Cancer benign follicular thyroid adenoma (FTA) malignant follicular thyroid carcinoma (FTC) tissue Down 0.28 18316623 628 CALR_HUMAN ENSP00000320866 follicular thyroid carcinoma Normal vs. Cancer benign follicular thyroid adenoma (FTA) malignant follicular thyroid carcinoma (FTC) tissue Down 0.44 18316623 629 ACTB_HUMAN ENSP00000349960 follicular thyroid carcinoma Normal vs. Cancer benign follicular thyroid adenoma (FTA) malignant follicular thyroid carcinoma (FTC) tissue Down 0.49 18316623 630 ACTB_HUMAN ENSP00000349960 follicular thyroid carcinoma Normal vs. Cancer benign follicular thyroid adenoma (FTA) malignant follicular thyroid carcinoma (FTC) tissue Down 0.56 18316623 631 ENPL_HUMAN ENSP00000299767 follicular thyroid carcinoma Normal vs. Cancer benign follicular thyroid adenoma (FTA) malignant follicular thyroid carcinoma (FTC) tissue Down 0.6 18316623 632 H2B1C_HUMAN ENSP00000353074 follicular thyroid carcinoma Normal vs. Cancer benign follicular thyroid adenoma (FTA) malignant follicular thyroid carcinoma (FTC) tissue Down 0.61 18316623 633 HS90B_HUMAN ENSP00000360609 follicular thyroid carcinoma Normal vs. Cancer benign follicular thyroid adenoma (FTA) malignant follicular thyroid carcinoma (FTC) tissue Down 0.67 18316623 634 LMNA_HUMAN ENSP00000357283 follicular thyroid carcinoma Normal vs. Cancer benign follicular thyroid adenoma (FTA) malignant follicular thyroid carcinoma (FTC) tissue Down 0.75 18316623 635 SND1_HUMAN ENSP00000346762 follicular thyroid carcinoma Normal vs. Cancer benign follicular thyroid adenoma (FTA) malignant follicular thyroid carcinoma (FTC) tissue Down 0.78 18316623 636 ACTB_HUMAN ENSP00000349960 follicular thyroid carcinoma Normal vs. Cancer benign follicular thyroid adenoma (FTA) malignant follicular thyroid carcinoma (FTC) tissue Up 1.2 18316623 637 ACTB_HUMAN ENSP00000349960 follicular thyroid carcinoma Normal vs. Cancer benign follicular thyroid adenoma (FTA) malignant follicular thyroid carcinoma (FTC) tissue Up 1.3 18316623 638 NDKA_HUMAN ENSP00000013034 follicular thyroid carcinoma Normal vs. Cancer benign follicular thyroid adenoma (FTA) malignant follicular thyroid carcinoma (FTC) tissue Up 1.6 18316623 639 K1C18_HUMAN ENSP00000373489 follicular thyroid carcinoma Normal vs. Cancer benign follicular thyroid adenoma (FTA) malignant follicular thyroid carcinoma (FTC) tissue Up 1.8 18316623 640 K2C8_HUMAN ENSP00000293308 follicular thyroid carcinoma Normal vs. Cancer benign follicular thyroid adenoma (FTA) malignant follicular thyroid carcinoma (FTC) tissue Up 1.9 18316623 641 K2C8_HUMAN ENSP00000293308 follicular thyroid carcinoma Normal vs. Cancer benign follicular thyroid adenoma (FTA) malignant follicular thyroid carcinoma (FTC) tissue Up 2.3 18316623 642 H2B1C_HUMAN ENSP00000353074 follicular thyroid carcinoma Normal vs. Cancer benign follicular thyroid adenoma (FTA) malignant follicular thyroid carcinoma (FTC) tissue Up 2.5 18316623 643 A1AT_HUMAN ENSP00000348068 pancreatic ductal adenocarcinoma Normal vs. Cancer adjacent normal tissue pancreatic ductal adenocarcinoma (PDAC) tissue Up 3.1 18366394 644 A1AT_HUMAN ENSP00000348068 pancreatic ductal adenocarcinoma Normal vs. Cancer adjacent normal tissue pancreatic ductal adenocarcinoma (PDAC) tissue Up 3.4 18366394 645 GELS_HUMAN ENSP00000362924 pancreatic ductal adenocarcinoma Normal vs. Cancer adjacent normal tissue pancreatic ductal adenocarcinoma (PDAC) tissue Up 6.5 18366394 646 KPYM_HUMAN ENSP00000334983 Lung Cancer Treatment (none vs. FK228 treatment) normal H322 cells FK228 treated H322 cells cell line Down 18549279 647 PGAM1_HUMAN ENSP00000359991 Lung Cancer Treatment (none vs. FK228 treatment) normal H322 cells FK228 treated H322 cells cell line Down 18549279 648 G3BP1_HUMAN ENSP00000348578 Lung Cancer Treatment (none vs. FK228 treatment) normal H322 cells FK228 treated H322 cells cell line Down 18549279 649 FUBP1_HUMAN ENSP00000359804 Lung Cancer Treatment (none vs. FK228 treatment) normal H322 cells FK228 treated H322 cells cell line Down 18549279 650 GRB2_HUMAN ENSP00000376347 Lung Cancer Treatment (none vs. FK228 treatment) normal H322 cells FK228 treated H322 cells cell line Up 18549279 651 SYUG_HUMAN ENSP00000361087 Prostate Cancer Metastasis benign prostatic hyperplasia (BPH) prostate cancer (Tumour Node Metastasis [TNM] stage T1-T3) tissue Down 0.18 18553995 652 GAGC1_HUMAN ENSP00000218068 Prostate Cancer Metastasis benign prostatic hyperplasia (BPH) prostate cancer (Tumour Node Metastasis [TNM] stage T1-T3) tissue Down 0.25 18553995 653 GSTP1_HUMAN ENSP00000381607 Prostate Cancer Metastasis benign prostatic hyperplasia (BPH) prostate cancer (Tumour Node Metastasis [TNM] stage T1-T3) tissue Down 0.29 18553995 654 RRAS_HUMAN ENSP00000246792 Prostate Cancer Metastasis benign prostatic hyperplasia (BPH) prostate cancer (Tumour Node Metastasis [TNM] stage T1-T3) tissue Down 0.31 18553995 655 ERCC3_HUMAN ENSP00000285398 Prostate Cancer Metastasis benign prostatic hyperplasia (BPH) prostate cancer (Tumour Node Metastasis [TNM] stage T1-T3) tissue Down 0.32 18553995 656 TGFI1_HUMAN ENSP00000378332 Prostate Cancer Metastasis benign prostatic hyperplasia (BPH) prostate cancer (Tumour Node Metastasis [TNM] stage T1-T3) tissue Down 0.38 18553995 657 PPAP_HUMAN ENSP00000337471 Prostate Cancer Metastasis benign prostatic hyperplasia (BPH) prostate cancer (Tumour Node Metastasis [TNM] stage T1-T3) tissue Down 0.42 18553995 658 ZYX_HUMAN ENSP00000324422 Prostate Cancer Metastasis benign prostatic hyperplasia (BPH) prostate cancer (Tumour Node Metastasis [TNM] stage T1-T3) tissue Down 0.45 18553995 659 VINC_HUMAN ENSP00000211998 Prostate Cancer Metastasis benign prostatic hyperplasia (BPH) prostate cancer (Tumour Node Metastasis [TNM] stage T1-T3) tissue Down 0.46 18553995 660 1433B_HUMAN ENSP00000361930 Prostate Cancer Metastasis benign prostatic hyperplasia (BPH) prostate cancer (Tumour Node Metastasis [TNM] stage T1-T3) tissue Down 0.52 18553995 661 EZRI_HUMAN ENSP00000356042 Prostate Cancer Metastasis benign prostatic hyperplasia (BPH) prostate cancer (Tumour Node Metastasis [TNM] stage T1-T3) tissue Up 2.3 18553995 662 CNBP_HUMAN ENSP00000410619 Prostate Cancer Metastasis benign prostatic hyperplasia (BPH) prostate cancer (Tumour Node Metastasis [TNM] stage T1-T3) tissue Up 2.3 18553995 663 FKBP4_HUMAN ENSP00000001008 Prostate Cancer Metastasis benign prostatic hyperplasia (BPH) prostate cancer (Tumour Node Metastasis [TNM] stage T1-T3) tissue Up 2.5 18553995 664 FAS_HUMAN ENSP00000304592 Prostate Cancer Metastasis benign prostatic hyperplasia (BPH) prostate cancer (Tumour Node Metastasis [TNM] stage T1-T3) tissue Up 2.8 18553995 665 NPM_HUMAN ENSP00000296930 Prostate Cancer Metastasis benign prostatic hyperplasia (BPH) prostate cancer (Tumour Node Metastasis [TNM] stage T1-T3) tissue Up 3 18553995 666 TEBP_HUMAN ENSP00000262033 Prostate Cancer Metastasis benign prostatic hyperplasia (BPH) prostate cancer (Tumour Node Metastasis [TNM] stage T1-T3) tissue Up 3.1 18553995 667 HS90B_HUMAN ENSP00000360609 Prostate Cancer Metastasis benign prostatic hyperplasia (BPH) prostate cancer (Tumour Node Metastasis [TNM] stage T1-T3) tissue Up 3.2 18553995 668 COF1_HUMAN ENSP00000309629 Prostate Cancer Metastasis benign prostatic hyperplasia (BPH) prostate cancer (Tumour Node Metastasis [TNM] stage T1-T3) tissue Up 3.3 18553995 669 CBX1_HUMAN ENSP00000377060 Prostate Cancer Metastasis benign prostatic hyperplasia (BPH) prostate cancer (Tumour Node Metastasis [TNM] stage T1-T3) tissue Up 3.4 18553995 670 ALBU_HUMAN ENSP00000295897 papillary thyroid carcinoma Normal vs. Cancer normal control malignant papillary thyroid cancer (classical variant) tissue Up 1.1 18665625 671 TTHY_HUMAN ENSP00000237014 papillary thyroid carcinoma Normal vs. Cancer normal control malignant papillary thyroid cancer (classical variant) tissue Up 1.5 18665625 672 ACTB_HUMAN ENSP00000349960 papillary thyroid carcinoma Normal vs. Cancer normal control malignant papillary thyroid cancer (classical variant) tissue Up 1.5 18665625 673 PARK7_HUMAN ENSP00000366708 papillary thyroid carcinoma Normal vs. Cancer normal control malignant papillary thyroid cancer (classical variant) tissue Up 2.1 18665625 674 COF1_HUMAN ENSP00000309629 papillary thyroid carcinoma Normal vs. Cancer normal control malignant papillary thyroid cancer (classical variant) tissue Up 2.4 18665625 675 TTHY_HUMAN ENSP00000237014 papillary thyroid carcinoma Normal vs. Cancer normal control malignant papillary thyroid cancer (classical variant) tissue Up 3.9 18665625 676 G3P_HUMAN ENSP00000380068 papillary thyroid carcinoma Normal vs. Cancer normal control malignant papillary thyroid cancer (classical variant) tissue Up 3.9 18665625 677 APOA1_HUMAN ENSP00000236850 papillary thyroid carcinoma Normal vs. Cancer normal control malignant papillary thyroid cancer (classical variant) tissue Up 4.5 18665625 678 MOES_HUMAN ENSP00000353408 papillary thyroid carcinoma Normal vs. Cancer normal control malignant papillary thyroid cancer (classical variant) tissue Up 5.4 18665625 679 LEG3_HUMAN ENSP00000254301 papillary thyroid carcinoma Normal vs. Cancer normal control malignant papillary thyroid cancer (classical variant) tissue Up 6 18665625 680 ANXA1_HUMAN ENSP00000366109 papillary thyroid carcinoma Normal vs. Cancer normal control malignant papillary thyroid cancer (classical variant) tissue Up 13 18665625 681 TTHY_HUMAN ENSP00000237014 papillary thyroid carcinoma Normal vs. Cancer normal control malignant papillary thyroid cancer (tall cell variant) tissue Up 1.4 18665625 682 PARK7_HUMAN ENSP00000366708 papillary thyroid carcinoma Normal vs. Cancer normal control malignant papillary thyroid cancer (tall cell variant) tissue Up 1.8 18665625 683 ALBU_HUMAN ENSP00000295897 papillary thyroid carcinoma Normal vs. Cancer normal control malignant papillary thyroid cancer (tall cell variant) tissue Up 2 18665625 684 TTHY_HUMAN ENSP00000237014 papillary thyroid carcinoma Normal vs. Cancer normal control malignant papillary thyroid cancer (tall cell variant) tissue Up 2.1 18665625 685 MOES_HUMAN ENSP00000353408 papillary thyroid carcinoma Normal vs. Cancer normal control malignant papillary thyroid cancer (tall cell variant) tissue Up 2.5 18665625 686 ACTB_HUMAN ENSP00000349960 papillary thyroid carcinoma Normal vs. Cancer normal control malignant papillary thyroid cancer (tall cell variant) tissue Up 2.6 18665625 687 LEG3_HUMAN ENSP00000254301 papillary thyroid carcinoma Normal vs. Cancer normal control malignant papillary thyroid cancer (tall cell variant) tissue Up 3 18665625 688 G3P_HUMAN ENSP00000380068 papillary thyroid carcinoma Normal vs. Cancer normal control malignant papillary thyroid cancer (tall cell variant) tissue Up 3.1 18665625 689 COF1_HUMAN ENSP00000309629 papillary thyroid carcinoma Normal vs. Cancer normal control malignant papillary thyroid cancer (tall cell variant) tissue Up 3.2 18665625 690 ANXA1_HUMAN ENSP00000366109 papillary thyroid carcinoma Normal vs. Cancer normal control malignant papillary thyroid cancer (tall cell variant) tissue Up 5.7 18665625 691 APOA1_HUMAN ENSP00000236850 papillary thyroid carcinoma Normal vs. Cancer normal control malignant papillary thyroid cancer (tall cell variant) tissue Up 7.6 18665625 692 PLIN1_HUMAN ENSP00000402167 Breast Cancer Metastasis low-grade breast primary tumor tissues without metastases low-grade breast primary tumor tissues with metastases tissue Down 0.41 19053527 693 FABP4_HUMAN ENSP00000256104 Breast Cancer Metastasis low-grade breast primary tumor tissues without metastases low-grade breast primary tumor tissues with metastases tissue Down 0.47 19053527 694 TSP1_HUMAN ENSP00000260356 Breast Cancer Metastasis low-grade breast primary tumor tissues without metastases low-grade breast primary tumor tissues with metastases in lymph node tissue Down 0.25 19053527 695 FINC_HUMAN ENSP00000352696 Breast Cancer Metastasis low-grade breast primary tumor tissues without metastases low-grade breast primary tumor tissues with metastases in lymph node tissue Down 0.4 19053527 696 FABP4_HUMAN ENSP00000256104 Breast Cancer Metastasis low-grade breast primary tumor tissues without metastases low-grade breast primary tumor tissues with metastases in lymph node tissue Down 0.41 19053527 697 PLIN1_HUMAN ENSP00000402167 Breast Cancer Metastasis low-grade breast primary tumor tissues without metastases low-grade breast primary tumor tissues with metastases in lymph node tissue Down 0.42 19053527 698 GSTP1_HUMAN ENSP00000381607 Breast Cancer Metastasis low-grade breast primary tumor tissues without metastases low-grade breast primary tumor tissues with metastases in lymph node tissue Up 2.1 19053527 699 IFM1_HUMAN ENSP00000386187 Breast Cancer Metastasis low-grade breast primary tumor tissues without metastases low-grade breast primary tumor tissues with metastases in lymph node tissue Up 2.2 19053527 700 CALL5_HUMAN ENSP00000369689 Breast Cancer Metastasis low-grade breast primary tumor tissues without metastases low-grade breast primary tumor tissues with metastases in lymph node tissue Up 2.4 19053527 701 SPRE_HUMAN ENSP00000234454 Breast Cancer Metastasis low-grade breast primary tumor tissues without metastases low-grade breast primary tumor tissues with metastases in lymph node tissue Up 2.6 19053527 702 S10AB_HUMAN ENSP00000271638 Oral Premalignant Lesions Normal vs. Cancer normal oral tissues 1 oral premalignant lesions (OPLs) tissues 1 tissue Down 0.48 19072117 703 PTMA_HUMAN ENSP00000344547 Oral Premalignant Lesions Normal vs. Cancer normal oral tissues 1 oral premalignant lesions (OPLs) tissues 1 tissue Down 0.64 19072117 704 MARCS_HUMAN ENSP00000357624 Oral Premalignant Lesions Normal vs. Cancer normal oral tissues 1 oral premalignant lesions (OPLs) tissues 1 tissue Down 0.67 19072117 705 1433S_HUMAN ENSP00000340989 Oral Premalignant Lesions Normal vs. Cancer normal oral tissues 1 oral premalignant lesions (OPLs) tissues 1 tissue Down 0.74 19072117 706 1433Z_HUMAN ENSP00000379288 Oral Premalignant Lesions Normal vs. Cancer normal oral tissues 1 oral premalignant lesions (OPLs) tissues 1 tissue Up 1 19072117 707 GELS_HUMAN ENSP00000362924 Oral Premalignant Lesions Normal vs. Cancer normal oral tissues 1 oral premalignant lesions (OPLs) tissues 1 tissue Up 1 19072117 708 KPYM_HUMAN ENSP00000334983 Oral Premalignant Lesions Normal vs. Cancer normal oral tissues 1 oral premalignant lesions (OPLs) tissues 1 tissue Up 1 19072117 709 COF1_HUMAN ENSP00000309629 Oral Premalignant Lesions Normal vs. Cancer normal oral tissues 1 oral premalignant lesions (OPLs) tissues 1 tissue Up 1.1 19072117 710 HSPB1_HUMAN ENSP00000248553 Oral Premalignant Lesions Normal vs. Cancer normal oral tissues 1 oral premalignant lesions (OPLs) tissues 1 tissue Up 1.2 19072117 711 NPM_HUMAN ENSP00000296930 Oral Premalignant Lesions Normal vs. Cancer normal oral tissues 1 oral premalignant lesions (OPLs) tissues 1 tissue Up 1.2 19072117 712 ACTB_HUMAN ENSP00000349960 Oral Premalignant Lesions Normal vs. Cancer normal oral tissues 1 oral premalignant lesions (OPLs) tissues 1 tissue Up 1.2 19072117 713 CALL3_HUMAN ENSP00000315299 Oral Premalignant Lesions Normal vs. Cancer normal oral tissues 1 oral premalignant lesions (OPLs) tissues 1 tissue Up 1.2 19072117 714 EF2_HUMAN ENSP00000307940 Oral Premalignant Lesions Normal vs. Cancer normal oral tissues 1 oral premalignant lesions (OPLs) tissues 1 tissue Up 1.3 19072117 715 G3P_HUMAN ENSP00000380068 Oral Premalignant Lesions Normal vs. Cancer normal oral tissues 1 oral premalignant lesions (OPLs) tissues 1 tissue Up 1.4 19072117 716 ENPL_HUMAN ENSP00000299767 Oral Premalignant Lesions Normal vs. Cancer normal oral tissues 1 oral premalignant lesions (OPLs) tissues 1 tissue Up 2.9 19072117 717 H2B2E_HUMAN ENSP00000358151 Oral Premalignant Lesions Normal vs. Cancer normal oral tissues 1 oral premalignant lesions (OPLs) tissues 1 tissue Up 3 19072117 718 HNRPK_HUMAN ENSP00000365440 Oral Premalignant Lesions Normal vs. Cancer normal oral tissues 1 oral premalignant lesions (OPLs) tissues 1 tissue Up 9.9 19072117 719 S10AB_HUMAN ENSP00000271638 Oral Premalignant Lesions Normal vs. Cancer normal oral tissues 2 oral premalignant lesions (OPLs) tissues 2 tissue Down 0.45 19072117 720 MARCS_HUMAN ENSP00000357624 Oral Premalignant Lesions Normal vs. Cancer normal oral tissues 2 oral premalignant lesions (OPLs) tissues 2 tissue Down 0.5 19072117 721 PTMA_HUMAN ENSP00000344547 Oral Premalignant Lesions Normal vs. Cancer normal oral tissues 2 oral premalignant lesions (OPLs) tissues 2 tissue Down 0.61 19072117 722 NPM_HUMAN ENSP00000296930 Oral Premalignant Lesions Normal vs. Cancer normal oral tissues 2 oral premalignant lesions (OPLs) tissues 2 tissue Down 0.96 19072117 723 CALL3_HUMAN ENSP00000315299 Oral Premalignant Lesions Normal vs. Cancer normal oral tissues 2 oral premalignant lesions (OPLs) tissues 2 tissue Down 0.97 19072117 724 GELS_HUMAN ENSP00000362924 Oral Premalignant Lesions Normal vs. Cancer normal oral tissues 2 oral premalignant lesions (OPLs) tissues 2 tissue Up 1 19072117 725 HNRPK_HUMAN ENSP00000365440 Oral Premalignant Lesions Normal vs. Cancer normal oral tissues 2 oral premalignant lesions (OPLs) tissues 2 tissue Up 1.1 19072117 726 H2B2E_HUMAN ENSP00000358151 Oral Premalignant Lesions Normal vs. Cancer normal oral tissues 2 oral premalignant lesions (OPLs) tissues 2 tissue Up 1.2 19072117 727 COF1_HUMAN ENSP00000309629 Oral Premalignant Lesions Normal vs. Cancer normal oral tissues 2 oral premalignant lesions (OPLs) tissues 2 tissue Up 1.3 19072117 728 KPYM_HUMAN ENSP00000334983 Oral Premalignant Lesions Normal vs. Cancer normal oral tissues 2 oral premalignant lesions (OPLs) tissues 2 tissue Up 1.4 19072117 729 EF2_HUMAN ENSP00000307940 Oral Premalignant Lesions Normal vs. Cancer normal oral tissues 2 oral premalignant lesions (OPLs) tissues 2 tissue Up 1.5 19072117 730 G3P_HUMAN ENSP00000380068 Oral Premalignant Lesions Normal vs. Cancer normal oral tissues 2 oral premalignant lesions (OPLs) tissues 2 tissue Up 1.6 19072117 731 ACTB_HUMAN ENSP00000349960 Oral Premalignant Lesions Normal vs. Cancer normal oral tissues 2 oral premalignant lesions (OPLs) tissues 2 tissue Up 1.6 19072117 732 ENPL_HUMAN ENSP00000299767 Oral Premalignant Lesions Normal vs. Cancer normal oral tissues 2 oral premalignant lesions (OPLs) tissues 2 tissue Up 1.6 19072117 733 HSPB1_HUMAN ENSP00000248553 Oral Premalignant Lesions Normal vs. Cancer normal oral tissues 2 oral premalignant lesions (OPLs) tissues 2 tissue Up 1.9 19072117 734 1433S_HUMAN ENSP00000340989 Oral Premalignant Lesions Normal vs. Cancer normal oral tissues 2 oral premalignant lesions (OPLs) tissues 2 tissue Up 2.1 19072117 735 1433Z_HUMAN ENSP00000379288 Oral Premalignant Lesions Normal vs. Cancer normal oral tissues 2 oral premalignant lesions (OPLs) tissues 2 tissue Up 3.1 19072117 736 MARCS_HUMAN ENSP00000357624 Oral Premalignant Lesions Normal vs. Cancer normal oral tissues 3 oral premalignant lesions (OPLs) tissues 3 tissue Down 0.57 19072117 737 G3P_HUMAN ENSP00000380068 Oral Premalignant Lesions Normal vs. Cancer normal oral tissues 3 oral premalignant lesions (OPLs) tissues 3 tissue Down 0.75 19072117 738 HSPB1_HUMAN ENSP00000248553 Oral Premalignant Lesions Normal vs. Cancer normal oral tissues 3 oral premalignant lesions (OPLs) tissues 3 tissue Down 0.78 19072117 739 ACTB_HUMAN ENSP00000349960 Oral Premalignant Lesions Normal vs. Cancer normal oral tissues 3 oral premalignant lesions (OPLs) tissues 3 tissue Down 0.86 19072117 740 GELS_HUMAN ENSP00000362924 Oral Premalignant Lesions Normal vs. Cancer normal oral tissues 3 oral premalignant lesions (OPLs) tissues 3 tissue Down 0.95 19072117 741 HNRPK_HUMAN ENSP00000365440 Oral Premalignant Lesions Normal vs. Cancer normal oral tissues 3 oral premalignant lesions (OPLs) tissues 3 tissue Up 1.1 19072117 742 CALL3_HUMAN ENSP00000315299 Oral Premalignant Lesions Normal vs. Cancer normal oral tissues 3 oral premalignant lesions (OPLs) tissues 3 tissue Up 1.1 19072117 743 PTMA_HUMAN ENSP00000344547 Oral Premalignant Lesions Normal vs. Cancer normal oral tissues 3 oral premalignant lesions (OPLs) tissues 3 tissue Up 1.2 19072117 744 ENPL_HUMAN ENSP00000299767 Oral Premalignant Lesions Normal vs. Cancer normal oral tissues 3 oral premalignant lesions (OPLs) tissues 3 tissue Up 1.2 19072117 745 1433Z_HUMAN ENSP00000379288 Oral Premalignant Lesions Normal vs. Cancer normal oral tissues 3 oral premalignant lesions (OPLs) tissues 3 tissue Up 1.2 19072117 746 KPYM_HUMAN ENSP00000334983 Oral Premalignant Lesions Normal vs. Cancer normal oral tissues 3 oral premalignant lesions (OPLs) tissues 3 tissue Up 1.3 19072117 747 COF1_HUMAN ENSP00000309629 Oral Premalignant Lesions Normal vs. Cancer normal oral tissues 3 oral premalignant lesions (OPLs) tissues 3 tissue Up 1.4 19072117 748 ENPL_HUMAN ENSP00000299767 Oral Premalignant Lesions Normal vs. Cancer normal oral tissues 3 oral premalignant lesions (OPLs) tissues 3 tissue Up 1.5 19072117 749 NPM_HUMAN ENSP00000296930 Oral Premalignant Lesions Normal vs. Cancer normal oral tissues 3 oral premalignant lesions (OPLs) tissues 3 tissue Up 1.6 19072117 750 H2B2E_HUMAN ENSP00000358151 Oral Premalignant Lesions Normal vs. Cancer normal oral tissues 3 oral premalignant lesions (OPLs) tissues 3 tissue Up 1.7 19072117 751 1433S_HUMAN ENSP00000340989 Oral Premalignant Lesions Normal vs. Cancer normal oral tissues 3 oral premalignant lesions (OPLs) tissues 3 tissue Up 1.9 19072117 752 MARCS_HUMAN ENSP00000357624 Oral Premalignant Lesions Normal vs. Cancer normal oral tissues 4 oral premalignant lesions (OPLs) tissues 4 tissue Down 0.61 19072117 753 H2B2E_HUMAN ENSP00000358151 Oral Premalignant Lesions Normal vs. Cancer normal oral tissues 4 oral premalignant lesions (OPLs) tissues 4 tissue Down 0.87 19072117 754 GELS_HUMAN ENSP00000362924 Oral Premalignant Lesions Normal vs. Cancer normal oral tissues 4 oral premalignant lesions (OPLs) tissues 4 tissue Up 1 19072117 755 CALL3_HUMAN ENSP00000315299 Oral Premalignant Lesions Normal vs. Cancer normal oral tissues 4 oral premalignant lesions (OPLs) tissues 4 tissue Up 1.1 19072117 756 HSPB1_HUMAN ENSP00000248553 Oral Premalignant Lesions Normal vs. Cancer normal oral tissues 4 oral premalignant lesions (OPLs) tissues 4 tissue Up 1.3 19072117 757 ACTB_HUMAN ENSP00000349960 Oral Premalignant Lesions Normal vs. Cancer normal oral tissues 4 oral premalignant lesions (OPLs) tissues 4 tissue Up 1.4 19072117 758 G3P_HUMAN ENSP00000380068 Oral Premalignant Lesions Normal vs. Cancer normal oral tissues 4 oral premalignant lesions (OPLs) tissues 4 tissue Up 1.5 19072117 759 PTMA_HUMAN ENSP00000344547 Oral Premalignant Lesions Normal vs. Cancer normal oral tissues 4 oral premalignant lesions (OPLs) tissues 4 tissue Up 1.5 19072117 760 1433S_HUMAN ENSP00000340989 Oral Premalignant Lesions Normal vs. Cancer normal oral tissues 4 oral premalignant lesions (OPLs) tissues 4 tissue Up 1.5 19072117 761 NPM_HUMAN ENSP00000296930 Oral Premalignant Lesions Normal vs. Cancer normal oral tissues 4 oral premalignant lesions (OPLs) tissues 4 tissue Up 1.7 19072117 762 KPYM_HUMAN ENSP00000334983 Oral Premalignant Lesions Normal vs. Cancer normal oral tissues 4 oral premalignant lesions (OPLs) tissues 4 tissue Up 1.7 19072117 763 HNRPK_HUMAN ENSP00000365440 Oral Premalignant Lesions Normal vs. Cancer normal oral tissues 4 oral premalignant lesions (OPLs) tissues 4 tissue Up 1.7 19072117 764 1433Z_HUMAN ENSP00000379288 Oral Premalignant Lesions Normal vs. Cancer normal oral tissues 4 oral premalignant lesions (OPLs) tissues 4 tissue Up 1.9 19072117 765 COF1_HUMAN ENSP00000309629 Oral Premalignant Lesions Normal vs. Cancer normal oral tissues 4 oral premalignant lesions (OPLs) tissues 4 tissue Up 2.1 19072117 766 ENPL_HUMAN ENSP00000299767 Oral Premalignant Lesions Normal vs. Cancer normal oral tissues 4 oral premalignant lesions (OPLs) tissues 4 tissue Up 3.4 19072117 767 MARCS_HUMAN ENSP00000357624 Oral Premalignant Lesions Normal vs. Cancer normal oral tissues 5 oral premalignant lesions (OPLs) tissues 5 tissue Down 0.72 19072117 768 ENPL_HUMAN ENSP00000299767 Oral Premalignant Lesions Normal vs. Cancer normal oral tissues 5 oral premalignant lesions (OPLs) tissues 5 tissue Down 0.8 19072117 769 1433Z_HUMAN ENSP00000379288 Oral Premalignant Lesions Normal vs. Cancer normal oral tissues 5 oral premalignant lesions (OPLs) tissues 5 tissue Down 0.81 19072117 770 S10AB_HUMAN ENSP00000271638 Oral Premalignant Lesions Normal vs. Cancer normal oral tissues 5 oral premalignant lesions (OPLs) tissues 5 tissue Down 0.84 19072117 771 ACTB_HUMAN ENSP00000349960 Oral Premalignant Lesions Normal vs. Cancer normal oral tissues 5 oral premalignant lesions (OPLs) tissues 5 tissue Down 0.92 19072117 772 GELS_HUMAN ENSP00000362924 Oral Premalignant Lesions Normal vs. Cancer normal oral tissues 5 oral premalignant lesions (OPLs) tissues 5 tissue Up 1 19072117 773 KPYM_HUMAN ENSP00000334983 Oral Premalignant Lesions Normal vs. Cancer normal oral tissues 5 oral premalignant lesions (OPLs) tissues 5 tissue Up 1.1 19072117 774 G3P_HUMAN ENSP00000380068 Oral Premalignant Lesions Normal vs. Cancer normal oral tissues 5 oral premalignant lesions (OPLs) tissues 5 tissue Up 1.1 19072117 775 HSPB1_HUMAN ENSP00000248553 Oral Premalignant Lesions Normal vs. Cancer normal oral tissues 5 oral premalignant lesions (OPLs) tissues 5 tissue Up 1.1 19072117 776 COF1_HUMAN ENSP00000309629 Oral Premalignant Lesions Normal vs. Cancer normal oral tissues 5 oral premalignant lesions (OPLs) tissues 5 tissue Up 1.2 19072117 777 HNRPK_HUMAN ENSP00000365440 Oral Premalignant Lesions Normal vs. Cancer normal oral tissues 5 oral premalignant lesions (OPLs) tissues 5 tissue Up 1.2 19072117 778 EF2_HUMAN ENSP00000307940 Oral Premalignant Lesions Normal vs. Cancer normal oral tissues 5 oral premalignant lesions (OPLs) tissues 5 tissue Up 1.4 19072117 779 PEBP1_HUMAN ENSP00000261313 Oral Premalignant Lesions Normal vs. Cancer normal oral tissues 5 oral premalignant lesions (OPLs) tissues 5 tissue Up 1.4 19072117 780 1433S_HUMAN ENSP00000340989 Oral Premalignant Lesions Normal vs. Cancer normal oral tissues 5 oral premalignant lesions (OPLs) tissues 5 tissue Up 1.8 19072117 781 H2B2E_HUMAN ENSP00000358151 Oral Premalignant Lesions Normal vs. Cancer normal oral tissues 5 oral premalignant lesions (OPLs) tissues 5 tissue Up 2 19072117 782 PTMA_HUMAN ENSP00000344547 Oral Premalignant Lesions Normal vs. Cancer normal oral tissues 5 oral premalignant lesions (OPLs) tissues 5 tissue Up 3.9 19072117 783 CALL3_HUMAN ENSP00000315299 Oral Premalignant Lesions Normal vs. Cancer normal oral tissues 5 oral premalignant lesions (OPLs) tissues 5 tissue Up 4.5 19072117 784 MARCS_HUMAN ENSP00000357624 Oral Premalignant Lesions Normal vs. Cancer normal oral tissues 6 oral premalignant lesions (OPLs) tissues 6 tissue Down 0.6 19072117 785 ENPL_HUMAN ENSP00000299767 Oral Premalignant Lesions Normal vs. Cancer normal oral tissues 6 oral premalignant lesions (OPLs) tissues 6 tissue Down 0.99 19072117 786 CALL3_HUMAN ENSP00000315299 Oral Premalignant Lesions Normal vs. Cancer normal oral tissues 6 oral premalignant lesions (OPLs) tissues 6 tissue Up 1.1 19072117 787 ACTB_HUMAN ENSP00000349960 Oral Premalignant Lesions Normal vs. Cancer normal oral tissues 6 oral premalignant lesions (OPLs) tissues 6 tissue Up 1.1 19072117 788 G3P_HUMAN ENSP00000380068 Oral Premalignant Lesions Normal vs. Cancer normal oral tissues 6 oral premalignant lesions (OPLs) tissues 6 tissue Up 1.1 19072117 789 KPYM_HUMAN ENSP00000334983 Oral Premalignant Lesions Normal vs. Cancer normal oral tissues 6 oral premalignant lesions (OPLs) tissues 6 tissue Up 1.1 19072117 790 GELS_HUMAN ENSP00000362924 Oral Premalignant Lesions Normal vs. Cancer normal oral tissues 6 oral premalignant lesions (OPLs) tissues 6 tissue Up 1.1 19072117 791 COF1_HUMAN ENSP00000309629 Oral Premalignant Lesions Normal vs. Cancer normal oral tissues 6 oral premalignant lesions (OPLs) tissues 6 tissue Up 1.2 19072117 792 S10AB_HUMAN ENSP00000271638 Oral Premalignant Lesions Normal vs. Cancer normal oral tissues 6 oral premalignant lesions (OPLs) tissues 6 tissue Up 1.2 19072117 793 EF2_HUMAN ENSP00000307940 Oral Premalignant Lesions Normal vs. Cancer normal oral tissues 6 oral premalignant lesions (OPLs) tissues 6 tissue Up 1.3 19072117 794 HNRPK_HUMAN ENSP00000365440 Oral Premalignant Lesions Normal vs. Cancer normal oral tissues 6 oral premalignant lesions (OPLs) tissues 6 tissue Up 1.5 19072117 795 1433Z_HUMAN ENSP00000379288 Oral Premalignant Lesions Normal vs. Cancer normal oral tissues 6 oral premalignant lesions (OPLs) tissues 6 tissue Up 1.5 19072117 796 H2B2E_HUMAN ENSP00000358151 Oral Premalignant Lesions Normal vs. Cancer normal oral tissues 6 oral premalignant lesions (OPLs) tissues 6 tissue Up 1.5 19072117 797 PEBP1_HUMAN ENSP00000261313 Oral Premalignant Lesions Normal vs. Cancer normal oral tissues 6 oral premalignant lesions (OPLs) tissues 6 tissue Up 1.6 19072117 798 1433S_HUMAN ENSP00000340989 Oral Premalignant Lesions Normal vs. Cancer normal oral tissues 6 oral premalignant lesions (OPLs) tissues 6 tissue Up 1.6 19072117 799 HSPB1_HUMAN ENSP00000248553 Oral Premalignant Lesions Normal vs. Cancer normal oral tissues 6 oral premalignant lesions (OPLs) tissues 6 tissue Up 2.4 19072117 800 PTMA_HUMAN ENSP00000344547 Oral Premalignant Lesions Normal vs. Cancer normal oral tissues 6 oral premalignant lesions (OPLs) tissues 6 tissue Up 3.5 19072117 801 LMNA_HUMAN ENSP00000357283 Esophageal Cancer Normal vs. Cancer matched normal mucosal tissues from 82 ESCC (esophageal squamous cell carcinoma) patients primary tumor tissues from 82 ESCC (esophageal squamous cell carcinoma) patients tissue Down 0.16 19142970 802 VIME_HUMAN ENSP00000224237 Esophageal Cancer Normal vs. Cancer matched normal mucosal tissues from 82 ESCC (esophageal squamous cell carcinoma) patients primary tumor tissues from 82 ESCC (esophageal squamous cell carcinoma) patients tissue Down 0.17 19142970 803 TBB5_HUMAN ENSP00000406811 Esophageal Cancer Normal vs. Cancer matched normal mucosal tissues from 82 ESCC (esophageal squamous cell carcinoma) patients primary tumor tissues from 82 ESCC (esophageal squamous cell carcinoma) patients tissue Down 0.17 19142970 804 TBB4B_HUMAN ENSP00000341289 Esophageal Cancer Normal vs. Cancer matched normal mucosal tissues from 82 ESCC (esophageal squamous cell carcinoma) patients primary tumor tissues from 82 ESCC (esophageal squamous cell carcinoma) patients tissue Down 0.19 19142970 805 MOES_HUMAN ENSP00000353408 Esophageal Cancer Normal vs. Cancer matched normal mucosal tissues from 82 ESCC (esophageal squamous cell carcinoma) patients primary tumor tissues from 82 ESCC (esophageal squamous cell carcinoma) patients tissue Down 0.22 19142970 806 LMNA_HUMAN ENSP00000357283 Esophageal Cancer Normal vs. Cancer matched normal mucosal tissues from 82 ESCC (esophageal squamous cell carcinoma) patients primary tumor tissues from 82 ESCC (esophageal squamous cell carcinoma) patients tissue Down 0.23 19142970 807 ENPL_HUMAN ENSP00000299767 Esophageal Cancer Normal vs. Cancer matched normal mucosal tissues from 82 ESCC (esophageal squamous cell carcinoma) patients primary tumor tissues from 82 ESCC (esophageal squamous cell carcinoma) patients tissue Down 0.23 19142970 808 MOES_HUMAN ENSP00000353408 Esophageal Cancer Normal vs. Cancer matched normal mucosal tissues from 82 ESCC (esophageal squamous cell carcinoma) patients primary tumor tissues from 82 ESCC (esophageal squamous cell carcinoma) patients tissue Down 0.23 19142970 809 ANXA1_HUMAN ENSP00000366109 Esophageal Cancer Normal vs. Cancer matched normal mucosal tissues from 82 ESCC (esophageal squamous cell carcinoma) patients primary tumor tissues from 82 ESCC (esophageal squamous cell carcinoma) patients tissue Down 0.24 19142970 810 ANXA1_HUMAN ENSP00000366109 Esophageal Cancer Normal vs. Cancer matched normal mucosal tissues from 82 ESCC (esophageal squamous cell carcinoma) patients primary tumor tissues from 82 ESCC (esophageal squamous cell carcinoma) patients tissue Down 0.25 19142970 811 FLNA_HUMAN ENSP00000358866 Esophageal Cancer Normal vs. Cancer matched normal mucosal tissues from 82 ESCC (esophageal squamous cell carcinoma) patients primary tumor tissues from 82 ESCC (esophageal squamous cell carcinoma) patients tissue Down 0.25 19142970 812 TBB4B_HUMAN ENSP00000341289 Esophageal Cancer Normal vs. Cancer matched normal mucosal tissues from 82 ESCC (esophageal squamous cell carcinoma) patients primary tumor tissues from 82 ESCC (esophageal squamous cell carcinoma) patients tissue Down 0.26 19142970 813 FLNA_HUMAN ENSP00000358866 Esophageal Cancer Normal vs. Cancer matched normal mucosal tissues from 82 ESCC (esophageal squamous cell carcinoma) patients primary tumor tissues from 82 ESCC (esophageal squamous cell carcinoma) patients tissue Down 0.27 19142970 814 HNRPK_HUMAN ENSP00000365440 Esophageal Cancer Normal vs. Cancer matched normal mucosal tissues from 82 ESCC (esophageal squamous cell carcinoma) patients primary tumor tissues from 82 ESCC (esophageal squamous cell carcinoma) patients tissue Down 0.27 19142970 815 ANXA1_HUMAN ENSP00000366109 Esophageal Cancer Normal vs. Cancer matched normal mucosal tissues from 82 ESCC (esophageal squamous cell carcinoma) patients primary tumor tissues from 82 ESCC (esophageal squamous cell carcinoma) patients tissue Down 0.28 19142970 816 FLNA_HUMAN ENSP00000358866 Esophageal Cancer Normal vs. Cancer matched normal mucosal tissues from 82 ESCC (esophageal squamous cell carcinoma) patients primary tumor tissues from 82 ESCC (esophageal squamous cell carcinoma) patients tissue Down 0.29 19142970 817 LMNA_HUMAN ENSP00000357283 Esophageal Cancer Normal vs. Cancer matched normal mucosal tissues from 82 ESCC (esophageal squamous cell carcinoma) patients primary tumor tissues from 82 ESCC (esophageal squamous cell carcinoma) patients tissue Down 0.29 19142970 818 TTHY_HUMAN ENSP00000237014 Esophageal Cancer Normal vs. Cancer matched normal mucosal tissues from 82 ESCC (esophageal squamous cell carcinoma) patients primary tumor tissues from 82 ESCC (esophageal squamous cell carcinoma) patients tissue Down 0.3 19142970 819 VIME_HUMAN ENSP00000224237 Esophageal Cancer Normal vs. Cancer matched normal mucosal tissues from 82 ESCC (esophageal squamous cell carcinoma) patients primary tumor tissues from 82 ESCC (esophageal squamous cell carcinoma) patients tissue Down 0.3 19142970 820 UBA1_HUMAN ENSP00000338413 Esophageal Cancer Normal vs. Cancer matched normal mucosal tissues from 82 ESCC (esophageal squamous cell carcinoma) patients primary tumor tissues from 82 ESCC (esophageal squamous cell carcinoma) patients tissue Down 0.31 19142970 821 FLNA_HUMAN ENSP00000358866 Esophageal Cancer Normal vs. Cancer matched normal mucosal tissues from 82 ESCC (esophageal squamous cell carcinoma) patients primary tumor tissues from 82 ESCC (esophageal squamous cell carcinoma) patients tissue Down 0.31 19142970 822 ITAV_HUMAN ENSP00000261023 Esophageal Cancer Normal vs. Cancer matched normal mucosal tissues from 82 ESCC (esophageal squamous cell carcinoma) patients primary tumor tissues from 82 ESCC (esophageal squamous cell carcinoma) patients tissue Down 0.31 19142970 823 PLEC_HUMAN ENSP00000323856 Esophageal Cancer Normal vs. Cancer matched normal mucosal tissues from 82 ESCC (esophageal squamous cell carcinoma) patients primary tumor tissues from 82 ESCC (esophageal squamous cell carcinoma) patients tissue Down 0.31 19142970 824 IQGA1_HUMAN ENSP00000268182 Esophageal Cancer Normal vs. Cancer matched normal mucosal tissues from 82 ESCC (esophageal squamous cell carcinoma) patients primary tumor tissues from 82 ESCC (esophageal squamous cell carcinoma) patients tissue Down 0.31 19142970 825 VIME_HUMAN ENSP00000224237 Esophageal Cancer Normal vs. Cancer matched normal mucosal tissues from 82 ESCC (esophageal squamous cell carcinoma) patients primary tumor tissues from 82 ESCC (esophageal squamous cell carcinoma) patients tissue Down 0.31 19142970 826 ANXA1_HUMAN ENSP00000366109 Esophageal Cancer Normal vs. Cancer matched normal mucosal tissues from 82 ESCC (esophageal squamous cell carcinoma) patients primary tumor tissues from 82 ESCC (esophageal squamous cell carcinoma) patients tissue Down 0.32 19142970 827 MYH9_HUMAN ENSP00000216181 Esophageal Cancer Normal vs. Cancer matched normal mucosal tissues from 82 ESCC (esophageal squamous cell carcinoma) patients primary tumor tissues from 82 ESCC (esophageal squamous cell carcinoma) patients tissue Down 0.32 19142970 828 DPYL2_HUMAN ENSP00000309539 Esophageal Cancer Normal vs. Cancer matched normal mucosal tissues from 82 ESCC (esophageal squamous cell carcinoma) patients primary tumor tissues from 82 ESCC (esophageal squamous cell carcinoma) patients tissue Down 0.33 19142970 829 ANXA1_HUMAN ENSP00000366109 Esophageal Cancer Normal vs. Cancer matched normal mucosal tissues from 82 ESCC (esophageal squamous cell carcinoma) patients primary tumor tissues from 82 ESCC (esophageal squamous cell carcinoma) patients tissue Down 0.33 19142970 830 DPYL2_HUMAN ENSP00000309539 Esophageal Cancer Normal vs. Cancer matched normal mucosal tissues from 82 ESCC (esophageal squamous cell carcinoma) patients primary tumor tissues from 82 ESCC (esophageal squamous cell carcinoma) patients tissue Down 0.34 19142970 831 ANXA1_HUMAN ENSP00000366109 Esophageal Cancer Normal vs. Cancer matched normal mucosal tissues from 82 ESCC (esophageal squamous cell carcinoma) patients primary tumor tissues from 82 ESCC (esophageal squamous cell carcinoma) patients tissue Down 0.36 19142970 832 CNN3_HUMAN ENSP00000359225 Esophageal Cancer Normal vs. Cancer matched normal mucosal tissues from 82 ESCC (esophageal squamous cell carcinoma) patients primary tumor tissues from 82 ESCC (esophageal squamous cell carcinoma) patients tissue Down 0.36 19142970 833 MRE11_HUMAN ENSP00000325863 Esophageal Cancer Normal vs. Cancer matched normal mucosal tissues from 82 ESCC (esophageal squamous cell carcinoma) patients primary tumor tissues from 82 ESCC (esophageal squamous cell carcinoma) patients tissue Down 0.36 19142970 834 ITB1_HUMAN ENSP00000379350 Esophageal Cancer Normal vs. Cancer matched normal mucosal tissues from 82 ESCC (esophageal squamous cell carcinoma) patients primary tumor tissues from 82 ESCC (esophageal squamous cell carcinoma) patients tissue Down 0.36 19142970 835 SET_HUMAN ENSP00000361777 Esophageal Cancer Normal vs. Cancer matched normal mucosal tissues from 82 ESCC (esophageal squamous cell carcinoma) patients primary tumor tissues from 82 ESCC (esophageal squamous cell carcinoma) patients tissue Down 0.37 19142970 836 ITB1_HUMAN ENSP00000379350 Esophageal Cancer Normal vs. Cancer matched normal mucosal tissues from 82 ESCC (esophageal squamous cell carcinoma) patients primary tumor tissues from 82 ESCC (esophageal squamous cell carcinoma) patients tissue Down 0.37 19142970 837 DPYL3_HUMAN ENSP00000343690 Esophageal Cancer Normal vs. Cancer matched normal mucosal tissues from 82 ESCC (esophageal squamous cell carcinoma) patients primary tumor tissues from 82 ESCC (esophageal squamous cell carcinoma) patients tissue Down 0.38 19142970 838 ACTA_HUMAN ENSP00000402373 Esophageal Cancer Normal vs. Cancer matched normal mucosal tissues from 82 ESCC (esophageal squamous cell carcinoma) patients primary tumor tissues from 82 ESCC (esophageal squamous cell carcinoma) patients tissue Down 0.4 19142970 839 ANXA1_HUMAN ENSP00000366109 Esophageal Cancer Normal vs. Cancer matched normal mucosal tissues from 82 ESCC (esophageal squamous cell carcinoma) patients primary tumor tissues from 82 ESCC (esophageal squamous cell carcinoma) patients tissue Down 0.4 19142970 840 UBE2N_HUMAN ENSP00000316176 Esophageal Cancer Normal vs. Cancer matched normal mucosal tissues from 82 ESCC (esophageal squamous cell carcinoma) patients primary tumor tissues from 82 ESCC (esophageal squamous cell carcinoma) patients tissue Down 0.4 19142970 841 VINC_HUMAN ENSP00000211998 Esophageal Cancer Normal vs. Cancer matched normal mucosal tissues from 82 ESCC (esophageal squamous cell carcinoma) patients primary tumor tissues from 82 ESCC (esophageal squamous cell carcinoma) patients tissue Down 0.4 19142970 842 ANXA1_HUMAN ENSP00000366109 Esophageal Cancer Normal vs. Cancer matched normal mucosal tissues from 82 ESCC (esophageal squamous cell carcinoma) patients primary tumor tissues from 82 ESCC (esophageal squamous cell carcinoma) patients tissue Down 0.41 19142970 843 ITAV_HUMAN ENSP00000261023 Esophageal Cancer Normal vs. Cancer matched normal mucosal tissues from 82 ESCC (esophageal squamous cell carcinoma) patients primary tumor tissues from 82 ESCC (esophageal squamous cell carcinoma) patients tissue Down 0.41 19142970 844 ITB1_HUMAN ENSP00000379350 Esophageal Cancer Normal vs. Cancer matched normal mucosal tissues from 82 ESCC (esophageal squamous cell carcinoma) patients primary tumor tissues from 82 ESCC (esophageal squamous cell carcinoma) patients tissue Down 0.41 19142970 845 ACTB_HUMAN ENSP00000349960 Esophageal Cancer Normal vs. Cancer matched normal mucosal tissues from 82 ESCC (esophageal squamous cell carcinoma) patients primary tumor tissues from 82 ESCC (esophageal squamous cell carcinoma) patients tissue Down 0.41 19142970 846 2AAA_HUMAN ENSP00000324804 Esophageal Cancer Normal vs. Cancer matched normal mucosal tissues from 82 ESCC (esophageal squamous cell carcinoma) patients primary tumor tissues from 82 ESCC (esophageal squamous cell carcinoma) patients tissue Down 0.43 19142970 847 2AAA_HUMAN ENSP00000324804 Esophageal Cancer Normal vs. Cancer matched normal mucosal tissues from 82 ESCC (esophageal squamous cell carcinoma) patients primary tumor tissues from 82 ESCC (esophageal squamous cell carcinoma) patients tissue Down 0.44 19142970 848 DESM_HUMAN ENSP00000363071 Esophageal Cancer Normal vs. Cancer matched normal mucosal tissues from 82 ESCC (esophageal squamous cell carcinoma) patients primary tumor tissues from 82 ESCC (esophageal squamous cell carcinoma) patients tissue Down 0.45 19142970 849 STAM1_HUMAN ENSP00000366746 Esophageal Cancer Normal vs. Cancer matched normal mucosal tissues from 82 ESCC (esophageal squamous cell carcinoma) patients primary tumor tissues from 82 ESCC (esophageal squamous cell carcinoma) patients tissue Down 0.46 19142970 850 HSPB1_HUMAN ENSP00000248553 Esophageal Cancer Normal vs. Cancer matched normal mucosal tissues from 82 ESCC (esophageal squamous cell carcinoma) patients primary tumor tissues from 82 ESCC (esophageal squamous cell carcinoma) patients tissue Down 0.46 19142970 851 K1C14_HUMAN ENSP00000167586 Esophageal Cancer Normal vs. Cancer matched normal mucosal tissues from 82 ESCC (esophageal squamous cell carcinoma) patients primary tumor tissues from 82 ESCC (esophageal squamous cell carcinoma) patients tissue Down 0.47 19142970 852 ENPL_HUMAN ENSP00000299767 Esophageal Cancer Normal vs. Cancer matched normal mucosal tissues from 82 ESCC (esophageal squamous cell carcinoma) patients primary tumor tissues from 82 ESCC (esophageal squamous cell carcinoma) patients tissue Down 0.48 19142970 853 EZRI_HUMAN ENSP00000356042 Esophageal Cancer Normal vs. Cancer matched normal mucosal tissues from 82 ESCC (esophageal squamous cell carcinoma) patients primary tumor tissues from 82 ESCC (esophageal squamous cell carcinoma) patients tissue Down 0.48 19142970 854 XRCC5_HUMAN ENSP00000375977 Esophageal Cancer Normal vs. Cancer matched normal mucosal tissues from 82 ESCC (esophageal squamous cell carcinoma) patients primary tumor tissues from 82 ESCC (esophageal squamous cell carcinoma) patients tissue Down 0.49 19142970 855 MOES_HUMAN ENSP00000353408 Esophageal Cancer Normal vs. Cancer matched normal mucosal tissues from 82 ESCC (esophageal squamous cell carcinoma) patients primary tumor tissues from 82 ESCC (esophageal squamous cell carcinoma) patients tissue Down 0.49 19142970 856 VIME_HUMAN ENSP00000224237 Esophageal Cancer Normal vs. Cancer matched normal mucosal tissues from 82 ESCC (esophageal squamous cell carcinoma) patients primary tumor tissues from 82 ESCC (esophageal squamous cell carcinoma) patients tissue Up 2.1 19142970 857 DESM_HUMAN ENSP00000363071 Esophageal Cancer Normal vs. Cancer matched normal mucosal tissues from 82 ESCC (esophageal squamous cell carcinoma) patients primary tumor tissues from 82 ESCC (esophageal squamous cell carcinoma) patients tissue Up 2.1 19142970 858 K1C14_HUMAN ENSP00000167586 Esophageal Cancer Normal vs. Cancer matched normal mucosal tissues from 82 ESCC (esophageal squamous cell carcinoma) patients primary tumor tissues from 82 ESCC (esophageal squamous cell carcinoma) patients tissue Up 2.1 19142970 859 TPM2_HUMAN ENSP00000354219 Esophageal Cancer Normal vs. Cancer matched normal mucosal tissues from 82 ESCC (esophageal squamous cell carcinoma) patients primary tumor tissues from 82 ESCC (esophageal squamous cell carcinoma) patients tissue Up 2.1 19142970 860 TSP1_HUMAN ENSP00000260356 Esophageal Cancer Normal vs. Cancer matched normal mucosal tissues from 82 ESCC (esophageal squamous cell carcinoma) patients primary tumor tissues from 82 ESCC (esophageal squamous cell carcinoma) patients tissue Up 2.1 19142970 861 1433Z_HUMAN ENSP00000379288 Esophageal Cancer Normal vs. Cancer matched normal mucosal tissues from 82 ESCC (esophageal squamous cell carcinoma) patients primary tumor tissues from 82 ESCC (esophageal squamous cell carcinoma) patients tissue Up 2.2 19142970 862 TPM2_HUMAN ENSP00000354219 Esophageal Cancer Normal vs. Cancer matched normal mucosal tissues from 82 ESCC (esophageal squamous cell carcinoma) patients primary tumor tissues from 82 ESCC (esophageal squamous cell carcinoma) patients tissue Up 2.2 19142970 863 VIME_HUMAN ENSP00000224237 Esophageal Cancer Normal vs. Cancer matched normal mucosal tissues from 82 ESCC (esophageal squamous cell carcinoma) patients primary tumor tissues from 82 ESCC (esophageal squamous cell carcinoma) patients tissue Up 2.2 19142970 864 K1C14_HUMAN ENSP00000167586 Esophageal Cancer Normal vs. Cancer matched normal mucosal tissues from 82 ESCC (esophageal squamous cell carcinoma) patients primary tumor tissues from 82 ESCC (esophageal squamous cell carcinoma) patients tissue Up 2.3 19142970 865 K1C14_HUMAN ENSP00000167586 Esophageal Cancer Normal vs. Cancer matched normal mucosal tissues from 82 ESCC (esophageal squamous cell carcinoma) patients primary tumor tissues from 82 ESCC (esophageal squamous cell carcinoma) patients tissue Up 2.4 19142970 866 DESM_HUMAN ENSP00000363071 Esophageal Cancer Normal vs. Cancer matched normal mucosal tissues from 82 ESCC (esophageal squamous cell carcinoma) patients primary tumor tissues from 82 ESCC (esophageal squamous cell carcinoma) patients tissue Up 2.6 19142970 867 VIME_HUMAN ENSP00000224237 Esophageal Cancer Normal vs. Cancer matched normal mucosal tissues from 82 ESCC (esophageal squamous cell carcinoma) patients primary tumor tissues from 82 ESCC (esophageal squamous cell carcinoma) patients tissue Up 2.6 19142970 868 SODM_HUMAN ENSP00000337127 Oral Cancer Normal vs. Cancer matched adjacent normal surrounding mucosa specimens from patients primary oral squamous cell carcinoma (OSCC) from patients tissue Up 2.1 16889763 869 GSTP1_HUMAN ENSP00000381607 Oral Cancer Normal vs. Cancer matched adjacent normal surrounding mucosa specimens from patients primary oral squamous cell carcinoma (OSCC) from patients tissue Up 2.5 16889763 870 GDIR2_HUMAN ENSP00000228945 Oral Cancer Normal vs. Cancer matched adjacent normal surrounding mucosa specimens from patients primary oral squamous cell carcinoma (OSCC) from patients tissue Up 2.6 16889763 871 VIME_HUMAN ENSP00000224237 Oral Cancer Normal vs. Cancer matched adjacent normal surrounding mucosa specimens from patients primary oral squamous cell carcinoma (OSCC) from patients tissue Up 3 16889763 872 1433S_HUMAN ENSP00000340989 Oral Cancer Normal vs. Cancer matched adjacent normal surrounding mucosa specimens from patients primary oral squamous cell carcinoma (OSCC) from patients tissue Up 3.6 16889763 873 HSPB1_HUMAN ENSP00000248553 Oral Cancer Normal vs. Cancer matched adjacent normal surrounding mucosa specimens from patients primary oral squamous cell carcinoma (OSCC) from patients tissue Up 4.3 16889763 874 TPM2_HUMAN ENSP00000354219 Oral Cancer Normal vs. Cancer matched adjacent normal surrounding mucosa specimens from patients primary oral squamous cell carcinoma (OSCC) from patients tissue Up 6 16889763 875 TACD2_HUMAN ENSP00000360269 Oral Cancer Normal vs. Cancer adjacent non-tumorous tissues primary oral squamous cell carcinoma (OSCC) lesions tissue Down 0.3 19297561 876 HS71L_HUMAN ENSP00000364805 Oral Cancer Normal vs. Cancer adjacent non-tumorous tissues primary oral squamous cell carcinoma (OSCC) lesions tissue Down 0.35 19297561 877 HSP71_HUMAN ENSP00000364801 Oral Cancer Normal vs. Cancer adjacent non-tumorous tissues primary oral squamous cell carcinoma (OSCC) lesions tissue Down 0.36 19297561 878 PGAM1_HUMAN ENSP00000359991 Oral Cancer Normal vs. Cancer adjacent non-tumorous tissues primary oral squamous cell carcinoma (OSCC) lesions tissue Up 2.5 19297561 879 ITA6_HUMAN ENSP00000341078 Oral Cancer Normal vs. Cancer adjacent non-tumorous tissues primary oral squamous cell carcinoma (OSCC) lesions tissue Up 2.7 19297561 880 GTR1_HUMAN ENSP00000416293 Oral Cancer Normal vs. Cancer adjacent non-tumorous tissues primary oral squamous cell carcinoma (OSCC) lesions tissue Up 2.7 19297561 881 FLNA_HUMAN ENSP00000358866 Oral Cancer Normal vs. Cancer adjacent non-tumorous tissues primary oral squamous cell carcinoma (OSCC) lesions tissue Up 2.9 19297561 882 S10A2_HUMAN ENSP00000357698 Oral Cancer Normal vs. Cancer adjacent non-tumorous tissues primary oral squamous cell carcinoma (OSCC) lesions tissue Up 3.3 19297561 883 ITB4_HUMAN ENSP00000200181 Oral Cancer Normal vs. Cancer adjacent non-tumorous tissues primary oral squamous cell carcinoma (OSCC) lesions tissue Up 3.5 19297561 884 IFM1_HUMAN ENSP00000386187 Oral Cancer Normal vs. Cancer adjacent non-tumorous tissues primary oral squamous cell carcinoma (OSCC) lesions tissue Up 3.5 19297561 885 NDRG1_HUMAN ENSP00000404854 Oral Cancer Normal vs. Cancer adjacent non-tumorous tissues primary oral squamous cell carcinoma (OSCC) lesions tissue Up 3.8 19297561 886 ACTN1_HUMAN ENSP00000193403 Oral Cancer Normal vs. Cancer adjacent non-tumorous tissues primary oral squamous cell carcinoma (OSCC) lesions tissue Up 4 19297561 887 SODM_HUMAN ENSP00000337127 Oral Cancer Normal vs. Cancer adjacent non-tumorous tissues primary oral squamous cell carcinoma (OSCC) lesions tissue Up 4 19297561 888 LIMA1_HUMAN ENSP00000340184 Oral Cancer Normal vs. Cancer adjacent non-tumorous tissues primary oral squamous cell carcinoma (OSCC) lesions tissue Up 4.3 19297561 889 FIBA_HUMAN ENSP00000306361 Oral Cancer Normal vs. Cancer adjacent non-tumorous tissues primary oral squamous cell carcinoma (OSCC) lesions tissue Up 4.8 19297561 890 HLAG_HUMAN ENSP00000405238 Oral Cancer Normal vs. Cancer adjacent non-tumorous tissues primary oral squamous cell carcinoma (OSCC) lesions tissue Up 4.9 19297561 891 DRA_HUMAN ENSP00000372746 Oral Cancer Normal vs. Cancer adjacent non-tumorous tissues primary oral squamous cell carcinoma (OSCC) lesions tissue Up 5 19297561 892 K1C14_HUMAN ENSP00000167586 Oral Cancer Normal vs. Cancer adjacent non-tumorous tissues primary oral squamous cell carcinoma (OSCC) lesions tissue Up 7.3 19297561 893 FINC_HUMAN ENSP00000352696 Oral Cancer Normal vs. Cancer adjacent non-tumorous tissues primary oral squamous cell carcinoma (OSCC) lesions tissue Up 9.9 19297561 894 ISG15_HUMAN ENSP00000368699 Oral Cancer Normal vs. Cancer adjacent non-tumorous tissues primary oral squamous cell carcinoma (OSCC) lesions tissue Up 21 19297561 895 SYWC_HUMAN ENSP00000347495 Oral Cancer Normal vs. Cancer adjacent non-tumorous tissues primary oral squamous cell carcinoma (OSCC) lesions tissue Up 24 19297561 896 K1C16_HUMAN ENSP00000301653 Oral Cancer Normal vs. Cancer adjacent non-tumorous tissues primary oral squamous cell carcinoma (OSCC) lesions tissue Up 27 19297561 897 TENA_HUMAN ENSP00000345861 Oral Cancer Normal vs. Cancer adjacent non-tumorous tissues primary oral squamous cell carcinoma (OSCC) lesions tissue Up 66 19297561 898 TSP1_HUMAN ENSP00000260356 Oral Cancer Normal vs. Cancer adjacent non-tumorous tissues primary oral squamous cell carcinoma (OSCC) lesions tissue Up 85 19297561 899 TTHY_HUMAN ENSP00000237014 Breast Cancer Metastasis cerebrospinal fluid of control and breast carcinoma without Leptomeningeal Metastasis individuals cerebrospinal fluid of breast carcinoma with Leptomeningeal Metastasis individuals tissue Down 17274072 900 CO1A1_HUMAN ENSP00000225964 breast ductal carcinoma Normal vs. Cancer normal tissues cancerous tissues tissue Up 18482919 901 G3P_HUMAN ENSP00000380068 breast ductal carcinoma Normal vs. Cancer normal tissues cancerous tissues tissue Up 18482919 902 K1C18_HUMAN ENSP00000373489 breast ductal carcinoma Normal vs. Cancer normal tissues cancerous tissues tissue Up 18482919 903 K2C8_HUMAN ENSP00000293308 breast ductal carcinoma Normal vs. Cancer normal tissues cancerous tissues tissue Up 18482919 904 ANXA2_HUMAN ENSP00000411352 breast ductal carcinoma Normal vs. Cancer normal tissues cancerous tissues tissue Up 18482919 905 CO1A2_HUMAN ENSP00000297268 breast ductal carcinoma Normal vs. Cancer normal tissues cancerous tissues tissue Up 18482919 906 ACTG_HUMAN ENSP00000331514 breast ductal carcinoma Normal vs. Cancer normal tissues cancerous tissues tissue Up 18482919 907 1433S_HUMAN ENSP00000340989 Breast Cancer Normal vs. Cancer serum samples of control individuals serum samples of individuals with breast cancer tissue Down 12687611 908 HSPB1_HUMAN ENSP00000248553 Breast Cancer Normal vs. Cancer serum samples of control individuals serum samples of individuals with breast cancer tissue Up 12687611 909 CATD_HUMAN ENSP00000236671 Breast Cancer Treatment (Antiestrogen-sensitive vs. Antiestrogen-resistant) human breast carcinoma cell line T47D Antiestrogen-resistant Derivative T47D-r cell line Down 0.04 14557597 910 IF4E_HUMAN ENSP00000389624 Breast Cancer Treatment (Antiestrogen-sensitive vs. Antiestrogen-resistant) human breast carcinoma cell line T47D Antiestrogen-resistant Derivative T47D-r cell line Down 0.16 14557597 911 PP1A_HUMAN ENSP00000365936 Breast Cancer Treatment (Antiestrogen-sensitive vs. Antiestrogen-resistant) human breast carcinoma cell line T47D Antiestrogen-resistant Derivative T47D-r cell line Down 0.43 14557597 912 COMT_HUMAN ENSP00000385150 Breast Cancer Treatment (Antiestrogen-sensitive vs. Antiestrogen-resistant) human breast carcinoma cell line T47D Antiestrogen-resistant Derivative T47D-r cell line Up 1.5 14557597 913 PRDX1_HUMAN ENSP00000262746 Breast Cancer Treatment (Antiestrogen-sensitive vs. Antiestrogen-resistant) human breast carcinoma cell line T47D Antiestrogen-resistant Derivative T47D-r cell line Up 2.4 14557597 914 HCD2_HUMAN ENSP00000168216 Breast Cancer Treatment (Antiestrogen-sensitive vs. Antiestrogen-resistant) human breast carcinoma cell line T47D Antiestrogen-resistant Derivative T47D-r cell line Up 5.1 14557597 915 PTBP1_HUMAN ENSP00000014112 Breast Cancer Treatment (Antiestrogen-sensitive vs. Antiestrogen-resistant) human breast carcinoma cell line T47D Antiestrogen-resistant Derivative T47D-r cell line Up 14557597 916 ECHB_HUMAN ENSP00000325136 Breast Cancer Treatment (Antiestrogen-sensitive vs. Antiestrogen-resistant) human breast carcinoma cell line T47D Antiestrogen-resistant Derivative T47D-r cell line Up 14557597 917 EFTU_HUMAN ENSP00000322439 Breast Cancer Normal vs. Cancer normal MCF10A cell line malignant CA1a cell line cell line Down 0.7 14997480 918 HSPB1_HUMAN ENSP00000248553 Breast Cancer Normal vs. Cancer normal MCF10A cell line malignant CA1a cell line cell line Up 2 14997480 919 NPM_HUMAN ENSP00000296930 Breast Cancer Normal vs. Cancer normal MCF10A cell line malignant CA1a cell line cell line Up 2 14997480 920 ACTB_HUMAN ENSP00000349960 Breast Cancer Normal vs. Cancer normal MCF10A cell line malignant CA1a cell line cell line Up 2 14997480 921 HSP7C_HUMAN ENSP00000227378 Breast Cancer Normal vs. Cancer normal MCF10A cell line malignant CA1a cell line cell line Up 3 14997480 922 ANXA2_HUMAN ENSP00000411352 Breast Cancer Normal vs. Cancer normal MCF10A cell line malignant CA1a cell line cell line Up 4 14997480 923 IPYR_HUMAN ENSP00000362329 Breast Cancer Normal vs. Cancer normal MCF10A cell line malignant CA1a cell line cell line Up 7 14997480 924 KPYM_HUMAN ENSP00000334983 Breast Cancer Normal vs. Cancer normal MCF10A cell line malignant CA1a cell line cell line Up 1500 14997480 925 EFTU_HUMAN ENSP00000322439 Breast Cancer Normal vs. Cancer normal MCF10A cell line malignant CA1d cell line cell line Down 0.4 14997480 926 KAD2_HUMAN ENSP00000346921 Breast Cancer Normal vs. Cancer normal MCF10A cell line malignant CA1d cell line cell line Up 2 14997480 927 ACTB_HUMAN ENSP00000349960 Breast Cancer Normal vs. Cancer normal MCF10A cell line malignant CA1d cell line cell line Up 2.5 14997480 928 IPYR_HUMAN ENSP00000362329 Breast Cancer Normal vs. Cancer normal MCF10A cell line malignant CA1d cell line cell line Up 3 14997480 929 K2C8_HUMAN ENSP00000293308 Breast Cancer Normal vs. Cancer normal MCF10A cell line malignant CA1d cell line cell line Up 4 14997480 930 KPYM_HUMAN ENSP00000334983 Breast Cancer Normal vs. Cancer normal MCF10A cell line malignant CA1d cell line cell line Up 320 14997480 931 ANXA1_HUMAN ENSP00000366109 Breast Cancer Treatment (metastasis vs. metastasis-suppressed BRMS1) metastatic MDA-MB-435 metastasis-suppressed BRMS1 transfected-MDA-MB-435 cells cell line Down 15168732 932 HS90B_HUMAN ENSP00000360609 Breast Cancer Treatment (metastasis vs. metastasis-suppressed BRMS1) metastatic MDA-MB-435 metastasis-suppressed BRMS1 transfected-MDA-MB-435 cells cell line Up 15168732 933 VIME_HUMAN ENSP00000224237 Breast Cancer Treatment (metastasis vs. metastasis-suppressed BRMS1) metastatic MDA-MB-435 metastasis-suppressed BRMS1 transfected-MDA-MB-435 cells cell line Up 15168732 934 COF1_HUMAN ENSP00000309629 Breast Cancer Normal vs. Cancer matched normal breast tissue breast cancer tissues tissue Down 0.12 15767701 935 G3P_HUMAN ENSP00000380068 Breast Cancer Normal vs. Cancer matched normal breast tissue breast cancer tissues tissue Down 0.2 15767701 936 FABP4_HUMAN ENSP00000256104 Breast Cancer Normal vs. Cancer matched normal breast tissue breast cancer tissues tissue Down <0.1 15767701 937 TPIS_HUMAN ENSP00000379933 Breast Cancer Normal vs. Cancer matched normal breast tissue breast cancer tissues tissue Up 2 15767701 938 SODM_HUMAN ENSP00000337127 Breast Cancer Normal vs. Cancer matched normal breast tissue breast cancer tissues tissue Up 2.1 15767701 939 PGAM1_HUMAN ENSP00000359991 Breast Cancer Normal vs. Cancer matched normal breast tissue breast cancer tissues tissue Up >10 15767701 940 DEST_HUMAN ENSP00000246069 Breast Cancer Normal vs. Cancer matched normal breast tissue breast cancer tissues tissue Up 15767701 941 GNA13_HUMAN ENSP00000400717 Breast Cancer Treatment (mitoxantrone-sensitive vs. mitoxantrone-resistant) drug susceptible parental MCF-7 breast cancer cell line resistance to the anticancer drug mitoxantrone MCF-7 breast cancer cell line cell line Down 0.085 16335961 942 TACD2_HUMAN ENSP00000360269 Breast Cancer Treatment (mitoxantrone-sensitive vs. mitoxantrone-resistant) drug susceptible parental MCF-7 breast cancer cell line resistance to the anticancer drug mitoxantrone MCF-7 breast cancer cell line cell line Down 0.24 16335961 943 GTR1_HUMAN ENSP00000416293 Breast Cancer Treatment (mitoxantrone-sensitive vs. mitoxantrone-resistant) drug susceptible parental MCF-7 breast cancer cell line resistance to the anticancer drug mitoxantrone MCF-7 breast cancer cell line cell line Down 0.25 16335961 944 ITB1_HUMAN ENSP00000379350 Breast Cancer Treatment (mitoxantrone-sensitive vs. mitoxantrone-resistant) drug susceptible parental MCF-7 breast cancer cell line resistance to the anticancer drug mitoxantrone MCF-7 breast cancer cell line cell line Down 0.3 16335961 945 EPHB4_HUMAN ENSP00000350896 Breast Cancer Treatment (mitoxantrone-sensitive vs. mitoxantrone-resistant) drug susceptible parental MCF-7 breast cancer cell line resistance to the anticancer drug mitoxantrone MCF-7 breast cancer cell line cell line Up 2.3 16335961 946 CLH1_HUMAN ENSP00000269122 Breast Cancer Treatment (mitoxantrone-sensitive vs. mitoxantrone-resistant) drug susceptible parental MCF-7 breast cancer cell line resistance to the anticancer drug mitoxantrone MCF-7 breast cancer cell line cell line Up 3.7 16335961 947 4F2_HUMAN ENSP00000367124 Breast Cancer Treatment (mitoxantrone-sensitive vs. mitoxantrone-resistant) drug susceptible parental MCF-7 breast cancer cell line resistance to the anticancer drug mitoxantrone MCF-7 breast cancer cell line cell line Up 4.4 16335961 948 TFR1_HUMAN ENSP00000376197 Breast Cancer Treatment (mitoxantrone-sensitive vs. mitoxantrone-resistant) drug susceptible parental MCF-7 breast cancer cell line resistance to the anticancer drug mitoxantrone MCF-7 breast cancer cell line cell line Up 16335961 949 SPB5_HUMAN ENSP00000372221 Breast Cancer Normal vs. Cancer corresponding adjacent normal breast epithelia malignant breast epithelia tissue Down 0.17 16470630 950 DCC_HUMAN ENSP00000389140 Breast Cancer Normal vs. Cancer corresponding adjacent normal breast epithelia malignant breast epithelia tissue Down 0.29 16470630 951 RFC5_HUMAN ENSP00000408295 Breast Cancer Normal vs. Cancer corresponding adjacent normal breast epithelia malignant breast epithelia tissue Down 0.3 16470630 952 DAG1_HUMAN ENSP00000312435 Breast Cancer Normal vs. Cancer corresponding adjacent normal breast epithelia malignant breast epithelia tissue Down 0.83 16470630 953 ERBB3_HUMAN ENSP00000408340 Breast Cancer Normal vs. Cancer corresponding adjacent normal breast epithelia malignant breast epithelia tissue Up 1.4 16470630 954 GRB2_HUMAN ENSP00000376347 Breast Cancer Normal vs. Cancer corresponding adjacent normal breast epithelia malignant breast epithelia tissue Up 2 16470630 955 DAF_HUMAN ENSP00000356031 Breast Cancer Normal vs. Cancer corresponding adjacent normal breast epithelia malignant breast epithelia tissue Up 2.1 16470630 956 ATM_HUMAN ENSP00000278616 Breast Cancer Normal vs. Cancer corresponding adjacent normal breast epithelia malignant breast epithelia tissue Up 2.1 16470630 957 1433E_HUMAN ENSP00000264335 Breast Cancer Normal vs. Cancer corresponding adjacent normal breast epithelia malignant breast epithelia tissue Up 2.5 16470630 958 MK03_HUMAN ENSP00000327293 Breast Cancer Normal vs. Cancer corresponding adjacent normal breast epithelia malignant breast epithelia tissue Up 3.7 16470630 959 1433S_HUMAN ENSP00000340989 Breast Cancer Normal vs. Cancer corresponding adjacent normal breast epithelia malignant breast epithelia tissue Up 3.7 16470630 960 CCNE1_HUMAN ENSP00000262643 Breast Cancer Normal vs. Cancer corresponding adjacent normal breast epithelia malignant breast epithelia tissue Up 6.5 16470630 961 HSPB1_HUMAN ENSP00000248553 Breast Cancer Normal vs. Cancer corresponding adjacent normal breast epithelia malignant breast epithelia tissue Up 8 16470630 962 IPYR_HUMAN ENSP00000362329 Breast Cancer Treatment (none vs. multidrug resistant) MCF7 multidrug resistant MCF7/AdVp3000 cells cell line Down 0.53 16540677 963 NPM_HUMAN ENSP00000296930 Breast Cancer Treatment (none vs. multidrug resistant) MCF7 multidrug resistant MCF7/AdVp3000 cells cell line Down 0.59 16540677 964 NDKA_HUMAN ENSP00000013034 Breast Cancer Treatment (none vs. multidrug resistant) MCF7 multidrug resistant MCF7/AdVp3000 cells cell line Down 0.59 16540677 965 HSPB1_HUMAN ENSP00000248553 Breast Cancer Treatment (none vs. multidrug resistant) MCF7 multidrug resistant MCF7/AdVp3000 cells cell line Up 1.6 16540677 966 K1C18_HUMAN ENSP00000373489 Breast Cancer Treatment (none vs. multidrug resistant) MCF7 multidrug resistant MCF7/AdVp3000 cells cell line Up 1.8 16540677 967 1433S_HUMAN ENSP00000340989 Breast Cancer Treatment (none vs. multidrug resistant) MCF7 multidrug resistant MCF7/AdVp3000 cells cell line Up 5.7 16540677 968 ALBU_HUMAN ENSP00000295897 Breast Cancer Normal vs. Cancer serum samples from control individuals serum samples from patients with breast cancer tissue Down 0.4 16550499 969 ALBU_HUMAN ENSP00000295897 Breast Cancer Normal vs. Cancer serum samples from control individuals serum samples from patients with breast cancer tissue Down 0.62 16550499 970 HBB_HUMAN ENSP00000333994 Breast Cancer Normal vs. Cancer serum samples from control individuals serum samples from patients with breast cancer tissue Up 1.3 16550499 971 ALBU_HUMAN ENSP00000295897 Breast Cancer Normal vs. Cancer serum samples from control individuals serum samples from patients with breast cancer tissue Up 1.4 16550499 972 HBB_HUMAN ENSP00000333994 Breast Cancer Normal vs. Cancer serum samples from control individuals serum samples from patients with breast cancer tissue Up 1.4 16550499 973 ANXA2_HUMAN ENSP00000411352 Breast Cancer Normal vs. Cancer non-cancerous human mammary epithelial cell line HMEC cell line cancer cell lines BT-474 cell line Down 0.11 16596714 974 EZRI_HUMAN ENSP00000356042 Breast Cancer Normal vs. Cancer non-cancerous human mammary epithelial cell line HMEC cell line cancer cell lines BT-474 cell line Down 0.29 16596714 975 PGAM1_HUMAN ENSP00000359991 Breast Cancer Normal vs. Cancer non-cancerous human mammary epithelial cell line HMEC cell line cancer cell lines BT-474 cell line Down 0.31 16596714 976 K1C18_HUMAN ENSP00000373489 Breast Cancer Normal vs. Cancer non-cancerous human mammary epithelial cell line HMEC cell line cancer cell lines BT-474 cell line Up 7.7 16596714 977 IQGA1_HUMAN ENSP00000268182 Breast Cancer Normal vs. Cancer non-cancerous human mammary epithelial cell line HMEC cell line cancer cell lines MDA-231 cell line Down 0.22 16596714 978 ACTN4_HUMAN ENSP00000252699 Breast Cancer Normal vs. Cancer non-cancerous human mammary epithelial cell line HMEC cell line cancer cell lines MDA-231 cell line Down 0.23 16596714 979 EZRI_HUMAN ENSP00000356042 Breast Cancer Normal vs. Cancer non-cancerous human mammary epithelial cell line HMEC cell line cancer cell lines MDA-231 cell line Down 0.23 16596714 980 HS90B_HUMAN ENSP00000360609 Breast Cancer Normal vs. Cancer non-cancerous human mammary epithelial cell line HMEC cell line cancer cell lines MDA-231 cell line Down 0.25 16596714 981 ANXA2_HUMAN ENSP00000411352 Breast Cancer Normal vs. Cancer non-cancerous human mammary epithelial cell line HMEC cell line cancer cell lines MDA-231 cell line Down 0.26 16596714 982 MYH9_HUMAN ENSP00000216181 Breast Cancer Normal vs. Cancer non-cancerous human mammary epithelial cell line HMEC cell line cancer cell lines MDA-231 cell line Down 0.28 16596714 983 ENPL_HUMAN ENSP00000299767 Breast Cancer Normal vs. Cancer non-cancerous human mammary epithelial cell line HMEC cell line cancer cell lines MDA-231 cell line Down 0.29 16596714 984 CALR_HUMAN ENSP00000320866 Breast Cancer Normal vs. Cancer non-cancerous human mammary epithelial cell line HMEC cell line cancer cell lines MDA-231 cell line Down 0.29 16596714 985 S10A2_HUMAN ENSP00000357698 Breast Cancer Normal vs. Cancer non-cancerous human mammary epithelial cell line HMEC cell line cancer cell lines SKBR-3 cell line Down 0.1 16596714 986 MYH9_HUMAN ENSP00000216181 Breast Cancer Normal vs. Cancer non-cancerous human mammary epithelial cell line HMEC cell line cancer cell lines SKBR-3 cell line Down 0.27 16596714 987 EZRI_HUMAN ENSP00000356042 Breast Cancer Normal vs. Cancer non-cancerous human mammary epithelial cell line HMEC cell line cancer cell lines SKBR-3 cell line Down 0.3 16596714 988 RASK_HUMAN ENSP00000256078 Breast Cancer Normal vs. Cancer non-cancerous human mammary epithelial cell line HMEC cell line cancer cell lines SKBR-3 cell line Up 3.1 16596714 989 RASH_HUMAN ENSP00000388246 Breast Cancer Normal vs. Cancer non-cancerous human mammary epithelial cell line HMEC cell line cancer cell lines SKBR-3 cell line Up 4.9 16596714 990 EZRI_HUMAN ENSP00000356042 Breast Cancer Normal vs. Cancer non-cancerous human mammary epithelial cell line HMEC cell line cancer cell lines MCF7c18 cell line Down 0.16 16596714 991 CALR_HUMAN ENSP00000320866 Breast Cancer Normal vs. Cancer non-cancerous human mammary epithelial cell line HMEC cell line cancer cell lines MCF7c18 cell line Down 0.17 16596714 992 IQGA1_HUMAN ENSP00000268182 Breast Cancer Normal vs. Cancer non-cancerous human mammary epithelial cell line HMEC cell line cancer cell lines MCF7c18 cell line Down 0.17 16596714 993 MYH9_HUMAN ENSP00000216181 Breast Cancer Normal vs. Cancer non-cancerous human mammary epithelial cell line HMEC cell line cancer cell lines MCF7c18 cell line Down 0.23 16596714 994 ANXA2_HUMAN ENSP00000411352 Breast Cancer Normal vs. Cancer non-cancerous human mammary epithelial cell line HMEC cell line cancer cell lines MCF7c18 cell line Down 0.26 16596714 995 HSPB1_HUMAN ENSP00000248553 Breast Cancer Metastasis MDA-MB-435 (human breast cancer cell line) MDA-MB-435HM (A highly metastatic variant of parental MDA-MB-435 cell line) cell line Up 16637015 996 CATD_HUMAN ENSP00000236671 Breast Cancer Metastasis MDA-MB-435 (human breast cancer cell line) MDA-MB-435HM (A highly metastatic variant of parental MDA-MB-435 cell line) cell line Up 16637015 997 TPM2_HUMAN ENSP00000354219 Breast Cancer Metastasis MDA-MB-435 (human breast cancer cell line) MDA-MB-435HM (A highly metastatic variant of parental MDA-MB-435 cell line) cell line Up 16637015 998 SUMO3_HUMAN ENSP00000330343 Breast Cancer Normal vs. Cancer adjacent normal breast tissues breast cancer tissues tissue Up 17004105 999 TGM2_HUMAN ENSP00000355330 Breast Cancer Normal vs. Cancer Normal (HTB-125) cells malignant (HTB-126) breast cancer cells cell line Down 0.15 17022634 1000 RAD50_HUMAN ENSP00000265335 Breast Cancer Normal vs. Cancer Normal (HTB-125) cells malignant (HTB-126) breast cancer cells cell line Up 3.3 17022634 1001 IF6_HUMAN ENSP00000363574 Breast Cancer Normal vs. Cancer Normal (HTB-125) cells malignant (HTB-126) breast cancer cells cell line Up 3.4 17022634 1002 XRCC6_HUMAN ENSP00000384257 Breast Cancer Normal vs. Cancer Normal (HTB-125) cells malignant (HTB-126) breast cancer cells cell line Up 5 17022634 1003 TPIS_HUMAN ENSP00000379933 Breast Cancer Treatment (chemosensitive vs. adriamycin-resistant) chemosensitive MCF-7 cells adriamycin-resistant MCF-7 cells cell line Up 2.4 17487377 1004 1433E_HUMAN ENSP00000264335 Breast Cancer Treatment (chemosensitive vs. adriamycin-resistant) chemosensitive MCF-7 cells adriamycin-resistant MCF-7 cells cell line Up 2.7 17487377 1005 ENOA_HUMAN ENSP00000234590 Breast Cancer Treatment (chemosensitive vs. adriamycin-resistant) chemosensitive MCF-7 cells adriamycin-resistant MCF-7 cells cell line Up 3 17487377 1006 ANXA1_HUMAN ENSP00000366109 Breast Cancer Treatment (chemosensitive vs. adriamycin-resistant) chemosensitive MCF-7 cells adriamycin-resistant MCF-7 cells cell line Up 17487377 1007 PCNA_HUMAN ENSP00000368458 Breast Cancer Treatment (chemosensitive vs. paclitaxel-resistant) chemosensitive MCF-7 cells paclitaxel-resistant MCF-7 cells cell line Up 2.2 17487377 1008 1433E_HUMAN ENSP00000264335 Breast Cancer Treatment (chemosensitive vs. paclitaxel-resistant) chemosensitive MCF-7 cells paclitaxel-resistant MCF-7 cells cell line Up 2.3 17487377 1009 A1AT_HUMAN ENSP00000348068 Breast Cancer Metastasis nontumorigenic MCF10A, premalignant/tumorigenic MCF10AT tumorigenic/locally invasive MCF10 DCIS.com, and tumorigenic/metastatic MCF 10CA cl. D cell line Up 17608509 1010 ENOA_HUMAN ENSP00000234590 Breast Cancer Metastasis nontumorigenic MCF10A, premalignant/tumorigenic MCF10AT tumorigenic/locally invasive MCF10 DCIS.com, and tumorigenic/metastatic MCF 10CA cl. D cell line Up 17608509 1011 TBB5_HUMAN ENSP00000406811 Melanoma Treatment (none vs. metastasis suppressor 1 (BRMS1) overEXPressed) WT melanoma cell line Mel-BRMS1 melanoma cell line(overEXPressing BRMS1) cell line Down 0.34 17854218 1012 GDIR1_HUMAN ENSP00000269321 Melanoma Treatment (none vs. metastasis suppressor 1 (BRMS1) overEXPressed) WT melanoma cell line Mel-BRMS1 melanoma cell line(overEXPressing BRMS1) cell line Down 0.34 17854218 1013 CATD_HUMAN ENSP00000236671 Melanoma Treatment (none vs. metastasis suppressor 1 (BRMS1) overEXPressed) WT melanoma cell line Mel-BRMS1 melanoma cell line(overEXPressing BRMS1) cell line Down 0.35 17854218 1014 1433B_HUMAN ENSP00000361930 Melanoma Treatment (none vs. metastasis suppressor 1 (BRMS1) overEXPressed) WT melanoma cell line Mel-BRMS1 melanoma cell line(overEXPressing BRMS1) cell line Down 0.35 17854218 1015 ACTN1_HUMAN ENSP00000193403 Melanoma Treatment (none vs. metastasis suppressor 1 (BRMS1) overEXPressed) WT melanoma cell line Mel-BRMS1 melanoma cell line(overEXPressing BRMS1) cell line Down 0.37 17854218 1016 ENOA_HUMAN ENSP00000234590 Melanoma Treatment (none vs. metastasis suppressor 1 (BRMS1) overEXPressed) WT melanoma cell line Mel-BRMS1 melanoma cell line(overEXPressing BRMS1) cell line Down 0.46 17854218 1017 GSTP1_HUMAN ENSP00000381607 Melanoma Treatment (none vs. metastasis suppressor 1 (BRMS1) overEXPressed) WT melanoma cell line Mel-BRMS1 melanoma cell line(overEXPressing BRMS1) cell line Down 0.48 17854218 1018 LMNA_HUMAN ENSP00000357283 Melanoma Treatment (none vs. metastasis suppressor 1 (BRMS1) overEXPressed) WT melanoma cell line Mel-BRMS1 melanoma cell line(overEXPressing BRMS1) cell line Down 0.49 17854218 1019 TBB4B_HUMAN ENSP00000341289 Melanoma Treatment (none vs. metastasis suppressor 1 (BRMS1) overEXPressed) WT melanoma cell line Mel-BRMS1 melanoma cell line(overEXPressing BRMS1) cell line Down 0.5 17854218 1020 HSPB1_HUMAN ENSP00000248553 Melanoma Treatment (none vs. metastasis suppressor 1 (BRMS1) overEXPressed) WT melanoma cell line Mel-BRMS1 melanoma cell line(overEXPressing BRMS1) cell line Down 0.51 17854218 1021 G3P_HUMAN ENSP00000380068 Melanoma Treatment (none vs. metastasis suppressor 1 (BRMS1) overEXPressed) WT melanoma cell line Mel-BRMS1 melanoma cell line(overEXPressing BRMS1) cell line Down 0.53 17854218 1022 STIP1_HUMAN ENSP00000305958 Melanoma Treatment (none vs. metastasis suppressor 1 (BRMS1) overEXPressed) WT melanoma cell line Mel-BRMS1 melanoma cell line(overEXPressing BRMS1) cell line Down 0.59 17854218 1023 ANXA2_HUMAN ENSP00000411352 Melanoma Treatment (none vs. metastasis suppressor 1 (BRMS1) overEXPressed) WT melanoma cell line Mel-BRMS1 melanoma cell line(overEXPressing BRMS1) cell line Down 0.67 17854218 1024 PGAM1_HUMAN ENSP00000359991 Melanoma Treatment (none vs. metastasis suppressor 1 (BRMS1) overEXPressed) WT melanoma cell line Mel-BRMS1 melanoma cell line(overEXPressing BRMS1) cell line Down 0.72 17854218 1025 COF1_HUMAN ENSP00000309629 Melanoma Treatment (none vs. metastasis suppressor 1 (BRMS1) overEXPressed) WT melanoma cell line Mel-BRMS1 melanoma cell line(overEXPressing BRMS1) cell line Down 1.9 17854218 1026 YBOX1_HUMAN ENSP00000361626 Melanoma Treatment (none vs. metastasis suppressor 1 (BRMS1) overEXPressed) WT melanoma cell line Mel-BRMS1 melanoma cell line(overEXPressing BRMS1) cell line Up 2.3 17854218 1027 VIME_HUMAN ENSP00000224237 Melanoma Treatment (none vs. metastasis suppressor 1 (BRMS1) overEXPressed) WT melanoma cell line Mel-BRMS1 melanoma cell line(overEXPressing BRMS1) cell line Up 3.3 17854218 1028 KPYM_HUMAN ENSP00000334983 Melanoma Treatment (none vs. metastasis suppressor 1 (BRMS1) overEXPressed) WT melanoma cell line Mel-BRMS1 melanoma cell line(overEXPressing BRMS1) cell line Up 3.3 17854218 1029 TBB5_HUMAN ENSP00000406811 Melanoma Treatment (none vs. metastasis suppressor 1 (BRMS1) silenced) WT melanoma cell line sh635 melanoma cell line (silencing BRMS1) cell line Up 1.2 17854218 1030 TBB4B_HUMAN ENSP00000341289 Melanoma Treatment (none vs. metastasis suppressor 1 (BRMS1) silenced) WT melanoma cell line sh635 melanoma cell line (silencing BRMS1) cell line Up 1.2 17854218 1031 1433B_HUMAN ENSP00000361930 Melanoma Treatment (none vs. metastasis suppressor 1 (BRMS1) silenced) WT melanoma cell line sh635 melanoma cell line (silencing BRMS1) cell line Up 1.4 17854218 1032 HSPB1_HUMAN ENSP00000248553 Melanoma Treatment (none vs. metastasis suppressor 1 (BRMS1) silenced) WT melanoma cell line sh635 melanoma cell line (silencing BRMS1) cell line Up 1.7 17854218 1033 ENOA_HUMAN ENSP00000234590 Melanoma Treatment (none vs. metastasis suppressor 1 (BRMS1) silenced) WT melanoma cell line sh635 melanoma cell line (silencing BRMS1) cell line Up 1.8 17854218 1034 PGAM1_HUMAN ENSP00000359991 Melanoma Treatment (none vs. metastasis suppressor 1 (BRMS1) silenced) WT melanoma cell line sh635 melanoma cell line (silencing BRMS1) cell line Up 1.9 17854218 1035 HNRPC_HUMAN ENSP00000319690 Melanoma Treatment (none vs. metastasis suppressor 1 (BRMS1) silenced) WT melanoma cell line sh635 melanoma cell line (silencing BRMS1) cell line Up 2.2 17854218 1036 CATD_HUMAN ENSP00000236671 Melanoma Treatment (none vs. metastasis suppressor 1 (BRMS1) silenced) WT melanoma cell line sh635 melanoma cell line (silencing BRMS1) cell line Up 2.5 17854218 1037 CLIC1_HUMAN ENSP00000379229 Breast Cancer Normal vs. Cancer clinically normal peripheral tissue breast cancer tissues tissue Up 18257521 1038 TERT_HUMAN ENSP00000309572 Breast Cancer Normal vs. Cancer clinically normal peripheral tissue breast cancer tissues tissue Up 18257521 1039 CO3_HUMAN ENSP00000245907 Breast Cancer Normal vs. Cancer clinically normal peripheral tissue breast cancer tissues tissue Up 18257521 1040 TTHY_HUMAN ENSP00000237014 Breast Cancer Normal vs. Cancer clinically normal peripheral tissue breast cancer tissues tissue Up 18257521 1041 GELS_HUMAN ENSP00000362924 Breast Cancer Normal vs. Cancer clinically normal peripheral tissue breast cancer tissues tissue Up 18257521 1042 CO4A2_HUMAN ENSP00000353654 Breast Cancer Normal vs. Cancer clinically normal peripheral tissue breast cancer tissues tissue Up 18257521 1043 ACTN1_HUMAN ENSP00000193403 Breast Cancer Normal vs. Cancer clinically normal peripheral tissue breast cancer tissues tissue Up 18257521 1044 PLSL_HUMAN ENSP00000315757 Breast Cancer Normal vs. Cancer clinically normal peripheral tissue breast cancer tissues tissue Up 18257521 1045 VINC_HUMAN ENSP00000211998 Breast Cancer Normal vs. Cancer clinically normal peripheral tissue breast cancer tissues tissue Up 18257521 1046 FLNA_HUMAN ENSP00000358866 Breast Cancer Normal vs. Cancer clinically normal peripheral tissue breast cancer tissues tissue Up 18257521 1047 MOES_HUMAN ENSP00000353408 Breast Cancer Normal vs. Cancer clinically normal peripheral tissue breast cancer tissues tissue Up 18257521 1048 MYH9_HUMAN ENSP00000216181 Breast Cancer Normal vs. Cancer clinically normal peripheral tissue breast cancer tissues tissue Up 18257521 1049 IQGA1_HUMAN ENSP00000268182 Breast Cancer Normal vs. Cancer clinically normal peripheral tissue breast cancer tissues tissue Up 18257521 1050 RAD_HUMAN ENSP00000388744 Breast Cancer Normal vs. Cancer clinically normal peripheral tissue breast cancer tissues tissue Up 18257521 1051 TERA_HUMAN ENSP00000351777 Breast Cancer Normal vs. Cancer clinically normal peripheral tissue breast cancer tissues tissue Up 18257521 1052 1433E_HUMAN ENSP00000264335 Breast Cancer Normal vs. Cancer clinically normal peripheral tissue breast cancer tissues tissue Up 18257521 1053 PRDX1_HUMAN ENSP00000262746 Breast Cancer Normal vs. Cancer clinically normal peripheral tissue breast cancer tissues tissue Up 18257521 1054 SPTN1_HUMAN ENSP00000361816 Breast Cancer Normal vs. Cancer clinically normal peripheral tissue breast cancer tissues tissue Up 18257521 1055 CLIC1_HUMAN ENSP00000379229 Breast Cancer Metastasis Tumors That Have Not Metastasized to the Lymph Nodes Tumors That Have Metastasized to the Lymph Nodes tissue Down 18257521 1056 ITB2_HUMAN ENSP00000303242 Breast Cancer Metastasis Tumors That Have Not Metastasized to the Lymph Nodes Tumors That Have Metastasized to the Lymph Nodes tissue Down 18257521 1057 CATD_HUMAN ENSP00000236671 Breast Cancer Metastasis Tumors That Have Not Metastasized to the Lymph Nodes Tumors That Have Metastasized to the Lymph Nodes tissue Down 18257521 1058 CAN1_HUMAN ENSP00000279247 Breast Cancer Metastasis Tumors That Have Not Metastasized to the Lymph Nodes Tumors That Have Metastasized to the Lymph Nodes tissue Down 18257521 1059 ANXA6_HUMAN ENSP00000346550 Breast Cancer Metastasis Tumors That Have Not Metastasized to the Lymph Nodes Tumors That Have Metastasized to the Lymph Nodes tissue Down 18257521 1060 PLSL_HUMAN ENSP00000315757 Breast Cancer Metastasis Tumors That Have Not Metastasized to the Lymph Nodes Tumors That Have Metastasized to the Lymph Nodes tissue Down 18257521 1061 MOES_HUMAN ENSP00000353408 Breast Cancer Metastasis Tumors That Have Not Metastasized to the Lymph Nodes Tumors That Have Metastasized to the Lymph Nodes tissue Down 18257521 1062 TLN1_HUMAN ENSP00000316029 Breast Cancer Metastasis Tumors That Have Not Metastasized to the Lymph Nodes Tumors That Have Metastasized to the Lymph Nodes tissue Down 18257521 1063 EZRI_HUMAN ENSP00000356042 Breast Cancer Metastasis Tumors That Have Not Metastasized to the Lymph Nodes Tumors That Have Metastasized to the Lymph Nodes tissue Up 18257521 1064 MPCP_HUMAN ENSP00000228318 Breast Cancer Metastasis Tumors That Have Not Metastasized to the Lymph Nodes Tumors That Have Metastasized to the Lymph Nodes tissue Up 18257521 1065 CO4A3_HUMAN ENSP00000379823 Breast Cancer Metastasis Tumors That Have Not Metastasized to the Lymph Nodes Tumors That Have Metastasized to the Lymph Nodes tissue Up 18257521 1066 DCR1C_HUMAN ENSP00000367527 Breast Cancer Metastasis Tumors That Have Not Metastasized to the Lymph Nodes Tumors That Have Metastasized to the Lymph Nodes tissue Up 18257521 1067 RTN4_HUMAN ENSP00000337838 Breast Cancer Metastasis Tumors That Have Not Metastasized to the Lymph Nodes Tumors That Have Metastasized to the Lymph Nodes tissue Up 18257521 1068 ALBU_HUMAN ENSP00000295897 Neoplasms by Histologic Type Normal vs. Cancer the saliva from health women the saliva of ductal carcinoma in situ breast cancer patients tissue Down 0.73 18259946 1069 PIGR_HUMAN ENSP00000348888 Neoplasms by Histologic Type Normal vs. Cancer the saliva from health women the saliva of ductal carcinoma in situ breast cancer patients tissue Down 0.86 18259946 1070 TRFL_HUMAN ENSP00000231751 Neoplasms by Histologic Type Normal vs. Cancer the saliva from health women the saliva of ductal carcinoma in situ breast cancer patients tissue Up 1.6 18259946 1071 ANXA1_HUMAN ENSP00000366109 Neoplasms by Histologic Type Normal vs. Cancer the saliva from health women the saliva of ductal carcinoma in situ breast cancer patients tissue Up 3.1 18259946 1072 PLSL_HUMAN ENSP00000315757 Neoplasms by Histologic Type Normal vs. Cancer the saliva from women diagnosed with a benign breast tumor the saliva of ductal carcinoma in situ breast cancer patients tissue Down 0.69 18259946 1073 ENOA_HUMAN ENSP00000234590 Neoplasms by Histologic Type Normal vs. Cancer the saliva from women diagnosed with a benign breast tumor the saliva of ductal carcinoma in situ breast cancer patients tissue Down 0.73 18259946 1074 PIGR_HUMAN ENSP00000348888 Neoplasms by Histologic Type Normal vs. Cancer the saliva from women diagnosed with a benign breast tumor the saliva of ductal carcinoma in situ breast cancer patients tissue Down 0.76 18259946 1075 TRFL_HUMAN ENSP00000231751 Neoplasms by Histologic Type Normal vs. Cancer the saliva from women diagnosed with a benign breast tumor the saliva of ductal carcinoma in situ breast cancer patients tissue Up 1.3 18259946 1076 ANXA1_HUMAN ENSP00000366109 Neoplasms by Histologic Type Normal vs. Cancer the saliva from women diagnosed with a benign breast tumor the saliva of ductal carcinoma in situ breast cancer patients tissue Up 1.9 18259946 1077 THIO_HUMAN ENSP00000363641 Neoplasms by Histologic Type Normal vs. Cancer the saliva from women diagnosed with a benign breast tumor the saliva of ductal carcinoma in situ breast cancer patients tissue Up 1.9 18259946 1078 CO3_HUMAN ENSP00000245907 breast ductal carcinoma Normal vs. Cancer surrounding histologically normal tissues breast tumor samples tissue Down 0.24 18401453 1079 SODM_HUMAN ENSP00000337127 breast ductal carcinoma Normal vs. Cancer surrounding histologically normal tissues breast tumor samples tissue Up 3.9 18401453 1080 HBB_HUMAN ENSP00000333994 breast ductal carcinoma Normal vs. Cancer surrounding histologically normal tissues breast tumor samples tissue Up 6 18401453 1081 HBB_HUMAN ENSP00000333994 breast ductal carcinoma Normal vs. Cancer surrounding histologically normal tissues breast tumor samples tissue Up 6.8 18401453 1082 ENOA_HUMAN ENSP00000234590 breast ductal carcinoma Normal vs. Cancer surrounding histologically normal tissues breast tumor samples tissue Up 11 18401453 1083 GPX1_HUMAN ENSP00000407375 Breast Cancer Metastasis breast cancer tissue samples patients developed distant metastases within three-year follow-up. tissue Down 0.34 18416831 1084 NPM_HUMAN ENSP00000296930 Breast Cancer Metastasis breast cancer tissue samples patients developed distant metastases within three-year follow-up. tissue Up 1.2 18416831 1085 S10AB_HUMAN ENSP00000271638 Breast Cancer Treatment (none vs. 17b-Estradiol treatment) MCF-7 human breast cancer cells MCF-7 human with 17b-Estradiol treatment breast cancer cells cell line Down 0.48 18491314 1086 G6PI_HUMAN ENSP00000348877 Breast Cancer Treatment (none vs. 17b-Estradiol treatment) MCF-7 human breast cancer cells MCF-7 human with 17b-Estradiol treatment breast cancer cells cell line Up 2 18491314 1087 HSP72_HUMAN ENSP00000247207 Breast Cancer Treatment (none vs. 17b-Estradiol treatment) MCF-7 human breast cancer cells MCF-7 human with 17b-Estradiol treatment breast cancer cells cell line Up 2.1 18491314 1088 TBB5_HUMAN ENSP00000406811 Breast Cancer Treatment (none vs. 17b-Estradiol treatment) MCF-7 human breast cancer cells MCF-7 human with 17b-Estradiol treatment breast cancer cells cell line Up 2.2 18491314 1089 EF2_HUMAN ENSP00000307940 Breast Cancer Treatment (none vs. 17b-Estradiol treatment) MCF-7 human breast cancer cells MCF-7 human with 17b-Estradiol treatment breast cancer cells cell line Up 2.2 18491314 1090 IQGA1_HUMAN ENSP00000268182 Breast Cancer Treatment (none vs. 17b-Estradiol treatment) MCF-7 human breast cancer cells MCF-7 human with 17b-Estradiol treatment breast cancer cells cell line Up 2.3 18491314 1091 H4_HUMAN ENSP00000376663 Breast Cancer Treatment (none vs. 17b-Estradiol treatment) MCF-7 human breast cancer cells MCF-7 human with 17b-Estradiol treatment breast cancer cells cell line Up 2.3 18491314 1092 HS90B_HUMAN ENSP00000360609 Breast Cancer Treatment (none vs. 17b-Estradiol treatment) MCF-7 human breast cancer cells MCF-7 human with 17b-Estradiol treatment breast cancer cells cell line Up 2.4 18491314 1093 H2B1D_HUMAN ENSP00000367008 Breast Cancer Treatment (none vs. 17b-Estradiol treatment) MCF-7 human breast cancer cells MCF-7 human with 17b-Estradiol treatment breast cancer cells cell line Up 2.4 18491314 1094 FUBP1_HUMAN ENSP00000359804 Breast Cancer Treatment (none vs. 17b-Estradiol treatment) MCF-7 human breast cancer cells MCF-7 human with 17b-Estradiol treatment breast cancer cells cell line Up 2.4 18491314 1095 NHRF1_HUMAN ENSP00000262613 Breast Cancer Treatment (none vs. 17b-Estradiol treatment) MCF-7 human breast cancer cells MCF-7 human with 17b-Estradiol treatment breast cancer cells cell line Up 2.6 18491314 1096 TBA1C_HUMAN ENSP00000301072 Breast Cancer Treatment (none vs. 17b-Estradiol treatment) MCF-7 human breast cancer cells MCF-7 human with 17b-Estradiol treatment breast cancer cells cell line Up 2.6 18491314 1097 H31_HUMAN ENSP00000353581 Breast Cancer Treatment (none vs. 17b-Estradiol treatment) MCF-7 human breast cancer cells MCF-7 human with 17b-Estradiol treatment breast cancer cells cell line Up 2.7 18491314 1098 FAS_HUMAN ENSP00000304592 Breast Cancer Treatment (none vs. 17b-Estradiol treatment) MCF-7 human breast cancer cells MCF-7 human with 17b-Estradiol treatment breast cancer cells cell line Up 2.8 18491314 1099 HSP7C_HUMAN ENSP00000227378 Breast Cancer Treatment (none vs. 17b-Estradiol treatment) MCF-7 human breast cancer cells MCF-7 human with 17b-Estradiol treatment breast cancer cells cell line Up 2.9 18491314 1100 FKBP4_HUMAN ENSP00000001008 Breast Cancer Treatment (none vs. 17b-Estradiol treatment) MCF-7 human breast cancer cells MCF-7 human with 17b-Estradiol treatment breast cancer cells cell line Up 2.9 18491314 1101 G3BP1_HUMAN ENSP00000348578 Breast Cancer Treatment (none vs. 17b-Estradiol treatment) MCF-7 human breast cancer cells MCF-7 human with 17b-Estradiol treatment breast cancer cells cell line Up 2.9 18491314 1102 EF1A1_HUMAN ENSP00000330054 Breast Cancer Treatment (none vs. 17b-Estradiol treatment) MCF-7 human breast cancer cells MCF-7 human with 17b-Estradiol treatment breast cancer cells cell line Up 3.2 18491314 1103 PCNA_HUMAN ENSP00000368458 Breast Cancer Treatment (none vs. 17b-Estradiol treatment) MCF-7 human breast cancer cells MCF-7 human with 17b-Estradiol treatment breast cancer cells cell line Up 3.5 18491314 1104 PRKDC_HUMAN ENSP00000313420 Breast Cancer Treatment (none vs. 17b-Estradiol treatment) MCF-7 human breast cancer cells MCF-7 human with 17b-Estradiol treatment breast cancer cells cell line Up 5.8 18491314 1105 TFF1_HUMAN ENSP00000291527 Breast Cancer Treatment (none vs. 17b-Estradiol treatment) MCF-7 human breast cancer cells MCF-7 human with 17b-Estradiol treatment breast cancer cells cell line Up 8.4 18491314 1106 G3P_HUMAN ENSP00000380068 Hepatocellular Carcinoma Normal vs. Cancer normal liver tissues tumorous liver tissues tissue Up 1.9 11866469 1107 HS90A_HUMAN ENSP00000335153 Hepatocellular Carcinoma Normal vs. Cancer normal liver tissues tumorous liver tissues tissue Up 2.1 11866469 1108 TBB5_HUMAN ENSP00000406811 Hepatocellular Carcinoma Normal vs. Cancer normal liver tissues tumorous liver tissues tissue Up 2.1 11866469 1109 HSP7C_HUMAN ENSP00000227378 Hepatocellular Carcinoma Normal vs. Cancer normal liver tissues tumorous liver tissues tissue Up 2.4 11866469 1110 ANXA2_HUMAN ENSP00000411352 Hepatocellular Carcinoma Normal vs. Cancer normal liver tissues tumorous liver tissues tissue Up 2.4 11866469 1111 VIME_HUMAN ENSP00000224237 Hepatocellular Carcinoma Normal vs. Cancer normal liver tissues tumorous liver tissues tissue Up 2.5 11866469 1112 ENPL_HUMAN ENSP00000299767 Hepatocellular Carcinoma Normal vs. Cancer normal liver tissues tumorous liver tissues tissue Up 2.6 11866469 1113 LMNB1_HUMAN ENSP00000261366 Hepatocellular Carcinoma Normal vs. Cancer normal liver tissues tumorous liver tissues tissue Up 3.3 11866469 1114 NPM_HUMAN ENSP00000296930 Hepatocellular Carcinoma Normal vs. Cancer normal liver tissues tumorous liver tissues tissue Up 11866469 1115 HSPB1_HUMAN ENSP00000248553 hepatitis B virus Normal vs. Cancer surrounding nontumorous liver tissues hepatitis B surface antigen-positive (B-type HCC) tissue Down 0.052 14654528 1116 ASSY_HUMAN ENSP00000361470 hepatitis B virus Normal vs. Cancer surrounding nontumorous liver tissues hepatitis B surface antigen-positive (B-type HCC) tissue Down 0.088 14654528 1117 SODC_HUMAN ENSP00000270142 hepatitis B virus Normal vs. Cancer surrounding nontumorous liver tissues hepatitis B surface antigen-positive (B-type HCC) tissue Down 0.4 14654528 1118 PEBP1_HUMAN ENSP00000261313 hepatitis B virus Normal vs. Cancer surrounding nontumorous liver tissues hepatitis B surface antigen-positive (B-type HCC) tissue Down 0.62 14654528 1119 ENOA_HUMAN ENSP00000234590 hepatitis B virus Normal vs. Cancer surrounding nontumorous liver tissues hepatitis B surface antigen-positive (B-type HCC) tissue Down 0.67 14654528 1120 TBB5_HUMAN ENSP00000406811 hepatitis B virus Normal vs. Cancer surrounding nontumorous liver tissues hepatitis B surface antigen-positive (B-type HCC) tissue Up 1.8 14654528 1121 RSSA_HUMAN ENSP00000346067 hepatitis B virus Normal vs. Cancer surrounding nontumorous liver tissues hepatitis B surface antigen-positive (B-type HCC) tissue Up 2.1 14654528 1122 VIME_HUMAN ENSP00000224237 hepatitis B virus Normal vs. Cancer surrounding nontumorous liver tissues hepatitis B surface antigen-positive (B-type HCC) tissue Up 2.3 14654528 1123 TERA_HUMAN ENSP00000351777 hepatitis B virus Normal vs. Cancer surrounding nontumorous liver tissues hepatitis B surface antigen-positive (B-type HCC) tissue Up 2.5 14654528 1124 HS90A_HUMAN ENSP00000335153 hepatitis B virus Normal vs. Cancer surrounding nontumorous liver tissues hepatitis B surface antigen-positive (B-type HCC) tissue Up 2.9 14654528 1125 EF2_HUMAN ENSP00000307940 hepatitis B virus Normal vs. Cancer surrounding nontumorous liver tissues hepatitis B surface antigen-positive (B-type HCC) tissue Up 2.9 14654528 1126 HSP7C_HUMAN ENSP00000227378 hepatitis B virus Normal vs. Cancer surrounding nontumorous liver tissues hepatitis B surface antigen-positive (B-type HCC) tissue Up 3.5 14654528 1127 NDKA_HUMAN ENSP00000013034 hepatitis B virus Normal vs. Cancer surrounding nontumorous liver tissues hepatitis B surface antigen-positive (B-type HCC) tissue Up 4.2 14654528 1128 LMNB1_HUMAN ENSP00000261366 hepatitis B virus Normal vs. Cancer surrounding nontumorous liver tissues hepatitis B surface antigen-positive (B-type HCC) tissue Up 4.8 14654528 1129 ENPL_HUMAN ENSP00000299767 hepatitis B virus Normal vs. Cancer surrounding nontumorous liver tissues hepatitis B surface antigen-positive (B-type HCC) tissue Up 5.7 14654528 1130 NPM_HUMAN ENSP00000296930 hepatitis B virus Normal vs. Cancer surrounding nontumorous liver tissues hepatitis B surface antigen-positive (B-type HCC) tissue Up 6.9 14654528 1131 CLIC1_HUMAN ENSP00000379229 hepatitis B virus Normal vs. Cancer surrounding nontumorous liver tissues hepatitis B surface antigen-positive (B-type HCC) tissue Up 9.6 14654528 1132 HSP71_HUMAN ENSP00000364801 hepatitis B virus Normal vs. Cancer surrounding nontumorous liver tissues hepatitis B surface antigen-positive (B-type HCC) tissue Up 20 14654528 1133 ACADM_HUMAN ENSP00000359878 hepatitis C virus Normal vs. Cancer surrounding nontumorous liver tissues anti-HCV-positive (C-type HCC) tissue Down 0.081 14654528 1134 ASSY_HUMAN ENSP00000361470 hepatitis C virus Normal vs. Cancer surrounding nontumorous liver tissues anti-HCV-positive (C-type HCC) tissue Down 0.088 14654528 1135 VIME_HUMAN ENSP00000224237 hepatitis C virus Normal vs. Cancer surrounding nontumorous liver tissues anti-HCV-positive (C-type HCC) tissue Up 2.3 14654528 1136 HS90A_HUMAN ENSP00000335153 hepatitis C virus Normal vs. Cancer surrounding nontumorous liver tissues anti-HCV-positive (C-type HCC) tissue Up 2.9 14654528 1137 EF2_HUMAN ENSP00000307940 hepatitis C virus Normal vs. Cancer surrounding nontumorous liver tissues anti-HCV-positive (C-type HCC) tissue Up 2.9 14654528 1138 HSP7C_HUMAN ENSP00000227378 hepatitis C virus Normal vs. Cancer surrounding nontumorous liver tissues anti-HCV-positive (C-type HCC) tissue Up 3.5 14654528 1139 NDKA_HUMAN ENSP00000013034 hepatitis C virus Normal vs. Cancer surrounding nontumorous liver tissues anti-HCV-positive (C-type HCC) tissue Up 4.2 14654528 1140 HSPB1_HUMAN ENSP00000248553 hepatitis C virus Normal vs. Cancer surrounding nontumorous liver tissues anti-HCV-positive (C-type HCC) tissue Up 4.4 14654528 1141 TBB5_HUMAN ENSP00000406811 hepatitis C virus Normal vs. Cancer surrounding nontumorous liver tissues anti-HCV-positive (C-type HCC) tissue Up 5.1 14654528 1142 ENPL_HUMAN ENSP00000299767 hepatitis C virus Normal vs. Cancer surrounding nontumorous liver tissues anti-HCV-positive (C-type HCC) tissue Up 5.7 14654528 1143 NPM_HUMAN ENSP00000296930 hepatitis C virus Normal vs. Cancer surrounding nontumorous liver tissues anti-HCV-positive (C-type HCC) tissue Up 6.9 14654528 1144 HSP71_HUMAN ENSP00000364801 hepatitis C virus Normal vs. Cancer surrounding nontumorous liver tissues anti-HCV-positive (C-type HCC) tissue Up 20 14654528 1145 ASSY_HUMAN ENSP00000361470 Hepatocellular Carcinoma Normal vs. Cancer surrounding nontumorous liver tissues hepatitis B surface antigen-negative and anti-HCV-negative tissue Down 0.088 14654528 1146 TERA_HUMAN ENSP00000351777 Hepatocellular Carcinoma Normal vs. Cancer surrounding nontumorous liver tissues hepatitis B surface antigen-negative and anti-HCV-negative tissue Down 0.13 14654528 1147 CLIC1_HUMAN ENSP00000379229 Hepatocellular Carcinoma Normal vs. Cancer surrounding nontumorous liver tissues hepatitis B surface antigen-negative and anti-HCV-negative tissue Down 0.38 14654528 1148 PEBP1_HUMAN ENSP00000261313 Hepatocellular Carcinoma Normal vs. Cancer surrounding nontumorous liver tissues hepatitis B surface antigen-negative and anti-HCV-negative tissue Down 0.59 14654528 1149 ENOA_HUMAN ENSP00000234590 Hepatocellular Carcinoma Normal vs. Cancer surrounding nontumorous liver tissues hepatitis B surface antigen-negative and anti-HCV-negative tissue Up 2 14654528 1150 VIME_HUMAN ENSP00000224237 Hepatocellular Carcinoma Normal vs. Cancer surrounding nontumorous liver tissues hepatitis B surface antigen-negative and anti-HCV-negative tissue Up 2.3 14654528 1151 HSPB1_HUMAN ENSP00000248553 Hepatocellular Carcinoma Normal vs. Cancer surrounding nontumorous liver tissues hepatitis B surface antigen-negative and anti-HCV-negative tissue Up 2.7 14654528 1152 HS90A_HUMAN ENSP00000335153 Hepatocellular Carcinoma Normal vs. Cancer surrounding nontumorous liver tissues hepatitis B surface antigen-negative and anti-HCV-negative tissue Up 2.9 14654528 1153 EF2_HUMAN ENSP00000307940 Hepatocellular Carcinoma Normal vs. Cancer surrounding nontumorous liver tissues hepatitis B surface antigen-negative and anti-HCV-negative tissue Up 2.9 14654528 1154 ACADM_HUMAN ENSP00000359878 Hepatocellular Carcinoma Normal vs. Cancer surrounding nontumorous liver tissues hepatitis B surface antigen-negative and anti-HCV-negative tissue Up 3.2 14654528 1155 HSP7C_HUMAN ENSP00000227378 Hepatocellular Carcinoma Normal vs. Cancer surrounding nontumorous liver tissues hepatitis B surface antigen-negative and anti-HCV-negative tissue Up 3.5 14654528 1156 NDKA_HUMAN ENSP00000013034 Hepatocellular Carcinoma Normal vs. Cancer surrounding nontumorous liver tissues hepatitis B surface antigen-negative and anti-HCV-negative tissue Up 4.2 14654528 1157 ENPL_HUMAN ENSP00000299767 Hepatocellular Carcinoma Normal vs. Cancer surrounding nontumorous liver tissues hepatitis B surface antigen-negative and anti-HCV-negative tissue Up 5.7 14654528 1158 NPM_HUMAN ENSP00000296930 Hepatocellular Carcinoma Normal vs. Cancer surrounding nontumorous liver tissues hepatitis B surface antigen-negative and anti-HCV-negative tissue Up 6.9 14654528 1159 RET4_HUMAN ENSP00000360522 Hepatocellular Carcinoma Normal vs. Cancer surrounding nontumorous liver tissues hepatitis B surface antigen-negative and anti-HCV-negative tissue Up 16 14654528 1160 HSP71_HUMAN ENSP00000364801 Hepatocellular Carcinoma Normal vs. Cancer surrounding nontumorous liver tissues hepatitis B surface antigen-negative and anti-HCV-negative tissue Up 20 14654528 1161 F16P1_HUMAN ENSP00000408025 hepatitis B virus Normal vs. Cancer the adjacent non-tumor (normal) liver tissues poorly-differentiated HBV infected liver samples tissue Down 0.13 15852300 1162 GNMT_HUMAN ENSP00000361894 hepatitis B virus Normal vs. Cancer the adjacent non-tumor (normal) liver tissues poorly-differentiated HBV infected liver samples tissue Down 0.22 15852300 1163 EFTU_HUMAN ENSP00000322439 hepatitis B virus Normal vs. Cancer the adjacent non-tumor (normal) liver tissues poorly-differentiated HBV infected liver samples tissue Down 0.31 15852300 1164 PEBP1_HUMAN ENSP00000261313 hepatitis B virus Normal vs. Cancer the adjacent non-tumor (normal) liver tissues poorly-differentiated HBV infected liver samples tissue Down 0.38 15852300 1165 A1AT_HUMAN ENSP00000348068 hepatitis B virus Normal vs. Cancer the adjacent non-tumor (normal) liver tissues poorly-differentiated HBV infected liver samples tissue Up 5 15852300 1166 COMT_HUMAN ENSP00000385150 hepatitis C virus Normal vs. Cancer the adjacent non-tumorous liver tissues tumorous liver tissues tissue Down 0.1 16097030 1167 CATD_HUMAN ENSP00000236671 hepatitis C virus Normal vs. Cancer the adjacent non-tumorous liver tissues tumorous liver tissues tissue Down 0.19 16097030 1168 ANXA6_HUMAN ENSP00000346550 hepatitis C virus Normal vs. Cancer the adjacent non-tumorous liver tissues tumorous liver tissues tissue Down 0.22 16097030 1169 PRDX1_HUMAN ENSP00000262746 hepatitis C virus Normal vs. Cancer the adjacent non-tumorous liver tissues tumorous liver tissues tissue Down 0.5 16097030 1170 F16P1_HUMAN ENSP00000408025 hepatitis C virus Normal vs. Cancer the adjacent non-tumorous liver tissues tumorous liver tissues tissue Down 16097030 1171 CLIC1_HUMAN ENSP00000379229 hepatitis C virus Normal vs. Cancer the adjacent non-tumorous liver tissues tumorous liver tissues tissue Up 1.7 16097030 1172 NDKA_HUMAN ENSP00000013034 hepatitis C virus Normal vs. Cancer the adjacent non-tumorous liver tissues tumorous liver tissues tissue Up 2 16097030 1173 LMNB1_HUMAN ENSP00000261366 hepatitis C virus Normal vs. Cancer the adjacent non-tumorous liver tissues tumorous liver tissues tissue Up 2 16097030 1174 FKBP4_HUMAN ENSP00000001008 hepatitis C virus Normal vs. Cancer the adjacent non-tumorous liver tissues tumorous liver tissues tissue Up 2.9 16097030 1175 NPM_HUMAN ENSP00000296930 hepatitis C virus Normal vs. Cancer the adjacent non-tumorous liver tissues tumorous liver tissues tissue Up 3.3 16097030 1176 APOE_HUMAN ENSP00000252486 hepatitis C virus Normal vs. Cancer the adjacent non-tumorous liver tissues tumorous liver tissues tissue Up 3.8 16097030 1177 TTHY_HUMAN ENSP00000237014 hepatitis B virus Normal vs. Cancer serum samples of healthy volunteers serum samples of HBV patients tissue Down 16240287 1178 A1AT_HUMAN ENSP00000348068 hepatitis B virus Normal vs. Cancer serum samples of healthy volunteers serum samples of HBV patients tissue Up 16240287 1179 HSPB1_HUMAN ENSP00000248553 hepatitis B virus Normal vs. Cancer serum samples of healthy volunteers serum samples of HBV patients tissue Up 16240287 1180 TTHY_HUMAN ENSP00000237014 Hepatocellular Carcinoma Normal vs. Cancer serum samples of healthy volunteers serum samples of HCC patients tissue Down 16240287 1181 A1AT_HUMAN ENSP00000348068 Hepatocellular Carcinoma Normal vs. Cancer serum samples of healthy volunteers serum samples of HCC patients tissue Up 16240287 1182 HSPB1_HUMAN ENSP00000248553 Hepatocellular Carcinoma Normal vs. Cancer serum samples of healthy volunteers serum samples of HCC patients tissue Up 16240287 1183 THIO_HUMAN ENSP00000363641 Hepatocellular Carcinoma Normal vs. Cancer the surrounding nontumor tissue tumorous liver tissues tissue Up 16335951 1184 SODC_HUMAN ENSP00000270142 hepatitis C virus Normal vs. Cancer nontumor tissues liver tumor tissues tissue Down 16762624 1185 A1AT_HUMAN ENSP00000348068 hepatitis C virus Normal vs. Cancer nontumor tissues liver tumor tissues tissue Down 16762624 1186 CALR_HUMAN ENSP00000320866 hepatitis C virus Normal vs. Cancer nontumor tissues liver tumor tissues tissue Down 16762624 1187 TPIS_HUMAN ENSP00000379933 hepatitis C virus Normal vs. Cancer nontumor tissues liver tumor tissues tissue Down 16762624 1188 A1AT_HUMAN ENSP00000348068 hepatitis C virus Normal vs. Cancer nontumor tissues liver tumor tissues tissue Up 16762624 1189 APOA1_HUMAN ENSP00000236850 hepatitis C virus Normal vs. Cancer nontumor tissues liver tumor tissues tissue Up 16762624 1190 TTHY_HUMAN ENSP00000237014 hepatitis C virus Normal vs. Cancer nontumor tissues liver tumor tissues tissue Up 16762624 1191 ALBU_HUMAN ENSP00000295897 hepatitis C virus Normal vs. Cancer nontumor tissues liver tumor tissues tissue Up 16762624 1192 TPM2_HUMAN ENSP00000354219 hepatitis C virus Normal vs. Cancer nontumor tissues liver tumor tissues tissue Up 16762624 1193 CALR_HUMAN ENSP00000320866 hepatitis C virus Normal vs. Cancer nontumor tissues liver tumor tissues tissue Up 16762624 1194 TPIS_HUMAN ENSP00000379933 hepatitis C virus Normal vs. Cancer nontumor tissues liver tumor tissues tissue Up 16762624 1195 G3P_HUMAN ENSP00000380068 Hepatocellular Carcinoma Normal vs. Cancer non-tumor Chang liver cell Hep3B cell line without metastasis cell line Down 17214954 1196 PRDX1_HUMAN ENSP00000262746 Hepatocellular Carcinoma Normal vs. Cancer non-tumor Chang liver cell Hep3B cell line without metastasis cell line Down 17214954 1197 CATD_HUMAN ENSP00000236671 Hepatocellular Carcinoma Normal vs. Cancer non-tumor Chang liver cell Hep3B cell line without metastasis cell line Up 17214954 1198 SODM_HUMAN ENSP00000337127 Hepatocellular Carcinoma Metastasis non-tumor Chang liver cell MHCC97H cell line with highly metastatic potential cell line Down 17214954 1199 PRDX1_HUMAN ENSP00000262746 Hepatocellular Carcinoma Metastasis non-tumor Chang liver cell MHCC97H cell line with highly metastatic potential cell line Down 17214954 1200 CLIC1_HUMAN ENSP00000379229 Hepatocellular Carcinoma Metastasis non-tumor Chang liver cell MHCC97H cell line with highly metastatic potential cell line Up 17214954 1201 CATD_HUMAN ENSP00000236671 Hepatocellular Carcinoma Metastasis non-tumor Chang liver cell MHCC97H cell line with highly metastatic potential cell line Up 17214954 1202 SODM_HUMAN ENSP00000337127 Hepatocellular Carcinoma Metastasis Hep3B cell line without metastasis MHCC97H cell line with highly metastatic potential cell line Down 17214954 1203 TBB4B_HUMAN ENSP00000341289 Hepatocellular Carcinoma Metastasis Hep3B cell line without metastasis MHCC97H cell line with highly metastatic potential cell line Down 17214954 1204 PRDX1_HUMAN ENSP00000262746 Hepatocellular Carcinoma Metastasis Hep3B cell line without metastasis MHCC97H cell line with highly metastatic potential cell line Down 17214954 1205 TBB2B_HUMAN ENSP00000259818 Hepatocellular Carcinoma Metastasis Hep3B cell line without metastasis MHCC97H cell line with highly metastatic potential cell line Down 17214954 1206 G3P_HUMAN ENSP00000380068 Hepatocellular Carcinoma Metastasis Hep3B cell line without metastasis MHCC97H cell line with highly metastatic potential cell line Up 17214954 1207 CATD_HUMAN ENSP00000236671 Hepatocellular Carcinoma Metastasis Hep3B cell line without metastasis MHCC97H cell line with highly metastatic potential cell line Up 17214954 1208 TTHY_HUMAN ENSP00000237014 Hepatocellular Carcinoma Normal vs. Cancer serum from normal liver tissue liver serum from HCC patients tissue Down 17447055 1209 CRP_HUMAN ENSP00000255030 Hepatocellular Carcinoma Normal vs. Cancer serum from normal liver tissue liver serum from HCC patients tissue Up 17447055 1210 ALBU_HUMAN ENSP00000295897 Hepatocellular Carcinoma Normal vs. Cancer serum from normal liver tissue liver serum from HCC patients tissue Up 17447055 1211 ANXA6_HUMAN ENSP00000346550 Hepatocellular Carcinoma Normal vs. Cancer serum from normal liver tissue liver serum from HCC patients tissue Up 17447055 1212 HSPB1_HUMAN ENSP00000248553 Hepatocellular Carcinoma Treatment (none vs. Suberonylanilide hydroxamic acid (SAHA) treatment) Jurkat lymphoma cell line (which was highly sensitive to SAHA) were treated with 2.5 uM SAHA for 48 h HepG2 cells treated with 5uM SAHA for 48 h tissue Down 17593366 1213 GSTP1_HUMAN ENSP00000381607 Hepatocellular Carcinoma Treatment (none vs. Suberonylanilide hydroxamic acid (SAHA) treatment) Jurkat lymphoma cell line (which was highly sensitive to SAHA) were treated with 2.5 uM SAHA for 48 h HepG2 cells treated with 5uM SAHA for 48 h tissue Down 17593366 1214 ENPL_HUMAN ENSP00000299767 Hepatocellular Carcinoma Treatment (none vs. Suberonylanilide hydroxamic acid (SAHA) treatment) Jurkat lymphoma cell line (which was highly sensitive to SAHA) were treated with 2.5 uM SAHA for 48 h HepG2 cells treated with 5uM SAHA for 48 h tissue Down 17593366 1215 CNBP_HUMAN ENSP00000410619 Hepatocellular Carcinoma Treatment (none vs. Suberonylanilide hydroxamic acid (SAHA) treatment) Jurkat lymphoma cell line (which was highly sensitive to SAHA) were treated with 2.5 uM SAHA for 48 h HepG2 cells treated with 5uM SAHA for 48 h tissue Down 17593366 1216 TEBP_HUMAN ENSP00000262033 Hepatocellular Carcinoma Treatment (none vs. Suberonylanilide hydroxamic acid (SAHA) treatment) Jurkat lymphoma cell line (which was highly sensitive to SAHA) were treated with 2.5 uM SAHA for 48 h HepG2 cells treated with 5uM SAHA for 48 h tissue Down 17593366 1217 SODM_HUMAN ENSP00000337127 Hepatocellular Carcinoma Treatment (none vs. Suberonylanilide hydroxamic acid (SAHA) treatment) Jurkat lymphoma cell line (which was highly sensitive to SAHA) were treated with 2.5 uM SAHA for 48 h HepG2 cells treated with 5uM SAHA for 48 h tissue Up 17593366 1218 THIO_HUMAN ENSP00000363641 Hepatocellular Carcinoma Treatment (none vs. Suberonylanilide hydroxamic acid (SAHA) treatment) Jurkat lymphoma cell line (which was highly sensitive to SAHA) were treated with 2.5 uM SAHA for 48 h HepG2 cells treated with 5uM SAHA for 48 h tissue Up 17593366 1219 TPIS_HUMAN ENSP00000379933 Hepatocellular Carcinoma Treatment (none vs. Suberonylanilide hydroxamic acid (SAHA) treatment) Jurkat lymphoma cell line (which was highly sensitive to SAHA) were treated with 2.5 uM SAHA for 48 h HepG2 cells treated with 5uM SAHA for 48 h tissue Up 17593366 1220 RHOA_HUMAN ENSP00000400175 Hepatocellular Carcinoma Treatment (none vs. Suberonylanilide hydroxamic acid (SAHA) treatment) Jurkat lymphoma cell line (which was highly sensitive to SAHA) were treated with 2.5 uM SAHA for 48 h HepG2 cells treated with 5uM SAHA for 48 h tissue Up 17593366 1221 PRDX1_HUMAN ENSP00000262746 Hepatocellular Carcinoma Treatment (none vs. Suberonylanilide hydroxamic acid (SAHA) treatment) Jurkat lymphoma cell line (which was highly sensitive to SAHA) were treated with 2.5 uM SAHA for 48 h HepG2 cells treated with 5uM SAHA for 48 h tissue Up 17593366 1222 PARK7_HUMAN ENSP00000366708 hepatitis B virus Normal vs. Cancer the adjacent non-tumour tissues human HBV-infected (G1) HCC frozen tumour tissues tissue Down 0.32 17671684 1223 TPIS_HUMAN ENSP00000379933 hepatitis B virus Normal vs. Cancer the adjacent non-tumour tissues human HBV-infected (G1) HCC frozen tumour tissues tissue Down 0.38 17671684 1224 NDKA_HUMAN ENSP00000013034 hepatitis B virus Normal vs. Cancer the adjacent non-tumour tissues human HBV-infected (G1) HCC frozen tumour tissues tissue Up 2.1 17671684 1225 TBB5_HUMAN ENSP00000406811 hepatitis B virus Normal vs. Cancer the adjacent non-tumour tissues human HBV-infected (G1) HCC frozen tumour tissues tissue Up 2.1 17671684 1226 CLIC1_HUMAN ENSP00000379229 hepatitis B virus Normal vs. Cancer the adjacent non-tumour tissues human HBV-infected (G1) HCC frozen tumour tissues tissue Up 2.2 17671684 1227 HSPB1_HUMAN ENSP00000248553 hepatitis B virus Normal vs. Cancer the adjacent non-tumour tissues human HBV-infected (G1) HCC frozen tumour tissues tissue Up 2.2 17671684 1228 APOA1_HUMAN ENSP00000236850 hepatitis B virus Normal vs. Cancer the adjacent non-tumour tissues human HBV-infected (G1) HCC frozen tumour tissues tissue Up 2.6 17671684 1229 IPYR_HUMAN ENSP00000362329 hepatitis B virus Normal vs. Cancer the adjacent non-tumour tissues human HBV-infected (G1) HCC frozen tumour tissues tissue Up 2.8 17671684 1230 TBA1C_HUMAN ENSP00000301072 hepatitis B virus Normal vs. Cancer the adjacent non-tumour tissues human HBV-infected (G1) HCC frozen tumour tissues tissue Up 2.8 17671684 1231 GSTP1_HUMAN ENSP00000381607 hepatitis B virus Normal vs. Cancer the adjacent non-tumour tissues human HBV-infected (G1) HCC frozen tumour tissues tissue Up 3.2 17671684 1232 TTHY_HUMAN ENSP00000237014 Hepatocellular Carcinoma Normal vs. Cancer liver tissues from healthy volunteer liver tissues from HCC patients with PVTT (portal vein tumor thrombi) tissue Up 17828420 1233 TTHY_HUMAN ENSP00000237014 Hepatocellular Carcinoma Normal vs. Cancer liver tissues from healthy volunteer liver tissues from HCC patients without PVTT (portal vein tumor thrombi) tissue Up 17828420 1234 FA10_HUMAN ENSP00000364709 hepatitis C virus Normal vs. Cancer pRcCMV/QSG cells (negative control)(QSG7701 cells were transfected with the non-EXPression vector pRcCMV as a negative control) pRcHCNS3/QSG cells(Plasmid pRcHCNS3-5’ was introduced into QSG7701 cells and cells were seeded into selection medium containing 400 μg/ml G418 until several G418-resistant clones) cell line Down 17928924 1235 CCND2_HUMAN ENSP00000261254 hepatitis C virus Normal vs. Cancer pRcCMV/QSG cells (negative control)(QSG7701 cells were transfected with the non-EXPression vector pRcCMV as a negative control) pRcHCNS3/QSG cells(Plasmid pRcHCNS3-5’ was introduced into QSG7701 cells and cells were seeded into selection medium containing 400 μg/ml G418 until several G418-resistant clones) cell line Down 17928924 1236 STAR_HUMAN ENSP00000276449 hepatitis C virus Normal vs. Cancer pRcCMV/QSG cells (negative control)(QSG7701 cells were transfected with the non-EXPression vector pRcCMV as a negative control) pRcHCNS3/QSG cells(Plasmid pRcHCNS3-5’ was introduced into QSG7701 cells and cells were seeded into selection medium containing 400 μg/ml G418 until several G418-resistant clones) cell line Down 17928924 1237 FST_HUMAN ENSP00000256759 hepatitis C virus Normal vs. Cancer pRcCMV/QSG cells (negative control)(QSG7701 cells were transfected with the non-EXPression vector pRcCMV as a negative control) pRcHCNS3/QSG cells(Plasmid pRcHCNS3-5’ was introduced into QSG7701 cells and cells were seeded into selection medium containing 400 μg/ml G418 until several G418-resistant clones) cell line Up 17928924 1238 TFF2_HUMAN ENSP00000291526 hepatitis C virus Normal vs. Cancer pRcCMV/QSG cells (negative control)(QSG7701 cells were transfected with the non-EXPression vector pRcCMV as a negative control) pRcHCNS3/QSG cells(Plasmid pRcHCNS3-5’ was introduced into QSG7701 cells and cells were seeded into selection medium containing 400 μg/ml G418 until several G418-resistant clones) cell line Up 17928924 1239 ASSY_HUMAN ENSP00000361470 Hepatocellular Carcinoma Normal vs. Cancer the adjacent non-tumor tissue HCC tissues tissue Down 18571811 1240 FIBA_HUMAN ENSP00000306361 Hepatocellular Carcinoma Normal vs. Cancer the adjacent non-tumor tissue HCC tissues tissue Down 18571811 1241 K1C18_HUMAN ENSP00000373489 Hepatocellular Carcinoma Normal vs. Cancer the adjacent non-tumor tissue HCC tissues tissue Down 18571811 1242 F16P1_HUMAN ENSP00000408025 Hepatocellular Carcinoma Normal vs. Cancer the adjacent non-tumor tissue HCC tissues tissue Down 18571811 1243 AK1C4_HUMAN ENSP00000263126 Hepatocellular Carcinoma Normal vs. Cancer the adjacent non-tumor tissue HCC tissues tissue Down 18571811 1244 ACOC_HUMAN ENSP00000369255 Hepatocellular Carcinoma Normal vs. Cancer the adjacent non-tumor tissue HCC tissues tissue Down 18571811 1245 GNMT_HUMAN ENSP00000361894 Hepatocellular Carcinoma Normal vs. Cancer the adjacent non-tumor tissue HCC tissues tissue Down 18571811 1246 FINC_HUMAN ENSP00000352696 Hepatocellular Carcinoma Normal vs. Cancer the adjacent non-tumor tissue HCC tissues tissue Up 18571811 1247 K2C8_HUMAN ENSP00000293308 Hepatocellular Carcinoma Normal vs. Cancer the adjacent non-tumor tissue HCC tissues tissue Up 18571811 1248 XRCC5_HUMAN ENSP00000375977 Hepatocellular Carcinoma Normal vs. Cancer the adjacent non-tumor tissue HCC tissues tissue Up 18571811 1249 ENPL_HUMAN ENSP00000299767 Hepatocellular Carcinoma Normal vs. Cancer the adjacent non-tumor tissue HCC tissues tissue Up 18571811 1250 CALR_HUMAN ENSP00000320866 Hepatocellular Carcinoma Normal vs. Cancer the adjacent non-tumor tissue HCC tissues tissue Up 18571811 1251 CLH1_HUMAN ENSP00000269122 Hepatocellular Carcinoma Normal vs. Cancer the adjacent non-tumor tissue HCC tissues tissue Up 18571811 1252 FUBP1_HUMAN ENSP00000359804 hepatitis B virus Normal vs. Cancer the adjacent nontumour (normal) tissues moderately differentiated liver tumour tissues tissue Up 3.6 19003864 1253 NDRG1_HUMAN ENSP00000404854 Hepatocellular Carcinoma Normal vs. Cancer the normal liver cell line L02 the human liver cancer cell line HepG2 cell line Down 0.29 19120023 1254 NICA_HUMAN ENSP00000294785 Hepatocellular Carcinoma Normal vs. Cancer the normal liver cell line L02 the human liver cancer cell line HepG2 cell line Down 0.31 19120023 1255 ANXA2_HUMAN ENSP00000411352 Hepatocellular Carcinoma Normal vs. Cancer the normal liver cell line L02 the human liver cancer cell line HepG2 cell line Up 3.4 19120023 1256 MOES_HUMAN ENSP00000353408 Hepatocellular Carcinoma Normal vs. Cancer the normal liver cell line L02 the human liver cancer cell line HepG2 cell line Up 4.1 19120023 1257 RHOA_HUMAN ENSP00000400175 Hepatocellular Carcinoma Normal vs. Cancer the normal liver cell line L02 the human liver cancer cell line HepG2 cell line Up 5.2 19120023 1258 EZRI_HUMAN ENSP00000356042 Hepatocellular Carcinoma Normal vs. Cancer the normal liver cell line L02 the human liver cancer cell line HepG2 cell line Up 5.4 19120023 1259 ITB1_HUMAN ENSP00000379350 Hepatocellular Carcinoma Normal vs. Cancer the normal liver cell line L02 the human liver cancer cell line HepG2 cell line Up 6.2 19120023 1260 CALM_HUMAN ENSP00000375785 Hepatocellular Carcinoma Normal vs. Cancer the normal liver cell line L02 the human liver cancer cell line HepG2 cell line Up 7.3 19120023 1261 LASP1_HUMAN ENSP00000325240 Hepatocellular Carcinoma Normal vs. Cancer the normal liver cell line L02 the human liver cancer cell line HepG2 cell line Up 7.7 19120023 1262 TSP1_HUMAN ENSP00000260356 hepatitis B virus Normal vs. Cancer HBx negative HepG2 cells HBx positive HepG2 cells cell line Up 3.5 19187611 1263 NPM_HUMAN ENSP00000296930 hepatitis B virus Normal vs. Cancer HBx negative HepG2 cells HBx positive HepG2 cells cell line Up 3.9 19187611 1264 ENOA_HUMAN ENSP00000234590 hepatitis B virus Normal vs. Cancer HBx negative HepG2 cells HBx positive HepG2 cells cell line Up 5.3 19187611 1265 GRB2_HUMAN ENSP00000376347 hepatitis B virus Normal vs. Cancer HBx negative HepG2 cells HBx positive HepG2 cells cell line Up 6.1 19187611 1266 MAGAC_HUMAN ENSP00000350592 hepatitis B virus Normal vs. Cancer HBx negative HepG2 cells HBx positive HepG2 cells cell line Up 12 19187611 1267 HS90B_HUMAN ENSP00000360609 hepatitis B virus Normal vs. Cancer HBx negative HepG2 cells HBx positive HepG2 cells cell line Up 14 19187611 1268 PGAM1_HUMAN ENSP00000359991 hepatitis B virus Normal vs. Cancer HBx negative HepG2 cells HBx positive HepG2 cells cell line Up 16 19187611 1269 BAG2_HUMAN ENSP00000359727 hepatitis B virus Normal vs. Cancer HBx negative HepG2 cells HBx positive HepG2 cells cell line Up 21 19187611 1270 K2C8_HUMAN ENSP00000293308 hepatitis B virus Normal vs. Cancer HepG2-RepSal cell lines HepG2-HBV cell lines cell line Down 0.41 19626621 1271 NQO1_HUMAN ENSP00000319788 hepatitis B virus Normal vs. Cancer HepG2-RepSal cell lines HepG2-HBV cell lines cell line Down 0.48 19626621 1272 PARK7_HUMAN ENSP00000366708 hepatitis B virus Normal vs. Cancer HepG2-RepSal cell lines HepG2-HBV cell lines cell line Up 1.6 19626621 1273 1433E_HUMAN ENSP00000264335 hepatitis B virus Normal vs. Cancer HepG2-RepSal cell lines HepG2-HBV cell lines cell line Up 1.8 19626621 1274 RLA2_HUMAN ENSP00000322419 hepatitis B virus Normal vs. Cancer HepG2-RepSal cell lines HepG2-HBV cell lines cell line Up 1.8 19626621 1275 PPAC_HUMAN ENSP00000272065 hepatitis B virus Normal vs. Cancer HepG2-RepSal cell lines HepG2-HBV cell lines cell line Up 2.7 19626621 1276 CALR_HUMAN ENSP00000320866 hepatitis B virus Treatment (none vs tetracycline-treatment) non-tetracycline-treated (HBV induction) HepAD38 cells tetracycline-treated (HBV suppression) HepAD38 cells cell line Down 0.45 19671925 1277 ENOA_HUMAN ENSP00000234590 hepatitis B virus Treatment (none vs tetracycline-treatment) non-tetracycline-treated (HBV induction) HepAD38 cells tetracycline-treated (HBV suppression) HepAD38 cells cell line Down 0.48 19671925 1278 TBA1C_HUMAN ENSP00000301072 hepatitis B virus Treatment (none vs tetracycline-treatment) non-tetracycline-treated (HBV induction) HepAD38 cells tetracycline-treated (HBV suppression) HepAD38 cells cell line Down 0.48 19671925 1279 SODC_HUMAN ENSP00000270142 hepatitis B virus Treatment (none vs tetracycline-treatment) non-tetracycline-treated (HBV induction) HepAD38 cells tetracycline-treated (HBV suppression) HepAD38 cells cell line Up 2 19671925 1280 PCNA_HUMAN ENSP00000368458 hepatitis B virus Treatment (none vs tetracycline-treatment) non-tetracycline-treated (HBV induction) HepAD38 cells tetracycline-treated (HBV suppression) HepAD38 cells cell line Up 2 19671925 1281 HNRPK_HUMAN ENSP00000365440 hepatitis B virus Treatment (none vs tetracycline-treatment) non-tetracycline-treated (HBV induction) HepAD38 cells tetracycline-treated (HBV suppression) HepAD38 cells cell line Up 2 19671925 1282 CATD_HUMAN ENSP00000236671 hepatitis B virus Treatment (none vs tetracycline-treatment) non-tetracycline-treated (HBV induction) HepAD38 cells tetracycline-treated (HBV suppression) HepAD38 cells cell line Up 2.1 19671925 1283 ASSY_HUMAN ENSP00000361470 Hepatocellular Carcinoma Normal vs. Cancer non-HCC liver tissue HCC liver tissue tissue Down 0.5 19956837 1284 KC1E_HUMAN ENSP00000380044 Hepatocellular Carcinoma Normal vs. Cancer non-HCC liver tissue HCC liver tissue tissue Down 0.59 19956837 1285 F16P1_HUMAN ENSP00000408025 Hepatocellular Carcinoma Normal vs. Cancer non-HCC liver tissue HCC liver tissue tissue Down 0.63 19956837 1286 HSP7C_HUMAN ENSP00000227378 Hepatocellular Carcinoma Normal vs. Cancer non-HCC liver tissue HCC liver tissue tissue Down 0.64 19956837 1287 CALR_HUMAN ENSP00000320866 Hepatocellular Carcinoma Normal vs. Cancer non-HCC liver tissue HCC liver tissue tissue Down 0.65 19956837 1288 THIO_HUMAN ENSP00000363641 Hepatocellular Carcinoma Normal vs. Cancer non-HCC liver tissue HCC liver tissue tissue Up 1.8 19956837 1289 F16P1_HUMAN ENSP00000408025 Hepatocellular Carcinoma Normal vs. Cancer 7 normal liver tissues and 11 adjacent nontumor tissues 6 well-differentiated HCCs,and one moderately-differentiated HCC were grouped together, while the 13 moderately differentiated HCCs and 7 poorly-differentiated HCCs tissue Down 18937283 1290 GDIR2_HUMAN ENSP00000228945 Hepatocellular Carcinoma Normal vs. Cancer 7 normal liver tissues and 11 adjacent nontumor tissues 6 well-differentiated HCCs,and one moderately-differentiated HCC were grouped together, while the 13 moderately differentiated HCCs and 7 poorly-differentiated HCCs tissue Down 18937283 1291 GNMT_HUMAN ENSP00000361894 Hepatocellular Carcinoma Normal vs. Cancer 7 normal liver tissues and 11 adjacent nontumor tissues 6 well-differentiated HCCs,and one moderately-differentiated HCC were grouped together, while the 13 moderately differentiated HCCs and 7 poorly-differentiated HCCs tissue Down 18937283 1292 VIME_HUMAN ENSP00000224237 Hepatocellular Carcinoma Normal vs. Cancer 7 normal liver tissues and 11 adjacent nontumor tissues 6 well-differentiated HCCs,and one moderately-differentiated HCC were grouped together, while the 13 moderately differentiated HCCs and 7 poorly-differentiated HCCs tissue Up 18937283 1293 PCNA_HUMAN ENSP00000368458 Hepatocellular Carcinoma Normal vs. Cancer 7 normal liver tissues and 11 adjacent nontumor tissues 6 well-differentiated HCCs,and one moderately-differentiated HCC were grouped together, while the 13 moderately differentiated HCCs and 7 poorly-differentiated HCCs tissue Up 18937283 1294 ENPL_HUMAN ENSP00000299767 Hepatocellular Carcinoma Normal vs. Cancer 7 normal liver tissues and 11 adjacent nontumor tissues 6 well-differentiated HCCs,and one moderately-differentiated HCC were grouped together, while the 13 moderately differentiated HCCs and 7 poorly-differentiated HCCs tissue Up 18937283 1295 LMNB1_HUMAN ENSP00000261366 Hepatocellular Carcinoma Normal vs. Cancer 7 normal liver tissues and 11 adjacent nontumor tissues 6 well-differentiated HCCs,and one moderately-differentiated HCC were grouped together, while the 13 moderately differentiated HCCs and 7 poorly-differentiated HCCs tissue Up 18937283 1296 A2MG_HUMAN ENSP00000323929 Hepatocellular Carcinoma Metastasis MHCC97L (low metastatic potential) cell line HCCLM6 (high metastatic potential) cell line cell line Down 0.13 19016532 1297 A1AT_HUMAN ENSP00000348068 Hepatocellular Carcinoma Metastasis MHCC97L (low metastatic potential) cell line HCCLM6 (high metastatic potential) cell line cell line Down 0.26 19016532 1298 SQSTM_HUMAN ENSP00000374455 Hepatocellular Carcinoma Metastasis MHCC97L (low metastatic potential) cell line HCCLM6 (high metastatic potential) cell line cell line Down 0.32 19016532 1299 SYUG_HUMAN ENSP00000361087 Hepatocellular Carcinoma Metastasis MHCC97L (low metastatic potential) cell line HCCLM6 (high metastatic potential) cell line cell line Down 0.41 19016532 1300 PPAC_HUMAN ENSP00000272065 Hepatocellular Carcinoma Metastasis MHCC97L (low metastatic potential) cell line HCCLM6 (high metastatic potential) cell line cell line Down 0.47 19016532 1301 1433T_HUMAN ENSP00000371267 Hepatocellular Carcinoma Metastasis MHCC97L (low metastatic potential) cell line HCCLM6 (high metastatic potential) cell line cell line Down 0.55 19016532 1302 HMOX1_HUMAN ENSP00000216117 Hepatocellular Carcinoma Metastasis MHCC97L (low metastatic potential) cell line HCCLM6 (high metastatic potential) cell line cell line Down 0.57 19016532 1303 GRB2_HUMAN ENSP00000376347 Hepatocellular Carcinoma Metastasis MHCC97L (low metastatic potential) cell line HCCLM6 (high metastatic potential) cell line cell line Down 0.57 19016532 1304 MPCP_HUMAN ENSP00000228318 Hepatocellular Carcinoma Metastasis MHCC97L (low metastatic potential) cell line HCCLM6 (high metastatic potential) cell line cell line Down 0.6 19016532 1305 NAMPT_HUMAN ENSP00000222553 Hepatocellular Carcinoma Metastasis MHCC97L (low metastatic potential) cell line HCCLM6 (high metastatic potential) cell line cell line Down 0.62 19016532 1306 H11_HUMAN ENSP00000244573 Hepatocellular Carcinoma Metastasis MHCC97L (low metastatic potential) cell line HCCLM6 (high metastatic potential) cell line cell line Down 0.65 19016532 1307 TGM2_HUMAN ENSP00000355330 Hepatocellular Carcinoma Metastasis MHCC97L (low metastatic potential) cell line HCCLM6 (high metastatic potential) cell line cell line Up 1.5 19016532 1308 ACTN1_HUMAN ENSP00000193403 Hepatocellular Carcinoma Metastasis MHCC97L (low metastatic potential) cell line HCCLM6 (high metastatic potential) cell line cell line Up 1.5 19016532 1309 VINC_HUMAN ENSP00000211998 Hepatocellular Carcinoma Metastasis MHCC97L (low metastatic potential) cell line HCCLM6 (high metastatic potential) cell line cell line Up 1.5 19016532 1310 FAS_HUMAN ENSP00000304592 Hepatocellular Carcinoma Metastasis MHCC97L (low metastatic potential) cell line HCCLM6 (high metastatic potential) cell line cell line Up 1.5 19016532 1311 CDK4_HUMAN ENSP00000257904 Hepatocellular Carcinoma Metastasis MHCC97L (low metastatic potential) cell line HCCLM6 (high metastatic potential) cell line cell line Up 1.5 19016532 1312 PRKDC_HUMAN ENSP00000313420 Hepatocellular Carcinoma Metastasis MHCC97L (low metastatic potential) cell line HCCLM6 (high metastatic potential) cell line cell line Up 1.6 19016532 1313 CLIC1_HUMAN ENSP00000379229 Hepatocellular Carcinoma Metastasis MHCC97L (low metastatic potential) cell line HCCLM6 (high metastatic potential) cell line cell line Up 1.6 19016532 1314 CLH1_HUMAN ENSP00000269122 Hepatocellular Carcinoma Metastasis MHCC97L (low metastatic potential) cell line HCCLM6 (high metastatic potential) cell line cell line Up 1.6 19016532 1315 STMN1_HUMAN ENSP00000382633 Hepatocellular Carcinoma Metastasis MHCC97L (low metastatic potential) cell line HCCLM6 (high metastatic potential) cell line cell line Up 1.7 19016532 1316 GELS_HUMAN ENSP00000362924 Hepatocellular Carcinoma Metastasis MHCC97L (low metastatic potential) cell line HCCLM6 (high metastatic potential) cell line cell line Up 1.7 19016532 1317 LMNA_HUMAN ENSP00000357283 Hepatocellular Carcinoma Metastasis MHCC97L (low metastatic potential) cell line HCCLM6 (high metastatic potential) cell line cell line Up 1.7 19016532 1318 SPTB2_HUMAN ENSP00000349259 Hepatocellular Carcinoma Metastasis MHCC97L (low metastatic potential) cell line HCCLM6 (high metastatic potential) cell line cell line Up 1.8 19016532 1319 VIGLN_HUMAN ENSP00000312042 Hepatocellular Carcinoma Metastasis MHCC97L (low metastatic potential) cell line HCCLM6 (high metastatic potential) cell line cell line Up 1.8 19016532 1320 PDC6I_HUMAN ENSP00000307387 Hepatocellular Carcinoma Metastasis MHCC97L (low metastatic potential) cell line HCCLM6 (high metastatic potential) cell line cell line Up 1.9 19016532 1321 MARCS_HUMAN ENSP00000357624 Hepatocellular Carcinoma Metastasis MHCC97L (low metastatic potential) cell line HCCLM6 (high metastatic potential) cell line cell line Up 1.9 19016532 1322 CALR_HUMAN ENSP00000320866 Hepatocellular Carcinoma Metastasis MHCC97L (low metastatic potential) cell line HCCLM6 (high metastatic potential) cell line cell line Up 2 19016532 1323 MYH9_HUMAN ENSP00000216181 Hepatocellular Carcinoma Metastasis MHCC97L (low metastatic potential) cell line HCCLM6 (high metastatic potential) cell line cell line Up 2 19016532 1324 HMGA2_HUMAN ENSP00000346658 Hepatocellular Carcinoma Metastasis MHCC97L (low metastatic potential) cell line HCCLM6 (high metastatic potential) cell line cell line Up 2.1 19016532 1325 MYPT1_HUMAN ENSP00000261207 Hepatocellular Carcinoma Metastasis MHCC97L (low metastatic potential) cell line HCCLM6 (high metastatic potential) cell line cell line Up 2.1 19016532 1326 SCRB1_HUMAN ENSP00000261693 Hepatocellular Carcinoma Metastasis MHCC97L (low metastatic potential) cell line HCCLM6 (high metastatic potential) cell line cell line Up 2.1 19016532 1327 FINC_HUMAN ENSP00000352696 Hepatocellular Carcinoma Metastasis MHCC97L (low metastatic potential) cell line HCCLM6 (high metastatic potential) cell line cell line Up 2.2 19016532 1328 AMPN_HUMAN ENSP00000300060 Hepatocellular Carcinoma Metastasis MHCC97L (low metastatic potential) cell line HCCLM6 (high metastatic potential) cell line cell line Up 2.2 19016532 1329 ACLY_HUMAN ENSP00000253792 Hepatocellular Carcinoma Metastasis MHCC97L (low metastatic potential) cell line HCCLM6 (high metastatic potential) cell line cell line Up 2.4 19016532 1330 S12A2_HUMAN ENSP00000262461 Hepatocellular Carcinoma Metastasis MHCC97L (low metastatic potential) cell line HCCLM6 (high metastatic potential) cell line cell line Up 2.5 19016532 1331 VILI_HUMAN ENSP00000248444 Hepatocellular Carcinoma Metastasis MHCC97L (low metastatic potential) cell line HCCLM6 (high metastatic potential) cell line cell line Up 2.6 19016532 1332 ACSL1_HUMAN ENSP00000281455 Hepatocellular Carcinoma Metastasis MHCC97L (low metastatic potential) cell line HCCLM6 (high metastatic potential) cell line cell line Up 2.8 19016532 1333 VIME_HUMAN ENSP00000224237 Hepatocellular Carcinoma Metastasis MHCC97L (low metastatic potential) cell line HCCLM6 (high metastatic potential) cell line cell line Up 11 19016532 1334 C1R_HUMAN ENSP00000290575 hepatitis C virus Normal vs. Cancer plasma samples from HCV-cirrhotic patients plasma samples from HCV-HCC patients tissue Up 19136905 1335 SPB5_HUMAN ENSP00000372221 Hepatocellular Carcinoma Treatment (none vs resveratrol-treatment) the HCC cell line SK-HEP-1 the HCC cell line SK-HEP-1 treated with resveratrol cell line Down 19996131 1336 TFR1_HUMAN ENSP00000376197 Hepatocellular Carcinoma Treatment (none vs resveratrol-treatment) the HCC cell line SK-HEP-1 the HCC cell line SK-HEP-1 treated with resveratrol cell line Up 19996131 1337 HMOX1_HUMAN ENSP00000216117 Hepatocellular Carcinoma Treatment (none vs resveratrol-treatment) the HCC cell line SK-HEP-1 the HCC cell line SK-HEP-1 treated with resveratrol cell line Up 19996131 1338 CSK_HUMAN ENSP00000414764 Hepatocellular Carcinoma Treatment (none vs resveratrol-treatment) the HCC cell line SK-HEP-1 the HCC cell line SK-HEP-1 treated with resveratrol cell line Up 19996131 1339 KHDR1_HUMAN ENSP00000313829 Hepatocellular Carcinoma Treatment (none vs resveratrol-treatment) the HCC cell line SK-HEP-1 the HCC cell line SK-HEP-1 treated with resveratrol cell line Up 19996131 1340 ACOC_HUMAN ENSP00000369255 Hepatocellular Carcinoma Cancer vs. Cancer MO(multicentric occurrence) HCC tissues IM(intrahepatic metastasis) HCC tissues tissue Down 20038311 1341 LMNA_HUMAN ENSP00000357283 Hepatocellular Carcinoma Cancer vs. Cancer MO(multicentric occurrence) HCC tissues IM(intrahepatic metastasis) HCC tissues tissue Up 20038311 1342 ALBU_HUMAN ENSP00000295897 Hepatocellular Carcinoma Cancer vs. Cancer MO(multicentric occurrence) HCC tissues IM(intrahepatic metastasis) HCC tissues tissue Up 20038311 1343 A1AT_HUMAN ENSP00000348068 hepatitis B virus Normal vs. Cancer adjacent paired nontumorous tissues HCC tissues tissue Up 3 20525558 1344 GDIR1_HUMAN ENSP00000269321 hepatitis B virus Normal vs. Cancer adjacent paired nontumorous tissues HCC tissues tissue Up 3.2 20525558 1345 HCD2_HUMAN ENSP00000168216 hepatitis B virus Normal vs. Cancer adjacent paired nontumorous tissues HCC tissues tissue Up 3.5 20525558 1346 GDIR2_HUMAN ENSP00000228945 hepatitis B virus Normal vs. Cancer adjacent paired nontumorous tissues HCC tissues tissue Up 4.8 20525558 1347 ACTN4_HUMAN ENSP00000252699 Hepatocellular Carcinoma Cancer vs. Cancer (HCC vs. HuCCA) hepatocellular carcinoma (HCC-S102, HepG2, SK-Hep-1, and Alexander) cell lines cholangiocarcinoma (HuCCA-1) cell lines cell line Up 20069059 1348 STK10_HUMAN ENSP00000176763 Hepatocellular Carcinoma Cancer vs. Cancer (HCC vs. HuCCA) hepatocellular carcinoma (HCC-S102, HepG2, SK-Hep-1, and Alexander) cell lines cholangiocarcinoma (HuCCA-1) cell lines cell line Up 20069059 1349 ALBU_HUMAN ENSP00000295897 Hepatocellular Carcinoma Cancer vs. Cancer (HCC vs. HuCCA) hepatocellular carcinoma (HCC-S102, HepG2, SK-Hep-1, and Alexander) cell lines cholangiocarcinoma (HuCCA-1) cell lines cell line Up 20069059 1350 TRFL_HUMAN ENSP00000231751 Hepatocellular Carcinoma Cancer vs. Cancer (HCC vs. HuCCA) hepatocellular carcinoma (HCC-S102, HepG2, SK-Hep-1, and Alexander) cell lines cholangiocarcinoma (HuCCA-1) cell lines cell line Up 20069059 1351 ANXA1_HUMAN ENSP00000366109 Hepatocellular Carcinoma Cancer vs. Cancer (HCC vs. HuCCA) hepatocellular carcinoma (HCC-S102, HepG2, SK-Hep-1, and Alexander) cell lines cholangiocarcinoma (HuCCA-1) cell lines cell line Up 20069059 1352 G3P_HUMAN ENSP00000380068 Hepatocellular Carcinoma Cancer vs. Cancer (HCC vs. HuCCA) hepatocellular carcinoma (HCC-S102, HepG2, SK-Hep-1, and Alexander) cell lines cholangiocarcinoma (HuCCA-1) cell lines cell line Up 20069059 1353 K1C18_HUMAN ENSP00000373489 Hepatocellular Carcinoma Cancer vs. Cancer (HCC vs. HuCCA) hepatocellular carcinoma (HCC-S102, HepG2, SK-Hep-1, and Alexander) cell lines cholangiocarcinoma (HuCCA-1) cell lines cell line Up 20069059 1354 K2C8_HUMAN ENSP00000293308 Hepatocellular Carcinoma Cancer vs. Cancer (HCC vs. HuCCA) hepatocellular carcinoma (HCC-S102, HepG2, SK-Hep-1, and Alexander) cell lines cholangiocarcinoma (HuCCA-1) cell lines cell line Up 20069059 1355 ENOA_HUMAN ENSP00000234590 Hepatocellular Carcinoma Cancer vs. Cancer (HCC vs. HuCCA) hepatocellular carcinoma (HCC-S102, HepG2, SK-Hep-1, and Alexander) cell lines cholangiocarcinoma (HuCCA-1) cell lines cell line Up 20069059 1356 CATD_HUMAN ENSP00000236671 Hepatocellular Carcinoma Cancer vs. Cancer (HCC vs. HuCCA) hepatocellular carcinoma (HCC-S102, HepG2, SK-Hep-1, and Alexander) cell lines cholangiocarcinoma (HuCCA-1) cell lines cell line Up 20069059 1357 ANXA2_HUMAN ENSP00000411352 Hepatocellular Carcinoma Cancer vs. Cancer (HCC vs. HuCCA) hepatocellular carcinoma (HCC-S102, HepG2, SK-Hep-1, and Alexander) cell lines cholangiocarcinoma (HuCCA-1) cell lines cell line Up 20069059 1358 TBB5_HUMAN ENSP00000406811 Hepatocellular Carcinoma Cancer vs. Cancer (HCC vs. HuCCA) hepatocellular carcinoma (HCC-S102, HepG2, SK-Hep-1, and Alexander) cell lines cholangiocarcinoma (HuCCA-1) cell lines cell line Up 20069059 1359 HS90A_HUMAN ENSP00000335153 Hepatocellular Carcinoma Cancer vs. Cancer (HCC vs. HuCCA) hepatocellular carcinoma (HCC-S102, HepG2, SK-Hep-1, and Alexander) cell lines cholangiocarcinoma (HuCCA-1) cell lines cell line Up 20069059 1360 TSP1_HUMAN ENSP00000260356 Hepatocellular Carcinoma Cancer vs. Cancer (HCC vs. HuCCA) hepatocellular carcinoma (HCC-S102, HepG2, SK-Hep-1, and Alexander) cell lines cholangiocarcinoma (HuCCA-1) cell lines cell line Up 20069059 1361 K1C16_HUMAN ENSP00000301653 Hepatocellular Carcinoma Cancer vs. Cancer (HCC vs. HuCCA) hepatocellular carcinoma (HCC-S102, HepG2, SK-Hep-1, and Alexander) cell lines cholangiocarcinoma (HuCCA-1) cell lines cell line Up 20069059 1362 PTPRF_HUMAN ENSP00000361491 Hepatocellular Carcinoma Cancer vs. Cancer (HCC vs. HuCCA) hepatocellular carcinoma (HCC-S102, HepG2, SK-Hep-1, and Alexander) cell lines cholangiocarcinoma (HuCCA-1) cell lines cell line Up 20069059 1363 LAMC1_HUMAN ENSP00000258341 Hepatocellular Carcinoma Cancer vs. Cancer (HCC vs. HuCCA) hepatocellular carcinoma (HCC-S102, HepG2, SK-Hep-1, and Alexander) cell lines cholangiocarcinoma (HuCCA-1) cell lines cell line Up 20069059 1364 EF2_HUMAN ENSP00000307940 Hepatocellular Carcinoma Cancer vs. Cancer (HCC vs. HuCCA) hepatocellular carcinoma (HCC-S102, HepG2, SK-Hep-1, and Alexander) cell lines cholangiocarcinoma (HuCCA-1) cell lines cell line Up 20069059 1365 KPYM_HUMAN ENSP00000334983 Hepatocellular Carcinoma Cancer vs. Cancer (HCC vs. HuCCA) hepatocellular carcinoma (HCC-S102, HepG2, SK-Hep-1, and Alexander) cell lines cholangiocarcinoma (HuCCA-1) cell lines cell line Up 20069059 1366 EZRI_HUMAN ENSP00000356042 Hepatocellular Carcinoma Cancer vs. Cancer (HCC vs. HuCCA) hepatocellular carcinoma (HCC-S102, HepG2, SK-Hep-1, and Alexander) cell lines cholangiocarcinoma (HuCCA-1) cell lines cell line Up 20069059 1367 DESP_HUMAN ENSP00000369129 Hepatocellular Carcinoma Cancer vs. Cancer (HCC vs. HuCCA) hepatocellular carcinoma (HCC-S102, HepG2, SK-Hep-1, and Alexander) cell lines cholangiocarcinoma (HuCCA-1) cell lines cell line Up 20069059 1368 FLNA_HUMAN ENSP00000358866 Hepatocellular Carcinoma Cancer vs. Cancer (HCC vs. HuCCA) hepatocellular carcinoma (HCC-S102, HepG2, SK-Hep-1, and Alexander) cell lines cholangiocarcinoma (HuCCA-1) cell lines cell line Up 20069059 1369 ITA6_HUMAN ENSP00000341078 Hepatocellular Carcinoma Cancer vs. Cancer (HCC vs. HuCCA) hepatocellular carcinoma (HCC-S102, HepG2, SK-Hep-1, and Alexander) cell lines cholangiocarcinoma (HuCCA-1) cell lines cell line Up 20069059 1370 MOES_HUMAN ENSP00000353408 Hepatocellular Carcinoma Cancer vs. Cancer (HCC vs. HuCCA) hepatocellular carcinoma (HCC-S102, HepG2, SK-Hep-1, and Alexander) cell lines cholangiocarcinoma (HuCCA-1) cell lines cell line Up 20069059 1371 PRDX5_HUMAN ENSP00000265462 Hepatocellular Carcinoma Cancer vs. Cancer (HCC vs. HuCCA) hepatocellular carcinoma (HCC-S102, HepG2, SK-Hep-1, and Alexander) cell lines cholangiocarcinoma (HuCCA-1) cell lines cell line Up 20069059 1372 TPIS_HUMAN ENSP00000379933 Hepatocellular Carcinoma Cancer vs. Cancer (HCC vs. HuCCA) hepatocellular carcinoma (HCC-S102, HepG2, SK-Hep-1, and Alexander) cell lines cholangiocarcinoma (HuCCA-1) cell lines cell line Up 20069059 1373 ACTB_HUMAN ENSP00000349960 Hepatocellular Carcinoma Cancer vs. Cancer (HCC vs. HuCCA) hepatocellular carcinoma (HCC-S102, HepG2, SK-Hep-1, and Alexander) cell lines cholangiocarcinoma (HuCCA-1) cell lines cell line Up 20069059 1374 EF1A1_HUMAN ENSP00000330054 Hepatocellular Carcinoma Cancer vs. Cancer (HCC vs. HuCCA) hepatocellular carcinoma (HCC-S102, HepG2, SK-Hep-1, and Alexander) cell lines cholangiocarcinoma (HuCCA-1) cell lines cell line Up 20069059 1375 HBB_HUMAN ENSP00000333994 Hepatocellular Carcinoma Cancer vs. Cancer (HCC vs. HuCCA) hepatocellular carcinoma (HCC-S102, HepG2, SK-Hep-1, and Alexander) cell lines cholangiocarcinoma (HuCCA-1) cell lines cell line Up 20069059 1376 PRDX1_HUMAN ENSP00000262746 Hepatocellular Carcinoma Cancer vs. Cancer (HCC vs. HuCCA) hepatocellular carcinoma (HCC-S102, HepG2, SK-Hep-1, and Alexander) cell lines cholangiocarcinoma (HuCCA-1) cell lines cell line Up 20069059 1377 LIPH_HUMAN ENSP00000296252 Hepatocellular Carcinoma Cancer vs. Cancer (HCC vs. HuCCA) hepatocellular carcinoma (HCC-S102, HepG2, SK-Hep-1, and Alexander) cell lines cholangiocarcinoma (HuCCA-1) cell lines cell line Up 20069059 1378 PTPRH_HUMAN ENSP00000365528 Hepatocellular Carcinoma Cancer vs. Cancer (HCC vs. HuCCA) hepatocellular carcinoma (HCC-S102, HepG2, SK-Hep-1, and Alexander) cell lines cholangiocarcinoma (HuCCA-1) cell lines cell line Up 20069059 1379 RBM27_HUMAN ENSP00000265271 Hepatocellular Carcinoma Cancer vs. Cancer (HCC vs. HuCCA) hepatocellular carcinoma (HCC-S102, HepG2, SK-Hep-1, and Alexander) cell lines cholangiocarcinoma (HuCCA-1) cell lines cell line Up 20069059 1380 PLSL_HUMAN ENSP00000315757 Neoplasms by Histologic Type Normal vs. Cancer reactive lymph node samples non-Hodgkin’s lymphoma (mantle cell lymphoma MCL) samples tissue Down 0.2 12874873 1381 HBB_HUMAN ENSP00000333994 Neoplasms by Histologic Type Normal vs. Cancer reactive lymph node samples non-Hodgkin’s lymphoma (mantle cell lymphoma MCL) samples tissue Down 0.25 12874873 1382 GSTP1_HUMAN ENSP00000381607 Neoplasms by Histologic Type Normal vs. Cancer reactive lymph node samples non-Hodgkin’s lymphoma (mantle cell lymphoma MCL) samples tissue Up 3 12874873 1383 STMN1_HUMAN ENSP00000382633 Neoplasms by Histologic Type Normal vs. Cancer reactive lymph node samples non-Hodgkin’s lymphoma (mantle cell lymphoma MCL) samples tissue Up 3 12874873 1384 HSPB1_HUMAN ENSP00000248553 Neoplasms by Histologic Type Normal vs. Cancer reactive lymph node samples non-Hodgkin’s lymphoma (mantle cell lymphoma MCL) samples tissue Up 4 12874873 1385 A1AT_HUMAN ENSP00000348068 Neoplasms by Histologic Type Normal vs. Cancer reactive lymph node samples non-Hodgkin’s lymphoma (mantle cell lymphoma MCL) samples tissue Up 6 12874873 1386 H2B1M_HUMAN ENSP00000352442 Neoplasms by Histologic Type Normal vs. Cancer reactive lymph node samples non-Hodgkin’s lymphoma (mantle cell lymphoma MCL) samples tissue Up 7 12874873 1387 FA7_HUMAN ENSP00000364731 Lung Cancer Normal vs. Cancer paired surrounding normal bronchial epithelial tissue human lung squamous carcinoma tissue tissue Down 12943690 1388 IL20_HUMAN ENSP00000356063 Lung Cancer Normal vs. Cancer paired surrounding normal bronchial epithelial tissue human lung squamous carcinoma tissue tissue Down 12943690 1389 CCND2_HUMAN ENSP00000261254 Lung Cancer Normal vs. Cancer paired surrounding normal bronchial epithelial tissue human lung squamous carcinoma tissue tissue Up 12943690 1390 BAX_HUMAN ENSP00000263262 Lung Cancer Normal vs. Cancer paired surrounding normal bronchial epithelial tissue human lung squamous carcinoma tissue tissue Up 12943690 1391 IKZF1_HUMAN ENSP00000331614 Lung Cancer Normal vs. Cancer paired surrounding normal bronchial epithelial tissue human lung squamous carcinoma tissue tissue Up 12943690 1392 SREC_HUMAN ENSP00000323964 Lung Cancer Normal vs. Cancer paired surrounding normal bronchial epithelial tissue human lung squamous carcinoma tissue tissue Up 12943690 1393 TNR27_HUMAN ENSP00000379365 Lung Cancer Normal vs. Cancer paired surrounding normal bronchial epithelial tissue human lung squamous carcinoma tissue tissue Up 12943690 1394 CHIP_HUMAN ENSP00000219548 Lung Cancer Normal vs. Cancer paired surrounding normal bronchial epithelial tissue human lung squamous carcinoma tissue tissue Up 12943690 1395 HSPB1_HUMAN ENSP00000248553 Small cell lung carcinoma Treatment(none vs paclitaxel treatment) H69-EPR cells H69-EPR 24h after a 1-h treatment with 10ng/ml paclitaxel tissue Down 15152945 1396 1433S_HUMAN ENSP00000340989 Non-small cell lung carcinoma Normal vs. Cancer the immortalized human normal bronchial epithelial cell line HBE4-E6/E7 Human lung cancer cell lines H1299, H23, H226, SW-1573 cell line Down 15359725 1397 K2C8_HUMAN ENSP00000293308 Non-small cell lung carcinoma Normal vs. Cancer the immortalized human normal bronchial epithelial cell line HBE4-E6/E7 Human lung cancer cell lines H1299, H23, H226, SW-1573 cell line Up 15359725 1398 HS90B_HUMAN ENSP00000360609 Non-small cell lung carcinoma Normal vs. Cancer the immortalized human normal bronchial epithelial cell line HBE4-E6/E7 Human lung cancer cell lines H1299, H23, H226, SW-1573 cell line Up 15359725 1399 PCNA_HUMAN ENSP00000368458 Non-small cell lung carcinoma Normal vs. Cancer the immortalized human normal bronchial epithelial cell line HBE4-E6/E7 Human lung cancer cell lines H1299, H23, H226, SW-1573 cell line Up 15359725 1400 NDKA_HUMAN ENSP00000013034 Non-small cell lung carcinoma Normal vs. Cancer the immortalized human normal bronchial epithelial cell line HBE4-E6/E7 Human lung cancer cell lines H1299, H23, H226, SW-1573 cell line Up 15359725 1401 YBOX1_HUMAN ENSP00000361626 Non-small cell lung carcinoma Normal vs. Cancer the immortalized human normal bronchial epithelial cell line HBE4-E6/E7 Human lung cancer cell lines H1299, H23, H226, SW-1573 cell line Up 15359725 1402 ENOA_HUMAN ENSP00000234590 Colorectal Cancer Treatment (none vs transfected with HPV-16 E6 gene) Human colon adenocarcinoma cell line (RKO) Human colon adenocarcinoma cell line (RKO) were transfected with HPV-16 E6 gene(RC10.1) cell line Down 15684709 1403 NPM_HUMAN ENSP00000296930 Colorectal Cancer Treatment (none vs transfected with HPV-16 E6 gene) Human colon adenocarcinoma cell line (RKO) Human colon adenocarcinoma cell line (RKO) were transfected with HPV-16 E6 gene(RC10.1) cell line Down 15684709 1404 HNRPC_HUMAN ENSP00000319690 Colorectal Cancer Treatment (none vs transfected with HPV-16 E6 gene) Human colon adenocarcinoma cell line (RKO) Human colon adenocarcinoma cell line (RKO) were transfected with HPV-16 E6 gene(RC10.1) cell line Down 15684709 1405 HNRPC_HUMAN ENSP00000319690 Colorectal Cancer Treatment (none vs transfected with HPV-16 E6 gene) Human colon adenocarcinoma cell line (RKO) Human colon adenocarcinoma cell line (RKO) were transfected with HPV-16 E6 gene(RC10.1) cell line Down 15684709 1406 G3P_HUMAN ENSP00000380068 Colorectal Cancer Treatment (none vs transfected with HPV-16 E6 gene) Human colon adenocarcinoma cell line (RKO) Human colon adenocarcinoma cell line (RKO) were transfected with HPV-16 E6 gene(RC10.1) cell line Up 15684709 1407 CATD_HUMAN ENSP00000236671 Colorectal Cancer Treatment (none vs transfected with HPV-16 E6 gene) Human colon adenocarcinoma cell line (RKO) Human colon adenocarcinoma cell line (RKO) were transfected with HPV-16 E6 gene(RC10.1) cell line Up 15684709 1408 HS90B_HUMAN ENSP00000360609 Colorectal Cancer Treatment (none vs transfected with HPV-16 E6 gene) Human colon adenocarcinoma cell line (RKO) Human colon adenocarcinoma cell line (RKO) were transfected with HPV-16 E6 gene(RC10.1) cell line Up 15684709 1409 CDK5_HUMAN ENSP00000297518 Colorectal Cancer Treatment (none vs transfected with HPV-16 E6 gene) Human colon adenocarcinoma cell line (RKO) Human colon adenocarcinoma cell line (RKO) were transfected with HPV-16 E6 gene(RC10.1) cell line Up 15684709 1410 CALR_HUMAN ENSP00000320866 Lung Cancer Treatment(none vs transfected with HPV-16 E7 gene) Human lung adenocarcinoma cell line (A549) Human lung adenocarcinoma cell line (A549) were transfected with HPV-16 E6 gene(A549E6) cell line Down 15684709 1411 H2B1H_HUMAN ENSP00000348706 Lung Cancer Treatment(none vs transfected with HPV-16 E7 gene) Human lung adenocarcinoma cell line (A549) Human lung adenocarcinoma cell line (A549) were transfected with HPV-16 E6 gene(A549E6) cell line Down 15684709 1412 SODC_HUMAN ENSP00000270142 Lung Cancer Treatment(none vs transfected with HPV-16 E7 gene) Human lung adenocarcinoma cell line (A549) Human lung adenocarcinoma cell line (A549) were transfected with HPV-16 E6 gene(A549E6) cell line Up 15684709 1413 HS90B_HUMAN ENSP00000360609 Lung Cancer Treatment(none vs transfected with HPV-16 E7 gene) Human lung adenocarcinoma cell line (A549) Human lung adenocarcinoma cell line (A549) were transfected with HPV-16 E6 gene(A549E6) cell line Up 15684709 1414 HSP7C_HUMAN ENSP00000227378 Lung Cancer Treatment(none vs transfected with HPV-16 E7 gene) Human lung adenocarcinoma cell line (A549) Human lung adenocarcinoma cell line (A549) were transfected with HPV-16 E6 gene(A549E6) cell line Up 15684709 1415 ENPL_HUMAN ENSP00000299767 Lung Cancer Treatment(none vs transfected with HPV-16 E7 gene) Human lung adenocarcinoma cell line (A549) Human lung adenocarcinoma cell line (A549) were transfected with HPV-16 E6 gene(A549E6) cell line Up 15684709 1416 STMN1_HUMAN ENSP00000382633 Brain Cancer Cancer vs. Cancer human NB cell line (SK-N-AS) human NB cell line (SK-N-DZ) cell line Down 15750928 1417 ENPL_HUMAN ENSP00000299767 Brain Cancer Cancer vs. Cancer human NB cell line (SK-N-AS) human NB cell line (SK-N-DZ) cell line Up 15750928 1418 SODC_HUMAN ENSP00000270142 Neoplasms by Histologic Type Cancer vs. Cancer human NB cell line (SK-N-AS) human NB cell line (SK-N-FI) cell line Up 15750928 1419 G3P_HUMAN ENSP00000380068 Neoplasms by Histologic Type Cancer vs. Cancer human NB cell line (SK-N-AS) human NB cell line (SK-N-FI) cell line Up 15750928 1420 KPYM_HUMAN ENSP00000334983 Neoplasms by Histologic Type Cancer vs. Cancer human NB cell line (SK-N-AS) human NB cell line (SK-N-FI) cell line Up 15750928 1421 ENPL_HUMAN ENSP00000299767 Neoplasms by Histologic Type Cancer vs. Cancer human NB cell line (SK-N-AS) human NB cell line (SK-N-FI) cell line Up 15750928 1422 NDKA_HUMAN ENSP00000013034 Neoplasms by Histologic Type Cancer vs. Cancer human NB cell line (SK-N-AS) human NB cell line (SK-N-FI) cell line Up 15750928 1423 COF1_HUMAN ENSP00000309629 Neoplasms by Histologic Type Cancer vs. Cancer human NB cell line (SK-N-AS) human NB cell line (SK-N-FI) cell line Up 15750928 1424 TAGL2_HUMAN ENSP00000357075 Neoplasms by Histologic Type Cancer vs. Cancer human NB cell line (SK-N-AS) human NB cell line (SK-N-FI) cell line Up 15750928 1425 CALM_HUMAN ENSP00000375785 Neoplasms by Histologic Type Cancer vs. Cancer human NB cell line (SK-N-AS) human NB cell line (SK-N-FI) cell line Up 15750928 1426 EF1A1_HUMAN ENSP00000330054 Neoplasms by Histologic Type Cancer vs. Cancer human NB cell line (SK-N-AS) human NB cell line (SK-N-FI) cell line Up 15750928 1427 SET_HUMAN ENSP00000361777 Neoplasms by Histologic Type Cancer vs. Cancer human NB cell line (SK-N-AS) human NB cell line (SK-N-FI) cell line Up 15750928 1428 SODC_HUMAN ENSP00000270142 Neoplasms by Histologic Type Cancer vs. Cancer human NB cell line (SK-N-DZ) human NB cell line (SK-N-FI) cell line Up 15750928 1429 G3P_HUMAN ENSP00000380068 Neoplasms by Histologic Type Cancer vs. Cancer human NB cell line (SK-N-DZ) human NB cell line (SK-N-FI) cell line Up 15750928 1430 KPYM_HUMAN ENSP00000334983 Neoplasms by Histologic Type Cancer vs. Cancer human NB cell line (SK-N-DZ) human NB cell line (SK-N-FI) cell line Up 15750928 1431 ENPL_HUMAN ENSP00000299767 Neoplasms by Histologic Type Cancer vs. Cancer human NB cell line (SK-N-DZ) human NB cell line (SK-N-FI) cell line Up 15750928 1432 NDKA_HUMAN ENSP00000013034 Neoplasms by Histologic Type Cancer vs. Cancer human NB cell line (SK-N-DZ) human NB cell line (SK-N-FI) cell line Up 15750928 1433 STMN1_HUMAN ENSP00000382633 Neoplasms by Histologic Type Cancer vs. Cancer human NB cell line (SK-N-DZ) human NB cell line (SK-N-FI) cell line Up 15750928 1434 PGAM1_HUMAN ENSP00000359991 Neoplasms by Histologic Type Cancer vs. Cancer human NB cell line (SK-N-DZ) human NB cell line (SK-N-FI) cell line Up 15750928 1435 COF1_HUMAN ENSP00000309629 Neoplasms by Histologic Type Cancer vs. Cancer human NB cell line (SK-N-DZ) human NB cell line (SK-N-FI) cell line Up 15750928 1436 PEBP1_HUMAN ENSP00000261313 Neoplasms by Histologic Type Cancer vs. Cancer human NB cell line (SK-N-DZ) human NB cell line (SK-N-FI) cell line Up 15750928 1437 TAGL2_HUMAN ENSP00000357075 Neoplasms by Histologic Type Cancer vs. Cancer human NB cell line (SK-N-DZ) human NB cell line (SK-N-FI) cell line Up 15750928 1438 EF1A1_HUMAN ENSP00000330054 Neoplasms by Histologic Type Cancer vs. Cancer human NB cell line (SK-N-DZ) human NB cell line (SK-N-FI) cell line Up 15750928 1439 SET_HUMAN ENSP00000361777 Neoplasms by Histologic Type Cancer vs. Cancer human NB cell line (SK-N-DZ) human NB cell line (SK-N-FI) cell line Up 15750928 1440 ENOA_HUMAN ENSP00000234590 Lung Cancer Normal vs. Cancer hLSC(human lung squamous carcinoma) paired normal bronchial epithelial tissues hLSC(human lung squamous carcinoma) tissues tissue Down 16342241 1441 ANXA2_HUMAN ENSP00000411352 Lung Cancer Normal vs. Cancer hLSC(human lung squamous carcinoma) paired normal bronchial epithelial tissues hLSC(human lung squamous carcinoma) tissues tissue Down 16342241 1442 PGAM1_HUMAN ENSP00000359991 Lung Cancer Normal vs. Cancer hLSC(human lung squamous carcinoma) paired normal bronchial epithelial tissues hLSC(human lung squamous carcinoma) tissues tissue Up 16342241 1443 NAMPT_HUMAN ENSP00000222553 Lung Cancer Normal vs. Cancer hLSC(human lung squamous carcinoma) paired normal bronchial epithelial tissues hLSC(human lung squamous carcinoma) tissues tissue Up 16342241 1444 TPIS_HUMAN ENSP00000379933 Lung Cancer Normal vs. Cancer hLSC(human lung squamous carcinoma) paired normal bronchial epithelial tissues hLSC(human lung squamous carcinoma) tissues tissue Up 16342241 1445 TPIS_HUMAN ENSP00000379933 Lung Cancer Normal vs. Cancer hLSC(human lung squamous carcinoma) paired normal bronchial epithelial tissues hLSC(human lung squamous carcinoma) tissues tissue Up 16342241 1446 GDIR1_HUMAN ENSP00000269321 Non-small cell lung carcinoma Treatment (none vs. Antrodia camphorata treatment） Human non-small cell lung carcinoma A549 cell Human non-small cell lung carcinoma A549 cell treated with 0.4%v/v SACE cell line Down 0.43 16411266 1447 CD4_HUMAN ENSP00000011653 Non-small cell lung carcinoma Treatment (none vs. anticancer drug CPT and 10-OH treatment） EKVX cell line EKVX cell line treated anticancer drug CPT and 10-OH cell line Down 0.23 17009856 1448 LMNA_HUMAN ENSP00000357283 Non-small cell lung carcinoma Treatment (none vs. anticancer drug CPT and 10-OH treatment） EKVX cell line EKVX cell line treated anticancer drug CPT and 10-OH cell line Down 0.36 17009856 1449 LSHB_HUMAN ENSP00000221421 Lung Cancer Normal vs. Cancer paired tumor-adjacent normal tissues human lung squamous carcinoma tissues tissue Down 15626334 1450 FA7_HUMAN ENSP00000364731 Lung Cancer Normal vs. Cancer paired tumor-adjacent normal tissues human lung squamous carcinoma tissues tissue Down 15626334 1451 IBP1_HUMAN ENSP00000275525 Lung Cancer Normal vs. Cancer paired tumor-adjacent normal tissues human lung squamous carcinoma tissues tissue Down 15626334 1452 CD27_HUMAN ENSP00000266557 Lung Cancer Normal vs. Cancer paired tumor-adjacent normal tissues human lung squamous carcinoma tissues tissue Down 15626334 1453 HBB_HUMAN ENSP00000333994 Lung Cancer Normal vs. Cancer paired tumor-adjacent normal tissues human lung squamous carcinoma tissues tissue Down 15626334 1454 IL20_HUMAN ENSP00000356063 Lung Cancer Normal vs. Cancer paired tumor-adjacent normal tissues human lung squamous carcinoma tissues tissue Down 15626334 1455 ARI2_HUMAN ENSP00000403222 Lung Cancer Normal vs. Cancer paired tumor-adjacent normal tissues human lung squamous carcinoma tissues tissue Up 15626334 1456 FA7_HUMAN ENSP00000364731 Lung Cancer Normal vs. Cancer paired tumor-adjacent normal tissues human lung squamous carcinoma tissues tissue Up 15626334 1457 EPHA3_HUMAN ENSP00000337451 Lung Cancer Normal vs. Cancer paired tumor-adjacent normal tissues human lung squamous carcinoma tissues tissue Up 15626334 1458 CCND2_HUMAN ENSP00000261254 Lung Cancer Normal vs. Cancer paired tumor-adjacent normal tissues human lung squamous carcinoma tissues tissue Up 15626334 1459 PAXI_HUMAN ENSP00000391283 Lung Cancer Normal vs. Cancer paired tumor-adjacent normal tissues human lung squamous carcinoma tissues tissue Up 15626334 1460 BAX_HUMAN ENSP00000263262 Lung Cancer Normal vs. Cancer paired tumor-adjacent normal tissues human lung squamous carcinoma tissues tissue Up 15626334 1461 BST1_HUMAN ENSP00000265016 Lung Cancer Normal vs. Cancer paired tumor-adjacent normal tissues human lung squamous carcinoma tissues tissue Up 15626334 1462 IKZF1_HUMAN ENSP00000331614 Lung Cancer Normal vs. Cancer paired tumor-adjacent normal tissues human lung squamous carcinoma tissues tissue Up 15626334 1463 FHL2_HUMAN ENSP00000350846 Lung Cancer Normal vs. Cancer paired tumor-adjacent normal tissues human lung squamous carcinoma tissues tissue Up 15626334 1464 TNR27_HUMAN ENSP00000379365 Lung Cancer Normal vs. Cancer paired tumor-adjacent normal tissues human lung squamous carcinoma tissues tissue Up 15626334 1465 CHIP_HUMAN ENSP00000219548 Lung Cancer Normal vs. Cancer paired tumor-adjacent normal tissues human lung squamous carcinoma tissues tissue Up 15626334 1466 PSA7_HUMAN ENSP00000359910 Lung Cancer Cancer vs. Cancer the M-BE cells(a SV40T-transformed human bronchial epithelial cell line with the phenotypic features of early tumorigenesis at high passage) at P40 passage the M-BE cells (a SV40T-transformed human bronchial epithelial cell line with the phenotypic features of early tumorigenesis at high passage) at P140 and P200 passages cell line Down 17284061 1467 PAI1_HUMAN ENSP00000223095 Lung Cancer Cancer vs. Cancer the M-BE cells(a SV40T-transformed human bronchial epithelial cell line with the phenotypic features of early tumorigenesis at high passage) at P40 passage the M-BE cells (a SV40T-transformed human bronchial epithelial cell line with the phenotypic features of early tumorigenesis at high passage) at P140 and P200 passages cell line Down 17284061 1468 ENOA_HUMAN ENSP00000234590 Lung Cancer Cancer vs. Cancer the M-BE cells(a SV40T-transformed human bronchial epithelial cell line with the phenotypic features of early tumorigenesis at high passage) at P40 passage the M-BE cells (a SV40T-transformed human bronchial epithelial cell line with the phenotypic features of early tumorigenesis at high passage) at P140 and P200 passages cell line Down 17284061 1469 EF2_HUMAN ENSP00000307940 Lung Cancer Cancer vs. Cancer the M-BE cells(a SV40T-transformed human bronchial epithelial cell line with the phenotypic features of early tumorigenesis at high passage) at P40 passage the M-BE cells (a SV40T-transformed human bronchial epithelial cell line with the phenotypic features of early tumorigenesis at high passage) at P140 and P200 passages cell line Down 17284061 1470 KPYM_HUMAN ENSP00000334983 Lung Cancer Cancer vs. Cancer the M-BE cells(a SV40T-transformed human bronchial epithelial cell line with the phenotypic features of early tumorigenesis at high passage) at P40 passage the M-BE cells (a SV40T-transformed human bronchial epithelial cell line with the phenotypic features of early tumorigenesis at high passage) at P140 and P200 passages cell line Down 17284061 1471 EZRI_HUMAN ENSP00000356042 Lung Cancer Cancer vs. Cancer the M-BE cells(a SV40T-transformed human bronchial epithelial cell line with the phenotypic features of early tumorigenesis at high passage) at P40 passage the M-BE cells (a SV40T-transformed human bronchial epithelial cell line with the phenotypic features of early tumorigenesis at high passage) at P140 and P200 passages cell line Down 17284061 1472 TERA_HUMAN ENSP00000351777 Lung Cancer Cancer vs. Cancer the M-BE cells(a SV40T-transformed human bronchial epithelial cell line with the phenotypic features of early tumorigenesis at high passage) at P40 passage the M-BE cells (a SV40T-transformed human bronchial epithelial cell line with the phenotypic features of early tumorigenesis at high passage) at P140 and P200 passages cell line Down 17284061 1473 TIMP1_HUMAN ENSP00000218388 Lung Cancer Cancer vs. Cancer the M-BE cells(a SV40T-transformed human bronchial epithelial cell line with the phenotypic features of early tumorigenesis at high passage) at P40 passage the M-BE cells (a SV40T-transformed human bronchial epithelial cell line with the phenotypic features of early tumorigenesis at high passage) at P140 and P200 passages cell line Up 17284061 1474 ANXA1_HUMAN ENSP00000366109 Lung Cancer Cancer vs. Cancer the M-BE cells(a SV40T-transformed human bronchial epithelial cell line with the phenotypic features of early tumorigenesis at high passage) at P40 passage the M-BE cells (a SV40T-transformed human bronchial epithelial cell line with the phenotypic features of early tumorigenesis at high passage) at P140 and P200 passages cell line Up 17284061 1475 G3P_HUMAN ENSP00000380068 Lung Cancer Cancer vs. Cancer the M-BE cells(a SV40T-transformed human bronchial epithelial cell line with the phenotypic features of early tumorigenesis at high passage) at P40 passage the M-BE cells (a SV40T-transformed human bronchial epithelial cell line with the phenotypic features of early tumorigenesis at high passage) at P140 and P200 passages cell line Up 17284061 1476 CATD_HUMAN ENSP00000236671 Lung Cancer Cancer vs. Cancer the M-BE cells(a SV40T-transformed human bronchial epithelial cell line with the phenotypic features of early tumorigenesis at high passage) at P40 passage the M-BE cells (a SV40T-transformed human bronchial epithelial cell line with the phenotypic features of early tumorigenesis at high passage) at P140 and P200 passages cell line Up 17284061 1477 ANXA2_HUMAN ENSP00000411352 Lung Cancer Cancer vs. Cancer the M-BE cells(a SV40T-transformed human bronchial epithelial cell line with the phenotypic features of early tumorigenesis at high passage) at P40 passage the M-BE cells (a SV40T-transformed human bronchial epithelial cell line with the phenotypic features of early tumorigenesis at high passage) at P140 and P200 passages cell line Up 17284061 1478 TPM2_HUMAN ENSP00000354219 Lung Cancer Cancer vs. Cancer the M-BE cells(a SV40T-transformed human bronchial epithelial cell line with the phenotypic features of early tumorigenesis at high passage) at P40 passage the M-BE cells (a SV40T-transformed human bronchial epithelial cell line with the phenotypic features of early tumorigenesis at high passage) at P140 and P200 passages cell line Up 17284061 1479 HSP7C_HUMAN ENSP00000227378 Lung Cancer Cancer vs. Cancer the M-BE cells(a SV40T-transformed human bronchial epithelial cell line with the phenotypic features of early tumorigenesis at high passage) at P40 passage the M-BE cells (a SV40T-transformed human bronchial epithelial cell line with the phenotypic features of early tumorigenesis at high passage) at P140 and P200 passages cell line Up 17284061 1480 MK01_HUMAN ENSP00000381803 Lung Cancer Cancer vs. Cancer the M-BE cells(a SV40T-transformed human bronchial epithelial cell line with the phenotypic features of early tumorigenesis at high passage) at P40 passage the M-BE cells (a SV40T-transformed human bronchial epithelial cell line with the phenotypic features of early tumorigenesis at high passage) at P140 and P200 passages cell line Up 17284061 1481 MP2K6_HUMAN ENSP00000351997 Lung Cancer Cancer vs. Cancer the M-BE cells(a SV40T-transformed human bronchial epithelial cell line with the phenotypic features of early tumorigenesis at high passage) at P40 passage the M-BE cells (a SV40T-transformed human bronchial epithelial cell line with the phenotypic features of early tumorigenesis at high passage) at P140 and P200 passages cell line Up 17284061 1482 PRDX5_HUMAN ENSP00000265462 Non-small cell lung carcinoma Metastasis NCI-H226(lung squamous cell carcinoma (SCC) cell lines) H226Br (the brain metastatic cell line of NCI-H226) cell line Down 0.15 17418446 1483 ANXA1_HUMAN ENSP00000366109 Non-small cell lung carcinoma Metastasis NCI-H226(lung squamous cell carcinoma (SCC) cell lines) H226Br (the brain metastatic cell line of NCI-H226) cell line Down 0.28 17418446 1484 NPM_HUMAN ENSP00000296930 Non-small cell lung carcinoma Metastasis NCI-H226(lung squamous cell carcinoma (SCC) cell lines) H226Br (the brain metastatic cell line of NCI-H226) cell line Down 0.29 17418446 1485 HSPB1_HUMAN ENSP00000248553 Non-small cell lung carcinoma Metastasis NCI-H226(lung squamous cell carcinoma (SCC) cell lines) H226Br (the brain metastatic cell line of NCI-H226) cell line Down 0.31 17418446 1486 TPIS_HUMAN ENSP00000379933 Non-small cell lung carcinoma Metastasis NCI-H226(lung squamous cell carcinoma (SCC) cell lines) H226Br (the brain metastatic cell line of NCI-H226) cell line Down 0.31 17418446 1487 GSTP1_HUMAN ENSP00000381607 Non-small cell lung carcinoma Metastasis NCI-H226(lung squamous cell carcinoma (SCC) cell lines) H226Br (the brain metastatic cell line of NCI-H226) cell line Down 17418446 1488 1433S_HUMAN ENSP00000340989 Non-small cell lung carcinoma Metastasis NCI-H226(lung squamous cell carcinoma (SCC) cell lines) H226Br (the brain metastatic cell line of NCI-H226) cell line Down 17418446 1489 LEG3_HUMAN ENSP00000254301 Non-small cell lung carcinoma Metastasis NCI-H226(lung squamous cell carcinoma (SCC) cell lines) H226Br (the brain metastatic cell line of NCI-H226) cell line Up 5.5 17418446 1490 HCD2_HUMAN ENSP00000168216 Non-small cell lung carcinoma Metastasis NCI-H226(lung squamous cell carcinoma (SCC) cell lines) H226Br (the brain metastatic cell line of NCI-H226) cell line Up 7.6 17418446 1491 COF1_HUMAN ENSP00000309629 Lung Cancer Treatment (none vs. Mitoxantrone resistance) a squamous lung carcinoma cell line, DLKP mitoxantrone-resistant variant DLKP (DLKP-Mitox) cell line Down 0.27 17593620 1492 NDKA_HUMAN ENSP00000013034 Lung Cancer Treatment (none vs. Mitoxantrone resistance) a squamous lung carcinoma cell line, DLKP mitoxantrone-resistant variant DLKP (DLKP-Mitox) cell line Down 0.69 17593620 1493 TPIS_HUMAN ENSP00000379933 Lung Cancer Treatment (none vs. Mitoxantrone resistance) a squamous lung carcinoma cell line, DLKP mitoxantrone-resistant variant DLKP (DLKP-Mitox) cell line Down 0.8 17593620 1494 PARK7_HUMAN ENSP00000366708 Lung Cancer Treatment (none vs. Mitoxantrone resistance) a squamous lung carcinoma cell line, DLKP mitoxantrone-resistant variant DLKP (DLKP-Mitox) cell line Up 1.2 17593620 1495 GSTP1_HUMAN ENSP00000381607 Lung Cancer Treatment (none vs. Mitoxantrone resistance) a squamous lung carcinoma cell line, DLKP mitoxantrone-resistant variant DLKP (DLKP-Mitox) cell line Up 1.8 17593620 1496 K2C8_HUMAN ENSP00000293308 Small cell lung carcinoma Treatment (none vs. isogenic Doxorubicin-resistant) the lung cancer cell line H69 isogenic Doxorubicin-resistant subcell line H69AR cell line Down 0.12 18654985 1497 DESP_HUMAN ENSP00000369129 Small cell lung carcinoma Treatment (none vs. isogenic Doxorubicin-resistant) the lung cancer cell line H69 isogenic Doxorubicin-resistant subcell line H69AR cell line Down 0.15 18654985 1498 ARHG1_HUMAN ENSP00000346532 Small cell lung carcinoma Treatment (none vs. isogenic Doxorubicin-resistant) the lung cancer cell line H69 isogenic Doxorubicin-resistant subcell line H69AR cell line Down 0.38 18654985 1499 PRKDC_HUMAN ENSP00000313420 Small cell lung carcinoma Treatment (none vs. isogenic Doxorubicin-resistant) the lung cancer cell line H69 isogenic Doxorubicin-resistant subcell line H69AR cell line Down 0.42 18654985 1500 VIME_HUMAN ENSP00000224237 Small cell lung carcinoma Treatment (none vs. isogenic Doxorubicin-resistant) the lung cancer cell line H69 isogenic Doxorubicin-resistant subcell line H69AR cell line Up 2.2 18654985 1501 ANXA6_HUMAN ENSP00000346550 Small cell lung carcinoma Treatment (none vs. isogenic Doxorubicin-resistant) the lung cancer cell line H69 isogenic Doxorubicin-resistant subcell line H69AR cell line Up 2.4 18654985 1502 KIF11_HUMAN ENSP00000260731 Small cell lung carcinoma Treatment (none vs. isogenic Doxorubicin-resistant) the lung cancer cell line H69 isogenic Doxorubicin-resistant subcell line H69AR cell line Up 4.4 18654985 1503 HCD2_HUMAN ENSP00000168216 Lung Cancer Treatment(none vs betulin-treatment) Human lung carcinoma cells, A549 Human lung carcinoma cells (A549) treated with betulin cell line Down 0.1 19085751 1504 HS90A_HUMAN ENSP00000335153 Lung Cancer Treatment(none vs betulin-treatment) Human lung carcinoma cells, A549 Human lung carcinoma cells (A549) treated with betulin cell line Down 0.14 19085751 1505 SRSF1_HUMAN ENSP00000258962 Lung Cancer Treatment(none vs betulin-treatment) Human lung carcinoma cells, A549 Human lung carcinoma cells (A549) treated with betulin cell line Up 3 19085751 1506 HNRPC_HUMAN ENSP00000319690 Lung Cancer Treatment(none vs 20 mg/mL GTE treatment) Human lung carcinoma cells, A549 Human lung carcinoma cells (A549) treated with 20 mg/mL GTE cell line Up 2.1 19137550 1507 LMNA_HUMAN ENSP00000357283 Lung Cancer Treatment(none vs 20 mg/mL GTE treatment) Human lung carcinoma cells, A549 Human lung carcinoma cells (A549) treated with 20 mg/mL GTE cell line Up 2.4 19137550 1508 ANXA2_HUMAN ENSP00000411352 Lung Cancer Treatment(none vs 20 mg/mL GTE treatment) Human lung carcinoma cells, A549 Human lung carcinoma cells (A549) treated with 20 mg/mL GTE cell line Up 2.8 19137550 1509 ANXA1_HUMAN ENSP00000366109 Lung Cancer Treatment(none vs 20 mg/mL GTE treatment) Human lung carcinoma cells, A549 Human lung carcinoma cells (A549) treated with 20 mg/mL GTE cell line Up 3 19137550 1510 1433F_HUMAN ENSP00000248975 Lung Cancer Treatment(none vs 20 mg/mL GTE treatment) Human lung carcinoma cells, A549 Human lung carcinoma cells (A549) treated with 20 mg/mL GTE cell line Up 3.1 19137550 1511 FUBP1_HUMAN ENSP00000359804 Lung Cancer Treatment(none vs 20 mg/mL GTE treatment) Human lung carcinoma cells, A549 Human lung carcinoma cells (A549) treated with 20 mg/mL GTE cell line Up 5.5 19137550 1512 G6PI_HUMAN ENSP00000348877 Lung Cancer Treatment(none vs 20 mg/mL GTE treatment) Human lung carcinoma cells, A549 Human lung carcinoma cells (A549) treated with 20 mg/mL GTE cell line Up 8.7 19137550 1513 PRDX1_HUMAN ENSP00000262746 Lung Cancer Treatment(none vs 20 mg/mL GTE treatment) Human lung carcinoma cells, A549 Human lung carcinoma cells (A549) treated with 20 mg/mL GTE cell line Up 9.5 19137550 1514 HNRPC_HUMAN ENSP00000319690 Lung Cancer Treatment(none vs 40 mg/mL GTE treatment) Human lung carcinoma cells, A549 Human lung carcinoma cells (A549) treated with 40 mg/mL GTE cell line Up 1.3 19137550 1515 1433F_HUMAN ENSP00000248975 Lung Cancer Treatment(none vs 40 mg/mL GTE treatment) Human lung carcinoma cells, A549 Human lung carcinoma cells (A549) treated with 40 mg/mL GTE cell line Up 2.3 19137550 1516 ANXA2_HUMAN ENSP00000411352 Lung Cancer Treatment(none vs 40 mg/mL GTE treatment) Human lung carcinoma cells, A549 Human lung carcinoma cells (A549) treated with 40 mg/mL GTE cell line Up 2.6 19137550 1517 ANXA1_HUMAN ENSP00000366109 Lung Cancer Treatment(none vs 40 mg/mL GTE treatment) Human lung carcinoma cells, A549 Human lung carcinoma cells (A549) treated with 40 mg/mL GTE cell line Up 3.3 19137550 1518 LMNA_HUMAN ENSP00000357283 Lung Cancer Treatment(none vs 40 mg/mL GTE treatment) Human lung carcinoma cells, A549 Human lung carcinoma cells (A549) treated with 40 mg/mL GTE cell line Up 3.5 19137550 1519 G6PI_HUMAN ENSP00000348877 Lung Cancer Treatment(none vs 40 mg/mL GTE treatment) Human lung carcinoma cells, A549 Human lung carcinoma cells (A549) treated with 40 mg/mL GTE cell line Up 4.2 19137550 1520 FUBP1_HUMAN ENSP00000359804 Lung Cancer Treatment(none vs 40 mg/mL GTE treatment) Human lung carcinoma cells, A549 Human lung carcinoma cells (A549) treated with 40 mg/mL GTE cell line Up 6.3 19137550 1521 PRDX1_HUMAN ENSP00000262746 Lung Cancer Treatment(none vs 40 mg/mL GTE treatment) Human lung carcinoma cells, A549 Human lung carcinoma cells (A549) treated with 40 mg/mL GTE cell line Up 14 19137550 1522 RLA2_HUMAN ENSP00000322419 Lung Cancer Treatment (none vs transfected with pc3.1-hPNAS5) Human lung carcinoma cells, A549 A549 cells were transfected with pc3.1-hPNAS4,which is able to induce apoptosis in A549 human lung adenocarcinoma cells cell line Down 19795389 1523 PTMA_HUMAN ENSP00000344547 Lung Cancer Treatment (none vs transfected with pc3.1-hPNAS5) Human lung carcinoma cells, A549 A549 cells were transfected with pc3.1-hPNAS4,which is able to induce apoptosis in A549 human lung adenocarcinoma cells cell line Down 19795389 1524 TAGL2_HUMAN ENSP00000357075 Lung Cancer Treatment (none vs transfected with pc3.1-hPNAS5) Human lung carcinoma cells, A549 A549 cells were transfected with pc3.1-hPNAS4,which is able to induce apoptosis in A549 human lung adenocarcinoma cells cell line Down 19795389 1525 TERA_HUMAN ENSP00000351777 Lung Cancer Treatment (none vs transfected with pc3.1-hPNAS5) Human lung carcinoma cells, A549 A549 cells were transfected with pc3.1-hPNAS4,which is able to induce apoptosis in A549 human lung adenocarcinoma cells cell line Down 19795389 1526 TPIS_HUMAN ENSP00000379933 Lung Cancer Treatment (none vs transfected with pc3.1-hPNAS5) Human lung carcinoma cells, A549 A549 cells were transfected with pc3.1-hPNAS4,which is able to induce apoptosis in A549 human lung adenocarcinoma cells cell line Down 19795389 1527 IF4H_HUMAN ENSP00000265753 Lung Cancer Treatment (none vs transfected with pc3.1-hPNAS5) Human lung carcinoma cells, A549 A549 cells were transfected with pc3.1-hPNAS4,which is able to induce apoptosis in A549 human lung adenocarcinoma cells cell line Down 19795389 1528 LMNA_HUMAN ENSP00000357283 Lung Cancer Treatment (none vs transfected with pc3.1-hPNAS5) Human lung carcinoma cells, A549 A549 cells were transfected with pc3.1-hPNAS4,which is able to induce apoptosis in A549 human lung adenocarcinoma cells cell line Up 19795389 1529 ANXA1_HUMAN ENSP00000366109 Lung Cancer Treatment (none vs transfected with pc3.1-hPNAS5) Human lung carcinoma cells, A549 A549 cells were transfected with pc3.1-hPNAS4,which is able to induce apoptosis in A549 human lung adenocarcinoma cells cell line Up 19795389 1530 VIME_HUMAN ENSP00000224237 Lung Cancer Treatment (none vs transfected with pc3.1-hPNAS5) Human lung carcinoma cells, A549 A549 cells were transfected with pc3.1-hPNAS4,which is able to induce apoptosis in A549 human lung adenocarcinoma cells cell line Up 19795389 1531 G3P_HUMAN ENSP00000380068 Non-small cell lung carcinoma Treatment (none vs CIGB-300 treatment) The non-small cell lung cancer(NSCLC) cell line NCI-H125 NCI-H125 cell line incubated with 200 μmol/L of CIGB-300 during 45 min cell line Down 0.1 20804217 1532 G6PI_HUMAN ENSP00000348877 Non-small cell lung carcinoma Treatment (none vs CIGB-300 treatment) The non-small cell lung cancer(NSCLC) cell line NCI-H125 NCI-H125 cell line incubated with 200 μmol/L of CIGB-300 during 45 min cell line Down 0.1 20804217 1533 GSTP1_HUMAN ENSP00000381607 Non-small cell lung carcinoma Treatment (none vs CIGB-300 treatment) The non-small cell lung cancer(NSCLC) cell line NCI-H125 NCI-H125 cell line incubated with 200 μmol/L of CIGB-300 during 45 min cell line Down 0.1 20804217 1534 KPYM_HUMAN ENSP00000334983 Non-small cell lung carcinoma Treatment (none vs CIGB-300 treatment) The non-small cell lung cancer(NSCLC) cell line NCI-H125 NCI-H125 cell line incubated with 200 μmol/L of CIGB-300 during 45 min cell line Down 0.1 20804217 1535 COF1_HUMAN ENSP00000309629 Non-small cell lung carcinoma Treatment (none vs CIGB-300 treatment) The non-small cell lung cancer(NSCLC) cell line NCI-H125 NCI-H125 cell line incubated with 200 μmol/L of CIGB-300 during 45 min cell line Down 0.1 20804217 1536 GDIR1_HUMAN ENSP00000269321 Non-small cell lung carcinoma Treatment (none vs CIGB-300 treatment) The non-small cell lung cancer(NSCLC) cell line NCI-H125 NCI-H125 cell line incubated with 200 μmol/L of CIGB-300 during 45 min cell line Down 0.1 20804217 1537 TPIS_HUMAN ENSP00000379933 Non-small cell lung carcinoma Treatment (none vs CIGB-300 treatment) The non-small cell lung cancer(NSCLC) cell line NCI-H125 NCI-H125 cell line incubated with 200 μmol/L of CIGB-300 during 45 min cell line Down 0.1 20804217 1538 PAK2_HUMAN ENSP00000314067 Non-small cell lung carcinoma Treatment (none vs CIGB-300 treatment) The non-small cell lung cancer(NSCLC) cell line NCI-H125 NCI-H125 cell line incubated with 200 μmol/L of CIGB-300 during 45 min cell line Down 0.1 20804217 1539 SODC_HUMAN ENSP00000270142 Non-small cell lung carcinoma Treatment (none vs CIGB-300 treatment) The non-small cell lung cancer(NSCLC) cell line NCI-H125 NCI-H125 cell line incubated with 200 μmol/L of CIGB-300 during 45 min cell line Down 0.15 20804217 1540 GDIR1_HUMAN ENSP00000269321 Non-small cell lung carcinoma Treatment (none vs CIGB-300 treatment) The non-small cell lung cancer(NSCLC) cell line NCI-H125 NCI-H125 cell line incubated with 200 μmol/L of CIGB-300 during 45 min cell line Down 0.19 20804217 1541 GDIR2_HUMAN ENSP00000228945 Non-small cell lung carcinoma Treatment (none vs CIGB-300 treatment) The non-small cell lung cancer(NSCLC) cell line NCI-H125 NCI-H125 cell line incubated with 200 μmol/L of CIGB-300 during 45 min cell line Down 0.2 20804217 1542 EZRI_HUMAN ENSP00000356042 Non-small cell lung carcinoma Treatment (none vs CIGB-300 treatment) The non-small cell lung cancer(NSCLC) cell line NCI-H125 NCI-H125 cell line incubated with 200 μmol/L of CIGB-300 during 45 min cell line Down 0.2 20804217 1543 SYWC_HUMAN ENSP00000347495 Non-small cell lung carcinoma Treatment (none vs CIGB-300 treatment) The non-small cell lung cancer(NSCLC) cell line NCI-H125 NCI-H125 cell line incubated with 200 μmol/L of CIGB-300 during 45 min cell line Down 0.2 20804217 1544 PSA6_HUMAN ENSP00000261479 Non-small cell lung carcinoma Treatment (none vs CIGB-300 treatment) The non-small cell lung cancer(NSCLC) cell line NCI-H125 NCI-H125 cell line incubated with 200 μmol/L of CIGB-300 during 45 min cell line Down 0.2 20804217 1545 PAIRB_HUMAN ENSP00000360034 Non-small cell lung carcinoma Treatment (none vs CIGB-300 treatment) The non-small cell lung cancer(NSCLC) cell line NCI-H125 NCI-H125 cell line incubated with 200 μmol/L of CIGB-300 during 45 min cell line Down 0.2 20804217 1546 FUBP1_HUMAN ENSP00000359804 Non-small cell lung carcinoma Treatment (none vs CIGB-300 treatment) The non-small cell lung cancer(NSCLC) cell line NCI-H125 NCI-H125 cell line incubated with 200 μmol/L of CIGB-300 during 45 min cell line Down 0.2 20804217 1547 HSPB1_HUMAN ENSP00000248553 Non-small cell lung carcinoma Treatment (none vs CIGB-300 treatment) The non-small cell lung cancer(NSCLC) cell line NCI-H125 NCI-H125 cell line incubated with 200 μmol/L of CIGB-300 during 45 min cell line Down 0.3 20804217 1548 CATD_HUMAN ENSP00000236671 Non-small cell lung carcinoma Treatment (none vs CIGB-300 treatment) The non-small cell lung cancer(NSCLC) cell line NCI-H125 NCI-H125 cell line incubated with 200 μmol/L of CIGB-300 during 45 min cell line Down 0.3 20804217 1549 RAN_HUMAN ENSP00000376176 Non-small cell lung carcinoma Treatment (none vs CIGB-300 treatment) The non-small cell lung cancer(NSCLC) cell line NCI-H125 NCI-H125 cell line incubated with 200 μmol/L of CIGB-300 during 45 min cell line Down 0.3 20804217 1550 YBOX1_HUMAN ENSP00000361626 Non-small cell lung carcinoma Treatment (none vs CIGB-300 treatment) The non-small cell lung cancer(NSCLC) cell line NCI-H125 NCI-H125 cell line incubated with 200 μmol/L of CIGB-300 during 45 min cell line Down 0.3 20804217 1551 IF4H_HUMAN ENSP00000265753 Non-small cell lung carcinoma Treatment (none vs CIGB-300 treatment) The non-small cell lung cancer(NSCLC) cell line NCI-H125 NCI-H125 cell line incubated with 200 μmol/L of CIGB-300 during 45 min cell line Down 0.3 20804217 1552 HNRPK_HUMAN ENSP00000365440 Non-small cell lung carcinoma Treatment (none vs CIGB-300 treatment) The non-small cell lung cancer(NSCLC) cell line NCI-H125 NCI-H125 cell line incubated with 200 μmol/L of CIGB-300 during 45 min cell line Down 0.31 20804217 1553 GSTP1_HUMAN ENSP00000381607 Non-small cell lung carcinoma Treatment (none vs CIGB-300 treatment) The non-small cell lung cancer(NSCLC) cell line NCI-H125 NCI-H125 cell line incubated with 200 μmol/L of CIGB-300 during 45 min cell line Down 0.32 20804217 1554 HNRPC_HUMAN ENSP00000319690 Non-small cell lung carcinoma Treatment (none vs CIGB-300 treatment) The non-small cell lung cancer(NSCLC) cell line NCI-H125 NCI-H125 cell line incubated with 200 μmol/L of CIGB-300 during 45 min cell line Down 0.33 20804217 1555 LASP1_HUMAN ENSP00000325240 Non-small cell lung carcinoma Treatment (none vs CIGB-300 treatment) The non-small cell lung cancer(NSCLC) cell line NCI-H125 NCI-H125 cell line incubated with 200 μmol/L of CIGB-300 during 45 min cell line Down 0.33 20804217 1556 TPIS_HUMAN ENSP00000379933 Non-small cell lung carcinoma Treatment (none vs CIGB-300 treatment) The non-small cell lung cancer(NSCLC) cell line NCI-H125 NCI-H125 cell line incubated with 200 μmol/L of CIGB-300 during 45 min cell line Down 0.34 20804217 1557 LEG3_HUMAN ENSP00000254301 Non-small cell lung carcinoma Treatment (none vs CIGB-300 treatment) The non-small cell lung cancer(NSCLC) cell line NCI-H125 NCI-H125 cell line incubated with 200 μmol/L of CIGB-300 during 45 min cell line Down 0.4 20804217 1558 UBA1_HUMAN ENSP00000338413 Non-small cell lung carcinoma Treatment (none vs CIGB-300 treatment) The non-small cell lung cancer(NSCLC) cell line NCI-H125 NCI-H125 cell line incubated with 200 μmol/L of CIGB-300 during 45 min cell line Down 0.4 20804217 1559 PTBP1_HUMAN ENSP00000014112 Non-small cell lung carcinoma Treatment (none vs CIGB-300 treatment) The non-small cell lung cancer(NSCLC) cell line NCI-H125 NCI-H125 cell line incubated with 200 μmol/L of CIGB-300 during 45 min cell line Down 0.4 20804217 1560 SPB5_HUMAN ENSP00000372221 Non-small cell lung carcinoma Treatment (none vs CIGB-300 treatment) The non-small cell lung cancer(NSCLC) cell line NCI-H125 NCI-H125 cell line incubated with 200 μmol/L of CIGB-300 during 45 min cell line Down 0.4 20804217 1561 RS10_HUMAN ENSP00000347271 Non-small cell lung carcinoma Treatment (none vs CIGB-300 treatment) The non-small cell lung cancer(NSCLC) cell line NCI-H125 NCI-H125 cell line incubated with 200 μmol/L of CIGB-300 during 45 min cell line Down 0.4 20804217 1562 EWS_HUMAN ENSP00000381031 Non-small cell lung carcinoma Treatment (none vs CIGB-300 treatment) The non-small cell lung cancer(NSCLC) cell line NCI-H125 NCI-H125 cell line incubated with 200 μmol/L of CIGB-300 during 45 min cell line Down 0.4 20804217 1563 HSP7C_HUMAN ENSP00000227378 Non-small cell lung carcinoma Treatment (none vs CIGB-300 treatment) The non-small cell lung cancer(NSCLC) cell line NCI-H125 NCI-H125 cell line incubated with 200 μmol/L of CIGB-300 during 45 min cell line Down 0.5 20804217 1564 TOP1_HUMAN ENSP00000354522 Non-small cell lung carcinoma Treatment (none vs CIGB-300 treatment) The non-small cell lung cancer(NSCLC) cell line NCI-H125 NCI-H125 cell line incubated with 200 μmol/L of CIGB-300 during 45 min cell line Down 0.5 20804217 1565 PA2G4_HUMAN ENSP00000302886 Non-small cell lung carcinoma Treatment (none vs CIGB-300 treatment) The non-small cell lung cancer(NSCLC) cell line NCI-H125 NCI-H125 cell line incubated with 200 μmol/L of CIGB-300 during 45 min cell line Down 0.5 20804217 1566 DDX3X_HUMAN ENSP00000382840 Non-small cell lung carcinoma Treatment (none vs CIGB-300 treatment) The non-small cell lung cancer(NSCLC) cell line NCI-H125 NCI-H125 cell line incubated with 200 μmol/L of CIGB-300 during 45 min cell line Up 2 20804217 1567 ML12B_HUMAN ENSP00000383037 Non-small cell lung carcinoma Treatment (none vs CIGB-300 treatment) The non-small cell lung cancer(NSCLC) cell line NCI-H125 NCI-H125 cell line incubated with 200 μmol/L of CIGB-300 during 45 min cell line Up 2 20804217 1568 SF3B1_HUMAN ENSP00000335321 Non-small cell lung carcinoma Treatment (none vs CIGB-300 treatment) The non-small cell lung cancer(NSCLC) cell line NCI-H125 NCI-H125 cell line incubated with 200 μmol/L of CIGB-300 during 45 min cell line Up 2 20804217 1569 RLA2_HUMAN ENSP00000322419 Non-small cell lung carcinoma Treatment (none vs CIGB-300 treatment) The non-small cell lung cancer(NSCLC) cell line NCI-H125 NCI-H125 cell line incubated with 200 μmol/L of CIGB-300 during 45 min cell line Up 2 20804217 1570 MYL9_HUMAN ENSP00000279022 Non-small cell lung carcinoma Treatment (none vs CIGB-300 treatment) The non-small cell lung cancer(NSCLC) cell line NCI-H125 NCI-H125 cell line incubated with 200 μmol/L of CIGB-300 during 45 min cell line Up 2 20804217 1571 SRSF1_HUMAN ENSP00000258962 Non-small cell lung carcinoma Treatment (none vs CIGB-300 treatment) The non-small cell lung cancer(NSCLC) cell line NCI-H125 NCI-H125 cell line incubated with 200 μmol/L of CIGB-300 during 45 min cell line Up 2 20804217 1572 CADH1_HUMAN ENSP00000261769 Non-small cell lung carcinoma Treatment (none vs CIGB-300 treatment) The non-small cell lung cancer(NSCLC) cell line NCI-H125 NCI-H125 cell line incubated with 200 μmol/L of CIGB-300 during 45 min cell line Up 2.1 20804217 1573 TBA1B_HUMAN ENSP00000336799 Non-small cell lung carcinoma Treatment (none vs CIGB-300 treatment) The non-small cell lung cancer(NSCLC) cell line NCI-H125 NCI-H125 cell line incubated with 200 μmol/L of CIGB-300 during 45 min cell line Up 2.3 20804217 1574 TBB8_HUMAN ENSP00000328808 Non-small cell lung carcinoma Treatment (none vs CIGB-300 treatment) The non-small cell lung cancer(NSCLC) cell line NCI-H125 NCI-H125 cell line incubated with 200 μmol/L of CIGB-300 during 45 min cell line Up 2.3 20804217 1575 TBA1C_HUMAN ENSP00000301072 Non-small cell lung carcinoma Treatment (none vs CIGB-300 treatment) The non-small cell lung cancer(NSCLC) cell line NCI-H125 NCI-H125 cell line incubated with 200 μmol/L of CIGB-300 during 45 min cell line Up 2.3 20804217 1576 TBB4B_HUMAN ENSP00000341289 Non-small cell lung carcinoma Treatment (none vs CIGB-300 treatment) The non-small cell lung cancer(NSCLC) cell line NCI-H125 NCI-H125 cell line incubated with 200 μmol/L of CIGB-300 during 45 min cell line Up 2.4 20804217 1577 TBB2A_HUMAN ENSP00000369703 Non-small cell lung carcinoma Treatment (none vs CIGB-300 treatment) The non-small cell lung cancer(NSCLC) cell line NCI-H125 NCI-H125 cell line incubated with 200 μmol/L of CIGB-300 during 45 min cell line Up 2.5 20804217 1578 TBB2B_HUMAN ENSP00000259818 Non-small cell lung carcinoma Treatment (none vs CIGB-300 treatment) The non-small cell lung cancer(NSCLC) cell line NCI-H125 NCI-H125 cell line incubated with 200 μmol/L of CIGB-300 during 45 min cell line Up 2.5 20804217 1579 1433E_HUMAN ENSP00000264335 Non-small cell lung carcinoma Treatment (none vs CIGB-300 treatment) The non-small cell lung cancer(NSCLC) cell line NCI-H125 NCI-H125 cell line incubated with 200 μmol/L of CIGB-300 during 45 min cell line Up 2.6 20804217 1580 RL10_HUMAN ENSP00000413436 Non-small cell lung carcinoma Treatment (none vs CIGB-300 treatment) The non-small cell lung cancer(NSCLC) cell line NCI-H125 NCI-H125 cell line incubated with 200 μmol/L of CIGB-300 during 45 min cell line Up 2.7 20804217 1581 TBB3_HUMAN ENSP00000320295 Non-small cell lung carcinoma Treatment (none vs CIGB-300 treatment) The non-small cell lung cancer(NSCLC) cell line NCI-H125 NCI-H125 cell line incubated with 200 μmol/L of CIGB-300 during 45 min cell line Up 2.7 20804217 1582 TBA1A_HUMAN ENSP00000301071 Non-small cell lung carcinoma Treatment (none vs CIGB-300 treatment) The non-small cell lung cancer(NSCLC) cell line NCI-H125 NCI-H125 cell line incubated with 200 μmol/L of CIGB-300 during 45 min cell line Up 2.7 20804217 1583 TBB5_HUMAN ENSP00000406811 Non-small cell lung carcinoma Treatment (none vs CIGB-300 treatment) The non-small cell lung cancer(NSCLC) cell line NCI-H125 NCI-H125 cell line incubated with 200 μmol/L of CIGB-300 during 45 min cell line Up 2.8 20804217 1584 TBB6_HUMAN ENSP00000318697 Non-small cell lung carcinoma Treatment (none vs CIGB-300 treatment) The non-small cell lung cancer(NSCLC) cell line NCI-H125 NCI-H125 cell line incubated with 200 μmol/L of CIGB-300 during 45 min cell line Up 2.8 20804217 1585 TBB3_HUMAN ENSP00000320295 Non-small cell lung carcinoma Treatment (none vs CIGB-300 treatment) The non-small cell lung cancer(NSCLC) cell line NCI-H125 NCI-H125 cell line incubated with 200 μmol/L of CIGB-300 during 45 min cell line Up 4.2 20804217 1586 NPM_HUMAN ENSP00000296930 Non-small cell lung carcinoma Treatment (none vs CIGB-300 treatment) The non-small cell lung cancer(NSCLC) cell line NCI-H125 NCI-H125 cell line incubated with 200 μmol/L of CIGB-300 during 45 min cell line Up 11 20804217 1587 SODM_HUMAN ENSP00000337127 Lung Cancer Normal vs. Cancer matched pair of peritumoral tissues tumoral tissues from lung cancer tissue Up 14760715 1588 CLIC1_HUMAN ENSP00000379229 Gastric Cancer Normal vs. Cancer the non-infected human gastric biopsy tissues the H. pylori-infected human gastric biopsy tissues tissue Down 14711373 1589 K2C8_HUMAN ENSP00000293308 Gastric Cancer Normal vs. Cancer the non-infected human gastric biopsy tissues the H. pylori-infected human gastric biopsy tissues tissue Down 14711373 1590 GSTP1_HUMAN ENSP00000381607 Gastric Cancer Normal vs. Cancer the non-infected human gastric biopsy tissues the H. pylori-infected human gastric biopsy tissues tissue Down 14711373 1591 ENPL_HUMAN ENSP00000299767 Gastric Cancer Normal vs. Cancer the non-infected human gastric biopsy tissues the H. pylori-infected human gastric biopsy tissues tissue Up 14711373 1592 APOA1_HUMAN ENSP00000236850 Gastric Cancer Normal vs. Cancer paired surrounding normal stomach tissue human stomach adenocarcinoma tissue tissue Up 15559763 1593 NDKA_HUMAN ENSP00000013034 Gastric Cancer Normal vs. Cancer paired surrounding normal stomach tissue human stomach adenocarcinoma tissue tissue Up 15559763 1594 1433Z_HUMAN ENSP00000379288 Gastric Cancer Normal vs. Cancer paired surrounding normal stomach tissue human stomach adenocarcinoma tissue tissue Up 15559763 1595 TERA_HUMAN ENSP00000351777 Gastric Cancer Normal vs. Cancer non-cancer tissues gastric cancer tissues tissue Up 15789341 1596 HSP7C_HUMAN ENSP00000227378 Gastric Cancer Treatment (none vs. Vincristine-resistant) human gastric carcinoma cell line SGC7901 Vincristine-resistant human gastric carcinoma cell line SGC7901/VCR cell line Down 16525997 1597 COF1_HUMAN ENSP00000309629 Gastric Cancer Treatment (none vs. Vincristine-resistant) human gastric carcinoma cell line SGC7901 Vincristine-resistant human gastric carcinoma cell line SGC7901/VCR cell line Down 16525997 1598 GBB2_HUMAN ENSP00000377501 Gastric Cancer Treatment (none vs. Vincristine-resistant) human gastric carcinoma cell line SGC7901 Vincristine-resistant human gastric carcinoma cell line SGC7901/VCR cell line Down 16525997 1599 HSPB1_HUMAN ENSP00000248553 Gastric Cancer Treatment (none vs. Vincristine-resistant) human gastric carcinoma cell line SGC7901 Vincristine-resistant human gastric carcinoma cell line SGC7901/VCR cell line Up 16525997 1600 PGAM1_HUMAN ENSP00000359991 Gastric Cancer Treatment (none vs. Vincristine-resistant) human gastric carcinoma cell line SGC7901 Vincristine-resistant human gastric carcinoma cell line SGC7901/VCR cell line Up 16525997 1601 PRDX1_HUMAN ENSP00000262746 Gastric Cancer Treatment (none vs. Vincristine-resistant) human gastric carcinoma cell line SGC7901 Vincristine-resistant human gastric carcinoma cell line SGC7901/VCR cell line Up 16525997 1602 IPYR_HUMAN ENSP00000362329 Gastric Cancer Treatment (none vs. Vincristine-resistant) human gastric carcinoma cell line SGC7901 Vincristine-resistant human gastric carcinoma cell line SGC7901/VCR cell line Up 16525997 1603 HCD2_HUMAN ENSP00000168216 Gastric Cancer Treatment (none vs. Vincristine-resistant) human gastric carcinoma cell line SGC7901 Vincristine-resistant human gastric carcinoma cell line SGC7901/VCR cell line Up 16525997 1604 NR1I2_HUMAN ENSP00000336528 Gastric Cancer Treatment (none vs. 5-fluorouracil treatment) the MGC-803 cells at the apoptosisinitiation phase untreated with 5-fluorouracil the MGC-803 cells at the apoptosisinitiation phase treated with 5-fluorouracil for 12 hours cell line Down 0.11 16900703 1605 CNBP_HUMAN ENSP00000410619 Gastric Cancer Treatment (none vs. 5-fluorouracil treatment) the MGC-803 cells at the apoptosisinitiation phase untreated with 5-fluorouracil the MGC-803 cells at the apoptosisinitiation phase treated with 5-fluorouracil for 12 hours cell line Down 0.12 16900703 1606 K1C18_HUMAN ENSP00000373489 Gastric Cancer Treatment (none vs. 5-fluorouracil treatment) the MGC-803 cells at the apoptosisinitiation phase untreated with 5-fluorouracil the MGC-803 cells at the apoptosisinitiation phase treated with 5-fluorouracil for 12 hours cell line Down 0.2 16900703 1607 VIME_HUMAN ENSP00000224237 Gastric Cancer Treatment (none vs. 5-fluorouracil treatment) the MGC-803 cells at the apoptosisinitiation phase untreated with 5-fluorouracil the MGC-803 cells at the apoptosisinitiation phase treated with 5-fluorouracil for 12 hours cell line Down 0.43 16900703 1608 PRDX5_HUMAN ENSP00000265462 Gastric Cancer Treatment (none vs. 5-fluorouracil treatment) the MGC-803 cells at the apoptosisinitiation phase untreated with 5-fluorouracil the MGC-803 cells at the apoptosisinitiation phase treated with 5-fluorouracil for 12 hours cell line Up 3.8 16900703 1609 MOES_HUMAN ENSP00000353408 Gastric Cancer Treatment (none vs. 5-fluorouracil treatment) the MGC-803 cells at the apoptosisinitiation phase untreated with 5-fluorouracil the MGC-803 cells at the apoptosisinitiation phase treated with 5-fluorouracil for 12 hours cell line Up 3.9 16900703 1610 SYCP2_HUMAN ENSP00000360040 Gastric Cancer Treatment (none vs. 5-fluorouracil treatment) the MGC-803 cells at the apoptosisinitiation phase untreated with 5-fluorouracil the MGC-803 cells at the apoptosisinitiation phase treated with 5-fluorouracil for 12 hours cell line Up 8.8 16900703 1611 PRDX1_HUMAN ENSP00000262746 Gastric Cancer Treatment (none vs. 5-fluorouracil treatment) the MGC-803 cells at the apoptosisinitiation phase untreated with 5-fluorouracil the MGC-803 cells at the apoptosisinitiation phase treated with 5-fluorouracil for 12 hours cell line Up 15 16900703 1612 CALR_HUMAN ENSP00000320866 Gastric Cancer Treatment (none vs. 5-fluorouracil treatment) the MGC-803 cells at the apoptosisinitiation phase untreated with 5-fluorouracil the MGC-803 cells at the apoptosisinitiation phase treated with 5-fluorouracil for 12 hours cell line Up 20 16900703 1613 G3P_HUMAN ENSP00000380068 Gastric Cancer Treatment (none vs. 5-fluorouracil treatment) the MGC-803 cells at the apoptosisinitiation phase untreated with 5-fluorouracil the MGC-803 cells at the apoptosisinitiation phase treated with 5-fluorouracil for 12 hours cell line Up 23 16900703 1614 TITIN_HUMAN ENSP00000354117 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell(a well-established human gastric carcinoma cell line, originally cultured from a poorly differentiated adenocarcinoma that invaded through the stomach wall but showed no metastasis to lymph nodes or adjacent organs) the metastatic gastric cancer TMC-1 cells(derived from the lymph node of an individual with a moderately differentiated adenocarcinoma of the stomach and exhibited highly tumorigenic features) cell line Down 0.16 17022644 1615 GBG12_HUMAN ENSP00000360021 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell(a well-established human gastric carcinoma cell line, originally cultured from a poorly differentiated adenocarcinoma that invaded through the stomach wall but showed no metastasis to lymph nodes or adjacent organs) the metastatic gastric cancer TMC-1 cells(derived from the lymph node of an individual with a moderately differentiated adenocarcinoma of the stomach and exhibited highly tumorigenic features) cell line Down 0.2 17022644 1616 CSRP1_HUMAN ENSP00000345079 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell(a well-established human gastric carcinoma cell line, originally cultured from a poorly differentiated adenocarcinoma that invaded through the stomach wall but showed no metastasis to lymph nodes or adjacent organs) the metastatic gastric cancer TMC-1 cells(derived from the lymph node of an individual with a moderately differentiated adenocarcinoma of the stomach and exhibited highly tumorigenic features) cell line Down 0.3 17022644 1617 DAPK3_HUMAN ENSP00000301264 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell(a well-established human gastric carcinoma cell line, originally cultured from a poorly differentiated adenocarcinoma that invaded through the stomach wall but showed no metastasis to lymph nodes or adjacent organs) the metastatic gastric cancer TMC-1 cells(derived from the lymph node of an individual with a moderately differentiated adenocarcinoma of the stomach and exhibited highly tumorigenic features) cell line Down 0.31 17022644 1618 PEBB_HUMAN ENSP00000290858 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell(a well-established human gastric carcinoma cell line, originally cultured from a poorly differentiated adenocarcinoma that invaded through the stomach wall but showed no metastasis to lymph nodes or adjacent organs) the metastatic gastric cancer TMC-1 cells(derived from the lymph node of an individual with a moderately differentiated adenocarcinoma of the stomach and exhibited highly tumorigenic features) cell line Down 0.31 17022644 1619 RHOA_HUMAN ENSP00000400175 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell(a well-established human gastric carcinoma cell line, originally cultured from a poorly differentiated adenocarcinoma that invaded through the stomach wall but showed no metastasis to lymph nodes or adjacent organs) the metastatic gastric cancer TMC-1 cells(derived from the lymph node of an individual with a moderately differentiated adenocarcinoma of the stomach and exhibited highly tumorigenic features) cell line Down 0.35 17022644 1620 PGM1_HUMAN ENSP00000360125 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell(a well-established human gastric carcinoma cell line, originally cultured from a poorly differentiated adenocarcinoma that invaded through the stomach wall but showed no metastasis to lymph nodes or adjacent organs) the metastatic gastric cancer TMC-1 cells(derived from the lymph node of an individual with a moderately differentiated adenocarcinoma of the stomach and exhibited highly tumorigenic features) cell line Down 0.37 17022644 1621 ICAM1_HUMAN ENSP00000264832 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell(a well-established human gastric carcinoma cell line, originally cultured from a poorly differentiated adenocarcinoma that invaded through the stomach wall but showed no metastasis to lymph nodes or adjacent organs) the metastatic gastric cancer TMC-1 cells(derived from the lymph node of an individual with a moderately differentiated adenocarcinoma of the stomach and exhibited highly tumorigenic features) cell line Down 0.38 17022644 1622 KS6A1_HUMAN ENSP00000431651 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell(a well-established human gastric carcinoma cell line, originally cultured from a poorly differentiated adenocarcinoma that invaded through the stomach wall but showed no metastasis to lymph nodes or adjacent organs) the metastatic gastric cancer TMC-1 cells(derived from the lymph node of an individual with a moderately differentiated adenocarcinoma of the stomach and exhibited highly tumorigenic features) cell line Down 0.39 17022644 1623 SHIP2_HUMAN ENSP00000298229 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell(a well-established human gastric carcinoma cell line, originally cultured from a poorly differentiated adenocarcinoma that invaded through the stomach wall but showed no metastasis to lymph nodes or adjacent organs) the metastatic gastric cancer TMC-1 cells(derived from the lymph node of an individual with a moderately differentiated adenocarcinoma of the stomach and exhibited highly tumorigenic features) cell line Down 0.41 17022644 1624 UPAR_HUMAN ENSP00000339328 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell(a well-established human gastric carcinoma cell line, originally cultured from a poorly differentiated adenocarcinoma that invaded through the stomach wall but showed no metastasis to lymph nodes or adjacent organs) the metastatic gastric cancer TMC-1 cells(derived from the lymph node of an individual with a moderately differentiated adenocarcinoma of the stomach and exhibited highly tumorigenic features) cell line Down 0.42 17022644 1625 PGAM1_HUMAN ENSP00000359991 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell(a well-established human gastric carcinoma cell line, originally cultured from a poorly differentiated adenocarcinoma that invaded through the stomach wall but showed no metastasis to lymph nodes or adjacent organs) the metastatic gastric cancer TMC-1 cells(derived from the lymph node of an individual with a moderately differentiated adenocarcinoma of the stomach and exhibited highly tumorigenic features) cell line Down 0.44 17022644 1626 MYH9_HUMAN ENSP00000216181 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell(a well-established human gastric carcinoma cell line, originally cultured from a poorly differentiated adenocarcinoma that invaded through the stomach wall but showed no metastasis to lymph nodes or adjacent organs) the metastatic gastric cancer TMC-1 cells(derived from the lymph node of an individual with a moderately differentiated adenocarcinoma of the stomach and exhibited highly tumorigenic features) cell line Down 0.47 17022644 1627 PEBP1_HUMAN ENSP00000261313 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell(a well-established human gastric carcinoma cell line, originally cultured from a poorly differentiated adenocarcinoma that invaded through the stomach wall but showed no metastasis to lymph nodes or adjacent organs) the metastatic gastric cancer TMC-1 cells(derived from the lymph node of an individual with a moderately differentiated adenocarcinoma of the stomach and exhibited highly tumorigenic features) cell line Down 0.48 17022644 1628 DEST_HUMAN ENSP00000246069 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell(a well-established human gastric carcinoma cell line, originally cultured from a poorly differentiated adenocarcinoma that invaded through the stomach wall but showed no metastasis to lymph nodes or adjacent organs) the metastatic gastric cancer TMC-1 cells(derived from the lymph node of an individual with a moderately differentiated adenocarcinoma of the stomach and exhibited highly tumorigenic features) cell line Down 0.5 17022644 1629 KPYM_HUMAN ENSP00000334983 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell(a well-established human gastric carcinoma cell line, originally cultured from a poorly differentiated adenocarcinoma that invaded through the stomach wall but showed no metastasis to lymph nodes or adjacent organs) the metastatic gastric cancer TMC-1 cells(derived from the lymph node of an individual with a moderately differentiated adenocarcinoma of the stomach and exhibited highly tumorigenic features) cell line Down 0.51 17022644 1630 RHOC_HUMAN ENSP00000358647 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell(a well-established human gastric carcinoma cell line, originally cultured from a poorly differentiated adenocarcinoma that invaded through the stomach wall but showed no metastasis to lymph nodes or adjacent organs) the metastatic gastric cancer TMC-1 cells(derived from the lymph node of an individual with a moderately differentiated adenocarcinoma of the stomach and exhibited highly tumorigenic features) cell line Down 0.54 17022644 1631 VINC_HUMAN ENSP00000211998 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell(a well-established human gastric carcinoma cell line, originally cultured from a poorly differentiated adenocarcinoma that invaded through the stomach wall but showed no metastasis to lymph nodes or adjacent organs) the metastatic gastric cancer TMC-1 cells(derived from the lymph node of an individual with a moderately differentiated adenocarcinoma of the stomach and exhibited highly tumorigenic features) cell line Down 0.54 17022644 1632 FHL2_HUMAN ENSP00000350846 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell(a well-established human gastric carcinoma cell line, originally cultured from a poorly differentiated adenocarcinoma that invaded through the stomach wall but showed no metastasis to lymph nodes or adjacent organs) the metastatic gastric cancer TMC-1 cells(derived from the lymph node of an individual with a moderately differentiated adenocarcinoma of the stomach and exhibited highly tumorigenic features) cell line Down 0.54 17022644 1633 PRKDC_HUMAN ENSP00000313420 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell(a well-established human gastric carcinoma cell line, originally cultured from a poorly differentiated adenocarcinoma that invaded through the stomach wall but showed no metastasis to lymph nodes or adjacent organs) the metastatic gastric cancer TMC-1 cells(derived from the lymph node of an individual with a moderately differentiated adenocarcinoma of the stomach and exhibited highly tumorigenic features) cell line Down 0.55 17022644 1634 CSDE1_HUMAN ENSP00000351329 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell(a well-established human gastric carcinoma cell line, originally cultured from a poorly differentiated adenocarcinoma that invaded through the stomach wall but showed no metastasis to lymph nodes or adjacent organs) the metastatic gastric cancer TMC-1 cells(derived from the lymph node of an individual with a moderately differentiated adenocarcinoma of the stomach and exhibited highly tumorigenic features) cell line Down 0.56 17022644 1635 TAGL2_HUMAN ENSP00000357075 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell(a well-established human gastric carcinoma cell line, originally cultured from a poorly differentiated adenocarcinoma that invaded through the stomach wall but showed no metastasis to lymph nodes or adjacent organs) the metastatic gastric cancer TMC-1 cells(derived from the lymph node of an individual with a moderately differentiated adenocarcinoma of the stomach and exhibited highly tumorigenic features) cell line Down 0.56 17022644 1636 MCM5_HUMAN ENSP00000216122 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell(a well-established human gastric carcinoma cell line, originally cultured from a poorly differentiated adenocarcinoma that invaded through the stomach wall but showed no metastasis to lymph nodes or adjacent organs) the metastatic gastric cancer TMC-1 cells(derived from the lymph node of an individual with a moderately differentiated adenocarcinoma of the stomach and exhibited highly tumorigenic features) cell line Down 0.58 17022644 1637 RAD50_HUMAN ENSP00000265335 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell(a well-established human gastric carcinoma cell line, originally cultured from a poorly differentiated adenocarcinoma that invaded through the stomach wall but showed no metastasis to lymph nodes or adjacent organs) the metastatic gastric cancer TMC-1 cells(derived from the lymph node of an individual with a moderately differentiated adenocarcinoma of the stomach and exhibited highly tumorigenic features) cell line Down 0.58 17022644 1638 RIPK3_HUMAN ENSP00000216274 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell(a well-established human gastric carcinoma cell line, originally cultured from a poorly differentiated adenocarcinoma that invaded through the stomach wall but showed no metastasis to lymph nodes or adjacent organs) the metastatic gastric cancer TMC-1 cells(derived from the lymph node of an individual with a moderately differentiated adenocarcinoma of the stomach and exhibited highly tumorigenic features) cell line Down 0.58 17022644 1639 LRRF1_HUMAN ENSP00000375857 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell(a well-established human gastric carcinoma cell line, originally cultured from a poorly differentiated adenocarcinoma that invaded through the stomach wall but showed no metastasis to lymph nodes or adjacent organs) the metastatic gastric cancer TMC-1 cells(derived from the lymph node of an individual with a moderately differentiated adenocarcinoma of the stomach and exhibited highly tumorigenic features) cell line Down 0.59 17022644 1640 AT2A2_HUMAN ENSP00000378872 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell(a well-established human gastric carcinoma cell line, originally cultured from a poorly differentiated adenocarcinoma that invaded through the stomach wall but showed no metastasis to lymph nodes or adjacent organs) the metastatic gastric cancer TMC-1 cells(derived from the lymph node of an individual with a moderately differentiated adenocarcinoma of the stomach and exhibited highly tumorigenic features) cell line Down 0.64 17022644 1641 NAMPT_HUMAN ENSP00000222553 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell(a well-established human gastric carcinoma cell line, originally cultured from a poorly differentiated adenocarcinoma that invaded through the stomach wall but showed no metastasis to lymph nodes or adjacent organs) the metastatic gastric cancer TMC-1 cells(derived from the lymph node of an individual with a moderately differentiated adenocarcinoma of the stomach and exhibited highly tumorigenic features) cell line Down 0.65 17022644 1642 FAS_HUMAN ENSP00000304592 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell(a well-established human gastric carcinoma cell line, originally cultured from a poorly differentiated adenocarcinoma that invaded through the stomach wall but showed no metastasis to lymph nodes or adjacent organs) the metastatic gastric cancer TMC-1 cells(derived from the lymph node of an individual with a moderately differentiated adenocarcinoma of the stomach and exhibited highly tumorigenic features) cell line Down 0.65 17022644 1643 CDC42_HUMAN ENSP00000314458 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell(a well-established human gastric carcinoma cell line, originally cultured from a poorly differentiated adenocarcinoma that invaded through the stomach wall but showed no metastasis to lymph nodes or adjacent organs) the metastatic gastric cancer TMC-1 cells(derived from the lymph node of an individual with a moderately differentiated adenocarcinoma of the stomach and exhibited highly tumorigenic features) cell line Down 0.67 17022644 1644 ANXA1_HUMAN ENSP00000366109 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell(a well-established human gastric carcinoma cell line, originally cultured from a poorly differentiated adenocarcinoma that invaded through the stomach wall but showed no metastasis to lymph nodes or adjacent organs) the metastatic gastric cancer TMC-1 cells(derived from the lymph node of an individual with a moderately differentiated adenocarcinoma of the stomach and exhibited highly tumorigenic features) cell line Down 0.68 17022644 1645 HS90B_HUMAN ENSP00000360609 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell(a well-established human gastric carcinoma cell line, originally cultured from a poorly differentiated adenocarcinoma that invaded through the stomach wall but showed no metastasis to lymph nodes or adjacent organs) the metastatic gastric cancer TMC-1 cells(derived from the lymph node of an individual with a moderately differentiated adenocarcinoma of the stomach and exhibited highly tumorigenic features) cell line Down 0.68 17022644 1646 CY1_HUMAN ENSP00000317159 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell(a well-established human gastric carcinoma cell line, originally cultured from a poorly differentiated adenocarcinoma that invaded through the stomach wall but showed no metastasis to lymph nodes or adjacent organs) the metastatic gastric cancer TMC-1 cells(derived from the lymph node of an individual with a moderately differentiated adenocarcinoma of the stomach and exhibited highly tumorigenic features) cell line Down 0.68 17022644 1647 SSRP1_HUMAN ENSP00000278412 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell(a well-established human gastric carcinoma cell line, originally cultured from a poorly differentiated adenocarcinoma that invaded through the stomach wall but showed no metastasis to lymph nodes or adjacent organs) the metastatic gastric cancer TMC-1 cells(derived from the lymph node of an individual with a moderately differentiated adenocarcinoma of the stomach and exhibited highly tumorigenic features) cell line Down 0.68 17022644 1648 NSUN2_HUMAN ENSP00000264670 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell(a well-established human gastric carcinoma cell line, originally cultured from a poorly differentiated adenocarcinoma that invaded through the stomach wall but showed no metastasis to lymph nodes or adjacent organs) the metastatic gastric cancer TMC-1 cells(derived from the lymph node of an individual with a moderately differentiated adenocarcinoma of the stomach and exhibited highly tumorigenic features) cell line Down 0.68 17022644 1649 SMC1A_HUMAN ENSP00000323421 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell(a well-established human gastric carcinoma cell line, originally cultured from a poorly differentiated adenocarcinoma that invaded through the stomach wall but showed no metastasis to lymph nodes or adjacent organs) the metastatic gastric cancer TMC-1 cells(derived from the lymph node of an individual with a moderately differentiated adenocarcinoma of the stomach and exhibited highly tumorigenic features) cell line Down 0.68 17022644 1650 PRP4_HUMAN ENSP00000363313 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell(a well-established human gastric carcinoma cell line, originally cultured from a poorly differentiated adenocarcinoma that invaded through the stomach wall but showed no metastasis to lymph nodes or adjacent organs) the metastatic gastric cancer TMC-1 cells(derived from the lymph node of an individual with a moderately differentiated adenocarcinoma of the stomach and exhibited highly tumorigenic features) cell line Down 0.69 17022644 1651 ACLY_HUMAN ENSP00000253792 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell(a well-established human gastric carcinoma cell line, originally cultured from a poorly differentiated adenocarcinoma that invaded through the stomach wall but showed no metastasis to lymph nodes or adjacent organs) the metastatic gastric cancer TMC-1 cells(derived from the lymph node of an individual with a moderately differentiated adenocarcinoma of the stomach and exhibited highly tumorigenic features) cell line Down 0.69 17022644 1652 FUBP1_HUMAN ENSP00000359804 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell(a well-established human gastric carcinoma cell line, originally cultured from a poorly differentiated adenocarcinoma that invaded through the stomach wall but showed no metastasis to lymph nodes or adjacent organs) the metastatic gastric cancer TMC-1 cells(derived from the lymph node of an individual with a moderately differentiated adenocarcinoma of the stomach and exhibited highly tumorigenic features) cell line Down 0.69 17022644 1653 CLIC1_HUMAN ENSP00000379229 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell(a well-established human gastric carcinoma cell line, originally cultured from a poorly differentiated adenocarcinoma that invaded through the stomach wall but showed no metastasis to lymph nodes or adjacent organs) the metastatic gastric cancer TMC-1 cells(derived from the lymph node of an individual with a moderately differentiated adenocarcinoma of the stomach and exhibited highly tumorigenic features) cell line Down 2.4 17022644 1654 TGM2_HUMAN ENSP00000355330 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell(a well-established human gastric carcinoma cell line, originally cultured from a poorly differentiated adenocarcinoma that invaded through the stomach wall but showed no metastasis to lymph nodes or adjacent organs) the metastatic gastric cancer TMC-1 cells(derived from the lymph node of an individual with a moderately differentiated adenocarcinoma of the stomach and exhibited highly tumorigenic features) cell line Down 17022644 1655 AT2B4_HUMAN ENSP00000356187 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell(a well-established human gastric carcinoma cell line, originally cultured from a poorly differentiated adenocarcinoma that invaded through the stomach wall but showed no metastasis to lymph nodes or adjacent organs) the metastatic gastric cancer TMC-1 cells(derived from the lymph node of an individual with a moderately differentiated adenocarcinoma of the stomach and exhibited highly tumorigenic features) cell line Down 17022644 1656 GNAI2_HUMAN ENSP00000312999 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell(a well-established human gastric carcinoma cell line, originally cultured from a poorly differentiated adenocarcinoma that invaded through the stomach wall but showed no metastasis to lymph nodes or adjacent organs) the metastatic gastric cancer TMC-1 cells(derived from the lymph node of an individual with a moderately differentiated adenocarcinoma of the stomach and exhibited highly tumorigenic features) cell line Up 1.3 17022644 1657 TBB5_HUMAN ENSP00000406811 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell(a well-established human gastric carcinoma cell line, originally cultured from a poorly differentiated adenocarcinoma that invaded through the stomach wall but showed no metastasis to lymph nodes or adjacent organs) the metastatic gastric cancer TMC-1 cells(derived from the lymph node of an individual with a moderately differentiated adenocarcinoma of the stomach and exhibited highly tumorigenic features) cell line Up 1.3 17022644 1658 COMT_HUMAN ENSP00000385150 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell(a well-established human gastric carcinoma cell line, originally cultured from a poorly differentiated adenocarcinoma that invaded through the stomach wall but showed no metastasis to lymph nodes or adjacent organs) the metastatic gastric cancer TMC-1 cells(derived from the lymph node of an individual with a moderately differentiated adenocarcinoma of the stomach and exhibited highly tumorigenic features) cell line Up 1.4 17022644 1659 TERA_HUMAN ENSP00000351777 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell(a well-established human gastric carcinoma cell line, originally cultured from a poorly differentiated adenocarcinoma that invaded through the stomach wall but showed no metastasis to lymph nodes or adjacent organs) the metastatic gastric cancer TMC-1 cells(derived from the lymph node of an individual with a moderately differentiated adenocarcinoma of the stomach and exhibited highly tumorigenic features) cell line Up 1.4 17022644 1660 EXOS5_HUMAN ENSP00000221233 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell(a well-established human gastric carcinoma cell line, originally cultured from a poorly differentiated adenocarcinoma that invaded through the stomach wall but showed no metastasis to lymph nodes or adjacent organs) the metastatic gastric cancer TMC-1 cells(derived from the lymph node of an individual with a moderately differentiated adenocarcinoma of the stomach and exhibited highly tumorigenic features) cell line Up 1.4 17022644 1661 ACTN4_HUMAN ENSP00000252699 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell(a well-established human gastric carcinoma cell line, originally cultured from a poorly differentiated adenocarcinoma that invaded through the stomach wall but showed no metastasis to lymph nodes or adjacent organs) the metastatic gastric cancer TMC-1 cells(derived from the lymph node of an individual with a moderately differentiated adenocarcinoma of the stomach and exhibited highly tumorigenic features) cell line Up 1.4 17022644 1662 FLNA_HUMAN ENSP00000358866 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell(a well-established human gastric carcinoma cell line, originally cultured from a poorly differentiated adenocarcinoma that invaded through the stomach wall but showed no metastasis to lymph nodes or adjacent organs) the metastatic gastric cancer TMC-1 cells(derived from the lymph node of an individual with a moderately differentiated adenocarcinoma of the stomach and exhibited highly tumorigenic features) cell line Up 1.4 17022644 1663 S10AB_HUMAN ENSP00000271638 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell(a well-established human gastric carcinoma cell line, originally cultured from a poorly differentiated adenocarcinoma that invaded through the stomach wall but showed no metastasis to lymph nodes or adjacent organs) the metastatic gastric cancer TMC-1 cells(derived from the lymph node of an individual with a moderately differentiated adenocarcinoma of the stomach and exhibited highly tumorigenic features) cell line Up 1.4 17022644 1664 FKBP4_HUMAN ENSP00000001008 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell(a well-established human gastric carcinoma cell line, originally cultured from a poorly differentiated adenocarcinoma that invaded through the stomach wall but showed no metastasis to lymph nodes or adjacent organs) the metastatic gastric cancer TMC-1 cells(derived from the lymph node of an individual with a moderately differentiated adenocarcinoma of the stomach and exhibited highly tumorigenic features) cell line Up 1.5 17022644 1665 1433Z_HUMAN ENSP00000379288 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell(a well-established human gastric carcinoma cell line, originally cultured from a poorly differentiated adenocarcinoma that invaded through the stomach wall but showed no metastasis to lymph nodes or adjacent organs) the metastatic gastric cancer TMC-1 cells(derived from the lymph node of an individual with a moderately differentiated adenocarcinoma of the stomach and exhibited highly tumorigenic features) cell line Up 1.5 17022644 1666 SYSC_HUMAN ENSP00000234677 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell(a well-established human gastric carcinoma cell line, originally cultured from a poorly differentiated adenocarcinoma that invaded through the stomach wall but showed no metastasis to lymph nodes or adjacent organs) the metastatic gastric cancer TMC-1 cells(derived from the lymph node of an individual with a moderately differentiated adenocarcinoma of the stomach and exhibited highly tumorigenic features) cell line Up 1.5 17022644 1667 NASP_HUMAN ENSP00000255120 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell(a well-established human gastric carcinoma cell line, originally cultured from a poorly differentiated adenocarcinoma that invaded through the stomach wall but showed no metastasis to lymph nodes or adjacent organs) the metastatic gastric cancer TMC-1 cells(derived from the lymph node of an individual with a moderately differentiated adenocarcinoma of the stomach and exhibited highly tumorigenic features) cell line Up 1.5 17022644 1668 DESP_HUMAN ENSP00000369129 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell(a well-established human gastric carcinoma cell line, originally cultured from a poorly differentiated adenocarcinoma that invaded through the stomach wall but showed no metastasis to lymph nodes or adjacent organs) the metastatic gastric cancer TMC-1 cells(derived from the lymph node of an individual with a moderately differentiated adenocarcinoma of the stomach and exhibited highly tumorigenic features) cell line Up 1.6 17022644 1669 HS105_HUMAN ENSP00000318687 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell(a well-established human gastric carcinoma cell line, originally cultured from a poorly differentiated adenocarcinoma that invaded through the stomach wall but showed no metastasis to lymph nodes or adjacent organs) the metastatic gastric cancer TMC-1 cells(derived from the lymph node of an individual with a moderately differentiated adenocarcinoma of the stomach and exhibited highly tumorigenic features) cell line Up 1.6 17022644 1670 XRCC6_HUMAN ENSP00000384257 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell(a well-established human gastric carcinoma cell line, originally cultured from a poorly differentiated adenocarcinoma that invaded through the stomach wall but showed no metastasis to lymph nodes or adjacent organs) the metastatic gastric cancer TMC-1 cells(derived from the lymph node of an individual with a moderately differentiated adenocarcinoma of the stomach and exhibited highly tumorigenic features) cell line Up 1.6 17022644 1671 THIO_HUMAN ENSP00000363641 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell(a well-established human gastric carcinoma cell line, originally cultured from a poorly differentiated adenocarcinoma that invaded through the stomach wall but showed no metastasis to lymph nodes or adjacent organs) the metastatic gastric cancer TMC-1 cells(derived from the lymph node of an individual with a moderately differentiated adenocarcinoma of the stomach and exhibited highly tumorigenic features) cell line Up 1.6 17022644 1672 U2AF1_HUMAN ENSP00000291552 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell(a well-established human gastric carcinoma cell line, originally cultured from a poorly differentiated adenocarcinoma that invaded through the stomach wall but showed no metastasis to lymph nodes or adjacent organs) the metastatic gastric cancer TMC-1 cells(derived from the lymph node of an individual with a moderately differentiated adenocarcinoma of the stomach and exhibited highly tumorigenic features) cell line Up 1.6 17022644 1673 PRS7_HUMAN ENSP00000292644 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell(a well-established human gastric carcinoma cell line, originally cultured from a poorly differentiated adenocarcinoma that invaded through the stomach wall but showed no metastasis to lymph nodes or adjacent organs) the metastatic gastric cancer TMC-1 cells(derived from the lymph node of an individual with a moderately differentiated adenocarcinoma of the stomach and exhibited highly tumorigenic features) cell line Up 1.7 17022644 1674 UB2V1_HUMAN ENSP00000395264 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell(a well-established human gastric carcinoma cell line, originally cultured from a poorly differentiated adenocarcinoma that invaded through the stomach wall but showed no metastasis to lymph nodes or adjacent organs) the metastatic gastric cancer TMC-1 cells(derived from the lymph node of an individual with a moderately differentiated adenocarcinoma of the stomach and exhibited highly tumorigenic features) cell line Up 1.7 17022644 1675 TBB3_HUMAN ENSP00000320295 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell(a well-established human gastric carcinoma cell line, originally cultured from a poorly differentiated adenocarcinoma that invaded through the stomach wall but showed no metastasis to lymph nodes or adjacent organs) the metastatic gastric cancer TMC-1 cells(derived from the lymph node of an individual with a moderately differentiated adenocarcinoma of the stomach and exhibited highly tumorigenic features) cell line Up 1.8 17022644 1676 CTND1_HUMAN ENSP00000382004 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell(a well-established human gastric carcinoma cell line, originally cultured from a poorly differentiated adenocarcinoma that invaded through the stomach wall but showed no metastasis to lymph nodes or adjacent organs) the metastatic gastric cancer TMC-1 cells(derived from the lymph node of an individual with a moderately differentiated adenocarcinoma of the stomach and exhibited highly tumorigenic features) cell line Up 1.8 17022644 1677 LA_HUMAN ENSP00000386636 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell(a well-established human gastric carcinoma cell line, originally cultured from a poorly differentiated adenocarcinoma that invaded through the stomach wall but showed no metastasis to lymph nodes or adjacent organs) the metastatic gastric cancer TMC-1 cells(derived from the lymph node of an individual with a moderately differentiated adenocarcinoma of the stomach and exhibited highly tumorigenic features) cell line Up 1.8 17022644 1678 PRDX5_HUMAN ENSP00000265462 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell(a well-established human gastric carcinoma cell line, originally cultured from a poorly differentiated adenocarcinoma that invaded through the stomach wall but showed no metastasis to lymph nodes or adjacent organs) the metastatic gastric cancer TMC-1 cells(derived from the lymph node of an individual with a moderately differentiated adenocarcinoma of the stomach and exhibited highly tumorigenic features) cell line Up 1.8 17022644 1679 HMGB1_HUMAN ENSP00000382417 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell(a well-established human gastric carcinoma cell line, originally cultured from a poorly differentiated adenocarcinoma that invaded through the stomach wall but showed no metastasis to lymph nodes or adjacent organs) the metastatic gastric cancer TMC-1 cells(derived from the lymph node of an individual with a moderately differentiated adenocarcinoma of the stomach and exhibited highly tumorigenic features) cell line Up 1.9 17022644 1680 RCC1_HUMAN ENSP00000381931 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell(a well-established human gastric carcinoma cell line, originally cultured from a poorly differentiated adenocarcinoma that invaded through the stomach wall but showed no metastasis to lymph nodes or adjacent organs) the metastatic gastric cancer TMC-1 cells(derived from the lymph node of an individual with a moderately differentiated adenocarcinoma of the stomach and exhibited highly tumorigenic features) cell line Up 1.9 17022644 1681 ITB4_HUMAN ENSP00000200181 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell(a well-established human gastric carcinoma cell line, originally cultured from a poorly differentiated adenocarcinoma that invaded through the stomach wall but showed no metastasis to lymph nodes or adjacent organs) the metastatic gastric cancer TMC-1 cells(derived from the lymph node of an individual with a moderately differentiated adenocarcinoma of the stomach and exhibited highly tumorigenic features) cell line Up 2 17022644 1682 RUVB1_HUMAN ENSP00000318297 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell(a well-established human gastric carcinoma cell line, originally cultured from a poorly differentiated adenocarcinoma that invaded through the stomach wall but showed no metastasis to lymph nodes or adjacent organs) the metastatic gastric cancer TMC-1 cells(derived from the lymph node of an individual with a moderately differentiated adenocarcinoma of the stomach and exhibited highly tumorigenic features) cell line Up 2 17022644 1683 RASK_HUMAN ENSP00000256078 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell(a well-established human gastric carcinoma cell line, originally cultured from a poorly differentiated adenocarcinoma that invaded through the stomach wall but showed no metastasis to lymph nodes or adjacent organs) the metastatic gastric cancer TMC-1 cells(derived from the lymph node of an individual with a moderately differentiated adenocarcinoma of the stomach and exhibited highly tumorigenic features) cell line Up 2.1 17022644 1684 LMNA_HUMAN ENSP00000357283 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell(a well-established human gastric carcinoma cell line, originally cultured from a poorly differentiated adenocarcinoma that invaded through the stomach wall but showed no metastasis to lymph nodes or adjacent organs) the metastatic gastric cancer TMC-1 cells(derived from the lymph node of an individual with a moderately differentiated adenocarcinoma of the stomach and exhibited highly tumorigenic features) cell line Up 2.1 17022644 1685 PYR1_HUMAN ENSP00000264705 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell(a well-established human gastric carcinoma cell line, originally cultured from a poorly differentiated adenocarcinoma that invaded through the stomach wall but showed no metastasis to lymph nodes or adjacent organs) the metastatic gastric cancer TMC-1 cells(derived from the lymph node of an individual with a moderately differentiated adenocarcinoma of the stomach and exhibited highly tumorigenic features) cell line Up 2.2 17022644 1686 C163A_HUMAN ENSP00000352071 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell(a well-established human gastric carcinoma cell line, originally cultured from a poorly differentiated adenocarcinoma that invaded through the stomach wall but showed no metastasis to lymph nodes or adjacent organs) the metastatic gastric cancer TMC-1 cells(derived from the lymph node of an individual with a moderately differentiated adenocarcinoma of the stomach and exhibited highly tumorigenic features) cell line Up 2.2 17022644 1687 DDB1_HUMAN ENSP00000301764 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell(a well-established human gastric carcinoma cell line, originally cultured from a poorly differentiated adenocarcinoma that invaded through the stomach wall but showed no metastasis to lymph nodes or adjacent organs) the metastatic gastric cancer TMC-1 cells(derived from the lymph node of an individual with a moderately differentiated adenocarcinoma of the stomach and exhibited highly tumorigenic features) cell line Up 2.3 17022644 1688 MAP4_HUMAN ENSP00000353375 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell(a well-established human gastric carcinoma cell line, originally cultured from a poorly differentiated adenocarcinoma that invaded through the stomach wall but showed no metastasis to lymph nodes or adjacent organs) the metastatic gastric cancer TMC-1 cells(derived from the lymph node of an individual with a moderately differentiated adenocarcinoma of the stomach and exhibited highly tumorigenic features) cell line Up 2.3 17022644 1689 1433S_HUMAN ENSP00000340989 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell(a well-established human gastric carcinoma cell line, originally cultured from a poorly differentiated adenocarcinoma that invaded through the stomach wall but showed no metastasis to lymph nodes or adjacent organs) the metastatic gastric cancer TMC-1 cells(derived from the lymph node of an individual with a moderately differentiated adenocarcinoma of the stomach and exhibited highly tumorigenic features) cell line Up 2.4 17022644 1690 1433T_HUMAN ENSP00000371267 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell(a well-established human gastric carcinoma cell line, originally cultured from a poorly differentiated adenocarcinoma that invaded through the stomach wall but showed no metastasis to lymph nodes or adjacent organs) the metastatic gastric cancer TMC-1 cells(derived from the lymph node of an individual with a moderately differentiated adenocarcinoma of the stomach and exhibited highly tumorigenic features) cell line Up 2.5 17022644 1691 HCD2_HUMAN ENSP00000168216 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell(a well-established human gastric carcinoma cell line, originally cultured from a poorly differentiated adenocarcinoma that invaded through the stomach wall but showed no metastasis to lymph nodes or adjacent organs) the metastatic gastric cancer TMC-1 cells(derived from the lymph node of an individual with a moderately differentiated adenocarcinoma of the stomach and exhibited highly tumorigenic features) cell line Up 2.5 17022644 1692 ITA6_HUMAN ENSP00000341078 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell(a well-established human gastric carcinoma cell line, originally cultured from a poorly differentiated adenocarcinoma that invaded through the stomach wall but showed no metastasis to lymph nodes or adjacent organs) the metastatic gastric cancer TMC-1 cells(derived from the lymph node of an individual with a moderately differentiated adenocarcinoma of the stomach and exhibited highly tumorigenic features) cell line Up 3.3 17022644 1693 CTNB1_HUMAN ENSP00000379488 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell(a well-established human gastric carcinoma cell line, originally cultured from a poorly differentiated adenocarcinoma that invaded through the stomach wall but showed no metastasis to lymph nodes or adjacent organs) the metastatic gastric cancer TMC-1 cells(derived from the lymph node of an individual with a moderately differentiated adenocarcinoma of the stomach and exhibited highly tumorigenic features) cell line Up 5.9 17022644 1694 VIME_HUMAN ENSP00000224237 Gastric Cancer Metastasis the noninvasive gastric cancer SC-M1 cell(a well-established human gastric carcinoma cell line, originally cultured from a poorly differentiated adenocarcinoma that invaded through the stomach wall but showed no metastasis to lymph nodes or adjacent organs) the metastatic gastric cancer TMC-1 cells(derived from the lymph node of an individual with a moderately differentiated adenocarcinoma of the stomach and exhibited highly tumorigenic features) cell line Up 26 17022644 1695 CRK_HUMAN ENSP00000300574 Gastric Cancer Treatment (none v.s 100 umol/l of L-homocysteine thiolactone treated) SGC7901 cells were treated with M+H-(100 μmol/l of L-methionine) medium for 5 days SGC7901 cells were treated with M-H+(100 μmol/l of L-homocysteine thiolactone) medium for 5 days cell line Up 17116298 1696 A1AT_HUMAN ENSP00000348068 Gastric Cancer Normal vs. Cancer Fresh samples of the adjacent noncancerous mucosa Fresh samples of tumor tissue tissue Down 17154271 1697 TAGL_HUMAN ENSP00000278968 Gastric Cancer Normal vs. Cancer the corresponding noncancerous gastric mucosa the gastric tissues of patients consisting of the gastric cancer portions tissue Up 3.2 17929853 1698 CNN1_HUMAN ENSP00000252456 Gastric Cancer Normal vs. Cancer the corresponding noncancerous gastric mucosa the gastric tissues of patients consisting of the gastric cancer portions tissue Up 5.8 17929853 1699 SET_HUMAN ENSP00000361777 Gastric Cancer Treatment (none vs. Vincristine-resistant) human gastric carcinoma cell line SGC7901 Vincristine-resistant human gastric carcinoma cell line SGC7901/VCR cell line Down 0.17 18253933 1700 HSP7C_HUMAN ENSP00000227378 Gastric Cancer Treatment (none vs. Vincristine-resistant) human gastric carcinoma cell line SGC7901 Vincristine-resistant human gastric carcinoma cell line SGC7901/VCR cell line Down 0.42 18253933 1701 EF2_HUMAN ENSP00000307940 Gastric Cancer Treatment (none vs. Vincristine-resistant) human gastric carcinoma cell line SGC7901 Vincristine-resistant human gastric carcinoma cell line SGC7901/VCR cell line Down 0.42 18253933 1702 CLIC1_HUMAN ENSP00000379229 Gastric Cancer Treatment (none vs. Vincristine-resistant) human gastric carcinoma cell line SGC7901 Vincristine-resistant human gastric carcinoma cell line SGC7901/VCR cell line Down 0.43 18253933 1703 NDRG1_HUMAN ENSP00000404854 Gastric Cancer Treatment (none vs. Vincristine-resistant) human gastric carcinoma cell line SGC7901 Vincristine-resistant human gastric carcinoma cell line SGC7901/VCR cell line Down 0.48 18253933 1704 NPM_HUMAN ENSP00000296930 Gastric Cancer Treatment (none vs. Vincristine-resistant) human gastric carcinoma cell line SGC7901 Vincristine-resistant human gastric carcinoma cell line SGC7901/VCR cell line Up 1.7 18253933 1705 S10AB_HUMAN ENSP00000271638 Gastric Cancer Treatment (none vs. Vincristine-resistant) human gastric carcinoma cell line SGC7901 Vincristine-resistant human gastric carcinoma cell line SGC7901/VCR cell line Up 1.8 18253933 1706 IPYR_HUMAN ENSP00000362329 Gastric Cancer Treatment (none vs. Vincristine-resistant) human gastric carcinoma cell line SGC7901 Vincristine-resistant human gastric carcinoma cell line SGC7901/VCR cell line Up 1.8 18253933 1707 LMNA_HUMAN ENSP00000357283 Gastric Cancer Treatment (none vs. Vincristine-resistant) human gastric carcinoma cell line SGC7901 Vincristine-resistant human gastric carcinoma cell line SGC7901/VCR cell line Up 2.1 18253933 1708 ANXA1_HUMAN ENSP00000366109 Gastric Cancer Treatment (none vs. Vincristine-resistant) human gastric carcinoma cell line SGC7901 Vincristine-resistant human gastric carcinoma cell line SGC7901/VCR cell line Up 2.4 18253933 1709 HSPB1_HUMAN ENSP00000248553 Gastric Cancer Treatment (none vs. Vincristine-resistant) human gastric carcinoma cell line SGC7901 Vincristine-resistant human gastric carcinoma cell line SGC7901/VCR cell line Up 3.8 18253933 1710 GSTP1_HUMAN ENSP00000381607 Gastric Cancer Treatment (none vs. drug-resistant) gastric cancer SGC7901 cells drug-resistant SGC7901 cells (SGC7901/VCR) cell line Down 18309519 1711 TPIS_HUMAN ENSP00000379933 Gastric Cancer Treatment (none vs. drug-resistant) gastric cancer SGC7901 cells drug-resistant SGC7901 cells (SGC7901/VCR) cell line Down 18309519 1712 STAR_HUMAN ENSP00000276449 Gastric Cancer Treatment (none vs. drug-resistant) gastric cancer SGC7901 cells drug-resistant SGC7901 cells (SGC7901/VCR) cell line Up 18309519 1713 F16P1_HUMAN ENSP00000408025 Gastric Cancer Normal vs. Cancer the adjacent noncancerous gastric samples cancerous gastric samples tissue Down 0.28 18723843 1714 G3P_HUMAN ENSP00000380068 Gastric Cancer Normal vs. Cancer the adjacent noncancerous gastric samples cancerous gastric samples tissue Up 5.3 18723843 1715 ENOA_HUMAN ENSP00000234590 Gastric Cancer Normal vs. Cancer the adjacent noncancerous gastric samples cancerous gastric samples tissue Up 12 18723843 1716 KPYM_HUMAN ENSP00000334983 Gastric Cancer Normal vs. Cancer the adjacent noncancerous gastric samples cancerous gastric samples tissue Up 16 18723843 1717 LMNA_HUMAN ENSP00000357283 Gastric Cancer Cancer vs. Cancer (good vs. proo survival) Eight gastric cancer patients with relatively early TNM stage and survival time >34 months were identified as good survival (group G) the other eight with late stage and survival time <15 months as poor survival (group P) tissue Down 0.22 18830628 1718 K1C18_HUMAN ENSP00000373489 Gastric Cancer Cancer vs. Cancer (good vs. proo survival) Eight gastric cancer patients with relatively early TNM stage and survival time >34 months were identified as good survival (group G) the other eight with late stage and survival time <15 months as poor survival (group P) tissue Down 0.23 18830628 1719 K2C8_HUMAN ENSP00000293308 Gastric Cancer Cancer vs. Cancer (good vs. proo survival) Eight gastric cancer patients with relatively early TNM stage and survival time >34 months were identified as good survival (group G) the other eight with late stage and survival time <15 months as poor survival (group P) tissue Down 0.26 18830628 1720 MYH9_HUMAN ENSP00000216181 Gastric Cancer Cancer vs. Cancer (good vs. proo survival) Eight gastric cancer patients with relatively early TNM stage and survival time >34 months were identified as good survival (group G) the other eight with late stage and survival time <15 months as poor survival (group P) tissue Down 0.32 18830628 1721 ANXA1_HUMAN ENSP00000366109 Gastric Cancer Cancer vs. Cancer (good vs. proo survival) Eight gastric cancer patients with relatively early TNM stage and survival time >34 months were identified as good survival (group G) the other eight with late stage and survival time <15 months as poor survival (group P) tissue Down 0.38 18830628 1722 CNN1_HUMAN ENSP00000252456 Gastric Cancer Cancer vs. Cancer (good vs. proo survival) Eight gastric cancer patients with relatively early TNM stage and survival time >34 months were identified as good survival (group G) the other eight with late stage and survival time <15 months as poor survival (group P) tissue Up 3.3 18830628 1723 CALM_HUMAN ENSP00000375785 Gastric Cancer Cancer vs. Cancer (good vs. proo survival) Eight gastric cancer patients with relatively early TNM stage and survival time >34 months were identified as good survival (group G) the other eight with late stage and survival time <15 months as poor survival (group P) tissue Up 5 18830628 1724 S10A4_HUMAN ENSP00000357703 Gastric Cancer Cancer vs. Cancer (good vs. proo survival) Eight gastric cancer patients with relatively early TNM stage and survival time >34 months were identified as good survival (group G) the other eight with late stage and survival time <15 months as poor survival (group P) tissue Up 18830628 1725 ZN823_HUMAN ENSP00000340683 Gastric Cancer Normal vs. Cancer the paired norma1 gastric tissues from noncancerous regions stomach cancer tissues tissue Down 18837081 1726 AMPN_HUMAN ENSP00000300060 Gastric Cancer Normal vs. Cancer the matched nonmalignant gastric mucosa epithelial cells pooled laser capture microdissected GA cells tissue Down 0.22 19330469 1727 HSP7C_HUMAN ENSP00000227378 Gastric Cancer Normal vs. Cancer the matched nonmalignant gastric mucosa epithelial cells pooled laser capture microdissected GA cells tissue Down 0.23 19330469 1728 K1C18_HUMAN ENSP00000373489 Gastric Cancer Normal vs. Cancer the matched nonmalignant gastric mucosa epithelial cells pooled laser capture microdissected GA cells tissue Down 0.25 19330469 1729 TBAL3_HUMAN ENSP00000369784 Gastric Cancer Normal vs. Cancer the matched nonmalignant gastric mucosa epithelial cells pooled laser capture microdissected GA cells tissue Down 0.31 19330469 1730 HSP71_HUMAN ENSP00000364801 Gastric Cancer Normal vs. Cancer the matched nonmalignant gastric mucosa epithelial cells pooled laser capture microdissected GA cells tissue Down 0.31 19330469 1731 TBA1A_HUMAN ENSP00000301071 Gastric Cancer Normal vs. Cancer the matched nonmalignant gastric mucosa epithelial cells pooled laser capture microdissected GA cells tissue Down 0.34 19330469 1732 HS90A_HUMAN ENSP00000335153 Gastric Cancer Normal vs. Cancer the matched nonmalignant gastric mucosa epithelial cells pooled laser capture microdissected GA cells tissue Down 0.35 19330469 1733 PYGB_HUMAN ENSP00000216962 Gastric Cancer Normal vs. Cancer the matched nonmalignant gastric mucosa epithelial cells pooled laser capture microdissected GA cells tissue Down 0.41 19330469 1734 ANXA2_HUMAN ENSP00000411352 Gastric Cancer Normal vs. Cancer the matched nonmalignant gastric mucosa epithelial cells pooled laser capture microdissected GA cells tissue Down 0.43 19330469 1735 K2C8_HUMAN ENSP00000293308 Gastric Cancer Normal vs. Cancer the matched nonmalignant gastric mucosa epithelial cells pooled laser capture microdissected GA cells tissue Down 0.44 19330469 1736 A1AT_HUMAN ENSP00000348068 Gastric Cancer Normal vs. Cancer the matched nonmalignant gastric mucosa epithelial cells pooled laser capture microdissected GA cells tissue Down 0.45 19330469 1737 VIME_HUMAN ENSP00000224237 Gastric Cancer Normal vs. Cancer the matched nonmalignant gastric mucosa epithelial cells pooled laser capture microdissected GA cells tissue Down 0.46 19330469 1738 MOES_HUMAN ENSP00000353408 Gastric Cancer Normal vs. Cancer the matched nonmalignant gastric mucosa epithelial cells pooled laser capture microdissected GA cells tissue Down 0.46 19330469 1739 1433Z_HUMAN ENSP00000379288 Gastric Cancer Normal vs. Cancer the matched nonmalignant gastric mucosa epithelial cells pooled laser capture microdissected GA cells tissue Down 0.5 19330469 1740 PLAK_HUMAN ENSP00000377508 Gastric Cancer Normal vs. Cancer the matched nonmalignant gastric mucosa epithelial cells pooled laser capture microdissected GA cells tissue Up 2.2 19330469 1741 HCD2_HUMAN ENSP00000168216 Gastric Cancer Normal vs. Cancer the matched nonmalignant gastric mucosa epithelial cells pooled laser capture microdissected GA cells tissue Up 3.3 19330469 1742 K1C16_HUMAN ENSP00000301653 Gastric Cancer Normal vs. Cancer the matched nonmalignant gastric mucosa epithelial cells pooled laser capture microdissected GA cells tissue Up 4.3 19330469 1743 PEBP1_HUMAN ENSP00000261313 Gastric Cancer Normal vs. Cancer the matched nonmalignant gastric mucosa epithelial cells pooled laser capture microdissected GA cells tissue Up 4.4 19330469 1744 PIGR_HUMAN ENSP00000348888 Gastric Cancer Normal vs. Cancer the matched nonmalignant gastric mucosa epithelial cells pooled laser capture microdissected GA cells tissue Up 5.5 19330469 1745 ANXA1_HUMAN ENSP00000366109 Gastric Cancer Normal vs. Cancer the matched nonmalignant gastric mucosa epithelial cells pooled laser capture microdissected GA cells tissue Up 7 19330469 1746 ALBU_HUMAN ENSP00000295897 Gastric Cancer Normal vs. Cancer the margin tissue samples from non-cancerous regions human stomach tissue samples tissue Down 0.091 19424620 1747 ALBU_HUMAN ENSP00000295897 Gastric Cancer Normal vs. Cancer the margin tissue samples from non-cancerous regions human stomach tissue samples tissue Down 0.12 19424620 1748 PRDX5_HUMAN ENSP00000265462 Gastric Cancer Normal vs. Cancer the margin tissue samples from non-cancerous regions human stomach tissue samples tissue Down 0.38 19424620 1749 ZN160_HUMAN ENSP00000409597 Gastric Cancer Normal vs. Cancer the margin tissue samples from non-cancerous regions human stomach tissue samples tissue Down 0.55 19424620 1750 TBA1C_HUMAN ENSP00000301072 Gastric Cancer Normal vs. Cancer the margin tissue samples from non-cancerous regions human stomach tissue samples tissue Down 0.57 19424620 1751 APOA1_HUMAN ENSP00000236850 Gastric Cancer Normal vs. Cancer the margin tissue samples from non-cancerous regions human stomach tissue samples tissue Down 0.61 19424620 1752 THIO_HUMAN ENSP00000363641 Breast Cancer Metastasis breast cancer cell line MDA-MB 435 (435-P) 435-Liver metastasis cell line Down 0.22 18582095 1753 SODC_HUMAN ENSP00000270142 Breast Cancer Metastasis breast cancer cell line MDA-MB 435 (435-P) 435-Liver metastasis cell line Down 0.31 18582095 1754 IF6_HUMAN ENSP00000363574 Breast Cancer Metastasis breast cancer cell line MDA-MB 435 (435-P) 435-Liver metastasis cell line Down 0.37 18582095 1755 NACA_HUMAN ENSP00000377469 Breast Cancer Metastasis breast cancer cell line MDA-MB 435 (435-P) 435-Liver metastasis cell line Down 0.38 18582095 1756 CRK_HUMAN ENSP00000300574 Breast Cancer Metastasis breast cancer cell line MDA-MB 435 (435-P) 435-Liver metastasis cell line Up 1.4 18582095 1757 NACA_HUMAN ENSP00000377469 Breast Cancer Metastasis breast cancer cell line MDA-MB 435 (435-P) 435-Liver metastasis cell line Up 2 18582095 1758 NACA_HUMAN ENSP00000377469 Breast Cancer Metastasis breast cancer cell line MDA-MB 435 (435-P) 435-Liver metastasis cell line Up 2.4 18582095 1759 VIME_HUMAN ENSP00000224237 Breast Cancer Metastasis breast cancer cell line MDA-MB 435 (435-P) 435-Liver metastasis cell line Up 2.6 18582095 1760 HSPB1_HUMAN ENSP00000248553 Breast Cancer Metastasis breast cancer cell line MDA-MB 435 (435-P) 435-Liver metastasis cell line Up 3.4 18582095 1761 GSTP1_HUMAN ENSP00000381607 Breast Cancer Metastasis breast cancer cell line MDA-MB 435 (435-P) 435-Liver metastasis cell line Up 4.7 18582095 1762 SODC_HUMAN ENSP00000270142 Breast Cancer Metastasis breast cancer cell line MDA-MB 435 (435-P) 435-Liver metastasis cell line Up 5.7 18582095 1763 GSTP1_HUMAN ENSP00000381607 Breast Cancer Metastasis breast cancer cell line MDA-MB 435 (435-P) 435-Lung metastasis cell line Down 0.49 18582095 1764 NPM_HUMAN ENSP00000296930 Breast Cancer Metastasis breast cancer cell line MDA-MB 435 (435-P) 435-Lung metastasis cell line Down 0.64 18582095 1765 NPM_HUMAN ENSP00000296930 Breast Cancer Metastasis breast cancer cell line MDA-MB 435 (435-P) 435-Lung metastasis cell line Down 0.65 18582095 1766 TTC1_HUMAN ENSP00000231238 Breast Cancer Metastasis breast cancer cell line MDA-MB 435 (435-P) 435-Lung metastasis cell line Down 0.7 18582095 1767 VIME_HUMAN ENSP00000224237 Breast Cancer Metastasis breast cancer cell line MDA-MB 435 (435-P) 435-Lung metastasis cell line Down 0.73 18582095 1768 NPM_HUMAN ENSP00000296930 Breast Cancer Metastasis breast cancer cell line MDA-MB 435 (435-P) 435-Lung metastasis cell line Down 0.74 18582095 1769 EF1B_HUMAN ENSP00000376055 Breast Cancer Metastasis breast cancer cell line MDA-MB 435 (435-P) 435-Lung metastasis cell line Down 0.77 18582095 1770 PCNA_HUMAN ENSP00000368458 Breast Cancer Metastasis breast cancer cell line MDA-MB 435 (435-P) 435-Lung metastasis cell line Up 1.2 18582095 1771 CATD_HUMAN ENSP00000236671 Breast Cancer Metastasis breast cancer cell line MDA-MB 435 (435-P) 435-Lung metastasis cell line Up 1.3 18582095 1772 TBB5_HUMAN ENSP00000406811 Breast Cancer Metastasis breast cancer cell line MDA-MB 435 (435-P) 435-Lung metastasis cell line Up 1.3 18582095 1773 CALR_HUMAN ENSP00000320866 Breast Cancer Metastasis breast cancer cell line MDA-MB 435 (435-P) 435-Lung metastasis cell line Up 1.4 18582095 1774 RD23B_HUMAN ENSP00000350708 Breast Cancer Metastasis breast cancer cell line MDA-MB 435 (435-P) 435-Lung metastasis cell line Up 1.5 18582095 1775 VIME_HUMAN ENSP00000224237 Breast Cancer Metastasis breast cancer cell line MDA-MB 435 (435-P) 435-Lung metastasis cell line Up 1.5 18582095 1776 CALR_HUMAN ENSP00000320866 Breast Cancer Metastasis breast cancer cell line MDA-MB 435 (435-P) 435-Lung metastasis cell line Up 1.5 18582095 1777 SDC1_HUMAN ENSP00000370542 Breast Cancer Metastasis precancerous (MCF10AT1) malignant, metastatic cellular phenotype (MCF10CA1a) cell line Down 0.054 18729497 1778 4F2_HUMAN ENSP00000367124 Breast Cancer Metastasis precancerous (MCF10AT1) malignant, metastatic cellular phenotype (MCF10CA1a) cell line Down 0.43 18729497 1779 AMPN_HUMAN ENSP00000300060 Breast Cancer Metastasis precancerous (MCF10AT1) malignant, metastatic cellular phenotype (MCF10CA1a) cell line Down 18729497 1780 SDC4_HUMAN ENSP00000361818 Breast Cancer Metastasis precancerous (MCF10AT1) malignant, metastatic cellular phenotype (MCF10CA1a) cell line Down 18729497 1781 ENPL_HUMAN ENSP00000299767 Breast Cancer Metastasis precancerous (MCF10AT1) malignant, metastatic cellular phenotype (MCF10CA1a) cell line Up 2.9 18729497 1782 PLOD1_HUMAN ENSP00000196061 Breast Cancer Metastasis precancerous (MCF10AT1) malignant, metastatic cellular phenotype (MCF10CA1a) cell line Up 18729497 1783 ITA6_HUMAN ENSP00000341078 Breast Cancer Metastasis precancerous (MCF10AT1) malignant, metastatic cellular phenotype (MCF10CA1a) cell line Down 0.42 18729497 1784 4F2_HUMAN ENSP00000367124 Breast Cancer Metastasis precancerous (MCF10AT1) malignant, metastatic cellular phenotype (MCF10CA1a) cell line Down 0.45 18729497 1785 CADH1_HUMAN ENSP00000261769 Breast Cancer Metastasis precancerous (MCF10AT1) malignant, metastatic cellular phenotype (MCF10CA1a) cell line Down 18729497 1786 AMPN_HUMAN ENSP00000300060 Breast Cancer Metastasis precancerous (MCF10AT1) malignant, metastatic cellular phenotype (MCF10CA1a) cell line Down 18729497 1787 PLOD1_HUMAN ENSP00000196061 Breast Cancer Metastasis precancerous (MCF10AT1) malignant, metastatic cellular phenotype (MCF10CA1a) cell line Up 10 18729497 1788 ITB1_HUMAN ENSP00000379350 Breast Cancer Metastasis precancerous (MCF10AT1) malignant, metastatic cellular phenotype (MCF10CA1a) cell line Up 11 18729497 1789 1433S_HUMAN ENSP00000340989 Breast Cancer Normal vs. Cancer a normal human mammary epithelial cell (HMEC) 7 breast cancer cell lines,MDA-MB-231(metastatic), HCC1428, AU565, MDA-MB-468, SKBR-3, MCF7 and BT-474 cell line Down 0.14 18821527 1790 MMP1_HUMAN ENSP00000322788 Breast Cancer Normal vs. Cancer normal HTB-125 cell lines malignant HTB-126 breast cancer cells cell line Down 0.054 19053080 1791 MMP3_HUMAN ENSP00000299855 Breast Cancer Normal vs. Cancer normal HTB-125 cell lines malignant HTB-126 breast cancer cells cell line Down 0.062 19053080 1792 TIMP1_HUMAN ENSP00000218388 Breast Cancer Normal vs. Cancer normal HTB-125 cell lines malignant HTB-126 breast cancer cells cell line Down 0.27 19053080 1793 CO4A2_HUMAN ENSP00000353654 Breast Cancer Normal vs. Cancer normal HTB-125 cell lines malignant HTB-126 breast cancer cells cell line Up 3.2 19053080 1794 K2C8_HUMAN ENSP00000293308 Breast Cancer Treatment (TNF-a-sensitive vs. TNF-a-resistant ) TNF-a sensitive MCF-7 cell line MCF-7-VEC TNF-a resistant MCF-7 breast cancer cell line MCF-7-MEK5 cell line Down 19087274 1795 VIME_HUMAN ENSP00000224237 Breast Cancer Treatment (TNF-a-sensitive vs. TNF-a-resistant ) TNF-a sensitive MCF-7 cell line MCF-7-VEC TNF-a resistant MCF-7 breast cancer cell line MCF-7-MEK5 cell line Up 2.1 19087274 1796 GSTP1_HUMAN ENSP00000381607 Breast Cancer Treatment (TNF-a-sensitive vs. TNF-a-resistant ) TNF-a sensitive MCF-7 cell line MCF-7-VEC TNF-a resistant MCF-7 breast cancer cell line MCF-7-MEK5 cell line Up 5.4 19087274 1797 4F2_HUMAN ENSP00000367124 Breast Cancer Metastasis NM-2C5(not metastasis) M-4A4(established easily detectable metastases restricted to lymph nodes and lungs) cell line Down 0.5 19321434 1798 ICAM1_HUMAN ENSP00000264832 Breast Cancer Metastasis NM-2C5(not metastasis) M-4A4(established easily detectable metastases restricted to lymph nodes and lungs) cell line Up 2 19321434 1799 ITAV_HUMAN ENSP00000261023 Breast Cancer Metastasis NM-2C5(not metastasis) M-4A4(established easily detectable metastases restricted to lymph nodes and lungs) cell line Up 2 19321434 1800 ANXA2_HUMAN ENSP00000411352 Breast Cancer Metastasis NM-2C5(not metastasis) M-4A4(established easily detectable metastases restricted to lymph nodes and lungs) cell line Up 2 19321434 1801 DRA_HUMAN ENSP00000372746 Breast Cancer Metastasis NM-2C5(not metastasis) M-4A4(established easily detectable metastases restricted to lymph nodes and lungs) cell line Up >5 19321434 1802 ITB1_HUMAN ENSP00000379350 Breast Cancer Metastasis NM-2C5(not metastasis) M-4A4(established easily detectable metastases restricted to lymph nodes and lungs) cell line Up 2.0-5.1 19321434 1803 ITA6_HUMAN ENSP00000341078 Breast Cancer Metastasis NM-2C5(not metastasis) M-4A4(established easily detectable metastases restricted to lymph nodes and lungs) cell line Up 2.0-5.3 19321434 1804 NDRG1_HUMAN ENSP00000404854 Breast Cancer Metastasis NM-2C5(not metastasis) M-4A4(established easily detectable metastases restricted to lymph nodes and lungs) cell line Up 2.0-5.5 19321434 1805 NHRF1_HUMAN ENSP00000262613 Breast Cancer Treatment (tamoxifen-sensitive vs. tamoxifen-resistant) tumors were sensitive to tamoxifen therapy tumors were resistant to therapy tissue Down 0.41 19329653 1806 GFPT1_HUMAN ENSP00000349860 Breast Cancer Treatment (tamoxifen-sensitive vs. tamoxifen-resistant) tumors were sensitive to tamoxifen therapy tumors were resistant to therapy tissue Down 0.42 19329653 1807 PDC6I_HUMAN ENSP00000307387 Breast Cancer Treatment (tamoxifen-sensitive vs. tamoxifen-resistant) tumors were sensitive to tamoxifen therapy tumors were resistant to therapy tissue Down 0.45 19329653 1808 LSR_HUMAN ENSP00000354575 Breast Cancer Treatment (tamoxifen-sensitive vs. tamoxifen-resistant) tumors were sensitive to tamoxifen therapy tumors were resistant to therapy tissue Down 0.46 19329653 1809 NACA_HUMAN ENSP00000377469 Breast Cancer Treatment (tamoxifen-sensitive vs. tamoxifen-resistant) tumors were sensitive to tamoxifen therapy tumors were resistant to therapy tissue Down 0.46 19329653 1810 KAD2_HUMAN ENSP00000346921 Breast Cancer Treatment (tamoxifen-sensitive vs. tamoxifen-resistant) tumors were sensitive to tamoxifen therapy tumors were resistant to therapy tissue Down 0.49 19329653 1811 TBA4A_HUMAN ENSP00000248437 Breast Cancer Treatment (tamoxifen-sensitive vs. tamoxifen-resistant) tumors were sensitive to tamoxifen therapy tumors were resistant to therapy tissue Down 0.51 19329653 1812 EPCR_HUMAN ENSP00000216968 Breast Cancer Treatment (tamoxifen-sensitive vs. tamoxifen-resistant) tumors were sensitive to tamoxifen therapy tumors were resistant to therapy tissue Down 0.52 19329653 1813 TBB3_HUMAN ENSP00000320295 Breast Cancer Treatment (tamoxifen-sensitive vs. tamoxifen-resistant) tumors were sensitive to tamoxifen therapy tumors were resistant to therapy tissue Down 0.52 19329653 1814 OCLN_HUMAN ENSP00000379719 Breast Cancer Treatment (tamoxifen-sensitive vs. tamoxifen-resistant) tumors were sensitive to tamoxifen therapy tumors were resistant to therapy tissue Down 0.54 19329653 1815 NP1L1_HUMAN ENSP00000376947 Breast Cancer Treatment (tamoxifen-sensitive vs. tamoxifen-resistant) tumors were sensitive to tamoxifen therapy tumors were resistant to therapy tissue Down 0.54 19329653 1816 4F2_HUMAN ENSP00000367124 Breast Cancer Treatment (tamoxifen-sensitive vs. tamoxifen-resistant) tumors were sensitive to tamoxifen therapy tumors were resistant to therapy tissue Up 1.8 19329653 1817 EPHA2_HUMAN ENSP00000351209 Breast Cancer Treatment (tamoxifen-sensitive vs. tamoxifen-resistant) tumors were sensitive to tamoxifen therapy tumors were resistant to therapy tissue Up 2 19329653 1818 IF5_HUMAN ENSP00000376477 Breast Cancer Treatment (tamoxifen-sensitive vs. tamoxifen-resistant) tumors were sensitive to tamoxifen therapy tumors were resistant to therapy tissue Up 2 19329653 1819 EPHB2_HUMAN ENSP00000383053 Breast Cancer Treatment (tamoxifen-sensitive vs. tamoxifen-resistant) tumors were sensitive to tamoxifen therapy tumors were resistant to therapy tissue Up 2.2 19329653 1820 EPHB3_HUMAN ENSP00000332118 Breast Cancer Treatment (tamoxifen-sensitive vs. tamoxifen-resistant) tumors were sensitive to tamoxifen therapy tumors were resistant to therapy tissue Up 2.2 19329653 1821 COR1B_HUMAN ENSP00000377471 Breast Cancer Treatment (tamoxifen-sensitive vs. tamoxifen-resistant) tumors were sensitive to tamoxifen therapy tumors were resistant to therapy tissue Up 2.4 19329653 1822 ANT3_HUMAN ENSP00000356671 breast ductal carcinoma Metastasis Serum samples from patients with lymph node-negative invasive ductal carcinoma of the breast [IDCB-LN(-)] Serum samples from patients with lymph nodepositive invasive ductal carcinoma of the breast [IDCBLN(+)] tissue Up 19624269 1823 FA10_HUMAN ENSP00000364709 breast ductal carcinoma Normal vs. Cancer Serum samples from patients with benign breast diseases (BBD) Serum samples from patients with lymph node-negative invasive ductal carcinoma of the breast [IDCB-LN(-)] tissue Down 19624269 1824 THRB_HUMAN ENSP00000308541 breast ductal carcinoma Metastasis Serum samples from patients with lymph node-negative invasive ductal carcinoma of the breast [IDCB-LN(-)] Serum samples from patients with lymph nodepositive invasive ductal carcinoma of the breast [IDCBLN(+)] tissue Down 19624269 1825 COMP_HUMAN ENSP00000222271 breast ductal carcinoma Metastasis Serum samples from patients with lymph node-negative invasive ductal carcinoma of the breast [IDCB-LN(-)] Serum samples from patients with lymph nodepositive invasive ductal carcinoma of the breast [IDCBLN(+)] tissue Down 19624269 1826 CO5_HUMAN ENSP00000223642 breast ductal carcinoma Metastasis Serum samples from patients with lymph node-negative invasive ductal carcinoma of the breast [IDCB-LN(-)] Serum samples from patients with lymph nodepositive invasive ductal carcinoma of the breast [IDCBLN(+)] tissue Up 19624269 1827 FIBA_HUMAN ENSP00000306361 breast ductal carcinoma Metastasis Serum samples from patients with lymph node-negative invasive ductal carcinoma of the breast [IDCB-LN(-)] Serum samples from patients with lymph nodepositive invasive ductal carcinoma of the breast [IDCBLN(+)] tissue Up 19624269 1828 CATD_HUMAN ENSP00000236671 Breast Cancer Normal vs. Cancer normal interstitial fluids (NIF) from prospective breast cancer patients tumour interstitial fluids (TIF) from prospective breast cancer patients tissue Up 2 20005186 1829 HS90B_HUMAN ENSP00000360609 Breast Cancer Normal vs. Cancer normal interstitial fluids (NIF) from prospective breast cancer patients tumour interstitial fluids (TIF) from prospective breast cancer patients tissue Up 2.2 20005186 1830 PARK7_HUMAN ENSP00000366708 Breast Cancer Normal vs. Cancer normal interstitial fluids (NIF) from prospective breast cancer patients tumour interstitial fluids (TIF) from prospective breast cancer patients tissue Up 2.2 20005186 1831 DPYL2_HUMAN ENSP00000309539 Breast Cancer Normal vs. Cancer normal interstitial fluids (NIF) from prospective breast cancer patients tumour interstitial fluids (TIF) from prospective breast cancer patients tissue Up 2.3 20005186 1832 GSTP1_HUMAN ENSP00000381607 Breast Cancer Normal vs. Cancer normal interstitial fluids (NIF) from prospective breast cancer patients tumour interstitial fluids (TIF) from prospective breast cancer patients tissue Up 2.4 20005186 1833 PA2G4_HUMAN ENSP00000302886 Breast Cancer Normal vs. Cancer normal interstitial fluids (NIF) from prospective breast cancer patients tumour interstitial fluids (TIF) from prospective breast cancer patients tissue Up 2.4 20005186 1834 CLIC1_HUMAN ENSP00000379229 Breast Cancer Normal vs. Cancer normal interstitial fluids (NIF) from prospective breast cancer patients tumour interstitial fluids (TIF) from prospective breast cancer patients tissue Up 2.5 20005186 1835 FLNA_HUMAN ENSP00000358866 Breast Cancer Normal vs. Cancer normal interstitial fluids (NIF) from prospective breast cancer patients tumour interstitial fluids (TIF) from prospective breast cancer patients tissue Up 2.5 20005186 1836 SYWC_HUMAN ENSP00000347495 Breast Cancer Normal vs. Cancer normal interstitial fluids (NIF) from prospective breast cancer patients tumour interstitial fluids (TIF) from prospective breast cancer patients tissue Up 2.6 20005186 1837 1433E_HUMAN ENSP00000264335 Breast Cancer Normal vs. Cancer normal interstitial fluids (NIF) from prospective breast cancer patients tumour interstitial fluids (TIF) from prospective breast cancer patients tissue Up 2.9 20005186 1838 CALR_HUMAN ENSP00000320866 Breast Cancer Normal vs. Cancer normal interstitial fluids (NIF) from prospective breast cancer patients tumour interstitial fluids (TIF) from prospective breast cancer patients tissue Up 3.1 20005186 1839 THIO_HUMAN ENSP00000363641 Breast Cancer Normal vs. Cancer normal interstitial fluids (NIF) from prospective breast cancer patients tumour interstitial fluids (TIF) from prospective breast cancer patients tissue Up 3.3 20005186 1840 1433Z_HUMAN ENSP00000379288 Breast Cancer Normal vs. Cancer normal interstitial fluids (NIF) from prospective breast cancer patients tumour interstitial fluids (TIF) from prospective breast cancer patients tissue Up 3.3 20005186 1841 PRDX1_HUMAN ENSP00000262746 Breast Cancer Normal vs. Cancer normal interstitial fluids (NIF) from prospective breast cancer patients tumour interstitial fluids (TIF) from prospective breast cancer patients tissue Up 3.3 20005186 1842 S10AB_HUMAN ENSP00000271638 Breast Cancer Normal vs. Cancer normal interstitial fluids (NIF) from prospective breast cancer patients tumour interstitial fluids (TIF) from prospective breast cancer patients tissue Up 3.4 20005186 1843 SPB5_HUMAN ENSP00000372221 Breast Cancer Normal vs. Cancer normal interstitial fluids (NIF) from prospective breast cancer patients tumour interstitial fluids (TIF) from prospective breast cancer patients tissue Up 3.4 20005186 1844 GDIB_HUMAN ENSP00000369538 Breast Cancer Normal vs. Cancer normal interstitial fluids (NIF) from prospective breast cancer patients tumour interstitial fluids (TIF) from prospective breast cancer patients tissue Up 3.6 20005186 1845 TPIS_HUMAN ENSP00000379933 Breast Cancer Normal vs. Cancer normal interstitial fluids (NIF) from prospective breast cancer patients tumour interstitial fluids (TIF) from prospective breast cancer patients tissue Up 3.6 20005186 1846 1433Z_HUMAN ENSP00000379288 Breast Cancer Normal vs. Cancer normal interstitial fluids (NIF) from prospective breast cancer patients tumour interstitial fluids (TIF) from prospective breast cancer patients tissue Up 3.8 20005186 1847 STIP1_HUMAN ENSP00000305958 Breast Cancer Normal vs. Cancer normal interstitial fluids (NIF) from prospective breast cancer patients tumour interstitial fluids (TIF) from prospective breast cancer patients tissue Up 4.2 20005186 1848 EF1B_HUMAN ENSP00000376055 Breast Cancer Normal vs. Cancer normal interstitial fluids (NIF) from prospective breast cancer patients tumour interstitial fluids (TIF) from prospective breast cancer patients tissue Up 4.4 20005186 1849 ACTN4_HUMAN ENSP00000252699 Breast Cancer Normal vs. Cancer normal interstitial fluids (NIF) from prospective breast cancer patients tumour interstitial fluids (TIF) from prospective breast cancer patients tissue Up 4.8 20005186 1850 GDIB_HUMAN ENSP00000369538 Breast Cancer Normal vs. Cancer normal interstitial fluids (NIF) from prospective breast cancer patients tumour interstitial fluids (TIF) from prospective breast cancer patients tissue Up 4.9 20005186 1851 PGAM1_HUMAN ENSP00000359991 Breast Cancer Normal vs. Cancer normal interstitial fluids (NIF) from prospective breast cancer patients tumour interstitial fluids (TIF) from prospective breast cancer patients tissue Up 5.7 20005186 1852 FLNA_HUMAN ENSP00000358866 Breast Cancer Normal vs. Cancer normal interstitial fluids (NIF) from prospective breast cancer patients tumour interstitial fluids (TIF) from prospective breast cancer patients tissue Up 5.8 20005186 1853 UBA1_HUMAN ENSP00000338413 Breast Cancer Normal vs. Cancer normal interstitial fluids (NIF) from prospective breast cancer patients tumour interstitial fluids (TIF) from prospective breast cancer patients tissue Up 6.1 20005186 1854 SYWC_HUMAN ENSP00000347495 Breast Cancer Normal vs. Cancer normal interstitial fluids (NIF) from prospective breast cancer patients tumour interstitial fluids (TIF) from prospective breast cancer patients tissue Up 6.1 20005186 1855 EF2_HUMAN ENSP00000307940 Breast Cancer Normal vs. Cancer normal interstitial fluids (NIF) from prospective breast cancer patients tumour interstitial fluids (TIF) from prospective breast cancer patients tissue Up 6.2 20005186 1856 RAN_HUMAN ENSP00000376176 Breast Cancer Normal vs. Cancer normal interstitial fluids (NIF) from prospective breast cancer patients tumour interstitial fluids (TIF) from prospective breast cancer patients tissue Up 6.7 20005186 1857 UBA1_HUMAN ENSP00000338413 Breast Cancer Normal vs. Cancer normal interstitial fluids (NIF) from prospective breast cancer patients tumour interstitial fluids (TIF) from prospective breast cancer patients tissue Up 7.7 20005186 1858 IPYR_HUMAN ENSP00000362329 Breast Cancer Normal vs. Cancer normal interstitial fluids (NIF) from prospective breast cancer patients tumour interstitial fluids (TIF) from prospective breast cancer patients tissue Up 9.8 20005186 1859 VIME_HUMAN ENSP00000224237 Breast Cancer Normal vs. Cancer normal interstitial fluids (NIF) from prospective breast cancer patients tumour interstitial fluids (TIF) from prospective breast cancer patients tissue Up >10 20005186 1860 RSSA_HUMAN ENSP00000346067 Breast Cancer Normal vs. Cancer normal interstitial fluids (NIF) from prospective breast cancer patients tumour interstitial fluids (TIF) from prospective breast cancer patients tissue Up >10 20005186 1861 PCNA_HUMAN ENSP00000368458 Breast Cancer Normal vs. Cancer normal interstitial fluids (NIF) from prospective breast cancer patients tumour interstitial fluids (TIF) from prospective breast cancer patients tissue Up >10 20005186 1862 TPIS_HUMAN ENSP00000379933 Breast Cancer Normal vs. Cancer normal interstitial fluids (NIF) from prospective breast cancer patients tumour interstitial fluids (TIF) from prospective breast cancer patients tissue Up >10 20005186 1863 ACTB_HUMAN ENSP00000349960 Breast Cancer Normal vs. Cancer normal interstitial fluids (NIF) from prospective breast cancer patients tumour interstitial fluids (TIF) from prospective breast cancer patients tissue Up >10 20005186 1864 TAGL_HUMAN ENSP00000278968 Breast Cancer Normal vs. Cancer normal interstitial fluids (NIF) from prospective breast cancer patients tumour interstitial fluids (TIF) from prospective breast cancer patients tissue Up >10 20005186 1865 IPYR_HUMAN ENSP00000362329 Breast Cancer Normal vs. Cancer normal interstitial fluids (NIF) from prospective breast cancer patients tumour interstitial fluids (TIF) from prospective breast cancer patients tissue Up >10 20005186 1866 SPB5_HUMAN ENSP00000372221 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Secretomes] noninvasive breast cancer cells (MCF-7) [Secretomes] cell line Down 0.06 20052998 1867 GSTP1_HUMAN ENSP00000381607 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Secretomes] noninvasive breast cancer cells (MCF-7) [Secretomes] cell line Down 0.076 20052998 1868 PAI1_HUMAN ENSP00000223095 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Secretomes] noninvasive breast cancer cells (MCF-7) [Secretomes] cell line Down 0.091 20052998 1869 GSTP1_HUMAN ENSP00000381607 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Secretomes] noninvasive breast cancer cells (MCF-7) [Secretomes] cell line Down 0.18 20052998 1870 SODM_HUMAN ENSP00000337127 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Secretomes] noninvasive breast cancer cells (MCF-7) [Secretomes] cell line Down 0.23 20052998 1871 MOES_HUMAN ENSP00000353408 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Secretomes] noninvasive breast cancer cells (MCF-7) [Secretomes] cell line Down 0.33 20052998 1872 ENOA_HUMAN ENSP00000234590 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Secretomes] noninvasive breast cancer cells (MCF-7) [Secretomes] cell line Down 0.39 20052998 1873 1433Z_HUMAN ENSP00000379288 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Secretomes] noninvasive breast cancer cells (MCF-7) [Secretomes] cell line Down 0.44 20052998 1874 G3P_HUMAN ENSP00000380068 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Secretomes] noninvasive breast cancer cells (MCF-7) [Secretomes] cell line Down 0.58 20052998 1875 TERA_HUMAN ENSP00000351777 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Secretomes] noninvasive breast cancer cells (MCF-7) [Secretomes] cell line Down 0.76 20052998 1876 PGAM1_HUMAN ENSP00000359991 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Secretomes] noninvasive breast cancer cells (MCF-7) [Secretomes] cell line Down 0.83 20052998 1877 BPNT1_HUMAN ENSP00000318852 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Secretomes] noninvasive breast cancer cells (MCF-7) [Secretomes] cell line Up 1.2 20052998 1878 GDIB_HUMAN ENSP00000369538 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Secretomes] noninvasive breast cancer cells (MCF-7) [Secretomes] cell line Up 1.2 20052998 1879 PEBP1_HUMAN ENSP00000261313 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Secretomes] noninvasive breast cancer cells (MCF-7) [Secretomes] cell line Up 1.5 20052998 1880 CDN1B_HUMAN ENSP00000228872 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Secretomes] noninvasive breast cancer cells (MCF-7) [Secretomes] cell line Up 1.6 20052998 1881 NAR4_HUMAN ENSP00000228936 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Secretomes] noninvasive breast cancer cells (MCF-7) [Secretomes] cell line Up 1.8 20052998 1882 PRDX1_HUMAN ENSP00000262746 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Secretomes] noninvasive breast cancer cells (MCF-7) [Secretomes] cell line Up 2.1 20052998 1883 ACTB_HUMAN ENSP00000349960 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Secretomes] noninvasive breast cancer cells (MCF-7) [Secretomes] cell line Up 2.2 20052998 1884 HSPB1_HUMAN ENSP00000248553 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Secretomes] noninvasive breast cancer cells (MCF-7) [Secretomes] cell line Up 2.4 20052998 1885 ACTB_HUMAN ENSP00000349960 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Secretomes] noninvasive breast cancer cells (MCF-7) [Secretomes] cell line Up 2.6 20052998 1886 HSPB1_HUMAN ENSP00000248553 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Secretomes] noninvasive breast cancer cells (MCF-7) [Secretomes] cell line Up 3.4 20052998 1887 MERL_HUMAN ENSP00000344666 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Secretomes] noninvasive breast cancer cells (MCF-7) [Secretomes] cell line Up 4.8 20052998 1888 SPB5_HUMAN ENSP00000372221 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Secretomes] invasive breast cancer cells (MB-MDA-231) [Secretomes] cell line Down 0.046 20052998 1889 GSTP1_HUMAN ENSP00000381607 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Secretomes] invasive breast cancer cells (MB-MDA-231) [Secretomes] cell line Down 0.075 20052998 1890 PAI1_HUMAN ENSP00000223095 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Secretomes] invasive breast cancer cells (MB-MDA-231) [Secretomes] cell line Down 0.11 20052998 1891 GSTP1_HUMAN ENSP00000381607 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Secretomes] invasive breast cancer cells (MB-MDA-231) [Secretomes] cell line Down 0.22 20052998 1892 1433Z_HUMAN ENSP00000379288 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Secretomes] invasive breast cancer cells (MB-MDA-231) [Secretomes] cell line Down 0.23 20052998 1893 HSPB1_HUMAN ENSP00000248553 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Secretomes] invasive breast cancer cells (MB-MDA-231) [Secretomes] cell line Down 0.35 20052998 1894 SODM_HUMAN ENSP00000337127 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Secretomes] invasive breast cancer cells (MB-MDA-231) [Secretomes] cell line Down 0.58 20052998 1895 HSPB1_HUMAN ENSP00000248553 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Secretomes] invasive breast cancer cells (MB-MDA-231) [Secretomes] cell line Down 0.67 20052998 1896 G3P_HUMAN ENSP00000380068 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Secretomes] invasive breast cancer cells (MB-MDA-231) [Secretomes] cell line Down 0.89 20052998 1897 ACTB_HUMAN ENSP00000349960 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Secretomes] invasive breast cancer cells (MB-MDA-231) [Secretomes] cell line Down 0.96 20052998 1898 ACTB_HUMAN ENSP00000349960 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Secretomes] invasive breast cancer cells (MB-MDA-231) [Secretomes] cell line Up 1.2 20052998 1899 PEBP1_HUMAN ENSP00000261313 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Secretomes] invasive breast cancer cells (MB-MDA-231) [Secretomes] cell line Up 1.3 20052998 1900 PRDX1_HUMAN ENSP00000262746 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Secretomes] invasive breast cancer cells (MB-MDA-231) [Secretomes] cell line Up 1.3 20052998 1901 TERA_HUMAN ENSP00000351777 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Secretomes] invasive breast cancer cells (MB-MDA-231) [Secretomes] cell line Up 1.4 20052998 1902 MERL_HUMAN ENSP00000344666 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Secretomes] invasive breast cancer cells (MB-MDA-231) [Secretomes] cell line Up 1.5 20052998 1903 GDIB_HUMAN ENSP00000369538 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Secretomes] invasive breast cancer cells (MB-MDA-231) [Secretomes] cell line Up 1.7 20052998 1904 ENOA_HUMAN ENSP00000234590 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Secretomes] invasive breast cancer cells (MB-MDA-231) [Secretomes] cell line Up 1.9 20052998 1905 NAR4_HUMAN ENSP00000228936 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Secretomes] invasive breast cancer cells (MB-MDA-231) [Secretomes] cell line Up 1.9 20052998 1906 MOES_HUMAN ENSP00000353408 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Secretomes] invasive breast cancer cells (MB-MDA-231) [Secretomes] cell line Up 1.9 20052998 1907 BPNT1_HUMAN ENSP00000318852 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Secretomes] invasive breast cancer cells (MB-MDA-231) [Secretomes] cell line Up 2.9 20052998 1908 CDN1B_HUMAN ENSP00000228872 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Secretomes] invasive breast cancer cells (MB-MDA-231) [Secretomes] cell line Up 3.4 20052998 1909 PGAM1_HUMAN ENSP00000359991 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Secretomes] invasive breast cancer cells (MB-MDA-231) [Secretomes] cell line Up 4.8 20052998 1910 HSPB1_HUMAN ENSP00000248553 Breast Cancer Metastasis noninvasive breast cancer cells (MCF-7) [Secretomes] invasive breast cancer cells (MB-MDA-231) [Secretomes] cell line Down 0.15 20052998 1911 HSPB1_HUMAN ENSP00000248553 Breast Cancer Metastasis noninvasive breast cancer cells (MCF-7) [Secretomes] invasive breast cancer cells (MB-MDA-231) [Secretomes] cell line Down 0.2 20052998 1912 MERL_HUMAN ENSP00000344666 Breast Cancer Metastasis noninvasive breast cancer cells (MCF-7) [Secretomes] invasive breast cancer cells (MB-MDA-231) [Secretomes] cell line Down 0.33 20052998 1913 ACTB_HUMAN ENSP00000349960 Breast Cancer Metastasis noninvasive breast cancer cells (MCF-7) [Secretomes] invasive breast cancer cells (MB-MDA-231) [Secretomes] cell line Down 0.44 20052998 1914 ACTB_HUMAN ENSP00000349960 Breast Cancer Metastasis noninvasive breast cancer cells (MCF-7) [Secretomes] invasive breast cancer cells (MB-MDA-231) [Secretomes] cell line Down 0.47 20052998 1915 1433Z_HUMAN ENSP00000379288 Breast Cancer Metastasis noninvasive breast cancer cells (MCF-7) [Secretomes] invasive breast cancer cells (MB-MDA-231) [Secretomes] cell line Down 0.54 20052998 1916 PRDX1_HUMAN ENSP00000262746 Breast Cancer Metastasis noninvasive breast cancer cells (MCF-7) [Secretomes] invasive breast cancer cells (MB-MDA-231) [Secretomes] cell line Down 0.62 20052998 1917 SPB5_HUMAN ENSP00000372221 Breast Cancer Metastasis noninvasive breast cancer cells (MCF-7) [Secretomes] invasive breast cancer cells (MB-MDA-231) [Secretomes] cell line Down 0.8 20052998 1918 PEBP1_HUMAN ENSP00000261313 Breast Cancer Metastasis noninvasive breast cancer cells (MCF-7) [Secretomes] invasive breast cancer cells (MB-MDA-231) [Secretomes] cell line Down 0.85 20052998 1919 GSTP1_HUMAN ENSP00000381607 Breast Cancer Metastasis noninvasive breast cancer cells (MCF-7) [Secretomes] invasive breast cancer cells (MB-MDA-231) [Secretomes] cell line Up 1 20052998 1920 NAR4_HUMAN ENSP00000228936 Breast Cancer Metastasis noninvasive breast cancer cells (MCF-7) [Secretomes] invasive breast cancer cells (MB-MDA-231) [Secretomes] cell line Up 1.1 20052998 1921 PAI1_HUMAN ENSP00000223095 Breast Cancer Metastasis noninvasive breast cancer cells (MCF-7) [Secretomes] invasive breast cancer cells (MB-MDA-231) [Secretomes] cell line Up 1.3 20052998 1922 GSTP1_HUMAN ENSP00000381607 Breast Cancer Metastasis noninvasive breast cancer cells (MCF-7) [Secretomes] invasive breast cancer cells (MB-MDA-231) [Secretomes] cell line Up 1.3 20052998 1923 GDIB_HUMAN ENSP00000369538 Breast Cancer Metastasis noninvasive breast cancer cells (MCF-7) [Secretomes] invasive breast cancer cells (MB-MDA-231) [Secretomes] cell line Up 1.4 20052998 1924 G3P_HUMAN ENSP00000380068 Breast Cancer Metastasis noninvasive breast cancer cells (MCF-7) [Secretomes] invasive breast cancer cells (MB-MDA-231) [Secretomes] cell line Up 1.6 20052998 1925 TERA_HUMAN ENSP00000351777 Breast Cancer Metastasis noninvasive breast cancer cells (MCF-7) [Secretomes] invasive breast cancer cells (MB-MDA-231) [Secretomes] cell line Up 1.8 20052998 1926 CDN1B_HUMAN ENSP00000228872 Breast Cancer Metastasis noninvasive breast cancer cells (MCF-7) [Secretomes] invasive breast cancer cells (MB-MDA-231) [Secretomes] cell line Up 2.1 20052998 1927 BPNT1_HUMAN ENSP00000318852 Breast Cancer Metastasis noninvasive breast cancer cells (MCF-7) [Secretomes] invasive breast cancer cells (MB-MDA-231) [Secretomes] cell line Up 2.6 20052998 1928 SODM_HUMAN ENSP00000337127 Breast Cancer Metastasis noninvasive breast cancer cells (MCF-7) [Secretomes] invasive breast cancer cells (MB-MDA-231) [Secretomes] cell line Up 2.6 20052998 1929 ENOA_HUMAN ENSP00000234590 Breast Cancer Metastasis noninvasive breast cancer cells (MCF-7) [Secretomes] invasive breast cancer cells (MB-MDA-231) [Secretomes] cell line Up 4.9 20052998 1930 PGAM1_HUMAN ENSP00000359991 Breast Cancer Metastasis noninvasive breast cancer cells (MCF-7) [Secretomes] invasive breast cancer cells (MB-MDA-231) [Secretomes] cell line Up 5.9 20052998 1931 MOES_HUMAN ENSP00000353408 Breast Cancer Metastasis noninvasive breast cancer cells (MCF-7) [Secretomes] invasive breast cancer cells (MB-MDA-231) [Secretomes] cell line Up 6 20052998 1932 GSTP1_HUMAN ENSP00000381607 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Total Cell Proteomes] noninvasive breast cancer cells (MCF-7) [Total Cell Proteomes] cell line Down 0.036 20052998 1933 GSTP1_HUMAN ENSP00000381607 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Total Cell Proteomes] noninvasive breast cancer cells (MCF-7) [Total Cell Proteomes] cell line Down 0.058 20052998 1934 SPB5_HUMAN ENSP00000372221 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Total Cell Proteomes] noninvasive breast cancer cells (MCF-7) [Total Cell Proteomes] cell line Down 0.093 20052998 1935 ANXA2_HUMAN ENSP00000411352 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Total Cell Proteomes] noninvasive breast cancer cells (MCF-7) [Total Cell Proteomes] cell line Down 0.12 20052998 1936 ANXA2_HUMAN ENSP00000411352 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Total Cell Proteomes] noninvasive breast cancer cells (MCF-7) [Total Cell Proteomes] cell line Down 0.18 20052998 1937 ANXA1_HUMAN ENSP00000366109 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Total Cell Proteomes] noninvasive breast cancer cells (MCF-7) [Total Cell Proteomes] cell line Down 0.25 20052998 1938 VIME_HUMAN ENSP00000224237 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Total Cell Proteomes] noninvasive breast cancer cells (MCF-7) [Total Cell Proteomes] cell line Down 0.27 20052998 1939 VIME_HUMAN ENSP00000224237 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Total Cell Proteomes] noninvasive breast cancer cells (MCF-7) [Total Cell Proteomes] cell line Down 0.28 20052998 1940 1433E_HUMAN ENSP00000264335 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Total Cell Proteomes] noninvasive breast cancer cells (MCF-7) [Total Cell Proteomes] cell line Down 0.3 20052998 1941 HNRPK_HUMAN ENSP00000365440 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Total Cell Proteomes] noninvasive breast cancer cells (MCF-7) [Total Cell Proteomes] cell line Down 0.38 20052998 1942 SUMO3_HUMAN ENSP00000330343 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Total Cell Proteomes] noninvasive breast cancer cells (MCF-7) [Total Cell Proteomes] cell line Down 0.38 20052998 1943 MOES_HUMAN ENSP00000353408 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Total Cell Proteomes] noninvasive breast cancer cells (MCF-7) [Total Cell Proteomes] cell line Down 0.43 20052998 1944 UBE2N_HUMAN ENSP00000316176 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Total Cell Proteomes] noninvasive breast cancer cells (MCF-7) [Total Cell Proteomes] cell line Down 0.44 20052998 1945 STIP1_HUMAN ENSP00000305958 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Total Cell Proteomes] noninvasive breast cancer cells (MCF-7) [Total Cell Proteomes] cell line Down 0.45 20052998 1946 NEK7_HUMAN ENSP00000356353 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Total Cell Proteomes] noninvasive breast cancer cells (MCF-7) [Total Cell Proteomes] cell line Down 0.47 20052998 1947 1433Z_HUMAN ENSP00000379288 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Total Cell Proteomes] noninvasive breast cancer cells (MCF-7) [Total Cell Proteomes] cell line Down 0.51 20052998 1948 NDKA_HUMAN ENSP00000013034 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Total Cell Proteomes] noninvasive breast cancer cells (MCF-7) [Total Cell Proteomes] cell line Down 0.54 20052998 1949 KPYM_HUMAN ENSP00000334983 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Total Cell Proteomes] noninvasive breast cancer cells (MCF-7) [Total Cell Proteomes] cell line Down 0.56 20052998 1950 VDAC1_HUMAN ENSP00000378487 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Total Cell Proteomes] noninvasive breast cancer cells (MCF-7) [Total Cell Proteomes] cell line Down 0.61 20052998 1951 CLIC1_HUMAN ENSP00000379229 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Total Cell Proteomes] noninvasive breast cancer cells (MCF-7) [Total Cell Proteomes] cell line Down 0.88 20052998 1952 ACOC_HUMAN ENSP00000369255 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Total Cell Proteomes] noninvasive breast cancer cells (MCF-7) [Total Cell Proteomes] cell line Up 1.2 20052998 1953 ENOA_HUMAN ENSP00000234590 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Total Cell Proteomes] noninvasive breast cancer cells (MCF-7) [Total Cell Proteomes] cell line Up 1.3 20052998 1954 COF1_HUMAN ENSP00000309629 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Total Cell Proteomes] noninvasive breast cancer cells (MCF-7) [Total Cell Proteomes] cell line Up 1.3 20052998 1955 TPIS_HUMAN ENSP00000379933 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Total Cell Proteomes] noninvasive breast cancer cells (MCF-7) [Total Cell Proteomes] cell line Up 1.5 20052998 1956 GDIB_HUMAN ENSP00000369538 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Total Cell Proteomes] noninvasive breast cancer cells (MCF-7) [Total Cell Proteomes] cell line Up 1.5 20052998 1957 TPIS_HUMAN ENSP00000379933 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Total Cell Proteomes] noninvasive breast cancer cells (MCF-7) [Total Cell Proteomes] cell line Up 1.6 20052998 1958 EF2_HUMAN ENSP00000307940 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Total Cell Proteomes] noninvasive breast cancer cells (MCF-7) [Total Cell Proteomes] cell line Up 1.6 20052998 1959 TEBP_HUMAN ENSP00000262033 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Total Cell Proteomes] noninvasive breast cancer cells (MCF-7) [Total Cell Proteomes] cell line Up 1.6 20052998 1960 ML12B_HUMAN ENSP00000383037 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Total Cell Proteomes] noninvasive breast cancer cells (MCF-7) [Total Cell Proteomes] cell line Up 1.8 20052998 1961 PDC6I_HUMAN ENSP00000307387 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Total Cell Proteomes] noninvasive breast cancer cells (MCF-7) [Total Cell Proteomes] cell line Up 1.9 20052998 1962 CALR_HUMAN ENSP00000320866 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Total Cell Proteomes] noninvasive breast cancer cells (MCF-7) [Total Cell Proteomes] cell line Up 2.2 20052998 1963 ANXA6_HUMAN ENSP00000346550 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Total Cell Proteomes] noninvasive breast cancer cells (MCF-7) [Total Cell Proteomes] cell line Up 2.3 20052998 1964 ENPL_HUMAN ENSP00000299767 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Total Cell Proteomes] noninvasive breast cancer cells (MCF-7) [Total Cell Proteomes] cell line Up 2.4 20052998 1965 FKBP4_HUMAN ENSP00000001008 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Total Cell Proteomes] noninvasive breast cancer cells (MCF-7) [Total Cell Proteomes] cell line Up 2.8 20052998 1966 HBB_HUMAN ENSP00000333994 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Total Cell Proteomes] noninvasive breast cancer cells (MCF-7) [Total Cell Proteomes] cell line Up 2.9 20052998 1967 CALM_HUMAN ENSP00000375785 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Total Cell Proteomes] noninvasive breast cancer cells (MCF-7) [Total Cell Proteomes] cell line Up 2.9 20052998 1968 GRB2_HUMAN ENSP00000376347 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Total Cell Proteomes] noninvasive breast cancer cells (MCF-7) [Total Cell Proteomes] cell line Up 3.2 20052998 1969 CALM_HUMAN ENSP00000375785 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Total Cell Proteomes] noninvasive breast cancer cells (MCF-7) [Total Cell Proteomes] cell line Up 3.8 20052998 1970 HSPB1_HUMAN ENSP00000248553 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Total Cell Proteomes] noninvasive breast cancer cells (MCF-7) [Total Cell Proteomes] cell line Up 4.2 20052998 1971 F16P1_HUMAN ENSP00000408025 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Total Cell Proteomes] noninvasive breast cancer cells (MCF-7) [Total Cell Proteomes] cell line Up 4.6 20052998 1972 ROCK2_HUMAN ENSP00000317985 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Total Cell Proteomes] noninvasive breast cancer cells (MCF-7) [Total Cell Proteomes] cell line Up 5.2 20052998 1973 CATD_HUMAN ENSP00000236671 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Total Cell Proteomes] noninvasive breast cancer cells (MCF-7) [Total Cell Proteomes] cell line Up 5.2 20052998 1974 HSPB1_HUMAN ENSP00000248553 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Total Cell Proteomes] noninvasive breast cancer cells (MCF-7) [Total Cell Proteomes] cell line Up 7.6 20052998 1975 NDE1_HUMAN ENSP00000379641 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Total Cell Proteomes] noninvasive breast cancer cells (MCF-7) [Total Cell Proteomes] cell line Up 7.8 20052998 1976 CATD_HUMAN ENSP00000236671 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Total Cell Proteomes] noninvasive breast cancer cells (MCF-7) [Total Cell Proteomes] cell line Up 7.8 20052998 1977 HSPB1_HUMAN ENSP00000248553 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Total Cell Proteomes] noninvasive breast cancer cells (MCF-7) [Total Cell Proteomes] cell line Up 8 20052998 1978 ROCK2_HUMAN ENSP00000317985 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Total Cell Proteomes] noninvasive breast cancer cells (MCF-7) [Total Cell Proteomes] cell line Up 8 20052998 1979 CATD_HUMAN ENSP00000236671 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Total Cell Proteomes] noninvasive breast cancer cells (MCF-7) [Total Cell Proteomes] cell line Up 8.4 20052998 1980 CATD_HUMAN ENSP00000236671 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Total Cell Proteomes] noninvasive breast cancer cells (MCF-7) [Total Cell Proteomes] cell line Up 9.9 20052998 1981 HDAC1_HUMAN ENSP00000362649 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Total Cell Proteomes] noninvasive breast cancer cells (MCF-7) [Total Cell Proteomes] cell line Up 13 20052998 1982 F16P1_HUMAN ENSP00000408025 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Total Cell Proteomes] noninvasive breast cancer cells (MCF-7) [Total Cell Proteomes] cell line Up 13 20052998 1983 PRVA_HUMAN ENSP00000216200 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Total Cell Proteomes] noninvasive breast cancer cells (MCF-7) [Total Cell Proteomes] cell line Up 17 20052998 1984 K2C8_HUMAN ENSP00000293308 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Total Cell Proteomes] noninvasive breast cancer cells (MCF-7) [Total Cell Proteomes] cell line Up 18 20052998 1985 GSTP1_HUMAN ENSP00000381607 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Total Cell Proteomes] invasive breast cancer cells (MB-MDA-231) [Total Cell Proteomes] cell line Down 0.086 20052998 1986 SPB5_HUMAN ENSP00000372221 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Total Cell Proteomes] invasive breast cancer cells (MB-MDA-231) [Total Cell Proteomes] cell line Down 0.09 20052998 1987 CATD_HUMAN ENSP00000236671 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Total Cell Proteomes] invasive breast cancer cells (MB-MDA-231) [Total Cell Proteomes] cell line Down 0.11 20052998 1988 GSTP1_HUMAN ENSP00000381607 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Total Cell Proteomes] invasive breast cancer cells (MB-MDA-231) [Total Cell Proteomes] cell line Down 0.11 20052998 1989 CATD_HUMAN ENSP00000236671 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Total Cell Proteomes] invasive breast cancer cells (MB-MDA-231) [Total Cell Proteomes] cell line Down 0.19 20052998 1990 HSPB1_HUMAN ENSP00000248553 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Total Cell Proteomes] invasive breast cancer cells (MB-MDA-231) [Total Cell Proteomes] cell line Down 0.22 20052998 1991 COF1_HUMAN ENSP00000309629 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Total Cell Proteomes] invasive breast cancer cells (MB-MDA-231) [Total Cell Proteomes] cell line Down 0.26 20052998 1992 HSPB1_HUMAN ENSP00000248553 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Total Cell Proteomes] invasive breast cancer cells (MB-MDA-231) [Total Cell Proteomes] cell line Down 0.27 20052998 1993 ANXA2_HUMAN ENSP00000411352 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Total Cell Proteomes] invasive breast cancer cells (MB-MDA-231) [Total Cell Proteomes] cell line Down 0.28 20052998 1994 HSPB1_HUMAN ENSP00000248553 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Total Cell Proteomes] invasive breast cancer cells (MB-MDA-231) [Total Cell Proteomes] cell line Down 0.31 20052998 1995 CALM_HUMAN ENSP00000375785 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Total Cell Proteomes] invasive breast cancer cells (MB-MDA-231) [Total Cell Proteomes] cell line Down 0.38 20052998 1996 ROCK2_HUMAN ENSP00000317985 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Total Cell Proteomes] invasive breast cancer cells (MB-MDA-231) [Total Cell Proteomes] cell line Down 0.39 20052998 1997 ANXA2_HUMAN ENSP00000411352 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Total Cell Proteomes] invasive breast cancer cells (MB-MDA-231) [Total Cell Proteomes] cell line Down 0.42 20052998 1998 HNRPK_HUMAN ENSP00000365440 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Total Cell Proteomes] invasive breast cancer cells (MB-MDA-231) [Total Cell Proteomes] cell line Down 0.42 20052998 1999 CALM_HUMAN ENSP00000375785 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Total Cell Proteomes] invasive breast cancer cells (MB-MDA-231) [Total Cell Proteomes] cell line Down 0.47 20052998 2000 VDAC1_HUMAN ENSP00000378487 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Total Cell Proteomes] invasive breast cancer cells (MB-MDA-231) [Total Cell Proteomes] cell line Down 0.47 20052998 2001 CATD_HUMAN ENSP00000236671 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Total Cell Proteomes] invasive breast cancer cells (MB-MDA-231) [Total Cell Proteomes] cell line Down 0.48 20052998 2002 SUMO3_HUMAN ENSP00000330343 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Total Cell Proteomes] invasive breast cancer cells (MB-MDA-231) [Total Cell Proteomes] cell line Down 0.55 20052998 2003 ROCK2_HUMAN ENSP00000317985 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Total Cell Proteomes] invasive breast cancer cells (MB-MDA-231) [Total Cell Proteomes] cell line Down 0.64 20052998 2004 KPYM_HUMAN ENSP00000334983 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Total Cell Proteomes] invasive breast cancer cells (MB-MDA-231) [Total Cell Proteomes] cell line Down 0.65 20052998 2005 NEK7_HUMAN ENSP00000356353 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Total Cell Proteomes] invasive breast cancer cells (MB-MDA-231) [Total Cell Proteomes] cell line Down 0.65 20052998 2006 CATD_HUMAN ENSP00000236671 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Total Cell Proteomes] invasive breast cancer cells (MB-MDA-231) [Total Cell Proteomes] cell line Down 0.68 20052998 2007 TPIS_HUMAN ENSP00000379933 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Total Cell Proteomes] invasive breast cancer cells (MB-MDA-231) [Total Cell Proteomes] cell line Down 0.69 20052998 2008 CALR_HUMAN ENSP00000320866 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Total Cell Proteomes] invasive breast cancer cells (MB-MDA-231) [Total Cell Proteomes] cell line Down 0.74 20052998 2009 F16P1_HUMAN ENSP00000408025 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Total Cell Proteomes] invasive breast cancer cells (MB-MDA-231) [Total Cell Proteomes] cell line Down 0.89 20052998 2010 FKBP4_HUMAN ENSP00000001008 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Total Cell Proteomes] invasive breast cancer cells (MB-MDA-231) [Total Cell Proteomes] cell line Down 0.93 20052998 2011 PDC6I_HUMAN ENSP00000307387 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Total Cell Proteomes] invasive breast cancer cells (MB-MDA-231) [Total Cell Proteomes] cell line Down 0.93 20052998 2012 TPIS_HUMAN ENSP00000379933 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Total Cell Proteomes] invasive breast cancer cells (MB-MDA-231) [Total Cell Proteomes] cell line Down 0.95 20052998 2013 ANXA1_HUMAN ENSP00000366109 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Total Cell Proteomes] invasive breast cancer cells (MB-MDA-231) [Total Cell Proteomes] cell line Down 0.97 20052998 2014 NDKA_HUMAN ENSP00000013034 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Total Cell Proteomes] invasive breast cancer cells (MB-MDA-231) [Total Cell Proteomes] cell line Up 1.1 20052998 2015 STIP1_HUMAN ENSP00000305958 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Total Cell Proteomes] invasive breast cancer cells (MB-MDA-231) [Total Cell Proteomes] cell line Up 1.1 20052998 2016 ENPL_HUMAN ENSP00000299767 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Total Cell Proteomes] invasive breast cancer cells (MB-MDA-231) [Total Cell Proteomes] cell line Up 1.1 20052998 2017 EF2_HUMAN ENSP00000307940 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Total Cell Proteomes] invasive breast cancer cells (MB-MDA-231) [Total Cell Proteomes] cell line Up 1.1 20052998 2018 1433Z_HUMAN ENSP00000379288 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Total Cell Proteomes] invasive breast cancer cells (MB-MDA-231) [Total Cell Proteomes] cell line Up 1.1 20052998 2019 TEBP_HUMAN ENSP00000262033 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Total Cell Proteomes] invasive breast cancer cells (MB-MDA-231) [Total Cell Proteomes] cell line Up 1.2 20052998 2020 F16P1_HUMAN ENSP00000408025 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Total Cell Proteomes] invasive breast cancer cells (MB-MDA-231) [Total Cell Proteomes] cell line Up 1.2 20052998 2021 GDIB_HUMAN ENSP00000369538 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Total Cell Proteomes] invasive breast cancer cells (MB-MDA-231) [Total Cell Proteomes] cell line Up 1.2 20052998 2022 UBE2N_HUMAN ENSP00000316176 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Total Cell Proteomes] invasive breast cancer cells (MB-MDA-231) [Total Cell Proteomes] cell line Up 1.3 20052998 2023 1433E_HUMAN ENSP00000264335 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Total Cell Proteomes] invasive breast cancer cells (MB-MDA-231) [Total Cell Proteomes] cell line Up 1.3 20052998 2024 CLIC1_HUMAN ENSP00000379229 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Total Cell Proteomes] invasive breast cancer cells (MB-MDA-231) [Total Cell Proteomes] cell line Up 1.4 20052998 2025 ANXA6_HUMAN ENSP00000346550 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Total Cell Proteomes] invasive breast cancer cells (MB-MDA-231) [Total Cell Proteomes] cell line Up 1.4 20052998 2026 CLIC1_HUMAN ENSP00000379229 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Total Cell Proteomes] invasive breast cancer cells (MB-MDA-231) [Total Cell Proteomes] cell line Up 1.6 20052998 2027 ENOA_HUMAN ENSP00000234590 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Total Cell Proteomes] invasive breast cancer cells (MB-MDA-231) [Total Cell Proteomes] cell line Up 1.6 20052998 2028 ACOC_HUMAN ENSP00000369255 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Total Cell Proteomes] invasive breast cancer cells (MB-MDA-231) [Total Cell Proteomes] cell line Up 1.6 20052998 2029 GRB2_HUMAN ENSP00000376347 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Total Cell Proteomes] invasive breast cancer cells (MB-MDA-231) [Total Cell Proteomes] cell line Up 1.6 20052998 2030 K2C8_HUMAN ENSP00000293308 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Total Cell Proteomes] invasive breast cancer cells (MB-MDA-231) [Total Cell Proteomes] cell line Up 1.7 20052998 2031 ML12B_HUMAN ENSP00000383037 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Total Cell Proteomes] invasive breast cancer cells (MB-MDA-231) [Total Cell Proteomes] cell line Up 1.8 20052998 2032 HBB_HUMAN ENSP00000333994 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Total Cell Proteomes] invasive breast cancer cells (MB-MDA-231) [Total Cell Proteomes] cell line Up 2.4 20052998 2033 VIME_HUMAN ENSP00000224237 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Total Cell Proteomes] invasive breast cancer cells (MB-MDA-231) [Total Cell Proteomes] cell line Up 2.6 20052998 2034 MOES_HUMAN ENSP00000353408 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Total Cell Proteomes] invasive breast cancer cells (MB-MDA-231) [Total Cell Proteomes] cell line Up 3.5 20052998 2035 VIME_HUMAN ENSP00000224237 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Total Cell Proteomes] invasive breast cancer cells (MB-MDA-231) [Total Cell Proteomes] cell line Up 4.1 20052998 2036 NDE1_HUMAN ENSP00000379641 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Total Cell Proteomes] invasive breast cancer cells (MB-MDA-231) [Total Cell Proteomes] cell line Up 6.4 20052998 2037 PRVA_HUMAN ENSP00000216200 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Total Cell Proteomes] invasive breast cancer cells (MB-MDA-231) [Total Cell Proteomes] cell line Up 11 20052998 2038 HDAC1_HUMAN ENSP00000362649 Breast Cancer Normal vs. Cancer normal breast cells (MCF-10A) [Total Cell Proteomes] invasive breast cancer cells (MB-MDA-231) [Total Cell Proteomes] cell line Up 11 20052998 2039 CATD_HUMAN ENSP00000236671 Breast Cancer Metastasis noninvasive breast cancer cells (MCF-7) [Total Cell Proteomes] invasive breast cancer cells (MB-MDA-231) [Total Cell Proteomes] cell line Down 0.011 20052998 2040 CATD_HUMAN ENSP00000236671 Breast Cancer Metastasis noninvasive breast cancer cells (MCF-7) [Total Cell Proteomes] invasive breast cancer cells (MB-MDA-231) [Total Cell Proteomes] cell line Down 0.019 20052998 2041 CATD_HUMAN ENSP00000236671 Breast Cancer Metastasis noninvasive breast cancer cells (MCF-7) [Total Cell Proteomes] invasive breast cancer cells (MB-MDA-231) [Total Cell Proteomes] cell line Down 0.025 20052998 2042 HSPB1_HUMAN ENSP00000248553 Breast Cancer Metastasis noninvasive breast cancer cells (MCF-7) [Total Cell Proteomes] invasive breast cancer cells (MB-MDA-231) [Total Cell Proteomes] cell line Down 0.035 20052998 2043 HSPB1_HUMAN ENSP00000248553 Breast Cancer Metastasis noninvasive breast cancer cells (MCF-7) [Total Cell Proteomes] invasive breast cancer cells (MB-MDA-231) [Total Cell Proteomes] cell line Down 0.038 20052998 2044 ROCK2_HUMAN ENSP00000317985 Breast Cancer Metastasis noninvasive breast cancer cells (MCF-7) [Total Cell Proteomes] invasive breast cancer cells (MB-MDA-231) [Total Cell Proteomes] cell line Down 0.049 20052998 2045 HSPB1_HUMAN ENSP00000248553 Breast Cancer Metastasis noninvasive breast cancer cells (MCF-7) [Total Cell Proteomes] invasive breast cancer cells (MB-MDA-231) [Total Cell Proteomes] cell line Down 0.053 20052998 2046 CATD_HUMAN ENSP00000236671 Breast Cancer Metastasis noninvasive breast cancer cells (MCF-7) [Total Cell Proteomes] invasive breast cancer cells (MB-MDA-231) [Total Cell Proteomes] cell line Down 0.056 20052998 2047 F16P1_HUMAN ENSP00000408025 Breast Cancer Metastasis noninvasive breast cancer cells (MCF-7) [Total Cell Proteomes] invasive breast cancer cells (MB-MDA-231) [Total Cell Proteomes] cell line Down 0.07 20052998 2048 K2C8_HUMAN ENSP00000293308 Breast Cancer Metastasis noninvasive breast cancer cells (MCF-7) [Total Cell Proteomes] invasive breast cancer cells (MB-MDA-231) [Total Cell Proteomes] cell line Down 0.094 20052998 2049 CALM_HUMAN ENSP00000375785 Breast Cancer Metastasis noninvasive breast cancer cells (MCF-7) [Total Cell Proteomes] invasive breast cancer cells (MB-MDA-231) [Total Cell Proteomes] cell line Down 0.1 20052998 2050 ROCK2_HUMAN ENSP00000317985 Breast Cancer Metastasis noninvasive breast cancer cells (MCF-7) [Total Cell Proteomes] invasive breast cancer cells (MB-MDA-231) [Total Cell Proteomes] cell line Down 0.12 20052998 2051 CALM_HUMAN ENSP00000375785 Breast Cancer Metastasis noninvasive breast cancer cells (MCF-7) [Total Cell Proteomes] invasive breast cancer cells (MB-MDA-231) [Total Cell Proteomes] cell line Down 0.16 20052998 2052 COF1_HUMAN ENSP00000309629 Breast Cancer Metastasis noninvasive breast cancer cells (MCF-7) [Total Cell Proteomes] invasive breast cancer cells (MB-MDA-231) [Total Cell Proteomes] cell line Down 0.2 20052998 2053 F16P1_HUMAN ENSP00000408025 Breast Cancer Metastasis noninvasive breast cancer cells (MCF-7) [Total Cell Proteomes] invasive breast cancer cells (MB-MDA-231) [Total Cell Proteomes] cell line Down 0.26 20052998 2054 FKBP4_HUMAN ENSP00000001008 Breast Cancer Metastasis noninvasive breast cancer cells (MCF-7) [Total Cell Proteomes] invasive breast cancer cells (MB-MDA-231) [Total Cell Proteomes] cell line Down 0.33 20052998 2055 CALR_HUMAN ENSP00000320866 Breast Cancer Metastasis noninvasive breast cancer cells (MCF-7) [Total Cell Proteomes] invasive breast cancer cells (MB-MDA-231) [Total Cell Proteomes] cell line Down 0.35 20052998 2056 TPIS_HUMAN ENSP00000379933 Breast Cancer Metastasis noninvasive breast cancer cells (MCF-7) [Total Cell Proteomes] invasive breast cancer cells (MB-MDA-231) [Total Cell Proteomes] cell line Down 0.46 20052998 2057 PDC6I_HUMAN ENSP00000307387 Breast Cancer Metastasis noninvasive breast cancer cells (MCF-7) [Total Cell Proteomes] invasive breast cancer cells (MB-MDA-231) [Total Cell Proteomes] cell line Down 0.5 20052998 2058 GRB2_HUMAN ENSP00000376347 Breast Cancer Metastasis noninvasive breast cancer cells (MCF-7) [Total Cell Proteomes] invasive breast cancer cells (MB-MDA-231) [Total Cell Proteomes] cell line Down 0.51 20052998 2059 ENPL_HUMAN ENSP00000299767 Breast Cancer Metastasis noninvasive breast cancer cells (MCF-7) [Total Cell Proteomes] invasive breast cancer cells (MB-MDA-231) [Total Cell Proteomes] cell line Down 0.53 20052998 2060 TPIS_HUMAN ENSP00000379933 Breast Cancer Metastasis noninvasive breast cancer cells (MCF-7) [Total Cell Proteomes] invasive breast cancer cells (MB-MDA-231) [Total Cell Proteomes] cell line Down 0.6 20052998 2061 ANXA6_HUMAN ENSP00000346550 Breast Cancer Metastasis noninvasive breast cancer cells (MCF-7) [Total Cell Proteomes] invasive breast cancer cells (MB-MDA-231) [Total Cell Proteomes] cell line Down 0.61 20052998 2062 PRVA_HUMAN ENSP00000216200 Breast Cancer Metastasis noninvasive breast cancer cells (MCF-7) [Total Cell Proteomes] invasive breast cancer cells (MB-MDA-231) [Total Cell Proteomes] cell line Down 0.66 20052998 2063 EF2_HUMAN ENSP00000307940 Breast Cancer Metastasis noninvasive breast cancer cells (MCF-7) [Total Cell Proteomes] invasive breast cancer cells (MB-MDA-231) [Total Cell Proteomes] cell line Down 0.68 20052998 2064 TEBP_HUMAN ENSP00000262033 Breast Cancer Metastasis noninvasive breast cancer cells (MCF-7) [Total Cell Proteomes] invasive breast cancer cells (MB-MDA-231) [Total Cell Proteomes] cell line Down 0.72 20052998 2065 VDAC1_HUMAN ENSP00000378487 Breast Cancer Metastasis noninvasive breast cancer cells (MCF-7) [Total Cell Proteomes] invasive breast cancer cells (MB-MDA-231) [Total Cell Proteomes] cell line Down 0.78 20052998 2066 GDIB_HUMAN ENSP00000369538 Breast Cancer Metastasis noninvasive breast cancer cells (MCF-7) [Total Cell Proteomes] invasive breast cancer cells (MB-MDA-231) [Total Cell Proteomes] cell line Down 0.78 20052998 2067 NDE1_HUMAN ENSP00000379641 Breast Cancer Metastasis noninvasive breast cancer cells (MCF-7) [Total Cell Proteomes] invasive breast cancer cells (MB-MDA-231) [Total Cell Proteomes] cell line Down 0.85 20052998 2068 HBB_HUMAN ENSP00000333994 Breast Cancer Metastasis noninvasive breast cancer cells (MCF-7) [Total Cell Proteomes] invasive breast cancer cells (MB-MDA-231) [Total Cell Proteomes] cell line Down 0.87 20052998 2069 HDAC1_HUMAN ENSP00000362649 Breast Cancer Metastasis noninvasive breast cancer cells (MCF-7) [Total Cell Proteomes] invasive breast cancer cells (MB-MDA-231) [Total Cell Proteomes] cell line Down 0.93 20052998 2070 SPB5_HUMAN ENSP00000372221 Breast Cancer Metastasis noninvasive breast cancer cells (MCF-7) [Total Cell Proteomes] invasive breast cancer cells (MB-MDA-231) [Total Cell Proteomes] cell line Down 0.98 20052998 2071 KPYM_HUMAN ENSP00000334983 Breast Cancer Metastasis noninvasive breast cancer cells (MCF-7) [Total Cell Proteomes] invasive breast cancer cells (MB-MDA-231) [Total Cell Proteomes] cell line Up 1.1 20052998 2072 ML12B_HUMAN ENSP00000383037 Breast Cancer Metastasis noninvasive breast cancer cells (MCF-7) [Total Cell Proteomes] invasive breast cancer cells (MB-MDA-231) [Total Cell Proteomes] cell line Up 1.2 20052998 2073 HNRPK_HUMAN ENSP00000365440 Breast Cancer Metastasis noninvasive breast cancer cells (MCF-7) [Total Cell Proteomes] invasive breast cancer cells (MB-MDA-231) [Total Cell Proteomes] cell line Up 1.2 20052998 2074 ENOA_HUMAN ENSP00000234590 Breast Cancer Metastasis noninvasive breast cancer cells (MCF-7) [Total Cell Proteomes] invasive breast cancer cells (MB-MDA-231) [Total Cell Proteomes] cell line Up 1.2 20052998 2075 ACOC_HUMAN ENSP00000369255 Breast Cancer Metastasis noninvasive breast cancer cells (MCF-7) [Total Cell Proteomes] invasive breast cancer cells (MB-MDA-231) [Total Cell Proteomes] cell line Up 1.3 20052998 2076 SUMO3_HUMAN ENSP00000330343 Breast Cancer Metastasis noninvasive breast cancer cells (MCF-7) [Total Cell Proteomes] invasive breast cancer cells (MB-MDA-231) [Total Cell Proteomes] cell line Up 1.5 20052998 2077 CLIC1_HUMAN ENSP00000379229 Breast Cancer Metastasis noninvasive breast cancer cells (MCF-7) [Total Cell Proteomes] invasive breast cancer cells (MB-MDA-231) [Total Cell Proteomes] cell line Up 1.6 20052998 2078 NEK7_HUMAN ENSP00000356353 Breast Cancer Metastasis noninvasive breast cancer cells (MCF-7) [Total Cell Proteomes] invasive breast cancer cells (MB-MDA-231) [Total Cell Proteomes] cell line Up 1.7 20052998 2079 CLIC1_HUMAN ENSP00000379229 Breast Cancer Metastasis noninvasive breast cancer cells (MCF-7) [Total Cell Proteomes] invasive breast cancer cells (MB-MDA-231) [Total Cell Proteomes] cell line Up 1.8 20052998 2080 NDKA_HUMAN ENSP00000013034 Breast Cancer Metastasis noninvasive breast cancer cells (MCF-7) [Total Cell Proteomes] invasive breast cancer cells (MB-MDA-231) [Total Cell Proteomes] cell line Up 2 20052998 2081 GSTP1_HUMAN ENSP00000381607 Breast Cancer Metastasis noninvasive breast cancer cells (MCF-7) [Total Cell Proteomes] invasive breast cancer cells (MB-MDA-231) [Total Cell Proteomes] cell line Up 2.1 20052998 2082 1433Z_HUMAN ENSP00000379288 Breast Cancer Metastasis noninvasive breast cancer cells (MCF-7) [Total Cell Proteomes] invasive breast cancer cells (MB-MDA-231) [Total Cell Proteomes] cell line Up 2.3 20052998 2083 ANXA2_HUMAN ENSP00000411352 Breast Cancer Metastasis noninvasive breast cancer cells (MCF-7) [Total Cell Proteomes] invasive breast cancer cells (MB-MDA-231) [Total Cell Proteomes] cell line Up 2.4 20052998 2084 GSTP1_HUMAN ENSP00000381607 Breast Cancer Metastasis noninvasive breast cancer cells (MCF-7) [Total Cell Proteomes] invasive breast cancer cells (MB-MDA-231) [Total Cell Proteomes] cell line Up 2.4 20052998 2085 STIP1_HUMAN ENSP00000305958 Breast Cancer Metastasis noninvasive breast cancer cells (MCF-7) [Total Cell Proteomes] invasive breast cancer cells (MB-MDA-231) [Total Cell Proteomes] cell line Up 2.4 20052998 2086 ANXA2_HUMAN ENSP00000411352 Breast Cancer Metastasis noninvasive breast cancer cells (MCF-7) [Total Cell Proteomes] invasive breast cancer cells (MB-MDA-231) [Total Cell Proteomes] cell line Up 2.5 20052998 2087 UBE2N_HUMAN ENSP00000316176 Breast Cancer Metastasis noninvasive breast cancer cells (MCF-7) [Total Cell Proteomes] invasive breast cancer cells (MB-MDA-231) [Total Cell Proteomes] cell line Up 3 20052998 2088 ANXA1_HUMAN ENSP00000366109 Breast Cancer Metastasis noninvasive breast cancer cells (MCF-7) [Total Cell Proteomes] invasive breast cancer cells (MB-MDA-231) [Total Cell Proteomes] cell line Up 4 20052998 2089 1433E_HUMAN ENSP00000264335 Breast Cancer Metastasis noninvasive breast cancer cells (MCF-7) [Total Cell Proteomes] invasive breast cancer cells (MB-MDA-231) [Total Cell Proteomes] cell line Up 4.5 20052998 2090 MOES_HUMAN ENSP00000353408 Breast Cancer Metastasis noninvasive breast cancer cells (MCF-7) [Total Cell Proteomes] invasive breast cancer cells (MB-MDA-231) [Total Cell Proteomes] cell line Up 8.5 20052998 2091 VIME_HUMAN ENSP00000224237 Breast Cancer Metastasis noninvasive breast cancer cells (MCF-7) [Total Cell Proteomes] invasive breast cancer cells (MB-MDA-231) [Total Cell Proteomes] cell line Up 10 20052998 2092 VIME_HUMAN ENSP00000224237 Breast Cancer Metastasis noninvasive breast cancer cells (MCF-7) [Total Cell Proteomes] invasive breast cancer cells (MB-MDA-231) [Total Cell Proteomes] cell line Up 15 20052998 2093 CALR_HUMAN ENSP00000320866 Breast Cancer Normal vs. Cancer adjacent normal breast tissue from the same breast in 18 women with stage I/II ER positive/Her2/neu negative invasive breast cancer tumor from the same breast in 18 women with stage I/II ER positive/Her2/neu negative invasive breast cancer tissue Down 0.44 20087651 2094 PARK7_HUMAN ENSP00000366708 Breast Cancer Normal vs. Cancer adjacent normal breast tissue from the same breast in 18 women with stage I/II ER positive/Her2/neu negative invasive breast cancer tumor from the same breast in 18 women with stage I/II ER positive/Her2/neu negative invasive breast cancer tissue Up 1.4 20087651 2095 ACTA_HUMAN ENSP00000402373 Breast Cancer Normal vs. Cancer adjacent normal breast tissue from the same breast in 18 women with stage I/II ER positive/Her2/neu negative invasive breast cancer tumor from the same breast in 18 women with stage I/II ER positive/Her2/neu negative invasive breast cancer tissue Up 1.4 20087651 2096 GDIR1_HUMAN ENSP00000269321 Breast Cancer Normal vs. Cancer adjacent normal breast tissue from the same breast in 18 women with stage I/II ER positive/Her2/neu negative invasive breast cancer tumor from the same breast in 18 women with stage I/II ER positive/Her2/neu negative invasive breast cancer tissue Up 1.4 20087651 2097 VIME_HUMAN ENSP00000224237 Breast Cancer Normal vs. Cancer adjacent normal breast tissue from the same breast in 18 women with stage I/II ER positive/Her2/neu negative invasive breast cancer tumor from the same breast in 18 women with stage I/II ER positive/Her2/neu negative invasive breast cancer tissue Up 1.5 20087651 2098 PEBP1_HUMAN ENSP00000261313 Breast Cancer Normal vs. Cancer adjacent normal breast tissue from the same breast in 18 women with stage I/II ER positive/Her2/neu negative invasive breast cancer tumor from the same breast in 18 women with stage I/II ER positive/Her2/neu negative invasive breast cancer tissue Up 1.6 20087651 2099 TERA_HUMAN ENSP00000351777 Breast Cancer Normal vs. Cancer adjacent normal breast tissue from the same breast in 18 women with stage I/II ER positive/Her2/neu negative invasive breast cancer tumor from the same breast in 18 women with stage I/II ER positive/Her2/neu negative invasive breast cancer tissue Up 1.7 20087651 2100 TBB5_HUMAN ENSP00000406811 Breast Cancer Normal vs. Cancer adjacent normal breast tissue from the same breast in 18 women with stage I/II ER positive/Her2/neu negative invasive breast cancer tumor from the same breast in 18 women with stage I/II ER positive/Her2/neu negative invasive breast cancer tissue Up 1.7 20087651 2101 PGAM1_HUMAN ENSP00000359991 Breast Cancer Normal vs. Cancer adjacent normal breast tissue from the same breast in 18 women with stage I/II ER positive/Her2/neu negative invasive breast cancer tumor from the same breast in 18 women with stage I/II ER positive/Her2/neu negative invasive breast cancer tissue Up 1.7 20087651 2102 EFTU_HUMAN ENSP00000322439 Breast Cancer Normal vs. Cancer adjacent normal breast tissue from the same breast in 18 women with stage I/II ER positive/Her2/neu negative invasive breast cancer tumor from the same breast in 18 women with stage I/II ER positive/Her2/neu negative invasive breast cancer tissue Up 1.7 20087651 2103 ANXA2_HUMAN ENSP00000411352 Breast Cancer Normal vs. Cancer adjacent normal breast tissue from the same breast in 18 women with stage I/II ER positive/Her2/neu negative invasive breast cancer tumor from the same breast in 18 women with stage I/II ER positive/Her2/neu negative invasive breast cancer tissue Up 1.7 20087651 2104 1433E_HUMAN ENSP00000264335 Breast Cancer Normal vs. Cancer adjacent normal breast tissue from the same breast in 18 women with stage I/II ER positive/Her2/neu negative invasive breast cancer tumor from the same breast in 18 women with stage I/II ER positive/Her2/neu negative invasive breast cancer tissue Up 1.8 20087651 2105 ANXA1_HUMAN ENSP00000366109 Breast Cancer Normal vs. Cancer adjacent normal breast tissue from the same breast in 18 women with stage I/II ER positive/Her2/neu negative invasive breast cancer tumor from the same breast in 18 women with stage I/II ER positive/Her2/neu negative invasive breast cancer tissue Up 1.8 20087651 2106 CATD_HUMAN ENSP00000236671 Breast Cancer Normal vs. Cancer adjacent normal breast tissue from the same breast in 18 women with stage I/II ER positive/Her2/neu negative invasive breast cancer tumor from the same breast in 18 women with stage I/II ER positive/Her2/neu negative invasive breast cancer tissue Up 1.8 20087651 2107 CLIC1_HUMAN ENSP00000379229 Breast Cancer Normal vs. Cancer adjacent normal breast tissue from the same breast in 18 women with stage I/II ER positive/Her2/neu negative invasive breast cancer tumor from the same breast in 18 women with stage I/II ER positive/Her2/neu negative invasive breast cancer tissue Up 1.8 20087651 2108 VIME_HUMAN ENSP00000224237 Breast Cancer Normal vs. Cancer adjacent normal breast tissue from the same breast in 18 women with stage I/II ER positive/Her2/neu negative invasive breast cancer tumor from the same breast in 18 women with stage I/II ER positive/Her2/neu negative invasive breast cancer tissue Up 1.9 20087651 2109 GDIR1_HUMAN ENSP00000269321 Breast Cancer Normal vs. Cancer adjacent normal breast tissue from the same breast in 18 women with stage I/II ER positive/Her2/neu negative invasive breast cancer tumor from the same breast in 18 women with stage I/II ER positive/Her2/neu negative invasive breast cancer tissue Up 1.9 20087651 2110 VIME_HUMAN ENSP00000224237 Breast Cancer Normal vs. Cancer adjacent normal breast tissue from the same breast in 18 women with stage I/II ER positive/Her2/neu negative invasive breast cancer tumor from the same breast in 18 women with stage I/II ER positive/Her2/neu negative invasive breast cancer tissue Up 2 20087651 2111 ANXA2_HUMAN ENSP00000411352 Breast Cancer Normal vs. Cancer adjacent normal breast tissue from the same breast in 18 women with stage I/II ER positive/Her2/neu negative invasive breast cancer tumor from the same breast in 18 women with stage I/II ER positive/Her2/neu negative invasive breast cancer tissue Up 2 20087651 2112 VIME_HUMAN ENSP00000224237 Breast Cancer Normal vs. Cancer adjacent normal breast tissue from the same breast in 18 women with stage I/II ER positive/Her2/neu negative invasive breast cancer tumor from the same breast in 18 women with stage I/II ER positive/Her2/neu negative invasive breast cancer tissue Up 2.2 20087651 2113 TERA_HUMAN ENSP00000351777 Breast Cancer Normal vs. Cancer adjacent normal breast tissue from the same breast in 18 women with stage I/II ER positive/Her2/neu negative invasive breast cancer tumor from the same breast in 18 women with stage I/II ER positive/Her2/neu negative invasive breast cancer tissue Up 2.2 20087651 2114 ACTB_HUMAN ENSP00000349960 Breast Cancer Normal vs. Cancer adjacent normal breast tissue from the same breast in 18 women with stage I/II ER positive/Her2/neu negative invasive breast cancer tumor from the same breast in 18 women with stage I/II ER positive/Her2/neu negative invasive breast cancer tissue Up 2.4 20087651 2115 K2C8_HUMAN ENSP00000293308 Breast Cancer Normal vs. Cancer adjacent normal breast tissue from the same breast in 18 women with stage I/II ER positive/Her2/neu negative invasive breast cancer tumor from the same breast in 18 women with stage I/II ER positive/Her2/neu negative invasive breast cancer tissue Up 2.8 20087651 2116 ACTB_HUMAN ENSP00000349960 Breast Cancer Normal vs. Cancer adjacent normal breast tissue from the same breast in 18 women with stage I/II ER positive/Her2/neu negative invasive breast cancer tumor from the same breast in 18 women with stage I/II ER positive/Her2/neu negative invasive breast cancer tissue Up 2.9 20087651 2117 G3P_HUMAN ENSP00000380068 Breast Cancer Normal vs. Cancer adjacent normal breast tissue from the same breast in 18 women with stage I/II ER positive/Her2/neu negative invasive breast cancer tumor from the same breast in 18 women with stage I/II ER positive/Her2/neu negative invasive breast cancer tissue Up 2.9 20087651 2118 K2C8_HUMAN ENSP00000293308 Breast Cancer Normal vs. Cancer adjacent normal breast tissue from the same breast in 18 women with stage I/II ER positive/Her2/neu negative invasive breast cancer tumor from the same breast in 18 women with stage I/II ER positive/Her2/neu negative invasive breast cancer tissue Up 2.9 20087651 2119 TAGL2_HUMAN ENSP00000357075 Breast Cancer Metastasis human breast cancer cell line MDA-MB-231 highly metastatic variant of parental MDA-MB-231 cells (MDA-MB-231HM) cell line Down 20155427 2120 CLIC1_HUMAN ENSP00000379229 Breast Cancer Metastasis human breast cancer cell line MDA-MB-231 highly metastatic variant of parental MDA-MB-231 cells (MDA-MB-231HM) cell line Up 20155427 2121 STMN1_HUMAN ENSP00000382633 Breast Cancer Metastasis human breast cancer cell line MDA-MB-231 highly metastatic variant of parental MDA-MB-231 cells (MDA-MB-231HM) cell line Up 20155427 2122 GDIR2_HUMAN ENSP00000228945 Breast Cancer Metastasis human breast cancer cell line MDA-MB-231 highly metastatic variant of parental MDA-MB-231 cells (MDA-MB-231HM) cell line Up 20155427 2123 NDRG1_HUMAN ENSP00000404854 Breast Cancer Metastasis human breast cancer cell line MDA-MB-231 highly metastatic variant of parental MDA-MB-231 cells (MDA-MB-231HM) cell line Up 20155427 2124 FINC_HUMAN ENSP00000352696 Breast Cancer Normal vs. Cancer 16N (normal) cells NT cells (the primary tumor cells) cell line Down 0.02 20198662 2125 VIME_HUMAN ENSP00000224237 Breast Cancer Normal vs. Cancer 16N (normal) cells NT cells (the primary tumor cells) cell line Down 0.02 20198662 2126 GNA15_HUMAN ENSP00000262958 Breast Cancer Normal vs. Cancer 16N (normal) cells NT cells (the primary tumor cells) cell line Down 0.02 20198662 2127 GSTP1_HUMAN ENSP00000381607 Breast Cancer Normal vs. Cancer 16N (normal) cells NT cells (the primary tumor cells) cell line Down 0.03 20198662 2128 K1C16_HUMAN ENSP00000301653 Breast Cancer Normal vs. Cancer 16N (normal) cells NT cells (the primary tumor cells) cell line Down 0.1 20198662 2129 NEST_HUMAN ENSP00000357206 Breast Cancer Normal vs. Cancer 16N (normal) cells NT cells (the primary tumor cells) cell line Down 0.11 20198662 2130 DRA_HUMAN ENSP00000372746 Breast Cancer Normal vs. Cancer 16N (normal) cells NT cells (the primary tumor cells) cell line Down 0.18 20198662 2131 PAI2_HUMAN ENSP00000401645 Breast Cancer Normal vs. Cancer 16N (normal) cells NT cells (the primary tumor cells) cell line Down 0.22 20198662 2132 DESP_HUMAN ENSP00000369129 Breast Cancer Normal vs. Cancer 16N (normal) cells NT cells (the primary tumor cells) cell line Down 0.24 20198662 2133 EPHA2_HUMAN ENSP00000351209 Breast Cancer Normal vs. Cancer 16N (normal) cells NT cells (the primary tumor cells) cell line Down 0.25 20198662 2134 ASSY_HUMAN ENSP00000361470 Breast Cancer Normal vs. Cancer 16N (normal) cells NT cells (the primary tumor cells) cell line Up 4.9 20198662 2135 FAS_HUMAN ENSP00000304592 Breast Cancer Normal vs. Cancer 16N (normal) cells NT cells (the primary tumor cells) cell line Up 5.3 20198662 2136 G6PI_HUMAN ENSP00000348877 Breast Cancer Normal vs. Cancer 16N (normal) cells NT cells (the primary tumor cells) cell line Up 5.8 20198662 2137 ERBB2_HUMAN ENSP00000269571 Breast Cancer Normal vs. Cancer 16N (normal) cells NT cells (the primary tumor cells) cell line Up 6.9 20198662 2138 HPCA_HUMAN ENSP00000362566 Breast Cancer Normal vs. Cancer 16N (normal) cells NT cells (the primary tumor cells) cell line Up 7.4 20198662 2139 TGM2_HUMAN ENSP00000355330 Breast Cancer Normal vs. Cancer 16N (normal) cells NT cells (the primary tumor cells) cell line Up 7.9 20198662 2140 SODM_HUMAN ENSP00000337127 Breast Cancer Normal vs. Cancer 16N (normal) cells NT cells (the primary tumor cells) cell line Up 8.5 20198662 2141 NAMPT_HUMAN ENSP00000222553 Breast Cancer Normal vs. Cancer 16N (normal) cells NT cells (the primary tumor cells) cell line Up 10 20198662 2142 HPCA_HUMAN ENSP00000362566 Breast Cancer Metastasis NT cells (the primary tumor cells) MT2 (metastatic) cells cell line Down 0.26 20198662 2143 FINC_HUMAN ENSP00000352696 Breast Cancer Metastasis NT cells (the primary tumor cells) MT2 (metastatic) cells cell line Down 0.3 20198662 2144 UBE2N_HUMAN ENSP00000316176 Breast Cancer Metastasis NT cells (the primary tumor cells) MT2 (metastatic) cells cell line Down 0.31 20198662 2145 EPHA2_HUMAN ENSP00000351209 Breast Cancer Metastasis NT cells (the primary tumor cells) MT2 (metastatic) cells cell line Down 0.33 20198662 2146 ASSY_HUMAN ENSP00000361470 Breast Cancer Metastasis NT cells (the primary tumor cells) MT2 (metastatic) cells cell line Up 2.2 20198662 2147 ATPK_HUMAN ENSP00000292475 Breast Cancer Metastasis NT cells (the primary tumor cells) MT2 (metastatic) cells cell line Up 2.2 20198662 2148 GBG12_HUMAN ENSP00000360021 Breast Cancer Metastasis NT cells (the primary tumor cells) MT2 (metastatic) cells cell line Up 2.4 20198662 2149 CD14_HUMAN ENSP00000385519 Breast Cancer Normal vs. Cancer plasma samples from normal healthy volunteers plasma samples from breast cancer patients tissue Up 1.7 20346108 2150 FABP4_HUMAN ENSP00000256104 breast ductal carcinoma Normal vs. Cancer normal breast tissue from Chinese,Malay and Indian cohorts cancerous breast tissue from Chinese,Malay and Indian cohorts tissue Down 0.0011 20534901 2151 GSTP1_HUMAN ENSP00000381607 breast ductal carcinoma Normal vs. Cancer normal breast tissue from Chinese,Malay and Indian cohorts cancerous breast tissue from Chinese,Malay and Indian cohorts tissue Down 0.013 20534901 2152 TTHY_HUMAN ENSP00000237014 breast ductal carcinoma Normal vs. Cancer normal breast tissue from Chinese,Malay and Indian cohorts cancerous breast tissue from Chinese,Malay and Indian cohorts tissue Down 0.027 20534901 2153 ALBU_HUMAN ENSP00000295897 breast ductal carcinoma Normal vs. Cancer normal breast tissue from Chinese,Malay and Indian cohorts cancerous breast tissue from Chinese,Malay and Indian cohorts tissue Up 0.38 20534901 2154 SODC_HUMAN ENSP00000270142 breast ductal carcinoma Normal vs. Cancer normal breast tissue from Chinese,Malay and Indian cohorts cancerous breast tissue from Chinese,Malay and Indian cohorts tissue Up 2 20534901 2155 ALBU_HUMAN ENSP00000295897 breast ductal carcinoma Normal vs. Cancer normal breast tissue from Chinese,Malay and Indian cohorts cancerous breast tissue from Chinese,Malay and Indian cohorts tissue Up 69 20534901 2156 TBB4B_HUMAN ENSP00000341289 breast ductal carcinoma Normal vs. Cancer normal breast tissue from Chinese,Malay and Indian cohorts cancerous breast tissue from Chinese,Malay and Indian cohorts tissue Up 340 20534901 2157 TTHY_HUMAN ENSP00000237014 breast ductal carcinoma Normal vs. Cancer normal breast tissue from Chinese,Malay and Indian cohorts cancerous breast tissue from Chinese,Malay and Indian cohorts tissue Up 710 20534901 2158 1433Z_HUMAN ENSP00000379288 breast ductal carcinoma Normal vs. Cancer normal breast tissue from Chinese,Malay and Indian cohorts cancerous breast tissue from Chinese,Malay and Indian cohorts tissue Up 1000 20534901 2159 1433F_HUMAN ENSP00000248975 breast ductal carcinoma Normal vs. Cancer normal breast tissue from Chinese,Malay and Indian cohorts cancerous breast tissue from Chinese,Malay and Indian cohorts tissue Up 2200 20534901 2160 CALR_HUMAN ENSP00000320866 breast ductal carcinoma Normal vs. Cancer normal breast tissue from Chinese,Malay and Indian cohorts cancerous breast tissue from Chinese,Malay and Indian cohorts tissue Up 4800 20534901 2161 FLNA_HUMAN ENSP00000358866 Breast Cancer Normal vs. Cancer normal MCF10A1 premalignant epithelium MCF10AT1K.cl2 cell line Down 0.21 20543960 2162 AMPN_HUMAN ENSP00000300060 Breast Cancer Normal vs. Cancer normal MCF10A1 premalignant epithelium MCF10AT1K.cl2 cell line Down 0.47 20543960 2163 LEG3_HUMAN ENSP00000254301 Breast Cancer Normal vs. Cancer normal MCF10A1 premalignant epithelium MCF10AT1K.cl2 cell line Down 0.65 20543960 2164 1433Z_HUMAN ENSP00000379288 Breast Cancer Normal vs. Cancer normal MCF10A1 premalignant epithelium MCF10AT1K.cl2 cell line Down 0.71 20543960 2165 HSPB1_HUMAN ENSP00000248553 Breast Cancer Normal vs. Cancer normal MCF10A1 premalignant epithelium MCF10AT1K.cl2 cell line Down 0.75 20543960 2166 TERA_HUMAN ENSP00000351777 Breast Cancer Normal vs. Cancer normal MCF10A1 premalignant epithelium MCF10AT1K.cl2 cell line Up 1.3 20543960 2167 G3BP1_HUMAN ENSP00000348578 Breast Cancer Normal vs. Cancer normal MCF10A1 premalignant epithelium MCF10AT1K.cl2 cell line Up 1.5 20543960 2168 RD23B_HUMAN ENSP00000350708 Breast Cancer Normal vs. Cancer normal MCF10A1 premalignant epithelium MCF10AT1K.cl2 cell line Up 1.5 20543960 2169 MT2_HUMAN ENSP00000245185 Breast Cancer Normal vs. Cancer normal MCF10A1 premalignant epithelium MCF10AT1K.cl2 cell line Up 1.5 20543960 2170 ANXA1_HUMAN ENSP00000366109 Breast Cancer Normal vs. Cancer normal MCF10A1 premalignant epithelium MCF10AT1K.cl2 cell line Up 1.5 20543960 2171 ITB4_HUMAN ENSP00000200181 Breast Cancer Normal vs. Cancer normal MCF10A1 premalignant epithelium MCF10AT1K.cl2 cell line Up 1.6 20543960 2172 THIO_HUMAN ENSP00000363641 Breast Cancer Normal vs. Cancer normal MCF10A1 premalignant epithelium MCF10AT1K.cl2 cell line Up 1.6 20543960 2173 S10A2_HUMAN ENSP00000357698 Breast Cancer Normal vs. Cancer normal MCF10A1 premalignant epithelium MCF10AT1K.cl2 cell line Up 2.4 20543960 2174 FLNA_HUMAN ENSP00000358866 Breast Cancer Normal vs. Cancer normal MCF10A1 low grade MCF10CA1h cell line Down 0.16 20543960 2175 AMPN_HUMAN ENSP00000300060 Breast Cancer Normal vs. Cancer normal MCF10A1 low grade MCF10CA1h cell line Down 0.53 20543960 2176 1433Z_HUMAN ENSP00000379288 Breast Cancer Normal vs. Cancer normal MCF10A1 low grade MCF10CA1h cell line Down 0.66 20543960 2177 H2B1M_HUMAN ENSP00000352442 Breast Cancer Normal vs. Cancer normal MCF10A1 low grade MCF10CA1h cell line Down 0.73 20543960 2178 LEG3_HUMAN ENSP00000254301 Breast Cancer Normal vs. Cancer normal MCF10A1 low grade MCF10CA1h cell line Down 0.73 20543960 2179 SODC_HUMAN ENSP00000270142 Breast Cancer Normal vs. Cancer normal MCF10A1 low grade MCF10CA1h cell line Down 0.76 20543960 2180 G3BP1_HUMAN ENSP00000348578 Breast Cancer Normal vs. Cancer normal MCF10A1 low grade MCF10CA1h cell line Up 1.4 20543960 2181 NDKA_HUMAN ENSP00000013034 Breast Cancer Normal vs. Cancer normal MCF10A1 low grade MCF10CA1h cell line Up 1.4 20543960 2182 DDX5_HUMAN ENSP00000225792 Breast Cancer Normal vs. Cancer normal MCF10A1 low grade MCF10CA1h cell line Up 1.4 20543960 2183 PAK2_HUMAN ENSP00000314067 Breast Cancer Normal vs. Cancer normal MCF10A1 low grade MCF10CA1h cell line Up 1.4 20543960 2184 TERA_HUMAN ENSP00000351777 Breast Cancer Normal vs. Cancer normal MCF10A1 low grade MCF10CA1h cell line Up 1.4 20543960 2185 RD23B_HUMAN ENSP00000350708 Breast Cancer Normal vs. Cancer normal MCF10A1 low grade MCF10CA1h cell line Up 1.5 20543960 2186 THIO_HUMAN ENSP00000363641 Breast Cancer Normal vs. Cancer normal MCF10A1 low grade MCF10CA1h cell line Up 1.5 20543960 2187 ITA6_HUMAN ENSP00000341078 Breast Cancer Normal vs. Cancer normal MCF10A1 low grade MCF10CA1h cell line Up 1.6 20543960 2188 ITB4_HUMAN ENSP00000200181 Breast Cancer Normal vs. Cancer normal MCF10A1 low grade MCF10CA1h cell line Up 1.6 20543960 2189 MT2_HUMAN ENSP00000245185 Breast Cancer Normal vs. Cancer normal MCF10A1 low grade MCF10CA1h cell line Up 1.8 20543960 2190 S10A2_HUMAN ENSP00000357698 Breast Cancer Normal vs. Cancer normal MCF10A1 low grade MCF10CA1h cell line Up 2.5 20543960 2191 FLNA_HUMAN ENSP00000358866 Breast Cancer Normal vs. Cancer normal MCF10A1 high grade MCF10CA1a.cl1 cell line Down 0.17 20543960 2192 GDIR2_HUMAN ENSP00000228945 Breast Cancer Normal vs. Cancer normal MCF10A1 high grade MCF10CA1a.cl1 cell line Down 0.45 20543960 2193 AMPN_HUMAN ENSP00000300060 Breast Cancer Normal vs. Cancer normal MCF10A1 high grade MCF10CA1a.cl1 cell line Down 0.55 20543960 2194 ANM1_HUMAN ENSP00000406162 Breast Cancer Normal vs. Cancer normal MCF10A1 high grade MCF10CA1a.cl1 cell line Down 0.59 20543960 2195 SODC_HUMAN ENSP00000270142 Breast Cancer Normal vs. Cancer normal MCF10A1 high grade MCF10CA1a.cl1 cell line Down 0.68 20543960 2196 1433Z_HUMAN ENSP00000379288 Breast Cancer Normal vs. Cancer normal MCF10A1 high grade MCF10CA1a.cl1 cell line Down 0.68 20543960 2197 LEG3_HUMAN ENSP00000254301 Breast Cancer Normal vs. Cancer normal MCF10A1 high grade MCF10CA1a.cl1 cell line Down 0.71 20543960 2198 SRC8_HUMAN ENSP00000301843 Breast Cancer Normal vs. Cancer normal MCF10A1 high grade MCF10CA1a.cl1 cell line Down 0.73 20543960 2199 KPYM_HUMAN ENSP00000334983 Breast Cancer Normal vs. Cancer normal MCF10A1 high grade MCF10CA1a.cl1 cell line Down 0.73 20543960 2200 CAN2_HUMAN ENSP00000295006 Breast Cancer Normal vs. Cancer normal MCF10A1 high grade MCF10CA1a.cl1 cell line Down 0.74 20543960 2201 H2B1M_HUMAN ENSP00000352442 Breast Cancer Normal vs. Cancer normal MCF10A1 high grade MCF10CA1a.cl1 cell line Down 0.75 20543960 2202 NAMPT_HUMAN ENSP00000222553 Breast Cancer Normal vs. Cancer normal MCF10A1 high grade MCF10CA1a.cl1 cell line Down 0.76 20543960 2203 PLEC_HUMAN ENSP00000323856 Breast Cancer Normal vs. Cancer normal MCF10A1 high grade MCF10CA1a.cl1 cell line Down 0.76 20543960 2204 PGAM1_HUMAN ENSP00000359991 Breast Cancer Normal vs. Cancer normal MCF10A1 high grade MCF10CA1a.cl1 cell line Up 1.3 20543960 2205 VINC_HUMAN ENSP00000211998 Breast Cancer Normal vs. Cancer normal MCF10A1 high grade MCF10CA1a.cl1 cell line Up 1.3 20543960 2206 CDK1_HUMAN ENSP00000378699 Breast Cancer Normal vs. Cancer normal MCF10A1 high grade MCF10CA1a.cl1 cell line Up 1.3 20543960 2207 S10AB_HUMAN ENSP00000271638 Breast Cancer Normal vs. Cancer normal MCF10A1 high grade MCF10CA1a.cl1 cell line Up 1.4 20543960 2208 RD23B_HUMAN ENSP00000350708 Breast Cancer Normal vs. Cancer normal MCF10A1 high grade MCF10CA1a.cl1 cell line Up 1.4 20543960 2209 NDKA_HUMAN ENSP00000013034 Breast Cancer Normal vs. Cancer normal MCF10A1 high grade MCF10CA1a.cl1 cell line Up 1.4 20543960 2210 IF4B_HUMAN ENSP00000262056 Breast Cancer Normal vs. Cancer normal MCF10A1 high grade MCF10CA1a.cl1 cell line Up 1.4 20543960 2211 DDX5_HUMAN ENSP00000225792 Breast Cancer Normal vs. Cancer normal MCF10A1 high grade MCF10CA1a.cl1 cell line Up 1.4 20543960 2212 ITB4_HUMAN ENSP00000200181 Breast Cancer Normal vs. Cancer normal MCF10A1 high grade MCF10CA1a.cl1 cell line Up 1.5 20543960 2213 THIO_HUMAN ENSP00000363641 Breast Cancer Normal vs. Cancer normal MCF10A1 high grade MCF10CA1a.cl1 cell line Up 1.5 20543960 2214 S10A2_HUMAN ENSP00000357698 Breast Cancer Normal vs. Cancer normal MCF10A1 high grade MCF10CA1a.cl1 cell line Up 2.2 20543960 2215 VIME_HUMAN ENSP00000224237 Breast Cancer Normal vs. Cancer normal MCF10A1 high grade MCF10CA1a.cl1 cell line Up 3.8 20543960 2216 CTND1_HUMAN ENSP00000382004 Breast Cancer Normal vs. Cancer normal breast tissue pathological tissue (adenoma and invasive carcinoma) tissue Down 20560667 2217 SYUG_HUMAN ENSP00000361087 Breast Cancer Normal vs. Cancer normal breast tissue pathological tissue (adenoma and invasive carcinoma) tissue Down 20560667 2218 PIGR_HUMAN ENSP00000348888 Breast Cancer Normal vs. Cancer normal breast tissue pathological tissue (adenoma and invasive carcinoma) tissue Down 20560667 2219 B3AT_HUMAN ENSP00000262418 Breast Cancer Normal vs. Cancer normal breast tissue pathological tissue (adenoma and invasive carcinoma) tissue Down 20560667 2220 ANXA1_HUMAN ENSP00000366109 Breast Cancer Normal vs. Cancer normal breast tissue pathological tissue (adenoma and invasive carcinoma) tissue Down 20560667 2221 ANXA6_HUMAN ENSP00000346550 Breast Cancer Normal vs. Cancer normal breast tissue pathological tissue (adenoma and invasive carcinoma) tissue Down 20560667 2222 GSTP1_HUMAN ENSP00000381607 Breast Cancer Normal vs. Cancer normal breast tissue pathological tissue (adenoma and invasive carcinoma) tissue Down 20560667 2223 PGAM1_HUMAN ENSP00000359991 Breast Cancer Normal vs. Cancer normal breast tissue pathological tissue (adenoma and invasive carcinoma) tissue Down 20560667 2224 ACSL1_HUMAN ENSP00000281455 Breast Cancer Normal vs. Cancer normal breast tissue pathological tissue (adenoma and invasive carcinoma) tissue Down 20560667 2225 SPTB2_HUMAN ENSP00000349259 Breast Cancer Normal vs. Cancer normal breast tissue pathological tissue (adenoma and invasive carcinoma) tissue Down 20560667 2226 CAV1_HUMAN ENSP00000339191 Breast Cancer Normal vs. Cancer normal breast tissue pathological tissue (adenoma and invasive carcinoma) tissue Down 20560667 2227 FHL1_HUMAN ENSP00000377710 Breast Cancer Normal vs. Cancer normal breast tissue pathological tissue (adenoma and invasive carcinoma) tissue Down 20560667 2228 SPTN1_HUMAN ENSP00000361816 Breast Cancer Normal vs. Cancer normal breast tissue pathological tissue (adenoma and invasive carcinoma) tissue Down 20560667 2229 DPYL3_HUMAN ENSP00000343690 Breast Cancer Normal vs. Cancer normal breast tissue pathological tissue (adenoma and invasive carcinoma) tissue Down 20560667 2230 SFRP1_HUMAN ENSP00000220772 Breast Cancer Normal vs. Cancer normal breast tissue pathological tissue (adenoma and invasive carcinoma) tissue Down 20560667 2231 TFF1_HUMAN ENSP00000291527 Breast Cancer Normal vs. Cancer normal breast tissue pathological tissue (adenoma and invasive carcinoma) tissue Up 20560667 2232 HMGN2_HUMAN ENSP00000355228 Breast Cancer Normal vs. Cancer normal breast tissue pathological tissue (adenoma and invasive carcinoma) tissue Up 20560667 2233 RLA2_HUMAN ENSP00000322419 Breast Cancer Normal vs. Cancer normal breast tissue pathological tissue (adenoma and invasive carcinoma) tissue Up 20560667 2234 NPM_HUMAN ENSP00000296930 Breast Cancer Normal vs. Cancer normal breast tissue pathological tissue (adenoma and invasive carcinoma) tissue Up 20560667 2235 TPM2_HUMAN ENSP00000354219 Breast Cancer Normal vs. Cancer normal breast tissue pathological tissue (adenoma and invasive carcinoma) tissue Up 20560667 2236 LEG3_HUMAN ENSP00000254301 Breast Cancer Normal vs. Cancer normal breast tissue pathological tissue (adenoma and invasive carcinoma) tissue Up 20560667 2237 NUCL_HUMAN ENSP00000318195 Breast Cancer Normal vs. Cancer normal breast tissue pathological tissue (adenoma and invasive carcinoma) tissue Up 20560667 2238 COF1_HUMAN ENSP00000309629 Breast Cancer Normal vs. Cancer normal breast tissue pathological tissue (adenoma and invasive carcinoma) tissue Up 20560667 2239 EF1B_HUMAN ENSP00000376055 Breast Cancer Normal vs. Cancer normal breast tissue pathological tissue (adenoma and invasive carcinoma) tissue Up 20560667 2240 CALR_HUMAN ENSP00000320866 Breast Cancer Normal vs. Cancer normal breast tissue pathological tissue (adenoma and invasive carcinoma) tissue Up 20560667 2241 S10AB_HUMAN ENSP00000271638 Breast Cancer Normal vs. Cancer normal breast tissue pathological tissue (adenoma and invasive carcinoma) tissue Up 20560667 2242 TPIS_HUMAN ENSP00000379933 Breast Cancer Normal vs. Cancer normal breast tissue pathological tissue (adenoma and invasive carcinoma) tissue Up 20560667 2243 ENOA_HUMAN ENSP00000234590 Breast Cancer Cancer vs. Cancer (Non-TNBC vs. TNBC) a hormone-receptor-positive-Her2-negative (Non-TNBC, Case B) tumor specimen triple negative breast cancer (TNBC, Case A) tumor specimen cell line Up 20596302 2244 ANXA6_HUMAN ENSP00000346550 Breast Cancer Cancer vs. Cancer (Non-TNBC vs. TNBC) a hormone-receptor-positive-Her2-negative (Non-TNBC, Case B) tumor specimen triple negative breast cancer (TNBC, Case A) tumor specimen cell line Up 20596302 2245 HSP7C_HUMAN ENSP00000227378 Breast Cancer Cancer vs. Cancer (Non-TNBC vs. TNBC) a hormone-receptor-positive-Her2-negative (Non-TNBC, Case B) tumor specimen triple negative breast cancer (TNBC, Case A) tumor specimen cell line Up 20596302 2246 EF2_HUMAN ENSP00000307940 Breast Cancer Cancer vs. Cancer (Non-TNBC vs. TNBC) a hormone-receptor-positive-Her2-negative (Non-TNBC, Case B) tumor specimen triple negative breast cancer (TNBC, Case A) tumor specimen cell line Up 20596302 2247 KPYM_HUMAN ENSP00000334983 Breast Cancer Cancer vs. Cancer (Non-TNBC vs. TNBC) a hormone-receptor-positive-Her2-negative (Non-TNBC, Case B) tumor specimen triple negative breast cancer (TNBC, Case A) tumor specimen cell line Up 20596302 2248 ENPL_HUMAN ENSP00000299767 Breast Cancer Cancer vs. Cancer (Non-TNBC vs. TNBC) a hormone-receptor-positive-Her2-negative (Non-TNBC, Case B) tumor specimen triple negative breast cancer (TNBC, Case A) tumor specimen cell line Up 20596302 2249 EFTU_HUMAN ENSP00000322439 Breast Cancer Cancer vs. Cancer (Non-TNBC vs. TNBC) a hormone-receptor-positive-Her2-negative (Non-TNBC, Case B) tumor specimen triple negative breast cancer (TNBC, Case A) tumor specimen cell line Up 20596302 2250 PSA7_HUMAN ENSP00000359910 Breast Cancer Cancer vs. Cancer (Non-TNBC vs. TNBC) MCF7(hormone receptor positive but Her2 negative breast cancer,Non-TNBC) MDAMB231 cells (TNBC) cell line Up 20596302 2251 ANXA1_HUMAN ENSP00000366109 Breast Cancer Cancer vs. Cancer (Non-TNBC vs. TNBC) MCF7(hormone receptor positive but Her2 negative breast cancer,Non-TNBC) MDAMB231 cells (TNBC) cell line Up 20596302 2252 ITB1_HUMAN ENSP00000379350 Breast Cancer Cancer vs. Cancer (Non-TNBC vs. TNBC) MCF7(hormone receptor positive but Her2 negative breast cancer,Non-TNBC) MDAMB231 cells (TNBC) cell line Up 20596302 2253 ENOA_HUMAN ENSP00000234590 Breast Cancer Cancer vs. Cancer (Non-TNBC vs. TNBC) MCF7(hormone receptor positive but Her2 negative breast cancer,Non-TNBC) MDAMB231 cells (TNBC) cell line Up 20596302 2254 ANXA2_HUMAN ENSP00000411352 Breast Cancer Cancer vs. Cancer (Non-TNBC vs. TNBC) MCF7(hormone receptor positive but Her2 negative breast cancer,Non-TNBC) MDAMB231 cells (TNBC) cell line Up 20596302 2255 RALA_HUMAN ENSP00000005257 Breast Cancer Cancer vs. Cancer (Non-TNBC vs. TNBC) MCF7(hormone receptor positive but Her2 negative breast cancer,Non-TNBC) MDAMB231 cells (TNBC) cell line Up 20596302 2256 UBA1_HUMAN ENSP00000338413 Breast Cancer Cancer vs. Cancer (Non-TNBC vs. TNBC) MCF7(hormone receptor positive but Her2 negative breast cancer,Non-TNBC) MDAMB231 cells (TNBC) cell line Up 20596302 2257 ITA6_HUMAN ENSP00000341078 Breast Cancer Cancer vs. Cancer (Non-TNBC vs. TNBC) MCF7(hormone receptor positive but Her2 negative breast cancer,Non-TNBC) MDAMB231 cells (TNBC) cell line Up 20596302 2258 PRS7_HUMAN ENSP00000292644 Breast Cancer Cancer vs. Cancer (Non-TNBC vs. TNBC) MCF7(hormone receptor positive but Her2 negative breast cancer,Non-TNBC) MDAMB231 cells (TNBC) cell line Up 20596302 2259 EF1A1_HUMAN ENSP00000330054 Breast Cancer Cancer vs. Cancer (Non-TNBC vs. TNBC) MCF7(hormone receptor positive but Her2 negative breast cancer,Non-TNBC) MDAMB231 cells (TNBC) cell line Up 20596302 2260 ALBU_HUMAN ENSP00000295897 Neoplasms by Histologic Type Cancer vs. Cancer (ER- vs ER+) ERa (-) whole human breast tissue samples ERa (+) whole human breast tissue samples tissue Down 0.17 20602252 2261 ALBU_HUMAN ENSP00000295897 Neoplasms by Histologic Type Cancer vs. Cancer (ER- vs ER+) ERa (-) whole human breast tissue samples ERa (+) whole human breast tissue samples tissue Down 0.23 20602252 2262 SSX2_HUMAN ENSP00000364665 Neoplasms by Histologic Type Cancer vs. Cancer (ER- vs ER+) ERa (-) whole human breast tissue samples ERa (+) whole human breast tissue samples tissue Down 0.46 20602252 2263 APOA1_HUMAN ENSP00000236850 Neoplasms by Histologic Type Cancer vs. Cancer (ER- vs ER+) ERa (-) whole human breast tissue samples ERa (+) whole human breast tissue samples tissue Down 0.87 20602252 2264 ACTB_HUMAN ENSP00000349960 Neoplasms by Histologic Type Cancer vs. Cancer (ER- vs ER+) ERa (-) whole human breast tissue samples ERa (+) whole human breast tissue samples tissue Up 1.6 20602252 2265 SODC_HUMAN ENSP00000270142 Neoplasms by Histologic Type Cancer vs. Cancer (ER- vs ER+) ERa (-) whole human breast tissue samples ERa (+) whole human breast tissue samples tissue Up 2.5 20602252 2266 S10AB_HUMAN ENSP00000271638 Neoplasms by Histologic Type Cancer vs. Cancer (ER- vs ER+) ERa (-) whole human breast tissue samples ERa (+) whole human breast tissue samples tissue Up 3 20602252 2267 NDKA_HUMAN ENSP00000013034 Neoplasms by Histologic Type Cancer vs. Cancer (ER- vs ER+) ERa (-) whole human breast tissue samples ERa (+) whole human breast tissue samples tissue Up 3.3 20602252 2268 TAGL_HUMAN ENSP00000278968 Breast Cancer Normal vs. Cancer non-cancerous, normal breast epithelial (NBE) samples estrogen receptor (ER)-positive (luminal subtype), invasive malignant breast epithelial (MBE) samples tissue Down 0.57 20739354 2269 TBA4A_HUMAN ENSP00000248437 Breast Cancer Normal vs. Cancer non-cancerous, normal breast epithelial (NBE) samples estrogen receptor (ER)-positive (luminal subtype), invasive malignant breast epithelial (MBE) samples tissue Down 0.57 20739354 2270 TPM2_HUMAN ENSP00000354219 Breast Cancer Normal vs. Cancer non-cancerous, normal breast epithelial (NBE) samples estrogen receptor (ER)-positive (luminal subtype), invasive malignant breast epithelial (MBE) samples tissue Down 0.6 20739354 2271 CTNB1_HUMAN ENSP00000379488 Breast Cancer Normal vs. Cancer non-cancerous, normal breast epithelial (NBE) samples estrogen receptor (ER)-positive (luminal subtype), invasive malignant breast epithelial (MBE) samples tissue Down 0.63 20739354 2272 CSRP1_HUMAN ENSP00000345079 Breast Cancer Normal vs. Cancer non-cancerous, normal breast epithelial (NBE) samples estrogen receptor (ER)-positive (luminal subtype), invasive malignant breast epithelial (MBE) samples tissue Down 0.66 20739354 2273 LAMC1_HUMAN ENSP00000258341 Breast Cancer Normal vs. Cancer non-cancerous, normal breast epithelial (NBE) samples estrogen receptor (ER)-positive (luminal subtype), invasive malignant breast epithelial (MBE) samples tissue Down 0.67 20739354 2274 NID1_HUMAN ENSP00000264187 Breast Cancer Normal vs. Cancer non-cancerous, normal breast epithelial (NBE) samples estrogen receptor (ER)-positive (luminal subtype), invasive malignant breast epithelial (MBE) samples tissue Down 0.67 20739354 2275 AOFB_HUMAN ENSP00000367309 Breast Cancer Normal vs. Cancer non-cancerous, normal breast epithelial (NBE) samples estrogen receptor (ER)-positive (luminal subtype), invasive malignant breast epithelial (MBE) samples tissue Down 0.69 20739354 2276 ACTA_HUMAN ENSP00000402373 Breast Cancer Normal vs. Cancer non-cancerous, normal breast epithelial (NBE) samples estrogen receptor (ER)-positive (luminal subtype), invasive malignant breast epithelial (MBE) samples tissue Down 0.73 20739354 2277 ANXA1_HUMAN ENSP00000366109 Breast Cancer Normal vs. Cancer non-cancerous, normal breast epithelial (NBE) samples estrogen receptor (ER)-positive (luminal subtype), invasive malignant breast epithelial (MBE) samples tissue Down 0.74 20739354 2278 CALD1_HUMAN ENSP00000354826 Breast Cancer Normal vs. Cancer non-cancerous, normal breast epithelial (NBE) samples estrogen receptor (ER)-positive (luminal subtype), invasive malignant breast epithelial (MBE) samples tissue Down 0.75 20739354 2279 SPB5_HUMAN ENSP00000372221 Breast Cancer Normal vs. Cancer non-cancerous, normal breast epithelial (NBE) samples estrogen receptor (ER)-positive (luminal subtype), invasive malignant breast epithelial (MBE) samples tissue Down 0.78 20739354 2280 PGS2_HUMAN ENSP00000376862 Breast Cancer Normal vs. Cancer non-cancerous, normal breast epithelial (NBE) samples estrogen receptor (ER)-positive (luminal subtype), invasive malignant breast epithelial (MBE) samples tissue Down 0.82 20739354 2281 IGHA1_HUMAN ENSP00000374989 Breast Cancer Normal vs. Cancer non-cancerous, normal breast epithelial (NBE) samples estrogen receptor (ER)-positive (luminal subtype), invasive malignant breast epithelial (MBE) samples tissue Down 0.82 20739354 2282 AMPN_HUMAN ENSP00000300060 Breast Cancer Normal vs. Cancer non-cancerous, normal breast epithelial (NBE) samples estrogen receptor (ER)-positive (luminal subtype), invasive malignant breast epithelial (MBE) samples tissue Down 0.84 20739354 2283 MYLK_HUMAN ENSP00000353452 Breast Cancer Normal vs. Cancer non-cancerous, normal breast epithelial (NBE) samples estrogen receptor (ER)-positive (luminal subtype), invasive malignant breast epithelial (MBE) samples tissue Down 0.89 20739354 2284 GSTP1_HUMAN ENSP00000381607 Breast Cancer Normal vs. Cancer non-cancerous, normal breast epithelial (NBE) samples estrogen receptor (ER)-positive (luminal subtype), invasive malignant breast epithelial (MBE) samples tissue Down 0.92 20739354 2285 PGBM_HUMAN ENSP00000363827 Breast Cancer Normal vs. Cancer non-cancerous, normal breast epithelial (NBE) samples estrogen receptor (ER)-positive (luminal subtype), invasive malignant breast epithelial (MBE) samples tissue Down 0.99 20739354 2286 HSPB1_HUMAN ENSP00000248553 Breast Cancer Normal vs. Cancer non-cancerous, normal breast epithelial (NBE) samples estrogen receptor (ER)-positive (luminal subtype), invasive malignant breast epithelial (MBE) samples tissue Up 0.57 20739354 2287 RAB14_HUMAN ENSP00000362946 Breast Cancer Normal vs. Cancer non-cancerous, normal breast epithelial (NBE) samples estrogen receptor (ER)-positive (luminal subtype), invasive malignant breast epithelial (MBE) samples tissue Up 0.59 20739354 2288 SPRE_HUMAN ENSP00000234454 Breast Cancer Normal vs. Cancer non-cancerous, normal breast epithelial (NBE) samples estrogen receptor (ER)-positive (luminal subtype), invasive malignant breast epithelial (MBE) samples tissue Up 0.6 20739354 2289 PSA6_HUMAN ENSP00000261479 Breast Cancer Normal vs. Cancer non-cancerous, normal breast epithelial (NBE) samples estrogen receptor (ER)-positive (luminal subtype), invasive malignant breast epithelial (MBE) samples tissue Up 0.63 20739354 2290 ACLY_HUMAN ENSP00000253792 Breast Cancer Normal vs. Cancer non-cancerous, normal breast epithelial (NBE) samples estrogen receptor (ER)-positive (luminal subtype), invasive malignant breast epithelial (MBE) samples tissue Up 0.64 20739354 2291 NDKA_HUMAN ENSP00000013034 Breast Cancer Normal vs. Cancer non-cancerous, normal breast epithelial (NBE) samples estrogen receptor (ER)-positive (luminal subtype), invasive malignant breast epithelial (MBE) samples tissue Up 0.66 20739354 2292 H2AX_HUMAN ENSP00000364310 Breast Cancer Normal vs. Cancer non-cancerous, normal breast epithelial (NBE) samples estrogen receptor (ER)-positive (luminal subtype), invasive malignant breast epithelial (MBE) samples tissue Up 0.67 20739354 2293 DDX5_HUMAN ENSP00000225792 Breast Cancer Normal vs. Cancer non-cancerous, normal breast epithelial (NBE) samples estrogen receptor (ER)-positive (luminal subtype), invasive malignant breast epithelial (MBE) samples tissue Up 0.67 20739354 2294 PHS_HUMAN ENSP00000299299 Breast Cancer Normal vs. Cancer non-cancerous, normal breast epithelial (NBE) samples estrogen receptor (ER)-positive (luminal subtype), invasive malignant breast epithelial (MBE) samples tissue Up 0.67 20739354 2295 USO1_HUMAN ENSP00000264904 Breast Cancer Normal vs. Cancer non-cancerous, normal breast epithelial (NBE) samples estrogen receptor (ER)-positive (luminal subtype), invasive malignant breast epithelial (MBE) samples tissue Up 0.67 20739354 2296 GFPT1_HUMAN ENSP00000349860 Breast Cancer Normal vs. Cancer non-cancerous, normal breast epithelial (NBE) samples estrogen receptor (ER)-positive (luminal subtype), invasive malignant breast epithelial (MBE) samples tissue Up 0.78 20739354 2297 BIEA_HUMAN ENSP00000385757 Breast Cancer Normal vs. Cancer non-cancerous, normal breast epithelial (NBE) samples estrogen receptor (ER)-positive (luminal subtype), invasive malignant breast epithelial (MBE) samples tissue Up 0.78 20739354 2298 FINC_HUMAN ENSP00000352696 Breast Cancer Normal vs. Cancer non-cancerous, normal breast epithelial (NBE) samples estrogen receptor (ER)-positive (luminal subtype), invasive malignant breast epithelial (MBE) samples tissue Up 0.99 20739354 2299 H2B1C_HUMAN ENSP00000244601 Breast Cancer Normal vs. Cancer non-cancerous, normal breast epithelial (NBE) samples estrogen receptor (ER)-positive (luminal subtype), invasive malignant breast epithelial (MBE) samples tissue Down 0.42 20739354 2300 H2B1B_HUMAN ENSP00000350580 Breast Cancer Normal vs. Cancer non-cancerous, normal breast epithelial (NBE) samples estrogen receptor (ER)-positive (luminal subtype), invasive malignant breast epithelial (MBE) samples tissue Down 0.42 20739354 2301 H2B3B_HUMAN ENSP00000375736 Breast Cancer Normal vs. Cancer non-cancerous, normal breast epithelial (NBE) samples estrogen receptor (ER)-positive (luminal subtype), invasive malignant breast epithelial (MBE) samples tissue Down 0.42 20739354 2302 AT2B1_HUMAN ENSP00000392043 Breast Cancer Normal vs. Cancer non-cancerous, normal breast epithelial (NBE) samples estrogen receptor (ER)-positive (luminal subtype), invasive malignant breast epithelial (MBE) samples tissue Down 0.43 20739354 2303 CTND1_HUMAN ENSP00000382004 Breast Cancer Normal vs. Cancer non-cancerous, normal breast epithelial (NBE) samples estrogen receptor (ER)-positive (luminal subtype), invasive malignant breast epithelial (MBE) samples tissue Down 0.43 20739354 2304 SPTN1_HUMAN ENSP00000361816 Breast Cancer Normal vs. Cancer non-cancerous, normal breast epithelial (NBE) samples estrogen receptor (ER)-positive (luminal subtype), invasive malignant breast epithelial (MBE) samples tissue Down 0.44 20739354 2305 NEP_HUMAN ENSP00000353679 Breast Cancer Normal vs. Cancer non-cancerous, normal breast epithelial (NBE) samples estrogen receptor (ER)-positive (luminal subtype), invasive malignant breast epithelial (MBE) samples tissue Down 0.44 20739354 2306 PYGB_HUMAN ENSP00000216962 Breast Cancer Normal vs. Cancer non-cancerous, normal breast epithelial (NBE) samples estrogen receptor (ER)-positive (luminal subtype), invasive malignant breast epithelial (MBE) samples tissue Down 0.44 20739354 2307 ADDA_HUMAN ENSP00000399828 Breast Cancer Normal vs. Cancer non-cancerous, normal breast epithelial (NBE) samples estrogen receptor (ER)-positive (luminal subtype), invasive malignant breast epithelial (MBE) samples tissue Down 0.44 20739354 2308 CAV1_HUMAN ENSP00000339191 Breast Cancer Normal vs. Cancer non-cancerous, normal breast epithelial (NBE) samples estrogen receptor (ER)-positive (luminal subtype), invasive malignant breast epithelial (MBE) samples tissue Down 0.44 20739354 2309 H2B1D_HUMAN ENSP00000367008 Breast Cancer Normal vs. Cancer non-cancerous, normal breast epithelial (NBE) samples estrogen receptor (ER)-positive (luminal subtype), invasive malignant breast epithelial (MBE) samples tissue Down 0.45 20739354 2310 VINC_HUMAN ENSP00000211998 Breast Cancer Normal vs. Cancer non-cancerous, normal breast epithelial (NBE) samples estrogen receptor (ER)-positive (luminal subtype), invasive malignant breast epithelial (MBE) samples tissue Down 0.45 20739354 2311 SODM_HUMAN ENSP00000337127 Breast Cancer Normal vs. Cancer non-cancerous, normal breast epithelial (NBE) samples estrogen receptor (ER)-positive (luminal subtype), invasive malignant breast epithelial (MBE) samples tissue Down 0.46 20739354 2312 COMT_HUMAN ENSP00000385150 Breast Cancer Normal vs. Cancer non-cancerous, normal breast epithelial (NBE) samples estrogen receptor (ER)-positive (luminal subtype), invasive malignant breast epithelial (MBE) samples tissue Down 0.46 20739354 2313 ODPA_HUMAN ENSP00000440761 Breast Cancer Normal vs. Cancer non-cancerous, normal breast epithelial (NBE) samples estrogen receptor (ER)-positive (luminal subtype), invasive malignant breast epithelial (MBE) samples tissue Down 0.47 20739354 2314 TRFL_HUMAN ENSP00000231751 Breast Cancer Normal vs. Cancer non-cancerous, normal breast epithelial (NBE) samples estrogen receptor (ER)-positive (luminal subtype), invasive malignant breast epithelial (MBE) samples tissue Down 0.48 20739354 2315 FLNA_HUMAN ENSP00000358866 Breast Cancer Normal vs. Cancer non-cancerous, normal breast epithelial (NBE) samples estrogen receptor (ER)-positive (luminal subtype), invasive malignant breast epithelial (MBE) samples tissue Down 0.48 20739354 2316 GTF2I_HUMAN ENSP00000322542 Breast Cancer Normal vs. Cancer non-cancerous, normal breast epithelial (NBE) samples estrogen receptor (ER)-positive (luminal subtype), invasive malignant breast epithelial (MBE) samples tissue Down 0.48 20739354 2317 TACD2_HUMAN ENSP00000360269 Breast Cancer Normal vs. Cancer non-cancerous, normal breast epithelial (NBE) samples estrogen receptor (ER)-positive (luminal subtype), invasive malignant breast epithelial (MBE) samples tissue Down 0.49 20739354 2318 DPYL2_HUMAN ENSP00000309539 Breast Cancer Normal vs. Cancer non-cancerous, normal breast epithelial (NBE) samples estrogen receptor (ER)-positive (luminal subtype), invasive malignant breast epithelial (MBE) samples tissue Down 0.49 20739354 2319 FBRL_HUMAN ENSP00000221801 Breast Cancer Normal vs. Cancer non-cancerous, normal breast epithelial (NBE) samples estrogen receptor (ER)-positive (luminal subtype), invasive malignant breast epithelial (MBE) samples tissue Down 0.5 20739354 2320 APOA2_HUMAN ENSP00000356969 Breast Cancer Normal vs. Cancer non-cancerous, normal breast epithelial (NBE) samples estrogen receptor (ER)-positive (luminal subtype), invasive malignant breast epithelial (MBE) samples tissue Down 0.52 20739354 2321 MYL9_HUMAN ENSP00000279022 Breast Cancer Normal vs. Cancer non-cancerous, normal breast epithelial (NBE) samples estrogen receptor (ER)-positive (luminal subtype), invasive malignant breast epithelial (MBE) samples tissue Down 0.53 20739354 2322 APOA1_HUMAN ENSP00000236850 Breast Cancer Normal vs. Cancer non-cancerous, normal breast epithelial (NBE) samples estrogen receptor (ER)-positive (luminal subtype), invasive malignant breast epithelial (MBE) samples tissue Down 0.53 20739354 2323 SPTB2_HUMAN ENSP00000349259 Breast Cancer Normal vs. Cancer non-cancerous, normal breast epithelial (NBE) samples estrogen receptor (ER)-positive (luminal subtype), invasive malignant breast epithelial (MBE) samples tissue Down 0.54 20739354 2324 COIA1_HUMAN ENSP00000352798 Breast Cancer Normal vs. Cancer non-cancerous, normal breast epithelial (NBE) samples estrogen receptor (ER)-positive (luminal subtype), invasive malignant breast epithelial (MBE) samples tissue Down 0.56 20739354 2325 NEST_HUMAN ENSP00000357206 Breast Cancer Normal vs. Cancer non-cancerous, normal breast epithelial (NBE) samples estrogen receptor (ER)-positive (luminal subtype), invasive malignant breast epithelial (MBE) samples tissue Down 0.56 20739354 2326 TAGL_HUMAN ENSP00000278968 Breast Cancer Normal vs. Cancer non-cancerous, normal breast epithelial (NBE) samples estrogen receptor (ER)-positive (luminal subtype), invasive malignant breast epithelial (MBE) samples tissue Down 0.57 20739354 2327 TBA4A_HUMAN ENSP00000248437 Breast Cancer Normal vs. Cancer non-cancerous, normal breast epithelial (NBE) samples estrogen receptor (ER)-positive (luminal subtype), invasive malignant breast epithelial (MBE) samples tissue Down 0.57 20739354 2328 TPM2_HUMAN ENSP00000354219 Breast Cancer Normal vs. Cancer non-cancerous, normal breast epithelial (NBE) samples estrogen receptor (ER)-positive (luminal subtype), invasive malignant breast epithelial (MBE) samples tissue Down 0.6 20739354 2329 CTNB1_HUMAN ENSP00000379488 Breast Cancer Normal vs. Cancer non-cancerous, normal breast epithelial (NBE) samples estrogen receptor (ER)-positive (luminal subtype), invasive malignant breast epithelial (MBE) samples tissue Down 0.63 20739354 2330 CSRP1_HUMAN ENSP00000345079 Breast Cancer Normal vs. Cancer non-cancerous, normal breast epithelial (NBE) samples estrogen receptor (ER)-positive (luminal subtype), invasive malignant breast epithelial (MBE) samples tissue Down 0.66 20739354 2331 LAMC1_HUMAN ENSP00000258341 Breast Cancer Normal vs. Cancer non-cancerous, normal breast epithelial (NBE) samples estrogen receptor (ER)-positive (luminal subtype), invasive malignant breast epithelial (MBE) samples tissue Down 0.67 20739354 2332 NID1_HUMAN ENSP00000264187 Breast Cancer Normal vs. Cancer non-cancerous, normal breast epithelial (NBE) samples estrogen receptor (ER)-positive (luminal subtype), invasive malignant breast epithelial (MBE) samples tissue Down 0.67 20739354 2333 AOFB_HUMAN ENSP00000367309 Breast Cancer Normal vs. Cancer non-cancerous, normal breast epithelial (NBE) samples estrogen receptor (ER)-positive (luminal subtype), invasive malignant breast epithelial (MBE) samples tissue Down 0.69 20739354 2334 ACTA_HUMAN ENSP00000402373 Breast Cancer Normal vs. Cancer non-cancerous, normal breast epithelial (NBE) samples estrogen receptor (ER)-positive (luminal subtype), invasive malignant breast epithelial (MBE) samples tissue Down 0.73 20739354 2335 ANXA1_HUMAN ENSP00000366109 Breast Cancer Normal vs. Cancer non-cancerous, normal breast epithelial (NBE) samples estrogen receptor (ER)-positive (luminal subtype), invasive malignant breast epithelial (MBE) samples tissue Down 0.74 20739354 2336 CALD1_HUMAN ENSP00000354826 Breast Cancer Normal vs. Cancer non-cancerous, normal breast epithelial (NBE) samples estrogen receptor (ER)-positive (luminal subtype), invasive malignant breast epithelial (MBE) samples tissue Down 0.75 20739354 2337 SPB5_HUMAN ENSP00000372221 Breast Cancer Normal vs. Cancer non-cancerous, normal breast epithelial (NBE) samples estrogen receptor (ER)-positive (luminal subtype), invasive malignant breast epithelial (MBE) samples tissue Down 0.78 20739354 2338 PGS2_HUMAN ENSP00000376862 Breast Cancer Normal vs. Cancer non-cancerous, normal breast epithelial (NBE) samples estrogen receptor (ER)-positive (luminal subtype), invasive malignant breast epithelial (MBE) samples tissue Down 0.82 20739354 2339 IGHA1_HUMAN ENSP00000374989 Breast Cancer Normal vs. Cancer non-cancerous, normal breast epithelial (NBE) samples estrogen receptor (ER)-positive (luminal subtype), invasive malignant breast epithelial (MBE) samples tissue Down 0.82 20739354 2340 AMPN_HUMAN ENSP00000300060 Breast Cancer Normal vs. Cancer non-cancerous, normal breast epithelial (NBE) samples estrogen receptor (ER)-positive (luminal subtype), invasive malignant breast epithelial (MBE) samples tissue Down 0.84 20739354 2341 MYLK_HUMAN ENSP00000353452 Breast Cancer Normal vs. Cancer non-cancerous, normal breast epithelial (NBE) samples estrogen receptor (ER)-positive (luminal subtype), invasive malignant breast epithelial (MBE) samples tissue Down 0.89 20739354 2342 GSTP1_HUMAN ENSP00000381607 Breast Cancer Normal vs. Cancer non-cancerous, normal breast epithelial (NBE) samples estrogen receptor (ER)-positive (luminal subtype), invasive malignant breast epithelial (MBE) samples tissue Down 0.92 20739354 2343 PGBM_HUMAN ENSP00000363827 Breast Cancer Normal vs. Cancer non-cancerous, normal breast epithelial (NBE) samples estrogen receptor (ER)-positive (luminal subtype), invasive malignant breast epithelial (MBE) samples tissue Down 0.99 20739354 2344 RAN_HUMAN ENSP00000376176 Breast Cancer Normal vs. Cancer non-cancerous, normal breast epithelial (NBE) samples estrogen receptor (ER)-positive (luminal subtype), invasive malignant breast epithelial (MBE) samples tissue Up 0.43 20739354 2345 GDIR1_HUMAN ENSP00000269321 Breast Cancer Normal vs. Cancer non-cancerous, normal breast epithelial (NBE) samples estrogen receptor (ER)-positive (luminal subtype), invasive malignant breast epithelial (MBE) samples tissue Up 0.44 20739354 2346 ISG15_HUMAN ENSP00000368699 Breast Cancer Normal vs. Cancer non-cancerous, normal breast epithelial (NBE) samples estrogen receptor (ER)-positive (luminal subtype), invasive malignant breast epithelial (MBE) samples tissue Up 0.44 20739354 2347 PTN1_HUMAN ENSP00000360683 Breast Cancer Normal vs. Cancer non-cancerous, normal breast epithelial (NBE) samples estrogen receptor (ER)-positive (luminal subtype), invasive malignant breast epithelial (MBE) samples tissue Up 0.44 20739354 2348 ARY1_HUMAN ENSP00000307218 Breast Cancer Normal vs. Cancer non-cancerous, normal breast epithelial (NBE) samples estrogen receptor (ER)-positive (luminal subtype), invasive malignant breast epithelial (MBE) samples tissue Up 0.44 20739354 2349 KAPCB_HUMAN ENSP00000359723 Breast Cancer Normal vs. Cancer non-cancerous, normal breast epithelial (NBE) samples estrogen receptor (ER)-positive (luminal subtype), invasive malignant breast epithelial (MBE) samples tissue Up 0.44 20739354 2350 CSK21_HUMAN ENSP00000217244 Breast Cancer Normal vs. Cancer non-cancerous, normal breast epithelial (NBE) samples estrogen receptor (ER)-positive (luminal subtype), invasive malignant breast epithelial (MBE) samples tissue Up 0.44 20739354 2351 PP1A_HUMAN ENSP00000365936 Breast Cancer Normal vs. Cancer non-cancerous, normal breast epithelial (NBE) samples estrogen receptor (ER)-positive (luminal subtype), invasive malignant breast epithelial (MBE) samples tissue Up 0.45 20739354 2352 VIGLN_HUMAN ENSP00000312042 Breast Cancer Normal vs. Cancer non-cancerous, normal breast epithelial (NBE) samples estrogen receptor (ER)-positive (luminal subtype), invasive malignant breast epithelial (MBE) samples tissue Up 0.45 20739354 2353 CATD_HUMAN ENSP00000236671 Breast Cancer Normal vs. Cancer non-cancerous, normal breast epithelial (NBE) samples estrogen receptor (ER)-positive (luminal subtype), invasive malignant breast epithelial (MBE) samples tissue Up 0.46 20739354 2354 PP2AA_HUMAN ENSP00000418447 Breast Cancer Normal vs. Cancer non-cancerous, normal breast epithelial (NBE) samples estrogen receptor (ER)-positive (luminal subtype), invasive malignant breast epithelial (MBE) samples tissue Up 0.46 20739354 2355 LRRF1_HUMAN ENSP00000375857 Breast Cancer Normal vs. Cancer non-cancerous, normal breast epithelial (NBE) samples estrogen receptor (ER)-positive (luminal subtype), invasive malignant breast epithelial (MBE) samples tissue Up 0.46 20739354 2356 S10AB_HUMAN ENSP00000271638 Breast Cancer Normal vs. Cancer non-cancerous, normal breast epithelial (NBE) samples estrogen receptor (ER)-positive (luminal subtype), invasive malignant breast epithelial (MBE) samples tissue Up 0.46 20739354 2357 DDX3X_HUMAN ENSP00000382840 Breast Cancer Normal vs. Cancer non-cancerous, normal breast epithelial (NBE) samples estrogen receptor (ER)-positive (luminal subtype), invasive malignant breast epithelial (MBE) samples tissue Up 0.47 20739354 2358 STIP1_HUMAN ENSP00000305958 Breast Cancer Normal vs. Cancer non-cancerous, normal breast epithelial (NBE) samples estrogen receptor (ER)-positive (luminal subtype), invasive malignant breast epithelial (MBE) samples tissue Up 0.48 20739354 2359 F16P1_HUMAN ENSP00000408025 Breast Cancer Normal vs. Cancer non-cancerous, normal breast epithelial (NBE) samples estrogen receptor (ER)-positive (luminal subtype), invasive malignant breast epithelial (MBE) samples tissue Up 0.49 20739354 2360 NSUN2_HUMAN ENSP00000264670 Breast Cancer Normal vs. Cancer non-cancerous, normal breast epithelial (NBE) samples estrogen receptor (ER)-positive (luminal subtype), invasive malignant breast epithelial (MBE) samples tissue Up 0.5 20739354 2361 GORS2_HUMAN ENSP00000234160 Breast Cancer Normal vs. Cancer non-cancerous, normal breast epithelial (NBE) samples estrogen receptor (ER)-positive (luminal subtype), invasive malignant breast epithelial (MBE) samples tissue Up 0.51 20739354 2362 HS105_HUMAN ENSP00000318687 Breast Cancer Normal vs. Cancer non-cancerous, normal breast epithelial (NBE) samples estrogen receptor (ER)-positive (luminal subtype), invasive malignant breast epithelial (MBE) samples tissue Up 0.52 20739354 2363 SCAM3_HUMAN ENSP00000307275 Breast Cancer Normal vs. Cancer non-cancerous, normal breast epithelial (NBE) samples estrogen receptor (ER)-positive (luminal subtype), invasive malignant breast epithelial (MBE) samples tissue Up 0.54 20739354 2364 IFM1_HUMAN ENSP00000386187 Breast Cancer Normal vs. Cancer non-cancerous, normal breast epithelial (NBE) samples estrogen receptor (ER)-positive (luminal subtype), invasive malignant breast epithelial (MBE) samples tissue Up 0.56 20739354 2365 HSPB1_HUMAN ENSP00000248553 Breast Cancer Normal vs. Cancer non-cancerous, normal breast epithelial (NBE) samples estrogen receptor (ER)-positive (luminal subtype), invasive malignant breast epithelial (MBE) samples tissue Up 0.57 20739354 2366 RAB14_HUMAN ENSP00000362946 Breast Cancer Normal vs. Cancer non-cancerous, normal breast epithelial (NBE) samples estrogen receptor (ER)-positive (luminal subtype), invasive malignant breast epithelial (MBE) samples tissue Up 0.59 20739354 2367 SPRE_HUMAN ENSP00000234454 Breast Cancer Normal vs. Cancer non-cancerous, normal breast epithelial (NBE) samples estrogen receptor (ER)-positive (luminal subtype), invasive malignant breast epithelial (MBE) samples tissue Up 0.6 20739354 2368 PSA6_HUMAN ENSP00000261479 Breast Cancer Normal vs. Cancer non-cancerous, normal breast epithelial (NBE) samples estrogen receptor (ER)-positive (luminal subtype), invasive malignant breast epithelial (MBE) samples tissue Up 0.63 20739354 2369 ACLY_HUMAN ENSP00000253792 Breast Cancer Normal vs. Cancer non-cancerous, normal breast epithelial (NBE) samples estrogen receptor (ER)-positive (luminal subtype), invasive malignant breast epithelial (MBE) samples tissue Up 0.64 20739354 2370 NDKA_HUMAN ENSP00000013034 Breast Cancer Normal vs. Cancer non-cancerous, normal breast epithelial (NBE) samples estrogen receptor (ER)-positive (luminal subtype), invasive malignant breast epithelial (MBE) samples tissue Up 0.66 20739354 2371 H2AX_HUMAN ENSP00000364310 Breast Cancer Normal vs. Cancer non-cancerous, normal breast epithelial (NBE) samples estrogen receptor (ER)-positive (luminal subtype), invasive malignant breast epithelial (MBE) samples tissue Up 0.67 20739354 2372 DDX5_HUMAN ENSP00000225792 Breast Cancer Normal vs. Cancer non-cancerous, normal breast epithelial (NBE) samples estrogen receptor (ER)-positive (luminal subtype), invasive malignant breast epithelial (MBE) samples tissue Up 0.67 20739354 2373 PHS_HUMAN ENSP00000299299 Breast Cancer Normal vs. Cancer non-cancerous, normal breast epithelial (NBE) samples estrogen receptor (ER)-positive (luminal subtype), invasive malignant breast epithelial (MBE) samples tissue Up 0.67 20739354 2374 USO1_HUMAN ENSP00000264904 Breast Cancer Normal vs. Cancer non-cancerous, normal breast epithelial (NBE) samples estrogen receptor (ER)-positive (luminal subtype), invasive malignant breast epithelial (MBE) samples tissue Up 0.67 20739354 2375 GFPT1_HUMAN ENSP00000349860 Breast Cancer Normal vs. Cancer non-cancerous, normal breast epithelial (NBE) samples estrogen receptor (ER)-positive (luminal subtype), invasive malignant breast epithelial (MBE) samples tissue Up 0.78 20739354 2376 BIEA_HUMAN ENSP00000385757 Breast Cancer Normal vs. Cancer non-cancerous, normal breast epithelial (NBE) samples estrogen receptor (ER)-positive (luminal subtype), invasive malignant breast epithelial (MBE) samples tissue Up 0.78 20739354 2377 FINC_HUMAN ENSP00000352696 Breast Cancer Normal vs. Cancer non-cancerous, normal breast epithelial (NBE) samples estrogen receptor (ER)-positive (luminal subtype), invasive malignant breast epithelial (MBE) samples tissue Up 0.99 20739354 2378 APOA1_HUMAN ENSP00000236850 Breast Cancer Treatment (pre- vs. post-chemotherapy) sera from 39 HER2-postive breast cancer patients before chemotherapy sera from 39 HER2-postive breast cancer patients after chemotherapy tissue Down 20827732 2379 APOA1_HUMAN ENSP00000236850 Breast Cancer Treatment (pre- vs. post-chemotherapy) sera from 39 HER2-postive breast cancer patients before chemotherapy sera from 39 HER2-postive breast cancer patients after chemotherapy tissue Up 20827732 2380 LMNA_HUMAN ENSP00000357283 Breast Cancer Normal vs. Cancer normal zones interface zones tissue Down 0.88 20857901 2381 FGF5_HUMAN ENSP00000311697 Breast Cancer Normal vs. Cancer normal zones interface zones tissue Down 0.98 20857901 2382 NDKA_HUMAN ENSP00000013034 Breast Cancer Normal vs. Cancer normal zones interface zones tissue Up 1.8 20857901 2383 GDIR1_HUMAN ENSP00000269321 Breast Cancer Normal vs. Cancer normal zones interface zones tissue Up 2.2 20857901 2384 K2C8_HUMAN ENSP00000293308 Breast Cancer Normal vs. Cancer normal zones interface zones tissue Up 96 20857901 2385 NDKA_HUMAN ENSP00000013034 Breast Cancer Normal vs. Cancer interface zones tumor zones tissue Down 0.23 20857901 2386 FGF5_HUMAN ENSP00000311697 Breast Cancer Normal vs. Cancer interface zones tumor zones tissue Down 0.33 20857901 2387 LMNA_HUMAN ENSP00000357283 Breast Cancer Normal vs. Cancer interface zones tumor zones tissue Down 0.34 20857901 2388 K2C8_HUMAN ENSP00000293308 Breast Cancer Normal vs. Cancer interface zones tumor zones tissue Down 0.34 20857901 2389 GDIR1_HUMAN ENSP00000269321 Breast Cancer Normal vs. Cancer interface zones tumor zones tissue Down 0.39 20857901 2390 LMNA_HUMAN ENSP00000357283 Breast Cancer Normal vs. Cancer normal zones tumor zones tissue Up 2.6 20857901 2391 FGF5_HUMAN ENSP00000311697 Breast Cancer Normal vs. Cancer normal zones tumor zones tissue Up 3 20857901 2392 GDIR1_HUMAN ENSP00000269321 Breast Cancer Normal vs. Cancer normal zones tumor zones tissue Up 5.6 20857901 2393 NDKA_HUMAN ENSP00000013034 Breast Cancer Normal vs. Cancer normal zones tumor zones tissue Up 7.8 20857901 2394 K2C8_HUMAN ENSP00000293308 Breast Cancer Normal vs. Cancer normal zones tumor zones tissue Up 280 20857901 2395 K1C14_HUMAN ENSP00000167586 breast ductal carcinoma Normal vs. Cancer normal tissue adjacent to the tumour tissue from Malaysian Chinese patients cancerous tissues from Malaysian Chinese patients tissue Down 18564057 2396 ALBU_HUMAN ENSP00000295897 breast ductal carcinoma Normal vs. Cancer normal tissue adjacent to the tumour tissue from Malaysian Chinese patients cancerous tissues from Malaysian Chinese patients tissue Down 18564057 2397 VIME_HUMAN ENSP00000224237 breast ductal carcinoma Normal vs. Cancer normal tissue adjacent to the tumour tissue from Malaysian Chinese patients cancerous tissues from Malaysian Chinese patients tissue Down 18564057 2398 DESM_HUMAN ENSP00000363071 breast ductal carcinoma Normal vs. Cancer normal tissue adjacent to the tumour tissue from Malaysian Chinese patients cancerous tissues from Malaysian Chinese patients tissue Down 18564057 2399 ANPRB_HUMAN ENSP00000341083 breast ductal carcinoma Normal vs. Cancer normal tissue adjacent to the tumour tissue from Malaysian Chinese patients cancerous tissues from Malaysian Chinese patients tissue Down 18564057 2400 ACTN4_HUMAN ENSP00000252699 breast ductal carcinoma Normal vs. Cancer normal tissue adjacent to the tumour tissue from Malaysian Chinese patients cancerous tissues from Malaysian Chinese patients tissue Up 18564057 2401 LMNA_HUMAN ENSP00000357283 breast ductal carcinoma Normal vs. Cancer normal tissue adjacent to the tumour tissue from Malaysian Chinese patients cancerous tissues from Malaysian Chinese patients tissue Up 18564057 2402 ANXA1_HUMAN ENSP00000366109 breast ductal carcinoma Normal vs. Cancer normal tissue adjacent to the tumour tissue from Malaysian Chinese patients cancerous tissues from Malaysian Chinese patients tissue Up 18564057 2403 G3P_HUMAN ENSP00000380068 breast ductal carcinoma Normal vs. Cancer normal tissue adjacent to the tumour tissue from Malaysian Chinese patients cancerous tissues from Malaysian Chinese patients tissue Up 18564057 2404 K1C18_HUMAN ENSP00000373489 breast ductal carcinoma Normal vs. Cancer normal tissue adjacent to the tumour tissue from Malaysian Chinese patients cancerous tissues from Malaysian Chinese patients tissue Up 18564057 2405 K2C8_HUMAN ENSP00000293308 breast ductal carcinoma Normal vs. Cancer normal tissue adjacent to the tumour tissue from Malaysian Chinese patients cancerous tissues from Malaysian Chinese patients tissue Up 18564057 2406 ENOA_HUMAN ENSP00000234590 breast ductal carcinoma Normal vs. Cancer normal tissue adjacent to the tumour tissue from Malaysian Chinese patients cancerous tissues from Malaysian Chinese patients tissue Up 18564057 2407 ANXA2_HUMAN ENSP00000411352 breast ductal carcinoma Normal vs. Cancer normal tissue adjacent to the tumour tissue from Malaysian Chinese patients cancerous tissues from Malaysian Chinese patients tissue Up 18564057 2408 CO1A2_HUMAN ENSP00000297268 breast ductal carcinoma Normal vs. Cancer normal tissue adjacent to the tumour tissue from Malaysian Chinese patients cancerous tissues from Malaysian Chinese patients tissue Up 18564057 2409 HSP7C_HUMAN ENSP00000227378 breast ductal carcinoma Normal vs. Cancer normal tissue adjacent to the tumour tissue from Malaysian Chinese patients cancerous tissues from Malaysian Chinese patients tissue Up 18564057 2410 ENPL_HUMAN ENSP00000299767 breast ductal carcinoma Normal vs. Cancer normal tissue adjacent to the tumour tissue from Malaysian Chinese patients cancerous tissues from Malaysian Chinese patients tissue Up 18564057 2411 NUCL_HUMAN ENSP00000318195 breast ductal carcinoma Normal vs. Cancer normal tissue adjacent to the tumour tissue from Malaysian Chinese patients cancerous tissues from Malaysian Chinese patients tissue Up 18564057 2412 1433B_HUMAN ENSP00000361930 breast ductal carcinoma Normal vs. Cancer normal tissue adjacent to the tumour tissue from Malaysian Chinese patients cancerous tissues from Malaysian Chinese patients tissue Up 18564057 2413 1433S_HUMAN ENSP00000340989 breast ductal carcinoma Normal vs. Cancer normal tissue adjacent to the tumour tissue from Malaysian Chinese patients cancerous tissues from Malaysian Chinese patients tissue Up 18564057 2414 CENPA_HUMAN ENSP00000336868 breast ductal carcinoma Normal vs. Cancer normal tissue adjacent to the tumour tissue from Malaysian Chinese patients cancerous tissues from Malaysian Chinese patients tissue Up 18564057 2415 1433E_HUMAN ENSP00000264335 breast ductal carcinoma Normal vs. Cancer normal tissue adjacent to the tumour tissue from Malaysian Chinese patients cancerous tissues from Malaysian Chinese patients tissue Up 18564057 2416 RAN_HUMAN ENSP00000376176 breast ductal carcinoma Normal vs. Cancer normal tissue adjacent to the tumour tissue from Malaysian Chinese patients cancerous tissues from Malaysian Chinese patients tissue Up 18564057 2417 1433Z_HUMAN ENSP00000379288 breast ductal carcinoma Normal vs. Cancer normal tissue adjacent to the tumour tissue from Malaysian Chinese patients cancerous tissues from Malaysian Chinese patients tissue Up 18564057 2418 ACTG_HUMAN ENSP00000331514 breast ductal carcinoma Normal vs. Cancer normal tissue adjacent to the tumour tissue from Malaysian Chinese patients cancerous tissues from Malaysian Chinese patients tissue Up 18564057 2419 HBA_HUMAN ENSP00000322421 Oral Cancer Normal vs. Cancer oral leukoplakia control tissues OSCC tumor tissues tissue Down 0.13 19691830 2420 ALBU_HUMAN ENSP00000295897 Oral Cancer Normal vs. Cancer oral leukoplakia control tissues OSCC tumor tissues tissue Down 0.13 19691830 2421 ANXA1_HUMAN ENSP00000366109 Oral Cancer Normal vs. Cancer oral leukoplakia control tissues OSCC tumor tissues tissue Down 0.2 19691830 2422 CALL3_HUMAN ENSP00000315299 Oral Cancer Normal vs. Cancer oral leukoplakia control tissues OSCC tumor tissues tissue Down 0.24 19691830 2423 PEBP1_HUMAN ENSP00000261313 Oral Cancer Normal vs. Cancer oral leukoplakia control tissues OSCC tumor tissues tissue Down 0.26 19691830 2424 UBE2N_HUMAN ENSP00000316176 Oral Cancer Normal vs. Cancer oral leukoplakia control tissues OSCC tumor tissues tissue Down 0.31 19691830 2425 CLIC1_HUMAN ENSP00000379229 Oral Cancer Normal vs. Cancer oral leukoplakia control tissues OSCC tumor tissues tissue Down 0.45 19691830 2426 HBB_HUMAN ENSP00000333994 Oral Cancer Normal vs. Cancer oral leukoplakia control tissues OSCC tumor tissues tissue Down 0.5 19691830 2427 HSP71_HUMAN ENSP00000364801 Oral Cancer Normal vs. Cancer oral leukoplakia control tissues OSCC tumor tissues tissue Up 2.3 19691830 2428 EF1B_HUMAN ENSP00000376055 Oral Cancer Normal vs. Cancer oral leukoplakia control tissues OSCC tumor tissues tissue Up 2.4 19691830 2429 HNRPC_HUMAN ENSP00000319690 Oral Cancer Normal vs. Cancer oral leukoplakia control tissues OSCC tumor tissues tissue Up 3 19691830 2430 COF1_HUMAN ENSP00000309629 Oral Cancer Normal vs. Cancer oral leukoplakia control tissues OSCC tumor tissues tissue Up 3.1 19691830 2431 GDIR2_HUMAN ENSP00000228945 Oral Cancer Normal vs. Cancer oral leukoplakia control tissues OSCC tumor tissues tissue Up 3.1 19691830 2432 PARK7_HUMAN ENSP00000366708 Oral Cancer Normal vs. Cancer oral leukoplakia control tissues OSCC tumor tissues tissue Up 3.2 19691830 2433 TAGL_HUMAN ENSP00000278968 Oral Cancer Normal vs. Cancer oral leukoplakia control tissues OSCC tumor tissues tissue Up 3.3 19691830 2434 GDIR1_HUMAN ENSP00000269321 Oral Cancer Normal vs. Cancer oral leukoplakia control tissues OSCC tumor tissues tissue Up 3.4 19691830 2435 ACTA_HUMAN ENSP00000402373 Oral Cancer Normal vs. Cancer oral leukoplakia control tissues OSCC tumor tissues tissue Up 3.7 19691830 2436 TBA1B_HUMAN ENSP00000336799 Oral Cancer Normal vs. Cancer oral leukoplakia control tissues OSCC tumor tissues tissue Up 3.9 19691830 2437 IL4_HUMAN ENSP00000231449 Oral Cancer Normal vs. Cancer oral leukoplakia control tissues OSCC tumor tissues tissue Up 4.1 19691830 2438 K1C14_HUMAN ENSP00000167586 Oral Cancer Normal vs. Cancer oral leukoplakia control tissues OSCC tumor tissues tissue Up 4.3 19691830 2439 ENOA_HUMAN ENSP00000234590 Oral Cancer Normal vs. Cancer oral leukoplakia control tissues OSCC tumor tissues tissue Up 4.3 19691830 2440 NACA_HUMAN ENSP00000377469 Oral Cancer Normal vs. Cancer oral leukoplakia control tissues OSCC tumor tissues tissue Up 4.4 19691830 2441 KPYM_HUMAN ENSP00000334983 Oral Cancer Normal vs. Cancer oral leukoplakia control tissues OSCC tumor tissues tissue Up 5.2 19691830 2442 HSP7C_HUMAN ENSP00000227378 Oral Cancer Normal vs. Cancer oral leukoplakia control tissues OSCC tumor tissues tissue Up 5.3 19691830 2443 SPB5_HUMAN ENSP00000372221 Oral Cancer Normal vs. Cancer oral leukoplakia control tissues OSCC tumor tissues tissue Up 5.3 19691830 2444 GSTP1_HUMAN ENSP00000381607 Oral Cancer Normal vs. Cancer oral leukoplakia control tissues OSCC tumor tissues tissue Up 5.4 19691830 2445 HSPB1_HUMAN ENSP00000248553 Oral Cancer Normal vs. Cancer oral leukoplakia control tissues OSCC tumor tissues tissue Up 5.6 19691830 2446 S10AB_HUMAN ENSP00000271638 Oral Cancer Normal vs. Cancer oral leukoplakia control tissues OSCC tumor tissues tissue Up 5.6 19691830 2447 TBB5_HUMAN ENSP00000406811 Oral Cancer Normal vs. Cancer oral leukoplakia control tissues OSCC tumor tissues tissue Up 5.7 19691830 2448 ACTB_HUMAN ENSP00000349960 Oral Cancer Normal vs. Cancer oral leukoplakia control tissues OSCC tumor tissues tissue Up 5.9 19691830 2449 SET_HUMAN ENSP00000361777 Oral Cancer Normal vs. Cancer oral leukoplakia control tissues OSCC tumor tissues tissue Up 5.9 19691830 2450 PCNA_HUMAN ENSP00000368458 Oral Cancer Normal vs. Cancer oral leukoplakia control tissues OSCC tumor tissues tissue Up 8 19691830 2451 CXCL7_HUMAN ENSP00000296028 acute lymphocytic leukemia Normal vs. Cancer Serum samples from control healthy children Serum samples from ALL patients tissue Down 19291297 2452 PLF4_HUMAN ENSP00000296029 acute lymphocytic leukemia Normal vs. Cancer Serum samples from control healthy children Serum samples from ALL patients tissue Down 19291297 2453 C3AR_HUMAN ENSP00000302079 acute lymphocytic leukemia Normal vs. Cancer Serum samples from control healthy children Serum samples from ALL patients tissue Up 19291297 2454 CLIC1_HUMAN ENSP00000379229 chronic myeloid leukemia Treatment (Imatinib-sensitive vs. Imatinib-resistant) imatinib-sensitive KCL22S cells imatinib-resistant KCL22R cells cell line Down 20417730 2455 HSPB1_HUMAN ENSP00000248553 chronic myeloid leukemia Treatment (Imatinib-sensitive vs. Imatinib-resistant) imatinib-sensitive KCL22S cells imatinib-resistant KCL22R cells cell line Down 20417730 2456 HSP71_HUMAN ENSP00000364801 chronic myeloid leukemia Treatment (Imatinib-sensitive vs. Imatinib-resistant) imatinib-sensitive KCL22S cells imatinib-resistant KCL22R cells cell line Down 20417730 2457 XRCC5_HUMAN ENSP00000375977 chronic myeloid leukemia Treatment (Imatinib-sensitive vs. Imatinib-resistant) imatinib-sensitive KCL22S cells imatinib-resistant KCL22R cells cell line Down 20417730 2458 HNRH3_HUMAN ENSP00000265866 chronic myeloid leukemia Treatment (Imatinib-sensitive vs. Imatinib-resistant) imatinib-sensitive KCL22S cells imatinib-resistant KCL22R cells cell line Down 20417730 2459 TAGL2_HUMAN ENSP00000357075 chronic myeloid leukemia Treatment (Imatinib-sensitive vs. Imatinib-resistant) imatinib-sensitive KCL22S cells imatinib-resistant KCL22R cells cell line Down 20417730 2460 PRDX1_HUMAN ENSP00000262746 chronic myeloid leukemia Treatment (Imatinib-sensitive vs. Imatinib-resistant) imatinib-sensitive KCL22S cells imatinib-resistant KCL22R cells cell line Down 20417730 2461 LASP1_HUMAN ENSP00000325240 chronic myeloid leukemia Treatment (Imatinib-sensitive vs. Imatinib-resistant) imatinib-sensitive KCL22S cells imatinib-resistant KCL22R cells cell line Down 20417730 2462 ANXA1_HUMAN ENSP00000366109 chronic myeloid leukemia Treatment (Imatinib-sensitive vs. Imatinib-resistant) imatinib-sensitive KCL22S cells imatinib-resistant KCL22R cells cell line Down 20417730 2463 FUBP1_HUMAN ENSP00000359804 chronic myeloid leukemia Treatment (Imatinib-sensitive vs. Imatinib-resistant) imatinib-sensitive KCL22S cells imatinib-resistant KCL22R cells cell line Down 20417730 2464 VDAC1_HUMAN ENSP00000378487 chronic myeloid leukemia Treatment (Imatinib-sensitive vs. Imatinib-resistant) imatinib-sensitive KCL22S cells imatinib-resistant KCL22R cells cell line Up 1.3 20417730 2465 LA_HUMAN ENSP00000386636 chronic myeloid leukemia Treatment (Imatinib-sensitive vs. Imatinib-resistant) imatinib-sensitive KCL22S cells imatinib-resistant KCL22R cells cell line Up 1.3 20417730 2466 TPIS_HUMAN ENSP00000379933 chronic myeloid leukemia Treatment (Imatinib-sensitive vs. Imatinib-resistant) imatinib-sensitive KCL22S cells imatinib-resistant KCL22R cells cell line Up 1.3 20417730 2467 PCBP2_HUMAN ENSP00000408949 chronic myeloid leukemia Treatment (Imatinib-sensitive vs. Imatinib-resistant) imatinib-sensitive KCL22S cells imatinib-resistant KCL22R cells cell line Up 1.3 20417730 2468 ACTB_HUMAN ENSP00000349960 chronic myeloid leukemia Treatment (Imatinib-sensitive vs. Imatinib-resistant) imatinib-sensitive KCL22S cells imatinib-resistant KCL22R cells cell line Up 1.4 20417730 2469 GDIR1_HUMAN ENSP00000269321 chronic myeloid leukemia Treatment (Imatinib-sensitive vs. Imatinib-resistant) imatinib-sensitive KCL22S cells imatinib-resistant KCL22R cells cell line Up 1.5 20417730 2470 PLSL_HUMAN ENSP00000315757 chronic myeloid leukemia Treatment (Imatinib-sensitive vs. Imatinib-resistant) imatinib-sensitive KCL22S cells imatinib-resistant KCL22R cells cell line Up 1.8 20417730 2471 ML12B_HUMAN ENSP00000383037 Leukemia Normal vs. Cancer Normal white blood cells (NWBCs) including normal lymphoctyes and granulocytes (mainly neutrophils) bone marrow aspirates of a group of 61 patients with acute leukemia at the time of initial diagnosis before chemotherapy tissue Down 15501966 2472 SODM_HUMAN ENSP00000337127 Leukemia Normal vs. Cancer Normal white blood cells (NWBCs) including normal lymphoctyes and granulocytes (mainly neutrophils) bone marrow aspirates of a group of 61 patients with acute leukemia at the time of initial diagnosis before chemotherapy tissue Down 15501966 2473 MMP9_HUMAN ENSP00000361405 Leukemia Normal vs. Cancer Normal white blood cells (NWBCs) including normal lymphoctyes and granulocytes (mainly neutrophils) bone marrow aspirates of a group of 61 patients with acute leukemia at the time of initial diagnosis before chemotherapy tissue Down 15501966 2474 GDIR2_HUMAN ENSP00000228945 Leukemia Normal vs. Cancer Normal white blood cells (NWBCs) including normal lymphoctyes and granulocytes (mainly neutrophils) bone marrow aspirates of a group of 61 patients with acute leukemia at the time of initial diagnosis before chemotherapy tissue Down 15501966 2475 HMGB1_HUMAN ENSP00000382417 Leukemia Normal vs. Cancer Normal white blood cells (NWBCs) including normal lymphoctyes and granulocytes (mainly neutrophils) bone marrow aspirates of a group of 61 patients with acute leukemia at the time of initial diagnosis before chemotherapy tissue Up 15501966 2476 PCNA_HUMAN ENSP00000368458 Leukemia Normal vs. Cancer Normal white blood cells (NWBCs) including normal lymphoctyes and granulocytes (mainly neutrophils) bone marrow aspirates of a group of 61 patients with acute leukemia at the time of initial diagnosis before chemotherapy tissue Up 15501966 2477 STMN1_HUMAN ENSP00000382633 Leukemia Normal vs. Cancer Normal white blood cells (NWBCs) including normal lymphoctyes and granulocytes (mainly neutrophils) bone marrow aspirates of a group of 61 patients with acute leukemia at the time of initial diagnosis before chemotherapy tissue Up 15501966 2478 GDIR1_HUMAN ENSP00000269321 Leukemia Normal vs. Cancer Normal white blood cells (NWBCs) including normal lymphoctyes and granulocytes (mainly neutrophils) bone marrow aspirates of a group of 61 patients with acute leukemia at the time of initial diagnosis before chemotherapy tissue Up 15501966 2479 KAD2_HUMAN ENSP00000346921 Leukemia Cancer vs. Cancer (subtype) granulocytic(G), monocytic(M5) and lymphoid(ALL) lineage of acute leukemia subtype myeloid(AML) lineage tissue Up 15501966 2480 TPIS_HUMAN ENSP00000379933 Leukemia Cancer vs. Cancer (subtype) granulocytic(G), monocytic(M5) and lymphoid(ALL) lineage of acute leukemia subtype myeloid(AML) lineage tissue Up 15501966 2481 HSPB1_HUMAN ENSP00000248553 Leukemia Cancer vs. Cancer (subtype) myeloid(AML), granulocytic(G) and monocytic(M5) lineage of acute leukemia subtype lymphoid(ALL) lineage tissue Up 15501966 2482 STMN1_HUMAN ENSP00000382633 Leukemia Cancer vs. Cancer (subtype) myeloid(AML), granulocytic(G) and monocytic(M5) lineage of acute leukemia subtype lymphoid(ALL) lineage tissue Up 15501966 2483 COF1_HUMAN ENSP00000309629 Leukemia Cancer vs. Cancer (subtype) myeloid(AML), granulocytic(G) and monocytic(M5) lineage of acute leukemia subtype lymphoid(ALL) lineage tissue Up 15501966 2484 ANXA1_HUMAN ENSP00000366109 Leukemia Cancer vs. Cancer (subtype) M1, M4, M5 acute myeloid leukemia subtypes M2 and/or M3 acute myeloid leukemia subtypes tissue Up 15501966 2485 PARK7_HUMAN ENSP00000366708 Leukemia Cancer vs. Cancer (subtype) M1, M4, M5 acute myeloid leukemia subtypes M2 and/or M3 acute myeloid leukemia subtypes tissue Up 15501966 2486 VIME_HUMAN ENSP00000224237 chronic lymphocytic leukemia Cancer vs. Cancer (agressive) leukemic B cells from two patients with chronic lymphocytic leukemia (CLL) having mutated (M-CLL) immunoglobulin variable heavy chain genes (IgVH) more aggressive leukemic B cells from two patients with chronic lymphocytic leukemia (CLL) having unmutated (UM-CLL) immunoglobulin variable heavy chain genes (IgVH) tissue Down 0.3 16083281 2487 HBB_HUMAN ENSP00000333994 chronic lymphocytic leukemia Cancer vs. Cancer (agressive) leukemic B cells from two patients with chronic lymphocytic leukemia (CLL) having mutated (M-CLL) immunoglobulin variable heavy chain genes (IgVH) more aggressive leukemic B cells from two patients with chronic lymphocytic leukemia (CLL) having unmutated (UM-CLL) immunoglobulin variable heavy chain genes (IgVH) tissue Down 0.3 16083281 2488 GPX1_HUMAN ENSP00000407375 chronic lymphocytic leukemia Cancer vs. Cancer (agressive) leukemic B cells from two patients with chronic lymphocytic leukemia (CLL) having mutated (M-CLL) immunoglobulin variable heavy chain genes (IgVH) more aggressive leukemic B cells from two patients with chronic lymphocytic leukemia (CLL) having unmutated (UM-CLL) immunoglobulin variable heavy chain genes (IgVH) tissue Up 3 16083281 2489 ASAP2_HUMAN ENSP00000281419 Leukemia Cancer vs. Cancer (chronic vs. acute leukemia) chronic myeloid leukemia (CML) cell line K562 acute promyelocytic leukemia (APL) cell line NB4 cell line Down 17449014 2490 ADCY6_HUMAN ENSP00000311405 Leukemia Cancer vs. Cancer (chronic vs. acute leukemia) chronic myeloid leukemia (CML) cell line K562 acute promyelocytic leukemia (APL) cell line NB4 cell line Down 17449014 2491 4F2_HUMAN ENSP00000367124 Leukemia Cancer vs. Cancer (chronic vs. acute leukemia) chronic myeloid leukemia (CML) cell line K562 acute promyelocytic leukemia (APL) cell line NB4 cell line Down 17449014 2492 LEUK_HUMAN ENSP00000353238 Leukemia Cancer vs. Cancer (chronic vs. acute leukemia) chronic myeloid leukemia (CML) cell line K562 acute promyelocytic leukemia (APL) cell line NB4 cell line Down 17449014 2493 SHH_HUMAN ENSP00000297261 Leukemia Cancer vs. Cancer (chronic vs. acute leukemia) chronic myeloid leukemia (CML) cell line K562 acute promyelocytic leukemia (APL) cell line NB4 cell line Down 17449014 2494 HSP7C_HUMAN ENSP00000227378 Leukemia Cancer vs. Cancer (chronic vs. acute leukemia) chronic myeloid leukemia (CML) cell line K562 acute promyelocytic leukemia (APL) cell line NB4 cell line Up 17449014 2495 HSP72_HUMAN ENSP00000247207 Leukemia Cancer vs. Cancer (chronic vs. acute leukemia) chronic myeloid leukemia (CML) cell line K562 acute promyelocytic leukemia (APL) cell line NB4 cell line Up 17449014 2496 KCNC4_HUMAN ENSP00000358802 Leukemia Cancer vs. Cancer (chronic vs. acute leukemia) chronic myeloid leukemia (CML) cell line K562 acute promyelocytic leukemia (APL) cell line NB4 cell line Up 17449014 2497 HCD2_HUMAN ENSP00000168216 Leukemia Cancer vs. Cancer (chronic vs. acute leukemia) chronic myeloid leukemia (CML) cell line K562 acute promyelocytic leukemia (APL) cell line NB4 cell line Up 17449014 2498 BOC_HUMAN ENSP00000347546 Leukemia Cancer vs. Cancer (chronic vs. acute leukemia) chronic myeloid leukemia (CML) cell line K562 acute promyelocytic leukemia (APL) cell line NB4 cell line Up 17449014 2499 RD23B_HUMAN ENSP00000350708 acute myeloid leukemia Treatment (none vs. NSC606985 treatment) (cytosols) APL cell line NB4 cells (cytosols) APL cell line NB4 cells in the present of 25nM NSC606985 for 24 h. NSC606985 is a camptothecin analogue, induces apoptosis of acute myeloid leukemia (AML) cells cell line Down 0.06 17655343 2500 FUBP1_HUMAN ENSP00000359804 acute myeloid leukemia Treatment (none vs. NSC606985 treatment) (cytosols) APL cell line NB4 cells (cytosols) APL cell line NB4 cells in the present of 25nM NSC606985 for 24 h. NSC606985 is a camptothecin analogue, induces apoptosis of acute myeloid leukemia (AML) cells cell line Down 0.06 17655343 2501 FUBP1_HUMAN ENSP00000359804 acute myeloid leukemia Treatment (none vs. NSC606985 treatment) (cytosols) APL cell line NB4 cells (cytosols) APL cell line NB4 cells in the present of 25nM NSC606985 for 24 h. NSC606985 is a camptothecin analogue, induces apoptosis of acute myeloid leukemia (AML) cells cell line Down 0.09 17655343 2502 G3BP1_HUMAN ENSP00000348578 acute myeloid leukemia Treatment (none vs. NSC606985 treatment) (cytosols) APL cell line NB4 cells (cytosols) APL cell line NB4 cells in the present of 25nM NSC606985 for 24 h. NSC606985 is a camptothecin analogue, induces apoptosis of acute myeloid leukemia (AML) cells cell line Down 0.12 17655343 2503 FUBP1_HUMAN ENSP00000359804 acute myeloid leukemia Treatment (none vs. NSC606985 treatment) (cytosols) APL cell line NB4 cells (cytosols) APL cell line NB4 cells in the present of 25nM NSC606985 for 24 h. NSC606985 is a camptothecin analogue, induces apoptosis of acute myeloid leukemia (AML) cells cell line Down 0.12 17655343 2504 G3BP1_HUMAN ENSP00000348578 acute myeloid leukemia Treatment (none vs. NSC606985 treatment) (cytosols) APL cell line NB4 cells (cytosols) APL cell line NB4 cells in the present of 25nM NSC606985 for 24 h. NSC606985 is a camptothecin analogue, induces apoptosis of acute myeloid leukemia (AML) cells cell line Down 0.15 17655343 2505 HNRPK_HUMAN ENSP00000365440 acute myeloid leukemia Treatment (none vs. NSC606985 treatment) (cytosols) APL cell line NB4 cells (cytosols) APL cell line NB4 cells in the present of 25nM NSC606985 for 24 h. NSC606985 is a camptothecin analogue, induces apoptosis of acute myeloid leukemia (AML) cells cell line Down 0.16 17655343 2506 NACA_HUMAN ENSP00000377469 acute myeloid leukemia Treatment (none vs. NSC606985 treatment) (cytosols) APL cell line NB4 cells (cytosols) APL cell line NB4 cells in the present of 25nM NSC606985 for 24 h. NSC606985 is a camptothecin analogue, induces apoptosis of acute myeloid leukemia (AML) cells cell line Down 0.17 17655343 2507 1433E_HUMAN ENSP00000264335 acute myeloid leukemia Treatment (none vs. NSC606985 treatment) (cytosols) APL cell line NB4 cells (cytosols) APL cell line NB4 cells in the present of 25nM NSC606985 for 24 h. NSC606985 is a camptothecin analogue, induces apoptosis of acute myeloid leukemia (AML) cells cell line Down 0.49 17655343 2508 DYR_HUMAN ENSP00000396308 acute myeloid leukemia Treatment (none vs. NSC606985 treatment) (cytosols) APL cell line NB4 cells (cytosols) APL cell line NB4 cells in the present of 25nM NSC606985 for 24 h. NSC606985 is a camptothecin analogue, induces apoptosis of acute myeloid leukemia (AML) cells cell line Down 17655343 2509 HNRPK_HUMAN ENSP00000365440 acute myeloid leukemia Treatment (none vs. NSC606985 treatment) (cytosols) APL cell line NB4 cells (cytosols) APL cell line NB4 cells in the present of 25nM NSC606985 for 24 h. NSC606985 is a camptothecin analogue, induces apoptosis of acute myeloid leukemia (AML) cells cell line Down 17655343 2510 ACTB_HUMAN ENSP00000349960 acute myeloid leukemia Treatment (none vs. NSC606985 treatment) (cytosols) APL cell line NB4 cells (cytosols) APL cell line NB4 cells in the present of 25nM NSC606985 for 24 h. NSC606985 is a camptothecin analogue, induces apoptosis of acute myeloid leukemia (AML) cells cell line Up 3.9 17655343 2511 ACTB_HUMAN ENSP00000349960 acute myeloid leukemia Treatment (none vs. NSC606985 treatment) (cytosols) APL cell line NB4 cells (cytosols) APL cell line NB4 cells in the present of 25nM NSC606985 for 24 h. NSC606985 is a camptothecin analogue, induces apoptosis of acute myeloid leukemia (AML) cells cell line Up 5.1 17655343 2512 ACTB_HUMAN ENSP00000349960 acute myeloid leukemia Treatment (none vs. NSC606985 treatment) (cytosols) APL cell line NB4 cells (cytosols) APL cell line NB4 cells in the present of 25nM NSC606985 for 24 h. NSC606985 is a camptothecin analogue, induces apoptosis of acute myeloid leukemia (AML) cells cell line Up 7.5 17655343 2513 HNRPQ_HUMAN ENSP00000358635 acute myeloid leukemia Treatment (none vs. NSC606985 treatment) (cytosols) APL cell line NB4 cells (cytosols) APL cell line NB4 cells in the present of 25nM NSC606985 for 24 h. NSC606985 is a camptothecin analogue, induces apoptosis of acute myeloid leukemia (AML) cells cell line Up 17655343 2514 GELS_HUMAN ENSP00000362924 acute myeloid leukemia Treatment (none vs. NSC606985 treatment) (cytosols) APL cell line NB4 cells (cytosols) APL cell line NB4 cells in the present of 25nM NSC606985 for 24 h. NSC606985 is a camptothecin analogue, induces apoptosis of acute myeloid leukemia (AML) cells cell line Up 17655343 2515 HNRPC_HUMAN ENSP00000319690 acute myeloid leukemia Treatment (none vs. NSC606985 treatment) (cytosols) APL cell line NB4 cells (cytosols) APL cell line NB4 cells in the present of 25nM NSC606985 for 24 h. NSC606985 is a camptothecin analogue, induces apoptosis of acute myeloid leukemia (AML) cells cell line Up 17655343 2516 PRS6A_HUMAN ENSP00000298852 acute myeloid leukemia Treatment (none vs. NSC606985 treatment) (cytosols) APL cell line NB4 cells (cytosols) APL cell line NB4 cells in the present of 25nM NSC606985 for 24 h. NSC606985 is a camptothecin analogue, induces apoptosis of acute myeloid leukemia (AML) cells cell line Up 17655343 2517 DYN2_HUMAN ENSP00000352721 acute myeloid leukemia Treatment (none vs. NSC606985 treatment) (cytosols) APL cell line NB4 cells (cytosols) APL cell line NB4 cells in the present of 25nM NSC606985 for 24 h. NSC606985 is a camptothecin analogue, induces apoptosis of acute myeloid leukemia (AML) cells cell line Up 17655343 2518 GDIR2_HUMAN ENSP00000228945 acute myeloid leukemia Treatment (none vs. NSC606985 treatment) (cytosols) APL cell line NB4 cells (cytosols) APL cell line NB4 cells in the present of 25nM NSC606985 for 24 h. NSC606985 is a camptothecin analogue, induces apoptosis of acute myeloid leukemia (AML) cells cell line Up 17655343 2519 G3BP1_HUMAN ENSP00000348578 acute myeloid leukemia Treatment (none vs. NSC606985 treatment) (raw endoplasmic reticula) APL cell line NB4 cells (raw endoplasmic reticula) APL cell line NB4 cells in the present of 25nM NSC606985 for 24 h. NSC606985 is a camptothecin analogue, induces apoptosis of acute myeloid leukemia (AML) cells cell line Down 0.07 17655343 2520 FUBP1_HUMAN ENSP00000359804 acute myeloid leukemia Treatment (none vs. NSC606985 treatment) (raw endoplasmic reticula) APL cell line NB4 cells (raw endoplasmic reticula) APL cell line NB4 cells in the present of 25nM NSC606985 for 24 h. NSC606985 is a camptothecin analogue, induces apoptosis of acute myeloid leukemia (AML) cells cell line Down 0.07 17655343 2521 HNRPC_HUMAN ENSP00000319690 acute myeloid leukemia Treatment (none vs. NSC606985 treatment) (raw endoplasmic reticula) APL cell line NB4 cells (raw endoplasmic reticula) APL cell line NB4 cells in the present of 25nM NSC606985 for 24 h. NSC606985 is a camptothecin analogue, induces apoptosis of acute myeloid leukemia (AML) cells cell line Down 0.08 17655343 2522 FUBP1_HUMAN ENSP00000359804 acute myeloid leukemia Treatment (none vs. NSC606985 treatment) (raw endoplasmic reticula) APL cell line NB4 cells (raw endoplasmic reticula) APL cell line NB4 cells in the present of 25nM NSC606985 for 24 h. NSC606985 is a camptothecin analogue, induces apoptosis of acute myeloid leukemia (AML) cells cell line Down 0.09 17655343 2523 HNRPC_HUMAN ENSP00000319690 acute myeloid leukemia Treatment (none vs. NSC606985 treatment) (raw endoplasmic reticula) APL cell line NB4 cells (raw endoplasmic reticula) APL cell line NB4 cells in the present of 25nM NSC606985 for 24 h. NSC606985 is a camptothecin analogue, induces apoptosis of acute myeloid leukemia (AML) cells cell line Down 0.11 17655343 2524 RLA2_HUMAN ENSP00000322419 acute myeloid leukemia Treatment (none vs. NSC606985 treatment) (raw endoplasmic reticula) APL cell line NB4 cells (raw endoplasmic reticula) APL cell line NB4 cells in the present of 25nM NSC606985 for 24 h. NSC606985 is a camptothecin analogue, induces apoptosis of acute myeloid leukemia (AML) cells cell line Down 0.16 17655343 2525 NACA_HUMAN ENSP00000377469 acute myeloid leukemia Treatment (none vs. NSC606985 treatment) (raw endoplasmic reticula) APL cell line NB4 cells (raw endoplasmic reticula) APL cell line NB4 cells in the present of 25nM NSC606985 for 24 h. NSC606985 is a camptothecin analogue, induces apoptosis of acute myeloid leukemia (AML) cells cell line Down 0.18 17655343 2526 FUBP1_HUMAN ENSP00000359804 acute myeloid leukemia Treatment (none vs. NSC606985 treatment) (raw endoplasmic reticula) APL cell line NB4 cells (raw endoplasmic reticula) APL cell line NB4 cells in the present of 25nM NSC606985 for 24 h. NSC606985 is a camptothecin analogue, induces apoptosis of acute myeloid leukemia (AML) cells cell line Down 0.18 17655343 2527 G3BP1_HUMAN ENSP00000348578 acute myeloid leukemia Treatment (none vs. NSC606985 treatment) (raw endoplasmic reticula) APL cell line NB4 cells (raw endoplasmic reticula) APL cell line NB4 cells in the present of 25nM NSC606985 for 24 h. NSC606985 is a camptothecin analogue, induces apoptosis of acute myeloid leukemia (AML) cells cell line Down 0.23 17655343 2528 CALR_HUMAN ENSP00000320866 acute myeloid leukemia Treatment (none vs. NSC606985 treatment) (raw endoplasmic reticula) APL cell line NB4 cells (raw endoplasmic reticula) APL cell line NB4 cells in the present of 25nM NSC606985 for 24 h. NSC606985 is a camptothecin analogue, induces apoptosis of acute myeloid leukemia (AML) cells cell line Down 0.27 17655343 2529 GSTP1_HUMAN ENSP00000381607 acute myeloid leukemia Treatment (none vs. NSC606985 treatment) (raw endoplasmic reticula) APL cell line NB4 cells (raw endoplasmic reticula) APL cell line NB4 cells in the present of 25nM NSC606985 for 24 h. NSC606985 is a camptothecin analogue, induces apoptosis of acute myeloid leukemia (AML) cells cell line Up 6.6 17655343 2530 RAN_HUMAN ENSP00000376176 acute myeloid leukemia Treatment (none vs. NSC606985 treatment) (raw endoplasmic reticula) APL cell line NB4 cells (raw endoplasmic reticula) APL cell line NB4 cells in the present of 25nM NSC606985 for 24 h. NSC606985 is a camptothecin analogue, induces apoptosis of acute myeloid leukemia (AML) cells cell line Up 6.6 17655343 2531 PCNA_HUMAN ENSP00000368458 acute myeloid leukemia Treatment (none vs. NSC606985 treatment) (raw endoplasmic reticula) APL cell line NB4 cells (raw endoplasmic reticula) APL cell line NB4 cells in the present of 25nM NSC606985 for 24 h. NSC606985 is a camptothecin analogue, induces apoptosis of acute myeloid leukemia (AML) cells cell line Up 11 17655343 2532 TPIS_HUMAN ENSP00000379933 acute myeloid leukemia Treatment (none vs. NSC606985 treatment) (raw endoplasmic reticula) APL cell line NB4 cells (raw endoplasmic reticula) APL cell line NB4 cells in the present of 25nM NSC606985 for 24 h. NSC606985 is a camptothecin analogue, induces apoptosis of acute myeloid leukemia (AML) cells cell line Up 14 17655343 2533 RLA2_HUMAN ENSP00000322419 acute myeloid leukemia Treatment (none vs. NSC606985 treatment) (raw endoplasmic reticula) APL cell line NB4 cells (raw endoplasmic reticula) APL cell line NB4 cells in the present of 25nM NSC606985 for 24 h. NSC606985 is a camptothecin analogue, induces apoptosis of acute myeloid leukemia (AML) cells cell line Up 17655343 2534 HNRPC_HUMAN ENSP00000319690 acute myeloid leukemia Treatment (none vs. NSC606985 treatment) (raw endoplasmic reticula) APL cell line NB4 cells (raw endoplasmic reticula) APL cell line NB4 cells in the present of 25nM NSC606985 for 24 h. NSC606985 is a camptothecin analogue, induces apoptosis of acute myeloid leukemia (AML) cells cell line Up 17655343 2535 RSSA_HUMAN ENSP00000346067 acute myeloid leukemia Treatment (none vs. NSC606985 treatment) (raw endoplasmic reticula) APL cell line NB4 cells (raw endoplasmic reticula) APL cell line NB4 cells in the present of 25nM NSC606985 for 24 h. NSC606985 is a camptothecin analogue, induces apoptosis of acute myeloid leukemia (AML) cells cell line Up 17655343 2536 PRS6A_HUMAN ENSP00000298852 acute myeloid leukemia Treatment (none vs. NSC606985 treatment) (raw endoplasmic reticula) APL cell line NB4 cells (raw endoplasmic reticula) APL cell line NB4 cells in the present of 25nM NSC606985 for 24 h. NSC606985 is a camptothecin analogue, induces apoptosis of acute myeloid leukemia (AML) cells cell line Up 17655343 2537 LMNB1_HUMAN ENSP00000261366 acute myeloid leukemia Treatment (none vs. NSC606985 treatment) (raw endoplasmic reticula) APL cell line NB4 cells (raw endoplasmic reticula) APL cell line NB4 cells in the present of 25nM NSC606985 for 24 h. NSC606985 is a camptothecin analogue, induces apoptosis of acute myeloid leukemia (AML) cells cell line Up 17655343 2538 NACA_HUMAN ENSP00000377469 acute myeloid leukemia Treatment (none vs. NSC606985 treatment) (raw endoplasmic reticula) APL cell line NB4 cells (raw endoplasmic reticula) APL cell line NB4 cells in the present of 25nM NSC606985 for 24 h. NSC606985 is a camptothecin analogue, induces apoptosis of acute myeloid leukemia (AML) cells cell line Up 17655343 2539 EF1B_HUMAN ENSP00000376055 acute myeloid leukemia Treatment (none vs. NSC606985 treatment) (mitochondria) APL cell line NB4 cells (mitochondria) APL cell line NB4 cells in the present of 25nM NSC606985 for 24 h. NSC606985 is a camptothecin analogue, induces apoptosis of acute myeloid leukemia (AML) cells cell line Down 0.01 17655343 2540 EF1B_HUMAN ENSP00000376055 acute myeloid leukemia Treatment (none vs. NSC606985 treatment) (mitochondria) APL cell line NB4 cells (mitochondria) APL cell line NB4 cells in the present of 25nM NSC606985 for 24 h. NSC606985 is a camptothecin analogue, induces apoptosis of acute myeloid leukemia (AML) cells cell line Down 0.11 17655343 2541 RSSA_HUMAN ENSP00000346067 acute myeloid leukemia Treatment (none vs. NSC606985 treatment) (mitochondria) APL cell line NB4 cells (mitochondria) APL cell line NB4 cells in the present of 25nM NSC606985 for 24 h. NSC606985 is a camptothecin analogue, induces apoptosis of acute myeloid leukemia (AML) cells cell line Down 0.27 17655343 2542 EF1B_HUMAN ENSP00000376055 acute myeloid leukemia Treatment (none vs. NSC606985 treatment) (mitochondria) APL cell line NB4 cells (mitochondria) APL cell line NB4 cells in the present of 25nM NSC606985 for 24 h. NSC606985 is a camptothecin analogue, induces apoptosis of acute myeloid leukemia (AML) cells cell line Down 0.37 17655343 2543 ENOA_HUMAN ENSP00000234590 acute myeloid leukemia Treatment (none vs. NSC606985 treatment) (mitochondria) APL cell line NB4 cells (mitochondria) APL cell line NB4 cells in the present of 25nM NSC606985 for 24 h. NSC606985 is a camptothecin analogue, induces apoptosis of acute myeloid leukemia (AML) cells cell line Up 2.9 17655343 2544 TBB4B_HUMAN ENSP00000341289 acute myeloid leukemia Treatment (none vs. NSC606985 treatment) (mitochondria) APL cell line NB4 cells (mitochondria) APL cell line NB4 cells in the present of 25nM NSC606985 for 24 h. NSC606985 is a camptothecin analogue, induces apoptosis of acute myeloid leukemia (AML) cells cell line Up 4 17655343 2545 PGAM1_HUMAN ENSP00000359991 acute myeloid leukemia Treatment (none vs. NSC606985 treatment) (mitochondria) APL cell line NB4 cells (mitochondria) APL cell line NB4 cells in the present of 25nM NSC606985 for 24 h. NSC606985 is a camptothecin analogue, induces apoptosis of acute myeloid leukemia (AML) cells cell line Up 4.6 17655343 2546 TOM40_HUMAN ENSP00000252487 acute myeloid leukemia Treatment (none vs. NSC606985 treatment) (mitochondria) APL cell line NB4 cells (mitochondria) APL cell line NB4 cells in the present of 25nM NSC606985 for 24 h. NSC606985 is a camptothecin analogue, induces apoptosis of acute myeloid leukemia (AML) cells cell line Up 6.3 17655343 2547 THIO_HUMAN ENSP00000363641 acute myeloid leukemia Treatment (none vs. NSC606985 treatment) (mitochondria) APL cell line NB4 cells (mitochondria) APL cell line NB4 cells in the present of 25nM NSC606985 for 24 h. NSC606985 is a camptothecin analogue, induces apoptosis of acute myeloid leukemia (AML) cells cell line Up 9.7 17655343 2548 PARK7_HUMAN ENSP00000366708 acute myeloid leukemia Treatment (none vs. NSC606985 treatment) (mitochondria) APL cell line NB4 cells (mitochondria) APL cell line NB4 cells in the present of 25nM NSC606985 for 24 h. NSC606985 is a camptothecin analogue, induces apoptosis of acute myeloid leukemia (AML) cells cell line Up 11 17655343 2549 GSTP1_HUMAN ENSP00000381607 acute myeloid leukemia Treatment (none vs. NSC606985 treatment) (mitochondria) APL cell line NB4 cells (mitochondria) APL cell line NB4 cells in the present of 25nM NSC606985 for 24 h. NSC606985 is a camptothecin analogue, induces apoptosis of acute myeloid leukemia (AML) cells cell line Up 20 17655343 2550 TPIS_HUMAN ENSP00000379933 acute myeloid leukemia Treatment (none vs. NSC606985 treatment) (mitochondria) APL cell line NB4 cells (mitochondria) APL cell line NB4 cells in the present of 25nM NSC606985 for 24 h. NSC606985 is a camptothecin analogue, induces apoptosis of acute myeloid leukemia (AML) cells cell line Up 26 17655343 2551 HNRPQ_HUMAN ENSP00000358635 acute myeloid leukemia Treatment (none vs. NSC606985 treatment) (mitochondria) APL cell line NB4 cells (mitochondria) APL cell line NB4 cells in the present of 25nM NSC606985 for 24 h. NSC606985 is a camptothecin analogue, induces apoptosis of acute myeloid leukemia (AML) cells cell line Up 17655343 2552 PRS6A_HUMAN ENSP00000298852 acute myeloid leukemia Treatment (none vs. NSC606985 treatment) (mitochondria) APL cell line NB4 cells (mitochondria) APL cell line NB4 cells in the present of 25nM NSC606985 for 24 h. NSC606985 is a camptothecin analogue, induces apoptosis of acute myeloid leukemia (AML) cells cell line Up 17655343 2553 GDIR2_HUMAN ENSP00000228945 acute myeloid leukemia Treatment (none vs. NSC606985 treatment) (mitochondria) APL cell line NB4 cells (mitochondria) APL cell line NB4 cells in the present of 25nM NSC606985 for 24 h. NSC606985 is a camptothecin analogue, induces apoptosis of acute myeloid leukemia (AML) cells cell line Up 17655343 2554 PSA6_HUMAN ENSP00000261479 acute myeloid leukemia Treatment (none vs. NSC606985 treatment) (mitochondria) APL cell line NB4 cells (mitochondria) APL cell line NB4 cells in the present of 25nM NSC606985 for 24 h. NSC606985 is a camptothecin analogue, induces apoptosis of acute myeloid leukemia (AML) cells cell line Up 17655343 2555 PRDX1_HUMAN ENSP00000262746 acute myeloid leukemia Treatment (none vs. NSC606985 treatment) (mitochondria) APL cell line NB4 cells (mitochondria) APL cell line NB4 cells in the present of 25nM NSC606985 for 24 h. NSC606985 is a camptothecin analogue, induces apoptosis of acute myeloid leukemia (AML) cells cell line Up 17655343 2556 CALR_HUMAN ENSP00000320866 acute myeloid leukemia Treatment (none vs. NSC606985 treatment) (nuclei) APL cell line NB4 cells (nuclei) APL cell line NB4 cells in the present of 25nM NSC606985 for 24 h. NSC606985 is a camptothecin analogue, induces apoptosis of acute myeloid leukemia (AML) cells cell line Down 0.07 17655343 2557 GDIR2_HUMAN ENSP00000228945 acute myeloid leukemia Treatment (none vs. NSC606985 treatment) (nuclei) APL cell line NB4 cells (nuclei) APL cell line NB4 cells in the present of 25nM NSC606985 for 24 h. NSC606985 is a camptothecin analogue, induces apoptosis of acute myeloid leukemia (AML) cells cell line Down 0.13 17655343 2558 EF1B_HUMAN ENSP00000376055 acute myeloid leukemia Treatment (none vs. NSC606985 treatment) (nuclei) APL cell line NB4 cells (nuclei) APL cell line NB4 cells in the present of 25nM NSC606985 for 24 h. NSC606985 is a camptothecin analogue, induces apoptosis of acute myeloid leukemia (AML) cells cell line Down 0.14 17655343 2559 CALR_HUMAN ENSP00000320866 acute myeloid leukemia Treatment (none vs. NSC606985 treatment) (nuclei) APL cell line NB4 cells (nuclei) APL cell line NB4 cells in the present of 25nM NSC606985 for 24 h. NSC606985 is a camptothecin analogue, induces apoptosis of acute myeloid leukemia (AML) cells cell line Down 0.14 17655343 2560 CALR_HUMAN ENSP00000320866 acute myeloid leukemia Treatment (none vs. NSC606985 treatment) (nuclei) APL cell line NB4 cells (nuclei) APL cell line NB4 cells in the present of 25nM NSC606985 for 24 h. NSC606985 is a camptothecin analogue, induces apoptosis of acute myeloid leukemia (AML) cells cell line Down 0.16 17655343 2561 GDIR1_HUMAN ENSP00000269321 acute myeloid leukemia Treatment (none vs. NSC606985 treatment) (nuclei) APL cell line NB4 cells (nuclei) APL cell line NB4 cells in the present of 25nM NSC606985 for 24 h. NSC606985 is a camptothecin analogue, induces apoptosis of acute myeloid leukemia (AML) cells cell line Down 0.16 17655343 2562 EF1B_HUMAN ENSP00000376055 acute myeloid leukemia Treatment (none vs. NSC606985 treatment) (nuclei) APL cell line NB4 cells (nuclei) APL cell line NB4 cells in the present of 25nM NSC606985 for 24 h. NSC606985 is a camptothecin analogue, induces apoptosis of acute myeloid leukemia (AML) cells cell line Down 0.17 17655343 2563 LASP1_HUMAN ENSP00000325240 acute myeloid leukemia Treatment (none vs. NSC606985 treatment) (nuclei) APL cell line NB4 cells (nuclei) APL cell line NB4 cells in the present of 25nM NSC606985 for 24 h. NSC606985 is a camptothecin analogue, induces apoptosis of acute myeloid leukemia (AML) cells cell line Down 0.17 17655343 2564 NFYC_HUMAN ENSP00000312617 acute myeloid leukemia Treatment (none vs. NSC606985 treatment) (nuclei) APL cell line NB4 cells (nuclei) APL cell line NB4 cells in the present of 25nM NSC606985 for 24 h. NSC606985 is a camptothecin analogue, induces apoptosis of acute myeloid leukemia (AML) cells cell line Down 0.26 17655343 2565 RD23B_HUMAN ENSP00000350708 acute myeloid leukemia Treatment (none vs. NSC606985 treatment) (nuclei) APL cell line NB4 cells (nuclei) APL cell line NB4 cells in the present of 25nM NSC606985 for 24 h. NSC606985 is a camptothecin analogue, induces apoptosis of acute myeloid leukemia (AML) cells cell line Down 0.3 17655343 2566 RAN_HUMAN ENSP00000376176 acute myeloid leukemia Treatment (none vs. NSC606985 treatment) (nuclei) APL cell line NB4 cells (nuclei) APL cell line NB4 cells in the present of 25nM NSC606985 for 24 h. NSC606985 is a camptothecin analogue, induces apoptosis of acute myeloid leukemia (AML) cells cell line Down 0.3 17655343 2567 EF1B_HUMAN ENSP00000376055 acute myeloid leukemia Treatment (none vs. NSC606985 treatment) (nuclei) APL cell line NB4 cells (nuclei) APL cell line NB4 cells in the present of 25nM NSC606985 for 24 h. NSC606985 is a camptothecin analogue, induces apoptosis of acute myeloid leukemia (AML) cells cell line Down 0.31 17655343 2568 HNRPK_HUMAN ENSP00000365440 acute myeloid leukemia Treatment (none vs. NSC606985 treatment) (nuclei) APL cell line NB4 cells (nuclei) APL cell line NB4 cells in the present of 25nM NSC606985 for 24 h. NSC606985 is a camptothecin analogue, induces apoptosis of acute myeloid leukemia (AML) cells cell line Down 0.34 17655343 2569 EF1B_HUMAN ENSP00000376055 acute myeloid leukemia Treatment (none vs. NSC606985 treatment) (nuclei) APL cell line NB4 cells (nuclei) APL cell line NB4 cells in the present of 25nM NSC606985 for 24 h. NSC606985 is a camptothecin analogue, induces apoptosis of acute myeloid leukemia (AML) cells cell line Down 0.39 17655343 2570 CALR_HUMAN ENSP00000320866 acute myeloid leukemia Treatment (none vs. NSC606985 treatment) (nuclei) APL cell line NB4 cells (nuclei) APL cell line NB4 cells in the present of 25nM NSC606985 for 24 h. NSC606985 is a camptothecin analogue, induces apoptosis of acute myeloid leukemia (AML) cells cell line Down 17655343 2571 ACTB_HUMAN ENSP00000349960 acute myeloid leukemia Treatment (none vs. NSC606985 treatment) (nuclei) APL cell line NB4 cells (nuclei) APL cell line NB4 cells in the present of 25nM NSC606985 for 24 h. NSC606985 is a camptothecin analogue, induces apoptosis of acute myeloid leukemia (AML) cells cell line Down 17655343 2572 FUBP1_HUMAN ENSP00000359804 acute myeloid leukemia Treatment (none vs. NSC606985 treatment) (nuclei) APL cell line NB4 cells (nuclei) APL cell line NB4 cells in the present of 25nM NSC606985 for 24 h. NSC606985 is a camptothecin analogue, induces apoptosis of acute myeloid leukemia (AML) cells cell line Down 17655343 2573 PGAM1_HUMAN ENSP00000359991 acute myeloid leukemia Treatment (none vs. NSC606985 treatment) (nuclei) APL cell line NB4 cells (nuclei) APL cell line NB4 cells in the present of 25nM NSC606985 for 24 h. NSC606985 is a camptothecin analogue, induces apoptosis of acute myeloid leukemia (AML) cells cell line Up 2.3 17655343 2574 TBB5_HUMAN ENSP00000406811 acute myeloid leukemia Treatment (none vs. NSC606985 treatment) (nuclei) APL cell line NB4 cells (nuclei) APL cell line NB4 cells in the present of 25nM NSC606985 for 24 h. NSC606985 is a camptothecin analogue, induces apoptosis of acute myeloid leukemia (AML) cells cell line Up 3.5 17655343 2575 ENOA_HUMAN ENSP00000234590 acute myeloid leukemia Treatment (none vs. NSC606985 treatment) (nuclei) APL cell line NB4 cells (nuclei) APL cell line NB4 cells in the present of 25nM NSC606985 for 24 h. NSC606985 is a camptothecin analogue, induces apoptosis of acute myeloid leukemia (AML) cells cell line Up 5.7 17655343 2576 HNRPQ_HUMAN ENSP00000358635 acute myeloid leukemia Treatment (none vs. NSC606985 treatment) (nuclei) APL cell line NB4 cells (nuclei) APL cell line NB4 cells in the present of 25nM NSC606985 for 24 h. NSC606985 is a camptothecin analogue, induces apoptosis of acute myeloid leukemia (AML) cells cell line Up 6 17655343 2577 CLIC1_HUMAN ENSP00000379229 acute myeloid leukemia Treatment (none vs. NSC606985 treatment) (nuclei) APL cell line NB4 cells (nuclei) APL cell line NB4 cells in the present of 25nM NSC606985 for 24 h. NSC606985 is a camptothecin analogue, induces apoptosis of acute myeloid leukemia (AML) cells cell line Up 7.5 17655343 2578 COF1_HUMAN ENSP00000309629 acute myeloid leukemia Treatment (none vs. NSC606985 treatment) (nuclei) APL cell line NB4 cells (nuclei) APL cell line NB4 cells in the present of 25nM NSC606985 for 24 h. NSC606985 is a camptothecin analogue, induces apoptosis of acute myeloid leukemia (AML) cells cell line Up 8.1 17655343 2579 GSTP1_HUMAN ENSP00000381607 acute myeloid leukemia Treatment (none vs. NSC606985 treatment) (nuclei) APL cell line NB4 cells (nuclei) APL cell line NB4 cells in the present of 25nM NSC606985 for 24 h. NSC606985 is a camptothecin analogue, induces apoptosis of acute myeloid leukemia (AML) cells cell line Up 8.3 17655343 2580 GDIR2_HUMAN ENSP00000228945 acute myeloid leukemia Treatment (none vs. NSC606985 treatment) (nuclei) APL cell line NB4 cells (nuclei) APL cell line NB4 cells in the present of 25nM NSC606985 for 24 h. NSC606985 is a camptothecin analogue, induces apoptosis of acute myeloid leukemia (AML) cells cell line Up 8.4 17655343 2581 ENOA_HUMAN ENSP00000234590 acute myeloid leukemia Treatment (none vs. NSC606985 treatment) (nuclei) APL cell line NB4 cells (nuclei) APL cell line NB4 cells in the present of 25nM NSC606985 for 24 h. NSC606985 is a camptothecin analogue, induces apoptosis of acute myeloid leukemia (AML) cells cell line Up 12 17655343 2582 HNRPQ_HUMAN ENSP00000358635 acute myeloid leukemia Treatment (none vs. NSC606985 treatment) (nuclei) APL cell line NB4 cells (nuclei) APL cell line NB4 cells in the present of 25nM NSC606985 for 24 h. NSC606985 is a camptothecin analogue, induces apoptosis of acute myeloid leukemia (AML) cells cell line Up 17655343 2583 TOM40_HUMAN ENSP00000252487 acute myeloid leukemia Treatment (none vs. NSC606985 treatment) (nuclei) APL cell line NB4 cells (nuclei) APL cell line NB4 cells in the present of 25nM NSC606985 for 24 h. NSC606985 is a camptothecin analogue, induces apoptosis of acute myeloid leukemia (AML) cells cell line Up 17655343 2584 DYR_HUMAN ENSP00000396308 acute myeloid leukemia Treatment (none vs. NSC606985 treatment) (nuclei) APL cell line NB4 cells (nuclei) APL cell line NB4 cells in the present of 25nM NSC606985 for 24 h. NSC606985 is a camptothecin analogue, induces apoptosis of acute myeloid leukemia (AML) cells cell line Up 17655343 2585 LMNA_HUMAN ENSP00000357283 acute myeloid leukemia Treatment (none vs. NSC606985 treatment) (nuclei) APL cell line NB4 cells (nuclei) APL cell line NB4 cells in the present of 25nM NSC606985 for 24 h. NSC606985 is a camptothecin analogue, induces apoptosis of acute myeloid leukemia (AML) cells cell line Up 17655343 2586 ENOA_HUMAN ENSP00000234590 acute myeloid leukemia Treatment (none vs. NSC606985 treatment) (nuclei) APL cell line NB4 cells (nuclei) APL cell line NB4 cells in the present of 25nM NSC606985 for 24 h. NSC606985 is a camptothecin analogue, induces apoptosis of acute myeloid leukemia (AML) cells cell line Up 17655343 2587 HNRPC_HUMAN ENSP00000319690 acute myeloid leukemia Treatment (none vs. NSC606985 treatment) (nuclei) APL cell line NB4 cells (nuclei) APL cell line NB4 cells in the present of 25nM NSC606985 for 24 h. NSC606985 is a camptothecin analogue, induces apoptosis of acute myeloid leukemia (AML) cells cell line Up 17655343 2588 RSSA_HUMAN ENSP00000346067 acute myeloid leukemia Treatment (none vs. NSC606985 treatment) (nuclei) APL cell line NB4 cells (nuclei) APL cell line NB4 cells in the present of 25nM NSC606985 for 24 h. NSC606985 is a camptothecin analogue, induces apoptosis of acute myeloid leukemia (AML) cells cell line Up 17655343 2589 PRS6A_HUMAN ENSP00000298852 acute myeloid leukemia Treatment (none vs. NSC606985 treatment) (nuclei) APL cell line NB4 cells (nuclei) APL cell line NB4 cells in the present of 25nM NSC606985 for 24 h. NSC606985 is a camptothecin analogue, induces apoptosis of acute myeloid leukemia (AML) cells cell line Up 17655343 2590 PGAM1_HUMAN ENSP00000359991 acute myeloid leukemia Treatment (none vs. NSC606985 treatment) (nuclei) APL cell line NB4 cells (nuclei) APL cell line NB4 cells in the present of 25nM NSC606985 for 24 h. NSC606985 is a camptothecin analogue, induces apoptosis of acute myeloid leukemia (AML) cells cell line Up 17655343 2591 NUCL_HUMAN ENSP00000318195 acute myeloid leukemia Treatment (none vs. NSC606985 treatment) (nuclei) APL cell line NB4 cells (nuclei) APL cell line NB4 cells in the present of 25nM NSC606985 for 24 h. NSC606985 is a camptothecin analogue, induces apoptosis of acute myeloid leukemia (AML) cells cell line Up 17655343 2592 LMNB1_HUMAN ENSP00000261366 acute myeloid leukemia Treatment (none vs. NSC606985 treatment) (nuclei) APL cell line NB4 cells (nuclei) APL cell line NB4 cells in the present of 25nM NSC606985 for 24 h. NSC606985 is a camptothecin analogue, induces apoptosis of acute myeloid leukemia (AML) cells cell line Up 17655343 2593 CALR_HUMAN ENSP00000320866 acute myeloid leukemia Treatment (none vs. NSC606985 treatment) (nuclei) APL cell line NB4 cells (nuclei) APL cell line NB4 cells in the present of 25nM NSC606985 for 24 h. NSC606985 is a camptothecin analogue, induces apoptosis of acute myeloid leukemia (AML) cells cell line Up 17655343 2594 DYN2_HUMAN ENSP00000352721 acute myeloid leukemia Treatment (none vs. NSC606985 treatment) (nuclei) APL cell line NB4 cells (nuclei) APL cell line NB4 cells in the present of 25nM NSC606985 for 24 h. NSC606985 is a camptothecin analogue, induces apoptosis of acute myeloid leukemia (AML) cells cell line Up 17655343 2595 GDIR2_HUMAN ENSP00000228945 acute myeloid leukemia Treatment (none vs. NSC606985 treatment) (nuclei) APL cell line NB4 cells (nuclei) APL cell line NB4 cells in the present of 25nM NSC606985 for 24 h. NSC606985 is a camptothecin analogue, induces apoptosis of acute myeloid leukemia (AML) cells cell line Up 17655343 2596 TBA1B_HUMAN ENSP00000336799 acute myeloid leukemia Treatment (none vs. NSC606985 treatment) (nuclei) APL cell line NB4 cells (nuclei) APL cell line NB4 cells in the present of 25nM NSC606985 for 24 h. NSC606985 is a camptothecin analogue, induces apoptosis of acute myeloid leukemia (AML) cells cell line Up 17655343 2597 CCND3_HUMAN ENSP00000362082 Neoplasms by Histologic Type Cancer vs. Cancer (progression) low-grade follicular lymphoma(FL) transformed follicular lymphoma (DLBCL) tissue Up 15098007 2598 HCD2_HUMAN ENSP00000168216 Neoplasms by Histologic Type Treatment (none vs. SB203580 treatment 3 hour) follicular lymphoma derived-cells transformed follicular lymphoma derived-cells (OCI Ly-1) treated with SB203580 (induce caspase-3-mediated apoptosis) 3 hours cell line Down 0.1 15169874 2599 RAN_HUMAN ENSP00000376176 Neoplasms by Histologic Type Treatment (none vs. SB203580 treatment 3 hour) follicular lymphoma derived-cells transformed follicular lymphoma derived-cells (OCI Ly-1) treated with SB203580 (induce caspase-3-mediated apoptosis) 3 hours cell line Down 0.13 15169874 2600 PKD2_HUMAN ENSP00000237596 Neoplasms by Histologic Type Treatment (none vs. SB203580 treatment 3 hour) follicular lymphoma derived-cells transformed follicular lymphoma derived-cells (OCI Ly-1) treated with SB203580 (induce caspase-3-mediated apoptosis) 3 hours cell line Down 0.13 15169874 2601 TRI14_HUMAN ENSP00000343990 Neoplasms by Histologic Type Treatment (none vs. SB203580 treatment 3 hour) follicular lymphoma derived-cells transformed follicular lymphoma derived-cells (OCI Ly-1) treated with SB203580 (induce caspase-3-mediated apoptosis) 3 hours cell line Down 0.14 15169874 2602 TRAF1_HUMAN ENSP00000362994 Neoplasms by Histologic Type Treatment (none vs. SB203580 treatment 3 hour) follicular lymphoma derived-cells transformed follicular lymphoma derived-cells (OCI Ly-1) treated with SB203580 (induce caspase-3-mediated apoptosis) 3 hours cell line Down 0.15 15169874 2603 PEBP1_HUMAN ENSP00000261313 Neoplasms by Histologic Type Treatment (none vs. SB203580 treatment 3 hour) follicular lymphoma derived-cells transformed follicular lymphoma derived-cells (OCI Ly-1) treated with SB203580 (induce caspase-3-mediated apoptosis) 3 hours cell line Down 0.19 15169874 2604 INPP_HUMAN ENSP00000376142 Neoplasms by Histologic Type Treatment (none vs. SB203580 treatment 3 hour) follicular lymphoma derived-cells transformed follicular lymphoma derived-cells (OCI Ly-1) treated with SB203580 (induce caspase-3-mediated apoptosis) 3 hours cell line Down 0.22 15169874 2605 RAF1_HUMAN ENSP00000251849 Neoplasms by Histologic Type Treatment (none vs. SB203580 treatment 3 hour) follicular lymphoma derived-cells transformed follicular lymphoma derived-cells (OCI Ly-1) treated with SB203580 (induce caspase-3-mediated apoptosis) 3 hours cell line Down 0.24 15169874 2606 INP4A_HUMAN ENSP00000074304 Neoplasms by Histologic Type Treatment (none vs. SB203580 treatment 3 hour) follicular lymphoma derived-cells transformed follicular lymphoma derived-cells (OCI Ly-1) treated with SB203580 (induce caspase-3-mediated apoptosis) 3 hours cell line Down 0.26 15169874 2607 GRM4_HUMAN ENSP00000363296 Neoplasms by Histologic Type Treatment (none vs. SB203580 treatment 3 hour) follicular lymphoma derived-cells transformed follicular lymphoma derived-cells (OCI Ly-1) treated with SB203580 (induce caspase-3-mediated apoptosis) 3 hours cell line Down 0.27 15169874 2608 PLD1_HUMAN ENSP00000342793 Neoplasms by Histologic Type Treatment (none vs. SB203580 treatment 3 hour) follicular lymphoma derived-cells transformed follicular lymphoma derived-cells (OCI Ly-1) treated with SB203580 (induce caspase-3-mediated apoptosis) 3 hours cell line Down 0.29 15169874 2609 TPIS_HUMAN ENSP00000379933 Neoplasms by Histologic Type Treatment (none vs. SB203580 treatment 3 hour) follicular lymphoma derived-cells transformed follicular lymphoma derived-cells (OCI Ly-1) treated with SB203580 (induce caspase-3-mediated apoptosis) 3 hours cell line Down 0.3 15169874 2610 PGAM1_HUMAN ENSP00000359991 Neoplasms by Histologic Type Treatment (none vs. SB203580 treatment 3 hour) follicular lymphoma derived-cells transformed follicular lymphoma derived-cells (OCI Ly-1) treated with SB203580 (induce caspase-3-mediated apoptosis) 3 hours cell line Down 0.3 15169874 2611 MK10_HUMAN ENSP00000378595 Neoplasms by Histologic Type Treatment (none vs. SB203580 treatment 3 hour) follicular lymphoma derived-cells transformed follicular lymphoma derived-cells (OCI Ly-1) treated with SB203580 (induce caspase-3-mediated apoptosis) 3 hours cell line Down 0.34 15169874 2612 PK3CG_HUMAN ENSP00000352121 Neoplasms by Histologic Type Treatment (none vs. SB203580 treatment 3 hour) follicular lymphoma derived-cells transformed follicular lymphoma derived-cells (OCI Ly-1) treated with SB203580 (induce caspase-3-mediated apoptosis) 3 hours cell line Down 0.36 15169874 2613 ALBU_HUMAN ENSP00000295897 Neoplasms by Histologic Type Treatment (none vs. SB203580 treatment 3 hour) follicular lymphoma derived-cells transformed follicular lymphoma derived-cells (OCI Ly-1) treated with SB203580 (induce caspase-3-mediated apoptosis) 3 hours cell line Down 0.38 15169874 2614 GNAO_HUMAN ENSP00000262493 Neoplasms by Histologic Type Treatment (none vs. SB203580 treatment 3 hour) follicular lymphoma derived-cells transformed follicular lymphoma derived-cells (OCI Ly-1) treated with SB203580 (induce caspase-3-mediated apoptosis) 3 hours cell line Down 0.4 15169874 2615 SP100_HUMAN ENSP00000264052 Neoplasms by Histologic Type Treatment (none vs. SB203580 treatment 3 hour) follicular lymphoma derived-cells transformed follicular lymphoma derived-cells (OCI Ly-1) treated with SB203580 (induce caspase-3-mediated apoptosis) 3 hours cell line Down 0.4 15169874 2616 PEBP1_HUMAN ENSP00000261313 Neoplasms by Histologic Type Treatment (none vs. SB203580 treatment 3 hour) follicular lymphoma derived-cells transformed follicular lymphoma derived-cells (OCI Ly-1) treated with SB203580 (induce caspase-3-mediated apoptosis) 3 hours cell line Down 0.4 15169874 2617 IBP1_HUMAN ENSP00000275525 Neoplasms by Histologic Type Treatment (none vs. SB203580 treatment 3 hour) follicular lymphoma derived-cells transformed follicular lymphoma derived-cells (OCI Ly-1) treated with SB203580 (induce caspase-3-mediated apoptosis) 3 hours cell line Down 0.42 15169874 2618 ACVR1_HUMAN ENSP00000405004 Neoplasms by Histologic Type Treatment (none vs. SB203580 treatment 3 hour) follicular lymphoma derived-cells transformed follicular lymphoma derived-cells (OCI Ly-1) treated with SB203580 (induce caspase-3-mediated apoptosis) 3 hours cell line Down 0.43 15169874 2619 EPHB1_HUMAN ENSP00000381097 Neoplasms by Histologic Type Treatment (none vs. SB203580 treatment 3 hour) follicular lymphoma derived-cells transformed follicular lymphoma derived-cells (OCI Ly-1) treated with SB203580 (induce caspase-3-mediated apoptosis) 3 hours cell line Down 0.45 15169874 2620 IL6_HUMAN ENSP00000258743 Neoplasms by Histologic Type Treatment (none vs. SB203580 treatment 3 hour) follicular lymphoma derived-cells transformed follicular lymphoma derived-cells (OCI Ly-1) treated with SB203580 (induce caspase-3-mediated apoptosis) 3 hours cell line Down 0.54 15169874 2621 ITB3_HUMAN ENSP00000262017 Neoplasms by Histologic Type Treatment (none vs. SB203580 treatment 3 hour) follicular lymphoma derived-cells transformed follicular lymphoma derived-cells (OCI Ly-1) treated with SB203580 (induce caspase-3-mediated apoptosis) 3 hours cell line Down 0.59 15169874 2622 ISK1_HUMAN ENSP00000296695 Neoplasms by Histologic Type Treatment (none vs. SB203580 treatment 3 hour) follicular lymphoma derived-cells transformed follicular lymphoma derived-cells (OCI Ly-1) treated with SB203580 (induce caspase-3-mediated apoptosis) 3 hours cell line Down 0.6 15169874 2623 ZN267_HUMAN ENSP00000300870 Neoplasms by Histologic Type Treatment (none vs. SB203580 treatment 3 hour) follicular lymphoma derived-cells transformed follicular lymphoma derived-cells (OCI Ly-1) treated with SB203580 (induce caspase-3-mediated apoptosis) 3 hours cell line Down 0.66 15169874 2624 IRK8_HUMAN ENSP00000240662 Neoplasms by Histologic Type Treatment (none vs. SB203580 treatment 3 hour) follicular lymphoma derived-cells transformed follicular lymphoma derived-cells (OCI Ly-1) treated with SB203580 (induce caspase-3-mediated apoptosis) 3 hours cell line Down 0.67 15169874 2625 PLEC_HUMAN ENSP00000323856 Neoplasms by Histologic Type Treatment (none vs. SB203580 treatment 3 hour) follicular lymphoma derived-cells transformed follicular lymphoma derived-cells (OCI Ly-1) treated with SB203580 (induce caspase-3-mediated apoptosis) 3 hours cell line Up 1.5 15169874 2626 THRB_HUMAN ENSP00000308541 Neoplasms by Histologic Type Treatment (none vs. SB203580 treatment 3 hour) follicular lymphoma derived-cells transformed follicular lymphoma derived-cells (OCI Ly-1) treated with SB203580 (induce caspase-3-mediated apoptosis) 3 hours cell line Up 1.5 15169874 2627 KI2L1_HUMAN ENSP00000336769 Neoplasms by Histologic Type Treatment (none vs. SB203580 treatment 3 hour) follicular lymphoma derived-cells transformed follicular lymphoma derived-cells (OCI Ly-1) treated with SB203580 (induce caspase-3-mediated apoptosis) 3 hours cell line Up 1.6 15169874 2628 ACTB_HUMAN ENSP00000349960 Neoplasms by Histologic Type Treatment (none vs. SB203580 treatment 3 hour) follicular lymphoma derived-cells transformed follicular lymphoma derived-cells (OCI Ly-1) treated with SB203580 (induce caspase-3-mediated apoptosis) 3 hours cell line Up 2.5 15169874 2629 ZN823_HUMAN ENSP00000340683 Neoplasms by Histologic Type Treatment (none vs. SB203580 treatment 3 hour) follicular lymphoma derived-cells transformed follicular lymphoma derived-cells (OCI Ly-1) treated with SB203580 (induce caspase-3-mediated apoptosis) 3 hours cell line Up 3.8 15169874 2630 STAT4_HUMAN ENSP00000376134 Neoplasms by Histologic Type Treatment (none vs. SB203580 treatment 3 hour) follicular lymphoma derived-cells transformed follicular lymphoma derived-cells (OCI Ly-1) treated with SB203580 (induce caspase-3-mediated apoptosis) 3 hours cell line Up 4.5 15169874 2631 HSP7C_HUMAN ENSP00000227378 Neoplasms by Histologic Type Treatment (none vs. SB203580 treatment 3 hour) follicular lymphoma derived-cells transformed follicular lymphoma derived-cells (OCI Ly-1) treated with SB203580 (induce caspase-3-mediated apoptosis) 3 hours cell line Up 5.2 15169874 2632 CSF1_HUMAN ENSP00000358817 Neoplasms by Histologic Type Treatment (none vs. SB203580 treatment 21 hour) follicular lymphoma derived-cells transformed follicular lymphoma derived-cells (OCI Ly-1) treated with SB203580 (induce caspase-3-mediated apoptosis) 21 hours cell line Down 0.06 15169874 2633 LAMA1_HUMAN ENSP00000374309 Neoplasms by Histologic Type Treatment (none vs. SB203580 treatment 21 hour) follicular lymphoma derived-cells transformed follicular lymphoma derived-cells (OCI Ly-1) treated with SB203580 (induce caspase-3-mediated apoptosis) 21 hours cell line Down 0.16 15169874 2634 LMNB1_HUMAN ENSP00000261366 Neoplasms by Histologic Type Treatment (none vs. SB203580 treatment 21 hour) follicular lymphoma derived-cells transformed follicular lymphoma derived-cells (OCI Ly-1) treated with SB203580 (induce caspase-3-mediated apoptosis) 21 hours cell line Down 0.21 15169874 2635 ZIC1_HUMAN ENSP00000282928 Neoplasms by Histologic Type Treatment (none vs. SB203580 treatment 21 hour) follicular lymphoma derived-cells transformed follicular lymphoma derived-cells (OCI Ly-1) treated with SB203580 (induce caspase-3-mediated apoptosis) 21 hours cell line Down 0.21 15169874 2636 ARAF_HUMAN ENSP00000366244 Neoplasms by Histologic Type Treatment (none vs. SB203580 treatment 21 hour) follicular lymphoma derived-cells transformed follicular lymphoma derived-cells (OCI Ly-1) treated with SB203580 (induce caspase-3-mediated apoptosis) 21 hours cell line Down 0.22 15169874 2637 PP1A_HUMAN ENSP00000365936 Neoplasms by Histologic Type Treatment (none vs. SB203580 treatment 21 hour) follicular lymphoma derived-cells transformed follicular lymphoma derived-cells (OCI Ly-1) treated with SB203580 (induce caspase-3-mediated apoptosis) 21 hours cell line Down 0.24 15169874 2638 DYRK2_HUMAN ENSP00000342105 Neoplasms by Histologic Type Treatment (none vs. SB203580 treatment 21 hour) follicular lymphoma derived-cells transformed follicular lymphoma derived-cells (OCI Ly-1) treated with SB203580 (induce caspase-3-mediated apoptosis) 21 hours cell line Down 0.27 15169874 2639 PAX3_HUMAN ENSP00000343052 Neoplasms by Histologic Type Treatment (none vs. SB203580 treatment 21 hour) follicular lymphoma derived-cells transformed follicular lymphoma derived-cells (OCI Ly-1) treated with SB203580 (induce caspase-3-mediated apoptosis) 21 hours cell line Down 0.32 15169874 2640 PTH2R_HUMAN ENSP00000272847 Neoplasms by Histologic Type Treatment (none vs. SB203580 treatment 21 hour) follicular lymphoma derived-cells transformed follicular lymphoma derived-cells (OCI Ly-1) treated with SB203580 (induce caspase-3-mediated apoptosis) 21 hours cell line Down 0.32 15169874 2641 FZD2_HUMAN ENSP00000323901 Neoplasms by Histologic Type Treatment (none vs. SB203580 treatment 21 hour) follicular lymphoma derived-cells transformed follicular lymphoma derived-cells (OCI Ly-1) treated with SB203580 (induce caspase-3-mediated apoptosis) 21 hours cell line Down 0.32 15169874 2642 PARK7_HUMAN ENSP00000366708 Neoplasms by Histologic Type Treatment (none vs. SB203580 treatment 21 hour) follicular lymphoma derived-cells transformed follicular lymphoma derived-cells (OCI Ly-1) treated with SB203580 (induce caspase-3-mediated apoptosis) 21 hours cell line Down 0.34 15169874 2643 DLL4_HUMAN ENSP00000249749 Neoplasms by Histologic Type Treatment (none vs. SB203580 treatment 21 hour) follicular lymphoma derived-cells transformed follicular lymphoma derived-cells (OCI Ly-1) treated with SB203580 (induce caspase-3-mediated apoptosis) 21 hours cell line Down 0.36 15169874 2644 MAPK2_HUMAN ENSP00000356070 Neoplasms by Histologic Type Treatment (none vs. SB203580 treatment 21 hour) follicular lymphoma derived-cells transformed follicular lymphoma derived-cells (OCI Ly-1) treated with SB203580 (induce caspase-3-mediated apoptosis) 21 hours cell line Down 0.37 15169874 2645 HSP7C_HUMAN ENSP00000227378 Neoplasms by Histologic Type Treatment (none vs. SB203580 treatment 21 hour) follicular lymphoma derived-cells transformed follicular lymphoma derived-cells (OCI Ly-1) treated with SB203580 (induce caspase-3-mediated apoptosis) 21 hours cell line Down 0.38 15169874 2646 ABCA1_HUMAN ENSP00000363868 Neoplasms by Histologic Type Treatment (none vs. SB203580 treatment 21 hour) follicular lymphoma derived-cells transformed follicular lymphoma derived-cells (OCI Ly-1) treated with SB203580 (induce caspase-3-mediated apoptosis) 21 hours cell line Down 0.39 15169874 2647 KCNB1_HUMAN ENSP00000360806 Neoplasms by Histologic Type Treatment (none vs. SB203580 treatment 21 hour) follicular lymphoma derived-cells transformed follicular lymphoma derived-cells (OCI Ly-1) treated with SB203580 (induce caspase-3-mediated apoptosis) 21 hours cell line Down 0.39 15169874 2648 ITB3_HUMAN ENSP00000262017 Neoplasms by Histologic Type Treatment (none vs. SB203580 treatment 21 hour) follicular lymphoma derived-cells transformed follicular lymphoma derived-cells (OCI Ly-1) treated with SB203580 (induce caspase-3-mediated apoptosis) 21 hours cell line Down 0.4 15169874 2649 IL6_HUMAN ENSP00000258743 Neoplasms by Histologic Type Treatment (none vs. SB203580 treatment 21 hour) follicular lymphoma derived-cells transformed follicular lymphoma derived-cells (OCI Ly-1) treated with SB203580 (induce caspase-3-mediated apoptosis) 21 hours cell line Down 0.4 15169874 2650 KPYM_HUMAN ENSP00000334983 Neoplasms by Histologic Type Treatment (none vs. SB203580 treatment 21 hour) follicular lymphoma derived-cells transformed follicular lymphoma derived-cells (OCI Ly-1) treated with SB203580 (induce caspase-3-mediated apoptosis) 21 hours cell line Down 0.4 15169874 2651 GSTP1_HUMAN ENSP00000381607 Neoplasms by Histologic Type Treatment (none vs. SB203580 treatment 21 hour) follicular lymphoma derived-cells transformed follicular lymphoma derived-cells (OCI Ly-1) treated with SB203580 (induce caspase-3-mediated apoptosis) 21 hours cell line Down 0.45 15169874 2652 HMDH_HUMAN ENSP00000287936 Neoplasms by Histologic Type Treatment (none vs. SB203580 treatment 21 hour) follicular lymphoma derived-cells transformed follicular lymphoma derived-cells (OCI Ly-1) treated with SB203580 (induce caspase-3-mediated apoptosis) 21 hours cell line Down 0.46 15169874 2653 CRKL_HUMAN ENSP00000396646 Neoplasms by Histologic Type Treatment (none vs. SB203580 treatment 21 hour) follicular lymphoma derived-cells transformed follicular lymphoma derived-cells (OCI Ly-1) treated with SB203580 (induce caspase-3-mediated apoptosis) 21 hours cell line Down 0.46 15169874 2654 RSSA_HUMAN ENSP00000346067 Neoplasms by Histologic Type Treatment (none vs. SB203580 treatment 21 hour) follicular lymphoma derived-cells transformed follicular lymphoma derived-cells (OCI Ly-1) treated with SB203580 (induce caspase-3-mediated apoptosis) 21 hours cell line Down 0.5 15169874 2655 VGFR2_HUMAN ENSP00000263923 Neoplasms by Histologic Type Treatment (none vs. SB203580 treatment 21 hour) follicular lymphoma derived-cells transformed follicular lymphoma derived-cells (OCI Ly-1) treated with SB203580 (induce caspase-3-mediated apoptosis) 21 hours cell line Down 0.5 15169874 2656 HSF1_HUMAN ENSP00000431512 Neoplasms by Histologic Type Treatment (none vs. SB203580 treatment 21 hour) follicular lymphoma derived-cells transformed follicular lymphoma derived-cells (OCI Ly-1) treated with SB203580 (induce caspase-3-mediated apoptosis) 21 hours cell line Down 0.5 15169874 2657 PF2R_HUMAN ENSP00000359793 Neoplasms by Histologic Type Treatment (none vs. SB203580 treatment 21 hour) follicular lymphoma derived-cells transformed follicular lymphoma derived-cells (OCI Ly-1) treated with SB203580 (induce caspase-3-mediated apoptosis) 21 hours cell line Down 0.53 15169874 2658 KS6A1_HUMAN ENSP00000431651 Neoplasms by Histologic Type Treatment (none vs. SB203580 treatment 21 hour) follicular lymphoma derived-cells transformed follicular lymphoma derived-cells (OCI Ly-1) treated with SB203580 (induce caspase-3-mediated apoptosis) 21 hours cell line Down 0.54 15169874 2659 FHIT_HUMAN ENSP00000342087 Neoplasms by Histologic Type Treatment (none vs. SB203580 treatment 21 hour) follicular lymphoma derived-cells transformed follicular lymphoma derived-cells (OCI Ly-1) treated with SB203580 (induce caspase-3-mediated apoptosis) 21 hours cell line Down 0.56 15169874 2660 HS90A_HUMAN ENSP00000335153 Neoplasms by Histologic Type Treatment (none vs. SB203580 treatment 21 hour) follicular lymphoma derived-cells transformed follicular lymphoma derived-cells (OCI Ly-1) treated with SB203580 (induce caspase-3-mediated apoptosis) 21 hours cell line Down 0.58 15169874 2661 TRFR_HUMAN ENSP00000309818 Neoplasms by Histologic Type Treatment (none vs. SB203580 treatment 21 hour) follicular lymphoma derived-cells transformed follicular lymphoma derived-cells (OCI Ly-1) treated with SB203580 (induce caspase-3-mediated apoptosis) 21 hours cell line Down 0.62 15169874 2662 RPB1_HUMAN ENSP00000314949 Neoplasms by Histologic Type Treatment (none vs. SB203580 treatment 21 hour) follicular lymphoma derived-cells transformed follicular lymphoma derived-cells (OCI Ly-1) treated with SB203580 (induce caspase-3-mediated apoptosis) 21 hours cell line Down 0.63 15169874 2663 DCOR_HUMAN ENSP00000385333 Neoplasms by Histologic Type Treatment (none vs. SB203580 treatment 21 hour) follicular lymphoma derived-cells transformed follicular lymphoma derived-cells (OCI Ly-1) treated with SB203580 (induce caspase-3-mediated apoptosis) 21 hours cell line Down 0.64 15169874 2664 UPAR_HUMAN ENSP00000339328 Neoplasms by Histologic Type Treatment (none vs. SB203580 treatment 21 hour) follicular lymphoma derived-cells transformed follicular lymphoma derived-cells (OCI Ly-1) treated with SB203580 (induce caspase-3-mediated apoptosis) 21 hours cell line Down 0.64 15169874 2665 TPA_HUMAN ENSP00000220809 Neoplasms by Histologic Type Treatment (none vs. SB203580 treatment 21 hour) follicular lymphoma derived-cells transformed follicular lymphoma derived-cells (OCI Ly-1) treated with SB203580 (induce caspase-3-mediated apoptosis) 21 hours cell line Down 0.65 15169874 2666 EZH2_HUMAN ENSP00000419856 Neoplasms by Histologic Type Treatment (none vs. SB203580 treatment 21 hour) follicular lymphoma derived-cells transformed follicular lymphoma derived-cells (OCI Ly-1) treated with SB203580 (induce caspase-3-mediated apoptosis) 21 hours cell line Up 1.6 15169874 2667 ID4_HUMAN ENSP00000367972 Neoplasms by Histologic Type Treatment (none vs. SB203580 treatment 21 hour) follicular lymphoma derived-cells transformed follicular lymphoma derived-cells (OCI Ly-1) treated with SB203580 (induce caspase-3-mediated apoptosis) 21 hours cell line Up 1.7 15169874 2668 TEBP_HUMAN ENSP00000262033 Neoplasms by Histologic Type Treatment (none vs. SB203580 treatment 21 hour) follicular lymphoma derived-cells transformed follicular lymphoma derived-cells (OCI Ly-1) treated with SB203580 (induce caspase-3-mediated apoptosis) 21 hours cell line Up 1.8 15169874 2669 PLXC1_HUMAN ENSP00000258526 Neoplasms by Histologic Type Treatment (none vs. SB203580 treatment 21 hour) follicular lymphoma derived-cells transformed follicular lymphoma derived-cells (OCI Ly-1) treated with SB203580 (induce caspase-3-mediated apoptosis) 21 hours cell line Up 2 15169874 2670 TNR1A_HUMAN ENSP00000162749 Neoplasms by Histologic Type Treatment (none vs. SB203580 treatment 21 hour) follicular lymphoma derived-cells transformed follicular lymphoma derived-cells (OCI Ly-1) treated with SB203580 (induce caspase-3-mediated apoptosis) 21 hours cell line Up 2.1 15169874 2671 NDKA_HUMAN ENSP00000013034 Neoplasms by Histologic Type Treatment (none vs. SB203580 treatment 21 hour) follicular lymphoma derived-cells transformed follicular lymphoma derived-cells (OCI Ly-1) treated with SB203580 (induce caspase-3-mediated apoptosis) 21 hours cell line Up 2.4 15169874 2672 CBLB_HUMAN ENSP00000264122 Neoplasms by Histologic Type Treatment (none vs. SB203580 treatment 21 hour) follicular lymphoma derived-cells transformed follicular lymphoma derived-cells (OCI Ly-1) treated with SB203580 (induce caspase-3-mediated apoptosis) 21 hours cell line Up 4.5 15169874 2673 WEE1_HUMAN ENSP00000402084 Neoplasms by Histologic Type Treatment (none vs. SB203580 treatment 21 hour) follicular lymphoma derived-cells transformed follicular lymphoma derived-cells (OCI Ly-1) treated with SB203580 (induce caspase-3-mediated apoptosis) 21 hours cell line Up 5 15169874 2674 PENK_HUMAN ENSP00000400894 Brain Cancer Normal vs. Cancer cerebrospinal fluid (CSF) from non-neoplastic control patients cerebrospinal fluid (CSF) from patients with CNS lymphoma tissue Down 0.38 18056677 2675 A4_HUMAN ENSP00000284981 Brain Cancer Normal vs. Cancer cerebrospinal fluid (CSF) from non-neoplastic control patients cerebrospinal fluid (CSF) from patients with CNS lymphoma tissue Down 0.42 18056677 2676 A4_HUMAN ENSP00000284981 Brain Cancer Normal vs. Cancer cerebrospinal fluid (CSF) from non-neoplastic control patients cerebrospinal fluid (CSF) from patients with CNS lymphoma tissue Down 0.43 18056677 2677 NRCAM_HUMAN ENSP00000368314 Brain Cancer Normal vs. Cancer cerebrospinal fluid (CSF) from non-neoplastic control patients cerebrospinal fluid (CSF) from patients with CNS lymphoma tissue Down 0.45 18056677 2678 CNTN1_HUMAN ENSP00000325660 Brain Cancer Normal vs. Cancer cerebrospinal fluid (CSF) from non-neoplastic control patients cerebrospinal fluid (CSF) from patients with CNS lymphoma tissue Down 0.47 18056677 2679 C1R_HUMAN ENSP00000290575 Brain Cancer Normal vs. Cancer cerebrospinal fluid (CSF) from non-neoplastic control patients cerebrospinal fluid (CSF) from patients with CNS lymphoma tissue Up 1.6 18056677 2680 MPRI_HUMAN ENSP00000349437 Brain Cancer Normal vs. Cancer cerebrospinal fluid (CSF) from non-neoplastic control patients cerebrospinal fluid (CSF) from patients with CNS lymphoma tissue Up 2.3 18056677 2681 APOA1_HUMAN ENSP00000236850 Brain Cancer Normal vs. Cancer cerebrospinal fluid (CSF) from non-neoplastic control patients cerebrospinal fluid (CSF) from patients with CNS lymphoma tissue Up 2.4 18056677 2682 PLMN_HUMAN ENSP00000308938 Brain Cancer Normal vs. Cancer cerebrospinal fluid (CSF) from non-neoplastic control patients cerebrospinal fluid (CSF) from patients with CNS lymphoma tissue Up 2.4 18056677 2683 CO5_HUMAN ENSP00000223642 Brain Cancer Normal vs. Cancer cerebrospinal fluid (CSF) from non-neoplastic control patients cerebrospinal fluid (CSF) from patients with CNS lymphoma tissue Up 2.5 18056677 2684 OSTP_HUMAN ENSP00000378517 Brain Cancer Normal vs. Cancer cerebrospinal fluid (CSF) from non-neoplastic control patients cerebrospinal fluid (CSF) from patients with CNS lymphoma tissue Up 2.5 18056677 2685 ANT3_HUMAN ENSP00000356671 Brain Cancer Normal vs. Cancer cerebrospinal fluid (CSF) from non-neoplastic control patients cerebrospinal fluid (CSF) from patients with CNS lymphoma tissue Up 2.8 18056677 2686 MMP2_HUMAN ENSP00000219070 Brain Cancer Normal vs. Cancer cerebrospinal fluid (CSF) from non-neoplastic control patients cerebrospinal fluid (CSF) from patients with CNS lymphoma tissue Up 2.9 18056677 2687 C4BPA_HUMAN ENSP00000356037 Brain Cancer Normal vs. Cancer cerebrospinal fluid (CSF) from non-neoplastic control patients cerebrospinal fluid (CSF) from patients with CNS lymphoma tissue Up 3.8 18056677 2688 OSTP_HUMAN ENSP00000378517 Brain Cancer Normal vs. Cancer cerebrospinal fluid (CSF) from non-neoplastic control patients cerebrospinal fluid (CSF) from patients with CNS lymphoma tissue Up 4 18056677 2689 A2MG_HUMAN ENSP00000323929 Brain Cancer Normal vs. Cancer cerebrospinal fluid (CSF) from non-neoplastic control patients cerebrospinal fluid (CSF) from patients with CNS lymphoma tissue Up 4.2 18056677 2690 RET4_HUMAN ENSP00000360522 Brain Cancer Normal vs. Cancer cerebrospinal fluid (CSF) from non-neoplastic control patients cerebrospinal fluid (CSF) from patients with CNS lymphoma tissue Up 4.5 18056677 2691 CD14_HUMAN ENSP00000385519 Brain Cancer Normal vs. Cancer cerebrospinal fluid (CSF) from non-neoplastic control patients cerebrospinal fluid (CSF) from patients with CNS lymphoma tissue Up 4.6 18056677 2692 AMBP_HUMAN ENSP00000265132 Brain Cancer Normal vs. Cancer cerebrospinal fluid (CSF) from non-neoplastic control patients cerebrospinal fluid (CSF) from patients with CNS lymphoma tissue Up 4.6 18056677 2693 TTHY_HUMAN ENSP00000237014 Brain Cancer Normal vs. Cancer cerebrospinal fluid (CSF) from non-neoplastic control patients cerebrospinal fluid (CSF) from patients with CNS lymphoma tissue Up 5.1 18056677 2694 CO3_HUMAN ENSP00000245907 Brain Cancer Normal vs. Cancer cerebrospinal fluid (CSF) from non-neoplastic control patients cerebrospinal fluid (CSF) from patients with CNS lymphoma tissue Up 5.4 18056677 2695 APOA2_HUMAN ENSP00000356969 Brain Cancer Normal vs. Cancer cerebrospinal fluid (CSF) from non-neoplastic control patients cerebrospinal fluid (CSF) from patients with CNS lymphoma tissue Up 6.8 18056677 2696 CFAH_HUMAN ENSP00000356399 Brain Cancer Normal vs. Cancer cerebrospinal fluid (CSF) from non-neoplastic control patients cerebrospinal fluid (CSF) from patients with CNS lymphoma tissue Up 6.8 18056677 2697 GPX1_HUMAN ENSP00000407375 Neoplasms by Histologic Type Cancer vs. Cancer (sporadic systemic lymphomas (SSLs) vs. primary CNS lymphomas(PCNSLs)) diffuse large B-cell SSLs diffuse large B-cell PCNSLs cell line Down 18759588 2698 PARK7_HUMAN ENSP00000366708 Neoplasms by Histologic Type Cancer vs. Cancer (sporadic systemic lymphomas (SSLs) vs. primary CNS lymphomas(PCNSLs)) diffuse large B-cell SSLs diffuse large B-cell PCNSLs cell line Down 18759588 2699 1433B_HUMAN ENSP00000361930 Neoplasms by Histologic Type Cancer vs. Cancer (sporadic systemic lymphomas (SSLs) vs. primary CNS lymphomas(PCNSLs)) diffuse large B-cell SSLs diffuse large B-cell PCNSLs cell line Up 18759588 2700 F16P1_HUMAN ENSP00000408025 Renal Cancer Normal vs. Cancer normal renal cortex samples from patients malignant RCC tissue samples from patients tissue Down 0.33 12923786 2701 ASSY_HUMAN ENSP00000361470 Renal Cancer Normal vs. Cancer normal renal cortex samples from patients malignant RCC tissue samples from patients tissue Down 0.43 12923786 2702 ACADM_HUMAN ENSP00000359878 Renal Cancer Normal vs. Cancer normal renal cortex samples from patients malignant RCC tissue samples from patients tissue Down 0.53 12923786 2703 ACADM_HUMAN ENSP00000359878 Renal Cancer Normal vs. Cancer normal renal cortex samples from patients malignant RCC tissue samples from patients tissue Down 0.59 12923786 2704 PCKGC_HUMAN ENSP00000319814 Renal Cancer Normal vs. Cancer normal renal cortex samples from patients malignant RCC tissue samples from patients tissue Down 12923786 2705 EF2_HUMAN ENSP00000307940 Renal Cancer Normal vs. Cancer normal renal cortex samples from patients malignant RCC tissue samples from patients tissue Up 0.8-11.4 12923786 2706 KPYM_HUMAN ENSP00000334983 Renal Cancer Normal vs. Cancer normal renal cortex samples from patients malignant RCC tissue samples from patients tissue Up 1.1-20.8 12923786 2707 PGM1_HUMAN ENSP00000360125 Renal Cancer Normal vs. Cancer normal renal cortex samples from patients malignant RCC tissue samples from patients tissue Up 1.1-3.4 12923786 2708 ANXA1_HUMAN ENSP00000366109 Renal Cancer Normal vs. Cancer normal renal cortex samples from patients malignant RCC tissue samples from patients tissue Up 1.1-5.7 12923786 2709 SODM_HUMAN ENSP00000337127 Renal Cancer Normal vs. Cancer normal renal cortex samples from patients malignant RCC tissue samples from patients tissue Up 1.2-13.7 12923786 2710 PGAM1_HUMAN ENSP00000359991 Renal Cancer Normal vs. Cancer normal renal cortex samples from patients malignant RCC tissue samples from patients tissue Up 1.7-4.2 12923786 2711 TPIS_HUMAN ENSP00000379933 Renal Cancer Normal vs. Cancer normal renal cortex samples from patients malignant RCC tissue samples from patients tissue Up 1.7-4.4 12923786 2712 COF1_HUMAN ENSP00000309629 Renal Cancer Normal vs. Cancer normal renal cortex samples from patients malignant RCC tissue samples from patients tissue Up 1.8-3.0 12923786 2713 ENOA_HUMAN ENSP00000234590 Renal Cancer Normal vs. Cancer normal renal cortex samples from patients malignant RCC tissue samples from patients tissue Up 1.8-4.5 12923786 2714 G3P_HUMAN ENSP00000380068 Renal Cancer Normal vs. Cancer normal renal cortex samples from patients malignant RCC tissue samples from patients tissue Up 2.0-3.3 12923786 2715 KPYM_HUMAN ENSP00000334983 Renal Cancer Normal vs. Cancer normal renal cortex samples from patients malignant RCC tissue samples from patients tissue Up 2.1-3.5 12923786 2716 G3P_HUMAN ENSP00000380068 Renal Cancer Normal vs. Cancer normal renal cortex samples from patients malignant RCC tissue samples from patients tissue Up 2.1-5.4 12923786 2717 KPYM_HUMAN ENSP00000334983 Renal Cancer Normal vs. Cancer normal renal cortex samples from patients malignant RCC tissue samples from patients tissue Up 2.4-14.8 12923786 2718 VIME_HUMAN ENSP00000224237 Renal Cancer Normal vs. Cancer normal renal cortex samples from patients malignant RCC tissue samples from patients tissue Up 2.4-31.0 12923786 2719 TPIS_HUMAN ENSP00000379933 Renal Cancer Normal vs. Cancer normal renal cortex samples from patients malignant RCC tissue samples from patients tissue Up 2.7-6.1 12923786 2720 ANXA2_HUMAN ENSP00000411352 Renal Cancer Normal vs. Cancer normal renal cortex samples from patients malignant RCC tissue samples from patients tissue Up 2.9-10.4 12923786 2721 LMNB1_HUMAN ENSP00000261366 Renal Cancer Normal vs. Cancer normal renal cortex samples from patients malignant RCC tissue samples from patients tissue Up 3.4-6.4 12923786 2722 NHRF1_HUMAN ENSP00000262613 Renal Cancer Normal vs. Cancer normal tissues clear cell renal cell carcinoma (ccRCC) tissues, Grading 1-4 tissue Down 19164279 2723 ACTN4_HUMAN ENSP00000252699 Renal Cancer Normal vs. Cancer normal tissues clear cell renal cell carcinoma (ccRCC) tissues, Grading 1-4 tissue Down 19164279 2724 ASSY_HUMAN ENSP00000361470 Renal Cancer Normal vs. Cancer normal tissues clear cell renal cell carcinoma (ccRCC) tissues, Grading 1-4 tissue Down 19164279 2725 CO4A1_HUMAN ENSP00000364979 Renal Cancer Normal vs. Cancer normal tissues clear cell renal cell carcinoma (ccRCC) tissues, Grading 1-4 tissue Down 19164279 2726 AMBP_HUMAN ENSP00000265132 Renal Cancer Normal vs. Cancer normal tissues clear cell renal cell carcinoma (ccRCC) tissues, Grading 1-4 tissue Down 19164279 2727 VTNC_HUMAN ENSP00000226218 Renal Cancer Normal vs. Cancer normal tissues clear cell renal cell carcinoma (ccRCC) tissues, Grading 1-4 tissue Down 19164279 2728 CO4A2_HUMAN ENSP00000353654 Renal Cancer Normal vs. Cancer normal tissues clear cell renal cell carcinoma (ccRCC) tissues, Grading 1-4 tissue Down 19164279 2729 DHPR_HUMAN ENSP00000281243 Renal Cancer Normal vs. Cancer normal tissues clear cell renal cell carcinoma (ccRCC) tissues, Grading 1-4 tissue Down 19164279 2730 F16P1_HUMAN ENSP00000408025 Renal Cancer Normal vs. Cancer normal tissues clear cell renal cell carcinoma (ccRCC) tissues, Grading 1-4 tissue Down 19164279 2731 ACADM_HUMAN ENSP00000359878 Renal Cancer Normal vs. Cancer normal tissues clear cell renal cell carcinoma (ccRCC) tissues, Grading 1-4 tissue Down 19164279 2732 TF_HUMAN ENSP00000359226 Renal Cancer Normal vs. Cancer normal tissues clear cell renal cell carcinoma (ccRCC) tissues, Grading 1-4 tissue Down 19164279 2733 AMPN_HUMAN ENSP00000300060 Renal Cancer Normal vs. Cancer normal tissues clear cell renal cell carcinoma (ccRCC) tissues, Grading 1-4 tissue Down 19164279 2734 UD2B7_HUMAN ENSP00000304811 Renal Cancer Normal vs. Cancer normal tissues clear cell renal cell carcinoma (ccRCC) tissues, Grading 1-4 tissue Down 19164279 2735 PEBP1_HUMAN ENSP00000261313 Renal Cancer Normal vs. Cancer normal tissues clear cell renal cell carcinoma (ccRCC) tissues, Grading 1-4 tissue Down 19164279 2736 PCKGC_HUMAN ENSP00000319814 Renal Cancer Normal vs. Cancer normal tissues clear cell renal cell carcinoma (ccRCC) tissues, Grading 1-4 tissue Down 19164279 2737 SOAT1_HUMAN ENSP00000356591 Renal Cancer Normal vs. Cancer normal tissues clear cell renal cell carcinoma (ccRCC) tissues, Grading 1-4 tissue Down 19164279 2738 COIA1_HUMAN ENSP00000352798 Renal Cancer Normal vs. Cancer normal tissues clear cell renal cell carcinoma (ccRCC) tissues, Grading 1-4 tissue Down 19164279 2739 EFTU_HUMAN ENSP00000322439 Renal Cancer Normal vs. Cancer normal tissues clear cell renal cell carcinoma (ccRCC) tissues, Grading 1-4 tissue Down 19164279 2740 PGBM_HUMAN ENSP00000363827 Renal Cancer Normal vs. Cancer normal tissues clear cell renal cell carcinoma (ccRCC) tissues, Grading 1-4 tissue Down 19164279 2741 LRP2_HUMAN ENSP00000263816 Renal Cancer Normal vs. Cancer normal tissues clear cell renal cell carcinoma (ccRCC) tissues, Grading 1-4 tissue Down 19164279 2742 GLYAT_HUMAN ENSP00000340200 Renal Cancer Normal vs. Cancer normal tissues clear cell renal cell carcinoma (ccRCC) tissues, Grading 1-4 tissue Down 19164279 2743 HCD2_HUMAN ENSP00000168216 Renal Cancer Normal vs. Cancer normal tissues clear cell renal cell carcinoma (ccRCC) tissues, Grading 1-4 tissue Down 19164279 2744 AGRIN_HUMAN ENSP00000368678 Renal Cancer Normal vs. Cancer normal tissues clear cell renal cell carcinoma (ccRCC) tissues, Grading 1-4 tissue Up 19164279 2745 FINC_HUMAN ENSP00000352696 Renal Cancer Normal vs. Cancer normal tissues clear cell renal cell carcinoma (ccRCC) tissues, Grading 1-4 tissue Up 19164279 2746 ENOA_HUMAN ENSP00000234590 Renal Cancer Normal vs. Cancer normal tissues clear cell renal cell carcinoma (ccRCC) tissues, Grading 1-4 tissue Up 19164279 2747 HS90B_HUMAN ENSP00000360609 Renal Cancer Normal vs. Cancer normal tissues clear cell renal cell carcinoma (ccRCC) tissues, Grading 1-4 tissue Up 19164279 2748 VIME_HUMAN ENSP00000224237 Renal Cancer Normal vs. Cancer normal tissues clear cell renal cell carcinoma (ccRCC) tissues, Grading 1-4 tissue Up 19164279 2749 HSP7C_HUMAN ENSP00000227378 Renal Cancer Normal vs. Cancer normal tissues clear cell renal cell carcinoma (ccRCC) tissues, Grading 1-4 tissue Up 19164279 2750 KPYM_HUMAN ENSP00000334983 Renal Cancer Normal vs. Cancer normal tissues clear cell renal cell carcinoma (ccRCC) tissues, Grading 1-4 tissue Up 19164279 2751 COF1_HUMAN ENSP00000309629 Renal Cancer Normal vs. Cancer normal tissues clear cell renal cell carcinoma (ccRCC) tissues, Grading 1-4 tissue Up 19164279 2752 CALR_HUMAN ENSP00000320866 Renal Cancer Normal vs. Cancer normal tissues clear cell renal cell carcinoma (ccRCC) tissues, Grading 1-4 tissue Up 19164279 2753 CRIP2_HUMAN ENSP00000328521 Renal Cancer Normal vs. Cancer normal tissues clear cell renal cell carcinoma (ccRCC) tissues, Grading 1-4 tissue Up 19164279 2754 1433Z_HUMAN ENSP00000379288 Renal Cancer Normal vs. Cancer normal tissues clear cell renal cell carcinoma (ccRCC) tissues, Grading 1-4 tissue Up 19164279 2755 DPYL2_HUMAN ENSP00000309539 Renal Cancer Normal vs. Cancer normal tissues clear cell renal cell carcinoma (ccRCC) tissues, Grading 1-4 tissue Up 19164279 2756 NDRG1_HUMAN ENSP00000404854 Renal Cancer Normal vs. Cancer normal tissues clear cell renal cell carcinoma (ccRCC) tissues, Grading 1-4 tissue Up 19164279 2757 LA_HUMAN ENSP00000386636 Renal Cancer Normal vs. Cancer their adjacent normal kidney cortex Tumor tissue from patients diagnosed with RCC tissue Down 0.27 19610612 2758 CYC_HUMAN ENSP00000387279 Renal Cancer Normal vs. Cancer their adjacent normal kidney cortex Tumor tissue from patients diagnosed with RCC tissue Down 0.29 19610612 2759 YBOX1_HUMAN ENSP00000361626 Renal Cancer Normal vs. Cancer their adjacent normal kidney cortex Tumor tissue from patients diagnosed with RCC tissue Down 0.31 19610612 2760 PDCD5_HUMAN ENSP00000221784 Renal Cancer Normal vs. Cancer their adjacent normal kidney cortex Tumor tissue from patients diagnosed with RCC tissue Down 0.36 19610612 2761 HMGN2_HUMAN ENSP00000355228 Renal Cancer Normal vs. Cancer their adjacent normal kidney cortex Tumor tissue from patients diagnosed with RCC tissue Down 0.39 19610612 2762 ACADM_HUMAN ENSP00000359878 Renal Cancer Normal vs. Cancer their adjacent normal kidney cortex Tumor tissue from patients diagnosed with RCC tissue Down 0.39 19610612 2763 APEX1_HUMAN ENSP00000381111 Renal Cancer Normal vs. Cancer their adjacent normal kidney cortex Tumor tissue from patients diagnosed with RCC tissue Down 0.41 19610612 2764 H2A3_HUMAN ENSP00000355656 Renal Cancer Normal vs. Cancer their adjacent normal kidney cortex Tumor tissue from patients diagnosed with RCC tissue Down 0.41 19610612 2765 HBB_HUMAN ENSP00000333994 Renal Cancer Normal vs. Cancer their adjacent normal kidney cortex Tumor tissue from patients diagnosed with RCC tissue Down 0.41 19610612 2766 CALM_HUMAN ENSP00000375785 Renal Cancer Normal vs. Cancer their adjacent normal kidney cortex Tumor tissue from patients diagnosed with RCC tissue Down 0.42 19610612 2767 EFTU_HUMAN ENSP00000322439 Renal Cancer Normal vs. Cancer their adjacent normal kidney cortex Tumor tissue from patients diagnosed with RCC tissue Down 0.45 19610612 2768 CALM_HUMAN ENSP00000375785 Renal Cancer Normal vs. Cancer their adjacent normal kidney cortex Tumor tissue from patients diagnosed with RCC tissue Down 0.46 19610612 2769 G3P_HUMAN ENSP00000380068 Renal Cancer Normal vs. Cancer their adjacent normal kidney cortex Tumor tissue from patients diagnosed with RCC tissue Up 2.3 19610612 2770 NAMPT_HUMAN ENSP00000222553 Renal Cancer Normal vs. Cancer their adjacent normal kidney cortex Tumor tissue from patients diagnosed with RCC tissue Up 2.4 19610612 2771 CLIC1_HUMAN ENSP00000379229 Renal Cancer Normal vs. Cancer their adjacent normal kidney cortex Tumor tissue from patients diagnosed with RCC tissue Up 2.4 19610612 2772 VIME_HUMAN ENSP00000224237 Renal Cancer Normal vs. Cancer their adjacent normal kidney cortex Tumor tissue from patients diagnosed with RCC tissue Up 2.6 19610612 2773 COMT_HUMAN ENSP00000385150 Renal Cancer Normal vs. Cancer their adjacent normal kidney cortex Tumor tissue from patients diagnosed with RCC tissue Up 2.8 19610612 2774 BPNT1_HUMAN ENSP00000318852 Renal Cancer Normal vs. Cancer their adjacent normal kidney cortex Tumor tissue from patients diagnosed with RCC tissue Up 2.8 19610612 2775 PCBP2_HUMAN ENSP00000408949 Renal Cancer Normal vs. Cancer their adjacent normal kidney cortex Tumor tissue from patients diagnosed with RCC tissue Up 3.1 19610612 2776 1433F_HUMAN ENSP00000248975 Renal Cancer Normal vs. Cancer their adjacent normal kidney cortex Tumor tissue from patients diagnosed with RCC tissue Up 4.3 19610612 2777 ACTB_HUMAN ENSP00000349960 Neoplasms by Histologic Type Cancer vs. Cancer (subtype) The internal control consisted of a mixture of all the protein samples. 6 clear cell sarcomas, 10 myxoid liposarcomas,9 gastrointestinal stromal tumors (GIST),5 malignant peripheral nerve sheath tumors (MPNST),12 synovial sarcomas, 28 MFH (10 myxoid and 18 pleomorphic),and 10 leiomyosarcomas (7 conventional and 3 pleomorphic) 10 myxoid liposarcomas tissue Down 0.22 16807943 2778 CO1A1_HUMAN ENSP00000225964 Neoplasms by Histologic Type Cancer vs. Cancer (subtype) The internal control consisted of a mixture of all the protein samples. 6 clear cell sarcomas, 10 myxoid liposarcomas,9 gastrointestinal stromal tumors (GIST),5 malignant peripheral nerve sheath tumors (MPNST),12 synovial sarcomas, 28 MFH (10 myxoid and 18 pleomorphic),and 10 leiomyosarcomas (7 conventional and 3 pleomorphic) 10 myxoid liposarcomas tissue Down 0.44 16807943 2779 NP1L1_HUMAN ENSP00000376947 Neoplasms by Histologic Type Cancer vs. Cancer (subtype) The internal control consisted of a mixture of all the protein samples. 6 clear cell sarcomas, 10 myxoid liposarcomas,9 gastrointestinal stromal tumors (GIST),5 malignant peripheral nerve sheath tumors (MPNST),12 synovial sarcomas, 28 MFH (10 myxoid and 18 pleomorphic),and 10 leiomyosarcomas (7 conventional and 3 pleomorphic) 10 myxoid liposarcomas tissue Up 3.2 16807943 2780 GELS_HUMAN ENSP00000362924 Neoplasms by Histologic Type Cancer vs. Cancer (subtype) The internal control consisted of a mixture of all the protein samples. 6 clear cell sarcomas, 10 myxoid liposarcomas,9 gastrointestinal stromal tumors (GIST),5 malignant peripheral nerve sheath tumors (MPNST),12 synovial sarcomas, 28 MFH (10 myxoid and 18 pleomorphic),and 10 leiomyosarcomas (7 conventional and 3 pleomorphic) 10 myxoid liposarcomas tissue Up 6.1 16807943 2781 SODC_HUMAN ENSP00000270142 Neoplasms by Histologic Type Cancer vs. Cancer (subtype) The internal control consisted of a mixture of all the protein samples. 6 clear cell sarcomas, 10 myxoid liposarcomas,9 gastrointestinal stromal tumors (GIST),5 malignant peripheral nerve sheath tumors (MPNST),12 synovial sarcomas, 28 MFH (10 myxoid and 18 pleomorphic),and 10 leiomyosarcomas (7 conventional and 3 pleomorphic) 9 gastrointestinal stromal tumors (GIST) tissue Down 0.74 16807943 2782 KAP3_HUMAN ENSP00000265717 Neoplasms by Histologic Type Cancer vs. Cancer (subtype) The internal control consisted of a mixture of all the protein samples. 6 clear cell sarcomas, 10 myxoid liposarcomas,9 gastrointestinal stromal tumors (GIST),5 malignant peripheral nerve sheath tumors (MPNST),12 synovial sarcomas, 28 MFH (10 myxoid and 18 pleomorphic),and 10 leiomyosarcomas (7 conventional and 3 pleomorphic) 9 gastrointestinal stromal tumors (GIST) tissue Up 4.8 16807943 2783 GRB2_HUMAN ENSP00000376347 Neoplasms by Histologic Type Cancer vs. Cancer (subtype) The internal control consisted of a mixture of all the protein samples. 6 clear cell sarcomas, 10 myxoid liposarcomas,9 gastrointestinal stromal tumors (GIST),5 malignant peripheral nerve sheath tumors (MPNST),12 synovial sarcomas, 28 MFH (10 myxoid and 18 pleomorphic),and 10 leiomyosarcomas (7 conventional and 3 pleomorphic) 6 clear cell sarcomas tissue Up 1.6 16807943 2784 ACTB_HUMAN ENSP00000349960 Neoplasms by Histologic Type Cancer vs. Cancer (subtype) The internal control consisted of a mixture of all the protein samples. 6 clear cell sarcomas, 10 myxoid liposarcomas,9 gastrointestinal stromal tumors (GIST),5 malignant peripheral nerve sheath tumors (MPNST),12 synovial sarcomas, 28 MFH (10 myxoid and 18 pleomorphic),and 10 leiomyosarcomas (7 conventional and 3 pleomorphic) 6 clear cell sarcomas tissue Up 2 16807943 2785 CATD_HUMAN ENSP00000236671 Neoplasms by Histologic Type Cancer vs. Cancer (subtype) The internal control consisted of a mixture of all the protein samples. 6 clear cell sarcomas, 10 myxoid liposarcomas,9 gastrointestinal stromal tumors (GIST),5 malignant peripheral nerve sheath tumors (MPNST),12 synovial sarcomas, 28 MFH (10 myxoid and 18 pleomorphic),and 10 leiomyosarcomas (7 conventional and 3 pleomorphic) 6 clear cell sarcomas tissue Up 2.1 16807943 2786 SYWC_HUMAN ENSP00000347495 Neoplasms by Histologic Type Cancer vs. Cancer (subtype) The internal control consisted of a mixture of all the protein samples. 6 clear cell sarcomas, 10 myxoid liposarcomas,9 gastrointestinal stromal tumors (GIST),5 malignant peripheral nerve sheath tumors (MPNST),12 synovial sarcomas, 28 MFH (10 myxoid and 18 pleomorphic),and 10 leiomyosarcomas (7 conventional and 3 pleomorphic) 6 clear cell sarcomas tissue Up 3.6 16807943 2787 HNRPK_HUMAN ENSP00000365440 Neoplasms by Histologic Type Cancer vs. Cancer (subtype) The internal control consisted of a mixture of all the protein samples. 6 clear cell sarcomas, 10 myxoid liposarcomas,9 gastrointestinal stromal tumors (GIST),5 malignant peripheral nerve sheath tumors (MPNST),12 synovial sarcomas, 28 MFH (10 myxoid and 18 pleomorphic),and 10 leiomyosarcomas (7 conventional and 3 pleomorphic) 5 malignant peripheral nerve sheath tumors (MPNST) tissue Down 0.56 16807943 2788 HS90A_HUMAN ENSP00000335153 Neoplasms by Histologic Type Cancer vs. Cancer (subtype) The internal control consisted of a mixture of all the protein samples. 6 clear cell sarcomas, 10 myxoid liposarcomas,9 gastrointestinal stromal tumors (GIST),5 malignant peripheral nerve sheath tumors (MPNST),12 synovial sarcomas, 28 MFH (10 myxoid and 18 pleomorphic),and 10 leiomyosarcomas (7 conventional and 3 pleomorphic) 5 malignant peripheral nerve sheath tumors (MPNST) tissue Up 1.4 16807943 2789 HS90B_HUMAN ENSP00000360609 Neoplasms by Histologic Type Cancer vs. Cancer (subtype) The internal control consisted of a mixture of all the protein samples. 6 clear cell sarcomas, 10 myxoid liposarcomas,9 gastrointestinal stromal tumors (GIST),5 malignant peripheral nerve sheath tumors (MPNST),12 synovial sarcomas, 28 MFH (10 myxoid and 18 pleomorphic),and 10 leiomyosarcomas (7 conventional and 3 pleomorphic) 5 malignant peripheral nerve sheath tumors (MPNST) tissue Up 1.6 16807943 2790 HS90B_HUMAN ENSP00000360609 Neoplasms by Histologic Type Cancer vs. Cancer (subtype) The internal control consisted of a mixture of all the protein samples. 6 clear cell sarcomas, 10 myxoid liposarcomas,9 gastrointestinal stromal tumors (GIST),5 malignant peripheral nerve sheath tumors (MPNST),12 synovial sarcomas, 28 MFH (10 myxoid and 18 pleomorphic),and 10 leiomyosarcomas (7 conventional and 3 pleomorphic) 5 malignant peripheral nerve sheath tumors (MPNST) tissue Up 1.7 16807943 2791 HS90B_HUMAN ENSP00000360609 Neoplasms by Histologic Type Cancer vs. Cancer (subtype) The internal control consisted of a mixture of all the protein samples. 6 clear cell sarcomas, 10 myxoid liposarcomas,9 gastrointestinal stromal tumors (GIST),5 malignant peripheral nerve sheath tumors (MPNST),12 synovial sarcomas, 28 MFH (10 myxoid and 18 pleomorphic),and 10 leiomyosarcomas (7 conventional and 3 pleomorphic) 5 malignant peripheral nerve sheath tumors (MPNST) tissue Up 1.8 16807943 2792 MYL9_HUMAN ENSP00000279022 Neoplasms by Histologic Type Cancer vs. Cancer (subtype) The internal control consisted of a mixture of all the protein samples. 6 clear cell sarcomas, 10 myxoid liposarcomas,9 gastrointestinal stromal tumors (GIST),5 malignant peripheral nerve sheath tumors (MPNST),12 synovial sarcomas, 28 MFH (10 myxoid and 18 pleomorphic),and 10 leiomyosarcomas (7 conventional and 3 pleomorphic) 12 synovial sarcomas tissue Down 0.62 16807943 2793 PSA3_HUMAN ENSP00000216455 Neoplasms by Histologic Type Cancer vs. Cancer (subtype) The internal control consisted of a mixture of all the protein samples. 6 clear cell sarcomas, 10 myxoid liposarcomas,9 gastrointestinal stromal tumors (GIST),5 malignant peripheral nerve sheath tumors (MPNST),12 synovial sarcomas, 28 MFH (10 myxoid and 18 pleomorphic),and 10 leiomyosarcomas (7 conventional and 3 pleomorphic) 12 synovial sarcomas tissue Up 1.4 16807943 2794 HSP71_HUMAN ENSP00000364801 Neoplasms by Histologic Type Cancer vs. Cancer (subtype) The internal control consisted of a mixture of all the protein samples. 6 clear cell sarcomas, 10 myxoid liposarcomas,9 gastrointestinal stromal tumors (GIST),5 malignant peripheral nerve sheath tumors (MPNST),12 synovial sarcomas, 28 MFH (10 myxoid and 18 pleomorphic),and 10 leiomyosarcomas (7 conventional and 3 pleomorphic) 12 synovial sarcomas tissue Up 2.3 16807943 2795 HSP71_HUMAN ENSP00000364801 Neoplasms by Histologic Type Cancer vs. Cancer (subtype) The internal control consisted of a mixture of all the protein samples. 6 clear cell sarcomas, 10 myxoid liposarcomas,9 gastrointestinal stromal tumors (GIST),5 malignant peripheral nerve sheath tumors (MPNST),12 synovial sarcomas, 28 MFH (10 myxoid and 18 pleomorphic),and 10 leiomyosarcomas (7 conventional and 3 pleomorphic) 12 synovial sarcomas tissue Up 2.9 16807943 2796 ACTB_HUMAN ENSP00000349960 Neoplasms by Histologic Type Cancer vs. Cancer (subtype) The internal control consisted of a mixture of all the protein samples. 6 clear cell sarcomas, 10 myxoid liposarcomas,9 gastrointestinal stromal tumors (GIST),5 malignant peripheral nerve sheath tumors (MPNST),12 synovial sarcomas, 28 MFH (10 myxoid and 18 pleomorphic),and 10 leiomyosarcomas (7 conventional and 3 pleomorphic) 28 Malignat fibrous histiocytoma(MFH) (10 myxoid and 18 pleomorphic) tissue Down 0.56 16807943 2797 HNRPK_HUMAN ENSP00000365440 Neoplasms by Histologic Type Cancer vs. Cancer (subtype) The internal control consisted of a mixture of all the protein samples. 6 clear cell sarcomas, 10 myxoid liposarcomas,9 gastrointestinal stromal tumors (GIST),5 malignant peripheral nerve sheath tumors (MPNST),12 synovial sarcomas, 28 MFH (10 myxoid and 18 pleomorphic),and 10 leiomyosarcomas (7 conventional and 3 pleomorphic) 28 Malignat fibrous histiocytoma(MFH) (10 myxoid and 18 pleomorphic) tissue Down 0.61 16807943 2798 LASP1_HUMAN ENSP00000325240 Neoplasms by Histologic Type Cancer vs. Cancer (subtype) The internal control consisted of a mixture of all the protein samples. 6 clear cell sarcomas, 10 myxoid liposarcomas,9 gastrointestinal stromal tumors (GIST),5 malignant peripheral nerve sheath tumors (MPNST),12 synovial sarcomas, 28 MFH (10 myxoid and 18 pleomorphic),and 10 leiomyosarcomas (7 conventional and 3 pleomorphic) 28 Malignat fibrous histiocytoma(MFH) (10 myxoid and 18 pleomorphic) tissue Down 0.7 16807943 2799 ANXA1_HUMAN ENSP00000366109 Neoplasms by Histologic Type Cancer vs. Cancer (subtype) The internal control consisted of a mixture of all the protein samples. 6 clear cell sarcomas, 10 myxoid liposarcomas,9 gastrointestinal stromal tumors (GIST),5 malignant peripheral nerve sheath tumors (MPNST),12 synovial sarcomas, 28 MFH (10 myxoid and 18 pleomorphic),and 10 leiomyosarcomas (7 conventional and 3 pleomorphic) 28 Malignat fibrous histiocytoma(MFH) (10 myxoid and 18 pleomorphic) tissue Up 1.4 16807943 2800 ACTB_HUMAN ENSP00000349960 Neoplasms by Histologic Type Cancer vs. Cancer (subtype) The internal control consisted of a mixture of all the protein samples. 6 clear cell sarcomas, 10 myxoid liposarcomas,9 gastrointestinal stromal tumors (GIST),5 malignant peripheral nerve sheath tumors (MPNST),12 synovial sarcomas, 28 MFH (10 myxoid and 18 pleomorphic),and 10 leiomyosarcomas (7 conventional and 3 pleomorphic) 28 Malignat fibrous histiocytoma(MFH) (10 myxoid and 18 pleomorphic) tissue Up 1.6 16807943 2801 DPYL2_HUMAN ENSP00000309539 Neoplasms by Histologic Type Cancer vs. Cancer (subtype) The internal control consisted of a mixture of all the protein samples. 6 clear cell sarcomas, 10 myxoid liposarcomas,9 gastrointestinal stromal tumors (GIST),5 malignant peripheral nerve sheath tumors (MPNST),12 synovial sarcomas, 28 MFH (10 myxoid and 18 pleomorphic),and 10 leiomyosarcomas (7 conventional and 3 pleomorphic) 10 leiomyosarcomas (7 conventional and 3 pleomorphic) tissue Down 0.63 16807943 2802 VINC_HUMAN ENSP00000211998 Neoplasms by Histologic Type Cancer vs. Cancer (subtype) The internal control consisted of a mixture of all the protein samples. 6 clear cell sarcomas, 10 myxoid liposarcomas,9 gastrointestinal stromal tumors (GIST),5 malignant peripheral nerve sheath tumors (MPNST),12 synovial sarcomas, 28 MFH (10 myxoid and 18 pleomorphic),and 10 leiomyosarcomas (7 conventional and 3 pleomorphic) 10 leiomyosarcomas (7 conventional and 3 pleomorphic) tissue Up 2.1 16807943 2803 ACTA_HUMAN ENSP00000402373 Neoplasms by Histologic Type Cancer vs. Cancer (subtype) The internal control consisted of a mixture of all the protein samples. 6 clear cell sarcomas, 10 myxoid liposarcomas,9 gastrointestinal stromal tumors (GIST),5 malignant peripheral nerve sheath tumors (MPNST),12 synovial sarcomas, 28 MFH (10 myxoid and 18 pleomorphic),and 10 leiomyosarcomas (7 conventional and 3 pleomorphic) 10 leiomyosarcomas (7 conventional and 3 pleomorphic) tissue Up 7.5 16807943 2804 HS90B_HUMAN ENSP00000360609 Melanoma Treatment (none vs. kojic acid treatment) A375 human malignant melanoma cells A375 human malignant melanoma cells treated with 72h kojic acid cell line Down 0.4 18630942 2805 VIME_HUMAN ENSP00000224237 Melanoma Treatment (none vs. kojic acid treatment) A375 human malignant melanoma cells A375 human malignant melanoma cells treated with 72h kojic acid cell line Down 0.44 18630942 2806 NUCL_HUMAN ENSP00000318195 Melanoma Treatment (none vs. kojic acid treatment) A375 human malignant melanoma cells A375 human malignant melanoma cells treated with 72h kojic acid cell line Down 0.45 18630942 2807 VIME_HUMAN ENSP00000224237 Melanoma Treatment (none vs. kojic acid treatment) A375 human malignant melanoma cells A375 human malignant melanoma cells treated with 72h kojic acid cell line Down 0.47 18630942 2808 VIME_HUMAN ENSP00000224237 Melanoma Treatment (none vs. kojic acid treatment) A375 human malignant melanoma cells A375 human malignant melanoma cells treated with 72h kojic acid cell line Down 0.48 18630942 2809 VIME_HUMAN ENSP00000224237 Melanoma Treatment (none vs. kojic acid treatment) A375 human malignant melanoma cells A375 human malignant melanoma cells treated with 72h kojic acid cell line Down 0.5 18630942 2810 HSP7C_HUMAN ENSP00000227378 Melanoma Treatment (none vs. kojic acid treatment) A375 human malignant melanoma cells A375 human malignant melanoma cells treated with 72h kojic acid cell line Down 0.5 18630942 2811 ANX11_HUMAN ENSP00000265447 Melanoma Treatment (none vs. kojic acid treatment) A375 human malignant melanoma cells A375 human malignant melanoma cells treated with 72h kojic acid cell line Down 0.65 18630942 2812 ENPL_HUMAN ENSP00000299767 Melanoma Treatment (none vs. kojic acid treatment) A375 human malignant melanoma cells A375 human malignant melanoma cells treated with 72h kojic acid cell line Down 0.66 18630942 2813 ENPL_HUMAN ENSP00000299767 Melanoma Treatment (none vs. kojic acid treatment) A375 human malignant melanoma cells A375 human malignant melanoma cells treated with 72h kojic acid cell line Down 0.91 18630942 2814 TBB5_HUMAN ENSP00000406811 Melanoma Treatment (none vs. kojic acid treatment) A375 human malignant melanoma cells A375 human malignant melanoma cells treated with 72h kojic acid cell line Down 1 18630942 2815 2AAA_HUMAN ENSP00000324804 Melanoma Treatment (none vs. kojic acid treatment) A375 human malignant melanoma cells A375 human malignant melanoma cells treated with 72h kojic acid cell line Up 1.5 18630942 2816 KPYM_HUMAN ENSP00000334983 Melanoma Treatment (none vs. kojic acid treatment) A375 human malignant melanoma cells A375 human malignant melanoma cells treated with 72h kojic acid cell line Up 2.1 18630942 2817 MOES_HUMAN ENSP00000353408 Nonmelanoma Normal vs. Cancer non-HPV8-EXPressing adult keratinocytes cells HPV8-E7 and HPV8-CEREXPressing adult keratinocytes cells cell line Down 0.62 19243805 2818 LMNA_HUMAN ENSP00000357283 Nonmelanoma Normal vs. Cancer non-HPV8-EXPressing adult keratinocytes cells HPV8-E7 and HPV8-CEREXPressing adult keratinocytes cells cell line Down 0.65 19243805 2819 GELS_HUMAN ENSP00000362924 Nonmelanoma Normal vs. Cancer non-HPV8-EXPressing adult keratinocytes cells HPV8-E7 and HPV8-CEREXPressing adult keratinocytes cells cell line Down 0.65 19243805 2820 VINC_HUMAN ENSP00000211998 Nonmelanoma Normal vs. Cancer non-HPV8-EXPressing adult keratinocytes cells HPV8-E7 and HPV8-CEREXPressing adult keratinocytes cells cell line Down 0.68 19243805 2821 PDC6I_HUMAN ENSP00000307387 Nonmelanoma Normal vs. Cancer non-HPV8-EXPressing adult keratinocytes cells HPV8-E7 and HPV8-CEREXPressing adult keratinocytes cells cell line Down 0.7 19243805 2822 K1C14_HUMAN ENSP00000167586 Nonmelanoma Normal vs. Cancer non-HPV8-EXPressing adult keratinocytes cells HPV8-E7 and HPV8-CEREXPressing adult keratinocytes cells cell line Up 2.7 19243805 2823 P3C2A_HUMAN ENSP00000265970 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Down 18489135 2824 FAAH1_HUMAN ENSP00000243167 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Down 18489135 2825 TIM23_HUMAN ENSP00000260867 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Down 18489135 2826 PLD2_HUMAN ENSP00000263088 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Down 18489135 2827 AT2A1_HUMAN ENSP00000349595 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Down 18489135 2828 PLS1_HUMAN ENSP00000345494 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Down 18489135 2829 PLXB1_HUMAN ENSP00000351338 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Down 18489135 2830 SPY2_HUMAN ENSP00000366306 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Down 18489135 2831 FZD7_HUMAN ENSP00000286201 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Down 18489135 2832 VAMP4_HUMAN ENSP00000236192 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Down 18489135 2833 RENR_HUMAN ENSP00000367697 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Down 18489135 2834 NDUB4_HUMAN ENSP00000184266 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Down 18489135 2835 PIGR_HUMAN ENSP00000348888 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Down 18489135 2836 PRIO_HUMAN ENSP00000415284 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Down 18489135 2837 HSP71_HUMAN ENSP00000364801 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Down 18489135 2838 RHOC_HUMAN ENSP00000358647 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Down 18489135 2839 TNR16_HUMAN ENSP00000172229 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Down 18489135 2840 CY1_HUMAN ENSP00000317159 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Down 18489135 2841 HMOX1_HUMAN ENSP00000216117 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Down 18489135 2842 NCAM1_HUMAN ENSP00000318472 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Down 18489135 2843 ITB4_HUMAN ENSP00000200181 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Down 18489135 2844 PTN1_HUMAN ENSP00000360683 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Down 18489135 2845 SL9A1_HUMAN ENSP00000263980 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Down 18489135 2846 LMNB1_HUMAN ENSP00000261366 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Down 18489135 2847 FGFR2_HUMAN ENSP00000358057 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Down 18489135 2848 ERBB3_HUMAN ENSP00000408340 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Down 18489135 2849 COMT_HUMAN ENSP00000385150 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Down 18489135 2850 LAMA1_HUMAN ENSP00000374309 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Down 18489135 2851 TNR5_HUMAN ENSP00000361359 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Down 18489135 2852 1C18_HUMAN ENSP00000410214 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Down 18489135 2853 UFO_HUMAN ENSP00000301178 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Down 18489135 2854 GRPR_HUMAN ENSP00000369643 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Down 18489135 2855 SSR2_HUMAN ENSP00000350198 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Down 18489135 2856 ACSL1_HUMAN ENSP00000281455 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Down 18489135 2857 MTOR_HUMAN ENSP00000354558 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Down 18489135 2858 RAGP1_HUMAN ENSP00000401470 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Down 18489135 2859 PSN1_HUMAN ENSP00000326366 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Down 18489135 2860 RGS19_HUMAN ENSP00000378483 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Down 18489135 2861 RAC3_HUMAN ENSP00000304283 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Down 18489135 2862 TBB4B_HUMAN ENSP00000341289 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Down 18489135 2863 CAV1_HUMAN ENSP00000339191 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Down 18489135 2864 MGAT2_HUMAN ENSP00000307423 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Down 18489135 2865 SRBP2_HUMAN ENSP00000354476 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Down 18489135 2866 CNTN1_HUMAN ENSP00000325660 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Down 18489135 2867 VAMP3_HUMAN ENSP00000054666 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Down 18489135 2868 NRK_HUMAN ENSP00000434830 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Down 18489135 2869 FRS2_HUMAN ENSP00000381083 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Down 18489135 2870 NU133_HUMAN ENSP00000261396 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Down 18489135 2871 PVRL2_HUMAN ENSP00000252483 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Down 18489135 2872 LGR4_HUMAN ENSP00000368516 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Down 18489135 2873 TNR12_HUMAN ENSP00000326737 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Down 18489135 2874 AKIP_HUMAN ENSP00000368130 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Down 18489135 2875 TAOK2_HUMAN ENSP00000310094 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Down 18489135 2876 DAAM1_HUMAN ENSP00000247170 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Down 18489135 2877 PLXD1_HUMAN ENSP00000317128 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Down 18489135 2878 DDX3X_HUMAN ENSP00000382840 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Up 18489135 2879 ACACB_HUMAN ENSP00000367079 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Up 18489135 2880 TR10B_HUMAN ENSP00000317859 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Up 18489135 2881 PSA7_HUMAN ENSP00000359910 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Up 18489135 2882 XPO1_HUMAN ENSP00000385559 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Up 18489135 2883 ARC1B_HUMAN ENSP00000389631 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Up 18489135 2884 ARPC5_HUMAN ENSP00000352918 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Up 18489135 2885 PRP4_HUMAN ENSP00000363313 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Up 18489135 2886 ZW10_HUMAN ENSP00000200135 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Up 18489135 2887 TBCD4_HUMAN ENSP00000366863 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Up 18489135 2888 FZD6_HUMAN ENSP00000351605 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Up 18489135 2889 NRP2_HUMAN ENSP00000353582 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Up 18489135 2890 ADCY9_HUMAN ENSP00000294016 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Up 18489135 2891 USO1_HUMAN ENSP00000264904 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Up 18489135 2892 LRP6_HUMAN ENSP00000261349 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Up 18489135 2893 ATRN_HUMAN ENSP00000262919 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Up 18489135 2894 M4K4_HUMAN ENSP00000314363 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Up 18489135 2895 G3P_HUMAN ENSP00000380068 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Up 18489135 2896 HSPB1_HUMAN ENSP00000248553 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Up 18489135 2897 IF2A_HUMAN ENSP00000256383 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Up 18489135 2898 INSR_HUMAN ENSP00000303830 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Up 18489135 2899 NPM_HUMAN ENSP00000296930 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Up 18489135 2900 DAF_HUMAN ENSP00000356031 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Up 18489135 2901 K6PF_HUMAN ENSP00000352842 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Up 18489135 2902 GNAO_HUMAN ENSP00000262493 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Up 18489135 2903 PGFRB_HUMAN ENSP00000261799 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Up 18489135 2904 RRAS_HUMAN ENSP00000246792 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Up 18489135 2905 XRCC5_HUMAN ENSP00000375977 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Up 18489135 2906 RSMB_HUMAN ENSP00000412566 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Up 18489135 2907 PVR_HUMAN ENSP00000402060 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Up 18489135 2908 NEUM_HUMAN ENSP00000305010 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Up 18489135 2909 UBA1_HUMAN ENSP00000338413 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Up 18489135 2910 FGFR3_HUMAN ENSP00000414914 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Up 18489135 2911 TBG1_HUMAN ENSP00000251413 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Up 18489135 2912 MOES_HUMAN ENSP00000353408 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Up 18489135 2913 DDX6_HUMAN ENSP00000264018 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Up 18489135 2914 PTBP1_HUMAN ENSP00000014112 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Up 18489135 2915 RFA1_HUMAN ENSP00000254719 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Up 18489135 2916 APEX1_HUMAN ENSP00000381111 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Up 18489135 2917 NMT1_HUMAN ENSP00000258960 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Up 18489135 2918 SDC4_HUMAN ENSP00000361818 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Up 18489135 2919 MCM5_HUMAN ENSP00000216122 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Up 18489135 2920 GPC1_HUMAN ENSP00000264039 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Up 18489135 2921 ADDA_HUMAN ENSP00000399828 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Up 18489135 2922 VGFR2_HUMAN ENSP00000263923 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Up 18489135 2923 PRS7_HUMAN ENSP00000292644 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Up 18489135 2924 TGFR1_HUMAN ENSP00000364133 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Up 18489135 2925 IF4A3_HUMAN ENSP00000269349 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Up 18489135 2926 COIA1_HUMAN ENSP00000352798 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Up 18489135 2927 FEN1_HUMAN ENSP00000305480 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Up 18489135 2928 MATR3_HUMAN ENSP00000354346 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Up 18489135 2929 MSH2_HUMAN ENSP00000233146 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Up 18489135 2930 NOTC1_HUMAN ENSP00000277541 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Up 18489135 2931 RS10_HUMAN ENSP00000347271 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Up 18489135 2932 KC1A_HUMAN ENSP00000367074 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Up 18489135 2933 EFTU_HUMAN ENSP00000322439 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Up 18489135 2934 VASP_HUMAN ENSP00000245932 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Up 18489135 2935 PLK1_HUMAN ENSP00000300093 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Up 18489135 2936 ACLY_HUMAN ENSP00000253792 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Up 18489135 2937 BLM_HUMAN ENSP00000347232 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Up 18489135 2938 EPHB3_HUMAN ENSP00000332118 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Up 18489135 2939 TERA_HUMAN ENSP00000351777 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Up 18489135 2940 STXB1_HUMAN ENSP00000362396 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Up 18489135 2941 RHOB_HUMAN ENSP00000272233 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Up 18489135 2942 H2B1C_HUMAN ENSP00000353074 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Up 18489135 2943 RAN_HUMAN ENSP00000376176 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Up 18489135 2944 GNAI1_HUMAN ENSP00000343027 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Up 18489135 2945 EF1A1_HUMAN ENSP00000330054 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Up 18489135 2946 SHPS1_HUMAN ENSP00000351621 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Up 18489135 2947 GTF2I_HUMAN ENSP00000322542 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Up 18489135 2948 JAG1_HUMAN ENSP00000254958 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Up 18489135 2949 PGBM_HUMAN ENSP00000363827 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Up 18489135 2950 EFNB1_HUMAN ENSP00000204961 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Up 18489135 2951 CDK3_HUMAN ENSP00000400088 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Up 18489135 2952 ROR2_HUMAN ENSP00000364860 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Up 18489135 2953 NOTC2_HUMAN ENSP00000256646 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Up 18489135 2954 GFPT1_HUMAN ENSP00000349860 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Up 18489135 2955 PRDX1_HUMAN ENSP00000262746 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Up 18489135 2956 ZO1_HUMAN ENSP00000281537 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Up 18489135 2957 MCL1_HUMAN ENSP00000358022 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Up 18489135 2958 CD47_HUMAN ENSP00000355361 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Up 18489135 2959 G3BP1_HUMAN ENSP00000348578 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Up 18489135 2960 ILK_HUMAN ENSP00000379975 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Up 18489135 2961 FZD2_HUMAN ENSP00000323901 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Up 18489135 2962 SMC1A_HUMAN ENSP00000323421 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Up 18489135 2963 CND1_HUMAN ENSP00000325017 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Up 18489135 2964 PCM1_HUMAN ENSP00000327077 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Up 18489135 2965 NONO_HUMAN ENSP00000362947 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Up 18489135 2966 H2B2E_HUMAN ENSP00000358151 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Up 18489135 2967 STEA3_HUMAN ENSP00000396214 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Up 18489135 2968 PRP8_HUMAN ENSP00000304350 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Up 18489135 2969 CSPG4_HUMAN ENSP00000312506 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Up 18489135 2970 TBA1A_HUMAN ENSP00000301071 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Up 18489135 2971 SND1_HUMAN ENSP00000346762 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Up 18489135 2972 MARK2_HUMAN ENSP00000385751 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Up 18489135 2973 ARHG2_HUMAN ENSP00000354837 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Up 18489135 2974 KIF2C_HUMAN ENSP00000361298 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Up 18489135 2975 RGAP1_HUMAN ENSP00000413241 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Up 18489135 2976 DNJC5_HUMAN ENSP00000354111 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Up 18489135 2977 DDX18_HUMAN ENSP00000263239 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Up 18489135 2978 GBG12_HUMAN ENSP00000360021 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Up 18489135 2979 SMC3_HUMAN ENSP00000354720 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Up 18489135 2980 MAGD1_HUMAN ENSP00000325333 Testicular Cancer Normal vs. Cancer Human embryonic stem cells (hESC) line HUES-7 Human embryonal carcinoma cells (hECCs) line NT2/D1 cell line Up 18489135 2981 COF1_HUMAN ENSP00000309629 Ovarian Cancer Normal vs. Cancer control ovarian surface epithelium (OSE) lines derived from women without such histories SV-40-transformed FH-OSE cell lines cell line Down 0.33 15591324 2982 IPYR_HUMAN ENSP00000362329 Ovarian Cancer Normal vs. Cancer control ovarian surface epithelium (OSE) lines derived from women without such histories SV-40-transformed FH-OSE cell lines cell line Down 0.5 15591324 2983 HSPB1_HUMAN ENSP00000248553 Ovarian Cancer Normal vs. Cancer control ovarian surface epithelium (OSE) lines derived from women without such histories SV-40-transformed FH-OSE cell lines cell line Down 0.59 15591324 2984 TBB5_HUMAN ENSP00000406811 Ovarian Cancer Normal vs. Cancer control ovarian surface epithelium (OSE) lines derived from women without such histories SV-40-transformed FH-OSE cell lines cell line Up 6.6 15591324 2985 A2MG_HUMAN ENSP00000323929 Ovarian Cancer Normal vs. Cancer plasma of age-matched controls plasma of ovarian cancer (OVC) patients tissue Down 17137333 2986 CO3_HUMAN ENSP00000245907 Ovarian Cancer Normal vs. Cancer plasma of age-matched controls plasma of ovarian cancer (OVC) patients tissue Down 17137333 2987 APOE_HUMAN ENSP00000252486 Ovarian Cancer Normal vs. Cancer plasma of age-matched controls plasma of ovarian cancer (OVC) patients tissue Down 17137333 2988 FIBA_HUMAN ENSP00000306361 Ovarian Cancer Normal vs. Cancer plasma of age-matched controls plasma of ovarian cancer (OVC) patients tissue Down 17137333 2989 CO3_HUMAN ENSP00000245907 Ovarian Cancer Normal vs. Cancer plasma of age-matched controls plasma of ovarian cancer (OVC) patients tissue Up 17137333 2990 FIBA_HUMAN ENSP00000306361 Ovarian Cancer Normal vs. Cancer plasma of age-matched controls plasma of ovarian cancer (OVC) patients tissue Up 17137333 2991 CRP_HUMAN ENSP00000255030 Ovarian Cancer Normal vs. Cancer plasma of age-matched controls plasma of ovarian cancer (OVC) patients tissue Up 17137333 2992 CO1A1_HUMAN ENSP00000225964 Ovarian Cancer Metastasis low malignant potential human epithelial ovarian cancer cell lines TOV-81D highly proliferative human epithelial ovarian cancer cell lines TOV-112D cell line Down 0.08 17892554 2993 CSRP1_HUMAN ENSP00000345079 Ovarian Cancer Metastasis low malignant potential human epithelial ovarian cancer cell lines TOV-81D highly proliferative human epithelial ovarian cancer cell lines TOV-112D cell line Down 0.08 17892554 2994 FINC_HUMAN ENSP00000352696 Ovarian Cancer Metastasis low malignant potential human epithelial ovarian cancer cell lines TOV-81D highly proliferative human epithelial ovarian cancer cell lines TOV-112D cell line Down 0.11 17892554 2995 PAI1_HUMAN ENSP00000223095 Ovarian Cancer Metastasis low malignant potential human epithelial ovarian cancer cell lines TOV-81D highly proliferative human epithelial ovarian cancer cell lines TOV-112D cell line Down 0.15 17892554 2996 ICAM1_HUMAN ENSP00000264832 Ovarian Cancer Metastasis low malignant potential human epithelial ovarian cancer cell lines TOV-81D highly proliferative human epithelial ovarian cancer cell lines TOV-112D cell line Down 0.17 17892554 2997 TAGL2_HUMAN ENSP00000357075 Ovarian Cancer Metastasis low malignant potential human epithelial ovarian cancer cell lines TOV-81D highly proliferative human epithelial ovarian cancer cell lines TOV-112D cell line Down 0.2 17892554 2998 TAGL_HUMAN ENSP00000278968 Ovarian Cancer Metastasis low malignant potential human epithelial ovarian cancer cell lines TOV-81D highly proliferative human epithelial ovarian cancer cell lines TOV-112D cell line Down 0.2 17892554 2999 TENA_HUMAN ENSP00000345861 Ovarian Cancer Metastasis low malignant potential human epithelial ovarian cancer cell lines TOV-81D highly proliferative human epithelial ovarian cancer cell lines TOV-112D cell line Down 0.23 17892554 3000 K1C18_HUMAN ENSP00000373489 Ovarian Cancer Metastasis low malignant potential human epithelial ovarian cancer cell lines TOV-81D highly proliferative human epithelial ovarian cancer cell lines TOV-112D cell line Down 0.29 17892554 3001 ACTN4_HUMAN ENSP00000252699 Ovarian Cancer Metastasis low malignant potential human epithelial ovarian cancer cell lines TOV-81D highly proliferative human epithelial ovarian cancer cell lines TOV-112D cell line Down 0.33 17892554 3002 TSP1_HUMAN ENSP00000260356 Ovarian Cancer Metastasis low malignant potential human epithelial ovarian cancer cell lines TOV-81D highly proliferative human epithelial ovarian cancer cell lines TOV-112D cell line Down 0.35 17892554 3003 FLNA_HUMAN ENSP00000358866 Ovarian Cancer Metastasis low malignant potential human epithelial ovarian cancer cell lines TOV-81D highly proliferative human epithelial ovarian cancer cell lines TOV-112D cell line Down 0.36 17892554 3004 ANXA2_HUMAN ENSP00000411352 Ovarian Cancer Metastasis low malignant potential human epithelial ovarian cancer cell lines TOV-81D highly proliferative human epithelial ovarian cancer cell lines TOV-112D cell line Down 0.4 17892554 3005 ANXA1_HUMAN ENSP00000366109 Ovarian Cancer Metastasis low malignant potential human epithelial ovarian cancer cell lines TOV-81D highly proliferative human epithelial ovarian cancer cell lines TOV-112D cell line Up 3 17892554 3006 NOLC1_HUMAN ENSP00000359024 Ovarian Cancer Metastasis low malignant potential human epithelial ovarian cancer cell lines TOV-81D highly proliferative human epithelial ovarian cancer cell lines TOV-112D cell line Up 3.3 17892554 3007 HMGA2_HUMAN ENSP00000346658 Ovarian Cancer Metastasis low malignant potential human epithelial ovarian cancer cell lines TOV-81D highly proliferative human epithelial ovarian cancer cell lines TOV-112D cell line Up 8.1 17892554 3008 LMNA_HUMAN ENSP00000357283 Ovarian Cancer Metastasis low malignant potential human epithelial ovarian cancer cell lines TOV-81D highly proliferative human epithelial ovarian cancer cell lines TOV-112D cell line Down 17892554 3009 ANXA1_HUMAN ENSP00000366109 Ovarian Cancer Metastasis low malignant potential human epithelial ovarian cancer cell lines TOV-81D highly proliferative human epithelial ovarian cancer cell lines TOV-112D cell line Down 17892554 3010 SODM_HUMAN ENSP00000337127 Ovarian Cancer Metastasis low malignant potential human epithelial ovarian cancer cell lines TOV-81D highly proliferative human epithelial ovarian cancer cell lines TOV-112D cell line Down 17892554 3011 G3P_HUMAN ENSP00000380068 Ovarian Cancer Metastasis low malignant potential human epithelial ovarian cancer cell lines TOV-81D highly proliferative human epithelial ovarian cancer cell lines TOV-112D cell line Down 17892554 3012 PAI1_HUMAN ENSP00000223095 Ovarian Cancer Metastasis low malignant potential human epithelial ovarian cancer cell lines TOV-81D highly proliferative human epithelial ovarian cancer cell lines TOV-112D cell line Down 17892554 3013 TPM2_HUMAN ENSP00000354219 Ovarian Cancer Metastasis low malignant potential human epithelial ovarian cancer cell lines TOV-81D highly proliferative human epithelial ovarian cancer cell lines TOV-112D cell line Down 17892554 3014 HSP7C_HUMAN ENSP00000227378 Ovarian Cancer Metastasis low malignant potential human epithelial ovarian cancer cell lines TOV-81D highly proliferative human epithelial ovarian cancer cell lines TOV-112D cell line Down 17892554 3015 FKBP4_HUMAN ENSP00000001008 Ovarian Cancer Metastasis low malignant potential human epithelial ovarian cancer cell lines TOV-81D highly proliferative human epithelial ovarian cancer cell lines TOV-112D cell line Down 17892554 3016 CALD1_HUMAN ENSP00000354826 Ovarian Cancer Metastasis low malignant potential human epithelial ovarian cancer cell lines TOV-81D highly proliferative human epithelial ovarian cancer cell lines TOV-112D cell line Down 17892554 3017 CALD1_HUMAN ENSP00000354826 Ovarian Cancer Metastasis low malignant potential human epithelial ovarian cancer cell lines TOV-81D highly proliferative human epithelial ovarian cancer cell lines TOV-112D cell line Down 17892554 3018 EEA1_HUMAN ENSP00000317955 Ovarian Cancer Metastasis low malignant potential human epithelial ovarian cancer cell lines TOV-81D highly proliferative human epithelial ovarian cancer cell lines TOV-112D cell line Down 17892554 3019 RUVB1_HUMAN ENSP00000318297 Ovarian Cancer Metastasis low malignant potential human epithelial ovarian cancer cell lines TOV-81D highly proliferative human epithelial ovarian cancer cell lines TOV-112D cell line Down 17892554 3020 HSP71_HUMAN ENSP00000364801 Ovarian Cancer Metastasis low malignant potential human epithelial ovarian cancer cell lines TOV-81D highly proliferative human epithelial ovarian cancer cell lines TOV-112D cell line Up 17892554 3021 ENAH_HUMAN ENSP00000355809 Ovarian Cancer Metastasis low malignant potential human epithelial ovarian cancer cell lines TOV-81D highly proliferative human epithelial ovarian cancer cell lines TOV-112D cell line Up 17892554 3022 FUBP1_HUMAN ENSP00000359804 Ovarian Cancer Metastasis low malignant potential human epithelial ovarian cancer cell lines TOV-81D highly proliferative human epithelial ovarian cancer cell lines TOV-112D cell line Up 17892554 3023 PA2G4_HUMAN ENSP00000302886 Ovarian Cancer Metastasis low malignant potential human epithelial ovarian cancer cell lines TOV-81D highly proliferative human epithelial ovarian cancer cell lines TOV-112D cell line Up 17892554 3024 RUVB1_HUMAN ENSP00000318297 Ovarian Cancer Metastasis low malignant potential human epithelial ovarian cancer cell lines TOV-81D highly proliferative human epithelial ovarian cancer cell lines TOV-112D cell line Up 17892554 3025 LEG3_HUMAN ENSP00000254301 Ovarian Cancer Treatment (Paclitaxel-sensitive vs. Paclitaxel-resistant) human epithelial ovarian cancer cell lines A2780 (paclitaxel sensitive) A2780TC1 and (acquired paclitaxe resistant) cell line Down 0.32 18973835 3026 TBB1_HUMAN ENSP00000217133 Ovarian Cancer Treatment (Paclitaxel-sensitive vs. Paclitaxel-resistant) human epithelial ovarian cancer cell lines A2780 (paclitaxel sensitive) A2780TC1 and (acquired paclitaxe resistant) cell line Down 0.67 18973835 3027 RUVB1_HUMAN ENSP00000318297 Ovarian Cancer Treatment (Paclitaxel-sensitive vs. Paclitaxel-resistant) human epithelial ovarian cancer cell lines A2780 (paclitaxel sensitive) A2780TC1 and (acquired paclitaxe resistant) cell line Down 0.67 18973835 3028 ENOA_HUMAN ENSP00000234590 Ovarian Cancer Treatment (Paclitaxel-sensitive vs. Paclitaxel-resistant) human epithelial ovarian cancer cell lines A2780 (paclitaxel sensitive) A2780TC1 and (acquired paclitaxe resistant) cell line Down 0.77 18973835 3029 COF2_HUMAN ENSP00000298159 Ovarian Cancer Treatment (Paclitaxel-sensitive vs. Paclitaxel-resistant) human epithelial ovarian cancer cell lines A2780 (paclitaxel sensitive) A2780TC1 and (acquired paclitaxe resistant) cell line Down 0.77 18973835 3030 ENOA_HUMAN ENSP00000234590 Ovarian Cancer Treatment (Paclitaxel-sensitive vs. Paclitaxel-resistant) human epithelial ovarian cancer cell lines A2780 (paclitaxel sensitive) A2780TC1 and (acquired paclitaxe resistant) cell line Down 0.83 18973835 3031 LMNA_HUMAN ENSP00000357283 Ovarian Cancer Treatment (Paclitaxel-sensitive vs. Paclitaxel-resistant) human epithelial ovarian cancer cell lines A2780 (paclitaxel sensitive) A2780TC1 and (acquired paclitaxe resistant) cell line Up 1.2 18973835 3032 KPYM_HUMAN ENSP00000334983 Ovarian Cancer Treatment (Paclitaxel-sensitive vs. Paclitaxel-resistant) human epithelial ovarian cancer cell lines A2780 (paclitaxel sensitive) A2780TC1 and (acquired paclitaxe resistant) cell line Up 1.4 18973835 3033 CLH1_HUMAN ENSP00000269122 Ovarian Cancer Treatment (Paclitaxel-sensitive vs. Paclitaxel-resistant) human epithelial ovarian cancer cell lines A2780 (paclitaxel sensitive) A2780TC1 and (acquired paclitaxe resistant) cell line Up 1.6 18973835 3034 LEG3_HUMAN ENSP00000254301 Ovarian Cancer Treatment (Paclitaxel-sensitive vs. Paclitaxel-resistant) human epithelial ovarian cancer cell lines A2780 (paclitaxel sensitive) OVCAR3 (inherently paclitaxe resistant) cell line Down 0.23 18973835 3035 ENOA_HUMAN ENSP00000234590 Ovarian Cancer Treatment (Paclitaxel-sensitive vs. Paclitaxel-resistant) human epithelial ovarian cancer cell lines A2780 (paclitaxel sensitive) OVCAR3 (inherently paclitaxe resistant) cell line Down 0.53 18973835 3036 ENOA_HUMAN ENSP00000234590 Ovarian Cancer Treatment (Paclitaxel-sensitive vs. Paclitaxel-resistant) human epithelial ovarian cancer cell lines A2780 (paclitaxel sensitive) OVCAR3 (inherently paclitaxe resistant) cell line Down 0.56 18973835 3037 RUVB1_HUMAN ENSP00000318297 Ovarian Cancer Treatment (Paclitaxel-sensitive vs. Paclitaxel-resistant) human epithelial ovarian cancer cell lines A2780 (paclitaxel sensitive) OVCAR3 (inherently paclitaxe resistant) cell line Down 0.59 18973835 3038 COF2_HUMAN ENSP00000298159 Ovarian Cancer Treatment (Paclitaxel-sensitive vs. Paclitaxel-resistant) human epithelial ovarian cancer cell lines A2780 (paclitaxel sensitive) OVCAR3 (inherently paclitaxe resistant) cell line Down 0.67 18973835 3039 TBB1_HUMAN ENSP00000217133 Ovarian Cancer Treatment (Paclitaxel-sensitive vs. Paclitaxel-resistant) human epithelial ovarian cancer cell lines A2780 (paclitaxel sensitive) OVCAR3 (inherently paclitaxe resistant) cell line Down 0.77 18973835 3040 KPYM_HUMAN ENSP00000334983 Ovarian Cancer Treatment (Paclitaxel-sensitive vs. Paclitaxel-resistant) human epithelial ovarian cancer cell lines A2780 (paclitaxel sensitive) OVCAR3 (inherently paclitaxe resistant) cell line Up 1.3 18973835 3041 CLH1_HUMAN ENSP00000269122 Ovarian Cancer Treatment (Paclitaxel-sensitive vs. Paclitaxel-resistant) human epithelial ovarian cancer cell lines A2780 (paclitaxel sensitive) OVCAR3 (inherently paclitaxe resistant) cell line Up 1.3 18973835 3042 LMNA_HUMAN ENSP00000357283 Ovarian Cancer Treatment (Paclitaxel-sensitive vs. Paclitaxel-resistant) human epithelial ovarian cancer cell lines A2780 (paclitaxel sensitive) OVCAR3 (inherently paclitaxe resistant) cell line Up 1.5 18973835 3043 TIF1B_HUMAN ENSP00000253024 Ovarian Cancer Treatment (chemotherapy-sensitive vs. chemotherapy-resistant) chemosensitive tissue (serous histology, stage IIIC ovarian cancer, progression-free interval of 23 months) chemoresistant tissue (serous histology, stage IIIC ovarian cancer, progression-free interval of 0 months) tissue Down 0.14 19422301 3044 HSP71_HUMAN ENSP00000364801 Ovarian Cancer Treatment (chemotherapy-sensitive vs. chemotherapy-resistant) chemosensitive tissue (serous histology, stage IIIC ovarian cancer, progression-free interval of 23 months) chemoresistant tissue (serous histology, stage IIIC ovarian cancer, progression-free interval of 0 months) tissue Down 0.22 19422301 3045 ANX11_HUMAN ENSP00000265447 Ovarian Cancer Treatment (chemotherapy-sensitive vs. chemotherapy-resistant) chemosensitive tissue (serous histology, stage IIIC ovarian cancer, progression-free interval of 23 months) chemoresistant tissue (serous histology, stage IIIC ovarian cancer, progression-free interval of 0 months) tissue Down 0.22 19422301 3046 ENPL_HUMAN ENSP00000299767 Ovarian Cancer Treatment (chemotherapy-sensitive vs. chemotherapy-resistant) chemosensitive tissue (serous histology, stage IIIC ovarian cancer, progression-free interval of 23 months) chemoresistant tissue (serous histology, stage IIIC ovarian cancer, progression-free interval of 0 months) tissue Down 0.39 19422301 3047 SND1_HUMAN ENSP00000346762 Ovarian Cancer Treatment (chemotherapy-sensitive vs. chemotherapy-resistant) chemosensitive tissue (serous histology, stage IIIC ovarian cancer, progression-free interval of 23 months) chemoresistant tissue (serous histology, stage IIIC ovarian cancer, progression-free interval of 0 months) tissue Down 0.42 19422301 3048 TP53B_HUMAN ENSP00000371475 Ovarian Cancer Treatment (chemotherapy-sensitive vs. chemotherapy-resistant) chemosensitive tissue (serous histology, stage IIIC ovarian cancer, progression-free interval of 23 months) chemoresistant tissue (serous histology, stage IIIC ovarian cancer, progression-free interval of 0 months) tissue Down 0.44 19422301 3049 CTND1_HUMAN ENSP00000382004 Ovarian Cancer Treatment (chemotherapy-sensitive vs. chemotherapy-resistant) chemosensitive tissue (serous histology, stage IIIC ovarian cancer, progression-free interval of 23 months) chemoresistant tissue (serous histology, stage IIIC ovarian cancer, progression-free interval of 0 months) tissue Down 0.45 19422301 3050 PLAK_HUMAN ENSP00000377508 Ovarian Cancer Treatment (chemotherapy-sensitive vs. chemotherapy-resistant) chemosensitive tissue (serous histology, stage IIIC ovarian cancer, progression-free interval of 23 months) chemoresistant tissue (serous histology, stage IIIC ovarian cancer, progression-free interval of 0 months) tissue Down 0.47 19422301 3051 HNRPD_HUMAN ENSP00000313199 Ovarian Cancer Treatment (chemotherapy-sensitive vs. chemotherapy-resistant) chemosensitive tissue (serous histology, stage IIIC ovarian cancer, progression-free interval of 23 months) chemoresistant tissue (serous histology, stage IIIC ovarian cancer, progression-free interval of 0 months) tissue Down 0.48 19422301 3052 1433S_HUMAN ENSP00000340989 Ovarian Cancer Treatment (chemotherapy-sensitive vs. chemotherapy-resistant) chemosensitive tissue (serous histology, stage IIIC ovarian cancer, progression-free interval of 23 months) chemoresistant tissue (serous histology, stage IIIC ovarian cancer, progression-free interval of 0 months) tissue Down 0.49 19422301 3053 PCNA_HUMAN ENSP00000368458 Ovarian Cancer Treatment (chemotherapy-sensitive vs. chemotherapy-resistant) chemosensitive tissue (serous histology, stage IIIC ovarian cancer, progression-free interval of 23 months) chemoresistant tissue (serous histology, stage IIIC ovarian cancer, progression-free interval of 0 months) tissue Down 0.5 19422301 3054 VDAC1_HUMAN ENSP00000378487 Ovarian Cancer Treatment (chemotherapy-sensitive vs. chemotherapy-resistant) chemosensitive tissue (serous histology, stage IIIC ovarian cancer, progression-free interval of 23 months) chemoresistant tissue (serous histology, stage IIIC ovarian cancer, progression-free interval of 0 months) tissue Up 2 19422301 3055 KNG1_HUMAN ENSP00000265023 Ovarian Cancer Treatment (chemotherapy-sensitive vs. chemotherapy-resistant) chemosensitive tissue (serous histology, stage IIIC ovarian cancer, progression-free interval of 23 months) chemoresistant tissue (serous histology, stage IIIC ovarian cancer, progression-free interval of 0 months) tissue Up 2 19422301 3056 C163A_HUMAN ENSP00000352071 Ovarian Cancer Treatment (chemotherapy-sensitive vs. chemotherapy-resistant) chemosensitive tissue (serous histology, stage IIIC ovarian cancer, progression-free interval of 23 months) chemoresistant tissue (serous histology, stage IIIC ovarian cancer, progression-free interval of 0 months) tissue Up 2 19422301 3057 ACTA_HUMAN ENSP00000402373 Ovarian Cancer Treatment (chemotherapy-sensitive vs. chemotherapy-resistant) chemosensitive tissue (serous histology, stage IIIC ovarian cancer, progression-free interval of 23 months) chemoresistant tissue (serous histology, stage IIIC ovarian cancer, progression-free interval of 0 months) tissue Up 2.7 19422301 3058 TAGL2_HUMAN ENSP00000357075 Ovarian Cancer Treatment (chemotherapy-sensitive vs. chemotherapy-resistant) chemosensitive tissue (serous histology, stage IIIC ovarian cancer, progression-free interval of 23 months) chemoresistant tissue (serous histology, stage IIIC ovarian cancer, progression-free interval of 0 months) tissue Up 3.2 19422301 3059 FINC_HUMAN ENSP00000352696 Ovarian Cancer Treatment (chemotherapy-sensitive vs. chemotherapy-resistant) chemosensitive tissue (serous histology, stage IIIC ovarian cancer, progression-free interval of 23 months) chemoresistant tissue (serous histology, stage IIIC ovarian cancer, progression-free interval of 0 months) tissue Up 3.3 19422301 3060 A1AT_HUMAN ENSP00000348068 Ovarian Cancer Treatment (chemotherapy-sensitive vs. chemotherapy-resistant) chemosensitive tissue (serous histology, stage IIIC ovarian cancer, progression-free interval of 23 months) chemoresistant tissue (serous histology, stage IIIC ovarian cancer, progression-free interval of 0 months) tissue Up 3.4 19422301 3061 PGS2_HUMAN ENSP00000376862 Ovarian Cancer Treatment (chemotherapy-sensitive vs. chemotherapy-resistant) chemosensitive tissue (serous histology, stage IIIC ovarian cancer, progression-free interval of 23 months) chemoresistant tissue (serous histology, stage IIIC ovarian cancer, progression-free interval of 0 months) tissue Up 5.5 19422301 3062 RHOC_HUMAN ENSP00000358647 Ovarian Cancer Treatment (chemotherapy-sensitive vs. chemotherapy-resistant) chemosensitive tissue (serous histology, stage IIIC ovarian cancer, progression-free interval of 23 months) chemoresistant tissue (serous histology, stage IIIC ovarian cancer, progression-free interval of 0 months) tissue Up 10 19422301 3063 LEG3_HUMAN ENSP00000254301 Ovarian Cancer Treatment (Paclitaxel-sensitive vs. Paclitaxel-resistant) Paclitaxel Sensitive A2780 Epithelial Ovarian Cancer Cell Line Paclitaxel Resistant A2780TC1 Epithelial Ovarian Cancer Cell Line cell line Down 0.33 19714814 3064 TOM40_HUMAN ENSP00000252487 Ovarian Cancer Treatment (Paclitaxel-sensitive vs. Paclitaxel-resistant) Paclitaxel Sensitive A2780 Epithelial Ovarian Cancer Cell Line Paclitaxel Resistant A2780TC1 Epithelial Ovarian Cancer Cell Line cell line Down 0.5 19714814 3065 VINC_HUMAN ENSP00000211998 Ovarian Cancer Treatment (Paclitaxel-sensitive vs. Paclitaxel-resistant) Paclitaxel Sensitive A2780 Epithelial Ovarian Cancer Cell Line Paclitaxel Resistant A2780TC1 Epithelial Ovarian Cancer Cell Line cell line Down 0.5 19714814 3066 VINC_HUMAN ENSP00000211998 Ovarian Cancer Treatment (Paclitaxel-sensitive vs. Paclitaxel-resistant) Paclitaxel Sensitive A2780 Epithelial Ovarian Cancer Cell Line Paclitaxel Resistant A2780TC1 Epithelial Ovarian Cancer Cell Line cell line Down 0.56 19714814 3067 LEG3_HUMAN ENSP00000254301 Ovarian Cancer Treatment (Paclitaxel-sensitive vs. Paclitaxel-resistant) Paclitaxel Sensitive A2780 Epithelial Ovarian Cancer Cell Line Paclitaxel Resistant A2780TC1 Epithelial Ovarian Cancer Cell Line cell line Down 0.62 19714814 3068 HSPB1_HUMAN ENSP00000248553 Ovarian Cancer Treatment (Paclitaxel-sensitive vs. Paclitaxel-resistant) Paclitaxel Sensitive A2780 Epithelial Ovarian Cancer Cell Line Paclitaxel Resistant A2780TC1 Epithelial Ovarian Cancer Cell Line cell line Down 0.67 19714814 3069 TBB1_HUMAN ENSP00000217133 Ovarian Cancer Treatment (Paclitaxel-sensitive vs. Paclitaxel-resistant) Paclitaxel Sensitive A2780 Epithelial Ovarian Cancer Cell Line Paclitaxel Resistant A2780TC1 Epithelial Ovarian Cancer Cell Line cell line Down 0.67 19714814 3070 RUVB1_HUMAN ENSP00000318297 Ovarian Cancer Treatment (Paclitaxel-sensitive vs. Paclitaxel-resistant) Paclitaxel Sensitive A2780 Epithelial Ovarian Cancer Cell Line Paclitaxel Resistant A2780TC1 Epithelial Ovarian Cancer Cell Line cell line Down 0.67 19714814 3071 HSP7C_HUMAN ENSP00000227378 Ovarian Cancer Treatment (Paclitaxel-sensitive vs. Paclitaxel-resistant) Paclitaxel Sensitive A2780 Epithelial Ovarian Cancer Cell Line Paclitaxel Resistant A2780TC1 Epithelial Ovarian Cancer Cell Line cell line Down 0.71 19714814 3072 LEG3_HUMAN ENSP00000254301 Ovarian Cancer Treatment (Paclitaxel-sensitive vs. Paclitaxel-resistant) Paclitaxel Sensitive A2780 Epithelial Ovarian Cancer Cell Line Paclitaxel Resistant A2780TC1 Epithelial Ovarian Cancer Cell Line cell line Down 0.71 19714814 3073 GDIR1_HUMAN ENSP00000269321 Ovarian Cancer Treatment (Paclitaxel-sensitive vs. Paclitaxel-resistant) Paclitaxel Sensitive A2780 Epithelial Ovarian Cancer Cell Line Paclitaxel Resistant A2780TC1 Epithelial Ovarian Cancer Cell Line cell line Down 0.71 19714814 3074 LMNA_HUMAN ENSP00000357283 Ovarian Cancer Treatment (Paclitaxel-sensitive vs. Paclitaxel-resistant) Paclitaxel Sensitive A2780 Epithelial Ovarian Cancer Cell Line Paclitaxel Resistant A2780TC1 Epithelial Ovarian Cancer Cell Line cell line Down 0.77 19714814 3075 ENOA_HUMAN ENSP00000234590 Ovarian Cancer Treatment (Paclitaxel-sensitive vs. Paclitaxel-resistant) Paclitaxel Sensitive A2780 Epithelial Ovarian Cancer Cell Line Paclitaxel Resistant A2780TC1 Epithelial Ovarian Cancer Cell Line cell line Down 0.77 19714814 3076 COF2_HUMAN ENSP00000298159 Ovarian Cancer Treatment (Paclitaxel-sensitive vs. Paclitaxel-resistant) Paclitaxel Sensitive A2780 Epithelial Ovarian Cancer Cell Line Paclitaxel Resistant A2780TC1 Epithelial Ovarian Cancer Cell Line cell line Down 0.77 19714814 3077 ENOA_HUMAN ENSP00000234590 Ovarian Cancer Treatment (Paclitaxel-sensitive vs. Paclitaxel-resistant) Paclitaxel Sensitive A2780 Epithelial Ovarian Cancer Cell Line Paclitaxel Resistant A2780TC1 Epithelial Ovarian Cancer Cell Line cell line Down 0.83 19714814 3078 TERA_HUMAN ENSP00000351777 Ovarian Cancer Treatment (Paclitaxel-sensitive vs. Paclitaxel-resistant) Paclitaxel Sensitive A2780 Epithelial Ovarian Cancer Cell Line Paclitaxel Resistant A2780TC1 Epithelial Ovarian Cancer Cell Line cell line Down 0.91 19714814 3079 LMNA_HUMAN ENSP00000357283 Ovarian Cancer Treatment (Paclitaxel-sensitive vs. Paclitaxel-resistant) Paclitaxel Sensitive A2780 Epithelial Ovarian Cancer Cell Line Paclitaxel Resistant A2780TC1 Epithelial Ovarian Cancer Cell Line cell line Up 1.2 19714814 3080 LMNA_HUMAN ENSP00000357283 Ovarian Cancer Treatment (Paclitaxel-sensitive vs. Paclitaxel-resistant) Paclitaxel Sensitive A2780 Epithelial Ovarian Cancer Cell Line Paclitaxel Resistant A2780TC1 Epithelial Ovarian Cancer Cell Line cell line Up 1.3 19714814 3081 GRDN_HUMAN ENSP00000410608 Ovarian Cancer Treatment (Paclitaxel-sensitive vs. Paclitaxel-resistant) Paclitaxel Sensitive A2780 Epithelial Ovarian Cancer Cell Line Paclitaxel Resistant A2780TC1 Epithelial Ovarian Cancer Cell Line cell line Up 1.3 19714814 3082 PDC6I_HUMAN ENSP00000307387 Ovarian Cancer Treatment (Paclitaxel-sensitive vs. Paclitaxel-resistant) Paclitaxel Sensitive A2780 Epithelial Ovarian Cancer Cell Line Paclitaxel Resistant A2780TC1 Epithelial Ovarian Cancer Cell Line cell line Up 1.3 19714814 3083 KPYM_HUMAN ENSP00000334983 Ovarian Cancer Treatment (Paclitaxel-sensitive vs. Paclitaxel-resistant) Paclitaxel Sensitive A2780 Epithelial Ovarian Cancer Cell Line Paclitaxel Resistant A2780TC1 Epithelial Ovarian Cancer Cell Line cell line Up 1.4 19714814 3084 TPIS_HUMAN ENSP00000379933 Ovarian Cancer Treatment (Paclitaxel-sensitive vs. Paclitaxel-resistant) Paclitaxel Sensitive A2780 Epithelial Ovarian Cancer Cell Line Paclitaxel Resistant A2780TC1 Epithelial Ovarian Cancer Cell Line cell line Up 1.4 19714814 3085 HSPB1_HUMAN ENSP00000248553 Ovarian Cancer Treatment (Paclitaxel-sensitive vs. Paclitaxel-resistant) Paclitaxel Sensitive A2780 Epithelial Ovarian Cancer Cell Line Paclitaxel Resistant A2780TC1 Epithelial Ovarian Cancer Cell Line cell line Up 1.5 19714814 3086 CLH1_HUMAN ENSP00000269122 Ovarian Cancer Treatment (Paclitaxel-sensitive vs. Paclitaxel-resistant) Paclitaxel Sensitive A2780 Epithelial Ovarian Cancer Cell Line Paclitaxel Resistant A2780TC1 Epithelial Ovarian Cancer Cell Line cell line Up 1.6 19714814 3087 EF2_HUMAN ENSP00000307940 Ovarian Cancer Treatment (Paclitaxel-sensitive vs. Paclitaxel-resistant) Paclitaxel Sensitive A2780 Epithelial Ovarian Cancer Cell Line Paclitaxel Resistant A2780TC1 Epithelial Ovarian Cancer Cell Line cell line Up 1.7 19714814 3088 GDIR2_HUMAN ENSP00000228945 Ovarian Cancer Treatment (Paclitaxel-sensitive vs. Paclitaxel-resistant) Paclitaxel Sensitive A2780 Epithelial Ovarian Cancer Cell Line Paclitaxel Resistant A2780TC1 Epithelial Ovarian Cancer Cell Line cell line Up 1.8 19714814 3089 ENOA_HUMAN ENSP00000234590 Ovarian Cancer Treatment (Paclitaxel-sensitive vs. Paclitaxel-resistant) Paclitaxel Sensitive A2780 Epithelial Ovarian Cancer Cell Line Paclitaxel Resistant A2780TC1 Epithelial Ovarian Cancer Cell Line cell line Up 2 19714814 3090 EF2_HUMAN ENSP00000307940 Ovarian Cancer Treatment (Paclitaxel-sensitive vs. Paclitaxel-resistant) Paclitaxel Sensitive A2780 Epithelial Ovarian Cancer Cell Line Paclitaxel Resistant A2780TC1 Epithelial Ovarian Cancer Cell Line cell line Up 2.1 19714814 3091 CSPG4_HUMAN ENSP00000312506 Ovarian Cancer Treatment (cisplatin-sensitive vs. cisplatin-resistant) ovarian cancer cell line A2780 cisplatin resistant derivative cell line A2780cis cell line Up 3.2 19800108 3092 ITA6_HUMAN ENSP00000341078 Ovarian Cancer Treatment (cisplatin-sensitive vs. cisplatin-resistant) ovarian cancer cell line A2780 cisplatin resistant derivative cell line A2780cis cell line Up 3.7 19800108 3093 CD97_HUMAN ENSP00000242786 Ovarian Cancer Treatment (cisplatin-sensitive vs. cisplatin-resistant) ovarian cancer cell line A2780 cisplatin resistant derivative cell line A2780cis cell line Up 4.3 19800108 3094 ICOSL_HUMAN ENSP00000384432 Ovarian Cancer Treatment (cisplatin-sensitive vs. cisplatin-resistant) ovarian cancer cell line A2780 cisplatin resistant derivative cell line A2780cis cell line Up 5.1 19800108 3095 CD70_HUMAN ENSP00000245903 Ovarian Cancer Treatment (cisplatin-sensitive vs. cisplatin-resistant) ovarian cancer cell line A2780 cisplatin resistant derivative cell line A2780cis cell line Up 18 19800108 3096 AMRP_HUMAN ENSP00000421922 Ovarian Cancer Treatment (Paclitaxel-sensitive vs. Paclitaxel-resistant) human ovarian cancer cell line A2780 paclitaxel resistant A2780TC1 ovarian cancer cell line cell line Up 1.3 19951750 3097 TPIS_HUMAN ENSP00000379933 Ovarian Cancer Treatment (Paclitaxel-sensitive vs. Paclitaxel-resistant) human ovarian cancer cell line A2780 paclitaxel resistant A2780TC1 ovarian cancer cell line cell line Up 2.5 19951750 3098 CO3_HUMAN ENSP00000245907 Ovarian Cancer Normal vs. Cancer serum of non-cancer controls serum of ovarian carcinoma tissue Up 1.8 20162585 3099 CO3_HUMAN ENSP00000245907 Ovarian Cancer Normal vs. Cancer serum of non-cancer controls serum of ovarian carcinoma tissue Up 2.1 20162585 3100 KNG1_HUMAN ENSP00000265023 Ovarian Cancer Normal vs. Cancer serum of non-cancer controls serum of ovarian carcinoma tissue Up 2.2 20162585 3101 THRB_HUMAN ENSP00000308541 Ovarian Cancer Normal vs. Cancer serum of non-cancer controls serum of ovarian carcinoma tissue Up 2.3 20162585 3102 CO3_HUMAN ENSP00000245907 Ovarian Cancer Normal vs. Cancer serum of non-cancer controls serum of ovarian carcinoma tissue Up 2.3 20162585 3103 PROS_HUMAN ENSP00000377783 Ovarian Cancer Normal vs. Cancer serum of non-cancer controls serum of ovarian carcinoma tissue Up 2.3 20162585 3104 ENOA_HUMAN ENSP00000234590 Ovarian Cancer Treatment (Paclitaxel-sensitive vs. Paclitaxel-resistant) paclitaxel-sensitive parental SKOV3 cells paclitaxel-resistant subline (SKpac) from human epithelial ovarian cancer cell line, SKOV3 cell line Down 0.023 20858016 3105 PRS7_HUMAN ENSP00000292644 Ovarian Cancer Treatment (Paclitaxel-sensitive vs. Paclitaxel-resistant) paclitaxel-sensitive parental SKOV3 cells paclitaxel-resistant subline (SKpac) from human epithelial ovarian cancer cell line, SKOV3 cell line Down 0.024 20858016 3106 ENOA_HUMAN ENSP00000234590 Ovarian Cancer Treatment (Paclitaxel-sensitive vs. Paclitaxel-resistant) paclitaxel-sensitive parental SKOV3 cells paclitaxel-resistant subline (SKpac) from human epithelial ovarian cancer cell line, SKOV3 cell line Down 0.026 20858016 3107 GDIB_HUMAN ENSP00000369538 Ovarian Cancer Treatment (Paclitaxel-sensitive vs. Paclitaxel-resistant) paclitaxel-sensitive parental SKOV3 cells paclitaxel-resistant subline (SKpac) from human epithelial ovarian cancer cell line, SKOV3 cell line Down 0.35 20858016 3108 ENOA_HUMAN ENSP00000234590 Ovarian Cancer Treatment (Paclitaxel-sensitive vs. Paclitaxel-resistant) paclitaxel-sensitive parental SKOV3 cells paclitaxel-resistant subline (SKpac) from human epithelial ovarian cancer cell line, SKOV3 cell line Down 0.4 20858016 3109 SET_HUMAN ENSP00000361777 Ovarian Cancer Treatment (Paclitaxel-sensitive vs. Paclitaxel-resistant) paclitaxel-sensitive parental SKOV3 cells paclitaxel-resistant subline (SKpac) from human epithelial ovarian cancer cell line, SKOV3 cell line Down 0.44 20858016 3110 CATD_HUMAN ENSP00000236671 Ovarian Cancer Treatment (Paclitaxel-sensitive vs. Paclitaxel-resistant) paclitaxel-sensitive parental SKOV3 cells paclitaxel-resistant subline (SKpac) from human epithelial ovarian cancer cell line, SKOV3 cell line Up 11 20858016 3111 EZRI_HUMAN ENSP00000356042 Ovarian Cancer Treatment (Paclitaxel-sensitive vs. Paclitaxel-resistant) paclitaxel-sensitive parental SKOV3 cells paclitaxel-resistant subline (SKpac) from human epithelial ovarian cancer cell line, SKOV3 cell line Up 18 20858016 3112 STMN1_HUMAN ENSP00000382633 Ovarian Cancer Treatment (cisplatin-sensitive vs. cisplatin-resistant) A2780-sensitive cells A2780 cisplatin-resistant cells cell line Up 2.5 21080034 3113 HSPB1_HUMAN ENSP00000248553 Pancreatic Cancer Normal vs. Cancer adjacent healthy tissue from patients Samples of pancreatic adenocarcinomas from patients tissue Down 0.2 15526344 3114 ENPL_HUMAN ENSP00000299767 Pancreatic Cancer Normal vs. Cancer adjacent healthy tissue from patients Samples of pancreatic adenocarcinomas from patients tissue Down 0.33 15526344 3115 DESM_HUMAN ENSP00000363071 Pancreatic Cancer Normal vs. Cancer adjacent healthy tissue from patients Samples of pancreatic adenocarcinomas from patients tissue Down 0.33 15526344 3116 PGM1_HUMAN ENSP00000360125 Pancreatic Cancer Normal vs. Cancer adjacent healthy tissue from patients Samples of pancreatic adenocarcinomas from patients tissue Down 0.5 15526344 3117 DPYL2_HUMAN ENSP00000309539 Pancreatic Cancer Normal vs. Cancer adjacent healthy tissue from patients Samples of pancreatic adenocarcinomas from patients tissue Down 0.5 15526344 3118 ACTN4_HUMAN ENSP00000252699 Pancreatic Cancer Normal vs. Cancer adjacent healthy tissue from patients Samples of pancreatic adenocarcinomas from patients tissue Up 2 15526344 3119 ENOA_HUMAN ENSP00000234590 Pancreatic Cancer Normal vs. Cancer adjacent healthy tissue from patients Samples of pancreatic adenocarcinomas from patients tissue Up 2 15526344 3120 ANXA2_HUMAN ENSP00000411352 Pancreatic Cancer Normal vs. Cancer adjacent healthy tissue from patients Samples of pancreatic adenocarcinomas from patients tissue Up 2 15526344 3121 LEG3_HUMAN ENSP00000254301 Pancreatic Cancer Normal vs. Cancer adjacent healthy tissue from patients Samples of pancreatic adenocarcinomas from patients tissue Up 2 15526344 3122 TGM2_HUMAN ENSP00000355330 Pancreatic Cancer Normal vs. Cancer adjacent healthy tissue from patients Samples of pancreatic adenocarcinomas from patients tissue Up 2 15526344 3123 SYWC_HUMAN ENSP00000347495 Pancreatic Cancer Normal vs. Cancer adjacent healthy tissue from patients Samples of pancreatic adenocarcinomas from patients tissue Up 2 15526344 3124 MYL9_HUMAN ENSP00000279022 Pancreatic Cancer Normal vs. Cancer adjacent healthy tissue from patients Samples of pancreatic adenocarcinomas from patients tissue Up 2 15526344 3125 TAGL2_HUMAN ENSP00000357075 Pancreatic Cancer Normal vs. Cancer adjacent healthy tissue from patients Samples of pancreatic adenocarcinomas from patients tissue Up 2 15526344 3126 NAMPT_HUMAN ENSP00000222553 Pancreatic Cancer Normal vs. Cancer adjacent healthy tissue from patients Samples of pancreatic adenocarcinomas from patients tissue Up 2 15526344 3127 IQGA1_HUMAN ENSP00000268182 Pancreatic Cancer Normal vs. Cancer adjacent healthy tissue from patients Samples of pancreatic adenocarcinomas from patients tissue Up 2 15526344 3128 DEST_HUMAN ENSP00000246069 Pancreatic Cancer Normal vs. Cancer adjacent healthy tissue from patients Samples of pancreatic adenocarcinomas from patients tissue Up 2 15526344 3129 CALD1_HUMAN ENSP00000354826 Pancreatic Cancer Normal vs. Cancer adjacent healthy tissue from patients Samples of pancreatic adenocarcinomas from patients tissue Up 2 15526344 3130 GELS_HUMAN ENSP00000362924 Pancreatic Cancer Normal vs. Cancer adjacent healthy tissue from patients Samples of pancreatic adenocarcinomas from patients tissue Up 3 15526344 3131 KPYM_HUMAN ENSP00000334983 Pancreatic Cancer Normal vs. Cancer adjacent healthy tissue from patients Samples of pancreatic adenocarcinomas from patients tissue Up 3 15526344 3132 RAN_HUMAN ENSP00000376176 Pancreatic Cancer Normal vs. Cancer adjacent healthy tissue from patients Samples of pancreatic adenocarcinomas from patients tissue Up 3 15526344 3133 ANXA1_HUMAN ENSP00000366109 Pancreatic Cancer Normal vs. Cancer adjacent healthy tissue from patients Samples of pancreatic adenocarcinomas from patients tissue Up 4 15526344 3134 FLNA_HUMAN ENSP00000358866 Pancreatic Cancer Normal vs. Cancer adjacent healthy tissue from patients Samples of pancreatic adenocarcinomas from patients tissue Up 4 15526344 3135 THRB_HUMAN ENSP00000308541 Pancreatic Cancer Normal vs. Cancer adjacent healthy tissue from patients Samples of pancreatic adenocarcinomas from patients tissue Up <2 15526344 3136 APOE_HUMAN ENSP00000252486 Pancreatic Cancer Normal vs. Cancer adjacent healthy tissue from patients Samples of pancreatic adenocarcinomas from patients tissue Up <2 15526344 3137 CATD_HUMAN ENSP00000236671 Pancreatic Cancer Normal vs. Cancer adjacent healthy tissue from patients Samples of pancreatic adenocarcinomas from patients tissue Up <2 15526344 3138 PLSL_HUMAN ENSP00000315757 Pancreatic Cancer Normal vs. Cancer adjacent healthy tissue from patients Samples of pancreatic adenocarcinomas from patients tissue Up <2 15526344 3139 COF1_HUMAN ENSP00000309629 Pancreatic Cancer Normal vs. Cancer adjacent healthy tissue from patients Samples of pancreatic adenocarcinomas from patients tissue Up <2 15526344 3140 EFTU_HUMAN ENSP00000322439 Pancreatic Cancer Normal vs. Cancer adjacent healthy tissue from patients Samples of pancreatic adenocarcinomas from patients tissue Up <2 15526344 3141 GDIR1_HUMAN ENSP00000269321 Pancreatic Cancer Normal vs. Cancer adjacent healthy tissue from patients Samples of pancreatic adenocarcinomas from patients tissue Up <2 15526344 3142 IPYR_HUMAN ENSP00000362329 Pancreatic Cancer Normal vs. Cancer adjacent healthy tissue from patients Samples of pancreatic adenocarcinomas from patients tissue Up <2 15526344 3143 TAGL_HUMAN ENSP00000278968 pancreatic ductal adenocarcinoma Normal vs. Cancer normal pancreatic ducts pancreatic intra-epithelial neoplasias (PanINs cells),the precursor lesions of pancreatic ductal adenocarcinoma tissue Down 0.22 15924292 3144 RS20_HUMAN ENSP00000009589 Pancreatic Cancer Normal vs. Cancer normal pancreas pancreatic cancer tissues tissue Down 0.24 16230073 3145 COMP_HUMAN ENSP00000222271 Pancreatic Cancer Normal vs. Cancer normal pancreas pancreatic cancer tissues tissue Down 0.27 16230073 3146 HBA_HUMAN ENSP00000322421 Pancreatic Cancer Normal vs. Cancer normal pancreas pancreatic cancer tissues tissue Down 0.32 16230073 3147 RS6_HUMAN ENSP00000369757 Pancreatic Cancer Normal vs. Cancer normal pancreas pancreatic cancer tissues tissue Down 0.44 16230073 3148 COF1_HUMAN ENSP00000309629 Pancreatic Cancer Normal vs. Cancer normal pancreas pancreatic cancer tissues tissue Up 2 16230073 3149 MYH9_HUMAN ENSP00000216181 Pancreatic Cancer Normal vs. Cancer normal pancreas pancreatic cancer tissues tissue Up 2.3 16230073 3150 GELS_HUMAN ENSP00000362924 Pancreatic Cancer Normal vs. Cancer normal pancreas pancreatic cancer tissues tissue Up 2.4 16230073 3151 FINC_HUMAN ENSP00000352696 Pancreatic Cancer Normal vs. Cancer normal pancreas pancreatic cancer tissues tissue Up 2.4 16230073 3152 TSP1_HUMAN ENSP00000260356 Pancreatic Cancer Normal vs. Cancer normal pancreas pancreatic cancer tissues tissue Up 2.5 16230073 3153 PGS2_HUMAN ENSP00000376862 Pancreatic Cancer Normal vs. Cancer normal pancreas pancreatic cancer tissues tissue Up 2.6 16230073 3154 ACTG_HUMAN ENSP00000331514 Pancreatic Cancer Normal vs. Cancer normal pancreas pancreatic cancer tissues tissue Up 2.6 16230073 3155 ITB1_HUMAN ENSP00000379350 Pancreatic Cancer Normal vs. Cancer normal pancreas pancreatic cancer tissues tissue Up 2.7 16230073 3156 AMBP_HUMAN ENSP00000265132 Pancreatic Cancer Normal vs. Cancer normal pancreas pancreatic cancer tissues tissue Up 2.7 16230073 3157 VIME_HUMAN ENSP00000224237 Pancreatic Cancer Normal vs. Cancer normal pancreas pancreatic cancer tissues tissue Up 2.7 16230073 3158 TGM2_HUMAN ENSP00000355330 Pancreatic Cancer Normal vs. Cancer normal pancreas pancreatic cancer tissues tissue Up 2.8 16230073 3159 FLNA_HUMAN ENSP00000358866 Pancreatic Cancer Normal vs. Cancer normal pancreas pancreatic cancer tissues tissue Up 2.9 16230073 3160 ZYX_HUMAN ENSP00000324422 Pancreatic Cancer Normal vs. Cancer normal pancreas pancreatic cancer tissues tissue Up 3.1 16230073 3161 RET4_HUMAN ENSP00000360522 Pancreatic Cancer Normal vs. Cancer normal pancreas pancreatic cancer tissues tissue Up 3.3 16230073 3162 CATD_HUMAN ENSP00000236671 Pancreatic Cancer Normal vs. Cancer normal pancreas pancreatic cancer tissues tissue Up 3.4 16230073 3163 ACTC_HUMAN ENSP00000290378 Pancreatic Cancer Normal vs. Cancer normal pancreas pancreatic cancer tissues tissue Up 3.8 16230073 3164 ACTB_HUMAN ENSP00000349960 Pancreatic Cancer Normal vs. Cancer normal pancreas pancreatic cancer tissues tissue Up 4.2 16230073 3165 TBA1C_HUMAN ENSP00000301072 Hepatocellular Carcinoma Normal vs. Cancer non-tumor tissues tumor tissues tissue Up 2.1 19658107 3166 CATD_HUMAN ENSP00000236671 Hepatocellular Carcinoma Normal vs. Cancer non-tumor tissues tumor tissues tissue Up 2.6 19658107 3167 NPM_HUMAN ENSP00000296930 Gastric Cancer Treatment (none vs. hexamethylene bisacetamide (HMBA) treatment) BGC-823 cells of gastric cancer BGC-823 cells of gastric cancer treated with hexamethylene bisacetamide (HMBA) cell line Down 20440860 3168 DDX5_HUMAN ENSP00000225792 Gastric Cancer Treatment (none vs. drug-resistant) gastric cancer SGC7901 cells drug-resistant SGC7901 cells (SGC7901/VCR) cell line Down 0.45 20625496 3169 H4_HUMAN ENSP00000376663 Gastric Cancer Treatment (none vs. drug-resistant) gastric cancer SGC7901 cells drug-resistant SGC7901 cells (SGC7901/VCR) cell line Down 0.53 20625496 3170 GBB2_HUMAN ENSP00000377501 Gastric Cancer Treatment (none vs. drug-resistant) gastric cancer SGC7901 cells drug-resistant SGC7901 cells (SGC7901/VCR) cell line Down 0.59 20625496 3171 LMNA_HUMAN ENSP00000357283 Gastric Cancer Treatment (none vs. drug-resistant) gastric cancer SGC7901 cells drug-resistant SGC7901 cells (SGC7901/VCR) cell line Down 0.61 20625496 3172 G6PI_HUMAN ENSP00000348877 Gastric Cancer Treatment (none vs. drug-resistant) gastric cancer SGC7901 cells drug-resistant SGC7901 cells (SGC7901/VCR) cell line Down 0.61 20625496 3173 H2B1K_HUMAN ENSP00000380100 Gastric Cancer Treatment (none vs. drug-resistant) gastric cancer SGC7901 cells drug-resistant SGC7901 cells (SGC7901/VCR) cell line Down 0.62 20625496 3174 PRDX5_HUMAN ENSP00000265462 Gastric Cancer Treatment (none vs. drug-resistant) gastric cancer SGC7901 cells drug-resistant SGC7901 cells (SGC7901/VCR) cell line Down 0.64 20625496 3175 NONO_HUMAN ENSP00000362947 Gastric Cancer Treatment (none vs. drug-resistant) gastric cancer SGC7901 cells drug-resistant SGC7901 cells (SGC7901/VCR) cell line Down 0.65 20625496 3176 KPYM_HUMAN ENSP00000334983 Gastric Cancer Treatment (none vs. drug-resistant) gastric cancer SGC7901 cells drug-resistant SGC7901 cells (SGC7901/VCR) cell line Down 0.67 20625496 3177 HS90A_HUMAN ENSP00000335153 Gastric Cancer Treatment (none vs. drug-resistant) gastric cancer SGC7901 cells drug-resistant SGC7901 cells (SGC7901/VCR) cell line Down 0.69 20625496 3178 THIO_HUMAN ENSP00000363641 Gastric Cancer Treatment (none vs. drug-resistant) gastric cancer SGC7901 cells drug-resistant SGC7901 cells (SGC7901/VCR) cell line Down 0.74 20625496 3179 PLEC_HUMAN ENSP00000323856 Gastric Cancer Treatment (none vs. drug-resistant) gastric cancer SGC7901 cells drug-resistant SGC7901 cells (SGC7901/VCR) cell line Down 0.76 20625496 3180 SET_HUMAN ENSP00000361777 Gastric Cancer Treatment (none vs. drug-resistant) gastric cancer SGC7901 cells drug-resistant SGC7901 cells (SGC7901/VCR) cell line Up 1.3 20625496 3181 CIP4_HUMAN ENSP00000320117 Gastric Cancer Treatment (none vs. drug-resistant) gastric cancer SGC7901 cells drug-resistant SGC7901 cells (SGC7901/VCR) cell line Up 1.3 20625496 3182 PARK7_HUMAN ENSP00000366708 Gastric Cancer Treatment (none vs. drug-resistant) gastric cancer SGC7901 cells drug-resistant SGC7901 cells (SGC7901/VCR) cell line Up 1.4 20625496 3183 EF1A1_HUMAN ENSP00000330054 Gastric Cancer Treatment (none vs. drug-resistant) gastric cancer SGC7901 cells drug-resistant SGC7901 cells (SGC7901/VCR) cell line Up 1.4 20625496 3184 MYH9_HUMAN ENSP00000216181 Gastric Cancer Treatment (none vs. drug-resistant) gastric cancer SGC7901 cells drug-resistant SGC7901 cells (SGC7901/VCR) cell line Up 1.4 20625496 3185 EF2_HUMAN ENSP00000307940 Gastric Cancer Treatment (none vs. drug-resistant) gastric cancer SGC7901 cells drug-resistant SGC7901 cells (SGC7901/VCR) cell line Up 1.4 20625496 3186 TIF1B_HUMAN ENSP00000253024 Gastric Cancer Treatment (none vs. drug-resistant) gastric cancer SGC7901 cells drug-resistant SGC7901 cells (SGC7901/VCR) cell line Up 1.4 20625496 3187 FLNA_HUMAN ENSP00000358866 Gastric Cancer Treatment (none vs. drug-resistant) gastric cancer SGC7901 cells drug-resistant SGC7901 cells (SGC7901/VCR) cell line Up 1.4 20625496 3188 VIGLN_HUMAN ENSP00000312042 Gastric Cancer Treatment (none vs. drug-resistant) gastric cancer SGC7901 cells drug-resistant SGC7901 cells (SGC7901/VCR) cell line Up 1.4 20625496 3189 HSP71_HUMAN ENSP00000364801 Gastric Cancer Treatment (none vs. drug-resistant) gastric cancer SGC7901 cells drug-resistant SGC7901 cells (SGC7901/VCR) cell line Up 1.4 20625496 3190 CALR_HUMAN ENSP00000320866 Gastric Cancer Treatment (none vs. drug-resistant) gastric cancer SGC7901 cells drug-resistant SGC7901 cells (SGC7901/VCR) cell line Up 1.5 20625496 3191 VINC_HUMAN ENSP00000211998 Gastric Cancer Treatment (none vs. drug-resistant) gastric cancer SGC7901 cells drug-resistant SGC7901 cells (SGC7901/VCR) cell line Up 1.5 20625496 3192 HCD2_HUMAN ENSP00000168216 Gastric Cancer Treatment (none vs. drug-resistant) gastric cancer SGC7901 cells drug-resistant SGC7901 cells (SGC7901/VCR) cell line Up 1.5 20625496 3193 UBA1_HUMAN ENSP00000338413 Gastric Cancer Treatment (none vs. drug-resistant) gastric cancer SGC7901 cells drug-resistant SGC7901 cells (SGC7901/VCR) cell line Up 1.5 20625496 3194 DDX3X_HUMAN ENSP00000382840 Gastric Cancer Treatment (none vs. drug-resistant) gastric cancer SGC7901 cells drug-resistant SGC7901 cells (SGC7901/VCR) cell line Up 1.6 20625496 3195 ECHB_HUMAN ENSP00000325136 Gastric Cancer Treatment (none vs. drug-resistant) gastric cancer SGC7901 cells drug-resistant SGC7901 cells (SGC7901/VCR) cell line Up 1.6 20625496 3196 ASSY_HUMAN ENSP00000361470 Gastric Cancer Treatment (none vs. drug-resistant) gastric cancer SGC7901 cells drug-resistant SGC7901 cells (SGC7901/VCR) cell line Up 1.7 20625496 3197 TBA1C_HUMAN ENSP00000301072 Gastric Cancer Treatment (none vs. drug-resistant) gastric cancer SGC7901 cells drug-resistant SGC7901 cells (SGC7901/VCR) cell line Up 1.8 20625496 3198 IPYR_HUMAN ENSP00000362329 Gastric Cancer Treatment (none vs. drug-resistant) gastric cancer SGC7901 cells drug-resistant SGC7901 cells (SGC7901/VCR) cell line Up 2 20625496 3199 HSPB1_HUMAN ENSP00000248553 Gastric Cancer Treatment (none vs. drug-resistant) gastric cancer SGC7901 cells drug-resistant SGC7901 cells (SGC7901/VCR) cell line Up 2.7 20625496 3200 MDR1_HUMAN ENSP00000265724 Gastric Cancer Treatment (none vs. drug-resistant) gastric cancer SGC7901 cells drug-resistant SGC7901 cells (SGC7901/VCR) cell line Up 4.4 20625496 3201 PEBP1_HUMAN ENSP00000261313 Gastric Cancer Normal vs. Cancer the adjacent noncancerous gastric samples cancerous gastric samples tissue Down 20677338 3202 HSPB1_HUMAN ENSP00000248553 Gastric Cancer Normal vs. Cancer the adjacent noncancerous gastric samples cancerous gastric samples tissue Up 20677338 3203 RSSA_HUMAN ENSP00000346067 Gastric Cancer Normal vs. Cancer the adjacent noncancerous gastric samples cancerous gastric samples tissue Up 20677338 3204 PCNA_HUMAN ENSP00000368458 Gastric Cancer Normal vs. Cancer the adjacent noncancerous gastric samples cancerous gastric samples tissue Up 20677338 3205 NDKA_HUMAN ENSP00000013034 Gastric Cancer Normal vs. Cancer the adjacent noncancerous gastric samples cancerous gastric samples tissue Up 20677338 3206 CCL2_HUMAN ENSP00000225831 Gastric Cancer Normal vs. Cancer the normal gastric epithelium HFE145 MKN7 well-differentiated gastric cancer cell lines cell line Down 0.02 20812763 3207 PAI1_HUMAN ENSP00000223095 Gastric Cancer Normal vs. Cancer the normal gastric epithelium HFE145 MKN7 well-differentiated gastric cancer cell lines cell line Down 0.08 20812763 3208 TAGL_HUMAN ENSP00000278968 Gastric Cancer Normal vs. Cancer the normal gastric epithelium HFE145 MKN7 well-differentiated gastric cancer cell lines cell line Down 0.08 20812763 3209 CO1A1_HUMAN ENSP00000225964 Gastric Cancer Normal vs. Cancer the normal gastric epithelium HFE145 MKN7 well-differentiated gastric cancer cell lines cell line Down 0.09 20812763 3210 VIME_HUMAN ENSP00000224237 Gastric Cancer Normal vs. Cancer the normal gastric epithelium HFE145 MKN7 well-differentiated gastric cancer cell lines cell line Down 0.09 20812763 3211 C1R_HUMAN ENSP00000290575 Gastric Cancer Normal vs. Cancer the normal gastric epithelium HFE145 MKN7 well-differentiated gastric cancer cell lines cell line Down 0.1 20812763 3212 CO1A2_HUMAN ENSP00000297268 Gastric Cancer Normal vs. Cancer the normal gastric epithelium HFE145 MKN7 well-differentiated gastric cancer cell lines cell line Down 0.1 20812763 3213 PGS2_HUMAN ENSP00000376862 Gastric Cancer Normal vs. Cancer the normal gastric epithelium HFE145 MKN7 well-differentiated gastric cancer cell lines cell line Down 0.11 20812763 3214 MMP2_HUMAN ENSP00000219070 Gastric Cancer Normal vs. Cancer the normal gastric epithelium HFE145 MKN7 well-differentiated gastric cancer cell lines cell line Down 0.11 20812763 3215 PYGB_HUMAN ENSP00000216962 Gastric Cancer Normal vs. Cancer the normal gastric epithelium HFE145 MKN7 well-differentiated gastric cancer cell lines cell line Up 1.5 20812763 3216 K1C18_HUMAN ENSP00000373489 Gastric Cancer Normal vs. Cancer the normal gastric epithelium HFE145 MKN7 well-differentiated gastric cancer cell lines cell line Up 3.1 20812763 3217 ITA6_HUMAN ENSP00000341078 Gastric Cancer Normal vs. Cancer the normal gastric epithelium HFE145 MKN7 well-differentiated gastric cancer cell lines cell line Up 3.4 20812763 3218 K2C8_HUMAN ENSP00000293308 Gastric Cancer Normal vs. Cancer the normal gastric epithelium HFE145 MKN7 well-differentiated gastric cancer cell lines cell line Up 4.1 20812763 3219 1433S_HUMAN ENSP00000340989 Gastric Cancer Normal vs. Cancer the normal gastric epithelium HFE145 MKN7 well-differentiated gastric cancer cell lines cell line Up 6.3 20812763 3220 SPB5_HUMAN ENSP00000372221 Gastric Cancer Normal vs. Cancer the normal gastric epithelium HFE145 MKN7 well-differentiated gastric cancer cell lines cell line Up 6.9 20812763 3221 TAGL_HUMAN ENSP00000278968 Gastric Cancer Normal vs. Cancer the normal gastric epithelium HFE145 MKN45 poorly differentiated gastric cancer cell lines cell line Down 0.02 20812763 3222 VIME_HUMAN ENSP00000224237 Gastric Cancer Normal vs. Cancer the normal gastric epithelium HFE145 MKN45 poorly differentiated gastric cancer cell lines cell line Down 0.03 20812763 3223 MMP2_HUMAN ENSP00000219070 Gastric Cancer Normal vs. Cancer the normal gastric epithelium HFE145 MKN45 poorly differentiated gastric cancer cell lines cell line Down 0.04 20812763 3224 CO1A1_HUMAN ENSP00000225964 Gastric Cancer Normal vs. Cancer the normal gastric epithelium HFE145 MKN45 poorly differentiated gastric cancer cell lines cell line Down 0.05 20812763 3225 PAI1_HUMAN ENSP00000223095 Gastric Cancer Normal vs. Cancer the normal gastric epithelium HFE145 MKN45 poorly differentiated gastric cancer cell lines cell line Down 0.05 20812763 3226 CO1A2_HUMAN ENSP00000297268 Gastric Cancer Normal vs. Cancer the normal gastric epithelium HFE145 MKN45 poorly differentiated gastric cancer cell lines cell line Down 0.05 20812763 3227 C1R_HUMAN ENSP00000290575 Gastric Cancer Normal vs. Cancer the normal gastric epithelium HFE145 MKN45 poorly differentiated gastric cancer cell lines cell line Down 0.06 20812763 3228 PGS2_HUMAN ENSP00000376862 Gastric Cancer Normal vs. Cancer the normal gastric epithelium HFE145 MKN45 poorly differentiated gastric cancer cell lines cell line Down 0.07 20812763 3229 CCL2_HUMAN ENSP00000225831 Gastric Cancer Normal vs. Cancer the normal gastric epithelium HFE145 MKN45 poorly differentiated gastric cancer cell lines cell line Down 0.08 20812763 3230 PYGB_HUMAN ENSP00000216962 Gastric Cancer Normal vs. Cancer the normal gastric epithelium HFE145 MKN45 poorly differentiated gastric cancer cell lines cell line Up 3.8 20812763 3231 1433S_HUMAN ENSP00000340989 Gastric Cancer Normal vs. Cancer the normal gastric epithelium HFE145 MKN45 poorly differentiated gastric cancer cell lines cell line Up 3.9 20812763 3232 SPB5_HUMAN ENSP00000372221 Gastric Cancer Normal vs. Cancer the normal gastric epithelium HFE145 MKN45 poorly differentiated gastric cancer cell lines cell line Up 4.9 20812763 3233 ITA6_HUMAN ENSP00000341078 Gastric Cancer Normal vs. Cancer the normal gastric epithelium HFE145 MKN45 poorly differentiated gastric cancer cell lines cell line Up 5.3 20812763 3234 K1C18_HUMAN ENSP00000373489 Gastric Cancer Normal vs. Cancer the normal gastric epithelium HFE145 MKN45 poorly differentiated gastric cancer cell lines cell line Up 7.7 20812763 3235 K2C8_HUMAN ENSP00000293308 Gastric Cancer Normal vs. Cancer the normal gastric epithelium HFE145 MKN45 poorly differentiated gastric cancer cell lines cell line Up 12 20812763 3236 TTHY_HUMAN ENSP00000237014 Breast Cancer Metastasis tissues from breast cancer without Leptomeningeal metastasis (LM) CSF(cerebrospinal fluid) samples of breast cancer with Leptomeningeal metastasis (LM) tissue Down 17274072 3237 LASP1_HUMAN ENSP00000325240 Biliary Tract Cancer Metastasis cell lines with low metastatic potential(GBC-SD18L) cell lines with high metastatic potential(GBC-SD18H) cell line Down 0.18 19299076 3238 LMNA_HUMAN ENSP00000357283 Biliary Tract Cancer Metastasis cell lines with low metastatic potential(GBC-SD18L) cell lines with high metastatic potential(GBC-SD18H) cell line Down 0.29 19299076 3239 EFTU_HUMAN ENSP00000322439 Biliary Tract Cancer Metastasis cell lines with low metastatic potential(GBC-SD18L) cell lines with high metastatic potential(GBC-SD18H) cell line Down 0.32 19299076 3240 TAGL2_HUMAN ENSP00000357075 Biliary Tract Cancer Metastasis cell lines with low metastatic potential(GBC-SD18L) cell lines with high metastatic potential(GBC-SD18H) cell line Down 0.33 19299076 3241 PA2G4_HUMAN ENSP00000302886 Biliary Tract Cancer Metastasis cell lines with low metastatic potential(GBC-SD18L) cell lines with high metastatic potential(GBC-SD18H) cell line Down 0.33 19299076 3242 GDIB_HUMAN ENSP00000369538 Biliary Tract Cancer Metastasis cell lines with low metastatic potential(GBC-SD18L) cell lines with high metastatic potential(GBC-SD18H) cell line Up 3 19299076 3243 FUBP1_HUMAN ENSP00000359804 Biliary Tract Cancer Metastasis cell lines with low metastatic potential(GBC-SD18L) cell lines with high metastatic potential(GBC-SD18H) cell line Up 3.1 19299076 3244 GDIR1_HUMAN ENSP00000269321 Biliary Tract Cancer Metastasis cell lines with low metastatic potential(GBC-SD18L) cell lines with high metastatic potential(GBC-SD18H) cell line Up 3.5 19299076 3245 HNRPK_HUMAN ENSP00000365440 Biliary Tract Cancer Metastasis cell lines with low metastatic potential(GBC-SD18L) cell lines with high metastatic potential(GBC-SD18H) cell line Up 3.6 19299076 3246 EZRI_HUMAN ENSP00000356042 Biliary Tract Cancer Metastasis cell lines with low metastatic potential(GBC-SD18L) cell lines with high metastatic potential(GBC-SD18H) cell line Up 3.7 19299076 3247 VIME_HUMAN ENSP00000224237 Biliary Tract Cancer Metastasis cell lines with low metastatic potential(GBC-SD18L) cell lines with high metastatic potential(GBC-SD18H) cell line Up 3.8 19299076 3248 TPIS_HUMAN ENSP00000379933 Biliary Tract Cancer Metastasis cell lines with low metastatic potential(GBC-SD18L) cell lines with high metastatic potential(GBC-SD18H) cell line Up 3.8 19299076 3249 CLIC1_HUMAN ENSP00000379229 Biliary Tract Cancer Metastasis cell lines with low metastatic potential(GBC-SD18L) cell lines with high metastatic potential(GBC-SD18H) cell line Up 4.7 19299076 3250 CNN1_HUMAN ENSP00000252456 Esophageal Cancer Normal vs. Cancer the adjacent normal tissue tissues from esophageal cancer tissue Down 0.29 16400690 3251 ANXA6_HUMAN ENSP00000346550 Esophageal Cancer Normal vs. Cancer the adjacent normal tissue tissues from esophageal cancer tissue Down 0.31 16400690 3252 CNN1_HUMAN ENSP00000252456 Esophageal Cancer Normal vs. Cancer the adjacent normal tissue tissues from esophageal cancer tissue Down 0.35 16400690 3253 HSP7C_HUMAN ENSP00000227378 Esophageal Cancer Normal vs. Cancer the adjacent normal tissue tissues from esophageal cancer tissue Down 0.4 16400690 3254 A1AT_HUMAN ENSP00000348068 Esophageal Cancer Normal vs. Cancer the adjacent normal tissue tissues from esophageal cancer tissue Down 0.43 16400690 3255 DESM_HUMAN ENSP00000363071 Esophageal Cancer Normal vs. Cancer the adjacent normal tissue tissues from esophageal cancer tissue Down 0.47 16400690 3256 ANXA1_HUMAN ENSP00000366109 Esophageal Cancer Normal vs. Cancer the adjacent normal tissue tissues from esophageal cancer tissue Down 0.5 16400690 3257 CALR_HUMAN ENSP00000320866 Esophageal Cancer Normal vs. Cancer the adjacent normal tissue tissues from esophageal cancer tissue Up 2.4 16400690 3258 ENOA_HUMAN ENSP00000234590 Esophageal Cancer Normal vs. Cancer the adjacent normal tissue tissues from esophageal cancer tissue Up 2.4 16400690 3259 G3P_HUMAN ENSP00000380068 Esophageal Cancer Normal vs. Cancer Mas-8D, mammary serine protease inhibitor (maspin)-transfected cells EC109, maspin-null esophageal cancer cell line cell line Down 0.27 19090015 3260 TPIS_HUMAN ENSP00000379933 Esophageal Cancer Normal vs. Cancer Mas-8D, mammary serine protease inhibitor (maspin)-transfected cells EC109, maspin-null esophageal cancer cell line cell line Down 0.28 19090015 3261 ENOA_HUMAN ENSP00000234590 Esophageal Cancer Normal vs. Cancer Mas-8D, mammary serine protease inhibitor (maspin)-transfected cells EC109, maspin-null esophageal cancer cell line cell line Down 0.31 19090015 3262 PARK7_HUMAN ENSP00000366708 Esophageal Cancer Normal vs. Cancer Mas-8D, mammary serine protease inhibitor (maspin)-transfected cells EC109, maspin-null esophageal cancer cell line cell line Down 0.32 19090015 3263 STMN1_HUMAN ENSP00000382633 Esophageal Cancer Normal vs. Cancer Mas-8D, mammary serine protease inhibitor (maspin)-transfected cells EC109, maspin-null esophageal cancer cell line cell line Down 0.45 19090015 3264 SODM_HUMAN ENSP00000337127 Esophageal Cancer Normal vs. Cancer Mas-8D, mammary serine protease inhibitor (maspin)-transfected cells EC109, maspin-null esophageal cancer cell line cell line Up 2.4 19090015 3265 G3P_HUMAN ENSP00000380068 Esophageal Cancer Normal vs. Cancer Mas-8D, mammary serine protease inhibitor (maspin)-transfected cells 109-Neo, empty vector transfected EC109 cells cell line Down 0.29 19090015 3266 ENOA_HUMAN ENSP00000234590 Esophageal Cancer Normal vs. Cancer Mas-8D, mammary serine protease inhibitor (maspin)-transfected cells 109-Neo, empty vector transfected EC109 cells cell line Down 0.32 19090015 3267 TPIS_HUMAN ENSP00000379933 Esophageal Cancer Normal vs. Cancer Mas-8D, mammary serine protease inhibitor (maspin)-transfected cells 109-Neo, empty vector transfected EC109 cells cell line Down 0.36 19090015 3268 PARK7_HUMAN ENSP00000366708 Esophageal Cancer Normal vs. Cancer Mas-8D, mammary serine protease inhibitor (maspin)-transfected cells 109-Neo, empty vector transfected EC109 cells cell line Down 0.39 19090015 3269 STMN1_HUMAN ENSP00000382633 Esophageal Cancer Normal vs. Cancer Mas-8D, mammary serine protease inhibitor (maspin)-transfected cells 109-Neo, empty vector transfected EC109 cells cell line Down 0.48 19090015 3270 SODM_HUMAN ENSP00000337127 Esophageal Cancer Normal vs. Cancer Mas-8D, mammary serine protease inhibitor (maspin)-transfected cells 109-Neo, empty vector transfected EC109 cells cell line Up 2.2 19090015 3271 K1C14_HUMAN ENSP00000167586 Uterine Cancer Treatment(none vs. transfected with the pOP13 vector that containing E7) The HPV negative cervical cancer cell line, C33A(C33A/mock control cells) The HPV negative cervical cancer cell line(C33A) transfected with the pOP13 vector that containing E7(C33A/E7 transfectants) cell line Down 14997504 3272 GSTP1_HUMAN ENSP00000381607 Uterine Cancer Treatment(none vs. transfected with the pOP13 vector that containing E7) The HPV negative cervical cancer cell line, C33A(C33A/mock control cells) The HPV negative cervical cancer cell line(C33A) transfected with the pOP13 vector that containing E7(C33A/E7 transfectants) cell line Down 14997504 3273 VAV_HUMAN ENSP00000302269 Uterine Cancer Treatment(none vs. transfected with the pOP13 vector that containing E7) The HPV negative cervical cancer cell line, C33A(C33A/mock control cells) The HPV negative cervical cancer cell line(C33A) transfected with the pOP13 vector that containing E7(C33A/E7 transfectants) cell line Down 14997504 3274 AMPH_HUMAN ENSP00000348602 Uterine Cancer Treatment(none vs. transfected with the pOP13 vector that containing E7) The HPV negative cervical cancer cell line, C33A(C33A/mock control cells) The HPV negative cervical cancer cell line(C33A) transfected with the pOP13 vector that containing E7(C33A/E7 transfectants) cell line Down 14997504 3275 ACTB_HUMAN ENSP00000349960 Uterine Cancer Treatment(none vs. transfected with the pOP13 vector that containing E7) The HPV negative cervical cancer cell line, C33A(C33A/mock control cells) The HPV negative cervical cancer cell line(C33A) transfected with the pOP13 vector that containing E7(C33A/E7 transfectants) cell line Down 14997504 3276 SNF5_HUMAN ENSP00000263121 Uterine Cancer Treatment(none vs. transfected with the pOP13 vector that containing E7) The HPV negative cervical cancer cell line, C33A(C33A/mock control cells) The HPV negative cervical cancer cell line(C33A) transfected with the pOP13 vector that containing E7(C33A/E7 transfectants) cell line Down 14997504 3277 RIR2B_HUMAN ENSP00000251810 Uterine Cancer Treatment(none vs. transfected with the pOP13 vector that containing E7) The HPV negative cervical cancer cell line, C33A(C33A/mock control cells) The HPV negative cervical cancer cell line(C33A) transfected with the pOP13 vector that containing E7(C33A/E7 transfectants) cell line Down 14997504 3278 ENOA_HUMAN ENSP00000234590 Uterine Cancer Treatment(none vs. transfected with the pOP13 vector that containing E7) The HPV negative cervical cancer cell line, C33A(C33A/mock control cells) The HPV negative cervical cancer cell line(C33A) transfected with the pOP13 vector that containing E7(C33A/E7 transfectants) cell line Up 14997504 3279 SYCP2_HUMAN ENSP00000360040 Uterine Cancer Treatment(none vs. transfected with the pOP13 vector that containing E7) The HPV negative cervical cancer cell line, C33A(C33A/mock control cells) The HPV negative cervical cancer cell line(C33A) transfected with the pOP13 vector that containing E7(C33A/E7 transfectants) cell line Up 14997504 3280 MYC_HUMAN ENSP00000367207 Uterine Cancer Treatment(none vs. 5-Fluorouracil treatment) cervical carcinoma cells 5-FU–treated cervical carcinoma cells cell line Down 15585135 3281 RASK_HUMAN ENSP00000256078 Uterine Cancer Treatment(none vs. 5-Fluorouracil treatment) cervical carcinoma cells 5-FU–treated cervical carcinoma cells cell line Down 15585135 3282 SRC8_HUMAN ENSP00000301843 Uterine Cancer Treatment(none vs. 5-Fluorouracil treatment) cervical carcinoma cells 5-FU–treated cervical carcinoma cells cell line Down 15585135 3283 MK13_HUMAN ENSP00000211287 Uterine Cancer Treatment(none vs. 5-Fluorouracil treatment) cervical carcinoma cells 5-FU–treated cervical carcinoma cells cell line Up 15585135 3284 TNR6_HUMAN ENSP00000347979 Uterine Cancer Treatment(none vs. 5-Fluorouracil treatment) cervical carcinoma cells 5-FU–treated cervical carcinoma cells cell line Up 15585135 3285 PP2BA_HUMAN ENSP00000378323 Uterine Cancer Treatment(none vs. 5-Fluorouracil treatment) cervical carcinoma cells 5-FU–treated cervical carcinoma cells cell line Up 15585135 3286 CASP8_HUMAN ENSP00000351273 Uterine Cancer Treatment(none vs. 5-Fluorouracil treatment) cervical carcinoma cells 5-FU–treated cervical carcinoma cells cell line Up 15585135 3287 IF4H_HUMAN ENSP00000265753 Uterine Cancer Treatment(none vs. 5-Fluorouracil treatment) cervical carcinoma cells 5-FU–treated cervical carcinoma cells cell line Up 15585135 3288 VIME_HUMAN ENSP00000224237 Gastric Cancer Normal vs. Cancer precancerous, spasmolytic polypeptide EXPressing metaplasia(SPEM) gastric adenocarcinoma tissue Down 0.19 15761955 3289 HSP7C_HUMAN ENSP00000227378 Gastric Cancer Normal vs. Cancer precancerous, spasmolytic polypeptide EXPressing metaplasia(SPEM) gastric adenocarcinoma tissue Down 0.2 15761955 3290 VIME_HUMAN ENSP00000224237 Gastric Cancer Normal vs. Cancer precancerous, spasmolytic polypeptide EXPressing metaplasia(SPEM) gastric adenocarcinoma tissue Down 0.3 15761955 3291 1433Z_HUMAN ENSP00000379288 Gastric Cancer Normal vs. Cancer precancerous, spasmolytic polypeptide EXPressing metaplasia(SPEM) gastric adenocarcinoma tissue Down 0.32 15761955 3292 G3P_HUMAN ENSP00000380068 Gastric Cancer Normal vs. Cancer precancerous, spasmolytic polypeptide EXPressing metaplasia(SPEM) gastric adenocarcinoma tissue Down 0.34 15761955 3293 PLSL_HUMAN ENSP00000315757 Gastric Cancer Normal vs. Cancer precancerous, spasmolytic polypeptide EXPressing metaplasia(SPEM) gastric adenocarcinoma tissue Down 0.36 15761955 3294 GSTP1_HUMAN ENSP00000381607 Gastric Cancer Normal vs. Cancer precancerous, spasmolytic polypeptide EXPressing metaplasia(SPEM) gastric adenocarcinoma tissue Down 0.43 15761955 3295 UBA1_HUMAN ENSP00000338413 Gastric Cancer Normal vs. Cancer precancerous, spasmolytic polypeptide EXPressing metaplasia(SPEM) gastric adenocarcinoma tissue Down 0.43 15761955 3296 TBA1B_HUMAN ENSP00000336799 Gastric Cancer Normal vs. Cancer precancerous, spasmolytic polypeptide EXPressing metaplasia(SPEM) gastric adenocarcinoma tissue Down 0.43 15761955 3297 EF2_HUMAN ENSP00000307940 Gastric Cancer Normal vs. Cancer precancerous, spasmolytic polypeptide EXPressing metaplasia(SPEM) gastric adenocarcinoma tissue Down 0.45 15761955 3298 SPTB2_HUMAN ENSP00000349259 Gastric Cancer Normal vs. Cancer precancerous, spasmolytic polypeptide EXPressing metaplasia(SPEM) gastric adenocarcinoma tissue Down 0.45 15761955 3299 G3P_HUMAN ENSP00000380068 Gastric Cancer Normal vs. Cancer precancerous, spasmolytic polypeptide EXPressing metaplasia(SPEM) gastric adenocarcinoma tissue Down 0.48 15761955 3300 ACTN1_HUMAN ENSP00000193403 Gastric Cancer Normal vs. Cancer precancerous, spasmolytic polypeptide EXPressing metaplasia(SPEM) gastric adenocarcinoma tissue Down 0.48 15761955 3301 ENOA_HUMAN ENSP00000234590 Gastric Cancer Normal vs. Cancer precancerous, spasmolytic polypeptide EXPressing metaplasia(SPEM) gastric adenocarcinoma tissue Down 0.5 15761955 3302 EF2_HUMAN ENSP00000307940 Gastric Cancer Normal vs. Cancer precancerous, spasmolytic polypeptide EXPressing metaplasia(SPEM) gastric adenocarcinoma tissue Down 0.5 15761955 3303 HS90B_HUMAN ENSP00000360609 Gastric Cancer Normal vs. Cancer precancerous, spasmolytic polypeptide EXPressing metaplasia(SPEM) gastric adenocarcinoma tissue Down 0.53 15761955 3304 2AAA_HUMAN ENSP00000324804 Gastric Cancer Normal vs. Cancer precancerous, spasmolytic polypeptide EXPressing metaplasia(SPEM) gastric adenocarcinoma tissue Down 0.53 15761955 3305 ENPL_HUMAN ENSP00000299767 Gastric Cancer Normal vs. Cancer precancerous, spasmolytic polypeptide EXPressing metaplasia(SPEM) gastric adenocarcinoma tissue Down 0.56 15761955 3306 HSP71_HUMAN ENSP00000364801 Gastric Cancer Normal vs. Cancer precancerous, spasmolytic polypeptide EXPressing metaplasia(SPEM) gastric adenocarcinoma tissue Down 0.67 15761955 3307 KC1A_HUMAN ENSP00000367074 Gastric Cancer Normal vs. Cancer precancerous, spasmolytic polypeptide EXPressing metaplasia(SPEM) gastric adenocarcinoma tissue Up 2.8 15761955 3308 TPM2_HUMAN ENSP00000354219 Gastric Cancer Normal vs. Cancer precancerous, spasmolytic polypeptide EXPressing metaplasia(SPEM) gastric adenocarcinoma tissue Up 4.7 15761955 3309 TBB5_HUMAN ENSP00000406811 Gastric Cancer Normal vs. Cancer precancerous, spasmolytic polypeptide EXPressing metaplasia(SPEM) gastric adenocarcinoma tissue Up 8.1 15761955 3310 MPIP2_HUMAN ENSP00000245960 Uterine Cancer Normal vs. Cancer HaCaT cells (immortalized human keratinocyte cell line) cervical cancer tissue samples infected by the high-risk HPV types 16/18 divided into nuclear fractions cell line Down 0.17 15838902 3311 MPIP1_HUMAN ENSP00000303706 Uterine Cancer Normal vs. Cancer HaCaT cells (immortalized human keratinocyte cell line) cervical cancer tissue samples infected by the high-risk HPV types 16/18 divided into nuclear fractions cell line Up 2.2 15838902 3312 CDC37_HUMAN ENSP00000222005 Uterine Cancer Normal vs. Cancer HaCaT cells (immortalized human keratinocyte cell line) cervical cancer tissue samples infected by the high-risk HPV types 16/18 divided into nuclear fractions cell line Up 2.4 15838902 3313 STIP1_HUMAN ENSP00000305958 Uterine Cancer Normal vs. Cancer HaCaT cells (immortalized human keratinocyte cell line) cervical cancer tissue samples infected by the high-risk HPV types 16/18 divided into nuclear fractions cell line Up 2.6 15838902 3314 ZBT17_HUMAN ENSP00000364885 Uterine Cancer Normal vs. Cancer HaCaT cells (immortalized human keratinocyte cell line) cervical cancer tissue samples infected by the high-risk HPV types 16/18 divided into nuclear fractions cell line Up 3.6 15838902 3315 VIME_HUMAN ENSP00000224237 Uterine Cancer Normal vs. Cancer HaCaT cells (immortalized human keratinocyte cell line) cervical cancer tissue samples infected by the high-risk HPV types 16/18 divided into nuclear fractions cell line Up 8.7 15838902 3316 TE2IP_HUMAN ENSP00000300086 Uterine Cancer Normal vs. Cancer HaCaT cells (immortalized human keratinocyte cell line) cervical cancer tissue samples infected by the high-risk HPV types 16/18 divided into nuclear fractions cell line Up 10 15838902 3317 RAN_HUMAN ENSP00000376176 Uterine Cancer Normal vs. Cancer HaCaT cells (immortalized human keratinocyte cell line) cervical cancer tissue samples infected by the high-risk HPV types 16/18 divided into nuclear fractions cell line Up 10 15838902 3318 FGR_HUMAN ENSP00000382126 Uterine Cancer Normal vs. Cancer HaCaT cells (immortalized human keratinocyte cell line) cervical cancer tissue samples infected by the high-risk HPV types 16/18 divided into nuclear fractions cell line Up 11 15838902 3319 FYN_HUMAN ENSP00000357667 Uterine Cancer Normal vs. Cancer HaCaT cells (immortalized human keratinocyte cell line) cervical cancer tissue samples infected by the high-risk HPV types 16/18 divided into nuclear fractions cell line Up 25 15838902 3320 MDM4_HUMAN ENSP00000356151 Uterine Cancer Normal vs. Cancer HaCaT cells (immortalized human keratinocyte cell line) cervical cancer tissue samples infected by the high-risk HPV types 16/18 divided into nuclear fractions cell line Up 110 15838902 3321 NFKB1_HUMAN ENSP00000378297 Uterine Cancer Normal vs. Cancer HaCaT cells (immortalized human keratinocyte cell line) cervical cancer tissue samples infected by the high-risk HPV types 16/18 divided into nuclear fractions cell line Up 170 15838902 3322 MAP4_HUMAN ENSP00000353375 Uterine Cancer Normal vs. Cancer HaCaT cells (immortalized human keratinocyte cell line) cervical cancer tissue samples infected by the high-risk HPV types 16/18 divided into nuclear fractions cell line Up 390 15838902 3323 PCNA_HUMAN ENSP00000368458 Uterine Cancer Normal vs. Cancer HaCaT cells (immortalized human keratinocyte cell line) cervical cancer tissue samples infected by the high-risk HPV types 16/18 divided into nuclear fractions cell line Up 430 15838902 3324 KIF11_HUMAN ENSP00000260731 Uterine Cancer Normal vs. Cancer HaCaT cells (immortalized human keratinocyte cell line) cervical cancer tissue samples infected by the high-risk HPV types 16/18 divided into nuclear fractions cell line Up 11000 15838902 3325 1433S_HUMAN ENSP00000340989 Uterine Cancer Normal vs. Cancer HaCaT cells (immortalized human keratinocyte cell line) cervical cancer tissue samples infected by the high-risk HPV types 16/18 divided into cytoplasmic fractions cell line Down 0.1 15838902 3326 TRAF2_HUMAN ENSP00000247668 Uterine Cancer Normal vs. Cancer HaCaT cells (immortalized human keratinocyte cell line) cervical cancer tissue samples infected by the high-risk HPV types 16/18 divided into cytoplasmic fractions cell line Down 0.22 15838902 3327 HS90A_HUMAN ENSP00000335153 Uterine Cancer Normal vs. Cancer HaCaT cells (immortalized human keratinocyte cell line) cervical cancer tissue samples infected by the high-risk HPV types 16/18 divided into cytoplasmic fractions cell line Up 1.6 15838902 3328 MPIP2_HUMAN ENSP00000245960 Uterine Cancer Normal vs. Cancer HaCaT cells (immortalized human keratinocyte cell line) cervical cancer tissue samples infected by the high-risk HPV types 16/18 divided into cytoplasmic fractions cell line Up 2.1 15838902 3329 M3K8_HUMAN ENSP00000263056 Uterine Cancer Normal vs. Cancer HaCaT cells (immortalized human keratinocyte cell line) cervical cancer tissue samples infected by the high-risk HPV types 16/18 divided into cytoplasmic fractions cell line Up 6.2 15838902 3330 LYN_HUMAN ENSP00000428924 Uterine Cancer Normal vs. Cancer HaCaT cells (immortalized human keratinocyte cell line) cervical cancer tissue samples infected by the high-risk HPV types 16/18 divided into cytoplasmic fractions cell line Up 220 15838902 3331 MMP7_HUMAN ENSP00000260227 Uterine Cancer Normal vs. Cancer HaCaT cells (immortalized human keratinocyte cell line) cervical cancer tissue samples infected by the high-risk HPV types 16/18 divided into cytoplasmic fractions cell line Up 1900 15838902 3332 TR13B_HUMAN ENSP00000261652 Uterine Cancer Normal vs. Cancer tissue biopsies from non-tumor cervix tissues tissue biopsies from squamous cell carcinoma(SCC) tissues tissue Down 16051329 3333 APOA1_HUMAN ENSP00000236850 Uterine Cancer Normal vs. Cancer tissue biopsies from non-tumor cervix tissues tissue biopsies from squamous cell carcinoma(SCC) tissues tissue Down 16051329 3334 ANXA1_HUMAN ENSP00000366109 Uterine Cancer Normal vs. Cancer tissue biopsies from non-tumor cervix tissues tissue biopsies from squamous cell carcinoma(SCC) tissues tissue Down 16051329 3335 ENOA_HUMAN ENSP00000234590 Uterine Cancer Normal vs. Cancer tissue biopsies from non-tumor cervix tissues tissue biopsies from squamous cell carcinoma(SCC) tissues tissue Down 16051329 3336 TPM2_HUMAN ENSP00000354219 Uterine Cancer Normal vs. Cancer tissue biopsies from non-tumor cervix tissues tissue biopsies from squamous cell carcinoma(SCC) tissues tissue Down 16051329 3337 VIME_HUMAN ENSP00000224237 Uterine Cancer Normal vs. Cancer tissue biopsies from non-tumor cervix tissues tissue biopsies from squamous cell carcinoma(SCC) tissues tissue Down 16051329 3338 AK1C4_HUMAN ENSP00000263126 Uterine Cancer Normal vs. Cancer tissue biopsies from non-tumor cervix tissues tissue biopsies from squamous cell carcinoma(SCC) tissues tissue Down 16051329 3339 MYL9_HUMAN ENSP00000279022 Uterine Cancer Normal vs. Cancer tissue biopsies from non-tumor cervix tissues tissue biopsies from squamous cell carcinoma(SCC) tissues tissue Down 16051329 3340 1433E_HUMAN ENSP00000264335 Uterine Cancer Normal vs. Cancer tissue biopsies from non-tumor cervix tissues tissue biopsies from squamous cell carcinoma(SCC) tissues tissue Down 16051329 3341 SHPS1_HUMAN ENSP00000351621 Uterine Cancer Normal vs. Cancer tissue biopsies from non-tumor cervix tissues tissue biopsies from squamous cell carcinoma(SCC) tissues tissue Down 16051329 3342 HSPB1_HUMAN ENSP00000248553 Uterine Cancer Normal vs. Cancer tissue biopsies from non-tumor cervix tissues tissue biopsies from squamous cell carcinoma(SCC) tissues tissue Up 16051329 3343 ANXA2_HUMAN ENSP00000411352 Uterine Cancer Normal vs. Cancer tissue biopsies from non-tumor cervix tissues tissue biopsies from squamous cell carcinoma(SCC) tissues tissue Up 16051329 3344 K1C16_HUMAN ENSP00000301653 Uterine Cancer Normal vs. Cancer tissue biopsies from non-tumor cervix tissues tissue biopsies from squamous cell carcinoma(SCC) tissues tissue Up 16051329 3345 GSTP1_HUMAN ENSP00000381607 Uterine Cancer Normal vs. Cancer tissue biopsies from non-tumor cervix tissues tissue biopsies from squamous cell carcinoma(SCC) tissues tissue Up 16051329 3346 PIPNA_HUMAN ENSP00000316809 Uterine Cancer Normal vs. Cancer tissue biopsies from non-tumor cervix tissues tissue biopsies from squamous cell carcinoma(SCC) tissues tissue Up 16051329 3347 DBNL_HUMAN ENSP00000411701 Uterine Cancer Normal vs. Cancer tissue biopsies from non-tumor cervix tissues tissue biopsies from squamous cell carcinoma(SCC) tissues tissue Up 16051329 3348 ENOA_HUMAN ENSP00000234590 Uterine Cancer Cancer vs. Cancer cervical cancer Caski cells HPV16-positive cervical mucosa epithelial H8 cells cell line Down 17616526 3349 COF1_HUMAN ENSP00000309629 Uterine Cancer Cancer vs. Cancer cervical cancer Caski cells HPV16-positive cervical mucosa epithelial H8 cells cell line Down 17616526 3350 COF2_HUMAN ENSP00000298159 Uterine Cancer Cancer vs. Cancer cervical cancer Caski cells HPV16-positive cervical mucosa epithelial H8 cells cell line Down 17616526 3351 APOA1_HUMAN ENSP00000236850 Uterine Cancer Cancer vs. Cancer cervical cancer Caski cells HPV16-positive cervical mucosa epithelial H8 cells cell line Up 17616526 3352 G3P_HUMAN ENSP00000380068 Uterine Cancer Cancer vs. Cancer cervical cancer Caski cells HPV16-positive cervical mucosa epithelial H8 cells cell line Up 17616526 3353 G3P_HUMAN ENSP00000380068 Uterine Cancer Cancer vs. Cancer cervical cancer Caski cells HPV16-positive cervical mucosa epithelial H8 cells cell line Up 17616526 3354 HSPB1_HUMAN ENSP00000248553 Uterine Cancer Cancer vs. Cancer cervical cancer Caski cells HPV16-positive cervical mucosa epithelial H8 cells cell line Up 17616526 3355 RLA2_HUMAN ENSP00000322419 Uterine Cancer Cancer vs. Cancer cervical cancer Caski cells HPV16-positive cervical mucosa epithelial H8 cells cell line Up 17616526 3356 IPYR_HUMAN ENSP00000362329 Uterine Cancer Cancer vs. Cancer cervical cancer Caski cells HPV16-positive cervical mucosa epithelial H8 cells cell line Up 17616526 3357 ROCK1_HUMAN ENSP00000382697 Uterine Cancer Normal vs. Cancer the matching adjacent normal cervical tissues tissues from human squamous cervical cancer tissue Down 0.098 19007971 3358 VIME_HUMAN ENSP00000224237 Uterine Cancer Normal vs. Cancer the matching adjacent normal cervical tissues tissues from human squamous cervical cancer tissue Down 0.1 19007971 3359 ALBU_HUMAN ENSP00000295897 Uterine Cancer Normal vs. Cancer the matching adjacent normal cervical tissues tissues from human squamous cervical cancer tissue Up 8.8 19007971 3360 TYK2_HUMAN ENSP00000264818 Uterine Cancer Normal vs. Cancer the matching adjacent normal cervical tissues tissues from human squamous cervical cancer tissue Up 19007971 3361 PGAM1_HUMAN ENSP00000359991 Uterine Cancer Treatment (none vs. Suberonylanilide hydroxamic acid (SAHA) treatment) the human cervical cancer cell line HeLa the human cervical cancer cell line HeLa following SAHA treatment cell line Down 0.2 19179759 3362 HSPB1_HUMAN ENSP00000248553 Uterine Cancer Treatment (none vs. Suberonylanilide hydroxamic acid (SAHA) treatment) the human cervical cancer cell line HeLa the human cervical cancer cell line HeLa following SAHA treatment cell line Down 19179759 3363 SODM_HUMAN ENSP00000337127 Uterine Cancer Treatment (none vs. Suberonylanilide hydroxamic acid (SAHA) treatment) the human cervical cancer cell line HeLa the human cervical cancer cell line HeLa following SAHA treatment cell line Up 19179759 3364 TEBP_HUMAN ENSP00000262033 Uterine Cancer Treatment (none vs. Suberonylanilide hydroxamic acid (SAHA) treatment) the human cervical cancer cell line HeLa the human cervical cancer cell line HeLa following SAHA treatment cell line Up 19179759 3365 ANT3_HUMAN ENSP00000356671 Uterine Cancer Normal vs. Cancer Plasma samples from patients with benign gynecological disease Plasma samples from patients with cervical cancer tissue Down 19471570 3366 CO3_HUMAN ENSP00000245907 Uterine Cancer Normal vs. Cancer Plasma samples from patients with benign gynecological disease Plasma samples from patients with cervical cancer tissue Up 19471570 3367 LMNB1_HUMAN ENSP00000261366 Uterine Cancer Treatment (Concurrent chemoradiotherapy-lowly vs. Concurrent chemoradiotherapy-highly sensitive) tissues from CCRT-lowly sensitive (CCRT-LS) group tissues from CCRT-highly sensitive (CCRT-HS) group tissue Down 19507834 3368 SYWC_HUMAN ENSP00000347495 Uterine Cancer Treatment (Concurrent chemoradiotherapy-lowly vs. Concurrent chemoradiotherapy-highly sensitive) tissues from CCRT-lowly sensitive (CCRT-LS) group tissues from CCRT-highly sensitive (CCRT-HS) group tissue Down 19507834 3369 ACTB_HUMAN ENSP00000349960 Uterine Cancer Treatment (Concurrent chemoradiotherapy-lowly vs. Concurrent chemoradiotherapy-highly sensitive) tissues from CCRT-lowly sensitive (CCRT-LS) group tissues from CCRT-highly sensitive (CCRT-HS) group tissue Up 19507834 3370 HBB_HUMAN ENSP00000333994 Uterine Cancer Treatment (Concurrent chemoradiotherapy-lowly vs. Concurrent chemoradiotherapy-highly sensitive) tissues from CCRT-lowly sensitive (CCRT-LS) group tissues from CCRT-highly sensitive (CCRT-HS) group tissue Up 19507834 3371 CALL5_HUMAN ENSP00000369689 Uterine Cancer Treatment (Concurrent chemoradiotherapy-lowly vs. Concurrent chemoradiotherapy-highly sensitive) tissues from CCRT-lowly sensitive (CCRT-LS) group tissues from CCRT-highly sensitive (CCRT-HS) group tissue Up 19507834 3372 G3P_HUMAN ENSP00000380068 Uterine Cancer Treatment(21% oxygen vs. 1% oxygen (mild hypoxia) supplemented ) The human uterine cervix squamous cell carcinoma (SiHa) cell line supplement with 21% oxygen) The human uterine cervix squamous cell carcinoma (SiHa) cell line supplement with 1% oxygen) cell line Up 19541378 3373 ENOA_HUMAN ENSP00000234590 Uterine Cancer Treatment(21% oxygen vs. 1% oxygen (mild hypoxia) supplemented ) The human uterine cervix squamous cell carcinoma (SiHa) cell line supplement with 21% oxygen) The human uterine cervix squamous cell carcinoma (SiHa) cell line supplement with 1% oxygen) cell line Up 19541378 3374 HSP7C_HUMAN ENSP00000227378 Uterine Cancer Treatment(21% oxygen vs. 1% oxygen (mild hypoxia) supplemented ) The human uterine cervix squamous cell carcinoma (SiHa) cell line supplement with 21% oxygen) The human uterine cervix squamous cell carcinoma (SiHa) cell line supplement with 1% oxygen) cell line Up 19541378 3375 KPYM_HUMAN ENSP00000334983 Uterine Cancer Treatment(21% oxygen vs. 1% oxygen (mild hypoxia) supplemented ) The human uterine cervix squamous cell carcinoma (SiHa) cell line supplement with 21% oxygen) The human uterine cervix squamous cell carcinoma (SiHa) cell line supplement with 1% oxygen) cell line Up 19541378 3376 PRDX1_HUMAN ENSP00000262746 Uterine Cancer Treatment(21% oxygen vs. 1% oxygen (mild hypoxia) supplemented ) The human uterine cervix squamous cell carcinoma (SiHa) cell line supplement with 21% oxygen) The human uterine cervix squamous cell carcinoma (SiHa) cell line supplement with 1% oxygen) cell line Up 19541378 3377 G3P_HUMAN ENSP00000380068 Uterine Cancer Treatment(21% oxygen vs. 0% oxygen (mild hypoxia) supplemented ) The human uterine cervix squamous cell carcinoma (SiHa) cell line supplement with 21% oxygen) The human uterine cervix squamous cell carcinoma (SiHa) cell line supplement with 0% oxygen) cell line Up 19541378 3378 ENOA_HUMAN ENSP00000234590 Uterine Cancer Treatment(21% oxygen vs. 0% oxygen (mild hypoxia) supplemented ) The human uterine cervix squamous cell carcinoma (SiHa) cell line supplement with 21% oxygen) The human uterine cervix squamous cell carcinoma (SiHa) cell line supplement with 0% oxygen) cell line Up 19541378 3379 HSP7C_HUMAN ENSP00000227378 Uterine Cancer Treatment(21% oxygen vs. 0% oxygen (mild hypoxia) supplemented ) The human uterine cervix squamous cell carcinoma (SiHa) cell line supplement with 21% oxygen) The human uterine cervix squamous cell carcinoma (SiHa) cell line supplement with 0% oxygen) cell line Up 19541378 3380 KPYM_HUMAN ENSP00000334983 Uterine Cancer Treatment(21% oxygen vs. 0% oxygen (mild hypoxia) supplemented ) The human uterine cervix squamous cell carcinoma (SiHa) cell line supplement with 21% oxygen) The human uterine cervix squamous cell carcinoma (SiHa) cell line supplement with 0% oxygen) cell line Up 19541378 3381 PRDX1_HUMAN ENSP00000262746 Uterine Cancer Treatment(21% oxygen vs. 0% oxygen (mild hypoxia) supplemented ) The human uterine cervix squamous cell carcinoma (SiHa) cell line supplement with 21% oxygen) The human uterine cervix squamous cell carcinoma (SiHa) cell line supplement with 0% oxygen) cell line Up 19541378 3382 G3P_HUMAN ENSP00000380068 Head and Neck Cancer Treatment(21% oxygen vs. 1% oxygen (mild hypoxia) supplemented ) FaDuDD(a head and neck squamous cell carcinoma) supplement with 21% oxygen FaDuDD(a head and neck squamous cell carcinoma) supplement with 1% oxygen cell line Up 19541378 3383 ENOA_HUMAN ENSP00000234590 Head and Neck Cancer Treatment(21% oxygen vs. 1% oxygen (mild hypoxia) supplemented ) FaDuDD(a head and neck squamous cell carcinoma) supplement with 21% oxygen FaDuDD(a head and neck squamous cell carcinoma) supplement with 1% oxygen cell line Up 19541378 3384 HSP7C_HUMAN ENSP00000227378 Head and Neck Cancer Treatment(21% oxygen vs. 1% oxygen (mild hypoxia) supplemented ) FaDuDD(a head and neck squamous cell carcinoma) supplement with 21% oxygen FaDuDD(a head and neck squamous cell carcinoma) supplement with 1% oxygen cell line Up 19541378 3385 KPYM_HUMAN ENSP00000334983 Head and Neck Cancer Treatment(21% oxygen vs. 1% oxygen (mild hypoxia) supplemented ) FaDuDD(a head and neck squamous cell carcinoma) supplement with 21% oxygen FaDuDD(a head and neck squamous cell carcinoma) supplement with 1% oxygen cell line Up 19541378 3386 PRDX1_HUMAN ENSP00000262746 Head and Neck Cancer Treatment(21% oxygen vs. 1% oxygen (mild hypoxia) supplemented ) FaDuDD(a head and neck squamous cell carcinoma) supplement with 21% oxygen FaDuDD(a head and neck squamous cell carcinoma) supplement with 1% oxygen cell line Up 19541378 3387 G3P_HUMAN ENSP00000380068 Head and Neck Cancer Treatment(21% oxygen vs 0% oxygen (mild hypoxia) supplemented ) FaDuDD(a head and neck squamous cell carcinoma) supplement with 21% oxygen FaDuDD(a head and neck squamous cell carcinoma) supplement with 0% oxygen cell line Up 19541378 3388 ENOA_HUMAN ENSP00000234590 Head and Neck Cancer Treatment(21% oxygen vs 0% oxygen (mild hypoxia) supplemented ) FaDuDD(a head and neck squamous cell carcinoma) supplement with 21% oxygen FaDuDD(a head and neck squamous cell carcinoma) supplement with 0% oxygen cell line Up 19541378 3389 HSP7C_HUMAN ENSP00000227378 Head and Neck Cancer Treatment(21% oxygen vs 0% oxygen (mild hypoxia) supplemented ) FaDuDD(a head and neck squamous cell carcinoma) supplement with 21% oxygen FaDuDD(a head and neck squamous cell carcinoma) supplement with 0% oxygen cell line Up 19541378 3390 KPYM_HUMAN ENSP00000334983 Head and Neck Cancer Treatment(21% oxygen vs 0% oxygen (mild hypoxia) supplemented ) FaDuDD(a head and neck squamous cell carcinoma) supplement with 21% oxygen FaDuDD(a head and neck squamous cell carcinoma) supplement with 0% oxygen cell line Up 19541378 3391 PRDX1_HUMAN ENSP00000262746 Head and Neck Cancer Treatment(21% oxygen vs 0% oxygen (mild hypoxia) supplemented ) FaDuDD(a head and neck squamous cell carcinoma) supplement with 21% oxygen FaDuDD(a head and neck squamous cell carcinoma) supplement with 0% oxygen cell line Up 19541378 3392 TR13B_HUMAN ENSP00000261652 Uterine Cancer Normal vs. Cancer Normal cervix tissue biopsies the squamous cell carcinoma (SCC) tissue biopsies tissue Down 19771267 3393 APOA1_HUMAN ENSP00000236850 Uterine Cancer Normal vs. Cancer Normal cervix tissue biopsies the squamous cell carcinoma (SCC) tissue biopsies tissue Down 19771267 3394 ANXA1_HUMAN ENSP00000366109 Uterine Cancer Normal vs. Cancer Normal cervix tissue biopsies the squamous cell carcinoma (SCC) tissue biopsies tissue Down 19771267 3395 ENOA_HUMAN ENSP00000234590 Uterine Cancer Normal vs. Cancer Normal cervix tissue biopsies the squamous cell carcinoma (SCC) tissue biopsies tissue Down 19771267 3396 TPM2_HUMAN ENSP00000354219 Uterine Cancer Normal vs. Cancer Normal cervix tissue biopsies the squamous cell carcinoma (SCC) tissue biopsies tissue Down 19771267 3397 VIME_HUMAN ENSP00000224237 Uterine Cancer Normal vs. Cancer Normal cervix tissue biopsies the squamous cell carcinoma (SCC) tissue biopsies tissue Down 19771267 3398 AK1C4_HUMAN ENSP00000263126 Uterine Cancer Normal vs. Cancer Normal cervix tissue biopsies the squamous cell carcinoma (SCC) tissue biopsies tissue Down 19771267 3399 MYL9_HUMAN ENSP00000279022 Uterine Cancer Normal vs. Cancer Normal cervix tissue biopsies the squamous cell carcinoma (SCC) tissue biopsies tissue Down 19771267 3400 1433E_HUMAN ENSP00000264335 Uterine Cancer Normal vs. Cancer Normal cervix tissue biopsies the squamous cell carcinoma (SCC) tissue biopsies tissue Down 19771267 3401 SHPS1_HUMAN ENSP00000351621 Uterine Cancer Normal vs. Cancer Normal cervix tissue biopsies the squamous cell carcinoma (SCC) tissue biopsies tissue Down 19771267 3402 HSPB1_HUMAN ENSP00000248553 Uterine Cancer Normal vs. Cancer Normal cervix tissue biopsies the squamous cell carcinoma (SCC) tissue biopsies tissue Up 19771267 3403 ANXA2_HUMAN ENSP00000411352 Uterine Cancer Normal vs. Cancer Normal cervix tissue biopsies the squamous cell carcinoma (SCC) tissue biopsies tissue Up 19771267 3404 K1C16_HUMAN ENSP00000301653 Uterine Cancer Normal vs. Cancer Normal cervix tissue biopsies the squamous cell carcinoma (SCC) tissue biopsies tissue Up 19771267 3405 GSTP1_HUMAN ENSP00000381607 Uterine Cancer Normal vs. Cancer Normal cervix tissue biopsies the squamous cell carcinoma (SCC) tissue biopsies tissue Up 19771267 3406 PIPNA_HUMAN ENSP00000316809 Uterine Cancer Normal vs. Cancer Normal cervix tissue biopsies the squamous cell carcinoma (SCC) tissue biopsies tissue Up 19771267 3407 DBNL_HUMAN ENSP00000411701 Uterine Cancer Normal vs. Cancer Normal cervix tissue biopsies the squamous cell carcinoma (SCC) tissue biopsies tissue Up 19771267 3408 TNF10_HUMAN ENSP00000241261 Uterine Cancer Treatment (none vs. paclitaxel treatment) HPV-18 positive HeLa cervical carcinoma cells HPV-18 positive HeLa cervical carcinoma cells treated with paclitaxel cell line Up 20368835 3409 G3P_HUMAN ENSP00000380068 Hepatocellular Carcinoma Normal vs. Cancer cirrhotic liver tissues tumorous liver tissues tissue Up 1.7 11866469 3410 HSP7C_HUMAN ENSP00000227378 Hepatocellular Carcinoma Normal vs. Cancer cirrhotic liver tissues tumorous liver tissues tissue Up 2 11866469 3411 LMNB1_HUMAN ENSP00000261366 Hepatocellular Carcinoma Normal vs. Cancer cirrhotic liver tissues tumorous liver tissues tissue Up 2 11866469 3412 TBB5_HUMAN ENSP00000406811 Hepatocellular Carcinoma Normal vs. Cancer cirrhotic liver tissues tumorous liver tissues tissue Up 2 11866469 3413 VIME_HUMAN ENSP00000224237 Hepatocellular Carcinoma Normal vs. Cancer cirrhotic liver tissues tumorous liver tissues tissue Up 2.2 11866469 3414 ENPL_HUMAN ENSP00000299767 Hepatocellular Carcinoma Normal vs. Cancer cirrhotic liver tissues tumorous liver tissues tissue Up 2.6 11866469 3415 HS90A_HUMAN ENSP00000335153 Hepatocellular Carcinoma Normal vs. Cancer cirrhotic liver tissues tumorous liver tissues tissue Up 2.8 11866469 3416 ANXA2_HUMAN ENSP00000411352 Hepatocellular Carcinoma Normal vs. Cancer cirrhotic liver tissues tumorous liver tissues tissue Up 3.3 11866469 3417 NPM_HUMAN ENSP00000296930 Hepatocellular Carcinoma Normal vs. Cancer cirrhotic liver tissues tumorous liver tissues tissue Up 11866469 3418 FIBA_HUMAN ENSP00000306361 Pancreatic Cancer Normal vs. Cancer pooled pancreatic juices from 10 normal controls pancreatic cancerous juice tissue Down 0.2 16739137 3419 CO3_HUMAN ENSP00000245907 Pancreatic Cancer Normal vs. Cancer pooled pancreatic juices from 10 normal controls pancreatic cancerous juice tissue Up 3 16739137 3420 HBB_HUMAN ENSP00000333994 Pancreatic Cancer Normal vs. Cancer pooled pancreatic juices from 10 normal controls pancreatic cancerous juice tissue Up 3.3 16739137 3421 ALBU_HUMAN ENSP00000295897 Pancreatic Cancer Normal vs. Cancer pooled pancreatic juices from 10 normal controls pancreatic cancerous juice tissue Up 3.7 16739137 3422 ALBU_HUMAN ENSP00000295897 pancreatic ductal adenocarcinoma Normal vs. Cancer samples of normal adjacent tissue clinical pancreatic ductal adenocarcinoma (PDAC) tissue samples tissue Down 17492507 3423 G3P_HUMAN ENSP00000380068 pancreatic ductal adenocarcinoma Normal vs. Cancer samples of normal adjacent tissue clinical pancreatic ductal adenocarcinoma (PDAC) tissue samples tissue Down 17492507 3424 STIP1_HUMAN ENSP00000305958 pancreatic ductal adenocarcinoma Normal vs. Cancer samples of normal adjacent tissue clinical pancreatic ductal adenocarcinoma (PDAC) tissue samples tissue Down 17492507 3425 HSPB1_HUMAN ENSP00000248553 pancreatic ductal adenocarcinoma Normal vs. Cancer samples of normal adjacent tissue clinical pancreatic ductal adenocarcinoma (PDAC) tissue samples tissue Up 17492507 3426 ENOA_HUMAN ENSP00000234590 pancreatic ductal adenocarcinoma Normal vs. Cancer samples of normal adjacent tissue clinical pancreatic ductal adenocarcinoma (PDAC) tissue samples tissue Up 17492507 3427 ANXA2_HUMAN ENSP00000411352 pancreatic ductal adenocarcinoma Normal vs. Cancer samples of normal adjacent tissue clinical pancreatic ductal adenocarcinoma (PDAC) tissue samples tissue Up 17492507 3428 TBB5_HUMAN ENSP00000406811 pancreatic ductal adenocarcinoma Normal vs. Cancer samples of normal adjacent tissue clinical pancreatic ductal adenocarcinoma (PDAC) tissue samples tissue Up 17492507 3429 TPM2_HUMAN ENSP00000354219 pancreatic ductal adenocarcinoma Normal vs. Cancer samples of normal adjacent tissue clinical pancreatic ductal adenocarcinoma (PDAC) tissue samples tissue Up 17492507 3430 NDKA_HUMAN ENSP00000013034 pancreatic ductal adenocarcinoma Normal vs. Cancer samples of normal adjacent tissue clinical pancreatic ductal adenocarcinoma (PDAC) tissue samples tissue Up 17492507 3431 1433S_HUMAN ENSP00000340989 pancreatic ductal adenocarcinoma Normal vs. Cancer samples of normal adjacent tissue clinical pancreatic ductal adenocarcinoma (PDAC) tissue samples tissue Up 17492507 3432 TAGL_HUMAN ENSP00000278968 pancreatic ductal adenocarcinoma Normal vs. Cancer samples of normal adjacent tissue clinical pancreatic ductal adenocarcinoma (PDAC) tissue samples tissue Up 17492507 3433 PRDX1_HUMAN ENSP00000262746 pancreatic ductal adenocarcinoma Normal vs. Cancer samples of normal adjacent tissue clinical pancreatic ductal adenocarcinoma (PDAC) tissue samples tissue Up 17492507 3434 PARK7_HUMAN ENSP00000366708 pancreatic ductal adenocarcinoma Normal vs. Cancer samples of normal adjacent tissue clinical pancreatic ductal adenocarcinoma (PDAC) tissue samples tissue Up 17492507 3435 TAGL2_HUMAN ENSP00000357075 Pancreatic Cancer Normal vs. Cancer Pooled sera from controls Pooled sera from patients with early stage pancreatic cancer tissue Up 1.6 19199705 3436 MMP7_HUMAN ENSP00000260227 Pancreatic Cancer Normal vs. Cancer Pooled sera from controls Pooled sera from patients with early stage pancreatic cancer tissue Up 1.6 19199705 3437 PGBM_HUMAN ENSP00000363827 Pancreatic Cancer Normal vs. Cancer Pooled sera from controls Pooled sera from patients with early stage pancreatic cancer tissue Up 1.7 19199705 3438 K1C18_HUMAN ENSP00000373489 Pancreatic Cancer Normal vs. Cancer Pooled sera from controls Pooled sera from patients with early stage pancreatic cancer tissue Up 1.8 19199705 3439 K2C8_HUMAN ENSP00000293308 Pancreatic Cancer Normal vs. Cancer Pooled sera from controls Pooled sera from patients with early stage pancreatic cancer tissue Up 2 19199705 3440 SPB5_HUMAN ENSP00000372221 Pancreatic Cancer Normal vs. Cancer Pooled sera from controls Pooled sera from patients with early stage pancreatic cancer tissue Up 2.4 19199705 3441 BAIP2_HUMAN ENSP00000316338 Pancreatic Cancer Normal vs. Cancer Pooled sera from controls Pooled sera from patients with early stage pancreatic cancer tissue Up 2.4 19199705 3442 ENOA_HUMAN ENSP00000234590 Pancreatic Cancer Normal vs. Cancer Pooled sera from controls Pooled sera from patients with early stage pancreatic cancer tissue Up 2.5 19199705 3443 MYEF2_HUMAN ENSP00000316950 Pancreatic Cancer Normal vs. Cancer Pooled sera from controls Pooled sera from patients with early stage pancreatic cancer tissue Up 2.6 19199705 3444 ACTN1_HUMAN ENSP00000193403 Pancreatic Cancer Normal vs. Cancer Pooled sera from controls Pooled sera from patients with early stage pancreatic cancer tissue Up 2.8 19199705 3445 TPIS_HUMAN ENSP00000379933 Pancreatic Cancer Normal vs. Cancer Pooled sera from controls Pooled sera from patients with early stage pancreatic cancer tissue Up 3 19199705 3446 MOES_HUMAN ENSP00000353408 Pancreatic Cancer Normal vs. Cancer Pooled sera from controls Pooled sera from patients with early stage pancreatic cancer tissue Up 3 19199705 3447 UFO_HUMAN ENSP00000301178 Pancreatic Cancer Normal vs. Cancer Pooled sera from controls Pooled sera from patients with early stage pancreatic cancer tissue Up 3.6 19199705 3448 PGAM1_HUMAN ENSP00000359991 Pancreatic Cancer Normal vs. Cancer Pooled sera from controls Pooled sera from patients with early stage pancreatic cancer tissue Up 4.1 19199705 3449 APLP2_HUMAN ENSP00000263574 Pancreatic Cancer Normal vs. Cancer Pooled sera from controls Pooled sera from patients with early stage pancreatic cancer tissue Up 5.5 19199705 3450 PVRL1_HUMAN ENSP00000264025 Pancreatic Cancer Normal vs. Cancer Pooled sera from controls Pooled sera from patients with early stage pancreatic cancer tissue Up 5.6 19199705 3451 TAL1_HUMAN ENSP00000294339 Pancreatic Cancer Normal vs. Cancer Pooled sera from controls Pooled sera from patients with early stage pancreatic cancer tissue Up 6 19199705 3452 STIP1_HUMAN ENSP00000305958 Pancreatic Cancer Normal vs. Cancer Pooled sera from controls Pooled sera from patients with early stage pancreatic cancer tissue Up 7 19199705 3453 SEM7A_HUMAN ENSP00000261918 Pancreatic Cancer Normal vs. Cancer Pooled sera from controls Pooled sera from patients with early stage pancreatic cancer tissue Up 8.3 19199705 3454 CLIC1_HUMAN ENSP00000379229 Pancreatic Cancer Normal vs. Cancer Pooled sera from controls Pooled sera from patients with early stage pancreatic cancer tissue Up 14 19199705 3455 UBE2N_HUMAN ENSP00000316176 Pancreatic Cancer Normal vs. Cancer Pooled sera from controls Pooled sera from patients with early stage pancreatic cancer tissue Up 18 19199705 3456 GDIR1_HUMAN ENSP00000269321 Pancreatic Cancer Normal vs. Cancer Pooled sera from controls Pooled sera from patients with early stage pancreatic cancer tissue Up 23 19199705 3457 HNRPD_HUMAN ENSP00000313199 Pancreatic Cancer Normal vs. Cancer Pooled sera from controls Pooled sera from patients with early stage pancreatic cancer tissue Up 24 19199705 3458 S10A4_HUMAN ENSP00000357703 Pancreatic Cancer Normal vs. Cancer Pooled sera from controls Pooled sera from patients with early stage pancreatic cancer tissue Up 26 19199705 3459 PEBP1_HUMAN ENSP00000261313 Pancreatic Cancer Normal vs. Cancer Pooled sera from controls Pooled sera from patients with early stage pancreatic cancer tissue Up 56 19199705 3460 MYH9_HUMAN ENSP00000216181 Pancreatic Cancer Normal vs. Cancer Pooled sera from controls Pooled sera from patients with early stage pancreatic cancer tissue Up 63 19199705 3461 UB2L3_HUMAN ENSP00000344259 Pancreatic Cancer Normal vs. Cancer Pooled sera from controls Pooled sera from patients with early stage pancreatic cancer tissue Up 330 19199705 3462 FLNA_HUMAN ENSP00000358866 Pancreatic Cancer Normal vs. Cancer Pooled sera from controls Pooled sera from patients with early stage pancreatic cancer tissue Up 620 19199705 3463 G3P_HUMAN ENSP00000380068 Pancreatic Cancer Normal vs. Cancer paired adjacent noncancerous cancerous pancreatic tissue specimens tissue Up 250 19357035 3464 S10AB_HUMAN ENSP00000271638 Pancreatic Cancer Normal vs. Cancer paired adjacent noncancerous cancerous pancreatic tissue specimens tissue Up 350 19357035 3465 LEG3_HUMAN ENSP00000254301 Pancreatic Cancer Normal vs. Cancer paired adjacent noncancerous cancerous pancreatic tissue specimens tissue Up 420 19357035 3466 ACTG_HUMAN ENSP00000331514 Pancreatic Cancer Normal vs. Cancer paired adjacent noncancerous cancerous pancreatic tissue specimens tissue Up 670 19357035 3467 G3P_HUMAN ENSP00000380068 Pancreatic Cancer Normal vs. Cancer paired adjacent noncancerous cancerous pancreatic tissue specimens tissue Up 1100 19357035 3468 G3P_HUMAN ENSP00000380068 Pancreatic Cancer Normal vs. Cancer paired adjacent noncancerous cancerous pancreatic tissue specimens tissue Up 1300 19357035 3469 G3P_HUMAN ENSP00000380068 Pancreatic Cancer Normal vs. Cancer paired adjacent noncancerous cancerous pancreatic tissue specimens tissue Up 19357035 3470 NAMPT_HUMAN ENSP00000222553 Pancreatic Cancer Treatment (none vs. IL-1 treatment) untreated Colo357 human pancreatic adenocarcinoma cells IL-1-stimulated Colo357 human pancreatic adenocarcinoma cells cell line Up 1.7 19513556 3471 PCBP2_HUMAN ENSP00000408949 Pancreatic Cancer Treatment (none vs. IL-1 treatment) untreated Colo357 human pancreatic adenocarcinoma cells IL-1-stimulated Colo357 human pancreatic adenocarcinoma cells cell line Up 1.8 19513556 3472 LMNA_HUMAN ENSP00000357283 Pancreatic Cancer Treatment (none vs. IL-1 treatment) untreated Colo357 human pancreatic adenocarcinoma cells IL-1-stimulated Colo357 human pancreatic adenocarcinoma cells cell line Up 2 19513556 3473 PGH2_HUMAN ENSP00000356438 Pancreatic Cancer Treatment (none vs. IL-1 treatment) untreated Colo357 human pancreatic adenocarcinoma cells IL-1-stimulated Colo357 human pancreatic adenocarcinoma cells cell line Up 2 19513556 3474 PGH2_HUMAN ENSP00000356438 Pancreatic Cancer Treatment (none vs. IL-1 treatment) untreated Colo357 human pancreatic adenocarcinoma cells IL-1-stimulated Colo357 human pancreatic adenocarcinoma cells cell line Up 3.2 19513556 3475 PGH2_HUMAN ENSP00000356438 Pancreatic Cancer Treatment (none vs. IL-1 treatment) untreated Colo357 human pancreatic adenocarcinoma cells IL-1-stimulated Colo357 human pancreatic adenocarcinoma cells cell line Up 3.4 19513556 3476 LMNA_HUMAN ENSP00000357283 Pancreatic Cancer Treatment (none vs. IL-1 treatment) untreated Colo357 human pancreatic adenocarcinoma cells IL-1-stimulated Colo357 human pancreatic adenocarcinoma cells cell line Up 3.5 19513556 3477 PGH2_HUMAN ENSP00000356438 Pancreatic Cancer Treatment (none vs. IL-1 treatment) untreated Colo357 human pancreatic adenocarcinoma cells IL-1-stimulated Colo357 human pancreatic adenocarcinoma cells cell line Up 3.5 19513556 3478 FUBP1_HUMAN ENSP00000359804 Pancreatic Cancer Treatment (Gemcitabine-sensitive vs. Gemcitabine-resistant) GEM sensitive human pancreatic adenocarcinoma cell line KLM1 GEM-resistant human pancreatic adenocarcinoma cell line KLM1-R cell line Down 0.4 20944110 3479 STMN1_HUMAN ENSP00000382633 Pancreatic Cancer Treatment (Gemcitabine-sensitive vs. Gemcitabine-resistant) GEM sensitive human pancreatic adenocarcinoma cell line KLM1 GEM-resistant human pancreatic adenocarcinoma cell line KLM1-R cell line Down 0.42 20944110 3480 G3P_HUMAN ENSP00000380068 Pancreatic Cancer Treatment (Gemcitabine-sensitive vs. Gemcitabine-resistant) GEM sensitive human pancreatic adenocarcinoma cell line KLM1 GEM-resistant human pancreatic adenocarcinoma cell line KLM1-R cell line Down 0.49 20944110 3481 SYUG_HUMAN ENSP00000361087 Pancreatic Cancer Treatment (Gemcitabine-sensitive vs. Gemcitabine-resistant) GEM sensitive human pancreatic adenocarcinoma cell line KLM1 GEM-resistant human pancreatic adenocarcinoma cell line KLM1-R cell line Down <0.01 20944110 3482 EF2_HUMAN ENSP00000307940 Pancreatic Cancer Treatment (Gemcitabine-sensitive vs. Gemcitabine-resistant) GEM sensitive human pancreatic adenocarcinoma cell line KLM1 GEM-resistant human pancreatic adenocarcinoma cell line KLM1-R cell line Up 1.6 20944110 3483 S10AB_HUMAN ENSP00000271638 Pancreatic Cancer Treatment (Gemcitabine-sensitive vs. Gemcitabine-resistant) GEM sensitive human pancreatic adenocarcinoma cell line KLM1 GEM-resistant human pancreatic adenocarcinoma cell line KLM1-R cell line Up 2.2 20944110 3484 SYUG_HUMAN ENSP00000361087 Pancreatic Cancer Treatment (Gemcitabine-sensitive vs. Gemcitabine-resistant) GEM sensitive human pancreatic adenocarcinoma cell line KLM1 GEM-resistant human pancreatic adenocarcinoma cell line KLM1-R cell line Up 2.9 20944110 3485 HSPB1_HUMAN ENSP00000248553 Pancreatic Cancer Treatment (Gemcitabine-sensitive vs. Gemcitabine-resistant) GEM sensitive human pancreatic adenocarcinoma cell line KLM1 GEM-resistant human pancreatic adenocarcinoma cell line KLM1-R cell line Up 3 20944110 3486 EF2_HUMAN ENSP00000307940 Pancreatic Cancer Treatment (Gemcitabine-sensitive vs. Gemcitabine-resistant) GEM sensitive human pancreatic adenocarcinoma cell line KLM1 GEM-resistant human pancreatic adenocarcinoma cell line KLM1-R cell line Up 3.1 20944110 3487 HSPB1_HUMAN ENSP00000248553 Pancreatic Cancer Treatment (Gemcitabine-sensitive vs. Gemcitabine-resistant) GEM sensitive human pancreatic adenocarcinoma cell line KLM1 GEM-resistant human pancreatic adenocarcinoma cell line KLM1-R cell line Up 3.3 20944110 3488 APOA1_HUMAN ENSP00000236850 Pancreatic Cancer Normal vs. Cancer Pancreatic juice from patients with chronic pancreatitis(CP) Pancreatic juice from patients with pancreatic cancer (PC) tissue Down 0.34 20949480 3489 TTHY_HUMAN ENSP00000237014 Pancreatic Cancer Normal vs. Cancer Pancreatic juice from patients with chronic pancreatitis(CP) Pancreatic juice from patients with pancreatic cancer (PC) tissue Up 2.2 20949480 3490 APOA1_HUMAN ENSP00000236850 Pancreatic Cancer Normal vs. Cancer Pancreatic juice from patients with simple choledocholithiasis (CDS) Pancreatic juice from patients with pancreatic cancer (PC) tissue Down 0.47 20949480 3491 TTHY_HUMAN ENSP00000237014 Pancreatic Cancer Normal vs. Cancer Pancreatic juice from patients with simple choledocholithiasis (CDS) Pancreatic juice from patients with pancreatic cancer (PC) tissue Up 3.3 20949480